Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7448793279712178,1.9206341471314827,0.0,1.0,0.38,6/46,4.76%,CPA1;PRSS3;PPP1R14D;MUC13;CEL;AKR1C3
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7995110174270812,1.8884656489912834,0.0,0.9166712042835103,0.49,9/34,10.91%,GABRE;NPAS4;GRID2;GABRA5;GABRG3;ARRB2;DRD4;GRIN1;GABRG1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7772393262747513,1.837567613841351,0.0,1.0,0.72,19/33,19.05%,ARC;NGF;GRID2;NLGN1;GRIK1;CEL;LRRC4C;CX3CR1;NRG3;GRIK2;NLGN4X;PXK;LRP8;NLGN3;BCR;NLGN4Y;GRIK3;CACNA1A;BTBD9
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8258904175439873,-1.8210607747955425,0.0,0.13055602982186557,0.16,1/33,0.01%,CD44
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7402689842513858,-1.8152011910666108,0.0,0.07833361789311934,0.2,12/51,6.88%,CD44;IRF4;TRIM62;HCK;TRIM5;SP100;HLA-DRB1;IRF1;STAT1;TRIM25;HLA-A;CIITA
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7853689206794465,-1.787621839568343,0.0,0.1087966915182213,0.31,2/42,1.85%,CD44;TGFB1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7112511266135291,-1.7861995609105175,0.0,0.08812532012975925,0.33,22/74,15.02%,CD44;IRF4;WNT5A;TRIM62;HCK;TRIM5;SP100;HLA-DRB1;IRF1;STAT1;TRIM25;HLA-A;CIITA;OAS1;TLR2;AQP4;PTAFR;HLA-DPB1;RPL13A;OAS2;HLA-F;HLA-DPA1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8149222478415522,1.7855076914454848,0.0,1.0,0.92,2/20,2.20%,CPA1;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6817734863297182,1.7846175081776317,0.0,1.0,0.93,19/67,15.28%,ADRA1A;ARC;TSHZ3;NLGN1;CACNG4;NMU;CRHR2;ZDHHC12;SLC8A3;GRIK2;SYT1;CACNG2;RIMS2;RGS14;CLSTN2;MPP2;EPHB2;NLGN3;NRXN1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.9073523296145071,1.7761763424205903,0.0,1.0,0.94,4/13,4.03%,ADRA1A;NPAS4;NLGN1;ZDHHC12
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6084627528583317,1.7724849013684438,0.0,1.0,0.95,36/93,18.32%,PDLIM3;LAMA4;GPR161;AMOTL1;EDNRA;ADGRL2;PARVA;PDE10A;ALDH7A1;RASSF8;IL17RD;SLIT2;TENM3;PPFIBP1;MPDZ;GUCY1A2;FLRT2;ZNF462;RBMS3;WWTR1;FARP1;RNF150;MAGI1;DENND2A;ANK2;CSRP2;NAV1;CALD1;ANTXR1;DIXDC1;PYGO1;CDH11;TYRO3;AKAP12;PTPN14;DZIP1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7823766642917235,1.7712199414039806,0.0,1.0,0.95,5/31,7.86%,IRGM;SIRT1;PYHIN1;SNCA;KDM8
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8364013704941442,-1.7698412572046633,0.0,0.10052814296283649,0.43,1/29,0.01%,CD44
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6665321543955256,1.7635881441764258,0.0,1.0,0.97,37/101,19.05%,NPAS4;ARC;NGF;GRID2;NLGN1;GRIK1;NMU;GRM3;SNCAIP;CEL;LRRC4C;DLGAP4;CX3CR1;SLC8A3;GRM8;NRG3;GRIK2;SYT1;GRM7;GRM4;AKAP9;NLGN4X;GRM2;RIMS2;PXK;CDH2;LRP8;CLSTN2;NLGN3;DGKZ;BCR;SYN1;NLGN4Y;GRIK3;CACNA1A;GRM5;BTBD9
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.8505353318526144,1.761253492516479,0.0,1.0,0.97,4/17,7.69%,ADRA1A;ADRA1B;DRD5;DRD3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.7517918128665882,1.7581293468566137,0.0,0.9731686590929717,0.98,9/30,12.78%,GLYATL1;DDAH2;SLC39A8;KYAT1;GLUD1;RIMKLB;AADAT;ALDH18A1;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.8445482125531989,-1.7478597439552923,0.0,0.13817179822814107,0.61,1/16,0.31%,NEK2
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6513430184017188,1.7397356516592828,0.0,1.0,0.99,26/66,21.30%,ACADS;GLYATL2;ACAD10;CEL;PEX13;ABHD3;BDH2;SLC27A2;ECHS1;ABCD3;AIG1;ABCD2;ACADM;MECR;PLA2G15;PCCA;ACOX1;NUDT19;SLC27A4;ECI1;ECHDC1;LPIN2;PECR;HADHB;ECHDC2;DECR1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7618823870287716,1.7363919681639957,0.0,1.0,0.99,9/24,17.54%,NPAS4;GRID2;ARRB2;DRD4;GRIN1;MPP2;NLGN3;INSYN2A;INSYN1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9154664012187211,-1.732538519393865,0.0,0.15946486499670726,0.72,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8326478352454217,-1.730434425394839,0.0,0.1485074839223721,0.76,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7922625140607226,1.7301814482179076,0.029411764705882353,1.0,1.0,10/18,12.91%,HS6ST2;CSGALNACT1;HS3ST3B1;EXT1;NDST3;HS3ST5;HS2ST1;UGDH;B3GAT3;EXT2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.8056189156781633,1.7201088014821186,0.022727272727272728,1.0,1.0,2/10,4.45%,PLD6;PID1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.87317917378026,1.7190555638605571,0.02564102564102564,1.0,1.0,1/15,0.06%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.8753579827288469,1.718072924610879,0.0,0.9614537456692452,1.0,2/14,0.89%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.8896694131301727,1.7174237865677369,0.0,0.9132185820451544,1.0,2/13,1.62%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.9400868968111256,1.7166690002765157,0.0,0.871696256704926,1.0,1/8,0.54%,FOXO1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8809647955691928,1.711675380899823,0.0,0.880159724112896,1.0,3/11,3.63%,GABRE;GABRA5;GABRG3
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8004867149383659,-1.7099961527526364,0.0,0.1980099785631628,0.86,2/22,2.68%,CD44;COL5A1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.8055025683203955,1.709901513381478,0.0,0.8508247658805785,1.0,6/17,11.24%,NPAS4;ARC;APOE;LDLR;SGK1;RGS14
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8467726329498658,-1.7041131373401257,0.014285714285714285,0.20236184622389164,0.87,3/20,3.94%,CD44;TGFB1;LYVE1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9101783074295174,-1.70348342814191,0.0,0.18633906074575357,0.88,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.7191774252663572,1.7030767873407366,0.02702702702702703,0.8799478586573604,1.0,5/28,10.20%,ADRA1A;SLC8A1;JPH1;MICU1;MCU
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.8675000986138399,1.6927089978714243,0.0,0.9335590304493819,1.0,4/14,7.69%,ADRA1A;ADRA1B;DRD5;DRD3
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.8587594719067457,-1.6898038917587073,0.0,0.2268411018154914,0.93,2/22,1.54%,GPR62;SCTR
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.578581033118076,1.6841435489403995,0.029411764705882353,0.9839973379314517,1.0,40/127,19.68%,CDH20;SLC17A6;POU3F1;NGB;SPHKAP;SEZ6L;KCNB2;GRM3;LRRTM3;NXPH1;KCNC2;ELAVL3;CADM2;PAK5;NR4A2;CELF4;KCND2;ADGRA1;FEZF2;RAB3C;BRINP1;ELAVL4;GABRG1;OLFM3;SCRT1;RBFOX1;SNAP91;NRXN1;SRRM4;RIT2;KCND3;SYN1;SATB2;TMEM196;ADGRB3;GRM5;VSTM2B;CTNNA2;ST8SIA3;MMD2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.9213538735839982,1.6825539943111545,0.0,0.9595527724838915,1.0,2/7,2.86%,GRIN3A;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.8882526323220096,-1.678346075467481,0.0,0.2545842581526379,0.96,1/17,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.681965835833206,1.6767733987556792,0.05714285714285714,0.9782208353403562,1.0,17/45,15.28%,GPC4;GRID2;ROBO2;NLGN1;LHFPL4;IL1RAPL2;GPC6;SNCA;WNT3A;LRFN5;SYNDIG1;DLG5;CLSTN2;EPHB2;PTPRD;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.9557350854651797,1.6756409308533677,0.025,0.9558009229848782,1.0,2/6,0.89%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.6418782918633391,1.6750463081404396,0.03571428571428571,0.9261042614704472,1.0,7/48,9.90%,NGF;NYAP2;CNTNAP2;SRGAP2;SGK1;TNIK;PLXNB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.8064160856300356,1.673684163162956,0.021739130434782608,0.9048846662973986,1.0,1/15,0.84%,AUP1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8329815110868918,1.6725729680610375,0.02631578947368421,0.8830081374595397,1.0,4/16,5.11%,FGF10;SCRIB;ANGPT1;SEMA5A
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.6684304949639933,1.671662155277688,0.0,0.8640465588763105,1.0,3/50,2.20%,CPA1;PTGS1;MAPKAPK2
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6870311990303349,1.6716053130064976,0.03125,0.8375306289136946,1.0,8/26,13.62%,TEAD2;AMOTL1;TEAD4;LATS1;TJP2;CASP3;WWTR1;MOB1A
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.7028804649714161,-1.6675562330342193,0.0,0.2834930933274795,0.97,10/59,10.61%,CD44;TGFB1;CXCL13;IL7;IRF1;STAT1;TNFRSF1B;OSMR;TLR2;IL3RA
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.8831531658725947,-1.6671537293335754,0.0,0.2663343008366058,0.97,2/16,0.49%,GPR62;NMUR2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.7348594756620692,-1.6658863266808088,0.0,0.2549922457458312,0.97,4/34,2.84%,CD44;SIRPG;CXCL13;NODAL
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.8681496105657079,1.6616631315610886,0.0,0.8968970951001989,1.0,2/11,1.66%,NOX4;CBS
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7235858338846556,1.6589926504378398,0.0625,0.8887963570944305,1.0,11/36,11.09%,GRIN3A;GRID2;GRIK1;GRM3;GRM8;PLCB1;GRIK2;GRM7;GRM4;GRIN1;GRM2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.8407282109493494,1.6575076164243856,0.0,0.8802707012562716,1.0,1/14,0.10%,CLEC2A
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6396843180617772,1.6564936049981707,0.0,0.8640187151485818,1.0,12/44,14.88%,VWC2;VWC2L;GREM2;BAMBI;FSTL3;PPARG;GREM1;CRIM1;NOTCH1;DLX1;BMPER;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8142509488451252,-1.6543363191316574,0.0,0.28146344076302193,0.99,1/23,0.01%,CD44
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8091956746548291,1.6537037292955528,0.02857142857142857,0.8658616689109475,1.0,4/20,5.74%,ADRA1A;SLC8A1;TRPM2;JPH1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6610021686678439,-1.6525645528109287,0.014705882352941176,0.270903761880371,0.99,60/87,27.77%,RPL37A;RPL15;RPL3;RPL38;RPL35A;RPS9;RPL7A;RPL13;RPS27;RPL13A;RPS4X;RPS16;RPS20;RPS8;EIF4A2;RPS21;RPS11;TMA7;RPL27A;RPL9;RPL5;RPL21;RPL34;RPL4;RPL23;RPS14;RPL18A;RPL32;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;RPL12;RPL11;DRG1;RPL35;RPL22;RPL27;ZC3H15;RPL24;RPS13;RPS19;RPL28;RPL19;RPL26L1;RPS24;RPL10;RPS25;RPS3A;RPS6;RPL8;RPLP0;RPS12;RPS3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.7752361015364071,1.6512671952088347,0.0,0.8667898987872622,1.0,3/21,3.38%,GRIN3A;NLGN1;APOE
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.8378921001728394,1.6502823341408819,0.0,0.8529304860369386,1.0,5/12,9.15%,SCRIB;WNT4;LATS1;ZNF703;AKT2
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.7013843986805227,1.6500673279059221,0.05128205128205128,0.8335493238950904,1.0,10/29,11.12%,MFSD2A;APOE;PPARG;LCN12;ACACB;SLC27A2;ABCD3;ABCD2;ACSL1;CPT1A
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7471979190594124,1.6480930501791111,0.02857142857142857,0.8302714380261146,1.0,8/31,6.53%,CDH20;CDH19;CDH12;CDH7;NLGN1;CDH5;CDH13;CDH6
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.66739197460559,-1.6475256767088884,0.014285714285714285,0.2789776216193549,0.99,60/88,27.77%,RPL37A;RPL15;SEC62;RPL3;RPL38;RPL35A;RPS9;RPL7A;SRP14;RPL13;RPS27;RPL13A;RPS4X;RPS16;RPS20;RPS8;RPS21;RPS11;RPL27A;RPL9;RPL5;RPL21;RPL34;SRP19;RPL4;RPL23;RPS14;RPL18A;RPL32;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;RPL12;RPL11;RPL35;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;RPL28;RPL19;SRP68;RPS24;RPL10;RPS25;RPS3A;RPS6;RPL8;RPLP0;RPS12;RPS3
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9645653899485993,-1.6439324122787533,0.0,0.28069546411701096,1.0,2/10,0.10%,CD44;ENPP2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7664503007194832,1.6431753959817443,0.025,0.8478653753905592,1.0,3/20,1.95%,ADRA1A;ADRA1B;PER2
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.6570573788556756,1.6403878619600472,0.0,0.851633436537735,1.0,8/38,11.76%,SMYD2;RFWD3;SIRT7;CRY1;ABL1;ANKLE1;RADX;MYC
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7244996287174271,1.64036531294577,0.0,0.8322781311618774,1.0,6/18,13.43%,SLC17A6;GRID2;GRIK1;GRIK2;UNC13B;UNC13C
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.8656060516436807,1.640356372789606,0.022222222222222223,0.8137830615805024,1.0,2/13,4.03%,PNP;AK3
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6683281076678359,-1.6394825574976704,0.014492753623188406,0.28784496098820844,1.0,59/85,27.77%,RPL37A;RPL15;RPL3;RPL38;RPL35A;RPS9;RPL7A;SRP14;RPL13;RPS27;RPL13A;RPS4X;RPS16;RPS20;RPS8;RPS21;RPS11;RPL27A;RPL9;RPL5;RPL21;RPL34;SRP19;RPL4;RPL23;RPS14;RPL18A;RPL32;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;RPL12;RPL11;RPL35;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;RPL28;RPL19;SRP68;RPS24;RPL10;RPS25;RPS3A;RPS6;RPL8;RPLP0;RPS12;RPS3
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.726389859033076,1.637920811522155,0.0,0.8136554646716935,1.0,13/26,19.58%,GRID2;NLGN1;VSTM5;SYNDIG1;SEMA4A;DLG5;CLSTN2;EPHB2;PTPRD;NLGN3;NRXN1;IL1RAP;SLITRK2
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6537663988058369,-1.6368849909238201,0.014084507042253521,0.28514623786093823,1.0,65/97,27.77%,RPL37A;RPL15;SEC62;RPL3;RPL38;RPL35A;RPS9;RPL7A;SRP14;RPL13;RPS27;RPL13A;RPS4X;RPS16;RPS20;RPS8;RPS21;RPS11;RPL27A;RPL9;RPL5;RPL21;RPL34;SRP19;RPL4;RPL23;RPS14;RPL18A;RPL32;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;SGTB;RPL12;RPL11;SPCS2;RPL35;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;RPL28;RPL19;SRP68;RPS24;RPL10;RPS25;RPS3A;RPS6;SPCS1;RPL8;CHMP4B;RPLP0;RPS12;ZFAND2A;RPS3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.6536005224667109,1.6351927193604394,0.027777777777777776,0.819483561276171,1.0,1/36,0.03%,IL7R
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.9683329242009622,1.634240508025441,0.0,0.8101793871192183,1.0,1/6,0.19%,PKD1L1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.86199752432646,-1.633874895732045,0.0,0.2892099878010457,1.0,1/14,0.01%,CD44
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.8584901498046184,1.6334742364503863,0.0,0.8006208200677494,1.0,1/12,0.85%,CTDNEP1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6792668711886322,-1.62235219659591,0.0,0.3304699504865972,1.0,21/62,12.81%,CLEC5A;LILRB3;ITGB2;FCGR3A;HCK;C3AR1;KLHDC4;TRIM25;VSIG4;TNFRSF1B;MS4A4A;LY86;TLR2;NLRP3;SLC11A1;PTAFR;SPI1;IGSF6;NFAM1;MYO1F;CLEC12A
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8556015209162369,1.6220143859170382,0.022222222222222223,0.8675749160540884,1.0,2/11,2.58%,PHLDB2;OSR1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8854279810758783,-1.6195912655846603,0.0,0.3347456604632633,1.0,4/10,8.75%,ENPP2;PDXDC1;CYP1B1;PPT1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.7584239630322888,1.6192888798049923,0.024390243902439025,0.8764583099779525,1.0,4/17,9.53%,ERBB2;SIRT7;EIF2AK3;FLNA
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.8193017251006957,1.6136254397819383,0.02631578947368421,0.9077076657800861,1.0,1/12,0.35%,NIPAL1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.8939712435280959,1.6123202073800251,0.020833333333333332,0.9002549626973649,1.0,2/9,1.56%,ARC;GRID2
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7712411065589041,1.6116125589378423,0.030303030303030304,0.8878993522972106,1.0,6/15,15.28%,TSHZ3;NLGN1;CACNG4;CACNG2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.857668016456496,-1.6111935699355744,0.015873015873015872,0.36605902207746155,1.0,3/16,3.94%,CD44;TGFB1;LYVE1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.8144525002595837,1.6103514164351749,0.0,0.881360295027597,1.0,5/11,13.56%,FGFR1;HMGB1;ITGA4;SP1;SIRT6
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.7109549043850122,1.6098810152702234,0.02564102564102564,0.8678412611981903,1.0,6/15,19.04%,ADAMTS12;NEU4;NGLY1;FBXO27;FBXO17;EDEM1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.7171049606532502,-1.6083191152553484,0.0,0.36338094967085915,1.0,1/41,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.9772474788254637,-1.6079267007553764,0.0,0.35250128051903706,1.0,2/6,1.54%,GPR62;SCTR
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.7016104977432059,1.6067821497967967,0.046511627906976744,0.8798735199010322,1.0,4/20,5.57%,ARC;TSHZ3;CRHR2;SLC8A3
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.8086215658052351,1.606512359298316,0.0,0.8668462937058561,1.0,4/10,15.52%,PNPLA3;GAL3ST1;DGKZ;PLA2G15
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.8397792945349576,-1.6027221295397072,0.015873015873015872,0.37523603743629297,1.0,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.9191034646396741,1.6026020134649646,0.023809523809523808,0.8824375770048961,1.0,2/6,3.38%,APOB;APOE
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8676148161759221,1.601748797502806,0.0,0.8783470974377591,1.0,5/7,12.91%,CSGALNACT1;EXT1;NDST3;HS2ST1;EXT2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.8899619809166264,1.599842772084868,0.0,0.877956554922273,1.0,1/11,0.03%,IL7R
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7539718888712496,1.5994655456163116,0.05714285714285714,0.8660513072727754,1.0,3/20,2.19%,IL7R;KIT;F2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.8766030542180014,1.5992923770011993,0.0,0.8530443087480931,1.0,3/12,4.39%,ADRA1A;EDNRA;SLC8A1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5457533865189306,1.5989180893175559,0.0,0.8431141664397859,1.0,52/168,15.77%,EFNB1;LAMA3;RAI14;MAFB;MID1;EDNRA;ADGRL2;EHD4;PARVA;PTPRO;CDH13;GOLIM4;COL12A1;MAGI2;NTN4;RASSF8;TRIB2;BCAM;PLSCR4;LRIG3;KANK1;CCN2;MYO1E;KITLG;MPDZ;EFEMP1;COL16A1;RND3;CAP2;EPB41L5;DACH1;WWTR1;UNC13B;RBFOX2;RASAL2;DDAH1;PTPRF;DST;NFIB;ITGA3;SYNPO;MAGI1;NR2F2;GPRC5A;EMC2;CALD1;PRICKLE2;DOCK1;PLPP3;ANTXR1;ETF1;CORO2B
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5744078888586518,1.5961987777232545,0.0,0.8545240039931029,1.0,26/94,15.27%,EYA4;GPR161;OSR1;RAI14;MID1;ADGRL2;KIAA1549;GPC6;KCNIP3;ZFHX4;IL17RD;PRTG;SLIT2;CDR2L;TENM3;MPDZ;AADAT;CAP2;RBFOX2;DDAH1;CDH2;MAGI1;NR2F2;FJX1;IGDCC4;ANTXR1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.9284802195906067,1.5954948916696527,0.0,0.8462847918333899,1.0,1/6,0.06%,ADRA1A
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7684762104738315,1.5888262120643377,0.02857142857142857,0.88768463698388,1.0,11/21,12.91%,HS6ST2;HS3ST3B1;EXT1;NDST3;HS3ST5;HPSE;HS2ST1;UGDH;B3GAT3;HS3ST4;EXT2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.719038419212271,1.5867402398864465,0.047619047619047616,0.8901672512184837,1.0,7/22,13.80%,MRAP2;PID1;LEPR;COX10;MYC;NR4A3;SDHAF4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.8456360009457167,1.5861835208680324,0.0,0.8801934997652276,1.0,4/13,5.11%,HSPB1;FGFR1;FGF18;SEMA5A
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5870681586044632,1.5857877901476651,0.0,0.8720583926464678,1.0,52/128,19.68%,SLC17A6;NOVA1;BCL2;ROBO2;EPHA7;GRM3;POU3F2;PROX1;LRRTM3;NXPH1;LRRC4C;ELAVL3;CADM2;PCLO;PAK5;HIVEP2;SLC35F1;EPHA3;ERC2;CELF4;ADGRA1;FEZF2;CELF5;RAB3C;ELAVL4;ASCL1;NPAS3;OLFM3;NOTCH1;SCRT1;RBFOX1;FUT9;SNAP91;SOX5;NF1;ANK2;NRXN1;SRRM4;EFR3B;PPFIA2;FAT3;SYN1;LSAMP;STIM2;ADGRB3;GRIK3;CTNNA2;UNC79;ST8SIA3;CREB1;PAX6;MMD2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5690158980601718,1.5853033772792293,0.0,0.8639336153046786,1.0,15/83,8.56%,ADRA1A;LGR5;GPR3;ADRA1B;GPR161;ADGRG6;GPR78;ADGRL2;ADGRG3;GPR26;DRD5;RXFP1;DRD3;ABCA1;ADCY2
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.6163733457492222,1.582988132464048,0.0,0.8711397485151909,1.0,27/72,19.39%,GCK;FOXO1;RAB31;CPEB1;CAPN10;ZBTB7B;IRS1;SIRT1;PPARG;SLC25A33;FER;AKT2;CELA2A;IRS2;TBC1D4;ENPP1;RAB10;INSR;PDE3B;GPLD1;MYO5A;MARS1;KAT2B;HDAC5;LPIN2;SYAP1;TRARG1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.7220922897807835,1.582719459191482,0.02631578947368421,0.8623988204682572,1.0,3/17,12.19%,AKR1C3;AKR1C1;STARD3NL
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.6198365046895401,1.5817100747170219,0.027777777777777776,0.8583032256323844,1.0,16/49,13.83%,FOXO1;PER2;MAFB;SIRT1;METRNL;PID1;PPARG;CTBP2;SDF4;NR4A2;BBS9;AKT2;NR4A1;GDF6;NR4A3;OSBPL11
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7928677359236512,1.5797226579373818,0.05263157894736842,0.8599100946849382,1.0,1/10,2.85%,BIN1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.7412266161822901,-1.575865949327089,0.0,0.5400667766964506,1.0,1/22,0.31%,NEK2
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6994974062749227,1.5750415765984656,0.0,0.8855976041383066,1.0,7/26,15.12%,ARC;TGFA;NCOA3;GREM1;HDAC1;EPHB2;NLGN3
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.9301491461214545,1.5747665646291134,0.0,0.8755087729223314,1.0,3/6,4.03%,ADRA1A;NLGN1;ZDHHC12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7700162877814569,-1.5724483466098087,0.0,0.5481247510101872,1.0,3/23,2.33%,CD44;SIRPG;ITGB2
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.8531144480628753,1.5714272760937313,0.04878048780487805,0.892768434941046,1.0,4/9,12.72%,GCK;SIRT1;LEPR;NR4A3
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.6636796484311263,-1.570465169272999,0.0,0.5501712694212053,1.0,7/59,8.63%,CD44;IRF4;MICB;IFNK;PIK3CG;PTPRC;ADA
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.8259760345303725,-1.5699108487507778,0.05555555555555555,0.5382469047656003,1.0,2/11,4.03%,BUB1;ZWILCH
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.646283087597946,-1.5696900811029173,0.015151515151515152,0.5229920959334733,1.0,21/70,14.46%,ST6GALNAC1;DUOX1;AHR;PLEKHS1;SFTPA1;CAPN8;VSIG2;MS4A8;FOXM1;CYP2B7P;SFTPD;SMIM22;TMC4;ITGB6;SYT2;DUOXA1;CYP2E1;PROM2;STEAP4;MUC5B;BPIFB1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.7462449524610887,1.5662944355480162,0.0,0.9239479334314378,1.0,3/22,7.44%,PNP;FHIT;REXO2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5209799673570211,1.5662191233765341,0.02702702702702703,0.9127870042653599,1.0,41/150,18.12%,GCK;CTDNEP1;DDAH2;PRR16;MFSD2A;IRS1;SAMD4A;SIRT1;SLC25A37;ZEB2;ERBB2;SNCA;PKD2;PPP1R3E;LDLR;SP1;PLIN5;AGXT2;PCIF1;AKT2;TYRP1;MLXIPL;CTC1;IRS2;STARD4;MYC;DDAH1;EIF3E;INSR;ABCB10;NR1H3;NIBAN1;BCL3;FAF1;GPLD1;OPN3;PIWIL2;DNA2;ELOVL5;YTHDF1;FXR2
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6385355973225367,1.5660582090403334,0.038461538461538464,0.9024770906369358,1.0,14/60,11.19%,VWC2;NGF;FGFR1;NEUROD2;BIN1;NLGN1;BRINP3;ZC4H2;DTX1;ZEB1;BEND6;BRINP1;ASCL1;HES1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8263848535894965,1.566014235560801,0.022727272727272728,0.8920396919732878,1.0,5/10,12.52%,OSR1;ROBO2;PKD2;SLIT2;BMP4
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.8117672556354648,1.564616888688631,0.0,0.8908389342832808,1.0,2/9,5.76%,SCRIB;SNCA
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7948927011350374,1.5639466718179955,0.03125,0.8768238817443668,1.0,6/18,7.60%,GPC4;IL1RAPL2;GPC6;SNCA;WNT3A;LRFN5
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7948927011350374,1.5639466718179955,0.03125,0.8768238817443668,1.0,6/18,7.60%,GPC4;IL1RAPL2;GPC6;SNCA;WNT3A;LRFN5
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.9381126586746245,1.5608706598176965,0.0,0.8930046832426866,1.0,2/6,2.65%,SLC26A3;BCL2
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.8335249294407642,1.5582522167778885,0.05128205128205128,0.90542041802404,1.0,2/8,2.58%,FGF10;OSR1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7883800647115954,1.558154883296034,0.0,0.896014322368801,1.0,4/18,10.23%,NPAS4;GRID2;ARRB2;GRIN1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6654261033043783,-1.5573394630090351,0.0,0.5994386854963942,1.0,4/74,2.33%,CD44;ENPP2;TGFB1;ITGB2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.6793250665408701,1.5561398292986652,0.041666666666666664,0.9032292536588997,1.0,13/35,21.40%,FOXO1;ZDHHC12;ZDHHC18;ZDHHC16;KAT6A;ZDHHC14;ZDHHC3;ZDHHC13;KAT2B;EP300;ZDHHC5;ZDHHC9;ZDHHC23
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6972011365255789,-1.555152617870514,0.013888888888888888,0.6001950815421876,1.0,3/46,5.72%,CD44;MMP9;BEX3
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.85075323272241,1.5539869662526247,0.027777777777777776,0.9128733198213187,1.0,2/8,6.50%,NGF;DCC
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),0.9286762675107411,1.5535189254806914,0.022222222222222223,0.9062564262128651,1.0,1/5,0.06%,ADRA1A
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.5255365338799849,1.5526732034212851,0.0,0.9011344042109084,1.0,47/149,17.03%,TEAD2;MYO10;KIT;PARD3;RAI14;MID1;ADGRL2;DCBLD2;PRDM5;ALDH7A1;DSP;FZD5;ERBB2;ARHGAP42;KCNIP3;PIWIL1;PML;ITGA4;IL17RD;PRTG;TEAD4;SPRY4;FBXO15;TENM3;LRIG3;ZFX;FZD1;KITLG;LRP6;RND3;HES1;MYC;RBFOX2;PTPRF;MAGI1;SMAD2;CDK8;DOCK1;FRAS1;ANTXR1;TSPAN6;ROR1;NR6A1;FZD7;PAWR;BCL3;NAV2
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.8708838861834902,1.5514887460657873,0.0625,0.902637965508257,1.0,1/7,0.76%,ACADS
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.7098184199094901,1.5512533311195822,0.07692307692307693,0.8953494254604716,1.0,8/17,17.88%,PROX1;WNT4;PRKCSH;PKD2;COBL;NF1;ARID5B;NIPBL
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6795536911396538,1.5501876389721134,0.030303030303030304,0.8965551368210889,1.0,18/44,16.67%,CDH20;CDH19;CDH12;CDH7;CDH5;CDH13;CSK;CADM2;CADM1;CDH6;ZNF703;JUP;CDH2;CDH10;CDH4;NECTIN3;CDHR3;CDH11
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.7545513547267657,1.5500273003338627,0.025,0.8883489124844964,1.0,5/13,10.78%,FGD4;VSTM5;SRGAP2;FGD5;FGD1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.921833572752853,1.5488473429684182,0.022727272727272728,0.8865586433180551,1.0,2/6,3.94%,ANGPT1;CFLAR
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7968018494819731,1.548617012717623,0.10526315789473684,0.8797316694170181,1.0,3/10,15.87%,DGKD;DGKZ;DGKH
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),-0.9286984221057974,-1.5462804398933971,0.0,0.6548972739172501,1.0,2/5,3.79%,KCNA5;SCN5A
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.7611723044571895,1.546152000994765,0.038461538461538464,0.8884224768787797,1.0,5/16,15.26%,FOXO1;KCNC2;TIMELESS;MTR;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.7940041407561307,1.546120630690695,0.07692307692307693,0.8801597241128959,1.0,2/8,6.45%,GCK;CRY1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5759682765929097,1.5455690521552496,0.0,0.8748295248800677,1.0,27/103,15.69%,ARC;KLHL20;BIN1;APOE;PACSIN2;FGD4;SYNE3;RHOBTB3;SIPA1;PCLO;PAK5;RHOBTB1;MAST1;MAST2;FGD5;TNIK;SH3KBP1;RND3;WASF3;FGD1;LRCH3;CSPG5;PDZD8;DST;MAST4;ZMYM4;SIPA1L3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.7266164636283176,1.5441442211060927,0.045454545454545456,0.8756967021312564,1.0,5/21,14.43%,NLGN1;APOE;DLG5;LRP8;FOXO6
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.8257543640617542,1.542205126370335,0.044444444444444446,0.8812231652829138,1.0,7/12,12.72%,IRS1;PLIN5;AKT2;ABCD2;TWIST1;IRS2;NR4A3
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7086771170848274,-1.5420689984251212,0.046875,0.6759710228276856,1.0,1/31,0.01%,CD44
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.7080194800136436,1.541431031747659,0.08108108108108109,0.8782773810271769,1.0,6/21,17.78%,DGKD;PGS1;DGKZ;PLA2G15;DGKH;MOGAT2
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.8130354853655846,1.5411187803274213,0.058823529411764705,0.8730201945557241,1.0,3/7,12.52%,FGF10;ASCL1;BMP4
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.708924531319955,1.5405089563219787,0.0,0.8710868191648388,1.0,3/17,7.21%,ST6GALNAC3;ST8SIA4;NEU4
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),0.7957496256676846,1.538955593525822,0.043478260869565216,0.8741265087576006,1.0,2/6,9.88%,OSR1;CEP290
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.8225599831009972,1.5375655484600779,0.0,0.8776853448420743,1.0,7/14,11.46%,MFSD2A;IRS1;PLIN5;AKT2;ABCD2;TWIST1;IRS2
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.8952445989716925,-1.5366214522129016,0.018518518518518517,0.7120325011054054,1.0,1/5,3.79%,SCN5A
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6664665784226618,-1.5360779066166361,0.03333333333333333,0.6994539297706448,1.0,17/49,12.81%,CLEC5A;LILRB3;FCGR3A;HCK;C3AR1;VSIG4;SLC7A7;MS4A4A;LY86;TLR2;SLC11A1;SPI1;ADGRE1;IGSF6;NFAM1;MYO1F;CLEC12A
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.6351157275800224,1.5359025620215911,0.0967741935483871,0.8811788811818785,1.0,17/43,21.20%,HDAC3;HDAC10;SIRT1;PRDM5;SIRT7;FLNA;MIER2;HDAC1;SIRT6;HDAC4;HDAC11;RCOR2;BAZ2A;HDAC5;TBL1X;HDAC7;BRMS1L
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.9824944749243395,-1.5346047954586228,0.0,0.6995892622405822,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5456712596381141,1.5343868127286533,0.0,0.8824902441237863,1.0,33/87,19.39%,GCK;FOXO1;RAB31;CPEB1;SLC30A10;CAPN10;IRS1;MGARP;PPARG;SLC25A33;NR4A2;FER;ADCY2;AKT2;NR4A1;PRKAR2A;IRS2;ADCY3;TBC1D4;NR4A3;ENPP1;NFKB1;RAB10;INSR;PDE3B;GPLD1;MYO5A;MARS1;KAT2B;HDAC5;LPIN2;SYAP1;TRARG1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6963950528031742,1.5338186339644468,0.0,0.8787390167188697,1.0,9/26,21.20%,IRS1;PID1;KANK1;ENPP1;PIP4K2A;PTPRE;SLC27A4;APPL2;NCK1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6707971221386506,1.5336868200491651,0.07142857142857142,0.8714480183579014,1.0,16/42,15.35%,TSHZ3;NLGN1;GRIK1;CACNG4;GRM3;GRM8;DRD3;SYT1;GRM7;GRM4;CACNG2;GRM2;CDH2;NLGN3;NRXN1;DGKZ
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6284598487730506,-1.5322058870041368,0.0,0.7085773094736729,1.0,3/78,1.10%,CD44;TBX1;FGF20
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.6781382289846942,1.5317119970740833,0.08333333333333333,0.8802353457061697,1.0,7/22,20.70%,ERBB2;SMARCB1;EIF2AK3;PIH1D1;SMARCA4;MARS1;IPPK
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.906822695324466,-1.5295648635388817,0.0,0.7150219772802173,1.0,4/10,6.68%,MCM2;MCM3;DONSON;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8000656494387666,1.5281500721020411,0.07894736842105263,0.899090088411882,1.0,5/12,11.31%,ZBTB7B;IRS1;SIRT1;SNX5;GKAP1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.8422012649486892,1.5280341419709085,0.025,0.8918123241673472,1.0,1/10,0.84%,MT1G
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.647892771288777,1.5272834171870193,0.05555555555555555,0.8909551214047211,1.0,6/32,14.36%,KIFC1;TOP2A;ESPL1;LATS1;SGO2;KLHL22
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.6959083168357053,1.526785755965377,0.029411764705882353,0.8874567084204982,1.0,7/17,20.83%,HPGD;CHMP6;ODC1;FAF1;FAP;SNF8;FURIN
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.7212228952906248,1.5267709730121997,0.07894736842105263,0.8799358888576128,1.0,9/18,17.88%,FGF10;OSR1;ROBO2;PKD2;GDF6;BMP4;NF1;SHH;NIPBL
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7150667135392157,1.5260054596808017,0.027777777777777776,0.8773722393939879,1.0,2/18,4.18%,ATP6V0D2;TCIRG1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.6055942247407526,1.5249246734442863,0.034482758620689655,0.8792534107753276,1.0,16/53,23.13%,TRDMT1;TFB1M;PUS7L;METTL1;TRMT9B;CTU1;PUS7;CDKAL1;TRMT61A;ANKRD16;NSUN4;DTWD1;TRMT1;THUMPD1;ADAR;ADAT2
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.8047265566801989,1.5246957933010976,0.04878048780487805,0.8736560966444886,1.0,2/8,1.32%,CLMP;KIT
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.7052292199259917,1.5245870938294699,0.046511627906976744,0.867386436840093,1.0,2/17,9.30%,AUP1;RHBDD1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.720470088099535,1.5243703037268732,0.05,0.8617239845145525,1.0,2/15,6.38%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.820856629746524,1.5230164853676114,0.06382978723404255,0.8668030879214494,1.0,4/10,7.66%,ALDH1A1;ACSS2;ADH4;SULT2A1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.9003451398605198,1.5219905756366037,0.0,0.8678235048552501,1.0,2/8,3.45%,GRID2;PROX1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.7286767256329447,1.5207952213749645,0.05714285714285714,0.8699374961286206,1.0,5/14,17.95%,PPARG;MLXIPL;NR4A3;NR1H3;ELOVL5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.9221085205903679,1.5203008134586136,0.043478260869565216,0.8668800418461169,1.0,2/5,3.15%,FOXO1;TRPC3
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.9296912903694687,1.519961527912309,0.021739130434782608,0.8620496415282694,1.0,4/6,6.23%,PER2;SIRT1;PPARG;CTBP2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.9262654762034941,1.5178538677256246,0.0,0.8616948347958421,1.0,1/5,0.66%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.9262654762034941,1.5178538677256246,0.0,0.8616948347958421,1.0,1/5,0.66%,PHLDB2
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.8149622147828973,1.517584162999057,0.07317073170731707,0.856540229956723,1.0,3/9,9.80%,APOE;SIRT1;MLXIPL
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.8240066809172626,1.5156594899184317,0.05263157894736842,0.8621747009985509,1.0,5/7,17.54%,NPAS4;DRD4;NLGN3;INSYN2A;INSYN1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5598097210113605,1.5144285795710661,0.05405405405405406,0.8643367198284304,1.0,33/107,19.68%,SLC17A6;SPHKAP;GRM3;LRRTM3;NXPH1;KCNC2;ELAVL3;MAGI2;PAK5;CELF4;ADGRA1;CELF5;GRIN1;GABRG1;OLFM3;SCRT1;RBFOX1;FUT9;SNAP91;NRXN1;SRRM4;RIT2;FRRS1L;GABRA2;PPFIA2;DLG2;LSAMP;TMEM196;GRM5;CTNNA2;UNC79;ST8SIA3;MMD2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7871072414293576,-1.5141840030401323,0.014492753623188406,0.8527682493364582,1.0,2/15,7.28%,AMACR;ACOX2
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.6397240137418183,1.5128168270466695,0.07894736842105263,0.8693651264505137,1.0,9/42,8.28%,TSKU;APOB;LIPC;APOE;CEL;SOAT1;AKR1C1;LDLR;ABCA1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.7264320703245946,1.5117749022807434,0.07317073170731707,0.8645772275694923,1.0,2/15,1.25%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.7264320703245946,1.5117749022807434,0.07317073170731707,0.8645772275694923,1.0,2/15,1.25%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.8330262862687732,-1.5107865689504567,0.0,0.86428091742075,1.0,2/11,0.97%,WNT5A;ARIH2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.7496348943364297,1.5094971974621825,0.06818181818181818,0.8714216916633049,1.0,5/13,10.64%,SLC30A10;SIRT1;CDK6;RBL1;TWIST1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.9025796351870113,-1.509124557531639,0.0,0.8652175150259939,1.0,3/8,6.68%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.6994296369090671,1.5087267507000202,0.07692307692307693,0.8697230475423873,1.0,6/17,19.31%,AOAH;NEU4;NGLY1;FBXO27;FBXO17;SAMHD1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.8787782821847795,-1.5084841236444944,0.0,0.8527808756449518,1.0,1/9,0.31%,NEK2
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.7028711228226316,1.5077874868406125,0.04081632653061224,0.8712903350067019,1.0,5/18,9.80%,F2;APOE;ZBTB20;PPARG;MLXIPL
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.8144538061750125,1.5068802359942592,0.0625,0.8720583926464678,1.0,1/9,12.19%,STARD3NL
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.7814456692210728,1.505904180537258,0.1111111111111111,0.8760110679232969,1.0,6/13,10.37%,EGLN3;P3H2;P3H3;JMJD4;PLOD3;P3H4
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.7725398528073357,1.5057837810150045,0.04,0.870498460405778,1.0,4/11,14.14%,MAFB;CBFB;GFI1B;RUNX1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5325850418213852,1.5047428968565912,0.0,0.8715818893874978,1.0,43/139,20.52%,CDH20;PCDH15;VWC2L;SLC17A6;SPHKAP;SEZ6L;PROX1;PCBP3;ELAVL3;CADM2;CNTNAP2;MAGI2;PAK5;HCN1;SAG;CELF4;RAB3C;RNF152;SGIP1;OLFM3;SCRT1;RBFOX1;SNAP91;NRXN1;NCAM1;SRRM4;FRRS1L;PPFIA2;LSAMP;TMEM196;ADGRB3;GRM5;AP3B2;SLC24A2;VSTM2B;CTNNA2;UNC79;LIN7A;ST8SIA3;MMD2;PAK3;RS1;TNR
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),0.8905696810725086,1.504013398277989,0.02127659574468085,0.8707081707353965,1.0,1/6,2.58%,OSR1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.7279563949263075,-1.5039495373050897,0.045454545454545456,0.8838371227211503,1.0,2/16,0.84%,IHO1;BUB1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6653269778012679,1.5036586142686559,0.06451612903225806,0.8664176923245429,1.0,15/38,21.20%,ZBTB7B;IRS1;SIRT1;PID1;SNX5;KANK1;GKAP1;VWA2;ENPP1;PIP4K2A;PTPRE;SLC27A4;SIK2;C1QTNF12;NCK1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8846263136046824,-1.5024273230321403,0.0,0.8627142450628876,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8846263136046824,-1.5024273230321403,0.0,0.8627142450628876,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.8332948052471928,-1.501392026081491,0.0,0.8537340381488661,1.0,1/10,1.01%,TICRR
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.7273416976440885,1.5012438391893552,0.045454545454545456,0.8769778725911782,1.0,8/23,14.72%,GCK;IRS1;PPP1R3A;PPP1R3E;AKT2;IRS2;ENPP1;INSR
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5824037556270031,-1.4984045380977298,0.030303030303030304,0.8703316872644173,1.0,57/104,27.77%,RPL37A;RPL15;RPL3;RPL38;RPL35A;RPS9;RPL7A;RPL13;RPS27;RPL13A;RPS4X;RPS16;RPS20;RPS8;RPS21;RPS11;RPL27A;RPL9;RPL5;RPL21;RPL34;RPL4;RPL23;RPS14;RPL18A;RPL32;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;RPL12;RPL11;RPL35;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;RPL28;RPL19;RPS24;RPL10;RPS25;RPS3A;UPF1;RPS6;RPL8;RPLP0;RPS12;RPS3
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.7116056933642015,1.4978720835553114,0.075,0.8961668558883759,1.0,3/21,6.38%,PNP;FHIT;NT5C1A
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.8218966473941219,1.4978327104281886,0.10810810810810811,0.8903216311874086,1.0,6/9,14.94%,SELPLG;PID1;PTGIS;PTPRT;NFKB1;ST3GAL6
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5640095530332433,1.4970468528486405,0.0,0.8917497598717529,1.0,28/65,21.59%,NPAS4;SLITRK6;GRID2;NLGN1;LRRTM3;FZD5;SDK1;WNT3A;DSCAM;FZD1;PLXNB1;NLGN4X;ACHE;FARP1;CDH2;RYK;NLGN3;NRXN1;GABRB2;GABRA2;KIRREL3;NLGN4Y;NRCAM;ADGRL3;CDK5;SDK2;PTEN;PCDHB6
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6940288414340692,1.4961560562628504,0.0,0.8923302175031007,1.0,7/25,17.27%,IRS1;PID1;KANK1;ENPP1;PIP4K2A;PTPRE;SLC27A4
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.7857737840214484,1.4960178813244243,0.0,0.8880670293154089,1.0,4/11,8.05%,CTDNEP1;MFSD2A;LDLR;PLIN5
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.9565918759836138,1.4953441602927267,0.0,0.8870286251976253,1.0,1/5,1.32%,KIT
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.8934300526453801,1.4952800066429872,0.023809523809523808,0.8816372433354864,1.0,3/6,7.18%,MFSD2A;APOE;LDLR
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.9249832022142791,1.494476060835277,0.024390243902439025,0.8819656249005555,1.0,1/5,1.91%,MIDN
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.8111525586327272,1.4941730434655855,0.043478260869565216,0.8788816970101496,1.0,6/12,14.72%,GCK;IRS1;PPP1R3E;AKT2;IRS2;INSR
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.8756261616513674,1.494016317567911,0.021739130434782608,0.8744429784451565,1.0,1/8,1.32%,KIT
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7733619663861444,1.4933470017948898,0.0,0.8745140270164503,1.0,4/14,8.05%,CTDNEP1;MFSD2A;LDLR;PLIN5
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.766540247638304,1.4929226795020567,0.05714285714285714,0.8712408141978011,1.0,6/17,11.07%,SLC5A8;MFSD2A;APOE;PPARG;LCN12;ACSL1
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),0.9816913363916207,1.4908686234699786,0.0,0.8797346607146831,1.0,1/5,0.87%,CLC
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7432409060035424,-1.4907863449072027,0.034482758620689655,0.9322439525676419,1.0,1/24,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.6033453188383007,1.490487144644668,0.07142857142857142,0.876858154097468,1.0,19/61,15.02%,VWC2;VWC2L;BAMBI;CDH5;FSTL3;PPARG;GREM1;UBE2O;CRIM1;CCN1;BMP4;NOTCH1;TWSG1;ITGA3;DLX1;BMPER;SMAD2;SMURF1;ELAPOR2
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5123438133892066,1.490162247421263,0.02702702702702703,0.8740173804817088,1.0,11/111,5.86%,ATP6V0D2;GCK;FOXO1;SH2B2;RAB31;CPEB1;CAPN10;IRS1;TCIRG1;PPARG;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7962631506870109,1.4892754128758308,0.0,0.8753356435965264,1.0,2/9,0.89%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.6068734541224812,1.4888769648939961,0.05555555555555555,0.8742547869073887,1.0,17/44,21.50%,PER2;HDAC3;HDAC10;SIRT1;PRDM5;SIRT7;MIER2;HDAC1;SIRT6;HDAC4;HDAC11;RCOR2;BAZ2A;HDAC5;TBL1X;BRMS1L;SMARCAD1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.5526435872386657,1.4888483137831352,0.03333333333333333,0.8691134382076193,1.0,33/96,22.30%,TEAD2;AMOTL1;RAI14;MID1;PARVA;ADAMTS1;COL12A1;B4GALT2;TEAD4;CDR2L;TENM3;MPDZ;RND3;P3H4;CAP2;RBFOX2;DDAH1;PTPRF;MAGI1;NR2F2;FJX1;ANTXR1;FZD7;FSHR;CHST3;ADCY6;GNA11;CSPG4;HTRA1;FSTL1;AMH;PTPN21;LAMC1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.671995010255114,1.4880587706069905,0.06976744186046512,0.8684600428461032,1.0,9/17,26.17%,PCM1;C2CD3;PIBF1;CCDC14;GOLGB1;CEP192;HOOK3;KIAA0753;CEP83
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.8117733683019971,1.4880034934180746,0.03125,0.8636027365656473,1.0,3/8,9.62%,SIRT1;PKIA;PRKAR2A
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.844187724462276,-1.4869923246631647,0.0,0.9569273445091554,1.0,3/11,5.27%,TBX1;WNT5A;STAT1
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.5875695233158373,1.4868965892911943,0.02631578947368421,0.8663394148267581,1.0,7/53,4.61%,ADGRF4;FAM83H;LAMA3;ADGRG6;PERP;ESRP1;DSP
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6160299521213015,-1.4864099647687885,0.0,0.945819092409497,1.0,23/75,12.81%,CLEC5A;C1QB;LILRB3;ITGB2;FCGR3A;HCK;C3AR1;CHIT1;VSIG4;TNFRSF1B;MS4A4A;GPIHBP1;LY86;PARVG;TLR2;SLC11A1;PTAFR;SPI1;ADGRE1;IGSF6;NFAM1;MYO1F;CLEC12A
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5980715463716268,-1.4862634174134866,0.0,0.9309111197834093,1.0,23/99,12.83%,CD44;ITGB2;FCGR3A;HCK;C3AR1;TNFRSF1B;TAGAP;PTPRC;PSAP;LY86;PARVG;OAS1;TLR2;IFIT3;PTAFR;SPI1;IFIT1;ADGRE1;IGSF6;NFAM1;MYO1F;CLEC12A;PLAU
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.9047111110046835,1.4859304476597417,0.0,0.8678412611981902,1.0,2/5,3.14%,ANGPT1;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7352390338985573,1.4846678191565466,0.05714285714285714,0.8705204727069059,1.0,3/12,9.62%,SIRT1;PKIA;PRKAR2A
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.8763180745844479,1.4844122912957918,0.0,0.8670448369927879,1.0,1/5,6.98%,KDM7A
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.8115735695361693,1.484359445953045,0.043478260869565216,0.8625195502292956,1.0,4/11,12.52%,MT1G;IFI16;PPARG;BMP4
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.8368015928540324,1.484221060746554,0.0,0.8584985342442336,1.0,4/8,13.23%,ITGA8;BMP4;ITGB4;ITGA3
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8779660392890805,-1.483819756877981,0.03333333333333333,0.9400034147174322,1.0,1/6,1.14%,BHMT
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5799222929023966,-1.4834608719968105,0.014705882352941176,0.9277356498462396,1.0,20/54,28.23%,COX6A1;COX6C;NDUFA2;NDUFS2;NDUFB4;COX7C;NDUFB9;NDUFC1;NDUFA1;NDUFB11;COX4I1;NDUFS5;NDUFB10;COX7A2L;NDUFB2;COX6B1;NDUFS6;SDHC;COX5A;UQCRH
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5867236682059662,-1.483452815123444,0.0,0.9120113167979982,1.0,4/99,1.85%,CD44;ENPP2;CRLF1;TGFB1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.8629792328654409,1.4824142677841505,0.023809523809523808,0.8672767531856431,1.0,2/5,6.83%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.7877994054511757,1.4821679635664287,0.022222222222222223,0.8637210753004476,1.0,4/10,8.82%,PNP;ZBTB7B;CBFB;NKAP
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.8225127598984997,1.481925293420257,0.09523809523809523,0.8600284703045389,1.0,3/8,7.68%,PNP;NT5C1A;PRTFDC1
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.9384738857553949,-1.4817544414302806,0.0,0.9137834120615409,1.0,2/6,0.86%,MICB;TCF7
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6390254160061039,-1.4813845813137851,0.016666666666666666,0.9023347897196479,1.0,25/63,15.78%,AHR;ITGB2;FCGR3A;HCK;CYTIP;HLA-DRB1;ALOX5;HLA-DMA;MS4A4A;TAGAP;CIITA;PTPRC;LY86;PARVG;TLR2;PTAFR;SPI1;HLA-DPB1;IGSF6;NFAM1;MYO1F;CLDN1;HLA-F;HLA-DPA1;ITGAM
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7216582256222511,-1.4813471984983158,0.045454545454545456,0.887991577030334,1.0,6/18,8.37%,MYH7;ACTC1;PKP2;TGFB1;MYBPC3;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.7637043600273192,1.4807935243110661,0.06666666666666667,0.8622924040294038,1.0,4/15,8.05%,CTDNEP1;MFSD2A;LDLR;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.8122621063490776,1.480645689414494,0.08695652173913043,0.8581229237839315,1.0,6/11,14.72%,GCK;IRS1;PPP1R3E;AKT2;IRS2;INSR
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.8351289532790827,1.480580397500702,0.06666666666666667,0.8534765792691072,1.0,1/7,3.43%,SLC39A8
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.5774756992396934,1.4804929250414198,0.027777777777777776,0.8492293402812104,1.0,15/42,16.13%,NOX4;DDAH2;CBS;NAALAD2;KYAT1;SRR;GLUD1;RIMKLB;AADAT;ALDH18A1;SLC25A12;DDAH1;THAP4;ASPG;MTHFR
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.5274440576498785,1.480209218148346,0.08695652173913043,0.846669288400843,1.0,30/131,19.58%,ARC;NGF;SLITRK6;NYAP2;LLGL1;PARD3;ALCAM;NLGN1;DSCAML1;SPTBN4;CNTNAP2;DCC;SRGAP2;SGK1;TNIK;PLXNB1;NTNG2;FARP1;MAP6;RAB10;EPHB2;RYK;IMPACT;PARD6B;CPNE1;CTNNA2;DCDC2;NRCAM;MNX1;SLITRK2
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.719457332726385,1.4793208526466743,0.10416666666666667,0.8482577807594015,1.0,5/12,19.71%,PPARG;PLIN5;LPL;OSBPL11;OSBPL8
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.7690154880150679,1.4786087640824137,0.05263157894736842,0.8492312479244143,1.0,5/11,8.31%,IRS1;PID1;AKR1C3;AKR1C1;LPL
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.772841118997676,1.4784487321972237,0.07692307692307693,0.8454396454807072,1.0,1/16,0.23%,PNP
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.9213110994113555,1.4779562666502444,0.0625,0.8393231347328816,1.0,3/5,4.71%,DPY19L3;DPM3;DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.9213110994113555,1.4779562666502444,0.0625,0.8393231347328816,1.0,3/5,4.71%,DPY19L3;DPM3;DPY19L1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.8285699841858487,1.4775663018657734,0.09090909090909091,0.8374836426231523,1.0,2/8,5.52%,VEGFC;IL16
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6475851572645503,-1.477440143793864,0.04225352112676056,0.8993066522963975,1.0,13/42,17.57%,IRF4;SP100;IRF1;STAT1;HLA-A;OAS1;IFIT3;IFIT1;OAS2;HLA-F;IFI27;ISG15;IFI6
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6475851572645503,-1.477440143793864,0.04225352112676056,0.8993066522963975,1.0,13/42,17.57%,IRF4;SP100;IRF1;STAT1;HLA-A;OAS1;IFIT3;IFIT1;OAS2;HLA-F;IFI27;ISG15;IFI6
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.8631276053884077,1.4773515828204882,0.043478260869565216,0.8350822327792587,1.0,1/5,10.03%,GCC2
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6981813471835034,1.4771972045663897,0.024390243902439025,0.8317973017592438,1.0,7/17,21.74%,PARD3;SCRIB;FSCN1;DLG2;MARK2;DLG1;LRRC7
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.8331453866663504,1.4771259951235298,0.044444444444444446,0.8282183107484858,1.0,1/6,0.87%,CLC
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.5704090578138927,-1.47695225212774,0.03278688524590164,0.8903921233851232,1.0,16/84,14.09%,CD44;RASGRP4;GMFG;ICAM3;NR1I3;GYPB;SLFN14;CA1;CEACAM1;PKLR;LOX;MYO1F;CLEC12A;UROS;ERMAP;THBS1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.806644051747007,-1.4757145716242026,0.0,0.8896602183694552,1.0,4/11,10.71%,AQP3;SLC5A1;UPK3A;AQP4
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6779751395507676,1.4725113068896152,0.02857142857142857,0.8572225008478179,1.0,6/24,10.02%,PNP;NUDT4B;NT5C1A;PRTFDC1;PDE9A;NUDT18
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),-0.9747983129796904,-1.4724570376793993,0.0,0.9107744528170144,1.0,1/5,0.71%,IHO1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7406664479730206,1.4722289350237456,0.061224489795918366,0.8545240039931028,1.0,6/15,11.46%,IRS1;PLIN5;AKT2;ABCD2;TWIST1;IRS2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.9475724391046731,-1.4718089187879686,0.0,0.9037165181934136,1.0,1/5,1.01%,TICRR
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7946202352435157,1.4717221377922847,0.07894736842105263,0.8546858456605257,1.0,7/14,14.33%,PER2;HDAC3;SIRT1;SIRT7;HDAC1;SIRT6;HDAC4
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5904897007405859,-1.471623840952563,0.01639344262295082,0.8922274762681263,1.0,16/75,10.30%,DENND1C;AQP3;UMODL1;TMEM184A;UPK1A;ELMO3;TRIM25;UPK1B;DTX2;TMC4;CARD14;LRP10;SLC14A1;SPINT1;ALOX15;UPK3A
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.795290894502106,1.4702661393235614,0.13333333333333333,0.8590320910608008,1.0,3/7,10.37%,P3H3;PLOD3;P3H4
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.6053978449732557,1.4702584488650448,0.029411764705882353,0.8546040905914153,1.0,4/31,7.83%,ARC;NLGN1;LZTS3;ABI3
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.7274212291586711,1.4698693438450208,0.07142857142857142,0.8483409917193122,1.0,2/14,1.25%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.7274212291586711,1.4698693438450208,0.07142857142857142,0.8483409917193122,1.0,2/14,1.25%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5645341365997922,1.4697236284213344,0.03125,0.8445867613070731,1.0,13/47,14.93%,NGF;SYT17;GOLGA4;PLCB1;SYT3;SYT1;RIMS2;MACF1;MAP3K13;PPIB;INSR;SMURF1;CPNE6
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.7189672551485964,1.4692123962618004,0.05263157894736842,0.8441661372780349,1.0,4/19,4.65%,SLC30A10;SLC39A8;TRPM2;SLC39A11
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.7474592941465619,1.4691059016635788,0.02564102564102564,0.8406267657372076,1.0,4/18,10.33%,HTR2C;DLGAP4;SLC8A3;AKAP9
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.6068306325261448,1.4690740691850401,0.06060606060606061,0.8366566839096107,1.0,7/27,12.21%,LGR5;EDNRA;DRD5;RXFP1;ADCY2;CAP2;ADCY3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5583339681455062,1.4677880194314716,0.03225806451612903,0.8423882944836576,1.0,23/74,21.11%,SLITRK6;LLGL1;PARD3;DSCAML1;SPTBN4;SEMA5A;DCC;DHFR;GRM7;NTNG2;MTR;ARHGAP35;RAB10;NREP;EPHB2;RYK;PARD6B;CTNNA2;NRCAM;SLITRK2;MARK2;PAK3;CDK5
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7956815788011229,1.46715486278621,0.14285714285714285,0.8347983607636721,1.0,3/8,17.53%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7956815788011229,1.46715486278621,0.14285714285714285,0.8347983607636721,1.0,3/8,17.53%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7956815788011229,1.46715486278621,0.14285714285714285,0.8347983607636721,1.0,3/8,17.53%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.802244575185321,-1.4660791732341114,0.01818181818181818,0.9306779840158703,1.0,5/15,14.44%,CRLF1;STAT1;IL27;OAS1;OAS2
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.6353551972465408,1.4655197376832414,0.06666666666666667,0.840806146368025,1.0,7/36,5.48%,IL7R;CD247;GPR174;RORA;TRAC;BCL11B;PYHIN1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.8882545627492947,-1.4653098801492959,0.03773584905660377,0.9263961665388151,1.0,1/8,0.90%,WNT5A
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8661917858026184,1.4651490771666682,0.021739130434782608,0.8350091826458734,1.0,3/7,11.31%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8661917858026184,1.4651490771666682,0.021739130434782608,0.8350091826458734,1.0,3/7,11.31%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.756316306317479,1.4646501414907318,0.047619047619047616,0.8340572577436176,1.0,4/10,17.95%,MLXIPL;ABCD2;NR1H3;ELOVL5
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.6663537718446861,1.4641396248083085,0.02564102564102564,0.833709152221196,1.0,5/24,9.35%,ARC;NLGN1;CACNG4;CNIH3;CACNG2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7689519728579278,1.4638243683790164,0.07894736842105263,0.8318846667444544,1.0,4/9,15.10%,LPCAT2;CHPT1;PLA2G4C;DHRS7B
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.581314163621322,-1.4634561321882122,0.015151515151515152,0.9293050733848071,1.0,20/53,28.23%,COX6A1;COX6C;NDUFA2;NDUFS2;NDUFB4;COX7C;NDUFB9;NDUFC1;NDUFA1;NDUFB11;COX4I1;NDUFS5;NDUFB10;COX7A2L;NDUFB2;COX6B1;NDUFS6;SDHC;COX5A;UQCRH
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.8506336230039246,-1.4628868237028676,0.046875,0.9217613393176646,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.7265602620841528,1.4622983741441784,0.13513513513513514,0.8364836437192287,1.0,3/9,19.17%,TNFSF14;FADD;FOXP3
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7994731311840767,-1.4609100351805053,0.016666666666666666,0.9302117124807923,1.0,3/11,6.68%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8261156829235237,1.4608928106453782,0.05263157894736842,0.8427248303530608,1.0,2/7,1.19%,PNP;SLC16A9
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.861900721098606,1.4602167964437651,0.10526315789473684,0.8427802255344694,1.0,1/5,6.45%,CRY1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.7254506928899014,1.4597615044368517,0.07692307692307693,0.8418186768309284,1.0,2/10,7.28%,BDH2;CHAC1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.8357108911416555,-1.459672890729536,0.06779661016949153,0.9193034126206758,1.0,2/7,9.63%,SFTPD;OAS1
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.8357108911416555,-1.459672890729536,0.06779661016949153,0.9193034126206758,1.0,2/7,9.63%,SFTPD;OAS1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.8463896520288015,1.4596532063474839,0.08,0.8384813546158115,1.0,2/6,6.51%,GREM2;GREM1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.9081323469834,1.4593577532699957,0.024390243902439025,0.8365415965016656,1.0,4/6,8.06%,HS6ST2;HS3ST3B1;HS3ST5;HS2ST1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.8644379423477371,-1.459341983433019,0.015151515151515152,0.9100772598296929,1.0,3/9,6.68%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8319181533232894,1.4585597396362038,0.15789473684210525,0.8385576149784013,1.0,1/5,7.12%,CEP120
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.8339420788751464,1.4584290988862925,0.020833333333333332,0.8354949873904207,1.0,2/7,3.08%,KIT;NFATC3
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.8557393835050533,1.458091710015219,0.07317073170731707,0.833808270562967,1.0,1/9,1.66%,CBS
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.9130883723196215,1.4564280656644177,0.06818181818181818,0.8420239421165095,1.0,1/5,2.66%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.905202763487783,1.456234396701071,0.023255813953488372,0.8387762971321852,1.0,1/7,1.52%,FGF10
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.6416842659330368,1.456108517148069,0.06976744186046512,0.8359778237262582,1.0,8/31,11.46%,GCK;GRP;CAPN10;DOC2B;UCN;GLUD1;MCU;IRS2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6807311337898709,1.4560247736391732,0.047619047619047616,0.833065105238119,1.0,6/18,14.33%,SMYD1;HDAC3;MAML1;HDAC1;NOTCH1;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.8012432366829769,1.4558558358783689,0.10810810810810811,0.8305251967381018,1.0,5/11,11.31%,ZBTB7B;IRS1;SIRT1;SNX5;GKAP1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.6500815631839724,1.4545915417646127,0.10256410256410256,0.8350512145687752,1.0,10/19,27.02%,OSBPL6;NUS1;ABCA13;NFKB1;NR1H3;LIPG;YJEFN3;ABCA2;ABCA8;ARV1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.7361015740546613,-1.4544495922684388,0.015873015873015872,0.9447737311916927,1.0,2/16,3.79%,CAV3;SCN5A
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.6943111119574484,1.4539471803128994,0.034482758620689655,0.8352748711597908,1.0,5/24,6.45%,GCK;ZNF692;SIRT1;SIRT7;CRY1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7929411951259913,1.453053440800327,0.02702702702702703,0.8363863298995368,1.0,3/11,8.66%,IRS1;PLCB1;EIF2AK3
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8941319062260944,1.452839728676901,0.05263157894736842,0.8336038389830644,1.0,4/6,7.97%,ROBO2;ALCAM;SLIT2;PTPRM
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.6750853601609943,1.4527587138344824,0.125,0.8305064178546703,1.0,5/15,14.62%,KCNC2;PKD2;MAT2A;GRIN1;CPSF7
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.8071156653208823,1.4525434538374005,0.045454545454545456,0.8283816490883336,1.0,3/10,5.86%,TFB1M;TEFM;SLC25A33
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7652441189536682,1.452212024356589,0.1276595744680851,0.8265443120874647,1.0,4/6,21.09%,SNX18;SNX9;SPIRE2;SNX33
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),-0.9131040620251694,-1.45204029210791,0.05660377358490566,0.9554552992596402,1.0,1/5,0.24%,AQP3
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.7357567661150363,1.4516128407980262,0.08695652173913043,0.8267988521394082,1.0,1/12,0.07%,COL22A1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7515270589004226,1.4515507400274459,0.09523809523809523,0.8233837223025232,1.0,5/9,12.72%,INSL5;UCN;LEPR;SGIP1;NR4A3
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7063327565779882,1.451440164996454,0.13157894736842105,0.8205289542615979,1.0,3/13,8.52%,RAB27A;NLGN1;SYNDIG1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.8971503817186034,1.4509819064050544,0.024390243902439025,0.819549675319033,1.0,1/7,0.37%,IRGM
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.48788344010409584,1.4506104613137052,0.043478260869565216,0.8186445292491706,1.0,19/183,4.45%,CPA1;MLPH;MXRA5;KIT;ST6GALNAC3;ESYT3;MITF;PAPSS2;CLEC14A;EDNRA;HS6ST2;CDH5;ALDH1A1;HDC;RIN2;HNMT;EXT1;HS3ST1;PID1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.7218545283678475,1.4505601580155423,0.022222222222222223,0.8156492257523733,1.0,3/14,5.76%,SCRIB;TBC1D16;SNCA
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8529583489789547,-1.4500567579452925,0.038461538461538464,0.961300367082124,1.0,4/6,13.75%,HK2;PINK1;ATP5IF1;TOMM7
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.701683103689486,1.4492378896375433,0.14285714285714285,0.8209044576175147,1.0,9/13,27.96%,ELP4;TRMT9B;CTU1;MTO1;ELP3;ADAT2;DPH3;ALKBH8;URM1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.751404637960694,1.4491654899429058,0.05405405405405406,0.8179897711863987,1.0,6/14,15.00%,GPC4;LRRC4C;GPC6;LRFN5;PTPRF;PTPRD
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.9432578778824154,1.4487834138022508,0.046511627906976744,0.8173004204858275,1.0,1/5,0.37%,IRGM
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.6117050336375739,1.448576117299779,0.05555555555555555,0.815134025385801,1.0,1/41,0.03%,IL7R
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.8030606939870066,1.4484447429537535,0.07317073170731707,0.812857131071125,1.0,4/7,17.93%,LETM2;TESMIN;SLC4A11;CLDN16
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.6125929040622619,1.448182349243149,0.027777777777777776,0.8112383511159362,1.0,10/21,33.29%,NAV3;CAMSAP3;ATXN7;CIB1;TRIM54;FGF13;CLASP2;SPEF1;APC2;CLASP1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5189426909628965,1.4481376019719108,0.08571428571428572,0.8084866824664998,1.0,20/128,11.10%,NTSR2;CDH20;GRIN3A;SPHKAP;GJB6;GRM3;LRRTM3;LRRC4C;BAALC;ELAVL3;CADM2;PTPRZ1;MAGI2;ZEB2;KCNIP1;ADCY2;ADGRA1;RGS7BP;GABRG1;NPAS3
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6248796330904158,1.4479798444004728,0.1111111111111111,0.805884307439284,1.0,11/34,17.39%,PCM1;CAPN10;PLK3;STX18;TENM1;CEP290;B3GAT3;MLC1;PGAP1;NEDD4;ICE1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5923056974846702,1.4459977175440517,0.0625,0.8141662184386614,1.0,9/37,12.05%,SKAP1;UTRN;RIN2;CDH13;CDK6;ABL1;COL16A1;JUP;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7596204744355782,1.445776733472773,0.09302325581395349,0.8121909414471066,1.0,3/10,19.57%,PID1;ENPP1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.8219574001678066,-1.445147283711494,0.018867924528301886,0.999075988704733,1.0,2/10,2.33%,TGFB1;ITGB2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.5921863708124546,-1.4448281408383663,0.0,0.9904744652705192,1.0,8/86,9.59%,CD44;ITGB2;ECM2;LYVE1;ITGB6;CD63;ITGBL1;PARVG
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7792947758647675,1.4440816682406947,0.021739130434782608,0.8184385328567373,1.0,2/10,5.81%,IRGM;JMJD4
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.7325307475181166,1.4439582580240053,0.05405405405405406,0.8154636150555575,1.0,5/10,20.70%,SMARCB1;PIH1D1;SMARCA4;MARS1;IPPK
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.6528963858486885,1.443559563629326,0.08108108108108109,0.815060531808694,1.0,8/25,13.84%,SMYD2;SMYD1;SIRT7;NSD1;FBLL1;FBL;CARM1;PRMT5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.9487950984022393,-1.4430031486500912,0.0,0.9976525531869669,1.0,1/5,0.90%,WNT5A
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.79861435014951,-1.4430016179720657,0.0847457627118644,0.9857757370775982,1.0,3/12,7.28%,PINK1;ALOX5;ACOX2
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8961672871350381,1.4430009879426762,0.09302325581395349,0.8154034556031251,1.0,4/6,8.52%,NLGN1;LHFPL4;APOE;GPHN
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.8580788467784655,-1.4429665631596318,0.0,0.9744087684587238,1.0,1/8,0.15%,CLEC5A
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.7306935318709322,1.4421153556160118,0.041666666666666664,0.8187030482701597,1.0,3/11,10.98%,SIRT7;SPAST;EPS8
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.7852671278031127,1.4412375072184849,0.1111111111111111,0.8215466852619282,1.0,3/8,13.99%,PTPRO;PTPRB;PTPRT
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.6862058232505646,1.4410282147978999,0.046511627906976744,0.8191686085523001,1.0,2/19,2.78%,CTDNEP1;TOR1B
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7543358272238293,1.4409318132812219,0.09523809523809523,0.8132543788002541,1.0,3/8,9.35%,CACNG4;GPHN;CACNG2
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7543358272238293,1.4409318132812219,0.09523809523809523,0.8132543788002541,1.0,3/8,9.35%,CACNG4;GPHN;CACNG2
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6149544947735067,1.4408945082387032,0.058823529411764705,0.810331782774924,1.0,17/57,15.37%,KIT;FGF10;CAPN10;PARVA;AUTS2;PHACTR1;FER;RALA;FARP2;TNIK;FLNA;RAP2A;MCU;GAB1;EFS;ANTXR1;CASS4
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.812127384025525,1.4408418210379952,0.1111111111111111,0.8074920626880561,1.0,3/6,10.02%,PNP;NT5C1A;NUDT18
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5554875309843329,1.4406894653027418,0.07407407407407407,0.805214159747239,1.0,31/102,14.60%,LGR5;MEGF10;LHFPL4;UNC5D;LRRC4C;ELAVL3;CADM2;PTPRZ1;PCLO;PAK5;SLC35F1;SAG;ERC2;RHBDL3;CASKIN1;MSI1;WNK2;CELF5;GALNT13;STOX2;HES1;CRABP1;CSPG5;RIMS4;NOTCH1;SCRT1;MAP6;SNAP91;ANK2;SRRM3;IGDCC4
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.6962333135099996,-1.4391315100110413,0.0,1.0,1.0,3/21,3.42%,DNAH11;TBX1;MMP21
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.5893617046201123,1.4389965124090691,0.05714285714285714,0.8120965884102286,1.0,11/25,33.29%,NAV3;CAMSAP3;ATXN7;CIB1;TRIM54;FGF13;CLASP2;TRPV4;SPEF1;APC2;CLASP1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7410781749821008,1.4387244263145695,0.13157894736842105,0.8107709463173849,1.0,1/9,0.46%,GRIN3A
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6893014175600563,1.438494599577565,0.07317073170731707,0.8087438144661996,1.0,7/21,12.74%,DPY19L3;TMTC2;DPM3;DPY19L1;FKTN;FKRP;TMTC3
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8135335764899889,1.437681006692284,0.06382978723404255,0.8103356904786305,1.0,5/9,17.32%,CEL;AKR1C1;LDLR;SOAT2;ABCG8
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9312886960354254,-1.437391650301143,0.0,1.0,1.0,1/7,0.10%,ENPP2
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.743116375439179,1.437235922828606,0.06,0.8106796250003439,1.0,3/14,5.76%,MT1G;MT4;SNCA
prerank,PanglaoDB_Augmented_2021__Basophils,-0.546756659744,-1.4365210356977811,0.0,1.0,1.0,22/99,12.81%,CD44;CLEC5A;LILRB3;FCGR3A;HCK;C3AR1;H1-3;HTR1B;GPR183;TEC;ID1;VSIG4;MS4A4A;RNF39;TLR2;IL3RA;PTAFR;SPI1;PLG;NFAM1;MYO1F;CLEC12A
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.7110628195333024,1.4362006379427408,0.10256410256410256,0.8127798468169045,1.0,4/22,3.43%,MT1G;SLC30A10;MT4;SLC39A8
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.7989178632916574,-1.4355913029771539,0.03773584905660377,1.0,1.0,2/11,2.33%,TGFB1;ITGB2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5869684725967707,-1.435575573079966,0.04285714285714286,0.9908477352202808,1.0,16/72,15.45%,INMT;C1QB;CRLF1;SFTPA1;CAPN8;SFTPD;VSIG4;MS4A4A;DUOXA1;SLCO2B1;SPINT1;PGC;ALOX15B;STEAP4;CXCL16;IFI27
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6921628611447124,1.4352440417782721,0.05405405405405406,0.8145138233550115,1.0,6/15,23.46%,ITPKB;ACER3;IP6K1;IPPK;IP6K2;CYP27A1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.8003750756135567,1.434801638855784,0.044444444444444446,0.8136162494948289,1.0,2/8,10.99%,PHLDB2;FERMT1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7444180344987104,1.434657746190428,0.06060606060606061,0.8116818575242492,1.0,5/15,6.85%,SELPLG;PODXL2;SLC39A8;CX3CR1;ITGA4
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.6790250212516711,1.4345934879545033,0.0,0.8088954833337888,1.0,5/19,7.87%,GANC;ST8SIA4;PRKCSH;MAN1A2;MAN2A1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.6429972413718308,1.4345309396041042,0.08823529411764706,0.8061297489521466,1.0,9/32,8.68%,APOH;HGFAC;PRSS3;TBC1D10A;PERP;IFI16;KLKB1;RIPK2;F12
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.8446493524932285,-1.433773816097681,0.0,0.997677616902476,1.0,2/7,3.79%,KCNA5;SCN5A
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.8092748523389628,1.433201829626274,0.0,0.8093987390763548,1.0,2/13,3.25%,IL7R;IRS1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.8092748523389628,1.433201829626274,0.0,0.8093987390763548,1.0,2/13,3.25%,IL7R;IRS1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.7507588892519423,1.433008254958304,0.07142857142857142,0.8074014015751017,1.0,4/14,11.59%,SLC5A8;RNLS;PTGIS;NAMPT
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.6702666107062822,1.432563240498977,0.07142857142857142,0.8070630490267972,1.0,8/15,26.17%,PCM1;C2CD3;PIBF1;CCDC14;CEP192;HOOK3;KIAA0753;CEP83
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.872683904041908,1.4321045139438253,0.09302325581395349,0.8072356343175836,1.0,1/5,4.06%,HRH3
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5634231549408214,1.4320842002530232,0.030303030303030304,0.8044234530343506,1.0,17/39,24.56%,MYO10;NLGN1;TRPM2;RALA;TENM1;FSCN1;DOCK11;FXR2;RAB5A;MIEN1;TENM2;PLPPR5;GPM6A;PALM;PPP1R16B;CAPZB;ARHGAP44
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.73885182789557,1.4315974289227602,0.02631578947368421,0.8044921423874679,1.0,2/14,4.49%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5754742019827548,1.4309537470976246,0.08333333333333333,0.8047838886527587,1.0,10/29,19.74%,NRG2;ERBB2;NRG1;PTPRR;GAB1;PIK3CA;MATK;ERBB3;SOS1;PTK6
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.6603592073801741,-1.4308242140487792,0.05357142857142857,1.0,1.0,2/18,4.03%,BUB1;ZWILCH
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6848965232002686,1.430468939581392,0.09090909090909091,0.8052962933688016,1.0,4/17,11.76%,MRAP2;PID1;LEPR;MYC
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.6379173436074143,-1.4303644728707077,0.02857142857142857,1.0,1.0,4/29,3.79%,KCNA5;PKP2;CAV3;SCN5A
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7519760246498003,1.4295540157609945,0.09375,0.8077471380602337,1.0,2/6,14.18%,SLC30A10;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.843318363177565,-1.4294519850026448,0.016129032258064516,1.0,1.0,2/9,2.41%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.6723193750275771,1.42943153298352,0.09523809523809523,0.8052596308091589,1.0,5/21,8.80%,APOE;CSK;WWP2;DRD3;DRD4
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.7490023446388367,1.429100182134242,0.06,0.8041671413464428,1.0,3/11,5.77%,APOH;APOE;SERPINE1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.8759259285834846,-1.4289005980231142,0.0,1.0,1.0,3/7,6.21%,DNAH11;CCDC39;DRC1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6847470069821164,1.428523214899214,0.07142857142857142,0.8045646822048778,1.0,6/15,24.62%,DHFR;ACER2;ACER3;GCH1;ACER1;ABCA2
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.7071086972263122,-1.4284872125065526,0.109375,0.9976656612220893,1.0,4/18,8.69%,C1QTNF1;ALOX12;BLK;CEACAM1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.8294646172622402,1.4281549594221958,0.08695652173913043,0.8037011615020918,1.0,3/8,6.77%,ALDH1A1;ACSS2;ADH4
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.6083612376090656,-1.4280895299812486,0.029411764705882353,0.991620154342881,1.0,12/66,9.59%,CD44;TCF7;SIRPG;GMFG;ITGB2;ARHGAP9;CYTIP;TAGAP;PTPRC;CD5;KLRB1;PARVG
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.555931142893314,1.4278272297019048,0.03333333333333333,0.8027346704177633,1.0,18/66,16.74%,VWC2;VWC2L;BAMBI;ADAMTS12;FSTL3;PPARG;GREM1;SLIT2;SPRY4;CRIM1;NOTCH1;DLX1;BMPER;SMURF1;CREB3L1;EMILIN1;NEDD4;SKI
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7654803499400776,1.4273144892436773,0.1111111111111111,0.8028071030521343,1.0,2/12,6.38%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.6331187342803034,1.4271686918652573,0.0625,0.800497082486285,1.0,8/31,11.65%,IRGM;DOC2B;HTRA2;SORBS3;MGARP;AKT2;STX18;PLA2G5
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.7888888557887769,1.427123347966648,0.05128205128205128,0.7980412620624983,1.0,4/8,17.82%,TEFM;POLG;PRIMPOL;DNA2
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),0.8703788992798056,1.4270965457217097,0.046511627906976744,0.7954411552741082,1.0,2/5,6.30%,OSR1;PKD2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6070759683314118,-1.426953080713149,0.0273972602739726,0.9934914208128188,1.0,5/64,4.99%,CD44;TGFB1;TERF2IP;IFNK;PINK1
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),0.8677587985140836,1.4267188735880805,0.06666666666666667,0.795216287853895,1.0,1/5,0.57%,PCDH15
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7012958506699026,1.4264588508916765,0.058823529411764705,0.7936047982101517,1.0,4/15,5.77%,ANGPT1;CDH5;SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.817410916084787,-1.4263486906722023,0.034482758620689655,0.989192706761428,1.0,1/9,0.35%,IRF4
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.8110187861922162,1.4262832213094658,0.023255813953488372,0.7922703872638419,1.0,5/10,17.32%,CEL;AKR1C1;LDLR;SOAT2;ABCG8
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.8451513022433303,1.4261313772831494,0.09302325581395349,0.7902027122249593,1.0,2/6,5.37%,SMYD1;MAML1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.750090572322083,-1.4255332067611748,0.07692307692307693,0.9860244152296397,1.0,2/11,12.50%,STAT1;IL12A
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6379596868929815,-1.4251387328423897,0.02857142857142857,0.9792348553619233,1.0,9/32,22.36%,MCM2;MCM3;RPA3;CDC6;POLE2;TOPBP1;POLE3;RPA2;ORC6
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.8539990001409297,1.4249403462908343,0.07317073170731707,0.7952305016752139,1.0,2/5,8.96%,HRH3;GRM7
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.7479456569288474,1.4244008109547788,0.06818181818181818,0.7927442280287367,1.0,3/12,8.86%,SPRY4;KANK1;EFNA5
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.7479456569288474,1.4244008109547788,0.06818181818181818,0.7927442280287367,1.0,3/12,8.86%,SPRY4;KANK1;EFNA5
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6352093117966997,1.4242267239095432,0.16129032258064516,0.7906504925835174,1.0,7/27,12.52%,FGF10;SCRIB;PKD2;SLIT2;HES1;RASIP1;BMP4
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.6189772390590604,1.4238073563730478,0.027777777777777776,0.7900827795309018,1.0,7/27,15.28%,NLGN1;SLC8A3;GRIN1;NLGN4X;RIMS2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.8313095572631127,-1.4237522883488307,0.058823529411764705,0.9832021010555494,1.0,1/7,0.70%,POLQ
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.7312281152497047,1.4231235183466489,0.08571428571428572,0.7910777401514745,1.0,5/9,23.06%,CPNE7;CRLS1;CPNE6;CPNE1;HDHD5
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.5433472510414776,1.4229776978221282,0.05714285714285714,0.7890104970202984,1.0,10/64,7.62%,GCK;ROBO2;URI1;AKR1C3;AKR1C1;MGARP;NCOA3;NCOA2;SLIT2;STAT5B
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.6433107971039844,1.422581449319066,0.06060606060606061,0.7881441870716211,1.0,8/36,13.85%,TSKU;APOB;APOE;SOAT1;SULT2A1;ABCA1;IDH2;SOAT2
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6222708846790049,1.4216184254582944,0.06060606060606061,0.7899588248834494,1.0,9/25,19.45%,FOXO1;SIRT1;NAA40;AANAT;KAT6A;DSCC1;ESCO1;KAT2B;EP300
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.6892244344669959,1.421504818610353,0.0625,0.7884285079746742,1.0,8/12,28.03%,CILK1;IFT140;TTC21B;WDR19;TTC21A;WDR35;DYNC2I2;DYNC2I1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.6580357404555623,1.4211790822629298,0.1111111111111111,0.788032632629764,1.0,12/20,30.54%,ACACB;ABCD3;ABCD2;CPT1A;PRKAG2;NPC2;PRKAA2;ACACA;ARV1;CERT1;THRSP;PLEKHA8
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.8075513161983391,1.4201825497002445,0.19444444444444445,0.789127276890125,1.0,1/5,2.58%,OSR1
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.8075513161983391,1.4201825497002445,0.19444444444444445,0.789127276890125,1.0,1/5,2.58%,OSR1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8042120942383348,-1.4199108528088038,0.02857142857142857,1.0,1.0,3/10,6.64%,DUOX1;IYD;CGA
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.5609158214853392,1.4193473243724466,0.07142857142857142,0.791010375031815,1.0,11/47,8.06%,NXPH2;GRP;NXPH4;GALR3;NMU;HCRTR1;CYSLTR1;GPR149;UTS2R;SORCS1;OPRD1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.6886712617019826,1.4190653207445902,0.11904761904761904,0.789652819274382,1.0,6/15,13.56%,FGFR1;PPARG;HMGB1;ITGA4;SP1;SIRT6
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),0.8527251774461553,1.418688353825112,0.10416666666666667,0.7887062975366762,1.0,1/5,0.87%,CLC
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.5028577310559849,1.4186196960961384,0.0,0.7865630333529475,1.0,21/157,9.90%,GPRIN3;ARC;TSKU;NGF;NYAP2;IFT88;NLGN1;APOE;GPRIN1;NRTN;CNTNAP2;HMGB1;WHRN;SRGAP2;PTPRM;SAMD14;SGK1;GRM7;TNIK;ADGRV1;PLXNB1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6869148926767725,1.4169467139704235,0.06666666666666667,0.7924767188157024,1.0,4/13,21.20%,PPP5C;PPP1R15B;PPP2R2B;NCK1
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7992204143624603,1.4168491001616403,0.08108108108108109,0.7904845011297502,1.0,2/10,10.14%,SIRT1;LEPR
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),0.8788735828561642,1.4156911463829014,0.023809523809523808,0.793667400513838,1.0,2/5,4.97%,AKR1C3;AKR1C1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.7149855790606109,1.4155978269338825,0.044444444444444446,0.7917830406425959,1.0,5/13,16.22%,TFB1M;TEFM;SLC25A33;EARS2;PNPT1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.7494443199732395,-1.4147114194726584,0.10344827586206896,1.0,1.0,1/13,1.54%,SCTR
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.8303157136209667,-1.4146409453622004,0.08333333333333333,1.0,1.0,1/6,1.85%,TGFB1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7080324435493041,-1.4142500580126072,0.07142857142857142,1.0,1.0,7/15,23.37%,ATP5F1E;ATP5MC3;STOML2;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.9026951407736241,1.4134858526518217,0.05172413793103448,0.8002685116760804,1.0,2/5,3.45%,GRID2;PROX1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6861725915717232,-1.413015305813911,0.05,1.0,1.0,8/21,20.22%,MMP9;PINK1;GPER1;CIDEB;MOAP1;BIK;BBC3;PDCD5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.847966393218269,1.4124441614587688,0.020833333333333332,0.8040785708459841,1.0,6/9,11.46%,IRS1;PLIN5;AKT2;ABCD2;TWIST1;IRS2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7352087868089308,-1.4123569214620348,0.08928571428571429,1.0,1.0,8/20,18.17%,TEKT5;CCDC39;TEKT3;DRC1;DNAH17;DNAH3;DNAH2;RSPH9
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5513503493876575,1.4121204874483781,0.09090909090909091,0.80340450091511,1.0,13/63,8.31%,TSKU;CYP7B1;APOB;EPHX2;LIPC;RORA;APOE;SIRT1;SOAT1;AKR1C1;LDLR;ABCA1;LPL
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4900826422760251,1.4118769270979454,0.0,0.8020506603516738,1.0,35/163,14.92%,SLC17A6;MEGF10;EDIL3;GRID2;LINGO2;NOVA1;NLGN1;EPHA7;ELAVL3;CADM2;CNTNAP2;PAK5;NRG1;KCNH7;SLC35F1;RALGPS2;ISOC1;ERC2;MAPK8;SYT1;BRINP1;GALNT13;DACH1;TRIM44;ACHE;RIMS4;OLFM3;GNL3L;SCRT1;FUT9;MAP6;SNAP91;ANK2;CLSTN2;CDH4
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.8642311083791931,1.4115261320779784,0.04878048780487805,0.8018742206749755,1.0,1/6,1.66%,CBS
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.7600099364625768,1.411359275155887,0.04081632653061224,0.8003879662401308,1.0,3/12,7.37%,GREM1;PLCB1;SLIT2
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.7461345783571889,1.411213530168284,0.08163265306122448,0.7987173669721995,1.0,6/10,19.66%,TGFBR1;POU3F2;ASCL1;MYT1L;SHH;PAX6
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.81428820086571,1.4109153953033355,0.10256410256410256,0.7981186645990916,1.0,3/9,6.77%,APOE;CEL;ADH4
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.6006930759175438,1.410866144720045,0.08823529411764706,0.7958882167221998,1.0,8/33,12.52%,FGF10;PKD2;SLIT2;LRP6;NOTCH4;MYC;RASIP1;BMP4
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7613124846513529,-1.4104536339867777,0.06896551724137931,1.0,1.0,2/12,9.93%,AQP3;SLC5A1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.8501478928272339,1.4103593217247508,0.025,0.7964048629807774,1.0,3/6,9.82%,MAGI2;MYO1E;JAG1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6688472309276811,1.410059709570742,0.05263157894736842,0.7950539138690513,1.0,7/28,9.56%,GRID2;PROX1;ZC4H2;MDGA2;NR4A2;TOX;LRP6
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.9228239974357348,-1.4096110676823197,0.0,1.0,1.0,1/5,5.34%,ALDOB
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.49227583973973504,1.409158333754829,0.07407407407407407,0.7973809877751591,1.0,23/101,20.13%,TEAD2;MATN1;CD247;LLGL1;MITF;PARD3;SLC7A9;PML;WASF3;HES1;IL2RB;MAGI1;SNX9;GEMIN5;CD40;OCLN;NDUFAF1;PARD6B;SKAP2;LIN7A;IL1RAP;TP53;WDR19
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6451721186370669,-1.4087235534567129,0.03508771929824561,1.0,1.0,9/30,20.49%,NDUFA2;NDUFS2;NDUFB4;NDUFB9;NDUFC1;NDUFA1;NDUFB11;NDUFS5;NDUFB10
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.8803646812838501,1.4084999058831702,0.044444444444444446,0.7985060000616118,1.0,3/5,10.90%,ZNF274;SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7108811483553568,-1.408038767928775,0.09090909090909091,1.0,1.0,7/14,23.37%,ATP5F1E;ATP5MC3;STOML2;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.8143782727310609,1.407960556745835,0.06521739130434782,0.7985820500731553,1.0,5/7,17.27%,SLC27A2;ABCD3;ABCD2;ACOX1;SLC27A4
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.68625628569238,1.4079556800371533,0.13333333333333333,0.7961547490091031,1.0,7/19,14.10%,GRM3;DRD5;DRD3;ADGRV1;CAP2;GRM2;NF1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.7494107544925245,-1.4078384197057732,0.05172413793103448,1.0,1.0,1/10,0.80%,MICB
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5371130676082991,1.4067351882148877,0.03571428571428571,0.8007572594994321,1.0,12/38,22.31%,EPHX2;PLPPR1;MTMR8;PLPP2;PLPP3;MTMR3;MTMR1;PIP4P2;PLPPR3;MTM1;PTEN;PLPPR5
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5939191551809964,1.40666758043955,0.09523809523809523,0.7987135650616116,1.0,12/40,20.29%,NGF;ROBO2;GOLGA4;SLIT2;PLXNB1;MACF1;MAP3K13;CHODL;MAP6;PLXNA4;NTRK2;LIMK1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6888187009303396,1.406637764521405,0.1,0.7964013964925862,1.0,7/14,18.79%,GRM3;GRM8;GRM7;GRM4;GRM2;GRIK3;GRM5
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.8757012279525033,1.4066348838724636,0.09302325581395349,0.7940564577645982,1.0,1/5,3.31%,ICOSLG
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8812473309601041,-1.4065401785253933,0.07246376811594203,1.0,1.0,3/6,6.68%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8812473309601041,-1.4065401785253933,0.07246376811594203,1.0,1.0,3/6,6.68%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.8509173722837687,1.4061879205138141,0.06060606060606061,0.7941444635911948,1.0,2/7,3.73%,SKAP1;SIRT1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6037848677373764,1.4061822127047048,0.0425531914893617,0.791773883102863,1.0,9/31,11.66%,ZNF692;RORA;IRS1;SIRT1;BCKDK;SIRT7;AKT2;IRS2;ADIPOR1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.7747969732270101,1.4059928547832683,0.07692307692307693,0.7898798179767416,1.0,2/7,6.50%,SIRT1;HMGB1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.7495070899006702,-1.4057817851603367,0.04918032786885246,1.0,1.0,4/14,6.76%,MYH7;PKP2;TGFB1;MYBPC3
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.6222426792333478,1.405249844570549,0.1111111111111111,0.7909476025090733,1.0,7/30,9.80%,CTDNEP1;MFSD2A;APOE;ZBTB20;LDLR;PLIN5;MLXIPL
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.7877003108191718,-1.405143793424957,0.11320754716981132,1.0,1.0,2/10,3.31%,SP100;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7632571348110646,1.405061484237346,0.11428571428571428,0.7897566924478483,1.0,4/8,12.72%,NLGN1;INSL5;SGIP1;NR4A3
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5777905468771065,-1.4047392634966676,0.031746031746031744,1.0,1.0,6/78,8.75%,NLRP4;UBE2L6;IRF1;TRIM25;POLR1C;POLR3H
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.6424924701679745,1.4046865082081148,0.047619047619047616,0.7894436025090478,1.0,3/17,8.72%,LLGL1;CDH5;KANK1
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.5886512404436186,-1.4040472014868997,0.07017543859649122,1.0,1.0,34/70,23.52%,LILRB3;RASGRP4;ITGB2;FCGR3A;HCK;MMP9;NR1I3;TAGAP;ARG2;CEACAM1;LY86;TLR2;NLRP3;SLC11A1;DOCK8;PTAFR;SPI1;IGSF6;NFAM1;MYO1F;CLEC12A;ITGAM;PSTPIP1;SERPINB1;ITGAX;BST1;FPR1;CD300LF;CEACAM8;TBXAS1;ADGRE3;HK3;CD24;OAS3
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6198167887069586,-1.4038844024832036,0.03225806451612903,1.0,1.0,5/48,4.55%,CD44;TGFB1;DCN;LYVE1;OGN
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.8384336289479222,1.4033013559641865,0.023809523809523808,0.7937020013559466,1.0,3/6,12.59%,VSTM5;ABI3;SEMA4A
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8279261705317678,1.4031325981010687,0.12,0.7924223661662514,1.0,2/5,13.82%,PPP5C;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.7955511362615665,-1.4030957669018258,0.06349206349206349,1.0,1.0,4/9,15.58%,EPN1;ALOX5;THBS1;PIK3CB
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),0.8124186398679643,1.4029161820052625,0.07317073170731707,0.791104784983301,1.0,1/6,2.58%,OSR1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.8443708389998112,1.4022307023087461,0.02702702702702703,0.7926938812551976,1.0,4/9,10.50%,POGLUT3;GALNT1;POGLUT2;GALNT13
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.8138270252710289,1.401407903123921,0.08888888888888889,0.7951318758085928,1.0,3/6,12.78%,DDAH2;ALDH18A1;DDAH1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5652995903957428,1.401274087690481,0.06818181818181818,0.7935476929835291,1.0,6/27,8.52%,SLC17A6;NLGN1;PCLO;SNCA;WNT3A;SYNDIG1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4702218890012336,1.400940262009784,0.0,0.7935443089104631,1.0,47/142,22.39%,CTDNEP1;DUSP2;DUSP4;EPHX2;DUSP15;PLPPR1;DUSP23;PTPRO;PTPRZ1;ALPL;CTDSP1;PPP5C;CTDSP2;PTPRM;PTPRR;PPP2R1B;DUSP18;PLPP2;PTPN9;PSPH;PTPRF;PPM1A;CDC14B;PTPRB;PTPRT;PPM1L;TAB1;PTPRD;PLPP3;PTPRE;SSH1;MTMR3;DUSP6;PPEF1;PTPN14;PPP1CB;PPP4R1;PLPPR3;PNKP;MTM1;PTPRJ;PTEN;PPP2R5D;PPM1H;PTPN21;PLPPR5;DAPP1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6152097333668062,1.4009032201298628,0.046511627906976744,0.7913917616231645,1.0,5/17,12.99%,ZBTB7B;WNT4;NRG1;NOTCH4;ARHGAP35
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.7061724977044523,1.4007048207477315,0.11428571428571428,0.7902784427733497,1.0,9/13,27.96%,ELP4;TRMT9B;CTU1;MTO1;ELP3;DPH3;ELP1;ALKBH8;URM1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7536798700318624,1.400641415432927,0.02564102564102564,0.7882366248867871,1.0,3/11,9.51%,NAA40;AANAT;METAP1D
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.7935346118827058,-1.4001575334452319,0.14285714285714285,1.0,1.0,2/9,3.31%,SP100;FOXM1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7462611550018426,-1.3994033642259593,0.078125,1.0,1.0,2/11,9.31%,ZWILCH;TTK
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7153082350484113,1.3992720435232617,0.05263157894736842,0.7924655854173959,1.0,1/15,0.51%,ARC
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.7649535295623129,1.3992548195362815,0.11764705882352941,0.7904291706451613,1.0,2/9,5.47%,APOB;PPARG
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.6199545463008298,1.397910352660634,0.15625,0.7957313400820071,1.0,4/25,6.21%,ATP6V0D2;RAB20;TCIRG1;RAB7A
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5760101751355491,-1.3978035988070925,0.014285714285714285,1.0,1.0,4/56,4.08%,GPR62;NMUR2;XCR1;P2RY12
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.84863831369623,1.3972781074024154,0.0,0.7963820411151791,1.0,4/7,14.34%,ARRB2;SAG;DRD3;ARRB1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.6415091995149946,-1.3971169666785155,0.01694915254237288,1.0,1.0,4/46,6.83%,CD44;MMP9;MMP19;SCUBE3
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),-0.8890295680764169,-1.3961164213969635,0.03389830508474576,1.0,1.0,1/5,0.79%,TBX1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.8832221305205277,-1.396003327924887,0.03125,1.0,1.0,2/6,4.20%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.7492782961887143,1.3958613128654125,0.10204081632653061,0.8021202206973779,1.0,6/10,23.27%,APOB;PPARG;ZDHHC3;MIA3;UNC119B;VMP1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6573606608507901,-1.3957476514509526,0.08064516129032258,1.0,1.0,9/31,15.59%,MYH7;ACTC1;CASQ2;SCN5A;MYBPC3;KCNQ1;TRDN;CSRP3;TTN
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.6384771609364666,-1.3954543868934692,0.03333333333333333,1.0,1.0,4/46,6.83%,CD44;MMP9;MMP19;SCUBE3
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.7959264847606339,1.394874519961333,0.13333333333333333,0.8043685874207035,1.0,3/6,13.15%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.7407284248804953,-1.3948726384568657,0.1864406779661017,1.0,1.0,1/9,0.31%,NEK2
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.8526334097945971,1.394572779446976,0.0,0.8040730464539798,1.0,4/5,14.34%,ARRB2;SAG;DRD3;ARRB1
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.8826621069426984,-1.3942786840313628,0.0392156862745098,1.0,1.0,2/5,6.27%,DUOX1;CYBA
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5514346637589231,1.3941529487269626,0.09090909090909091,0.8042143656627729,1.0,13/62,8.31%,TSKU;CYP7B1;APOB;EPHX2;LIPC;RORA;APOE;SIRT1;SOAT1;AKR1C1;LDLR;ABCA1;LPL
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),-0.8905435433256341,-1.393950803804427,0.05357142857142857,1.0,1.0,2/5,4.69%,SCN5A;GJC3
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.8748095135972708,1.393656355607034,0.07317073170731707,0.8045718897932013,1.0,2/5,9.72%,GLYATL2;AIG1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5319028077953472,-1.3932871267186013,0.0136986301369863,1.0,1.0,62/145,27.26%,RPL37A;RPL15;RPL3;RPL38;COPS5;RPL35A;RPS9;RPL7A;RPL13;RPS27;RPL13A;RPS4X;RPS16;YARS2;RPS20;RPS8;RPS21;RPS11;ABCF1;MRPL34;RPL27A;RPL9;RPL5;RPL21;RPL34;RPL4;RPL23;RPS14;WARS1;RPL18A;RPL32;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;RPL12;EEF1A1;RPL11;RPL35;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;RPL28;RPL19;RPS24;RPL10;RPS25;RPS3A;ASMT;RPS6;RPL8;RPLP0;RPS12
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.7694626324993566,1.3925275123046679,0.08333333333333333,0.8084762177055029,1.0,3/7,13.83%,PLIN5;LPL;OSBPL11
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.8039213318687741,1.3925150166416207,0.11764705882352941,0.8063167659900575,1.0,2/8,4.86%,MAPKAPK2;CX3CR1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.726579937368737,1.392431943863272,0.10256410256410256,0.8046426984968547,1.0,4/18,4.65%,SLC30A10;SLC39A8;TRPM2;SLC39A11
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.588611533484315,1.3923460143059023,0.05128205128205128,0.8029349606581099,1.0,13/38,18.39%,MFSD2A;KIAA0319;BCL11A;SARM1;DCC;TNIK;RAP2A;COBL;CSMD3;LRP8;NEDD4;MARK1;ADGRB3
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.5050239223083418,1.3923053719993561,0.0,0.8009370241283713,1.0,33/154,14.35%,SLC17A6;NGF;THEM4;NKAIN3;POU6F2;CDK14;CPNE4;GRIP1;NXPH1;HRH3;ELAVL3;YDJC;PAK5;DTX1;SLC35F1;KCTD8;CSDC2;ERC2;GPHN;ADGRA1;DPP10;CELF5;BRINP1;FGF12;BTBD10;AKAP7;OLFM3;FBLL1;SCRT1;RBFOX1;MAP6;SNAP91;SRRM3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6507962537898804,1.3920674992078388,0.046511627906976744,0.8002732542890453,1.0,6/14,18.36%,HDAC3;HDAC1;NOTCH1;HDAC4;FZD7;HDAC5
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6134636803039805,1.3919423141284744,0.1,0.798463824005112,1.0,5/20,13.15%,NGF;MAGI2;RAPGEF1;RAB35;RAP1A
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.5839104772755995,1.3918106158432684,0.09375,0.797003883505738,1.0,17/51,17.88%,TGFBR1;FGF10;OSR1;ROBO2;IFT88;ITGA8;PROX1;WNT4;CEP290;GDF6;BMP4;NF1;PYGO1;ARL3;HAS2;SHH;NIPBL
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6264956044318017,-1.3915631505138095,0.08823529411764706,1.0,1.0,9/34,20.22%,MMP9;PINK1;GPER1;CIDEB;CLU;MOAP1;BIK;BBC3;PDCD5
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.6372225768121593,-1.3915200947536974,0.06666666666666667,1.0,1.0,24/51,20.82%,LILRB3;ITGB2;FCGR3A;HCK;CYTIP;TNFRSF1B;TAGAP;PTPRC;LY86;PARVG;PTAFR;SPI1;ADGRE1;IGSF6;NFAM1;MYO1F;CLEC12A;ITGAM;CD86;PSTPIP1;ITGAX;FPR1;CD300LF;CEACAM8
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.8527905208212438,1.390416107532289,0.07317073170731707,0.8028757857681048,1.0,2/6,12.64%,LRP6;NOTCH1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.72187994067043,1.39007839206194,0.14634146341463414,0.8027205972292918,1.0,4/14,8.31%,APOB;PPARG;ABCA1;LPL
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5910682580048607,-1.3897906320878337,0.0410958904109589,1.0,1.0,6/68,7.49%,CD44;NODAL;UACA;GPER1;BEX3;NLRP12
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.6933146833382902,1.3887149970482517,0.1794871794871795,0.8081241295215384,1.0,5/12,27.26%,MSTO1;TRAK2;MTM1;TRAK1;MEF2A
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.5971085863950442,1.3887010937409519,0.07894736842105263,0.8059820016041088,1.0,9/29,14.72%,DDAH2;GLA;CX3CR1;PKD2;PTGIS;AGXT2;KHSRP;DDAH1;INSR
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.590649113144411,1.3885383615937898,0.11764705882352941,0.8048146193942392,1.0,7/33,8.37%,DAPK2;TGFBR1;BCL2;CX3CR1;DEPTOR;NR4A2;STYXL1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.8150943457471378,1.387994616560881,0.0975609756097561,0.8052406059133442,1.0,2/6,8.66%,FOXO1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7148140793406981,-1.3875360935948509,0.06944444444444445,1.0,1.0,10/17,23.57%,FLG;ALOX12;FLG2;HRNR;ALOX12B;CLDN1;STMN1;ABCA12;TMEM79;LSR
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7148140793406981,-1.3875360935948509,0.06944444444444445,1.0,1.0,10/17,23.57%,FLG;ALOX12;FLG2;HRNR;ALOX12B;CLDN1;STMN1;ABCA12;TMEM79;LSR
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6141289286957904,1.387461311787466,0.09375,0.8047895823129777,1.0,10/34,14.06%,DUSP2;DUSP4;PTPRO;PTPRZ1;DUSP18;PTPN9;PTPRF;PTPRB;PTPRT;UBASH3B
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.7606472612998246,-1.3874184791381743,0.06896551724137931,1.0,1.0,8/15,19.37%,TBX1;HCK;TBX6;GDF11;IKZF1;HES7;MESP1;BMX
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.781405218382446,1.3874104760811687,0.18604651162790697,0.8026792807561853,1.0,3/9,4.50%,APOB;MFSD2A;SOAT1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.8560171581626498,-1.3871449672432454,0.03636363636363636,1.0,1.0,2/8,2.41%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.8560171581626498,-1.3871449672432454,0.03636363636363636,1.0,1.0,2/8,2.41%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.7025476735686873,1.3870902793216613,0.08888888888888889,0.802693238950903,1.0,7/11,21.13%,KIT;DSP;JUP;SERPINB8;CAMSAP3;THBS4;VCL
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5088657542384601,1.386953400569075,0.0,0.8015088058730279,1.0,34/92,21.59%,CDH20;SLITRK6;CDH19;CDH12;CDH7;NLGN1;CDH5;FZD5;SDK1;CDH6;DSCAM;FLNA;LIMS1;ACHE;FARP1;FSCN1;CDH2;CDH10;RYK;NLGN3;PKP4;NRXN1;CDHR3;CDH11;KIRREL3;PARD6B;NRCAM;ADGRL3;MYO9A;CDH8;CDK5;SDK2;PTEN;PCDHB6
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.8469264457603006,1.3863593102653218,0.025,0.8020615464535215,1.0,1/6,0.60%,LHFPL2
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.8530811258855824,-1.3857375816529944,0.06451612903225806,1.0,1.0,1/7,0.79%,TBX1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.7850308735584262,1.3856366896596253,0.1388888888888889,0.8033101074574892,1.0,4/8,11.22%,CYP1A2;EPHX2;STS;ALLC
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.8998007342761365,1.385227428319131,0.06666666666666667,0.8028303235404618,1.0,2/5,8.31%,HMGB1;LPL
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6116408299190341,1.3851211069235372,0.09523809523809523,0.8011673616385095,1.0,5/20,13.29%,DUSP2;DUSP4;PPP5C;DUSP18;PPM1A
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.5877209152982442,-1.3849933218080066,0.05555555555555555,1.0,1.0,15/57,14.46%,ST6GALNAC1;DUOX1;PLEKHS1;CLCA4;MS4A8;CYP2B7P;TMC4;FUT2;DUOXA1;ZNF750;MAP3K19;SLC5A1;CP;PROM2;BPIFB1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5294483787147537,1.3847025866445388,0.10714285714285714,0.801266626316415,1.0,30/117,15.58%,ZNF385D;SLC17A6;RAB27A;FGF10;NOVA1;ROBO2;ANGPT1;UNC5D;CNGA3;CADM2;MAGI2;HFM1;RSPO2;CELF4;CFC1;PDZRN3;RAB3C;SGIP1;OLFM3;RNF150;RBFOX1;MAP6;SNAP91;PDZRN4;NREP;NKTR;PTPRD;ASXL3;NRXN1;FGF14
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.4925604224612944,1.3838617708831595,0.06060606060606061,0.8036836896194055,1.0,33/106,20.93%,MCOLN3;SEZ6L;PROX1;KCNC2;CACNB4;HCN1;KCNJ6;WSCD2;CELF4;CATSPER2;ADCY2;GRM4;CACNG2;MYT1L;XKR4;SEZ6;UNC13C;NR3C1;CPNE6;DPP6;GNG7;NRXN1;SRRM4;FRRS1L;CACNA1A;SLC7A14;AP3B2;SLC24A2;CTNNA2;ST8SIA3;TNR;ZNF493;OTUD7A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.6608307312459812,1.3834010984511669,0.10416666666666667,0.8042220925308932,1.0,9/20,25.19%,GATAD2A;DNMT1;TEX15;ATF7IP;BAZ2A;FOS;METTL4;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.7607497075002705,-1.382961385674155,0.05263157894736842,1.0,1.0,2/16,6.68%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),0.8923628399774979,1.3828115273373771,0.08333333333333333,0.8051622954291072,1.0,3/5,8.31%,LIPC;APOE;LPL
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.8165970486695732,1.3823434343109322,0.07142857142857142,0.8053308629840076,1.0,1/7,1.83%,RAB31
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.593930670808151,1.3820737848018048,0.05128205128205128,0.804613040029304,1.0,9/31,14.52%,SCRIB;NMU;SNCA;GRIK2;SYT1;RIMS2;WLS;PTPN23;CLSTN2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.763592161096689,1.3819531413456403,0.16279069767441862,0.8034573122816052,1.0,3/8,19.57%,PID1;ENPP1;APPL2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5985714245025835,1.3817402306568456,0.125,0.8029882779790858,1.0,9/18,24.95%,PARD3;RAP2A;FERMT1;SIPA1L3;CAMSAP3;MYO9A;MYO18A;CYTH1;CYTH3
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7133497114148506,1.3787838011256555,0.15384615384615385,0.8165407215534,1.0,4/10,11.19%,PACSIN2;WASHC2C;WASHC2A;RAB35
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.7172568303397455,1.3785728999521043,0.10416666666666667,0.8157616797094064,1.0,4/11,9.84%,TGFBR1;ADAMTS12;GREM1;EFEMP1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.7961110550558302,1.378175773575729,0.14634146341463414,0.8157018718423815,1.0,1/10,0.50%,GRP
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8836901410362811,1.3778079623464317,0.024390243902439025,0.815206387482845,1.0,1/5,4.03%,AK3
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6384273149488877,1.3777879330984701,0.02702702702702703,0.8132506725025269,1.0,12/29,21.74%,PARD3;SCRIB;RAP2A;PDZD11;DLG2;ANK1;CAMSAP3;LIN7A;MARK2;DLG1;MYO9A;LRRC7
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5413555626569814,1.3777173172687642,0.08333333333333333,0.8115020525230301,1.0,8/48,7.82%,PLCH1;NGF;FGFR1;IRS1;PI4KB;PLCB1;PIK3C2B;PLCL2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.6307339044509457,-1.3774750087931074,0.0967741935483871,1.0,1.0,1/34,0.31%,NEK2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.7822521437244461,1.3772120689949416,0.14893617021276595,0.8120043055665646,1.0,2/7,7.87%,CX3CR1;CARD9
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5696098960719294,-1.376867326943423,0.045454545454545456,1.0,1.0,23/76,12.81%,LILRB3;RASGRP4;MPL;TGFB1;GMFG;ITGB2;FCGR3A;HCK;ARHGAP9;PDE6B;ALOX12;IL21R;GP1BA;TNFRSF1B;TAGAP;PARVG;SLC11A1;SPI1;NFAM1;ITGA2B;WAS;MYO1F;CLEC12A
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6125485280046805,1.3765665321588367,0.08333333333333333,0.8132494745073019,1.0,9/29,12.68%,MT1G;VEGFC;HSPB1;MAPKAPK2;ERN1;NR4A1;NUS1;NOTCH1;GAB1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5651206129580643,-1.376439839351811,0.056338028169014086,1.0,1.0,23/71,16.43%,ECT2L;ANKUB1;VWA3B;CCDC39;CCDC187;DYDC2;C11ORF16;CFAP126;DRC1;CCDC60;VWA3A;EFHB;MAP3K19;ATP5MK;RSPH10B;DCDC2B;DRC3;DNAH3;AKAP14;BPIFB1;APOBEC4;ZMYND10;DNAI1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5406853807905797,1.376034831738048,0.05405405405405406,0.8143709640069832,1.0,14/38,20.83%,APOE;SPOPL;LDLR;MAPK8;CHMP6;ODC1;SSH1;ABCA7;FAF1;SHH;GSAP;SPOP;SNF8;FURIN
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.9268484361594622,1.3757483856977848,0.0,0.813808218878219,1.0,1/5,0.37%,IRGM
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.8148690845819737,-1.3755167285931522,0.017857142857142856,1.0,1.0,2/10,2.73%,TGFB1;TAF7
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.6573500031542097,1.3743772072943565,0.1111111111111111,0.8186219246273411,1.0,5/15,14.02%,ZBTB7B;SIRT1;METRNL;TFE3;SOX13
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.9055147163956312,1.374044668490191,0.043478260869565216,0.8177794718213993,1.0,1/5,1.45%,HIP1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.525078606775481,1.3729322861726123,0.027777777777777776,0.8212031858822858,1.0,15/44,15.08%,HSPB1;FGFR1;ANGPT1;FGF18;APOE;SIRT1;PPARG;HMGB1;VASH1;SP1;NUS1;JUP;NF1;MECP2;CD40
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.8210921670999973,1.372779567829322,0.07692307692307693,0.8197787719899459,1.0,2/8,9.36%,GLYATL1;GLUD1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.6702273071852118,1.372533513703545,0.025,0.8190168256634098,1.0,5/22,7.03%,PHLDB2;APOH;APOE;SERPINE1;CRK
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.8299144815165855,-1.3717180383820802,0.08928571428571429,1.0,1.0,3/9,8.69%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7362978246461834,1.3715230504687312,0.0,0.8237965206811996,1.0,5/14,8.31%,FOXO1;IRS1;PID1;PPP5C;LPL
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.6551615922215676,1.3715129070909624,0.07692307692307693,0.8218008176673511,1.0,4/24,3.43%,MT1G;SLC30A10;MT4;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.6318760202239969,-1.3712000931358839,0.078125,1.0,1.0,1/31,0.31%,NEK2
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),-0.8950195323856731,-1.371193312178376,0.03773584905660377,1.0,1.0,3/5,8.69%,TGFB1;FLT4;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7603580713122677,-1.370642559349408,0.08333333333333333,1.0,1.0,2/11,5.43%,AMBP;GPER1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.7851740883700614,1.3706149684532731,0.05405405405405406,0.8237948156721686,1.0,3/9,10.79%,TOP2A;HMGB1;TOP1MT
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.832593879140195,1.3702225415009093,0.17073170731707318,0.8239084913193272,1.0,2/6,3.71%,RNLS;SPTBN4
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.6549289533656377,1.3696642173458489,0.13513513513513514,0.8245928156179433,1.0,6/17,24.62%,ACER2;PLPP2;ACER3;PLPP3;ACER1;ABCA2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),0.8505366647627441,1.3688582644913738,0.045454545454545456,0.8273630943307303,1.0,2/5,6.26%,IRGM;RIPK2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6941211497485862,1.3686668075379027,0.14705882352941177,0.8264819745937726,1.0,9/18,21.91%,TSKU;APOE;SOAT1;ABCA1;SOAT2;ABCA7;ABCG8;NPC2;SCARB1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.5249580527855593,-1.3682432032181127,0.043478260869565216,1.0,1.0,20/105,12.09%,IRF4;AMBP;MICB;AHR;ITGB2;FCGR3A;COL1A1;CXCL13;ICAM3;HLA-DRB1;SFTPD;GPR151;IRF1;HLA-A;KLRB1;OSCAR;C17ORF99;CD160;SH2D1B;FGL1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.6910561251948535,-1.3682247304465498,0.13559322033898305,1.0,1.0,4/21,6.02%,SLC28A2;JCHAIN;TULP1;ACTG1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5103832124044854,1.367699024245501,0.09523809523809523,0.8291585712711664,1.0,17/56,16.67%,CDH20;GJB6;CDH19;CDH12;CDH7;CDH5;CDH6;ZNF703;CLDN12;PKN2;JUP;FSCN1;CDH2;CDH10;PKP4;CDHR3;CDH11
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.5238248694252016,1.3672419045585436,0.037037037037037035,0.8294464019341702,1.0,19/50,23.27%,ST6GALNAC3;GANC;ST8SIA4;PRKCSH;HPSE;MAN1A2;NEU4;MAN2A1;NGLY1;MAN1A1;FBXO27;ADAMTS13;FBXO17;ST8SIA3;ST3GAL2;LARGE1;ST8SIA1;HIF1A;GAL3ST2
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5201054532875345,1.3668094881354749,0.06896551724137931,0.8295447418909051,1.0,27/112,14.62%,NTSR2;SLC17A6;SPHKAP;LRRTM3;SPTBN4;NXPH1;KCNC2;ELAVL3;NKAIN2;CADM2;PAK5;LRFN5;KCNIP1;PARM1;ADGRA1;BRINP1;ABCC8;RGS7BP;OLFM3;SCRT1;RBFOX1;DLX1;MAP6;SNAP91;PTPRT;ANK2;SYN2
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8792775065652714,-1.3664246790624905,0.015384615384615385,1.0,1.0,2/6,5.81%,STAT1;IL21R
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8792775065652714,-1.3664246790624905,0.015384615384615385,1.0,1.0,2/6,5.81%,STAT1;IL21R
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6908168844783028,1.3658811800651225,0.1282051282051282,0.8303764472537577,1.0,4/11,11.09%,GRM3;DRD3;ADGRV1;GRM2
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6908168844783028,1.3658811800651225,0.1282051282051282,0.8303764472537577,1.0,4/11,11.09%,GRM3;DRD3;ADGRV1;GRM2
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.5886014343121059,1.3653979312058675,0.07317073170731707,0.8309573673445169,1.0,11/24,33.29%,NAV3;PIK3CA;CAMSAP3;ATXN7;CIB1;TRIM54;FGF13;CLASP2;SPEF1;APC2;CLASP1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5833231048958541,-1.365205245698552,0.08955223880597014,1.0,1.0,15/49,19.36%,PSMB9;TIMP3;SERPIND1;TIMP4;SERPINB7;SERPINB5;SERPINE3;SERPINA10;SPOCK3;VTN;A2ML1;SERPINF1;VSIR;SERPINB1;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6224717372205107,1.3650620821350556,0.13513513513513514,0.8309393650339733,1.0,5/21,12.45%,SEMA5A;GOLGA4;DSCAM;MACF1;MAP3K13
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5232429244109902,1.3647351824976472,0.1111111111111111,0.830624093833574,1.0,7/47,7.89%,GABRE;GABRR2;GABRA5;SLC12A1;GABRG3;ANO5;SLC12A9
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6944598324899816,1.3642748068215478,0.1276595744680851,0.8307552955288121,1.0,6/13,22.23%,DNMT1;RESF1;SIRT6;ATF7IP;MPHOSPH8;TPR
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.46295270149447487,1.3642713771104726,0.07407407407407407,0.8288512914921845,1.0,45/118,21.59%,SLITRK6;GPC4;NLGN1;LRRC4C;PPFIBP2;GPC6;CX3CR1;FZD5;CACNB4;SDK1;SLC8A3;ZC4H2;SNCA;DSCAM;PPFIA3;LRFN5;CHRNA1;GPHN;PPFIBP1;PDZRN3;NLGN4X;ACHE;UNC13B;FARP1;PTPRF;UNC13C;CDH2;RYK;PTPRD;NLGN3;NRXN1;NEDD4;F2R;PPFIA2;KIRREL3;GRM5;NRCAM;MUSK;SLITRK2;PAK3;ADGRL3;CDK5;SDK2;PTEN;PCDHB6
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.7532142070384549,1.3641757550641336,0.11627906976744186,0.8271408551715574,1.0,4/8,21.71%,MLST8;CLEC16A;SMG1;LARP1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7035307902714545,-1.364089173510842,0.1111111111111111,1.0,1.0,3/16,5.98%,AQP3;GPR151;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6262459489763731,1.363959704737206,0.10810810810810811,0.8263957687905723,1.0,9/29,12.64%,BAMBI;TWIST2;PPARG;RORB;GREM1;CDK6;CRIM1;TWIST1;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.8208029582126274,-1.363896080936478,0.03389830508474576,1.0,1.0,2/8,3.38%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.8088611503406746,-1.363852677930927,0.14,1.0,1.0,3/6,17.37%,TGFB1;MSN;TGFB3
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.851700031639784,1.3638140316517982,0.14285714285714285,0.8250297948718279,1.0,1/5,3.38%,APOE
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),0.8914343147268142,1.3636255219250908,0.021739130434782608,0.8241099849830567,1.0,4/5,9.56%,APOH;DNMT1;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5586952686275566,1.3633433085580944,0.02857142857142857,0.8235600753778234,1.0,5/45,4.99%,CSTA;TBC1D10A;F2;PERP;SPOPL
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.914755449418243,-1.3625088420163802,0.10714285714285714,1.0,1.0,3/5,7.21%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.914755449418243,-1.3625088420163802,0.10714285714285714,1.0,1.0,3/5,7.21%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.914755449418243,-1.3625088420163802,0.10714285714285714,1.0,1.0,3/5,7.21%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8758231344284942,1.3624177189138396,0.06,0.8269516545684853,1.0,1/5,3.96%,AUTS2
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.8312705286800777,1.3623213778304077,0.10869565217391304,0.8256699467154136,1.0,4/5,16.72%,SPATA7;ARL13B;BBIP1;ZDHHC3
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.822005769388211,-1.361626570819751,0.07575757575757576,1.0,1.0,3/7,5.98%,UMODL1;ITGB2;ANXA1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.7852522549849956,1.3614685098964399,0.09302325581395349,0.8274072057355477,1.0,3/8,11.31%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6151971329015766,-1.3608662161292229,0.08695652173913043,1.0,1.0,4/27,7.34%,UMODL1;ITGB2;CXCL13;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.7434942562234468,-1.3601574354121695,0.13333333333333333,1.0,1.0,2/11,4.58%,WNT5A;IL7
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.49568062838890375,1.3601111464951632,0.08695652173913043,0.832033671020875,1.0,31/146,16.04%,NTSR2;CDH20;SPHKAP;GJB6;NFATC3;APOE;LRRTM3;BAALC;TMEM132C;CADM2;PTPRZ1;SRR;KCNIP1;AANAT;LUZP2;SYNDIG1;ADGRA1;PLXNB1;IL23A;BRINP1;RGS7BP;GABRG1;RBFOX1;SNPH;MAP6;GSTA4;FGFR3;CD40;NRXN1;NKAIN4;KCNJ10
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.8192579983751791,1.3589244870840755,0.13953488372093023,0.8358798439059806,1.0,6/6,18.09%,SLC3A2;SLC38A5;SLC16A10;SLC25A29;SLC7A8;SLC36A4
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.575504795845227,1.358792592616936,0.06666666666666667,0.8344811714168461,1.0,12/38,21.03%,TNFRSF19;RIPK2;MAPK8;MAP3K10;MAP3K13;MAP2K7;TAB3;TAB1;MAP4K2;CRKL;TAB2;TRAF6
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.7850516499003084,1.358735687689072,0.14,0.8328372205584295,1.0,3/6,12.65%,SLC3A2;SLC6A17;SLC7A8
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.6957713335240695,1.3567155426472868,0.07894736842105263,0.8420730348818029,1.0,5/13,12.32%,MEGF10;XKR7;RHOBTB1;XKR6;XKR4
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.6408342229739936,-1.356592960218524,0.06779661016949153,1.0,1.0,1/31,0.10%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6564777707163011,1.3565214578452682,0.10256410256410256,0.8409203541599491,1.0,11/22,21.65%,CDH5;UBE2O;CCN1;BMP4;NOTCH1;SMAD2;ELAPOR2;RBPJ;ACVR2A;BMPR2;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6997958043353063,1.3562668702559302,0.17647058823529413,0.8402730080644404,1.0,4/11,13.97%,GREM1;ECM1;BCOR;ENPP1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.8221523367041602,1.3561786828149887,0.13333333333333333,0.83877339474519,1.0,2/5,10.41%,MAPK8;CAP2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.508265977341511,1.3561398034609689,0.041666666666666664,0.8371028780535722,1.0,25/87,20.51%,NGF;TGFBR1;BCL2;MFSD2A;SYT17;ERBB2;SLC25A33;GOLGA4;SYT3;SYT1;RPS6KA3;ADNP2;RIMS2;MACF1;MAP3K13;KLHL22;SMURF1;CPNE6;CPNE9;SLC44A4;BRAT1;ADAM10;LIMK1;DNPH1;LGI1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9051909676711009,-1.356036801452294,0.03773584905660377,1.0,1.0,3/6,7.21%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.7900727489465581,1.3560029788019412,0.046511627906976744,0.8358301829011823,1.0,4/7,9.56%,APOH;SIRT1;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),0.7836284325469975,1.3555483286584058,0.11764705882352941,0.8361912877343153,1.0,1/6,6.88%,BATF2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.48593444681362885,1.3553362848027213,0.027777777777777776,0.8352442475393743,1.0,7/70,7.39%,ADGRF4;NIPAL1;ANXA3;SIRT1;PERP;SERPINE1;CDCP1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5902517086377286,1.355313449379231,0.05405405405405406,0.8336321163671324,1.0,15/42,13.21%,GPC4;HS6ST2;HS3ST3B1;EXT1;HS3ST1;SDC4;GPC6;HS3ST5;HS2ST1;HS3ST2;GPC5;UGDH;B3GAT3;EXT2;SDC3
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.7598696646296296,-1.3552647863485037,0.08928571428571429,1.0,1.0,1/11,0.35%,IRF4
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.7638737840510846,-1.355171902712163,0.1111111111111111,1.0,1.0,1/7,3.79%,SCN5A
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5536262688643309,1.3550732372570315,0.06666666666666667,0.8329060581907269,1.0,8/32,19.91%,GSTM5;CHAC1;GSTZ1;GSTA4;GSTM2;ETHE1;GPX1;GSR
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.5537273981428449,1.353502352010553,0.08823529411764706,0.8398289267235313,1.0,18/32,30.16%,BIN1;APOE;LRRTM3;SP1;CASP3;RTN2;ABCA7;GSAP;NTRK2;RTN1;SLC2A13;ABCA2;ABCG1;ROCK1;RELA;EPHA4;PIN1;IGF1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.5597211588311001,1.3531839980022122,0.07894736842105263,0.8394071174359766,1.0,9/48,9.95%,TGFBR1;ZSWIM5;NRG2;ERBB2;NRG1;CDK6;ABL1;ABL2;PKN2
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.903893342394971,1.3529659759417323,0.11363636363636363,0.8383936632435702,1.0,1/5,0.05%,GABRE
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.4553739330338712,1.3529584727694939,0.034482758620689655,0.8365486926983436,1.0,14/91,9.74%,GRID2;RORA;CDH5;AOAH;APOE;METRNL;IFI16;PPARG;SERPINE1;CRK;PTGIS;LRFN5;DRD3;SHARPIN
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.6646028605903532,1.3523670177246323,0.15789473684210525,0.8377706759506105,1.0,3/12,11.20%,ACO1;GLUD1;IDH2
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.765592799849593,1.3521947518309962,0.1590909090909091,0.836941062839511,1.0,2/8,3.73%,HDAC10;SIRT1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.8146836417757383,1.3521458214413755,0.08571428571428572,0.8335665870062822,1.0,2/8,3.68%,APOE;CEL
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.8146836417757383,1.3521458214413755,0.08571428571428572,0.8335665870062822,1.0,2/8,3.68%,APOE;CEL
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.800867762785405,1.3519674168509788,0.04878048780487805,0.8323728677476859,1.0,3/7,9.82%,MAGI2;MYO1E;JAG1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5784705742315798,1.3515684300781932,0.05,0.832421874686282,1.0,13/30,21.19%,CAPN10;IRS1;PID1;AKT2;IRS2;ENPP1;INSR;OCLN;RTN2;APPL2;OSBPL8;PRKAG2;C1QTNF12
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.8185252606682308,-1.3513354948167924,0.11864406779661017,1.0,1.0,2/8,2.68%,TBX1;COL5A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5228320564123484,1.3510690947646207,0.06666666666666667,0.8332252118405956,1.0,23/64,23.79%,MYO10;TBC1D10A;IFT88;TBC1D16;TRPM2;FER;SDCCAG8;TBC1D22B;FSCN1;IFT140;SGSM3;TBC1D2;FXR2;TBC1D8;RAB5A;DCDC2;USP6NL;TBC1D5;ATP8B1;RABEP2;EVI5;PPP1R16B;CAPZB
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5413521151201973,1.3506738664294502,0.025,0.8334432356126562,1.0,17/47,13.21%,GPC4;HS6ST2;HS3ST3B1;EXT1;HS3ST1;SDC4;GPC6;HS3ST5;HPSE;HS2ST1;HS3ST2;GPC5;UGDH;GLB1;B3GAT3;EXT2;SDC3
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.7848961640720779,-1.3504018084446008,0.14583333333333334,1.0,1.0,1/8,1.26%,PLAAT4
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.8703449817672367,-1.3502900366585997,0.0,1.0,1.0,2/5,7.89%,CYP26B1;PRAME
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.48319085373386234,1.349679899791058,0.13043478260869565,0.8365286333595618,1.0,35/115,23.79%,FHDC1;STX5;BLZF1;UBXN2A;GBF1;STX6;TRAPPC12;PLK3;TICAM2;BET1;GCC2;TMED3;PI4K2B;ARHGAP21;VTI1A;FAM174B;GOLGA8H;PRMT5;COG7;SEC22B;COG4;GOLGB1;UBXN2B;USP6NL;TRIP11;GOLGA8S;ATP8B1;COG2;ZNF501;MYO18A;SYNE1;COG3;VMP1;TRAPPC11;CDK1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6626367185104245,1.3493844137727242,0.08823529411764706,0.8365340249616692,1.0,10/16,20.36%,NLGN1;CEL;NLGN4X;RET;NCAM2;NLGN3;NRXN1;NLGN4Y;ASTN2;NRXN3
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.6006390268126255,-1.3491746563886768,0.13043478260869565,1.0,1.0,9/28,14.34%,TGFB1;ESR1;GPER1;ANXA1;H2AZ1;WNT8B;FAM210B;SSTR1;SFRP1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.7164892059947378,-1.34909372636153,0.12727272727272726,1.0,1.0,5/14,15.59%,NRAP;ACTC1;NEB;CSRP3;TTN
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7672054721589877,-1.348928765575368,0.05084745762711865,1.0,1.0,3/11,10.71%,AQP3;UPK3A;AQP4
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),0.8624400443737348,1.348850029540182,0.07142857142857142,0.8374573220752776,1.0,2/5,4.45%,PER2;PID1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8791413105339126,-1.3486416012900504,0.10344827586206896,1.0,1.0,2/5,10.19%,COL5A1;SLC11A1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6761306758383544,1.3476871498119585,0.06976744186046512,0.8416332091730402,1.0,3/12,6.17%,PCM1;BICD1;CCDC120
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.6427568742961938,1.3474466891359964,0.09523809523809523,0.8408489119902026,1.0,2/15,3.71%,CCN4;ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),0.7076283267134083,1.3474142669057525,0.11764705882352941,0.8390209795728327,1.0,1/10,3.38%,APOE
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.7865777065886194,1.3474015972029698,0.1702127659574468,0.8372009774479459,1.0,3/5,21.20%,PPP1R15B;ABCA7;NCK1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5371369250838597,-1.3467160265503944,0.04225352112676056,1.0,1.0,25/118,13.31%,CD44;C1QB;MGST1;MPL;FCGR3A;DAB2;HMGB3;HCK;C3AR1;TAF7;LYVE1;VSIG4;MS4A4A;PTPRC;PROCR;TLR2;ABCG2;ABCB1;IL3RA;SPI1;GNL3;TXNIP;ITGA2B;CLEC12A;TEK
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.7073559159005821,1.3466644234284946,0.16129032258064516,0.8383818740475424,1.0,2/11,7.34%,SIRT1;POLD3
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5015524347377399,1.346623862227962,0.03125,0.8367388980784614,1.0,10/66,7.82%,PLCH1;NGF;NYAP2;FGFR1;IRS1;PI4KB;ERBB2;PLCB1;PIK3C2B;PLCL2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7968841123302783,-1.3463962714375586,0.09836065573770492,1.0,1.0,3/8,15.58%,DCN;IL12A;PIK3CB
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6395033070394905,-1.346219356781378,0.07246376811594203,1.0,1.0,9/29,20.51%,ITGB3BP;CENPU;RBBP7;CENPH;OIP5;SMARCA5;CENPM;CENPN;CENPL
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6413984435804748,1.3456945545130161,0.13333333333333333,0.8399582539250386,1.0,7/19,21.19%,GCK;CRY1;HDAC4;EP300;CLK2;GIT1;C1QTNF12
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8119023368405334,1.3455171745553605,0.0851063829787234,0.8390874413403242,1.0,4/5,16.74%,RNF10;HES1;NOTCH1;SKI
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.47989492046270543,1.345443579753054,0.0967741935483871,0.8377869361037334,1.0,25/85,13.62%,ADGRF4;MXRA5;LAMA3;ACTG2;EMP1;PARVA;PERP;CA3;COL12A1;DSP;SDC4;ERBB2;NTN4;LRIG3;FHL2;LTBP2;EFEMP1;COL16A1;RND3;MYO1C;FERMT1;WWTR1;ITGA3;PXN;CNN1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6458608588333002,1.3452699045240915,0.15789473684210525,0.8368579636535919,1.0,7/18,19.97%,NEUROD2;CDH13;RGN;RIT2;CD22;SLA2;PLCG2
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.859662130648088,-1.3448280466530704,0.1,1.0,1.0,1/6,0.86%,TCF7
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.8844123981892256,1.344353013063877,0.058823529411764705,0.8400495492246105,1.0,1/5,0.37%,IRGM
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.656594916739484,-1.3441222601841711,0.12903225806451613,1.0,1.0,2/23,6.29%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.6170243774540416,1.3431535972250563,0.18181818181818182,0.8454139399846476,1.0,14/27,26.80%,ESPL1;TGFA;DRD3;INSR;ANAPC7;NSMCE2;DLGAP5;DMRT1;BTC;LRP5;RB1;EDN1;PHIP;ANAPC4
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7272278969383293,-1.3427000995991332,0.1,1.0,1.0,2/13,9.31%,ZWILCH;TTK
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.7472502528731861,1.3421094772797402,0.14583333333333334,0.8485076260926484,1.0,3/11,5.76%,MT1G;MT4;SNCA
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.7849610603093006,1.3419715648987072,0.13953488372093023,0.8436843760354735,1.0,1/6,6.63%,GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.7849610603093006,1.3419715648987072,0.13953488372093023,0.8436843760354735,1.0,1/6,6.63%,GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.7849610603093006,1.3419715648987072,0.13953488372093023,0.8436843760354735,1.0,1/6,6.63%,GBF1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.792348139478981,1.3419303855831928,0.08163265306122448,0.8420027853691917,1.0,1/7,1.90%,CPEB1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.774556014022344,1.3418662441556843,0.045454545454545456,0.8405245294013689,1.0,3/10,13.63%,SKAP1;LCK;FUT9
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.768981331606339,-1.3417904000909284,0.10526315789473684,1.0,1.0,3/11,15.78%,ITGB2;HLA-F;ITGAM
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.8082610595727451,1.3411253023202625,0.13043478260869565,0.840876374579224,1.0,3/5,15.70%,SMYD5;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.8082610595727451,1.3411253023202625,0.13043478260869565,0.840876374579224,1.0,3/5,15.70%,SMYD5;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6423664719911758,-1.341080535855787,0.11594202898550725,1.0,1.0,9/27,20.51%,ITGB3BP;CENPU;RBBP7;CENPH;OIP5;SMARCA5;CENPM;CENPN;CENPL
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6423664719911758,-1.341080535855787,0.11594202898550725,1.0,1.0,9/27,20.51%,ITGB3BP;CENPU;RBBP7;CENPH;OIP5;SMARCA5;CENPM;CENPN;CENPL
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.87389310837847,1.3408465064859962,0.10204081632653061,0.840482377149245,1.0,2/5,7.22%,SEMA5A;DSCAM
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.5691965535953764,1.340223141505615,0.09375,0.8414523329508093,1.0,13/31,24.52%,PLEKHG2;COTL1;ABL1;LATS1;HCLS1;FCHSD2;TPPP3;CAMSAP3;PAK3;GBA2;ARHGAP18;MAP2;TPPP
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),0.7556140198188694,1.3400719991962746,0.20512820512820512,0.840637988928215,1.0,2/9,1.59%,DUSP2;DUSP4
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),-0.8004954084529523,-1.339968688501524,0.09523809523809523,1.0,1.0,5/8,12.15%,ALOX12;ALOX5;ALOX15;ALOX12B;ALOX15B
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),-0.8004954084529523,-1.339968688501524,0.09523809523809523,1.0,1.0,5/8,12.15%,ALOX12;ALOX5;ALOX15;ALOX12B;ALOX15B
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.7113534679584951,-1.3399081305273755,0.15789473684210525,1.0,1.0,2/10,3.18%,LMOD1;TMOD4
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.46482764783889624,1.3397011257639444,0.0,0.8406991590220558,1.0,24/221,9.69%,CPA1;HGFAC;PRSS3;PRSS57;CPN1;CAPN10;NAALAD2;KLK14;MMP17;ADAMTS12;HTRA2;CAPN2;KLKB1;TMPRSS7;MMP2;TRHDE;TMPRSS2;VASH1;F12;SENP1;CTSV;CELA2A;PGPEP1;ADGRV1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6119030427687169,1.3396484462783753,0.16279069767441862,0.839277310145923,1.0,3/19,7.10%,CHRM2;LYPD1;PLCB1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.7264125974154547,1.3396249717402149,0.10256410256410256,0.8376683451151661,1.0,5/11,22.02%,HDAC3;PKD2;HAS2;SREBF2;NFE2L2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6604484342855707,1.3395816962296438,0.11428571428571428,0.8361623311800279,1.0,8/14,28.88%,COQ2;PDSS2;UBIAD1;AIFM2;COQ9;COQ10A;COQ6;COQ3
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.7195621399823975,-1.3395372563742654,0.13636363636363635,1.0,1.0,1/20,0.10%,ENPP2
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8291080849116552,1.3393492947856953,0.047619047619047616,0.8353993243161064,1.0,2/7,5.76%,BCL2;SNCA
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.7670015855629414,1.339030300486576,0.125,0.8353427693355696,1.0,1/9,3.14%,CSGALNACT1
prerank,PanglaoDB_Augmented_2021__T Cells,0.5212423653581254,1.338961319711821,0.09090909090909091,0.8338189049230441,1.0,14/91,5.52%,IL7R;SKAP1;EEF1B2P3;DUSP2;CD247;SELPLG;GPR174;BCL2;RORA;TRAC;CCL4L2;TGIF1;PYHIN1;IL16
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6254188823878412,1.3384846947837772,0.1111111111111111,0.8341797104554132,1.0,7/21,11.77%,EYA4;FGFR1;BCL2;HTRA2;PPP2R1B;RET;HSPA1A
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.7143016354097824,1.3384575578149325,0.10869565217391304,0.8325691392688331,1.0,1/10,0.84%,EIF2S3B
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.6578146481142538,1.33828623901285,0.15217391304347827,0.8300005415567149,1.0,8/18,25.19%,GATAD2A;DNMT1;TEX15;ATF7IP;BAZ2A;FOS;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.6578146481142538,1.33828623901285,0.15217391304347827,0.8300005415567149,1.0,8/18,25.19%,GATAD2A;DNMT1;TEX15;ATF7IP;BAZ2A;FOS;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.8358901441622001,1.3382370859781192,0.0851063829787234,0.8284714428957521,1.0,4/8,14.12%,FGFR1;PLIN5;PLA2G5;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.6018182205739103,1.3382098235231186,0.125,0.8269800622822427,1.0,11/33,11.05%,VWC2;NGF;FGFR1;NEUROD2;BRINP3;PROX1;ZC4H2;ZEB1;BEND6;BRINP1;ASCL1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.42011730186759666,1.3381360323750733,0.0,0.8258092297698528,1.0,87/370,21.36%,ARC;AUP1;PNPLA3;RAB31;HPS3;TTC29;KLHL20;TOR1B;BIN1;APOE;PACSIN2;TFB1M;FGD4;SYNE3;SIPA1;REEP6;PCLO;BLZF1;PAK5;SLC25A33;MSTO1;RAB7A;PKD2;UBXN2A;GBF1;TRAPPC12;PLIN5;MAST1;IRAG2;EIF2AK3;MAST2;FGD5;TNIK;ZFYVE16;TICAM2;SMPD4;ABCD3;ABCD2;TTC17;SH3KBP1;TMED3;WASF3;FGD1;PI4K2B;MNS1;CHMP6;MYC;CSPG5;ARHGAP21;PDZD8;DST;MIEF2;FAM174B;GOLGA8H;FAM161B;COG7;MAST4;ZMYM4;COG4;SIPA1L3;LIG4;MARK4;MARK1;GABPA;GABPB1;DYRK3;GOLGB1;YTHDF1;ANK1;ARHGAP10;UBXN2B;MICAL1;DOP1B;MIA3;USP6NL;TMCC1;TRIP11;GOLGA8S;SH3D19;MICAL3;AFG1L;PLEKHF1;ATP8B1;BRWD1;FGD6;ATXN7;COG2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.4844821063713799,1.3381328735419087,0.06451612903225806,0.8241723157704645,1.0,26/122,14.35%,SLC17A6;MEGF10;ARX;CACNG4;APOE;POU3F2;NXPH1;ELAVL3;PTPRZ1;PAK5;SLC35F1;KCNIP1;RHBDL3;ADGRA1;MSI1;RND3;STOX2;ASCL1;NPAS3;CSPG5;RIMS4;SCRT1;DLX1;MAP6;SNAP91;SRRM3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.49576199586457836,1.3380944203945115,0.07692307692307693,0.8227612715866144,1.0,32/72,27.26%,SLITRK6;LLGL1;PARD3;MFSD2A;DSCAML1;SPTBN4;DCC;NTNG2;FARP1;MAP6;CDHR1;RAB10;RYK;PARD6B;CTNNA2;DCDC2;NRCAM;SLITRK2;PAK3;CDK5;ANK3;S100B;MAP2;TAOK2;UNK;PLPPR4;CNTN4;RB1;MEF2C;SLITRK3;DOCK7;MEF2A
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5456392254082002,1.3380230082949416,0.14705882352941177,0.821418427983273,1.0,25/67,25.29%,LLGL1;RFNG;MAML1;DTX1;CHAC1;WWP2;BEND6;JAG1;POFUT1;NOTCH4;DLK2;NOTCH1;ARRB1;RBPJ;KAT2B;SREBF2;EP300;NRARP;ZBTB7A;TCIM;JAG2;YJEFN3;NOTCH3;EPN2;EGFL7
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6556492972563178,1.3373114016013228,0.125,0.8235439990290594,1.0,3/15,4.45%,HSPB1;SIRT1;HTRA2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.8803878053434926,-1.3369942648649158,0.04918032786885246,1.0,1.0,2/5,11.56%,PINK1;REST
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.7136692257642521,1.3363487311311522,0.15384615384615385,0.8259412735990176,1.0,4/9,21.13%,ZNF703;SMAD7;PAK2;VCL
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.7173813863621555,1.3361130610772207,0.14705882352941177,0.8255012614574825,1.0,3/12,17.98%,TOP2A;RESF1;MPHOSPH8
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5170182687348502,1.3359701493365417,0.12121212121212122,0.8244737858886094,1.0,31/113,15.58%,EDIL3;PCDH17;ARX;MAFB;PLPPR1;KCNB2;ALDH1A1;PROX1;CNGA3;SLC38A5;GPC6;RFX6;CNTN3;RESP18;KCNIP1;DEPP1;CFC1;KLHL41;PDZRN3;RAB3C;ABCC8;RGS7BP;SCGN;DDAH1;MAGI1;MAP6;PTPRT;RAI2;PTPRD;ASXL3;FGF14
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6811141662316539,1.335933149154075,0.1590909090909091,0.8229861568337775,1.0,1/13,0.82%,SLC26A7
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.7043170736735472,1.335296973610811,0.11627906976744186,0.8244697167751274,1.0,1/14,1.90%,CPEB1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.6183517751355231,1.3347562165793354,0.11904761904761904,0.8259782165581241,1.0,2/15,8.72%,CDH5;KANK1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7169739577137132,1.3342111320618724,0.18181818181818182,0.8267731254475842,1.0,4/11,8.68%,HTRA2;HJV;TMPRSS2;F12
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.8023460467051593,1.3338523356576344,0.1111111111111111,0.8267358536656232,1.0,1/8,1.06%,DAPK2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.7125634455555045,1.3334860717938941,0.09375,0.8266680843363077,1.0,4/14,6.85%,SELPLG;PODXL2;CX3CR1;ITGA4
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.8272845239790348,1.3334477266734808,0.14893617021276595,0.8252242904703615,1.0,3/5,9.63%,ST6GALNAC3;GLA;GAL3ST1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6162192663024133,1.3328525513829055,0.16279069767441862,0.8263196753740771,1.0,7/20,11.49%,MRAP2;KLK14;BICD1;SNCA;CRY1;RGS14;RPGRIP1L
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.6899008395461977,1.3324927987294328,0.0975609756097561,0.826039870526666,1.0,2/12,0.94%,ADRA1A;DGKD
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6706728294001385,-1.3324509495994146,0.046153846153846156,1.0,1.0,6/16,17.71%,PKP2;CAV3;SCN5A;KCNQ1;KCNE3;KCNE2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.6005964197221239,1.3320158676058487,0.15625,0.8270077533752854,1.0,4/32,3.38%,APOH;DGKD;PNPLA3;APOE
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.740021826874054,1.3317103990901333,0.15555555555555556,0.8272132226154825,1.0,6/9,22.55%,TDO2;KYAT1;AADAT;KYNU;KYAT3;AFMID
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.6375242483226129,1.331413250048574,0.1282051282051282,0.8273573184860387,1.0,2/15,12.26%,HIP1;SGIP1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.4783981477554773,1.3309335165739047,0.08333333333333333,0.8283472163221433,1.0,36/109,19.88%,NGF;ZNF804A;ROBO2;GRIP1;APOE;MAGI2;TOX;EPHA3;RAPGEF1;SLIT2;TENM3;STYXL1;ARSB;FZD1;RETREG3;ABL2;PLXNB1;AVIL;RET;MAP3K13;CHODL;ARHGAP35;RAP1A;CUX1;FUT9;MAP6;PTPRD;ROR1;RIT2;PLXNA4;NTRK2;PTK7;EP300;PTK6;CARMIL2;MARK2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.8375295752279788,1.3306166250851208,0.09259259259259259,0.8283377079484068,1.0,2/5,11.70%,PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.6698661053456327,-1.3300976588300333,0.16923076923076924,1.0,1.0,5/18,21.79%,DAB2;CHMP3;MSN;MAP2K1;DENND10
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5881722126249761,-1.3300524497569022,0.10666666666666667,1.0,1.0,11/35,20.51%,ITGB3BP;CENPU;RBBP7;CENPH;OIP5;ANP32E;SMARCA5;CENPM;CENPN;RNF8;CENPL
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5987514209171636,1.329787828139419,0.11428571428571428,0.8313693542725005,1.0,6/22,10.23%,GRIN3A;TGFBR1;SDF4;SLIT2;DRD3;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6556372669953903,-1.3297288937197524,0.07142857142857142,1.0,1.0,5/20,14.09%,DUOX1;TGFB1;P2RY12;CAVIN1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.7393723009549737,-1.3296427938964126,0.19672131147540983,1.0,1.0,3/13,10.63%,WNT5A;CXCL13;DOCK8
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.5949208858639864,-1.3295748749279548,0.08771929824561403,1.0,1.0,10/43,10.19%,SIRPG;HCK;TULP1;SFTPD;CYBA;OLFM4;PTPRC;DOCK2;TLR2;SLC11A1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6352818292259341,1.3292586513413618,0.05128205128205128,0.8332172510888963,1.0,6/21,16.40%,MYO10;CCDC88B;DYNC1I2;CCDC88A;MAP6;TUBA1C
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.8374244247651326,1.3287517188618871,0.047619047619047616,0.83415819849253,1.0,2/6,1.69%,NUDT4B;FHIT
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5577683655581338,1.3286992123499204,0.12121212121212122,0.8328203815410097,1.0,5/32,11.19%,FOXO1;PER2;CX3CR1;ASCL1;HES1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5553143337616727,1.328694685408501,0.15217391304347827,0.8312188038842001,1.0,13/46,9.12%,GPC4;APOB;CYP4V2;ALDH1A1;APOE;SDC4;AKR1C3;GPC6;AKR1C1;ADH4;LPL;RPE65;GPC5
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5706710048180332,-1.3278069970296862,0.078125,1.0,1.0,15/49,29.15%,MCM2;ANXA1;MCMDC2;DDX1;PIF1;RBX1;HMGA1;RPS27A;DDB1;RECQL4;SUPV3L1;BLM;CETN2;UBB;MCM6
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.6427848585476532,1.3277930016896131,0.15789473684210525,0.8336194035115406,1.0,7/19,16.57%,CEP135;CEP120;CROCC;CCDC88A;ARHGAP35;SEPTIN9;MARK4
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7501409208113333,-1.3276879569594267,0.10526315789473684,1.0,1.0,2/10,5.27%,TBX1;STAT1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8095247837228386,1.3273543094888027,0.07317073170731707,0.8342844943199816,1.0,2/5,7.10%,LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.8390724825365609,-1.327320829654814,0.1,1.0,1.0,3/5,7.49%,TAF7;CIITA;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.9097709898413692,-1.3268666836571772,0.05454545454545454,1.0,1.0,1/5,0.90%,WNT5A
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6594004764216874,1.3260009690073795,0.08333333333333333,0.8397298807882161,1.0,4/14,11.51%,LDLR;ABCA1;LRP6;STARD4
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6426968957987396,1.325465333391801,0.125,0.8410034298841209,1.0,7/14,20.70%,SIRT7;SMARCB1;PIH1D1;SMARCA4;MARS1;MACROH2A2;IPPK
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.7453300193806714,1.325262369305413,0.2708333333333333,0.8404373052606104,1.0,2/8,15.51%,MTO1;TRMT61B
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.6108042088505969,1.3245777117230846,0.1320754716981132,0.8419409681928587,1.0,4/19,11.49%,PNP;POLD3;AMPD1;CDA
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.8171883442230645,1.3240084503615328,0.13043478260869565,0.8431735902778245,1.0,2/8,7.19%,VPS8;SAMD9
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.747027614893648,1.3238163847518614,0.09803921568627451,0.8424005918152393,1.0,6/10,18.84%,IRS1;SNCA;AKT2;IRS2;GPLD1;PRKCE
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7224207324574363,1.3237873960760156,0.10810810810810811,0.8409256326630183,1.0,5/13,17.98%,DNMT1;APOBEC1;RESF1;ATF7IP;MPHOSPH8
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),0.8594478491779467,1.3234132080549068,0.09302325581395349,0.8411271782701235,1.0,2/5,4.06%,GABRE;HRH3
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8089131760879127,1.3229526172901842,0.0851063829787234,0.8420301930119334,1.0,3/6,17.55%,DHFR;GCH1;FPGS
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.8538894759302522,1.3228235279036007,0.11904761904761904,0.8409147016738687,1.0,3/5,11.67%,GLYATL2;ABHD3;ACADM
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.7070869467224224,1.3227177804673251,0.1282051282051282,0.8398325457631003,1.0,3/11,8.40%,GREM2;GREM1;LTBP1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5776859262952925,1.3220944809099948,0.06896551724137931,0.8413148144182689,1.0,4/32,6.21%,ATP6V0D2;RAB20;TCIRG1;RAB7A
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6070958633101398,-1.3220670066355689,0.13333333333333333,1.0,1.0,6/29,15.58%,EPN1;ALOX5;CEACAM1;CEMIP2;THBS1;PIK3CB
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.72875459162125,1.3208345120165197,0.16279069767441862,0.8458989018967239,1.0,1/10,0.57%,PCDH15
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.7513850197939616,1.320821678103314,0.13333333333333333,0.8443497188709327,1.0,2/7,20.79%,SLC8B1;SLC35G1
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.8362608739398153,-1.3208028916467571,0.07407407407407407,1.0,1.0,1/6,8.69%,CEACAM1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6990018822537242,1.320627224940766,0.15,0.8433270922089372,1.0,1/11,0.84%,AUP1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.49576599842463,-1.3205471013029186,0.06756756756756757,1.0,1.0,65/154,27.70%,RPL37A;ERN2;PWP2;NOB1;SENP3;SLFN14;RPL15;RPL3;RPL38;RPL35A;RPS9;RPL7A;EMG1;RPL13;RPS27;RPL13A;RPS16;NOP53;RPL27A;RPL9;LAS1L;RPL5;RPL21;RPL34;RPL4;RPL23;WDR12;RPS14;EXOSC2;RPL18A;RPL32;IMP3;RPL36;EXOSC8;RPL18;RPL29;RPS7;RPS15;RPL41;RPS28;RPLP1;SBDS;RPL12;RPL11;RPL35;RPL22;RPL27;RPL24;PDCD11;RPLP2;RPS19;RPL28;RPL19;RPS24;RPL10;RPS25;PIH1D2;DDX49;DHX37;RPS6;EBNA1BP2;RPL8;RPLP0;UTP15;MRTO4
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.8338702008507171,-1.3201128635511812,0.14634146341463414,1.0,1.0,3/5,16.55%,ALOX5;PLAU;VIL1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.5725144558491951,1.3195374107610063,0.10344827586206896,0.8466978463357142,1.0,3/21,13.65%,PLD6;GDAP1;MIEF2
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),-0.7973093784247415,-1.3193369728365525,0.15384615384615385,1.0,1.0,2/5,14.83%,CD160;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),-0.7973093784247415,-1.3193369728365525,0.15384615384615385,1.0,1.0,2/5,14.83%,CD160;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.66410625317402,1.3189350399970003,0.05128205128205128,0.8484418800314721,1.0,8/14,21.00%,SHLD2;SHLD1;KMT5C;SMCHD1;SETMAR;KMT5B;WRAP53;PNKP
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.7296926967549476,1.3185999274896474,0.14893617021276595,0.8486545461878977,1.0,5/11,16.29%,ELOF1;CDCA4;ARID1A;SERTAD2;ARID1B
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.482998623403369,-1.3182626579857193,0.04,1.0,1.0,74/195,28.13%,RPL37A;NARS1;RPL15;RPL3;RPL38;DARS2;COPS5;RPL35A;RPS9;RPL7A;EEF2;RPL13;RPS27;RPL13A;RPS4X;RPS16;YARS2;MRPS34;RPS20;RPS8;RPS21;RPS11;ABCF1;MRPL34;TMA7;RPL27A;RPL9;RPL5;RPL21;RPL34;RPL4;RPL23;RPS14;WARS1;RPL18A;RPL32;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;PPA1;RPSA;RPL41;RPS28;RPLP1;RPL12;EEF1A1;RPL11;DRG1;RPL35;RPL22;RPL27;ZC3H15;RPL24;RPLP2;RPS13;RPS19;RPL28;RPL19;RPL26L1;RPS24;RPL10;RPS25;RPS3A;ASMT;RPS6;RPL8;RPLP0;RPS12;RPS3;MRPS2;GFM2
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.6253749528808368,1.3180264587995003,0.16216216216216217,0.8492972061867932,1.0,4/17,12.59%,AUP1;PNPLA3;PLIN5;PLA2G4C
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.6920643652199041,-1.3177829482961507,0.10526315789473684,1.0,1.0,5/17,9.60%,H1-3;BANF2;H1-0;HAT1;CHAF1A
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.7867627299306534,-1.3174083497010842,0.23529411764705882,1.0,1.0,1/6,6.93%,SLFN14
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.8383370917863633,1.3169155881824106,0.1111111111111111,0.8526034032461206,1.0,2/7,1.44%,TACR3;GRK5
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.7557676656092583,1.3165890288181465,0.16666666666666666,0.8524924886981586,1.0,1/5,1.66%,CBS
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.6410296180295192,1.3163616079526053,0.05555555555555555,0.8520963789817588,1.0,3/16,4.31%,RAB27A;NLGN1;DOC2B
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.7481936320086358,-1.3160999866835537,0.14035087719298245,1.0,1.0,3/7,19.93%,NFAM1;PRKCH;CD81
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6531785233234799,-1.3157672432869956,0.21428571428571427,1.0,1.0,3/16,17.00%,SNAP23;TOR1A;STX19
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5241011303586873,-1.3153708356390912,0.04,1.0,1.0,7/118,4.01%,CD44;NOTUM;WNT5A;COL1A1;HHIP;LECT2;BMP3
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.6886604531264758,1.314389177155673,0.17777777777777778,0.860225582001397,1.0,1/14,0.85%,CTDNEP1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.7211336987303842,1.314309201575564,0.21951219512195122,0.8590484567614979,1.0,5/10,16.94%,RAPGEF1;RAP2A;RAP1A;RAPGEF3;SGSM3
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.7368413421273468,-1.3141130242710004,0.14754098360655737,1.0,1.0,5/10,19.40%,STEAP4;COX17;STEAP2;ATOX1;CUTC
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.8381494032530541,1.3140254999792005,0.10204081632653061,0.8589549743977207,1.0,2/6,7.37%,GREM1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5814427493283671,1.3139021398445418,0.14285714285714285,0.8581530375867034,1.0,5/28,11.77%,RBM20;TRA2A;CELF4;ERN1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7971832993988701,1.3137569335088732,0.0975609756097561,0.8573823224035452,1.0,4/7,16.25%,APOE;ABCA1;ABL1;RIT2
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.6286053061647368,-1.3134846430700056,0.1076923076923077,1.0,1.0,3/28,3.79%,AQP3;TBX1;SCN5A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.812190458477087,-1.313378198724025,0.10526315789473684,1.0,1.0,3/7,11.62%,PINK1;DNAJA1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.7318415229443804,1.3133307018791742,0.24390243902439024,0.8577161101898373,1.0,3/6,25.83%,NTRK2;DOCK3;FYN
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.5073324623079911,1.3132710669029923,0.10256410256410256,0.8562722464695118,1.0,39/127,15.80%,SLC17A6;SEZ6L;PCDH17;NOVA1;ROBO2;MAFB;PLPPR1;EDARADD;KCNB2;PROX1;UNC5D;LRRC4C;ELAVL3;CADM2;CXXC4;PAK5;RGS16;KCNIP1;WSCD2;CELF4;ADGRA1;EFNA5;CFC1;RAB3C;ELAVL4;FGF12;ABCC8;SCGN;IAPP;RBFOX1;MAP6;SNAP91;PTPRT;DPP6;CD40;ASXL3;NRXN1;SERTM1;UBE2QL1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.8487065721605358,-1.3130108696778748,0.06896551724137931,1.0,1.0,1/6,10.45%,NDUFS2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5944424570251895,-1.3129765174622237,0.08450704225352113,1.0,1.0,10/35,20.51%,ITGB3BP;CENPU;HAT1;RBBP7;CENPH;OIP5;SMARCA5;CENPM;CENPN;CENPL
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8371166780792458,-1.3125350744661597,0.10909090909090909,1.0,1.0,1/5,4.08%,P2RY12
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.5042133344041917,-1.3121060246599654,0.04285714285714286,1.0,1.0,18/105,10.24%,CLEC5A;C1QB;FCGR3A;DAB2;HCK;C3AR1;TGFBI;MMP9;ESR1;LTB4R;VSIG4;SLC7A7;MMP19;MS4A4A;PSAP;P2RY6;TLR2;OSCAR
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7623267528186185,-1.312018357204906,0.15517241379310345,1.0,1.0,2/7,14.83%,HLA-A;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.6774448566731113,1.3119657929722133,0.14583333333333334,0.860688060543646,1.0,4/13,9.84%,TGFBR1;ADAMTS12;GREM1;EFEMP1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.6752506446948608,-1.311700002152154,0.17857142857142858,1.0,1.0,3/13,11.08%,CEP55;CHMP3;MITD1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.6959641589817466,-1.3109032865776526,0.15151515151515152,1.0,1.0,1/13,2.51%,SLC37A2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5113235224716193,-1.3102989480468477,0.05128205128205128,1.0,1.0,23/112,14.06%,NLRP4;EOLA1;TRIL;S100A13;HLA-DRB1;SFTPD;ALOX5;LRRC19;ANXA1;TNFRSF1B;PIK3CG;PTPRC;NLRP12;PLD4;HTR2B;SLC11A1;BTN3A3;IGF2BP2;NFAM1;ERMAP;TXK;TRIM56;NOS2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6426267433711842,-1.3102782666754034,0.09859154929577464,1.0,1.0,7/25,15.59%,MYH7;CASQ2;SCN5A;MYBPC3;KCNQ1;CSRP3;TTN
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.773275183739673,1.3102609068192,0.20930232558139536,0.8674760199668269,1.0,4/7,20.13%,ARL13B;BBIP1;ARL3;WDR19
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.8187773592172874,-1.3101423684488662,0.08064516129032258,1.0,1.0,2/7,5.65%,TEKT5;TEKT3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6218671984289152,1.309243962824136,0.12195121951219512,0.870818012733503,1.0,4/25,14.85%,ARC;ITGA3;INSR;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.7887754630272159,1.3091227303681816,0.13333333333333333,0.8697248732533243,1.0,3/6,16.57%,BICD1;CEP250;MARK4
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6928819763725457,-1.3090668753118684,0.13846153846153847,1.0,1.0,2/16,9.94%,NEK2;CAV2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.6524189810109442,-1.3090340558349174,0.11940298507462686,1.0,1.0,6/23,13.94%,AQP3;RAB11A;WFS1;AQP4;MYO5B;ADCY7
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5506677063114772,1.3089588352764134,0.10526315789473684,0.8688871608947528,1.0,14/24,37.11%,MTMR8;MTMR3;MTMR1;PIP4P2;MTM1;PTEN;MTMR11;MTMR9;OCRL;SYNJ2;MTMR10;TPTE2;INPP5J;MTMR12
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7672158190006915,1.3088478584123588,0.14893617021276595,0.8664132757332479,1.0,3/8,10.62%,GLA;PTGIS;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7672158190006915,1.3088478584123588,0.14893617021276595,0.8664132757332479,1.0,3/8,10.62%,GLA;PTGIS;KHSRP
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7835784641006556,-1.3080174136499705,0.19298245614035087,1.0,1.0,1/6,0.43%,C1QB
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6463457556101736,1.3071980811681594,0.09375,0.8732293106994733,1.0,8/15,22.78%,NR4A3;OCLN;RTN2;BRAF;CLIP3;PRKAG2;C1QTNF12;TRIB3
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5022130592411661,-1.3069332510904388,0.13513513513513514,1.0,1.0,10/90,7.77%,CD44;RASGRP4;TRIM58;GMFG;ICAM3;GYPB;CGA;SLFN14;PIK3CG;DOCK2
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5830313006577799,-1.306827295094972,0.078125,1.0,1.0,1/36,0.19%,EPN1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.7912062138783433,-1.3065364333299836,0.12,1.0,1.0,3/7,16.83%,SCTR;AQP4;AQP11
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.8347075412908154,-1.3064009908087895,0.09090909090909091,1.0,1.0,3/5,14.79%,SLC22A3;SLC6A4;SLC18A2
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.722212375163771,1.3063815793587856,0.2,0.8753322183760518,1.0,3/8,10.22%,UGDH;MAT2A;SPAST
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.6656123208521282,1.3063739553944953,0.16326530612244897,0.8737719113914241,1.0,4/13,6.04%,APOH;APOE;SERPINE1;HS3ST5
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.6154857180361916,1.306316194914265,0.13157894736842105,0.8724106759628064,1.0,7/23,9.80%,LIPC;RORA;APOE;SIRT1;ACSM2A;LPL;MLXIPL
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5252967528638968,1.306244650308252,0.16129032258064516,0.8713578371090658,1.0,8/56,9.15%,FOXO1;KLF10;MFSD2A;SIRT1;AKR1C3;RALB;LPL;FADS1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.5743772802998619,1.3062395398383582,0.1282051282051282,0.8698128764049716,1.0,5/27,4.51%,EPHX2;RORA;APOE;SIRT1;BCKDK
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7112815569532802,1.3061450219921105,0.18604651162790697,0.8687133647673729,1.0,4/8,21.73%,PCGF1;PCGF5;RNF2;PCGF6
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7278665229839614,1.3061304715393145,0.16326530612244897,0.867205985677806,1.0,6/12,18.84%,IRS1;PPARG;AKT2;IRS2;GPLD1;PRKCE
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6900090335202078,1.3059992554551858,0.18181818181818182,0.8662519588979944,1.0,6/9,28.52%,OSR1;NEDD4;PRKCE;STK39;HECW2;HECW1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.6301783005166759,1.3058821392495294,0.22580645161290322,0.8652739378461531,1.0,4/13,10.23%,GRIN3A;SDF4;DRD3;GRIN1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.637087703711518,-1.3058343455782437,0.07936507936507936,1.0,1.0,4/28,9.29%,MICB;AIM2;STAT1;TRAF3IP2
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.807393124838898,-1.305426974552993,0.07692307692307693,1.0,1.0,1/6,2.02%,GMFG
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.7690409826811532,1.3052139823704079,0.16666666666666666,0.8669752884098101,1.0,3/7,20.84%,GLUD1;ALDH18A1;GLUD2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.6435687859695345,1.305202342996695,0.15217391304347827,0.8654542791318982,1.0,5/15,8.68%,APOH;F2;SERPINE1;HPSE;F12
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.5224046912655723,1.3051554876065696,0.09090909090909091,0.8641290660344838,1.0,8/45,10.66%,TEAD2;KIT;MFSD2A;RARB;COL13A1;TEAD4;KITLG;COBL
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.45405669959997175,1.304992729389374,0.07692307692307693,0.863650515923862,1.0,11/89,4.65%,ADGRF4;LAMA3;ACTG2;HSPB1;EMP1;CD151;BCL2;DUSP23;SLC25A37;PERP;SDC4
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.7191309749772236,1.3047111994091771,0.13333333333333333,0.8635261289915388,1.0,1/8,1.16%,MEGF10
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.6125983087620531,-1.304140881578221,0.14754098360655737,1.0,1.0,5/29,11.14%,WNT5A;TRIM62;IFNK;SH2D1B;SPI1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6868750709563218,-1.3034628987261476,0.17142857142857143,1.0,1.0,3/15,8.75%,ENPP2;PDXDC1;PPT1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5976543228328969,1.3034397033676404,0.11627906976744186,0.8677600584103542,1.0,5/13,25.65%,TNIK;RAP2A;RAP1A;MAP4K4;STK26
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.5134257074376679,1.3032889367427178,0.14705882352941177,0.8668183414418573,1.0,6/40,3.73%,APOH;PNPLA3;APOB;LIPC;APOE;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),-0.8193458374594941,-1.3031883372809545,0.16666666666666666,1.0,1.0,1/5,4.74%,HLA-DRB1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8307555565267177,1.3026081512234462,0.34210526315789475,0.868900938782507,1.0,2/5,11.05%,TOX;ASCL1
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.7080689696645206,-1.3023891102725482,0.14285714285714285,1.0,1.0,1/12,2.51%,SLC37A2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.6009028547232086,1.3021442926743523,0.1794871794871795,0.8693876324854358,1.0,5/16,14.40%,PCGF1;RNF168;BCOR;UBE2A;RYBP
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5024676805784801,1.3019771955832828,0.11764705882352941,0.8685823888338827,1.0,5/64,4.18%,ATP6V0D2;FOXO1;SH2B2;IRS1;TCIRG1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.7110045119488455,1.3016730279757993,0.16981132075471697,0.8671409571555089,1.0,5/10,8.68%,APOH;F2;SERPINE1;HPSE;F12
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.7110045119488455,1.3016730279757993,0.16981132075471697,0.8671409571555089,1.0,5/10,8.68%,APOH;F2;SERPINE1;HPSE;F12
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7817251711453005,1.3015917408263848,0.21621621621621623,0.8660495820159796,1.0,3/6,18.76%,HSPA1A;LAPTM5;CPNE1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.7009821855000159,1.3011547205612088,0.16666666666666666,0.8663768205433351,1.0,1/12,0.37%,IRGM
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.7352409890166176,1.3010191568485796,0.15384615384615385,0.8655836472694832,1.0,2/8,6.60%,TSKU;HPSE
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.5441820266069288,1.3003642417897177,0.10526315789473684,0.8670279355583818,1.0,9/40,10.62%,GCK;GLA;PROX1;WNT4;AKR1C3;CRY1;PTGIS;WDTC1;KHSRP
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.7867050058185199,1.3003444738765602,0.20454545454545456,0.8655989537884445,1.0,3/7,8.02%,STX5;GBF1;PLK3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.46587240641774497,1.2999451821067203,0.14814814814814814,0.866110320770794,1.0,14/88,6.51%,F2;SCRIB;ANGPT1;APOE;PID1;AKR1C3;AKR1C1;ARRB2;MAGI2;PPARG;SNCA;WNT3A;ACACB;GREM1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.6577558611948956,1.2999013344602652,0.21428571428571427,0.86479364356409,1.0,3/14,13.95%,TDO2;ACACB;PPCS
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.8451873220223266,1.2998431610818508,0.14893617021276595,0.8635078679806617,1.0,1/5,1.52%,FGF10
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.677098442457853,1.2997672274668137,0.15384615384615385,0.8624111062370893,1.0,4/13,11.09%,GRM3;DRD3;ADGRV1;GRM2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.696849100590091,-1.2996980059958998,0.125,1.0,1.0,4/10,17.71%,KCNA5;KCNQ1;KCNE3;KCNE2
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.7726026324298784,1.2996223744098527,0.17073170731707318,0.8616867321621667,1.0,2/6,7.69%,GRID2;DRD3
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.6465857067400347,1.298849610975168,0.1282051282051282,0.8634096866065366,1.0,4/14,16.13%,AASS;PIH1D1;NSD1;MTHFR
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.45459510571956724,1.2986907809751467,0.030303030303030304,0.8625810945712934,1.0,29/85,17.20%,MYO10;VEGFC;GPR161;RAI14;MID1;EDNRA;ADGRL2;PARVA;ADAMTS12;P3H2;MMP2;LOXL1;IL17RD;SLIT2;CDR2L;TENM3;EFNA5;RND3;ZNF462;WWTR1;CSRP2;FJX1;CALD1;ANTXR1;ROR1;FZD7;CDH11;CXCL14;HAS2
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7920791125114794,1.2983026945690888,0.21951219512195122,0.8629343122954725,1.0,2/6,20.37%,JADE3;JADE2
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.7747352700370251,-1.2981957726735351,0.10714285714285714,1.0,1.0,3/8,14.85%,IFNK;GPR183;LCP1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5130288862400746,1.298063610047385,0.18518518518518517,0.8626847474655807,1.0,9/35,19.46%,OLFM2;ABCA1;LTBP2;RAB3C;PREB;RAB10;TVP23B;RAB3D;MIA3
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6437355778026576,-1.2977906955311296,0.16981132075471697,1.0,1.0,6/21,18.64%,DUOX1;ANXA1;ACTG1;CLDN1;VTN;GRN
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7792561050711437,-1.2975895917647278,0.171875,1.0,1.0,1/7,4.87%,CHIT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.7401717056798786,-1.2971989326974007,0.12698412698412698,1.0,1.0,3/10,11.56%,PINK1;GATA4;REST
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.6105111463999173,1.297025828728259,0.15384615384615385,0.8658045042138827,1.0,9/16,23.18%,PRKAR2A;ADGRV1;AKAP7;IAPP;AKAP12;FSHR;TCIM;AKAP6;CALCR
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.6128978221755116,1.2969337385021673,0.14285714285714285,0.8645864282011972,1.0,1/23,0.07%,COL22A1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.7957584885319967,-1.2965890750710822,0.11666666666666667,1.0,1.0,2/9,9.93%,AQP3;SLC5A1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.7872573554671296,1.2965744140664668,0.1891891891891892,0.8632537110573072,1.0,1/5,2.56%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.7872573554671296,1.2965744140664668,0.1891891891891892,0.8632537110573072,1.0,1/5,2.56%,PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.43943574742145564,1.296358451387713,0.08333333333333333,0.8629538203930955,1.0,43/125,21.75%,IRGM;FOXO1;IRS1;APOE;ZBTB20;SNCA;HMGB1;PLIN5;TRIM8;AKT2;DHRSX;MLXIPL;ABCD2;DXO;LIN28B;RNF152;KHSRP;TWIST1;TRIM65;IRS2;MOV10;PIM2;TICAM1;SNX9;INSR;PNPT1;TRIM14;LAPTM5;PFKFB4;FAF1;GPLD1;MID2;PFKFB3;ATF6;ADAM8;RC3H1;SH3D19;FURIN;PLEKHF1;SNX33;PRKAA2;TRIML2;NPRL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6900943367408625,1.2962418511013452,0.12195121951219512,0.8621370360286779,1.0,7/14,26.17%,TGFBR1;NOTCH1;RUNX1;RBPJ;BMPR1A;ZFPM2;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.5102236261274742,1.2962216171650418,0.06896551724137931,0.8608059381322746,1.0,17/59,18.40%,EYA4;FGF10;BRCC3;SIRT1;ERCC8;RNF168;PML;HMGB1;TOX;MYC;SIRT6;MECP2;SMCHD1;WRAP53;EYA3;RAD50;H2AX
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.6441795251914751,1.296037429408589,0.09302325581395349,0.8601244784378779,1.0,1/12,2.97%,ZBTB7B
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6029348875306866,1.295778634844017,0.1111111111111111,0.8598575323762349,1.0,4/17,14.90%,TET2;NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),0.724832084876544,1.295775768031218,0.175,0.8584596503691095,1.0,2/6,12.52%,GJB6;BMP4
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7464662916185604,1.2956592970301861,0.15789473684210525,0.85740023805613,1.0,3/7,12.30%,ALDH1A1;NPL;NAGK
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7297430919739378,1.295658608843243,0.10526315789473684,0.8559853861781495,1.0,3/8,15.58%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5844844674532149,1.295546307840797,0.0975609756097561,0.8549847328255687,1.0,4/24,8.36%,MSH4;POLD3;PMS1;ABL1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.7671387527015802,1.295411853267398,0.21951219512195122,0.854191802675761,1.0,1/6,3.45%,PROX1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6383660051283273,-1.2945381457424796,0.1206896551724138,1.0,1.0,5/26,8.88%,IHO1;MEIOB;STAG3;SYCP1;RNF212B
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.4653682823591532,1.2942738172270851,0.125,0.8574833944831222,1.0,24/95,13.28%,GCK;HGFAC;XKR7;PLPPR1;CACNG4;GOLT1A;SEMA6C;PTOV1;HRH3;SARDH;REEP6;PDE9A;SYT1;GAL3ST1;WNK2;EBF4;FAM163B;ABCC8;HCN3;SCGN;HID1;CRABP1;FBLL1;PRR36
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7246652767921052,1.2941909832821767,0.15789473684210525,0.856306915476844,1.0,3/12,5.45%,NLGN1;ZDHHC12;PCLO
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.8031290292855242,1.2940612121237025,0.05405405405405406,0.8553631437678916,1.0,3/6,14.45%,NGB;MYC;CA2
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.6003056044050684,-1.294050897274437,0.1111111111111111,1.0,1.0,5/30,7.34%,CLIC1;P2RY12;GP1BA;ACTG1;PIK3CG
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7062856860607423,1.2936358434526085,0.14285714285714285,0.8559710589018256,1.0,3/11,9.53%,PKD2;LATS1;FLNA
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7696504050098146,1.293397312241059,0.225,0.8541950489427056,1.0,2/5,15.28%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7696504050098146,1.293397312241059,0.225,0.8541950489427056,1.0,2/5,15.28%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5936000169119736,1.2933471484414552,0.1951219512195122,0.8529829555306171,1.0,7/18,19.16%,NGF;MAGI2;RAPGEF1;CASP3;RAP1A;NTRK2;SOS1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.7777472779041137,-1.2926792586562272,0.16129032258064516,1.0,1.0,3/6,18.98%,ALOX5;IL18BP;IL18
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.7777472779041137,-1.2926792586562272,0.16129032258064516,1.0,1.0,3/6,18.98%,ALOX5;IL18BP;IL18
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.5304967171955135,1.292660441787769,0.14893617021276595,0.8545744481491827,1.0,13/39,22.13%,ST6GALNAC3;GLA;ST6GAL2;ST8SIA4;NEU4;ST3GAL3;FUT9;ST3GAL6;NEU3;ST8SIA3;ST3GAL2;ST6GALNAC5;ST8SIA1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.7180039117317767,-1.2922951857745508,0.19047619047619047,1.0,1.0,1/10,4.08%,P2RY12
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.6536702313026372,1.2916907571132583,0.11764705882352941,0.855881588465466,1.0,7/13,28.88%,COQ2;PDSS2;UBIAD1;COQ9;COQ10A;COQ6;COQ3
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.6536702313026372,1.2916907571132583,0.11764705882352941,0.855881588465466,1.0,7/13,28.88%,COQ2;PDSS2;UBIAD1;COQ9;COQ10A;COQ6;COQ3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.5604949439950649,1.2916826755714002,0.10344827586206896,0.8545742036702356,1.0,8/42,6.44%,EYA4;FGF10;BRCC3;SIRT1;ERCC8;RNF168;SIRT7;PML
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4484414886843554,1.2915999185446125,0.04,0.8535968078597378,1.0,19/121,8.56%,LGR5;GPR3;ADRA1B;CHRM2;GRK5;GALR3;GPR161;ADGRG6;HTR1F;GPR78;ADGRL2;CRHR2;ADGRG3;GPR26;DRD5;GRM8;RXFP1;ABCA1;ADCY2
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.7840225692174008,-1.291381860301492,0.16666666666666666,1.0,1.0,1/8,0.10%,ENPP2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.7957071818247935,-1.2913289647089052,0.14285714285714285,1.0,1.0,2/6,14.83%,HLA-A;HLA-F
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.7957071818247935,-1.2913289647089052,0.14285714285714285,1.0,1.0,2/6,14.83%,HLA-A;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.7571882611926053,1.2911482451711733,0.17391304347826086,0.8538985289499225,1.0,3/7,5.77%,APOH;F2;SERPINE1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.7554999940305008,-1.291085447328042,0.16666666666666666,1.0,1.0,4/10,16.55%,IFNK;SLC11A1;LCP1;TNFSF18
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.7774348346191029,1.2910189763458308,0.1794871794871795,0.8529253621849895,1.0,3/6,20.07%,DRD5;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7413733804861088,1.2904168235198374,0.14634146341463414,0.8547733908321494,1.0,5/8,22.32%,COMMD1;WNK2;NEDD4;WNK3;WNK1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.47294982708578953,1.2904123506074088,0.14814814814814814,0.85347825783437,1.0,11/65,10.49%,EGLN3;NGF;HIP1;CFLAR;PPARG;SNCA;ANP32B;ACER2;EIF2AK3;SENP1;LCK
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.7737247179871564,1.2902084399138019,0.2391304347826087,0.8528584590253199,1.0,3/7,16.13%,CBS;MTR;MTHFR
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6190869383424829,1.2902061766472706,0.175,0.8515208844902518,1.0,3/15,11.20%,NXF5;IWS1;NXF1
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.7799800226151115,1.289374528208624,0.1891891891891892,0.8541770897969044,1.0,3/8,14.18%,PROX1;WNT4;NFKB1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5826204064674314,1.2888952533483466,0.13157894736842105,0.8545240039931027,1.0,1/15,1.74%,CPSF1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.7701772971580507,-1.2887466524712985,0.10714285714285714,1.0,1.0,3/7,11.09%,KCNA5;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.619461635703051,-1.2887253350884877,0.19718309859154928,1.0,1.0,2/24,1.26%,AQP3;PLAAT4
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.7932804639136961,1.2885506284855754,0.23809523809523808,0.8547710119433828,1.0,1/6,2.27%,HDAC10
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5400884144449812,1.2885480265636258,0.13513513513513514,0.8534142325593456,1.0,6/32,11.56%,RAB27A;SDC4;SNCA;RAB7A;SMPD3;RAB27B
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.5856445750340957,-1.2885214963142624,0.14516129032258066,1.0,1.0,9/29,28.10%,TOMM20;TIMM17A;PAM16;ROMO1;CHCHD4;DNAJC19;PEX1;TIMM21;GRPEL1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.5685150364028876,1.2883607930138754,0.1282051282051282,0.8530220312444043,1.0,4/25,9.84%,GDAP1;PEX13;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6503115205084178,-1.2875657652302162,0.203125,1.0,1.0,4/18,8.88%,IHO1;MEIOB;SYCP1;RNF212B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.46471092196862035,1.2874734876048701,0.05714285714285714,0.8557285976696178,1.0,19/67,14.68%,GMNC;SCRIB;BRINP3;HTRA2;SIPA1;TRIM35;HEXIM2;PPP1R13B;CDK6;NLRP2B;HECA;HPGD;LATS1;NR4A1;BRINP1;BMP4;MYOCD;NR2F2;RPS6KA2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5963863086666307,-1.2870816062632977,0.140625,1.0,1.0,8/27,26.01%,WNT5A;OAS1;CACTIN;ISG15;CDC37;OAS3;PTPN11;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.811257278374714,1.2868048641859353,0.10256410256410256,0.8574448242279205,1.0,3/6,8.82%,PNP;SH3RF1;NKAP
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.5451876086448848,1.2867428630738382,0.15789473684210525,0.8563374475346999,1.0,3/26,3.17%,CLMP;KIT;RARB
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),-0.8024727406276917,-1.2867058879780693,0.12727272727272726,1.0,1.0,2/5,7.31%,ANXA1;IL27
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.6871870041465862,1.2866380750654802,0.19148936170212766,0.8555761022657358,1.0,5/10,20.10%,SMC5;RAD50;NSMCE2;TPRKB;SMC6
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.6208429559891391,1.2863309016824254,0.14285714285714285,0.8557698794706228,1.0,4/15,7.10%,OSR1;WNT4;WNT3A;PLCB1
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),-0.8429280616512065,-1.286072111354086,0.11475409836065574,1.0,1.0,2/5,10.97%,ROS1;GATA4
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4421124314557151,1.286060477265562,0.08695652173913043,0.8554264554886857,1.0,62/223,21.49%,EFNB1;SLITRK6;LAMA3;LLGL1;PARD3;ROBO2;EPHA7;UNC5D;DSCAML1;PTPRO;SPTBN4;SEMA6C;UNC5C;AUTS2;NRTN;SEMA5A;BSG;NTN4;DOK5;DCC;EPHA3;DSCAM;SLIT2;EFNA5;SH3KBP1;NTNG2;DOK6;RET;IRS2;EVL;CNTN6;SEMA4A;NOTCH1;GAB1;ARHGAP35;EMB;RAB10;EPHB2;RYK;PIK3CA;NLGN3;NRXN1;NCAM1;SHH;EPHA6;PARD6B;EPHA8;CTNNA2;NRCAM;SOS1;EPHB4;CXCL12;SLITRK2;LGR6;PAK3;NRXN3;LGI1;TNR;CDK5;PTEN;ROBO4;PIK3CD
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.7266923363666997,1.286058615819415,0.125,0.8540856616713053,1.0,3/9,11.06%,KDM7A;KDM8;KDM2A
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.691931420470176,1.2858205083682857,0.1388888888888889,0.853770262518532,1.0,4/11,22.88%,ITPKB;IP6K1;IPPK;IP6K2
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8544622699623515,-1.285782913730268,0.11290322580645161,1.0,1.0,1/5,10.53%,SVIP
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.7561798797011527,1.2856857609736982,0.18421052631578946,0.8530188764860696,1.0,2/6,11.73%,CEP152;CCDC78
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.7246310454560884,1.2856593584857638,0.1794871794871795,0.8517365905635408,1.0,7/12,20.46%,THEM5;CRLS1;PGS1;PLA2G5;LCLAT1;PLA2G6;HADHB
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.7380212526542379,-1.285483176252622,0.08771929824561403,1.0,1.0,2/10,3.79%,PKP2;SCN5A
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6151654069768586,1.2853370398614954,0.10526315789473684,0.8519587379375019,1.0,7/30,12.73%,GCK;FOXO1;MAFB;ELP4;ABCC8;SCGN;IAPP
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.7310115886538249,1.285151793260726,0.18181818181818182,0.8512861638535559,1.0,4/8,13.15%,NGF;MAGI2;RAPGEF1;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6265651960755876,1.2849471209471133,0.2,0.851001685964221,1.0,10/14,33.18%,PPARG;ABCA1;NR1H3;OSBPL8;ABCG1;ITGAV;PPARD;ABHD5;PTPN2;NR1H2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5297990697163204,1.2848618568508383,0.11764705882352941,0.850139976685795,1.0,9/42,11.44%,ST6GALNAC3;ESYT3;GLA;STS;NEU4;SMPD4;ESYT2;GLB1;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.6690991556477803,1.2847752481105725,0.16279069767441862,0.8491606813674215,1.0,3/13,11.44%,SDC4;RAB7A;SMPD3
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.5602649705713071,1.28454839534191,0.2,0.8491929844936938,1.0,13/35,21.23%,PHLDB2;ERBB2;BICD1;EPHA3;EFNA5;MAP10;MACF1;KLHL42;MAP6;MARK4;CAMSAP3;MARK2;PRKAA2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.6053757220476658,1.2838661712521537,0.16666666666666666,0.851335123731288,1.0,10/26,24.15%,UBE2E3;ANAPC13;UBE2E2;UBE2D4;UBE2A;ANAPC7;UBE2L3;CDC26;FZR1;UBE2D3
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.6101433499958916,1.2835274256421425,0.125,0.8513400372601967,1.0,6/14,25.65%,TNIK;RAP2A;RAP1A;ESPN;MAP4K4;STK26
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.6381831965784778,-1.2834435053079005,0.15625,1.0,1.0,1/25,0.15%,CLEC5A
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5028334156619512,-1.2832610145664467,0.0967741935483871,1.0,1.0,33/120,12.81%,CLEC5A;AHR;ITGB2;FCGR3A;DAB2;SLC37A2;HCK;C3AR1;LYVE1;CYTIP;MMP9;SCIMP;CHIT1;VSIG4;SLC7A7;TNFRSF1B;MS4A4A;TAGAP;PTPRC;CPM;SLCO2B1;P2RY6;LY86;PARVG;TLR2;SLC11A1;PTAFR;SPI1;ADGRE1;IGSF6;NFAM1;MYO1F;CLEC12A
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5339475744722627,1.282479970326523,0.17073170731707318,0.854834739994555,1.0,14/30,24.81%,NLGN1;CEL;SNCA;WNT3A;SYT1;NLGN4X;NLGN3;NLGN4Y;RAB5A;CDK5;SYT7;SNCB;PLD2;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5260073534551213,1.2820066067620055,0.18604651162790697,0.8554070479296408,1.0,11/36,16.27%,PTPRO;SPRY4;ACER2;KANK1;EFNA5;JAG1;ADAM15;NOTCH1;NEXMIF;CORO2B;FZD7
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.7802440215643799,1.281954041665796,0.21621621621621623,0.8542857095134616,1.0,1/6,3.38%,APOE
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6885330900827801,1.281860786423499,0.21428571428571427,0.8533343562080644,1.0,5/14,16.45%,GLA;NEU4;ACER2;ACER3;NEU3
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6299392056117601,-1.281849869166099,0.16417910447761194,1.0,1.0,8/23,19.91%,KCNA5;SLC11A1;KCNQ1;ATP1A4;KCNE3;ATP4A;KCNE2;ATP1A1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.48783142869980695,1.2816883512760617,0.10714285714285714,0.8528372871656492,1.0,15/79,6.84%,FIBIN;RSPO3;MRGPRF;LAMA4;VEGFC;ACTG2;TPM2;TWIST2;EDNRA;ITGA8;ADAMTS1;COL12A1;COL13A1;MMP2;LOXL1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5715482090732434,-1.2813555397208745,0.16417910447761194,1.0,1.0,6/33,19.98%,UBE2L6;TRIM25;CACTIN;NLRC3;ISG15;DHX58
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.4724964762061159,1.2813489816781567,0.10344827586206896,0.8530296247494785,1.0,5/62,3.63%,GABRE;GABRR2;GABRA5;SLC12A1;GABRG3
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5779929239333094,-1.28085453580221,0.1,1.0,1.0,13/29,28.54%,ESR1;TRIM25;BRCA1;SFRP1;ZNF366;WBP2;CAV1;AR;CD24;GHRL;CRHBP;SRA1;RARA
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6562503281444363,1.280846929399764,0.1111111111111111,0.8535055856956609,1.0,7/17,25.40%,SLC19A1;DHFR;MTHFR;FPGS;SHMT2;MTHFD2L;MTHFD1L
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.8104982290683737,1.28005810717349,0.24390243902439024,0.855824649356867,1.0,3/5,13.15%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.6453919357548208,-1.2798756663603215,0.14516129032258066,1.0,1.0,6/25,18.09%,WNT5A;SCIMP;PTPRC;CLCF1;LACC1;CD86
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.6206031291826609,1.279707177236041,0.1875,0.8561532429064912,1.0,8/22,25.08%,PKN2;HES1;KLHL18;HSF1;EIF4EBP1;PPP1R10;EIF4E;RPS6KB1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.45061912943041105,1.2795638409597994,0.02702702702702703,0.8554199044525246,1.0,31/110,21.14%,TBC1D10A;KLHL20;STX5;RHOBTB3;SNX5;RAB7A;GBF1;STX8;STX6;WASHC2C;UBE2O;GCC2;WASHC2A;GGA1;VTI1A;VPS54;PTPN23;DENND2A;ARFRP1;EMP2;SNX32;VPS50;LAPTM5;ERC1;MON2;RAB5A;DOP1B;TBC1D5;KIF16B;SNF8;MAGEL2
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.6668636041746916,1.279117894834556,0.21428571428571427,0.856430793092922,1.0,6/14,20.10%,SMC5;RAD52;RAD50;NSMCE2;TPRKB;SMC6
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.71352804393453,1.2790154656302475,0.14285714285714285,0.8554171937098334,1.0,4/7,23.19%,SLC7A8;SLC4A11;TRPM7;CNNM4
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7449506426807397,-1.2789314698038814,0.15254237288135594,1.0,1.0,3/11,8.69%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.5906783684804436,1.278686635910857,0.15789473684210525,0.8554158444806541,1.0,6/22,13.85%,TGFBR1;ADAMTS12;GREM1;EFEMP1;GDF6;SOX5
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6854171827655974,-1.2785344154331804,0.1044776119402985,1.0,1.0,7/18,12.15%,ELOVL2;ALOX12;ALOX5;CYP2J2;ALOX15;ALOX12B;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6238021580062388,-1.2782512330670026,0.12903225806451613,1.0,1.0,3/18,4.18%,CASQ2;CAV3;MMP9
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.4770824615273238,-1.277894980118819,0.0,1.0,1.0,14/175,6.11%,CD44;CRLF1;FZD8;WNT5A;TIMP3;TGFB1;COL1A1;DAB2;COL5A1;ECM2;DCN;TGFBI;ENO2;RGS4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7226063183039761,1.2776419856339234,0.14634146341463414,0.8589296124601453,1.0,4/9,18.84%,OSR1;COMMD1;NEDD4;PRKCE
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.674059708047507,-1.2775104452199064,0.16071428571428573,1.0,1.0,4/19,9.88%,IRF4;HLA-DRB1;ZFPM1;NLRP3
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.6691157124371421,1.277363666911436,0.13636363636363635,0.8587591859406043,1.0,3/11,4.08%,DDAH2;APOE;KCNC2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.715069682078002,1.2770430047784818,0.17073170731707318,0.858869635291605,1.0,5/11,12.52%,OSR1;ROBO2;PKD2;SLIT2;BMP4
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.6847523835266438,1.2768874993250567,0.23529411764705882,0.8583498826896594,1.0,4/10,12.64%,F2;BIN1;HES1;NOTCH1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7009095246275772,1.2768467242543056,0.1956521739130435,0.8571794690729778,1.0,5/8,19.88%,CRY1;ABL1;ATM;MAPK12;MAP2K6
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.7495298563098898,1.2766201919497622,0.225,0.857105717777622,1.0,4/8,16.20%,CDH5;FER;CDH2;MMP24
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.7167557395735379,1.2765299310923497,0.2222222222222222,0.8564051412216241,1.0,3/10,9.82%,SCUBE1;PROX1;JAG1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.7839918646677495,-1.2765128379325523,0.21818181818181817,1.0,1.0,1/7,0.90%,WNT5A
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4775159650993905,-1.276275950523384,0.05555555555555555,1.0,1.0,4/137,1.85%,CD44;TBX1;WNT5A;TGFB1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5095496838856095,1.2761351384825919,0.14814814814814814,0.856866118630913,1.0,31/85,13.21%,GPC4;VCAN;ANGPT1;HS6ST2;CSGALNACT1;CHSY3;HS3ST3B1;EXT1;HS3ST1;CHST6;SDC4;GPC6;CHST12;HS3ST5;CHSY1;B4GALT2;UST;PRELP;HS2ST1;B4GALT3;HS3ST2;GPC5;UGDH;CHST11;ST3GAL3;CSPG5;CHPF2;B3GAT3;EXT2;DSEL;SDC3
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.7906569079212932,-1.2760190999703114,0.2,1.0,1.0,3/6,11.09%,KCNA5;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.714708943017087,-1.2752313567021947,0.140625,1.0,1.0,2/10,6.51%,TGFB1;TNFRSF1B
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6530503914420457,1.2751759947947323,0.25,0.8581538813910172,1.0,1/15,4.98%,JADE3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6530503914420457,1.2751759947947323,0.25,0.8581538813910172,1.0,1/15,4.98%,JADE3
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.5706828657060473,1.2743375584973917,0.16666666666666666,0.8604801621190037,1.0,2/12,4.73%,CYP1A2;STS
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.44330448252258997,-1.2740814164465852,0.0375,1.0,1.0,47/386,12.87%,CD44;CLEC5A;LILRB3;MGST1;GMFG;ITGB2;C3AR1;ARHGAP9;MMP9;CHIT1;ALOX5;FLG2;ATP6V1D;FTH1;CYBA;TBC1D10C;TNFRSF1B;OLFM4;A1BG;TCN1;PTPRC;HRNR;DOCK2;PSAP;PRDX4;CEACAM1;CD63;PDAP1;DYNLL1;SNAP23;CFD;TLR2;ENPP4;ORMDL3;SLC11A1;OSCAR;SVIP;ATP6AP2;PTAFR;PGAM1;NFAM1;SRP14;MMP25;CLEC12A;PLAU;EEF2;CTSZ
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.7014679944383343,1.2740577107918296,0.16279069767441862,0.8604943767212985,1.0,5/10,23.09%,ZBTB1;TFCP2;HSF1;TP53;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.6355967913772056,1.273416713008591,0.2962962962962963,0.8617975281752395,1.0,4/16,6.45%,GCK;BCKDK;WNT4;CRY1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7282661993557142,1.2733954012239246,0.19047619047619047,0.8605456631928391,1.0,5/8,23.28%,SPRED3;SPRED2;SPRED1;EP300;DYRK1A
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.7373581606309578,1.2729694559287787,0.1702127659574468,0.8611793540980579,1.0,2/8,8.02%,SNCA;PLK3
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5647492508553904,1.2728497617354382,0.18421052631578946,0.8605508158206756,1.0,2/16,9.49%,CPSF1;ERN1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5809911979479868,-1.272134740681872,0.13432835820895522,1.0,1.0,9/34,20.51%,ITGB3BP;CENPU;RBBP7;CENPH;OIP5;SMARCA5;CENPM;CENPN;CENPL
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7548562397145028,1.2719806371085478,0.175,0.8628987739880547,1.0,4/7,18.44%,DCP1B;DCPS;PATL1;PATL2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6637716752534397,-1.2717803899687137,0.16129032258064516,1.0,1.0,2/15,4.86%,TGFB1;ESR1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4848535452598584,1.271778518245191,0.10714285714285714,0.8621781628523993,1.0,8/64,4.99%,ADRA1A;GPR33;ADRA1B;CHRM2;GPR174;HTR2C;CX3CR1;DRD5
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5374603106881011,1.2713176219642124,0.08108108108108109,0.8629426225346447,1.0,7/62,8.28%,TSKU;APOB;APOE;CEL;SOAT1;SULT2A1;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.6936074428570782,1.271117000026672,0.19047619047619047,0.8624974351154058,1.0,2/9,5.76%,WNT4;SNCA
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.5406255805785251,1.2708199271462215,0.16129032258064516,0.8624630131077998,1.0,18/49,18.40%,EYA4;FGF10;SPRED3;BRCC3;SIRT1;ERCC8;RNF168;ANKLE1;SPRED2;MYC;SPRED1;SMCHD1;WRAP53;EYA3;ATM;FBH1;FXR2;H2AX
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.7423592893647952,-1.2708097923316852,0.23636363636363636,1.0,1.0,3/9,18.64%,PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5728840817805522,1.2705136999661657,0.13636363636363635,0.8623151186493929,1.0,10/19,19.32%,NLGN1;LHFPL4;APOE;CEL;GPHN;NLGN4X;NLGN3;NRXN1;NLGN4Y;MUSK
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4429290746050993,-1.2704169486671013,0.0379746835443038,1.0,1.0,47/388,12.87%,CD44;CLEC5A;LILRB3;MGST1;GMFG;ITGB2;C3AR1;ARHGAP9;MMP9;CHIT1;ALOX5;FLG2;ATP6V1D;FTH1;CYBA;TBC1D10C;TNFRSF1B;OLFM4;A1BG;TCN1;PTPRC;HRNR;DOCK2;PSAP;PRDX4;CEACAM1;CD63;PDAP1;DYNLL1;SNAP23;CFD;TLR2;ENPP4;ORMDL3;SLC11A1;OSCAR;SVIP;ATP6AP2;PTAFR;PGAM1;NFAM1;SRP14;MMP25;CLEC12A;PLAU;EEF2;CTSZ
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.801819745230776,1.2702581617170086,0.14583333333333334,0.8620769301597838,1.0,2/8,3.86%,SLC39A8;SLC25A37
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.6819112606673816,1.270121891820065,0.21428571428571427,0.8614770617515414,1.0,1/9,3.94%,CFLAR
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.8437316909180077,1.2700795711830388,0.12244897959183673,0.8577937224408927,1.0,1/5,3.38%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.8437316909180077,1.2700795711830388,0.12244897959183673,0.8577937224408927,1.0,1/5,3.38%,APOE
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.8437316909180077,1.2700795711830388,0.12244897959183673,0.8577937224408927,1.0,1/5,3.38%,APOE
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.6126756925845878,1.2697765037230166,0.23529411764705882,0.8579916376324951,1.0,5/23,5.47%,MT1G;TRPM2;FLT3;IFI16;PPARG
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7159236863442289,-1.2696106572767916,0.22807017543859648,1.0,1.0,4/7,18.98%,ANXA1;NLRP3;CD86;IL18
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6533239923345748,1.269268794529502,0.17142857142857143,0.8589309689919885,1.0,4/9,18.24%,DRD3;DRD4;GABRB2;HRH1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.6963368248415127,1.2690558301615047,0.22916666666666666,0.8584980121041584,1.0,4/10,18.44%,DCP1B;DCPS;PATL1;PATL2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.47359198839793903,1.2685429585863792,0.125,0.8594787411013929,1.0,24/82,14.55%,COL22A1;COL8A1;LAMA3;TGFBR1;CD151;P3H2;COL12A1;COL13A1;COL9A2;COLGALT1;GREM1;LOXL1;COLGALT2;PLOD3;COL16A1;P3H4;PLEC;COL9A1;ITGB4;DST;TLL1;NF1;PPIB;COL25A1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.6634078946523557,1.2681909012846682,0.15,0.8584361478962759,1.0,4/15,14.81%,FHDC1;PHACTR1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.6634078946523557,1.2681909012846682,0.15,0.8584361478962759,1.0,4/15,14.81%,FHDC1;PHACTR1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5986147296561419,1.2677898435435175,0.20454545454545456,0.8591002166581652,1.0,10/19,21.61%,RASSF2;NLRP2B;MLXIPL;GADD45A;SMAD7;NCK2;DMD;NCK1;PTEN;PDE4D
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7677788283640155,1.2675136699544736,0.19148936170212766,0.8589376143437127,1.0,3/5,13.08%,CSGALNACT1;B3GAT3;DSEL
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5599064033001167,1.2675127874332668,0.16666666666666666,0.8577293037215479,1.0,13/28,25.59%,SLC44A5;MFSD2A;ABHD3;CHPT1;ACHE;CEPT1;CHKA;SLC44A4;LPIN2;SLC44A2;PEMT;LPCAT3;PCTP
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7415840592797102,1.2673675771731712,0.13953488372093023,0.8572579473535178,1.0,3/8,19.57%,RAB31;ABCA7;APPL2
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.7286527890486169,1.2671618679393988,0.1875,0.8569433057186937,1.0,4/10,14.12%,FGFR1;SNCA;PLA2G5;FGFR3
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7662637232216707,1.2669189510888252,0.16666666666666666,0.8568068719067662,1.0,1/5,5.13%,CNTNAP2
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4802894333795191,1.2667701798334088,0.03571428571428571,0.8560953897554316,1.0,24/85,21.48%,LSM10;PCF11;PCBP3;RIDA;U2AF1;ERN1;DXO;SNRPB;HSPA1A;LSM2;SRSF4;TBRG4;HSF1;SRRM4;PNPT1;PTBP1;AGO3;SF3B4;METTL16;AURKAIP1;TP53;U2AF2;CPSF6;SNRPF
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.7448628381914065,1.2666911801593708,0.21621621621621623,0.8555627374261217,1.0,4/6,25.01%,PEX13;EFHC1;HTR6;FGF13
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6836967368465782,-1.2664190872915755,0.16666666666666666,1.0,1.0,9/17,26.01%,C3AR1;NLRP3;TXNIP;TXN;PSTPIP1;IL18;NT5E;ENTPD5;HSP90AB1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.4973363481000134,-1.2663407656288805,0.07575757575757576,1.0,1.0,27/134,14.43%,CD44;TGFB1;ITGB2;CXCL13;C3AR1;XCR1;PTGDR;LTB4R;ANXA1;CYBA;CIITA;PIK3CG;TAC4;TRAF3IP2;ALOX15;TLR2;NLRP3;SLC11A1;HRH4;NFAM1;HPR;MMP25;NLRC4;IL10RB;NOS2;THBS1;PTGER3
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4394329097910986,-1.2662981753602582,0.025,1.0,1.0,47/391,12.87%,CD44;CLEC5A;LILRB3;MGST1;GMFG;ITGB2;C3AR1;ARHGAP9;MMP9;CHIT1;ALOX5;FLG2;ATP6V1D;FTH1;CYBA;TBC1D10C;TNFRSF1B;OLFM4;A1BG;TCN1;PTPRC;HRNR;DOCK2;PSAP;PRDX4;CEACAM1;CD63;PDAP1;DYNLL1;SNAP23;CFD;TLR2;ENPP4;ORMDL3;SLC11A1;OSCAR;SVIP;ATP6AP2;PTAFR;PGAM1;NFAM1;SRP14;MMP25;CLEC12A;PLAU;EEF2;CTSZ
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.6986511661083485,1.2662908441586893,0.2553191489361702,0.8559805789999092,1.0,2/8,10.50%,GALNT1;GALNT13
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.7346795693001055,1.2659171092819952,0.15217391304347827,0.8551842079621936,1.0,3/8,19.29%,PDZD11;ANK1;LIN7A
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.7346795693001055,1.2659171092819952,0.15217391304347827,0.8551842079621936,1.0,3/8,19.29%,PDZD11;ANK1;LIN7A
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.47487568133202074,-1.2656946262909372,0.15384615384615385,1.0,1.0,27/118,12.81%,ITGB2;FCGR3A;DAB2;HCK;XCR1;CYTIP;SCIMP;HLA-DRB1;HLA-DMA;ANXA1;HLA-A;VSIG4;TNFRSF1B;TAGAP;PDCD1LG2;PTPRC;LY86;PARVG;SLC11A1;PTAFR;SPI1;ADGRE1;HLA-DPB1;IGSF6;NFAM1;MYO1F;CLEC12A
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.680352999779102,-1.2656388825016402,0.10606060606060606,1.0,1.0,7/16,25.36%,TRIM5;SCIMP;LY86;CACTIN;LY96;BMP6;CARD8
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.7417723369169266,1.2656192721690873,0.18181818181818182,0.855425006543282,1.0,5/9,10.03%,TSKU;IFT88;WHRN;ADGRV1;SLC4A7
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.6528240016912492,1.2656072736598014,0.18421052631578946,0.8542606683986519,1.0,7/13,21.18%,GLYATL2;CYP4Z1;ABHD3;ACADM;OXSM;ACAD9;ACOT7
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.7702560045838629,-1.2654671336907592,0.26,1.0,1.0,3/6,18.64%,PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6570028620690428,1.2653026697512373,0.2647058823529412,0.8546773997625079,1.0,1/11,1.25%,RAB27A
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.8262836011834122,1.2648178938513015,0.21621621621621623,0.8553555510392421,1.0,1/5,12.20%,UBE2D4
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.49704321423234665,1.2645109470617477,0.038461538461538464,0.8552669733355339,1.0,9/75,6.30%,NIPAL1;GRIN3A;SLC3A2;TRPC3;SLC39A8;SLC8A1;TRPM2;SLC8A3;PKD2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.4303555988619388,1.2637311120093584,0.02631578947368421,0.8573389579388411,1.0,26/108,18.12%,GCK;PRR16;IRS1;SAMD4A;SIRT1;SLC25A37;ERBB2;PPP1R3E;TMEM106A;PCIF1;AKT2;CTC1;IRS2;NAMPT;MYC;EIF3E;NFKB1;INSR;ABCB10;NIBAN1;BCL3;FAF1;PIWIL2;DNA2;YTHDF1;FXR2
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.8001119277237457,-1.2637134825640421,0.26229508196721313,1.0,1.0,1/7,6.59%,OLFM4
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5271284185882755,-1.2635598962606136,0.15789473684210525,1.0,1.0,23/60,18.09%,CLEC5A;ITGB2;HCK;C3AR1;SP100;APOL6;IRF1;GPR183;TNFRSF1B;MS4A4A;CIITA;PTPRC;LY86;TLR2;NLRP3;PTAFR;IGSF6;CSF2RA;ITGAM;TNFRSF11A;TFEC;NFKB2;CD86
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.730028463316135,1.263537493179855,0.20454545454545456,0.8570299394886838,1.0,3/6,12.23%,HMGB1;LGALS1;LGALS9
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.6073010321369576,1.263429405431305,0.21428571428571427,0.8563301026009824,1.0,2/13,5.48%,KLHL20;PYHIN1
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.8626126832346854,-1.2632893377352452,0.13559322033898305,1.0,1.0,1/5,0.86%,TCF7
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.492084602919707,-1.2632788463217879,0.08333333333333333,1.0,1.0,13/132,9.48%,CD44;TIMP3;DCN;BCL2L2;IRF1;ENO2;ANXA1;H1-0;CCND1;SOD2;PPT1;CLU;DNAJA1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5528583519114405,1.2629718466421394,0.07894736842105263,0.8572402277820192,1.0,8/24,24.58%,KDM7A;KDM8;KDM2A;KDM3B;JMJD1C;KDM4C;KDM5B;KDM5C
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7062483146782208,1.262552922455575,0.175,0.8576487235607769,1.0,1/9,0.76%,ACADS
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.5819984495379449,1.2625441644368736,0.2,0.8564742299436386,1.0,7/27,10.64%,SLC30A10;SIRT1;CDK6;VASH1;ABI3;RBL1;TWIST1
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.7486485996762149,1.262427549240127,0.22448979591836735,0.8556925098481454,1.0,2/5,14.10%,CDK6;NF1
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),0.739732015932425,1.2616150552307361,0.22448979591836735,0.8576356857878937,1.0,2/5,6.30%,OSR1;PKD2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7268556945465167,-1.261492218298727,0.1896551724137931,1.0,1.0,3/9,10.38%,AMBP;SLCO2B1;ABCG2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7268556945465167,-1.261492218298727,0.1896551724137931,1.0,1.0,3/9,10.38%,AMBP;SLCO2B1;ABCG2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.46673587558009955,1.2611433258472604,0.14705882352941177,0.8584945195672122,1.0,26/73,16.67%,CDH20;CDH19;CDH12;CDH7;CDH5;CDH13;DSP;CSK;CADM2;SDK1;CADM1;CDH6;TJP2;NLGN4X;JUP;LIMS1;FSCN1;CDH2;CDH10;CDH4;PKP4;NECTIN3;OCLN;CDHR3;F2R;CDH11
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7260901128732611,1.2610981849920786,0.17073170731707318,0.8574546625366171,1.0,6/11,10.96%,APOH;F2;KLKB1;SERPINE1;F12;F11
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.673587431091,-1.261027064741081,0.1724137931034483,1.0,1.0,6/17,17.66%,DUOX1;CYBA;PRDX4;GPX3;PXDN;PRDX1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5877376153662086,1.2610248336665923,0.11904761904761904,0.8565252815647815,1.0,1/23,0.84%,AUP1
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),0.8314084117883218,1.2607538791732318,0.1590909090909091,0.8563076200456976,1.0,3/5,16.83%,MEGF10;KLHL41;ZNF609
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.7692348960996088,1.260604654628117,0.1875,0.855704285766574,1.0,4/5,19.26%,POU3F2;ASCL1;MYT1L;MNX1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5224964303696802,1.2604286184015017,0.12121212121212122,0.8553597766866635,1.0,12/32,25.01%,CDH5;SNCA;NAV3;MAPRE1;CLIP3;CAMSAP3;ATXN7;CIB1;TRIM54;DYRK1A;MAP2;FGF13
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.7967121316326856,-1.2604091180958783,0.140625,1.0,1.0,3/5,14.22%,GPR183;PIK3CG;CXCL16
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6243372489824024,1.2602180090526691,0.1794871794871795,0.8552302221782211,1.0,6/17,16.12%,TMTC2;DPM3;FKTN;FKRP;TMTC3;POMT2
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7165991843977506,1.2601397254639124,0.22857142857142856,0.854310292850426,1.0,4/8,15.83%,NFIB;EPHB2;RYK;NCAM1
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.7802888366957121,1.2601295528419765,0.23404255319148937,0.8531581314592478,1.0,2/5,11.55%,BNIP2;BNIPL
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.5597179673348567,1.260084503609078,0.10526315789473684,0.8521370059023876,1.0,11/28,19.32%,MFSD2A;APOE;PLCB1;STAT5B;ABL1;LATS1;FGFR3;INSR;NIPBL;NRCAM;MUSK
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.4832303896982882,-1.2598681196277102,0.05405405405405406,1.0,1.0,12/131,5.43%,CD44;OLFML1;WNT5A;C1QTNF1;TIMP3;LMOD1;COL1A1;COL5A1;ANGPTL2;DCN;ESR1;GPER1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.4852794678593674,-1.2598443501862162,0.09090909090909091,1.0,1.0,10/134,3.65%,CD44;TRIL;TIMP3;SFTPA1;LMOD1;COL1A1;SPC25;COL5A1;ANGPTL2;TSPAN11
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.6311116113011382,1.2597980604798555,0.2,0.8507620154666315,1.0,5/12,11.90%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.6311116113011382,1.2597980604798555,0.2,0.8507620154666315,1.0,5/12,11.90%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5361925307355454,1.2597161014735643,0.20588235294117646,0.8498544739166377,1.0,7/36,13.68%,PHLDB2;SKA1;BICD1;EPHA3;EFNA5;MAPRE1;MAP6
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.6641359831382843,1.2594733545151866,0.14285714285714285,0.849903236713666,1.0,1/12,0.23%,PNP
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6464221423063932,1.2593072656280329,0.225,0.8493168475655005,1.0,4/18,3.92%,GRP;MRAP2;F2;KLK14
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.7759574799034675,1.2591899650937257,0.23684210526315788,0.8486052230130641,1.0,1/5,3.73%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.476473591281179,1.2589626729647339,0.13333333333333333,0.8483810572252671,1.0,10/55,10.81%,TSKU;NLGN1;KIAA0319;APOE;PTPRO;WNT3A;BCL11A;DCC;KANK1;PTPN9
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.6834434273849801,-1.2585021933831575,0.171875,1.0,1.0,3/11,21.79%,CHMP3;MAP2K1;DENND10
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7373455084943512,1.2583503992538054,0.25,0.8491904756099707,1.0,1/8,4.03%,AK3
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6560830072645334,-1.2580038559207836,0.13333333333333333,1.0,1.0,5/17,16.90%,GPSM2;DCTN1;ANKRD53;BORA;PSRC1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.7790026802236241,-1.2578938785418676,0.18867924528301888,1.0,1.0,1/7,1.33%,STAC
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5425336712872953,1.2573073571487452,0.125,0.8522082207844494,1.0,6/27,8.56%,FHIT;IFI16;GREM1;PPP1R13B;ZNF385B;ACER2
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.7409258946083688,-1.257293734838745,0.15384615384615385,1.0,1.0,2/8,10.45%,ATP6AP1;NDUFS2
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7760860987048996,1.25714030134288,0.22448979591836735,0.8517908727218738,1.0,3/6,17.70%,PCLO;ERC2;ERC1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6382643759423546,1.2570386502770174,0.2,0.8509757347873329,1.0,5/12,8.79%,APOE;HTR2C;KCNC2;PDE3A;PDE9A
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.4886225770174808,1.2563020638812683,0.1388888888888889,0.8526998452801253,1.0,9/38,19.91%,MLF1;DTX1;NR4A2;PPP5C;TAF1B;THRB;BCL3;BAZ2A;POLR2F
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.6706397105614573,1.256281275366742,0.21428571428571427,0.8515506541139796,1.0,4/9,17.35%,LRP6;OSBPL7;MLC1;GPLD1
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5691679510653195,1.256242040384279,0.1956521739130435,0.8505927544457957,1.0,5/19,7.48%,PROX1;PTPRZ1;TOX;TAFA1;TRIM71
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.6697384964723947,1.2557389289742023,0.15555555555555556,0.8512245222572545,1.0,2/12,6.38%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.6555690487132323,-1.2557097350531687,0.19696969696969696,1.0,1.0,4/16,14.06%,PTGES;PRDM12;TRPA1;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.5202715896545298,1.2555283698413706,0.12121212121212122,0.8510412582050162,1.0,5/31,12.82%,MAPK8;ABL1;ABL2;PHACTR4;B3GAT3
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.5449975371621664,1.2554897210943339,0.14705882352941177,0.850004586277614,1.0,5/33,6.21%,ATP6V0D2;RAB20;RAB31;TCIRG1;RAB7A
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.4774284310471289,1.2552571223138278,0.14705882352941177,0.8498858427933838,1.0,38/115,15.58%,ESRRG;SLITRK6;PCDH17;NOVA1;ARX;PLPPR1;PLCXD3;ADGRL2;PROX1;UNC5C;CXXC4;PCLO;PAK5;CNTN3;ETV1;ADGRA1;CFC1;GUCY1A2;FGF12;ABCC8;STOX2;RGS7BP;SCGN;PXK;NFIB;RNF180;MAGI1;MAP6;SNAP91;PDZRN4;PTPRT;ANK2;PTPRD;PPP1R9A;ASXL3;NRXN1;SERTM1;FGF14
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.5231896692491951,-1.2552439165857932,0.11267605633802817,1.0,1.0,17/69,14.46%,PLEKHS1;CAPN8;TMEM184A;MS4A8;MISP;EPN3;SMIM22;TMC4;ITGB6;FUT2;CEACAM1;LIPH;PROM2;SERPINB5;GALNT6;MUC5B;BPIFB1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6449422681253685,-1.2547496957561395,0.14285714285714285,1.0,1.0,3/15,17.21%,ZWILCH;TTK;BOD1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5452105017707263,1.2544789908070315,0.15384615384615385,0.8517614446219048,1.0,9/27,26.99%,RHCG;WNK2;SLC4A7;KLHL3;SLC4A11;WNK3;WNK1;SLC30A8;SLC30A3
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5260075335809676,1.2543019420554191,0.13333333333333333,0.8513917519090403,1.0,7/33,10.09%,PNP;BCL6;SOX12;HLA-DRA;ZBTB1;NKAP;IL23A
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),-0.8229417620949662,-1.254177779043186,0.14814814814814814,1.0,1.0,1/5,0.07%,SQOR
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.7846949142854587,1.2541679349859092,0.2608695652173913,0.850878034909399,1.0,2/5,7.87%,CX3CR1;CARD9
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.589537829810926,1.2540483541833194,0.17647058823529413,0.850179492654559,1.0,8/16,27.90%,TRPC3;PDE9A;NR4A3;AKAP6;EDN1;MEF2A;SLC9A1;ROCK1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.6785399340731497,1.2537059170155351,0.13636363636363635,0.8503918763142194,1.0,4/9,21.21%,KYAT1;GSTZ1;ASRGL1;PAH
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.8036977838272991,1.2535636164779043,0.125,0.8496339354443557,1.0,1/5,0.07%,COL22A1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7152315299194799,1.253557182842901,0.15384615384615385,0.8485483116574867,1.0,4/11,17.98%,DNMT1;RESF1;ATF7IP;MPHOSPH8
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7270975434959153,1.253331539418126,0.25,0.848103498532637,1.0,5/6,24.76%,TENT4A;ELAVL4;METTL16;LARP4B;RBM24
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.7885092835088336,1.252985345346917,0.13636363636363635,0.8483586071388957,1.0,4/5,20.85%,SEMA5A;BMP4;BMPER;NRARP
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.7554055790513768,-1.2526754321476663,0.19298245614035087,1.0,1.0,2/9,11.32%,PTPRC;PALM3
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.4492788296151281,1.2526107033042793,0.07407407407407407,0.8488798560142844,1.0,13/86,10.49%,MT1G;SLC30A10;MT4;CDH5;SLC39A8;HTR2C;SLC8A1;DRD5;RGN;SLC8A3;DRD3;DRD4;LCK
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.7558339554051033,1.2524728374716,0.1951219512195122,0.8471138305724416,1.0,1/5,4.47%,PDE3A
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.7558339554051033,1.2524728374716,0.1951219512195122,0.8471138305724416,1.0,1/5,4.47%,PDE3A
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),0.7282528497678253,1.2518751968760715,0.2682926829268293,0.8486159313339161,1.0,3/5,20.00%,BMP4;ADAM8;TP53
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.601066229903646,1.2513467438527788,0.2,0.8498078399763209,1.0,2/15,4.49%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.6505683023603233,-1.2512173336949592,0.21052631578947367,1.0,1.0,7/17,28.10%,TOMM20;TIMM17A;PAM16;ROMO1;DNAJC19;TIMM21;GRPEL1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5629246540922557,1.2501380893450698,0.2,0.8536472554325755,1.0,12/28,25.18%,PUS10;TRIM71;LIN28B;DGCR8;SMAD2;TARBP2;AGO3;AGO2;LIN28A;ADAR;TUT7;ZC3H7B
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.42945313312600264,1.2501112067225586,0.041666666666666664,0.8526302655832051,1.0,46/131,23.83%,EYA4;CTDNEP1;DUSP2;DUSP4;PTPRO;PTPRZ1;CTDSP1;PPP5C;CTDSP2;PTPRM;PTPRR;PPP2R1B;DUSP18;PTPN9;PTPRF;PPM1A;CDC14B;PTPRB;PTPRT;UBASH3B;PPM1L;TAB1;PTPRD;PPP1R15B;PTPRE;SSH1;EYA3;MTMR3;DUSP6;PPEF1;PTPN14;PPP1CB;PPP4R1;PPP2R2B;MTM1;PTPRJ;NCK1;PTEN;PPP2R5D;PPM1H;PTPN21;DAPP1;PPP3CC;DUSP29;PPM1E;CTTNBP2NL
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.7619084922779262,1.2500470675885371,0.11904761904761904,0.8519616521486685,1.0,4/6,20.05%,CARD9;IL23A;SMAD7;IL23R
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.7773493523960695,1.2497970378416214,0.2,0.8519853111707822,1.0,2/5,17.27%,MFSD2A;SLC27A4
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.7171396660311262,-1.2497005924814946,0.2459016393442623,1.0,1.0,1/7,0.79%,TBX1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.6184034996660381,1.2496014968057492,0.21052631578947367,0.8518669272182845,1.0,2/12,3.09%,MT1G;MT4
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),0.6667313010171829,1.24904853541828,0.2619047619047619,0.8527211680003237,1.0,2/9,16.96%,APOE;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.7358643671570916,1.2478304953330779,0.2619047619047619,0.8564458737937503,1.0,3/6,16.22%,LIN28B;NFKB1;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.6493034695592691,-1.2476809122348942,0.19642857142857142,1.0,1.0,1/11,3.38%,CAV3
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.6947480724406341,1.2476154960262302,0.23255813953488372,0.8560392965879601,1.0,5/10,23.32%,ACACB;CPT1A;PRKAG2;PRKAA2;ACACA
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6122774348805956,1.2475918314384962,0.19047619047619047,0.8550688008787655,1.0,6/15,20.66%,ANP32A;AAAS;NXT1;RGS14;NUTF2;XPO1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6642979772101955,1.2475491989312106,0.24324324324324326,0.8540605196848411,1.0,7/9,32.00%,STX18;PGAP1;GAS1;RNF139;SCFD1;SORL1;TBC1D20
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.7625491801776765,1.2472614832689057,0.2682926829268293,0.8539806184983356,1.0,2/5,15.02%,SLC25A37;ABCB10
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.4895671559358401,1.2469734640967431,0.13043478260869565,0.8537803279223574,1.0,17/80,12.91%,NGF;BAMBI;APOE;PPARG;PYHIN1;WNT3A;RALB;MED25;RIPK2;HMGB1;EPB41;GPSM1;HES1;ZNF618;BMP4;STING1;MARK3
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.45503298438800144,1.2468363542376213,0.15,0.8533396742718063,1.0,16/134,10.38%,ATP6V0D2;FOXO1;KLF10;MFSD2A;KPTN;SIRT1;TCIRG1;AKR1C3;IFI16;RALB;MLST8;MAPK8;EIF2AK3;FADS1;DAPL1;RNF152
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.46333013030617193,1.2462675429055854,0.1,0.8542032442496684,1.0,20/70,19.26%,MID1;POU3F2;CDR2L;TENM3;MSI1;AADAT;CSPG5;RIMS4;RBFOX2;DLX1;NR2F2;SRRM3;FOXO6;FJX1;IGDCC4;MPP2;FZD7;RCOR2;EPHA8;MNX1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6202031811987053,1.2460281482898667,0.14705882352941177,0.8542437008990096,1.0,4/12,19.36%,KHSRP;MOV10;PNPT1;RC3H1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.5665390438485762,1.2460250871790604,0.23076923076923078,0.8531442881565399,1.0,7/26,18.09%,SLC3A2;SLC38A5;SLC7A9;SLC6A17;SLC7A8;SLC6A20;SLC36A4
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7324584481126919,-1.2460153713969566,0.19642857142857142,1.0,1.0,3/7,24.46%,TRMT10A;TRNT1;TRMT10B
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.6746327205326775,-1.2453661316556004,0.19672131147540983,1.0,1.0,1/10,0.84%,BUB1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.6405395918342985,1.2453395013652946,0.2222222222222222,0.854484063633019,1.0,6/15,23.62%,KLHL20;GBF1;MON2;DOP1B;KIF16B;CORO7
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5097529166801885,1.245058645341026,0.14285714285714285,0.8543245585492953,1.0,9/45,9.60%,RSPO3;VEGFC;ANGPT1;PARVA;CDH13;SEMA5A;GREM1;SLIT2;NR4A1
prerank,MSigDB_Hallmark_2020__Apical Surface,0.5293649467369321,1.2448105446638391,0.175,0.8540260296318014,1.0,16/37,22.82%,HSPB1;SCUBE1;DCBLD2;RHCG;EFNA5;CROCC;AKAP7;IL2RB;ADIPOR2;EPHB4;ADAM10;PKHD1;SULF2;ATP8B1;GAS1;LYN
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.6331864653282996,-1.2445954348577035,0.24561403508771928,1.0,1.0,3/12,11.09%,KCNA5;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.5752950941871274,-1.2444477656069919,0.22580645161290322,1.0,1.0,1/30,0.31%,NEK2
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.7165528967229147,1.2444229416345562,0.19148936170212766,0.8544046431730828,1.0,2/8,3.43%,DDAH2;SLC39A8
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.7464408490528434,-1.2441658669135511,0.19230769230769232,1.0,1.0,2/9,6.29%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),-0.7728283536843367,-1.2436429163756317,0.12280701754385964,1.0,1.0,1/7,0.84%,BUB1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6965703644727709,1.2434731666757937,0.23255813953488372,0.857265792241209,1.0,5/10,13.04%,LAMA3;CD151;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.6908499754851622,1.2434143531583846,0.2391304347826087,0.8562701577688231,1.0,3/8,17.40%,MID1;MAPRE1;MID2
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.7298056535881865,1.2433586287569018,0.2894736842105263,0.855316697874358,1.0,1/5,7.28%,CHAC1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.7818153437422055,-1.2432838306161422,0.1836734693877551,1.0,1.0,1/6,7.78%,RNF213
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.484261352142082,1.2425939769748773,0.11538461538461539,0.8573938587835834,1.0,41/141,17.42%,CDH20;GPC4;GRID2;CDH19;CDH12;CDH7;ROBO2;ALCAM;NLGN1;CDH5;UNC5D;DSCAML1;LRRC4C;CDH13;GPC6;BSG;SDK1;CADM1;CDH6;CDH26;DSCAM;LRFN5;PTPRM;TENM3;CLDN12;TENM1;CNTN6;PTPRF;CDH2;PTPRT;EMB;MILR1;CDH10;CDH4;PTPRD;NECTIN3;CDHR3;MMP24;CDH11;AMIGO2;KIRREL3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.6992134087462215,-1.2425894930213113,0.27586206896551724,1.0,1.0,5/6,28.54%,NLRP3;CD86;IL18;TNFSF4;RARA
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5286391531649283,1.242130424839608,0.15151515151515152,0.8584180874718592,1.0,11/24,16.61%,PPFIBP2;CACNB4;ZC4H2;CHRNA1;GPHN;PPFIBP1;PDZRN3;UNC13B;UNC13C;NEDD4;F2R
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.7050956113813432,1.2420231445193906,0.17391304347826086,0.8576826926990956,1.0,3/7,11.51%,PROX1;SIRT1;STARD4
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.716229385677836,1.24190795732908,0.14814814814814814,0.8569688811618877,1.0,7/8,27.87%,MALT1;FOXP3;RC3H1;SMAD7;NFKBID;NFKBIZ;RC3H2
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.42646391550742974,1.2418460245362988,0.1111111111111111,0.8561584202238075,1.0,39/186,15.28%,EFNB1;LAMA3;ROBO2;ALCAM;EPHA7;UNC5D;DSCAML1;PTPRO;SPTBN4;SEMA6C;UNC5C;NRTN;SEMA5A;BSG;NTN4;DOK5;DCC;EPHA3;DSCAM;SLIT2;PTPRM;EFNA5;PLXNB1;SH3KBP1;DOK6;RET;IRS2;EVL;CNTN6;SEMA4A;NOTCH1;GAB1;ARHGAP35;NFIB;EMB;EPHB2;RYK;PIK3CA;NRXN1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5634020045287227,1.2418356199591902,0.20930232558139536,0.855114009059151,1.0,7/23,18.50%,PNP;AMPD1;GMPS;HPRT1;PRPSAP1;APRT;SHMT2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.39707827855702094,1.2415862406578144,0.0,0.8552114730228639,1.0,73/290,19.95%,TEAD2;ESRRG;INTS11;PKNOX1;CPSF1;HDAC3;HDAC10;ZBTB7B;RORA;RARB;LSM10;PCF11;ARRB2;MAML1;PPARG;CBFB;ELP4;ELOF1;RORB;IWS1;DTX1;GTF2I;MED17;NR4A2;ZBTB1;TEAD4;SP1;TRIP13;TAF3;ELOA;CCN2;NR4A1;TAF12;CCNH;NOTCH4;SNRPB;INTS9;WWTR1;HDAC1;NFIC;NOTCH1;NR4A3;NR3C2;SOX5;TFCP2;NFKB1;NR3C1;MLLT3;SNAPC3;CPSF7;INTS14;THRB;NR1H3;NR6A1;GTF2F2;PAPOLA;NR2C1;SETD2;ICE1;RBPJ;KAT2B;HDAC5;TTF2;SYMPK;RPRD2;NFIX;TBL1X;TAF4;TFDP1;NFX1;POU2F1;POLR2F;TRIP11
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.5712862403033082,1.2415494291810325,0.2222222222222222,0.8542101292441613,1.0,8/18,28.60%,CHAC1;PLSCR1;FPGS;PLOD2;GAMT;PTDSS2;SLC27A1;MGST2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),-0.8118083610937143,-1.2415377189005696,0.2127659574468085,1.0,1.0,1/5,1.85%,TGFB1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6039155350958929,1.2414995778372062,0.1875,0.8533288655259796,1.0,5/16,12.72%,FER;ABL1;PDGFD;RGS14;NR4A3
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.7308936564439232,-1.2414864874013718,0.2698412698412698,1.0,1.0,2/9,8.08%,GPER1;SOD2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.5434237997598242,1.2408480050938564,0.1956521739130435,0.854974062433493,1.0,9/36,18.89%,PLD6;PIWIL1;TRIM71;KHSRP;DGCR8;TARBP2;XPO5;PIWIL2;AGO2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.6999497941184383,1.240750145004854,0.20512820512820512,0.8542308568219217,1.0,3/7,17.22%,TOP2A;LIG4;MGMT
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4265993949693728,1.2404571172833176,0.08,0.8546020783653269,1.0,20/129,10.83%,PHLDB2;NGF;MEGF10;TGFBR1;SMYD5;FGFR1;BCL6;BIN1;MAFB;NLGN1;CBFB;GREM1;EPHA3;CDK6;ANP32B;CCN2;FADS1;KLHL41;RPS6KA3;NOTCH4
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7897551412044003,-1.2403868528017246,0.2830188679245283,1.0,1.0,2/5,11.62%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.5405273344664269,-1.240179205413167,0.17567567567567569,1.0,1.0,10/42,15.25%,AQP3;TGFB1;CYP1B1;ESR1;CYP24A1;ANXA1;WNT8B;CDKN2D;SFRP1;GLDC
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6564424355362528,1.2400942142032374,0.2631578947368421,0.8548359096407335,1.0,7/11,29.17%,PKD2;MYC;BMP4;SHH;BMP2;NPNT;GDNF
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5852482322226759,1.2396516636157964,0.12903225806451613,0.855322260638437,1.0,8/33,18.79%,HSPB1;MGARP;SPAST;TRAK2;RAB27B;KIF3B;DLG2;AP3B2
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6779790657706584,1.2395802087580907,0.2127659574468085,0.854543449299827,1.0,4/10,9.69%,TSKU;IFT88;WHRN;ADGRV1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6353696043405379,1.2395560763063684,0.21951219512195122,0.8535917959887468,1.0,2/12,2.80%,LAMA3;SCRIB
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.5232473927170715,1.2395020237376604,0.1388888888888889,0.8527588993656288,1.0,3/39,2.37%,NTSR2;PCDH15;USH2A
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6802950801970025,-1.2393516923376653,0.2786885245901639,1.0,1.0,2/9,9.50%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5124532262455206,-1.2385370649595528,0.17391304347826086,1.0,1.0,5/42,5.87%,DTL;PCLAF;UBE2L6;RPA3;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.744885249425894,1.2382114913936746,0.27906976744186046,0.8565387511346871,1.0,3/5,12.23%,HMGB1;LGALS1;LGALS9
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.4698393383943181,1.237808862435408,0.08,0.8569038625347343,1.0,14/95,10.49%,NGF;THEM4;ITPR2;CDK4;FGF17;RALB;PLCB1;MAPK8;ADCY2;PRKAR2A;ATF1;RPS6KA3;PPP2R1B;LCK
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.7286526506605677,1.2377883267239627,0.2826086956521739,0.855915359223485,1.0,3/5,21.92%,ABCA13;NR1H3;LIPG
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.6294469650093477,1.2375955746763845,0.2,0.8557592278498066,1.0,7/17,21.73%,PCGF1;RNF168;PCGF5;BCOR;RYBP;RNF2;PCGF6
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.4505947714074994,1.2373600729290324,0.14285714285714285,0.8555456546182243,1.0,28/124,16.24%,GRID2;POU6F2;PROKR2;EPHA7;IGDCC3;POU3F2;UNC5D;SIRT1;ELAVL3;PAK5;SLC35F1;ERC2;RHBDL3;CASKIN1;MSI1;B4GALNT4;ASCL1;SCGN;CSPG5;RIMS4;FBLL1;SCRT1;PRR36;SNAP91;LRP8;MPP2;NCAM1;PBX1
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.7988046134031478,1.2373310020845545,0.26,0.8547165293967286,1.0,3/5,19.79%,WASHC2C;CRACD;CARMIL2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.5288069960109626,1.2373051172210596,0.24390243902439024,0.8537548554746572,1.0,4/27,9.84%,GDAP1;PEX13;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6512971976650214,1.2372954860490313,0.20408163265306123,0.8527187392133444,1.0,5/14,9.82%,KIT;FGFR1;BICD1;ABL1;ABL2
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),-0.7388054380126606,-1.2371233239964172,0.23333333333333334,1.0,1.0,3/5,23.10%,SLC22A3;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),-0.7388054380126606,-1.2371233239964172,0.23333333333333334,1.0,1.0,3/5,23.10%,SLC22A3;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5607237282732553,1.2370490108540575,0.13953488372093023,0.8526058805273494,1.0,2/22,2.66%,PHLDB2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.7354467694851263,1.2370135373888176,0.21428571428571427,0.851726996828368,1.0,5/6,26.35%,IL23A;MALT1;IL23R;NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6964862058288095,-1.236943064944252,0.20588235294117646,1.0,1.0,4/10,16.28%,GPR183;PIK3CG;CXCL16;MSN
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5092541071374207,1.2368363893513397,0.15,0.8512138236820681,1.0,17/51,24.16%,SAMD4A;DCP1B;EXOSC1;DCPS;CNOT9;LSM2;LSM7;CNOT4;PATL1;PATL2;DIS3;RC3H1;SAMD4B;CNOT6;LSM6;TUT7;DCP1A
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.5349679462562732,1.2361800479519394,0.15384615384615385,0.8526129584737177,1.0,15/39,19.60%,SLC3A2;TRPM2;SLC38A5;PKD2;SLC7A2;SFXN2;SLC22A5;ABCC8;SLC25A29;SLC7A8;SLC6A20;SLC44A4;SLC36A4;KCNJ8;TRPM7
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.7064261007290907,1.2360886682895265,0.24444444444444444,0.85194726196632,1.0,5/8,21.65%,TGFBR1;NRG1;NOTCH1;RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6087143757667506,1.2356499735258997,0.15789473684210525,0.8523316947804044,1.0,4/20,9.84%,GDAP1;PEX13;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.532083864622518,1.2355535883290323,0.18421052631578946,0.8516679745679921,1.0,4/41,7.71%,GCK;NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.7397123162421857,-1.2351922763250867,0.23728813559322035,1.0,1.0,3/7,12.51%,AQP3;CYP24A1;CDKN2D
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5108982677572516,-1.2351716616593962,0.16666666666666666,1.0,1.0,3/82,2.60%,CD44;TGFB1;TERF2IP
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.6723041081777861,1.2351402868023882,0.16666666666666666,0.8523750952927308,1.0,4/11,9.82%,PTPRO;MAGI2;MYO1E;JAG1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.5960321716231871,-1.2351241245942377,0.2153846153846154,1.0,1.0,4/23,14.75%,MISP;GPSM2;DCTN1;NDEL1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.8065015963096943,1.2349292038579138,0.16326530612244897,0.8522827541048791,1.0,1/5,6.44%,PML
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.6907746378532775,-1.2348075568377126,0.2463768115942029,1.0,1.0,2/8,16.28%,DAB2;MSN
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5762386560977962,1.234609167073765,0.16666666666666666,0.8523803429330247,1.0,4/21,10.05%,RASSF2;GREM1;RAP2A;PDGFD
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.5927742472492505,1.2346030435357938,0.1875,0.8513976966614206,1.0,4/18,10.90%,AUTS2;DNMT1;BCOR;PIH1D1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.6032655848883626,1.2343528431776192,0.2608695652173913,0.8513447318710601,1.0,2/19,7.18%,APOB;LDLR
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.6342650608957003,-1.2341783295137332,0.25,1.0,1.0,2/19,3.38%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.47499165266169036,1.2341410917355649,0.0967741935483871,0.851046180132569,1.0,21/42,30.74%,RIDA;NANOS3;KHSRP;MOV10;TNRC6C;TNRC6A;PNPT1;YTHDF1;AGO2;RC3H1;METTL16;RBM24;MEX3D;TNRC6B;TOB1;PABPC1;ROCK1;NANOS1;YTHDF3;FTO;CELF1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.5638364781984204,1.2341114173796657,0.11764705882352941,0.8501442499021628,1.0,5/26,10.09%,IRGM;F2;SERPINE1;GALP;IL23A
prerank,PanglaoDB_Augmented_2021__Interneurons,0.41000355404175437,1.2339133009392813,0.12,0.8500552884382404,1.0,74/278,20.15%,SLC17A6;NXPH4;LYPD1;ARX;GABRA5;RORA;ADGRL2;GRM3;LRRTM3;PTPRO;NXPH1;KCNC2;PCF11;PCBP3;ELAVL3;CADM2;RORB;PAK5;DEPTOR;HIVEP2;CALN1;NCALD;SLC35F1;ETV1;ERC2;PDE1A;CELF4;PARM1;ADGRA1;SYT1;CCN2;NAT14;CACNG2;CELF5;RAB3C;BRINP1;ELAVL4;FGF12;RGS7BP;TIMELESS;OXR1;ARHGAP21;OLFM3;KCNQ5;SLC22A15;SCRT1;RBFOX1;DLX1;FAM81A;SNAP91;CDHR1;CDH4;FCHSD2;NRXN1;CACNA1I;RIT2;FRRS1L;CXCL14;PPFIA2;SYN1;ELMO1;TMEM196;ADGRB3;DZANK1;GRM5;VSTM2B;CTNNA2;FBXO11;ST8SIA3;PAX6;MMD2;TRIM9;NBEA;CASK
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.48175879756899137,-1.2336780314920375,0.125,1.0,1.0,12/100,5.98%,WNT5A;PTGES;GRK7;HCK;TRIM5;PDE6B;P2RY12;ALOX5;IRF1;LRRC19;GP1BA;ANXA1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.4968184407749696,1.233599463677001,0.2,0.8502490299125203,1.0,11/44,15.31%,HSPB1;SPRED3;CDH5;PML;FKTN;FER;SPRED2;CCDC88A;SPRED1;PPIB;PUM3
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.7829541620081022,-1.233564721179313,0.24561403508771928,1.0,1.0,1/5,9.55%,CARTPT
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.5307380553872529,-1.2333767409676273,0.19298245614035087,1.0,1.0,4/32,9.21%,NOTUM;WNT5A;LRP4;SMAD6
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.6357247421622934,1.2333313923424774,0.2558139534883721,0.8501413473140274,1.0,2/11,9.04%,SPEF2;DYNC1I2
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.792675847653084,-1.233295722651961,0.2033898305084746,1.0,1.0,1/5,5.60%,ATP6AP1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.5072844417602751,1.2332950021081714,0.13953488372093023,0.8492824474994438,1.0,11/29,13.91%,CSGALNACT1;HS3ST3B1;EXT1;NDST3;CHST12;CHST8;UGDH;CHST11;B3GAT3;EXT2;FAM20B
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.6587429185871291,1.2326601207308006,0.23684210526315788,0.8504896899645891,1.0,5/11,15.87%,CBS;PSAT1;SRR;PSPH;SERINC5
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.6729429489211507,1.2325114006175635,0.2857142857142857,0.8500634992677961,1.0,7/10,20.04%,CBS;PSAT1;SRR;PSPH;SERINC5;SHMT2;PHGDH
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.6400052881179809,1.2320079509413744,0.175,0.8509299490365492,1.0,1/9,0.54%,FOXO1
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.7113788083597984,-1.2314171811352386,0.2318840579710145,1.0,1.0,3/6,27.24%,TAFA3;IL18;NUPR1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.6496332386909017,1.2312901881899254,0.20512820512820512,0.852486084368658,1.0,4/16,8.46%,SLC30A10;BCL2;IL16;EPB41
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.6874721124025359,1.2312499177063683,0.225,0.8515921799409412,1.0,3/8,8.80%,SNCA;DRD3;DRD4
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.6800692542956128,1.230748609991417,0.2682926829268293,0.8524909773329424,1.0,1/10,1.32%,KIT
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.616112687507132,1.2305993680334046,0.2558139534883721,0.8519531665710176,1.0,4/12,14.02%,ZBTB7B;METRNL;TFE3;SOX13
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.6760143424304734,1.2304595916206271,0.20454545454545456,0.851584106494335,1.0,3/11,8.02%,STX5;GBF1;PLK3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7141915892577306,-1.2303517921150973,0.23333333333333334,1.0,1.0,4/6,27.26%,SVIP;AQP11;UBXN1;USP14
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.72393347831945,1.2302289211105775,0.17777777777777778,0.8513646068491527,1.0,2/8,15.98%,SNCA;VAMP8
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.40129332991730315,1.2301352408443422,0.1111111111111111,0.8506258821110879,1.0,34/215,12.64%,IL7R;RSPO3;TGFBR1;NLGN1;ZBTB7B;IRS1;SIRT1;KLK14;MAML1;SNX5;CTBP2;PKD2;RSPO2;PTGIS;DRD3;SMARCB1;MYORG;KANK1;ERN1;FLNA;JAG1;GRIN1;MYO1C;NOTCH4;PIH1D1;RIMS2;SMARCA4;GKAP1;MACF1;AGPAT2;TRIM44;LIMS1;KLK5;NOTCH1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5132068740179796,1.230003799796437,0.23076923076923078,0.8500001624445171,1.0,7/36,13.15%,IRGM;SNCAIP;APOE;RAPGEF1;LATS1;NOTCH1;RAP1A
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.7364809952939207,1.2299747139048687,0.2653061224489796,0.8491722337654724,1.0,4/7,8.31%,APOB;LIPC;APOE;LPL
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5059793115657102,-1.2298017381275594,0.16666666666666666,1.0,1.0,13/92,18.80%,NEK2;IHO1;BUB1;RAB11A;GPER1;CAV2;ATF5;SFRP1;ANKK1;CALM1;BORA;ECT2;RMI2
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.7206685553207597,1.2297738505424498,0.28205128205128205,0.8488456734903781,1.0,4/6,25.67%,MYC;MECP2;MPHOSPH8;KMT2A
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.705816192870313,1.2296499209932796,0.29411764705882354,0.8482797252481096,1.0,4/8,23.73%,DPH1;DPH5;DPH2;DPH3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5242432482017598,1.2295446673232115,0.14285714285714285,0.8476782167877165,1.0,3/33,6.97%,ATP6V0D2;TCIRG1;REP15
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.6596445617127191,-1.2294582759350756,0.2413793103448276,1.0,1.0,4/15,16.43%,ODAD1;DNAH17;ZMYND10;DNAI1
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.7628753775014725,-1.2293756039206005,0.24489795918367346,1.0,1.0,4/6,22.17%,HIGD1C;COX7A1;COX7A2;COX7A2L
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.7098539538669527,1.229076622523711,0.2857142857142857,0.848441982612369,1.0,4/8,20.64%,FSTL3;MAGI2;SKI;ACVR1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.6814467048997991,-1.229073891269032,0.2153846153846154,1.0,1.0,2/12,6.51%,MMP9;TNFRSF1B
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6321675955493393,1.2290541608082692,0.19444444444444445,0.8475103537233618,1.0,7/13,31.20%,NAA40;AANAT;KAT2B;EP300;CREBBP;NAA16;NAA50
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7979632925083928,1.22893693445762,0.3191489361702128,0.8469302780404584,1.0,2/5,8.83%,SLIT2;MYO9B
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.7982435372028784,-1.228873594779207,0.23880597014925373,1.0,1.0,2/6,17.66%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6902036663340894,1.2283714710555071,0.225,0.8483166299688245,1.0,3/9,20.77%,NEUROD2;NRXN1;ADGRL1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.7484376282219729,1.2283139980688254,0.2857142857142857,0.8474801654714037,1.0,2/5,21.08%,FSCN1;ATP8B1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.7655931890380803,1.2282886974609555,0.2727272727272727,0.8465907086730124,1.0,4/7,22.70%,AKR1C3;H6PD;EGR1;CLCN2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.5984975982982137,-1.2282295880124101,0.13636363636363635,1.0,1.0,4/19,6.13%,TRIM62;TRIM5;TRIM25;CHMP3
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.495996738934004,1.2280326093966274,0.1590909090909091,0.8468745547229644,1.0,10/32,16.32%,LZTR1;SPRY4;KANK1;ABL2;RASIP1;ARHGAP35;ITGA3;EPHB2;STAMBP;CCDC125
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.7072913136035484,1.227939052184696,0.2222222222222222,0.8461706891305393,1.0,1/10,1.90%,CPEB1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5678362051970056,1.2278995013640024,0.2558139534883721,0.8452859066526368,1.0,10/21,24.97%,TGFA;CBLB;CHMP6;GPRC5A;ZFYVE28;NCK2;SOCS4;BTC;TSG101;CBL
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4360151226273133,1.2273945423280346,0.125,0.8461720621700375,1.0,27/103,14.45%,DUSP15;ARX;HS6ST2;CACNG4;NKD2;CXXC4;PCLO;JPH1;RFX6;RGS16;LRIG3;MSI1;WNK2;PLXNB1;SLC7A2;ABCC8;COBL;HES1;CKMT1A;CKMT1B;DDAH1;PTPRF;PRR36;MAGI1;FGFR3;NR2F2;CGN
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.40068305570488877,1.2272657164747396,0.14285714285714285,0.8456172100476136,1.0,54/266,15.38%,GABRE;SLC17A6;CHRM2;GRID2;GABRR2;GALR3;NOVA1;GABRA5;NLGN1;HTR1F;GRIK1;GRM3;APOE;GABRG3;CEL;HTR2C;HCRTR1;HRH3;DRD5;CACNB4;SNCA;DTNA;PPFIA3;CHRNA10;ERC2;GRIK2;CHRNA1;KCND2;DRD4;SYT1;GRM7;GRM4;LRP6;PRKAR2A;RPS6KA3;APBA3;GRIN1;PDZD11;AKAP9;NLGN4X;GABRG1;UNC13B;HTR7;APBA1;GABRR1;UNC13C;SNPH;SYN2;RPS6KA2;CPNE6;NLGN3;FCHSD2;NRXN1;HTR1E
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.7621700510011779,-1.2271939522941986,0.22641509433962265,1.0,1.0,1/5,4.08%,P2RY12
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7493112171920551,1.2264327427746478,0.2708333333333333,0.8478471824162352,1.0,2/5,23.43%,SEC22B;TAPBP
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.6987857862582778,1.225735428185983,0.20454545454545456,0.8495267875954823,1.0,2/7,4.39%,EDNRA;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),0.777747321370776,1.2253002049101775,0.2553191489361702,0.8501678918232144,1.0,2/5,14.18%,AKR1C3;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.7557832436760502,-1.2250057879651632,0.21568627450980393,1.0,1.0,1/7,4.86%,ESR1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.6969522989995718,1.2250046849415617,0.3,0.8500460697831465,1.0,4/6,24.81%,ZDHHC12;NRXN1;PTEN;NLGN2
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.44886013422634136,1.2249180753420956,0.058823529411764705,0.8493631787941618,1.0,8/80,5.58%,ADGRF4;FAM83H;LAMA3;PERP;ESRP1;DSP;SDC4;ERBB2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6801896674159762,1.2242225208076722,0.20454545454545456,0.850761891752007,1.0,1/9,2.85%,BIN1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4591010148157424,1.2240845495508452,0.075,0.8502604169964353,1.0,6/64,5.77%,EYA4;TGFBR1;BCL2;CFLAR;SH3RF1;SERPINE1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.641336704120576,1.2240165378893564,0.25,0.8496698817869125,1.0,7/12,29.17%,PKD2;MYC;BMP4;SHH;BMP2;NPNT;GDNF
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6489336039027481,1.224014891943411,0.2,0.8487202341283954,1.0,4/11,27.90%,APOE;ABCA7;ABCA2;ROCK1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.6085747766747812,-1.2235939158734213,0.19402985074626866,1.0,1.0,2/23,1.85%,NOTUM;TGFB1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6437963481131411,1.2234847989418178,0.1891891891891892,0.8496991344456436,1.0,8/12,29.57%,IWS1;SETD2;KHDRBS1;CPSF6;TPR;NRDE2;NUP153;NSUN2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.5371426310170437,1.2234018645807274,0.23684210526315788,0.8490213873007231,1.0,4/23,5.77%,ANGPT1;CDH5;SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5579907851376081,-1.223308065321096,0.18032786885245902,1.0,1.0,1/35,0.31%,NEK2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.7004899835072902,1.2231575421893062,0.175,0.8492253265116951,1.0,3/12,10.03%,PCM1;BICD1;GCC2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7047552409081027,1.223077220642879,0.22580645161290322,0.8485676326026826,1.0,3/9,15.58%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4833377000922949,1.223001765253449,0.14705882352941177,0.8477680943882921,1.0,14/55,13.72%,ACADS;CYP4V2;ACAD10;PEX13;ADH4;BDH2;SLC27A2;ECHS1;ABCD3;ABCD2;ADIPOR1;ACADM;MECR;ADIPOR2
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.7042385098898132,1.2230001564355502,0.225,0.8467914030353103,1.0,4/8,24.96%,SLC16A10;SLC7A8;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),-0.7595985472171056,-1.2229963001466104,0.2727272727272727,1.0,1.0,3/5,17.20%,CYP3A5;CYP2E1;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.7700234643496728,-1.2229285329828667,0.15555555555555556,1.0,1.0,1/7,2.02%,GMFG
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.7091530179195022,1.2228894168353366,0.275,0.8462281751856376,1.0,2/6,25.92%,SMURF1;FNBP1L
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7539262242713183,-1.2228700266604213,0.2033898305084746,1.0,1.0,2/7,3.77%,TGFB1;ACMSD
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.7376280595515616,-1.2228598921408544,0.30357142857142855,1.0,1.0,3/6,23.10%,SLC22A3;SLC18A2;SLC22A1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.5929418596253712,1.2227639679539057,0.21052631578947367,0.8457733924579591,1.0,5/18,15.28%,NLGN1;GRIN1;RIMS2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.7644474734729059,1.2225169420204143,0.18867924528301888,0.8455693844334631,1.0,2/6,8.31%,APOB;LPL
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7675452527606363,1.2223014765593962,0.2702702702702703,0.8454905663362117,1.0,3/7,12.68%,HSPB1;MYO1C;GAB1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.6363073616066814,-1.2220919963309866,0.2537313432835821,1.0,1.0,1/17,0.90%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6000363166883522,1.2214597199920745,0.25,0.8473340071668357,1.0,11/23,22.30%,ATF3;NOTCH1;HSF1;CREB3L1;ATF6;RBPJ;CREB3L3;TP53;SESN2;NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),-0.8091929003995042,-1.2214380583516173,0.1509433962264151,1.0,1.0,3/6,7.31%,IRF4;HLA-DRB1;IL27
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5592424177553396,-1.2213152430945733,0.2,1.0,1.0,12/44,17.66%,MGST1;NQO1;SOD2;PRDX4;NDUFS2;NDUFB4;GPX3;CDKN2D;GLRX;TXN;ATOX1;PRDX1
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.6579394196359876,-1.220871575048993,0.16393442622950818,1.0,1.0,3/13,6.00%,JCHAIN;SFTPD;HLA-A
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6738377049943483,1.2207916790193918,0.2631578947368421,0.8489243563696822,1.0,6/9,26.63%,SIRT1;ESCO1;KAT2B;EP300;BAG6;CREBBP
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.4632146056528743,1.2207497868955317,0.1111111111111111,0.8480074261340801,1.0,18/78,8.56%,ADRA1A;KBTBD12;SMYD1;SRL;PPP1R3A;CMYA5;CADM2;FAM110D;DTNA;HIF3A;NT5C1A;ACACB;NMRK2;HFM1;ANO5;SLC35F1;CTAGE3P;ADCY2
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.542552148005817,-1.2206716461648999,0.17391304347826086,1.0,1.0,10/43,15.02%,WNT5A;SP100;STAT1;CIITA;TLR2;SLC11A1;AQP4;RPL13A;CXCL16;HLA-DPA1
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.7578278639801581,-1.2206556765626357,0.22807017543859648,1.0,1.0,3/6,23.52%,OAS1;OAS2;OAS3
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.5002997898059778,-1.2204524601175233,0.19444444444444445,1.0,1.0,4/56,0.90%,AQP3;TBX1;MICB;WNT5A
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.621738633415881,1.2203505178631218,0.20833333333333334,0.8484227948321723,1.0,3/13,9.63%,IWS1;SAFB2;SLTM
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.49625646787541666,1.219942542041825,0.1111111111111111,0.8491029540247834,1.0,7/42,11.58%,CSTA;URI1;PPP1R35;ECM1;PLIN5;GPSM1;RRP1B
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.7914753118766207,1.2199075245164333,0.2564102564102564,0.8483482144426039,1.0,3/6,11.52%,ABI3;KANK1;EVL
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5205866482033391,1.2198666806703167,0.19444444444444445,0.8475951921290984,1.0,6/31,8.17%,FHIT;SIRT1;IFI16;PML;PPP1R13B;ZNF385B
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.5319921978661015,1.2198375929193053,0.20512820512820512,0.8466849821382901,1.0,7/29,6.85%,COL8A1;DUSP2;LAMA3;DUSP4;COL12A1;MMP2;ITGA4
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.7010513819336784,-1.2188584484459117,0.23728813559322035,1.0,1.0,1/7,0.90%,WNT5A
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.6583332863864273,1.2184802814099613,0.1951219512195122,0.850573671171011,1.0,2/11,3.38%,LIPC;APOE
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.7876332205208465,-1.2181706316412562,0.32075471698113206,1.0,1.0,1/5,5.07%,ALOX5
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.5818614251997668,1.217687050086409,0.16666666666666666,0.8523396919647552,1.0,6/18,14.72%,DDAH2;PKD2;TMEM106A;AGXT2;DDAH1;INSR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.534225644132454,1.217577629784849,0.15384615384615385,0.8519022789525392,1.0,2/28,4.39%,ADRA1A;SLC8A1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.7764021159042607,1.2175049759282583,0.2222222222222222,0.8512725243399,1.0,2/5,16.45%,NEU4;NEU3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.6423049196387844,1.2173520054764722,0.2558139534883721,0.8508899727896808,1.0,2/8,5.36%,NFATC3;DNMT1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7500448374163704,-1.2169683640331213,0.24074074074074073,1.0,1.0,4/7,14.34%,AQP3;CYP24A1;CDKN2D;SFRP1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.4229575433376627,1.2168112054198887,0.11538461538461539,0.8521917303930394,1.0,47/157,20.29%,ARC;TSKU;ZNF804A;MFSD2A;APOE;PTPRO;LRRC4C;MAGI2;WNT3A;DCC;TOX;EPHA3;RAPGEF1;LZTS3;ABI3;TENM3;STYXL1;ARSB;KANK1;FZD1;RETREG3;ABL2;NTNG2;AVIL;PTPN9;RET;CCDC88A;CSMD3;ARHGAP35;RAP1A;CDH2;FUT9;ROR1;RIT2;SRCIN1;MARK1;MINAR1;PPFIA2;NTRK2;CTNNA2;PTK7;EP300;PTK6;MARK2;ADCY6;PAK3;PAK2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6891467976131688,-1.216568440489289,0.2631578947368421,1.0,1.0,1/9,1.85%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.7372148417468813,1.2164211729368597,0.2727272727272727,0.8528249401745657,1.0,1/5,2.85%,MAFB
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5179013262700872,-1.2162640810695338,0.1746031746031746,1.0,1.0,6/43,5.87%,DTL;SYCP1;PCLAF;UBE2L6;RPA3;TRIM25
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.5826681449957343,1.2162617679732235,0.21875,0.8523894436227679,1.0,5/22,9.01%,NLGN1;DSP;PCLO;CGNL1;TJP2
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.6831918548840268,1.2162591631947162,0.2894736842105263,0.8514306253509764,1.0,5/9,18.36%,HDAC3;HDAC1;NOTCH1;HDAC4;HDAC5
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.7748477107061635,-1.215990868850891,0.21153846153846154,1.0,1.0,2/6,4.74%,AHR;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7530967455303952,1.2159165560085352,0.2682926829268293,0.8517308713957812,1.0,2/6,15.12%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.5685119382703074,1.215600410146211,0.20454545454545456,0.8516293813084205,1.0,7/19,14.72%,ANGPT1;ARRB2;MAGI2;WNT3A;GREM1;ARRB1;INSR
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5886982534867843,1.215458656109854,0.20689655172413793,0.8512320138431905,1.0,7/24,21.03%,IRGM;RIPK2;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5906282584230176,1.215227965064712,0.2653061224489796,0.8511139112560032,1.0,1/11,0.54%,FOXO1
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7432263525619657,1.2152202837639274,0.2619047619047619,0.8501966402144923,1.0,4/6,24.96%,SLC16A10;SLC7A8;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),-0.7514380652540058,-1.2151035444031273,0.22413793103448276,1.0,1.0,1/5,5.82%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.6742654780206416,1.2146847150235986,0.3191489361702128,0.8515034417443512,1.0,3/7,22.63%,CFH;IL11;CD55
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.7297851223687151,-1.214673945193711,0.23529411764705882,1.0,1.0,1/6,4.99%,PINK1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.6379959224489299,1.2146533923603864,0.2558139534883721,0.8496395250405122,1.0,4/11,24.62%,ACER2;ACER3;ACER1;ABCA2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.6379959224489299,1.2146533923603864,0.2558139534883721,0.8496395250405122,1.0,4/11,24.62%,ACER2;ACER3;ACER1;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6776310228752715,1.2145549461884637,0.35,0.8490740128763214,1.0,4/9,22.61%,RALB;PIP4K2A;LRSAM1;ELAPOR1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.7908025694442375,1.214420659972193,0.23809523809523808,0.8485443234312338,1.0,3/5,17.65%,BCAT1;HIBADH;HIBCH
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.5928161213523288,-1.2142454889296996,0.22580645161290322,1.0,1.0,5/24,7.01%,HLA-DRB1;SFTPD;BLK;VSIG4;PDCD1LG2
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),-0.8018701205212415,-1.2142323752805861,0.22413793103448276,1.0,1.0,1/5,0.84%,BUB1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.7299181991141902,1.214210572945844,0.2631578947368421,0.8484301257424045,1.0,5/7,20.46%,THEM5;PLA2G5;LCLAT1;PLA2G6;HADHB
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.6811696359177465,1.2141553009086252,0.28888888888888886,0.8476264234947225,1.0,1/6,0.81%,FBP2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5967506316191231,-1.214076155975158,0.21875,1.0,1.0,6/21,11.40%,TGFB1;NODAL;CYP1B1;FLT4;GATA4;BRCA1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.62033661312037,1.2135238395213839,0.24390243902439024,0.8488398088445899,1.0,4/14,15.70%,SHLD2;SHLD1;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6208853143193992,1.2133975876314398,0.275,0.8484503711850978,1.0,5/12,21.01%,SCRIB;RAP2A;RAB10;CAMSAP3;MYO9A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.7326351249307635,1.2133427507264034,0.2608695652173913,0.8477008738727234,1.0,2/5,19.71%,PPARG;OSBPL8
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.70072597023753,1.2133304600774102,0.2,0.8468156910289059,1.0,4/8,28.31%,IL23A;IL23R;STAT3;TYK2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.5216133540657031,1.2132924480571359,0.20930232558139536,0.8460182061608617,1.0,15/33,25.51%,TGFBR1;URI1;HTRA2;ERBB2;STAT5B;MYC;ACVR2A;ACVR1;BMPR2;BMPR1A;CIB1;NOS1;ACVR1B;RPS6KB1;TWF2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4643685168860883,-1.2132531785026488,0.15942028985507245,1.0,1.0,23/135,13.63%,AQP3;PLEKHS1;VSIG2;TMEM184A;PLEKHG6;MISP;FMO5;EPN3;TMC4;ITGB6;CEACAM1;LIPH;SPINT1;ALOX15;BAIAP2L1;BRCA1;SCNN1G;LAMC2;INCENP;MYO5B;STAP2;SERPINB5;CLDN1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5067463812936754,-1.2131452818697175,0.15625,1.0,1.0,10/79,11.94%,SLC28A2;SLC22A8;SLC22A3;SLCO2B1;SLC5A1;ABCG2;ABCB1;LRP2;ATP1A4;SLC7A3
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.7584387159123629,1.2131202325557433,0.21951219512195122,0.8456335968953295,1.0,2/6,12.64%,LRP6;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6856697416360443,1.2128561347102254,0.3,0.8456091660659821,1.0,4/8,26.82%,CARD9;TICAM1;HIF1A;STAT3
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.6083867568104343,1.2127628601270917,0.2222222222222222,0.8448498248499866,1.0,3/14,3.43%,SLC30A10;TRPC3;SLC39A8
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5033307890891607,1.2121105595600177,0.18181818181818182,0.8464824294500309,1.0,13/51,21.51%,TCIRG1;ADAMTS12;HTRA2;CAPN2;RAB7A;CTSV;RSPRY1;CTSC;MALT1;BNIP3L;FAP;AFG1L;SIAH2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6951328993204156,1.2116336140074095,0.3076923076923077,0.845317641628067,1.0,6/12,26.80%,ESPL1;ANAPC7;NSMCE2;DLGAP5;RB1;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6951328993204156,1.2116336140074095,0.3076923076923077,0.845317641628067,1.0,6/12,26.80%,ESPL1;ANAPC7;NSMCE2;DLGAP5;RB1;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6951328993204156,1.2116336140074095,0.3076923076923077,0.845317641628067,1.0,6/12,26.80%,ESPL1;ANAPC7;NSMCE2;DLGAP5;RB1;ANAPC4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.6426515683202703,1.2114882886070752,0.2558139534883721,0.844936744429703,1.0,2/6,19.46%,GBF1;MIA3
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),0.7605891660492775,1.2106399573110305,0.30434782608695654,0.8471206763082346,1.0,2/5,9.67%,MEGF10;KLHL41
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.7874991787074721,1.2100350682184027,0.2631578947368421,0.8484347995978364,1.0,3/6,13.58%,UNC13B;UNC13C;SNPH
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5563706542887349,1.210020068571129,0.2,0.8475773431100421,1.0,6/18,21.89%,TGFBR1;PTPRR;LIG4;CHD7;ADAM10;HINFP
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6411141811367893,1.209876244055605,0.21052631578947367,0.8470771717142958,1.0,2/12,17.61%,ERN1;ATF6
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.642412361241545,1.2098002932845222,0.2916666666666667,0.8463921206036343,1.0,4/12,23.28%,ZBTB7B;FNTA;NIPBL;DYRK1A
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.7183084456263105,-1.20966600378548,0.2962962962962963,1.0,1.0,1/5,2.36%,COL1A1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.42105716277904626,1.2096255222490475,0.16129032258064516,0.846215193519494,1.0,45/150,19.68%,SLC17A6;GRID2;SEZ6L;GRM3;LRRTM3;NXPH1;HRH3;PCBP3;ELAVL3;CADM2;CNTNAP2;PAK5;HCN1;HIVEP2;PDE1A;CELF4;ADGRA1;PDE9A;CACNG2;GPSM1;CELF5;GRIN1;RAB3C;BRINP1;ELAVL4;OLFM3;SLC22A15;SCRT1;RBFOX1;SNAP91;PKP4;NRXN1;NKAIN4;SRRM4;RIT2;SYN1;TMEM196;ADGRB3;GRIK3;GRM5;SLC24A2;VSTM2B;CTNNA2;ST8SIA3;MMD2
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.5145198623313434,1.209085689733625,0.20512820512820512,0.8470170810481432,1.0,4/41,7.71%,GCK;NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.47192523495229655,1.2089284368093074,0.18518518518518517,0.8465533896391542,1.0,25/87,22.03%,CSTA;F2;SAMD4A;APOE;DHFR;RIDA;TRIM71;PCIF1;EIF2AK3;CNOT9;NANOS3;NFKB1;PUS7;MALSU1;SYNCRIP;DNAJC1;FXR2;PATL2;LSM14A;SAMD4B;LIN28A;EIF4A3;CDK5;LARP1;IGF2BP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.5907684103177877,-1.208782768886698,0.22580645161290322,1.0,1.0,1/18,0.35%,IRF4
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.45835980729194686,1.2085485570565353,0.10344827586206896,0.8468986839141335,1.0,10/58,9.47%,RASSF2;DUSP15;SH3RF1;TNFRSF19;HMGB1;PLCB1;CARD9;SH3RF3;CCN2;MAP3K10
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.689931320019028,1.2085078744560809,0.2972972972972973,0.8461166446464568,1.0,5/6,30.37%,NBDY;CNOT6;ATXN2;CNOT2;CNOT6L
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.7083431433505771,1.208460105517207,0.23809523809523808,0.8454538720588272,1.0,3/7,15.64%,ANGPT1;TJP2;OCLN
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.6098581374928341,1.2084468300231324,0.24528301886792453,0.8445911901237937,1.0,3/13,14.74%,PUS7L;PUS10;PUS7
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.5990777776804326,1.2084069062657994,0.24390243902439024,0.8438476915376041,1.0,6/18,9.80%,LIPC;RORA;APOE;ACSM2A;LPL;MLXIPL
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5277095107211027,-1.2081566757590492,0.22580645161290322,1.0,1.0,5/27,6.88%,TRIM62;TRIM5;HLA-DRB1;TRIM25;CIITA
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.56821926726471,1.2074449443621138,0.21428571428571427,0.8460691720570426,1.0,4/20,8.25%,MT1G;MT4;AKR1C3;MAPK8
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7812790305735271,-1.2074364377680509,0.2542372881355932,1.0,1.0,1/6,2.49%,TRIM62
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4578276636973081,1.2074193423211406,0.1,0.845325683175093,1.0,8/37,10.49%,ITPR2;HTR2C;SLC8A1;TRPM2;SLC8A3;PKD2;GRIN1;LCK
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.7025963992430673,-1.2073470377584277,0.29508196721311475,1.0,1.0,2/7,21.00%,CARTPT;CHRNB2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5912347106523026,-1.2073375995021751,0.2222222222222222,1.0,1.0,6/22,11.40%,TGFB1;NODAL;CYP1B1;FLT4;GATA4;BRCA1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.7285316309365844,1.2073180769280532,0.3111111111111111,0.8438434969614538,1.0,1/5,12.62%,GSTZ1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.7285316309365844,1.2073180769280532,0.3111111111111111,0.8438434969614538,1.0,1/5,12.62%,GSTZ1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.7352828027903511,-1.2072271713943252,0.2549019607843137,1.0,1.0,3/8,12.29%,ZFPM1;GATA4;HEY2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5723391955176752,1.207141128595178,0.2,0.8435048786197232,1.0,6/19,15.95%,LZTR1;SLIT2;CGNL1;SPRY4;EPHB2;STAMBP
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.7288582259582989,1.206874243169817,0.2830188679245283,0.8436332566753305,1.0,3/7,12.23%,KLRD1;ARRB2;LGALS9
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.6037563000738316,-1.2063238288154818,0.2,1.0,1.0,2/25,3.78%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.8100177191334641,-1.2063160853289685,0.31343283582089554,1.0,1.0,2/5,17.66%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.7186334420885763,-1.2062434116982428,0.24561403508771928,1.0,1.0,2/8,4.86%,TGFB1;ESR1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.7277823266808859,1.2062071109957389,0.3611111111111111,0.8450921349982792,1.0,1/7,1.93%,EMP1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.6929105121988008,-1.2061141532367492,0.18,1.0,1.0,1/8,9.55%,CARTPT
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5174512828825745,1.2056520109083513,0.1875,0.8465977434213048,1.0,10/30,24.16%,DCP1B;EXOSC1;DCPS;LSM2;LSM7;PATL1;DIS3;CNOT6;LSM6;DCP1A
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.7821611545092289,1.2052257858945867,0.3023255813953488,0.84727017746348,1.0,2/7,8.36%,APOE;ABL1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6855508805392134,1.2052246689186707,0.23255813953488372,0.8463659403477238,1.0,3/11,14.29%,CSGALNACT1;GMDS;GALT
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5643409179061053,-1.2051879977597333,0.1875,1.0,1.0,6/26,8.33%,MYH7;ACTC1;MYH4;MYH8;MYBPC3;NEB
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5643409179061053,-1.2051879977597333,0.1875,1.0,1.0,6/26,8.33%,MYH7;ACTC1;MYH4;MYH8;MYBPC3;NEB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6134656150509858,-1.2050267587188783,0.25396825396825395,1.0,1.0,6/19,17.71%,KCNA5;CAV3;SCN5A;KCNQ1;KCNE3;KCNE2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.479932040660639,1.2048735222757396,0.12903225806451613,0.8464905839129196,1.0,18/53,21.03%,TBKBP1;MAP3K14;CD14;RIPK2;TICAM2;SHARPIN;NKIRAS2;TANK;TICAM1;TAB3;TAB1;IRAK1BP1;BCL3;ZNF675;ERC1;FAIM;TAB2;TRAF6
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.5711228746463787,1.2048270174440667,0.2564102564102564,0.8458042024614082,1.0,1/19,0.84%,AUP1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.5632200844575842,-1.2046945199305943,0.2112676056338028,1.0,1.0,6/29,12.29%,MYH7;PKP2;TGFB1;MYBPC3;GATA4;HEY2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.6758693972579145,-1.204618436302166,0.3064516129032258,1.0,1.0,4/10,23.23%,ATP6AP1;ATP1A4;LACC1;PDK4
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.7347359860043227,1.2043960944034875,0.3023255813953488,0.8462928056567669,1.0,5/6,26.35%,NMU;MYOCD;F2R;SRF;ENO1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.5624163218832569,1.2043591112711807,0.18181818181818182,0.8454760056511412,1.0,5/17,11.90%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.6941272498766671,1.2041834104207665,0.29545454545454547,0.845056781868184,1.0,3/6,22.72%,MTR;MTHFR;PLOD2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.5506783711801863,1.2039466315546938,0.2571428571428571,0.8450832972681814,1.0,11/25,21.19%,CAPN10;IRS1;AKT2;IRS2;NR4A3;INSR;OCLN;BRAF;CLIP3;OSBPL8;C1QTNF12
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.46677209436561423,1.2037384176951944,0.20588235294117646,0.84482996242238,1.0,12/59,9.60%,TGFBR1;VEGFC;FGFR1;PROX1;SIRT1;CDH13;SEMA5A;HMGB1;ITGA4;ECM1;SP1;NR4A1
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.7595921794390181,-1.2034644030782318,0.21428571428571427,1.0,1.0,1/5,3.79%,SCN5A
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.7493281781691272,-1.203366114217182,0.21666666666666667,1.0,1.0,2/6,9.85%,PRDX4;TLR2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.5448830162587819,1.2032881519988852,0.20588235294117646,0.8452183650078194,1.0,10/24,25.29%,CHAC1;WWP2;BEND6;DLK2;ARRB1;NRARP;ZBTB7A;TCIM;NOTCH3;EGFL7
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.6985307254754892,-1.2030863679056836,0.25862068965517243,1.0,1.0,1/8,5.98%,ANXA1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.7687359264704237,-1.203059465362995,0.22033898305084745,1.0,1.0,1/5,2.92%,TRAIP
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.46535298665563785,-1.2030257860967921,0.13043478260869565,1.0,1.0,22/107,17.95%,NEK2;BUB1;HSPA1L;GAD1;SYCP1;ZC2HC1C;MEP1B;PEBP1;TTK;ALOX15;ART3;CCT6B;ARL4A;TNP1;GAPDHS;PCSK1N;CDKN3;GSG1;LDHC;HTR5A;TULP2;TOPBP1
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.7647542153915283,-1.202973470782725,0.3333333333333333,1.0,1.0,1/5,1.01%,SLC51A
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.7092179150586831,-1.202675427171925,0.3090909090909091,1.0,1.0,4/10,21.45%,CYP24A1;LRP2;CYP3A4;VDR
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5805524485314313,1.2026426453728976,0.18181818181818182,0.8466734855631834,1.0,7/25,15.18%,FGF10;ANGPT1;FLNA;GGA1;ANK2;SMURF1;EMP2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.5369093672737811,1.2022916096163296,0.17073170731707318,0.8468950578117302,1.0,9/30,15.64%,AUTS2;SLIT2;FER;ABI3;AVIL;WASF2;FSCN1;PIK3CA;OCLN
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.5709284268310194,1.2021813492968756,0.23255813953488372,0.8462803220980409,1.0,5/17,9.30%,NKD2;ASTL;KLKB1;F12;RHBDD1
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7489087948191469,1.201983275426007,0.3191489361702128,0.846174406483064,1.0,1/5,0.23%,PNP
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4137780700664741,1.2018847471108853,0.16,0.8456598506885236,1.0,40/203,14.27%,VWC2;NGF;CCN4;BAMBI;TGFBR1;APOB;SMYD1;FGFR1;NEUROD2;BRINP3;RIN2;WNT4;PPARG;ZC4H2;PLCB1;LPL;ABL1;ZNF703;CCN2;ZEB1;KITLG;BEND6;SP7;RPS6KA3;BRINP1;TWIST1;GDF6;ASCL1;BNIP2;PLA2G5;CCN1;WWTR1;BMP4;RAP1A;CDH2;DLX1;CARM1;SOX5;NFKB1;SMAD2
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.720390413198543,1.2017316659638428,0.2894736842105263,0.8452770756638781,1.0,4/5,10.90%,SIRT1;AUTS2;SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.8191621725724,-1.2017247250713394,0.18867924528301888,1.0,1.0,2/5,3.79%,CAV3;SCN5A
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6585229872413674,1.2017095580796044,0.25,0.8444871005848569,1.0,7/13,20.64%,TGFBR1;HJV;CFC1;GDF6;SMAD2;ACVR2A;ACVR1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.673041997721765,1.201702594995419,0.2727272727272727,0.843617268160395,1.0,5/10,25.28%,DLGAP4;AKAP9;DLGAP1;DLGAP2;NPTX2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.618608252525816,1.2016127254315072,0.25,0.8429446907314467,1.0,4/21,11.59%,SLC5A8;RNLS;PTGIS;NAMPT
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.523903767233613,-1.2015924595876089,0.1746031746031746,1.0,1.0,25/66,20.56%,RASGRP4;GMFG;ITGB2;HCK;C3AR1;ARHGAP9;CYTIP;TNFRSF1B;TAGAP;PTPRC;LY86;PARVG;SPI1;NFAM1;WAS;MYO1F;CLEC12A;ITGAM;TRAF3IP3;PSTPIP1;ITGAX;PGLYRP1;IL5RA;FPR1;CD300LF
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.5899721151272435,1.20137404439177,0.21621621621621623,0.8428103955614029,1.0,5/12,27.74%,ABCA1;STARD4;NPC2;ARV1;ABCG1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6149084166337998,-1.2013716001940904,0.22807017543859648,1.0,1.0,6/15,13.48%,ALOX12;ALOX5;ALOX15;ALOX12B;ALOX15B;PON3
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6271714701753461,1.2011143878768147,0.28846153846153844,0.8428714039386513,1.0,10/14,32.48%,LIN28B;TARBP2;AGO3;AGO2;LIN28A;ADAR;TUT7;DROSHA;PRKRA;TUT4
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7214803893308527,1.2010558519852093,0.23076923076923078,0.842169244478735,1.0,3/8,20.77%,NEUROD2;NRXN1;ADGRL1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.5030328689069872,1.200950839530276,0.20512820512820512,0.8416793843088641,1.0,8/44,5.77%,HIP1;RAB31;CD151;NLGN1;APOE;BICD1;SNCA;SERPINE1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5968337131717414,1.2009295796248283,0.21621621621621623,0.8408665248886155,1.0,7/17,20.77%,STX5;STX18;AKAP9;MYO5A;CAMSAP3;USP6NL;PDE4DIP
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.7168323864721957,1.2008792507745785,0.34146341463414637,0.8401524639259461,1.0,4/5,28.02%,NFKB1;RC3H1;RC3H2;RELA
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7131975731251514,1.200764408372296,0.2926829268292683,0.8396662316031744,1.0,4/6,27.47%,COLGALT1;EMILIN1;RB1;AEBP1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5767238877258133,-1.2006878640962377,0.21052631578947367,1.0,1.0,3/25,5.52%,TGFB1;P2RY12;GPR183
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.520048642992988,1.2006565880558746,0.1875,0.8392133111980647,1.0,10/28,24.16%,DCP1B;EXOSC1;DCPS;LSM2;LSM7;PATL1;DIS3;CNOT6;LSM6;DCP1A
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6169718429020066,1.2005624539844488,0.2978723404255319,0.8386161276986216,1.0,9/20,23.85%,TRIM71;LIN28B;KHSRP;DGCR8;TARBP2;XPO5;AGO2;LIN28A;TUT7
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6579462077631042,1.2005558581871547,0.3076923076923077,0.8377623109687191,1.0,3/11,15.98%,HMGB1;RAG2;LIG4
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.6399371082958937,1.2005036617322091,0.2708333333333333,0.8371839690934219,1.0,5/9,29.64%,MTHFR;SHMT2;MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.4648733797398598,-1.2004254784316593,0.18055555555555555,1.0,1.0,11/77,10.38%,SLC22A25;MGST1;SLC22A24;SLC22A6;ABCC6;CA14;SLC22A3;SLCO2A1;CA1;SLCO2B1;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.728222192133994,1.2003733149796878,0.2682926829268293,0.8368319956288564,1.0,2/6,14.85%,NEUROD2;EPHB2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.48301897154462403,-1.2003301550177599,0.10666666666666667,1.0,1.0,19/91,17.12%,BUB1;ERCC6L;TICRR;HK2;MCM3;ZNF296;SALL4;CHAF1A;CCNF;SLC7A3;CENPH;CLDN6;CDC6;SET;TERT;ZGRF1;ATAD5;PIF1;PAICS
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6615578173143342,1.200328718351407,0.21739130434782608,0.8361433428937682,1.0,3/11,11.21%,MGARP;SPAST;TRAK2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.6280951372815939,1.2002325530353384,0.25,0.8355203146481022,1.0,4/11,20.60%,PKD2;GRIN1;CPSF7;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6195694774254183,1.200125112137951,0.2,0.8349627077200644,1.0,8/13,30.16%,NOTCH1;RBPJ;BMPR1A;AKAP6;ZFPM2;EDN1;MEF2C;IGF1
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6058713731968807,1.199895397915913,0.2857142857142857,0.8348547354475822,1.0,1/16,1.30%,PNPLA3
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6681473591900257,1.1992809896665277,0.24489795918367346,0.8361550580782245,1.0,3/7,9.15%,LATS1;ZNF703;AKT2
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.6062782686840005,1.1991630964275999,0.21428571428571427,0.8356304878554326,1.0,4/13,17.48%,SIRT1;SIRT7;HDAC1;CHD1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5067564977781479,-1.1990677346002268,0.16129032258064516,1.0,1.0,10/77,11.94%,SLC28A2;SLC22A8;SLC22A3;SLCO2B1;SLC5A1;ABCG2;ABCB1;LRP2;ATP1A4;SLC7A3
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.49002989989189455,1.1990509979791444,0.23333333333333334,0.8352347393603144,1.0,23/75,21.65%,CCN4;BAMBI;TWIST2;WNT4;PPARG;RORB;GREM1;CDK6;CRIM1;TWIST1;CCN1;WWTR1;BMP4;NOTCH1;SUCO;SKI;ZHX3;ACVR2A;MEN1;ACVR1;HDAC7;BMPR2;BMPR1A
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),0.6964657740650714,1.1984838728242146,0.2826086956521739,0.8362913936409633,1.0,1/5,2.58%,OSR1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6426233899578139,-1.1980945916837844,0.22807017543859648,1.0,1.0,2/14,4.86%,TGFB1;ESR1
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.43625765234736075,-1.1980738491681004,0.11842105263157894,1.0,1.0,25/162,13.35%,MYH1;MYH7;ACTC1;MYBPH;CASQ2;TGFB1;COL1A1;MYH4;MYH8;CAV3;ATP6AP1;NQO1;MYBPC3;FOXO4;CKMT2;CKB;CLU;CFD;SVIL;APOD;GPX3;COX7A1;TPD52L1;CDKN1A;CSRP3
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.44285094329043867,-1.19803932450801,0.15789473684210525,1.0,1.0,5/167,1.88%,CD44;IRF4;AMACR;AHR;HK2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.6735656173044541,-1.1979645456394787,0.16981132075471697,1.0,1.0,2/14,9.88%,IRF4;NLRP3
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.4579147630066677,1.1975810659391428,0.16216216216216217,0.8381107690446107,1.0,36/99,26.22%,PHLDB2;RHOBTB3;SORBS3;CAPN2;BICD1;RHOBTB1;CRK;MLST8;EPHA3;ABL1;EFNA5;PLXNB1;RND3;CCDC88A;FSCN1;ARHGAP35;MAP6;IQCJ-SCHIP1;CORO2B;F11R;CAMSAP3;MARK2;PAK3;PAK2;PRKAA2;ARHGAP18;TAOK2;RHOBTB2;TPPP;ARHGAP44;CDK2AP2;CORO1A;TWF2;GRHL3;DLC1;CDK10
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5635887962512978,1.1975230710100693,0.2222222222222222,0.8374430752247609,1.0,3/15,6.03%,SMYD5;SIRT7;PIWIL1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.547450833047808,-1.1973690548048945,0.16129032258064516,1.0,1.0,5/29,11.14%,CTNNA1;CAV3;LATS2;DNAJA1;SPI1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.7397931560513504,-1.1972954123153716,0.30357142857142855,1.0,1.0,3/7,19.44%,SOX10;MYRF;PLP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5118454316159186,1.1970918398094155,0.21875,0.838096660620536,1.0,4/35,6.26%,IRGM;SPRED3;PARD3;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.4836069985405994,1.1968811496530798,0.1724137931034483,0.8380499123005791,1.0,14/38,25.72%,HDAC3;MLST8;TELO2;SIK3;PIH1D1;CLEC16A;KLHL22;PIK3CA;LIN28A;HTR6;RRAGD;GAS6;LAMTOR4;SEH1L
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.7853818257511516,1.1964011671628154,0.25,0.8389554637773495,1.0,2/5,12.52%,FGF10;BMP4
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.7682724578049005,-1.1961396255642174,0.2545454545454545,1.0,1.0,1/6,8.79%,CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.7682724578049005,-1.1961396255642174,0.2545454545454545,1.0,1.0,1/6,8.79%,CD63
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.7141954252630995,1.1960514322867473,0.2765957446808511,0.8394945280045043,1.0,2/5,19.13%,NOTCH1;FSHR
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6358277728248509,1.1957015332223726,0.17391304347826086,0.8397632520382966,1.0,2/10,6.17%,PCM1;CCDC120
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4886234330076642,1.1953524669303446,0.19444444444444445,0.8399206776519504,1.0,8/41,10.32%,HSPB1;FGFR1;ANGPT1;FGF18;SIRT1;HMGB1;SP1;NUS1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.751772494472504,1.195347366028239,0.27906976744186046,0.8390820368812696,1.0,2/5,15.94%,ADAMTS12;RNF207
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.6773135889666155,1.1953183124174689,0.3023255813953488,0.8382924689579049,1.0,3/6,18.79%,USP16;EIF5AL1;GRM5
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3936807363388517,1.1953024805970898,0.05555555555555555,0.8375045042181409,1.0,74/250,21.67%,KIT;PCM1;EMP1;FHDC1;IFT88;EHD4;PARVA;PTPRO;CDH13;FGD4;VSTM5;DZIP1L;SCLT1;GBF1;BBS9;SRGAP2;CILK1;TTC36;SPAG16;FGD5;TNIK;FLNA;RAP2A;CEP290;RAB11FIP3;AVIL;RPGR;FGD1;CEP250;CCDC88A;FSCN1;NOTCH1;MKS1;RILPL1;RAP1A;CDC14B;PTPN23;PIBF1;KIAA0586;EMP2;ARL13B;CEP20;TTC39C;SSTR3;BBIP1;EXOC7;CEP162;IFT140;ARL3;NEK1;KIF3B;CFAP70;PPP1R9B;RP2;CFAP221;TMEM138;DZIP1;CNGA4;PTPDC1;CFAP43;CEP41;DCDC2;POC1B;UNC119B;TCTN2;TMEM67;WDR19;PKHD1;EXOC4;VCL;FGD6;IQCB1;EXOC6;ASAP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6394121842699244,-1.1952805543399354,0.27692307692307694,1.0,1.0,4/12,23.00%,WNT5A;THBS1;TAFA3;TNIP2
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.5420004081939885,1.1952544602993245,0.2564102564102564,0.8367023803804126,1.0,6/27,6.93%,PER2;ATOH7;PER3;PML;CRY1;OPN5
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5905206180079259,1.1949696641427998,0.1111111111111111,0.8370195240734136,1.0,7/15,27.10%,TENT4A;TNRC6C;TNRC6A;AGO2;TNRC6B;TOB1;PABPC1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.42403700687912527,1.1947005327177203,0.13333333333333333,0.8372259472321087,1.0,17/100,12.09%,EPHX2;TOP2A;ALDH1A1;CEL;ATXN1;STS;PEX13;CADM1;ISOC1;SLC27A2;FADS1;ABCD3;ABCD2;ABCC8;ACSL1;IDH2;CRABP1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.47398055716386533,1.1946045753354912,0.19444444444444445,0.8366307630601467,1.0,10/54,9.82%,HIP1;CD151;APOE;PACSIN2;CDH13;SNCA;EPHA3;ABL1;ZFYVE16;ABL2
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),-0.7353909841300602,-1.1942808831798153,0.3157894736842105,1.0,1.0,3/5,23.52%,OAS1;OAS2;OAS3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.7585652586510746,1.1939389995824097,0.2653061224489796,0.8375119926004762,1.0,4/5,17.37%,KIT;OLFM2;MYOCD;SHH
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.43904635062191566,1.1938744438350954,0.17073170731707318,0.8368706872607621,1.0,19/83,17.70%,TBC1D10A;STX5;RHOBTB3;SNX5;RAB7A;GBF1;STX6;WASHC2C;UBE2O;GCC2;WASHC2A;GGA1;VTI1A;VPS54;DENND2A;ARFRP1;SNX32;VPS50;ERC1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.4337363328067811,1.193698842332214,0.19047619047619047,0.8366065651996991,1.0,26/86,22.23%,CPEB1;SAMD4A;DHFR;RIDA;TRIM71;PCIF1;EIF2AK3;CNOT9;NANOS3;EIF3E;PUS7;MALSU1;SYNCRIP;YTHDF1;FXR2;PATL2;AGO2;EIF4EBP1;LSM14A;METTL16;SAMD4B;LIN28A;EIF4A3;LARP1;IGF2BP1;TPR
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.47709468572798336,1.1936069556739004,0.21621621621621623,0.8360926339170454,1.0,12/37,25.82%,ITPKB;GPHN;FADS1;AGPAT5;PNPO;IP6K1;IPPK;CPS1;IP6K2;GK;PCYT2;MOCS1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.5816142340926452,1.1936011945342568,0.30303030303030304,0.835282755613452,1.0,4/18,14.41%,OPRD1;TSSK4;RPS6KA4;LRP8
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.41645843112680225,1.1935673213969955,0.038461538461538464,0.8345369647037255,1.0,28/118,13.79%,EPHX2;PC;RORA;ADGRL2;ADAMTS1;TBC1D16;GPC6;B4GALT2;BCAT1;CDR2L;PLIN5;LRIG3;ECHS1;MPDZ;CLDN12;PLXNB1;SLC7A2;AADAT;RND3;CAP2;CITED4;UNC13B;RBFOX2;DDAH1;PTPRF;KCTD3;MAGI1;CHKA
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.5105425727462752,1.1935008672258822,0.28205128205128205,0.8339954609252875,1.0,7/54,5.81%,GCK;GRP;PER2;ITPR2;HTR2C;KCNC2;RFX6
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.43703061245181674,-1.1933850403117674,0.14102564102564102,1.0,1.0,65/165,27.70%,RPL37A;PWP2;NOB1;SENP3;RPL15;EIF6;RPL3;RPL38;RPL35A;RPS9;RPL7A;EMG1;RPL13;RPS27;RPL13A;RPS16;NOP53;RPL27A;RPL9;LAS1L;RPL5;RPL21;RPL34;RPL4;RPL23;WDR12;RPS14;EXOSC2;RPL18A;RPL32;IMP3;RPL36;EXOSC8;RPL18;RPL29;RPS7;RPS15;RPL41;RPS28;RPLP1;NSA2;SBDS;RPL12;RPL11;RPL35;RPL22;RPL27;RPL24;PDCD11;RPLP2;RPS19;RPL28;RPL19;RPS24;RPL10;RPS25;PIH1D2;DDX49;DHX37;RPS6;EBNA1BP2;RPL8;RPLP0;UTP15;MRTO4
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6156904849704926,1.193299164643014,0.2857142857142857,0.8339381334856736,1.0,6/10,29.77%,IMPACT;SESN2;RRAGD;GCN1;SESN3;EIF2AK4
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.5970940239362297,-1.1931339131503258,0.25,1.0,1.0,2/17,6.29%,PLAAT4;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.6670563430915352,1.193082447674434,0.21428571428571427,0.8337719453790965,1.0,2/8,12.72%,ADAMTS1;NR4A3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5265187549538153,1.1930485832979698,0.1836734693877551,0.8331706241135408,1.0,6/21,10.23%,RAB27A;SLC30A10;SNCA;SLC25A33;ABCD2;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.6297678360672089,-1.1929554713990653,0.22950819672131148,1.0,1.0,3/11,15.76%,TRIM5;CIITA;PTX3
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.7698703264053218,-1.1926495058195694,0.21428571428571427,1.0,1.0,1/5,1.85%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.7044962043595102,1.1924517175655616,0.2857142857142857,0.8344038478990834,1.0,6/8,26.35%,CARD9;IL23A;MALT1;IL23R;NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.5107317372154176,-1.1924431813735932,0.16666666666666666,1.0,1.0,6/25,20.17%,TRIM5;IRF1;ERAP1;CASP8;DHX58;TKFC
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.7069762093465995,1.19219824208051,0.32558139534883723,0.8343308202823586,1.0,3/6,20.31%,PIH1D1;NIPBL;MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.732155565544769,1.192103964279495,0.3333333333333333,0.8337617531974802,1.0,3/7,12.64%,TGFBR1;JAG1;NOTCH1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.6202688648785522,1.191882921361413,0.2826086956521739,0.8338444146641663,1.0,6/11,29.64%,DHFR;MTHFR;SHMT2;MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.7670424301136178,-1.1914797672816058,0.2692307692307692,1.0,1.0,1/5,14.09%,THBS1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.5662527633284486,1.1913373002227954,0.1,0.8349018301962311,1.0,4/29,8.09%,ARC;APOE;PPFIA3;GRIK2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.44559233019190436,-1.191303397048781,0.19117647058823528,1.0,1.0,10/169,5.40%,GPR62;ENPP2;NFE2L3;PPP1R1B;SOX10;GJC3;SHISA6;FAM181B;SOWAHA;LGI4
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5852419451475664,1.1912865175262946,0.13725490196078433,0.8342875151423208,1.0,3/15,8.31%,APOH;LIPC;LPL
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.695685714719432,-1.1905132256388324,0.29508196721311475,1.0,1.0,2/7,18.49%,P2RY12;NTN1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.5260866535513233,1.190495254825157,0.21212121212121213,0.8360528182209042,1.0,4/34,3.05%,ADRA1A;KIT;FGFR1;EDNRA
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7188534573777194,-1.1904759899767883,0.23076923076923078,1.0,1.0,2/8,14.09%,TGFB1;THBS1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.6367572003449757,-1.1904731849403785,0.3137254901960784,1.0,1.0,3/10,16.71%,CHST9;B3GALT6;XYLT2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6484828184818323,-1.1903495877721497,0.26229508196721313,1.0,1.0,2/11,17.00%,SNAP23;STX19
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.729021661714824,-1.1901988099358605,0.24242424242424243,1.0,1.0,3/6,16.11%,PIK3CG;PIK3CB;RAC1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.680101365116515,1.1901100514806087,0.35555555555555557,0.8366265977525684,1.0,6/8,18.84%,CBFB;HMGB1;LGALS9;TWSG1;RUNX1;TARM1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.7535288319608708,1.1899968369489313,0.3,0.8361357078754302,1.0,3/5,24.62%,APOE;LAPTM5;ABCA2
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.6479582430991842,1.1899626411571245,0.3055555555555556,0.8354302159950588,1.0,3/11,11.90%,AADAT;IDH2;OGDH
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.37697161040743915,1.1896622989727546,0.0625,0.8355414185578645,1.0,67/354,15.47%,ATP6V0D2;EFNB1;FOXO1;SH2D6;NGF;KIT;SH2B2;FGF10;VEGFC;FGFR1;MAPKAPK2;ANGPT1;FGF18;EPHA7;IRS1;FRK;TCIRG1;ESRP1;SHC4;FLT3;FGF17;ERBB2;NRG1;HNRNPF;MMP2;CRK;PLCB1;EPHA3;RAPGEF1;TRIM71;FER;EIF2AK3;EFNA5;AKT2;HNRNPH1;SPRED2;PDGFD;GRIN1;NUS1;LCK;CD8A;FLRT2;MPZL1;RGS14;CASP3;RET;IRS2;NAMPT;TIAL1;WASF2;RBFOX2;GAB1;NR4A3;SPRED1;PXN;EFS;PTPRT;UBASH3B;FGFR3;VAV2;INSR;EPHB2;RYK;PIK3CA;DOCK1;CASS4;ROR1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.5112944500330215,1.1896371077513435,0.23809523809523808,0.8347610713587151,1.0,6/28,15.00%,PHLDB2;SERPINE1;ACER2;JAG1;ADAM15;NEXMIF
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.581571954939657,1.1896178381903595,0.17647058823529413,0.8341204394708817,1.0,7/21,17.20%,CSGALNACT1;EXT1;NDST3;HS2ST1;EXT2;FUT9;HAS2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6292257859699395,1.1894037422475996,0.2702702702702703,0.8340332192971541,1.0,5/13,18.77%,DYNC1I2;ARHGAP21;APBA1;CLIP3;CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7164153363587273,1.1892267698285768,0.2682926829268293,0.8337929482749268,1.0,2/7,3.07%,NLGN1;RORA
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.6919395483689603,1.1892223340726367,0.25,0.8329714773899269,1.0,2/7,22.30%,SESN2;HIF1A
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.49322394463608815,1.1890594502739065,0.23529411764705882,0.8327021401116039,1.0,15/44,23.80%,GMNC;SLFN11;RBBP6;CTC1;TERF1;CCDC88A;DSCC1;ESCO1;FAF1;DNA2;RAD17;ATR;STN1;SMC3;CCNA2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.502153676884352,1.1887982273768438,0.2564102564102564,0.8326777659362486,1.0,6/39,12.13%,GCK;ZBTB20;LPL;ERN1;IRS2;UNC13B
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.7682262897811827,-1.1883335646610385,0.23880597014925373,1.0,1.0,1/6,9.48%,DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.6110213058141996,1.1881123218640288,0.32432432432432434,0.8340728133277919,1.0,2/13,5.36%,AUTS2;DNMT1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.699986361505629,-1.1880769142974903,0.27586206896551724,1.0,1.0,2/8,5.47%,MISP;GPSM2
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.7890822979327405,1.1880009826971845,0.2653061224489796,0.8336049758286184,1.0,3/5,12.57%,SIRT7;FBLL1;FBL
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.4341133208597548,-1.1877265633718654,0.09859154929577464,1.0,1.0,39/173,16.95%,INMT;CYYR1;F8;TBX1;C1QTNF1;TIMP3;LMOD1;ANGPTL2;ELK3;CLDN5;OIT3;DCN;CYP1B1;S100A13;LYVE1;FLT4;ID1;SLCO2A1;GPIHBP1;PROCR;PALMD;USHBP1;APOLD1;ADIRF;ID3;ABCG2;NOSTRIN;LOX;PRKCH;COX7A1;ARAP3;TEK;MGP;A2M;IFI27;VWF;C1S;WFDC1;TMEM100
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.670232814334811,1.1876796309990911,0.3333333333333333,0.8340976815447115,1.0,1/7,1.30%,PNPLA3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.6997475478567208,1.1876514049233688,0.2857142857142857,0.833372043071539,1.0,2/6,15.36%,MAPK8;FNTA
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.617490836150445,1.1874488293648022,0.22857142857142856,0.8332103115256001,1.0,4/15,11.66%,RORA;SIRT1;BCKDK;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.4675912290845143,-1.1874218713879876,0.1875,1.0,1.0,14/122,9.51%,CD44;TGFB1;NODAL;ALKAL2;SCIMP;HLA-DRB1;GPER1;GPR183;FLT4;ATP6AP1;PTPRC;P2RY6;HTR2B;ALOX15
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.5675645897568727,-1.1872986040277522,0.22033898305084745,1.0,1.0,6/27,15.97%,NOTUM;CYP26B1;PTPRC;SFRP4;RPL13;TGM2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.7091864000991779,1.1871926530181889,0.26,0.8331855835610348,1.0,4/5,23.18%,ADGRV1;IAPP;TCIM;CALCR
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.7109402627129022,1.1870918584596195,0.32432432432432434,0.8326905515473274,1.0,4/9,15.27%,SLC38A5;SLC6A17;SLC7A8;SLC6A20
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5376019852149411,1.1867730875387086,0.17857142857142858,0.8329089045750244,1.0,12/34,22.14%,GRID2;ALCAM;NLGN1;CADM1;TENM3;TENM1;PTPRD;NECTIN3;AMIGO2;TENM4;ADGRL1;TENM2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.536250612188799,1.1865540209429197,0.15384615384615385,0.8328391134434284,1.0,13/34,25.83%,NOX4;TGFA;LRP8;CASS4;SRCIN1;ERBB3;NTRK2;GRM5;BTC;GAS6;DOCK3;DLG3;FYN
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.7009322649127044,-1.186377236685923,0.24561403508771928,1.0,1.0,1/9,5.24%,C15ORF62
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.7009322649127044,-1.186377236685923,0.24561403508771928,1.0,1.0,1/9,5.24%,C15ORF62
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7678908193021645,1.1863535075437541,0.3023255813953488,0.8327392015544011,1.0,3/5,21.20%,PXN;NCK2;NCK1
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.733668474691161,1.185380898134362,0.32653061224489793,0.8352843673273226,1.0,2/6,14.10%,WNT4;NF1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.5435766169447609,1.1853000416394575,0.2894736842105263,0.8347746021515449,1.0,6/26,6.93%,PER2;ATOH7;PER3;PML;CRY1;OPN5
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.7051262209657729,-1.1850956466004878,0.2857142857142857,1.0,1.0,3/9,15.78%,ITGB2;SPI1;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7630702390123505,-1.1849807616308476,0.29310344827586204,1.0,1.0,4/7,23.30%,STK17A;SFRP1;STK17B;BTG1
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.6857720607663416,1.1849701869866853,0.2926829268292683,0.8348239448719201,1.0,2/5,12.23%,RIPK2;LGALS9
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.5466899204071931,-1.1844960876691444,0.15873015873015872,1.0,1.0,4/26,12.15%,WNT5A;IL7;TLR2;ALOX15B
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),-0.7610117368806583,-1.1841053966254977,0.21818181818181817,1.0,1.0,1/5,3.79%,SCN5A
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.6054568581153554,1.1839495017880834,0.28,0.8376912147776845,1.0,4/12,27.21%,SENP6;ATG7;DESI2;SAE1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7442803601498886,1.183765593394372,0.35135135135135137,0.8373763147656865,1.0,2/6,18.50%,DNMT1;ZNF445
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5473521895625042,1.183549688242232,0.2894736842105263,0.8372425100110896,1.0,8/18,26.20%,TGFA;DRD3;INSR;DMRT1;BTC;LRP5;EDN1;PHIP
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5165277960514314,1.1832925577686482,0.16666666666666666,0.8371540418229599,1.0,7/23,20.07%,DRD5;SNCA;ABL1;PDE4B;NR4A3;GABPA;ADCY6
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.6180366504272617,1.1832888918794149,0.34210526315789475,0.8363602087391433,1.0,1/10,0.24%,GPR33
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6274798043717277,-1.1831776265617846,0.3,1.0,1.0,2/13,4.69%,PKP2;GJC3
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.42918054293241314,1.1830833015582618,0.18518518518518517,0.8364977166501806,1.0,9/104,5.57%,SLC26A3;SLC17A6;SLC26A7;SLC5A8;SLC5A12;SLC12A1;CNGA3;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.7135264002323551,1.1830647624849802,0.3333333333333333,0.8358259070879851,1.0,4/8,22.95%,PDE3A;PDE3B;PDE4D;CDC34
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.5695099571843977,1.1830622780454136,0.2777777777777778,0.8350206798171874,1.0,1/18,0.84%,EIF2S3B
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6554369809187064,-1.1827662783839847,0.2982456140350877,1.0,1.0,3/11,14.78%,SLCO2A1;SLCO2B1;SLCO1A2
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4788257094864913,1.1824160907656118,0.14814814814814814,0.8361011573237618,1.0,17/47,21.05%,NOVA1;PUF60;CELF4;KHDRBS2;CELF5;HNRNPL;NSRP1;RBFOX2;RBFOX1;CELF2;SRRM4;PTBP1;FXR2;KHDRBS1;KHDRBS3;RBM25;ZBTB7A
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.4063382097769285,1.1823072891746471,0.13043478260869565,0.8356557554433951,1.0,58/138,24.70%,KIT;GRK5;ADGRL2;IRS1;ATXN1;SFMBT1;MAGI2;PPARG;ERBB2;TENT4A;SERPINE1;LDLR;RASA2;PTPRM;LTBP1;FHL2;EFEMP1;RND3;CAP2;PHF3;MYC;CCN1;MMP16;DDAH1;NFIB;ABCC1;RUNX1;NFKB1;NR3C1;VAV2;CELF2;PLPP3;HAS2;MGMT;NIPBL;CACNA1A;PRKCE;ACVR2A;SPOP;SMAD7;BCKDHB;ADD3;PTGFR;DLG1;PTEN;PIK3CD;BMPR1A;PTPN21;SYNE1;LAMC1;CDC42BPA;ANXA4;DYRK1A;AKT3;INSIG1;PEX14;RXRA;CDK13
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5133208121093743,-1.182242936468337,0.21212121212121213,1.0,1.0,3/56,4.15%,MCM2;PSMB9;MCM3
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.7427090354331608,-1.1821689575249479,0.26666666666666666,1.0,1.0,3/6,22.87%,COL5A1;ITGA5;PLET1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6920229135120435,1.1818831310301323,0.25,0.8362559508818014,1.0,3/7,25.83%,ITGA3;INSR;FYN
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.6457590479770201,1.1816695423345975,0.2978723404255319,0.8363480353860954,1.0,3/11,8.76%,SEMA5A;WASHC2C;CRACD
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.7285468738164858,1.1815996340905868,0.3,0.8357696115756477,1.0,4/8,13.45%,RFX6;CDK6;BMP4;CDH2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5617104598008867,1.1814433647753635,0.3055555555555556,0.8353857617580779,1.0,6/19,18.54%,NLGN1;RIMS2;RIMS4;RAP1A;SYN1;RAB5A
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7906168080889311,-1.181400105158845,0.28,1.0,1.0,3/5,19.59%,MRLN;VDAC1;PLN
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.7328539992882517,1.1809073780388961,0.2558139534883721,0.8364299507028096,1.0,3/6,16.61%,PTPRO;EMP2;F2R
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5006300756780745,1.1808155751183773,0.21428571428571427,0.8360462035243488,1.0,7/28,15.44%,SLC26A7;SLC39A8;CA3;CYB5R4;SLC4A7;CA2;SLC4A11
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5373839191829208,1.1806348860438598,0.21621621621621623,0.8358412615944344,1.0,7/20,20.69%,RAB7A;STX8;PTPN23;EMP2;RAB5A;KIF16B;SNF8
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.43181044486241776,1.1805956484677762,0.1935483870967742,0.8351474794750774,1.0,10/95,11.20%,ARC;CPSF1;NUP210;NXF5;NUP42;AAAS;U2AF1;NXT1;SRRM1;NXF1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4876528717935228,1.1804974362094955,0.16216216216216217,0.8345883196292114,1.0,5/30,17.88%,PHLDB2;PLCB1;INSR;RPS6KA6;NIPBL
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.6802976011090771,-1.1802478572393311,0.3013698630136986,1.0,1.0,3/9,14.54%,P2RY12;SFTPD;TAFA4
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.6888341093336257,1.1801432780974215,0.29411764705882354,0.8347996663771236,1.0,2/8,7.42%,CX3CR1;TMEM106A
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.49611227866357177,-1.1800393533295754,0.22727272727272727,1.0,1.0,19/76,23.39%,DISC1;DAB2;SP100;LRPAP1;ZFPM1;EFHB;TMC8;MITD1;IFIT1;CTSZ;CDKN1A;ARHGAP28;LEF1;PLN;AURKA;GTPBP4;CAV1;PARK7;TFIP11
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.7142562611664486,1.1798861330828092,0.32558139534883723,0.8349810451957863,1.0,3/7,20.01%,CRLS1;PGS1;PLA2G6
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5036411996275545,1.1794436829448982,0.22580645161290322,0.8359005202558871,1.0,17/45,18.40%,EYA4;FGF10;HDAC10;BRCC3;SIRT1;ERCC8;RNF168;HMGB1;TIMELESS;SMCHD1;SPIDR;SPIRE2;WRAP53;EYA3;MGMT;FAM168A;H2AX
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.7214103309821607,-1.1792595470758958,0.27692307692307694,1.0,1.0,1/6,1.14%,BHMT
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.7088269071591546,1.1791041864407095,0.35135135135135137,0.8360657543341997,1.0,3/5,26.77%,MTMR3;MTMR1;MTMR9
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.43705315168016173,-1.1790637336274996,0.1891891891891892,1.0,1.0,5/166,1.91%,CD44;AQP3;MICB;ELOVL2;PTGES
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.5991745040195271,-1.1787423733638736,0.22950819672131148,1.0,1.0,6/14,28.54%,SFRP1;WBP2;AR;CRHBP;SRA1;RARA
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5177772120711314,1.1787285278002066,0.2682926829268293,0.8365107500189858,1.0,7/23,17.97%,NLGN1;CEL;SNCA;SYT1;NLGN4X;NLGN3;NLGN4Y
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5347668075388936,-1.1785853118981933,0.22535211267605634,1.0,1.0,12/39,14.42%,CLCA2;ITGB6;MUCL1;DUOXA1;ZNF750;ADIRF;SERPINB7;LAMC2;PROM2;SERPINB5;THBS1;MGP
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.5985362788024218,-1.1785622773228597,0.265625,1.0,1.0,4/19,8.47%,DTL;RAB11A;CCND1;CDC25A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5176469841940171,1.1785574435332393,0.22580645161290322,0.8364836437192286,1.0,5/20,10.49%,ITPR2;HTR2C;TRPM2;PKD2;LCK
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.44196237936446037,1.1783882973649376,0.20833333333333334,0.8361329054223147,1.0,33/115,16.67%,FIBIN;MEGF10;EDIL3;VCAN;EDNRA;ADGRL2;LHX2;DOK5;SLIT2;VAT1L;LRFN5;PAMR1;SYNDIG1;CCN2;MPDZ;GUCY1A2;PDZRN3;BRINP1;SCN7A;STOX2;WASF3;RGS7BP;EFS;MAP6;ANK2;COL25A1;PRICKLE2;PTPRD;ASXL3;PLPP3;PBX1;MARK1;CDH11
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6927239495323607,-1.1782086940765155,0.3508771929824561,1.0,1.0,3/12,14.38%,ITGB2;ALOX5;SELP
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5299410334375622,-1.1781159881076613,0.25396825396825395,1.0,1.0,4/34,3.18%,ACTC1;OBSCN;LMOD1;TMOD4
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.47076939768371034,1.1780695767763567,0.21621621621621623,0.8364148860276861,1.0,10/37,12.65%,LETM2;TMTC2;SLC12A1;SLC8A1;SNCA;TESMIN;SLC12A9;CNNM2;GRIN1;SLC7A8
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.7486364678234793,1.178065730091818,0.27906976744186046,0.8356536938860202,1.0,2/6,15.00%,PTPRF;PTPRD
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.7513791404698831,-1.1780494669815782,0.3333333333333333,1.0,1.0,2/5,14.06%,SLCO2A1;NOS2
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),0.7090110188931364,1.1780019260007843,0.35555555555555557,0.835069993703896,1.0,3/5,18.02%,ADGRG6;NF1;ERBB3
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5245958944984832,1.1779446144565355,0.23333333333333334,0.8343701359743976,1.0,1/39,0.10%,SYPL2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.64806343763534,-1.1778287394454114,0.2631578947368421,1.0,1.0,3/10,15.76%,TRIM5;CIITA;PTX3
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6680307923967338,-1.177790053333856,0.24489795918367346,1.0,1.0,3/9,23.37%,ATP5MC3;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.5914669394117688,-1.1772478315101722,0.2727272727272727,1.0,1.0,3/17,7.39%,SFTPD;VSIG4;PTPRC
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.6094997982132291,1.176878297705957,0.2777777777777778,0.8370981867580451,1.0,4/12,16.77%,KCNK6;KCNK2;KCNK12;KCNK10
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.5913647874207255,1.1768268492454383,0.23529411764705882,0.8365001455284649,1.0,2/10,12.30%,NPL;NAGK
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.6051008761363837,1.176725480744494,0.3142857142857143,0.8359616934642181,1.0,4/14,6.26%,TBC1D10A;PERP;IFI16;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4465688234432879,1.1766101771187145,0.13793103448275862,0.8355848783406925,1.0,17/70,14.31%,APOE;SIRT1;SLC8A1;PKIA;SLC8A3;HEXIM2;SPRY4;ABL1;LATS1;LRP6;PRKAR2A;RGS14;RASIP1;BMP4;NF1;MYOCD;NR2F2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.47221555299642126,1.1765517908801828,0.23684210526315788,0.8349169999578193,1.0,12/42,19.45%,PID1;HTRA2;MGARP;FZD5;MARCHF5;SIRT7;IAPP;USP36;MIEF2;SREBF2;INF2;EP300
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.7448733502770486,-1.1764555013934932,0.25,1.0,1.0,1/6,4.18%,MMP9
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6092704717463425,-1.1764100822085468,0.30158730158730157,1.0,1.0,7/16,33.50%,P2RY12;THBS1;CCL5;CSF1R;CXCL17;MAPK3;P2RX4
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.6593767131745905,1.1763801591286869,0.3,0.834745919848149,1.0,2/8,13.54%,MAN2A1;NGLY1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5948236030455277,-1.1759364399173542,0.2903225806451613,1.0,1.0,3/16,4.18%,HAMP;CAV3;MMP9
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4101583309930259,1.175700572438557,0.14285714285714285,0.8364972387729707,1.0,8/98,6.30%,MCOLN3;GRIN3A;SLC3A2;TRPC3;SLC8A1;TRPM2;SLC8A3;PKD2
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.6704841884905264,-1.175670967046924,0.3389830508474576,1.0,1.0,2/8,10.27%,GPR183;C17ORF99
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5072082500907027,1.175531852187345,0.3235294117647059,0.8362668091512344,1.0,2/24,3.05%,ADRA1A;EDNRA
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.5141679738495514,1.1753688119468981,0.2564102564102564,0.8360368106419807,1.0,6/35,7.16%,FBP2;PER2;PC;ENO3;CRY1;G6PC3
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.5131305390791205,1.175261664253273,0.17777777777777778,0.8356039568018877,1.0,9/38,6.51%,DGKD;HIP1;ANGPT1;ARRB2;MAGI2;BICD1;SERPINE1;WNT3A;GREM1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5976726949755384,-1.175235661266525,0.2786885245901639,1.0,1.0,4/15,13.25%,SLC25A31;BTBD18;MEIOC;SYCP3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.6550475365390285,1.1749779702286247,0.2727272727272727,0.8358247180046959,1.0,3/8,12.23%,HMGB1;LGALS1;LGALS9
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.7007452747452959,1.1744223836961138,0.2222222222222222,0.8367987180893789,1.0,6/8,28.65%,SLIT2;HIF1A;RNF113A;SLIT3;EDN1;PADI2
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.46061124417164984,1.174300882322961,0.175,0.8364532430512508,1.0,19/61,19.77%,SLC3A2;SLC39A8;SLC38A5;SLC19A1;SLC16A7;SLC7A2;SFXN2;SLC25A29;SLC25A1;SLC7A8;SLC25A12;ABCC1;SLC25A42;SLC6A20;SLC44A4;SLC36A4;SLC25A41;SLC1A3;LRRC8B
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.6847959678789813,-1.1740086347384335,0.35714285714285715,1.0,1.0,2/9,1.40%,F8;F7
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.408230118762502,1.1734348071220437,0.14285714285714285,0.8382783555000564,1.0,29/97,16.31%,KIT;RAI14;MID1;EDNRA;ADGRL2;PARVA;COL12A1;SLIT2;TEAD4;CDR2L;TENM3;LRIG3;KITLG;MPDZ;AADAT;RND3;CAP2;WWTR1;RBFOX2;BMP4;DDAH1;PTPRF;MAGI1;NR2F2;DOCK1;ANTXR1;TSPAN6;FZD7;TSPAN12
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.6656434983863014,1.1728308949249528,0.35,0.839334072015145,1.0,2/8,5.76%,DRD5;SNCA
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6366588741995706,1.1722270875675116,0.2894736842105263,0.8408643266058524,1.0,7/9,30.09%,COL13A1;BMP4;FGFR3;BMPR2;MEF2C;BMPR1B;TRPV4
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.567666608085276,1.172189845080294,0.2926829268292683,0.840170135773754,1.0,5/15,9.01%,SCRIB;CDH5;DSP;CGNL1;TJP2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.7323393860400641,-1.1718712664202702,0.3157894736842105,1.0,1.0,1/5,3.28%,LRPAP1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.6864296409377202,-1.1713086354480926,0.26229508196721313,1.0,1.0,3/12,11.69%,TBX1;SCN5A;ROGDI
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.4835456354953584,-1.1709960309157217,0.17857142857142858,1.0,1.0,17/61,20.47%,WNT5A;PTGES;HCK;ALOX5;IRF1;LRRC19;ANXA1;ALOX15;LACC1;ERAP1;GRN;BST1;SPATA2;CASP8;DHX58;TKFC;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6489298946203013,-1.170797861045932,0.32786885245901637,1.0,1.0,1/10,1.85%,TGFB1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.7642166344294004,1.170698917259861,0.32075471698113206,0.8442622213848537,1.0,5/5,23.59%,GREM1;NOTCH1;MYOCD;RBPJ;SRF
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.41748275465129475,1.1706246659268826,0.07407407407407407,0.8436381644612335,1.0,25/91,16.74%,VWC2;VWC2L;BAMBI;TGFBR1;SPRED3;SIRT1;FSTL3;MAGI2;PPARG;GREM1;IL17RD;CRIM1;SPRED2;FAM89B;HSPA1A;NOTCH1;SPRED1;PPM1A;DLX1;BMPER;SMAD2;SMURF1;BCL9L;EMILIN1;SKI
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.7592412673427104,-1.1706076515576194,0.20754716981132076,1.0,1.0,3/6,5.07%,PTGR1;ALOX12;ALOX5
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7368222158922788,1.170361085329794,0.29545454545454547,0.8438352609801923,1.0,3/5,24.66%,ENPP1;SMPDL3A;ITPA
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7263017998818578,1.1702280603461175,0.3023255813953488,0.843629559538864,1.0,3/5,24.38%,ABL1;MARK2;MAP2
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.6951380193525787,-1.170138106924421,0.2727272727272727,1.0,1.0,2/7,7.83%,CKMT2;CKB
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6135479029688102,-1.1700472436705216,0.26229508196721313,1.0,1.0,3/14,7.95%,DUOX1;STAT1;KCNJ11
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.7503730143642046,-1.1699428307779758,0.3225806451612903,1.0,1.0,4/6,23.84%,SCIMP;LY86;LY96;BMP6
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.459271127914174,1.1698497017437686,0.17857142857142858,0.8440129710419527,1.0,15/59,21.39%,TNFRSF19;RIPK2;MAPK8;MAP3K10;LGALS9;MAP3K13;NFKB1;MAP2K7;TAB3;TAB1;MAP4K2;CRKL;TAB2;TRAF6;CUL1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.42510547355073874,1.1696026759675366,0.22580645161290322,0.8441087529749045,1.0,24/71,25.94%,RBM20;ESRP1;HNRNPF;KHDRBS2;ERN1;HNRNPH1;FASTK;HNRNPL;RRP1B;HSPA1A;SRRM4;PTBP1;FUS;KHDRBS1;KHDRBS3;METTL16;U2AF2;CLK2;METTL4;DYRK1A;SRPK2;SETX;RBM39;SON
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.5716857936332981,1.1695682780763095,0.23255813953488372,0.8434303847530714,1.0,4/18,7.37%,SERPINE1;HMGB1;GREM1;SLIT2
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.6898134335878126,-1.1694117780556608,0.3157894736842105,1.0,1.0,2/8,5.98%,NMUR2;ANXA1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.6898134335878126,-1.1694117780556608,0.3157894736842105,1.0,1.0,2/8,5.98%,NMUR2;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.5919880156789479,1.169335855006586,0.37209302325581395,0.8432544540786903,1.0,4/16,16.08%,CEP135;CEP120;CORO2B;WRAP53
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6498872053280985,-1.1692543901056385,0.22580645161290322,1.0,1.0,1/13,0.90%,WNT5A
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.453316200162933,1.1692352541644058,0.25,0.8428070249328258,1.0,7/35,15.32%,KIAA0319;APOE;GOLGA4;ABL1;MACF1;MAP3K13;DIP2B
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.7919891399798755,1.169140724319693,0.2708333333333333,0.842217486180306,1.0,1/5,1.49%,TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5522958989379458,1.1691207505190087,0.3055555555555556,0.8415290701088495,1.0,3/20,5.47%,APOE;SIRT1;PPARG
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.4065757331224849,1.1691132542246543,0.13043478260869565,0.8407848502098928,1.0,54/165,26.48%,SNRPN;NOVA1;ATXN1;TENT4A;BICD1;HNRNPF;RBMS1;U2AF1;HNRNPH1;LIN28B;ELAVL4;HNRNPL;KHSRP;SF3B1;SRRM1;SNRPB;ZMAT5;APOBEC1;SRSF4;CELF2;SRRM4;PTBP1;SYNCRIP;FUS;PPP1R9B;SF3B4;PIWIL2;AURKAIP1;RBM6;XRN2;U2AF2;LIN28A;TSEN2;YJU2;CPSF6;NUFIP1;SNRPF;ADAR;SNRNP48;LSM6;SRPK2;TUT7;NRDE2;TCERG1;PDCD7;SETX;PABPC4;HNRNPUL1;SCAF11;RBM39;THOC1;SON;MAGOHB;SNRPG
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.43607109513363324,-1.1690793770248475,0.14084507042253522,1.0,1.0,22/120,22.16%,BUB1;ERCC6L;SPC25;ZWILCH;GPSM2;ITGB3BP;CENPU;TTK;DYNLL1;CENPH;NUF2;INCENP;RPS27;NDEL1;STMN1;CENPM;CENPN;AURKA;CENPL;DYNLL2;SKA2;SBDS
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.7324927306660025,1.1690216616345384,0.3125,0.8402700589723671,1.0,3/6,14.12%,COL13A1;BMP4;FGFR3
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.7741450020641685,1.1689291062681695,0.36363636363636365,0.839072570953867,1.0,4/5,13.02%,CD14;SARM1;TICAM2;TICAM1
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.7741450020641685,1.1689291062681695,0.36363636363636365,0.839072570953867,1.0,4/5,13.02%,CD14;SARM1;TICAM2;TICAM1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.6813481209688631,1.168923160797572,0.3,0.8383191073025574,1.0,1/7,7.05%,FKTN
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.46118776379485216,1.168892695265168,0.2,0.8376806357242675,1.0,9/72,5.52%,IL7R;SKAP1;CD247;SELPLG;GPR174;BCL2;TRAC;PYHIN1;IL16
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),0.7157244218904277,1.1688794051750568,0.29545454545454547,0.8369865748700563,1.0,2/5,15.44%,RHCG;SLC4A11
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7011126518473402,1.1685077177376335,0.2549019607843137,0.8375554367605258,1.0,3/5,29.68%,TICAM1;MIA3;AKT1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6434595509339338,-1.1684349469995756,0.29508196721311475,1.0,1.0,3/9,25.00%,VDAC1;PARK7;CAMKK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5112508696598527,1.1682071553162416,0.21212121212121213,0.8374576009963067,1.0,6/26,6.85%,ANGPT1;CDH5;AKR1C3;SEMA5A;SERPINE1;ITGA4
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.5527443574710302,1.168045135684528,0.3333333333333333,0.8372184425279007,1.0,8/16,27.24%,MOB3B;MARK3;DLG5;IQCJ-SCHIP1;WWC1;WWC2;NF2;WWC3
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6845375479466926,1.1680293766385585,0.3,0.8365273283858035,1.0,3/8,15.13%,WASF3;WASF2;FCHSD2
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),-0.7398460753499337,-1.167998252770589,0.27450980392156865,1.0,1.0,1/5,9.55%,CARTPT
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.7949719278539853,-1.1679765016754213,0.16326530612244897,1.0,1.0,3/5,16.83%,SCTR;AQP4;AQP11
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.637098875034406,-1.1678113249134159,0.3050847457627119,1.0,1.0,5/13,15.59%,TBX1;ACTC1;ZFPM1;HEY2;TTN
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.4940566413565912,-1.1675263864100127,0.2857142857142857,1.0,1.0,5/44,5.87%,DTL;PCLAF;UBE2L6;RPA3;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5876510151987125,1.1674312471645467,0.34285714285714286,0.837716011187288,1.0,4/16,13.15%,SPRED3;PARD3;SPRED2;SPRED1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5935523324674946,1.1672868429457393,0.28,0.8374913812068807,1.0,7/11,21.54%,SPRED3;PYHIN1;SPRED2;SPRED1;ATM;ATR;PLA2R1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6326177550676622,-1.1670667519359623,0.29310344827586204,1.0,1.0,4/11,19.44%,SOX10;CLU;MYRF;PLP1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.6402548660789962,-1.166763125108975,0.20689655172413793,1.0,1.0,1/15,0.71%,IHO1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.6596585703586422,-1.1665950320758094,0.31666666666666665,1.0,1.0,2/11,4.12%,LRPAP1;RIN3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.40176633951307594,1.1665686443092713,0.2,0.8395229556471423,1.0,39/211,12.62%,GABRE;CHRM2;GABRR2;GALR3;NOVA1;GABRA5;NLGN1;HTR1F;GRIK1;GRM3;GABRG3;CEL;HTR2C;HCRTR1;HRH3;DRD5;CACNB4;SNCA;DTNA;CHRNA10;GRIK2;CHRNA1;KCND2;DRD4;SYT1;GRM7;GRM4;LRP6;PRKAR2A;RPS6KA3;APBA3;GRIN1;AKAP9;NLGN4X;GABRG1;UNC13B;HTR7;APBA1;GABRR1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.43309543545599893,1.1665036680774519,0.17857142857142858,0.8388886022881272,1.0,24/79,21.05%,NOVA1;TRA2A;PUF60;CELF4;KHDRBS2;CELF5;HNRNPL;NSRP1;SFSWAP;RBFOX2;SRSF4;RBFOX1;CELF2;PCBP4;SRRM4;PTBP1;SF3B4;FXR2;KHDRBS1;KHDRBS3;METTL16;RBM25;U2AF2;ZBTB7A
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6395016119940733,1.1664279273150011,0.2857142857142857,0.8383679836277524,1.0,4/10,17.35%,MFSD2A;PLIN5;PDE3B;GPLD1
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),-0.7567976955199476,-1.166365812849945,0.2698412698412698,1.0,1.0,3/5,21.45%,CYP24A1;SFRP1;VDR
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.6989508727365092,-1.1661884334001622,0.37254901960784315,1.0,1.0,1/7,7.78%,RNF213
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.5076380369841815,1.1659866677527129,0.23684210526315788,0.8391559293511536,1.0,6/38,7.16%,FBP2;PER2;PC;ENO3;CRY1;G6PC3
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.7709638363324796,-1.1657924107492348,0.3148148148148148,1.0,1.0,1/5,3.72%,DCN
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.49692150567802207,1.1657143215296386,0.25806451612903225,0.8392681587138571,1.0,6/45,9.12%,TRIM67;GPC4;GPC6;RALB;GBF1;GPC5
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.40111258538123945,1.1654242544004654,0.2,0.8394222904627329,1.0,25/122,15.27%,FIBIN;EDIL3;CBS;EDNRA;ADGRL2;GPC6;SLIT2;TENM3;SYNDIG1;MPDZ;GUCY1A2;PDZRN3;COL16A1;CAP2;ABCC8;RBFOX2;SDC3;MAGI1;MAP6;ANK2;SRRM3;CALD1;PRICKLE2;PLPP3;ANTXR1
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.625387687381378,1.165396629210471,0.3181818181818182,0.8379785027435601,1.0,2/10,7.89%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.625387687381378,1.165396629210471,0.3181818181818182,0.8379785027435601,1.0,2/10,7.89%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.5953156212551802,1.165237759121602,0.26666666666666666,0.8376714749053438,1.0,4/13,24.66%,AK3;ENPP1;SMPDL3A;ITPA
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.4370001724968415,1.165206752167466,0.20689655172413793,0.8370153868095767,1.0,25/82,22.22%,LLGL1;KLHL20;COMMD1;ACBD3;GBF1;SORCS1;ARRB1;RAB10;VAMP8;ARL3;AP4S1;EXOC6B;GOLGB1;MYO5A;MON2;RP2;CLVS1;CLINT1;DOP1B;CCDC22;KIF16B;SH3D19;EXOC4;EXOC6;AP1B1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),0.7263163460247797,1.1651124957995058,0.35,0.8365281420385065,1.0,1/5,1.21%,MRAP2
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.6042348168247229,1.164974461316925,0.275,0.836293041823455,1.0,4/14,17.37%,OSR1;TWIST1;HDAC1;SHH
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7290941511365889,1.1649241156073422,0.35294117647058826,0.8349044394171178,1.0,4/6,23.73%,DPH1;DPH5;DPH2;DPH3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7290941511365889,1.1649241156073422,0.35294117647058826,0.8349044394171178,1.0,4/6,23.73%,DPH1;DPH5;DPH2;DPH3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5519690235319421,1.1645161835627404,0.2765957446808511,0.8347170180455782,1.0,2/16,2.65%,EYA4;BCL2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.5519690235319421,1.1645161835627404,0.2765957446808511,0.8347170180455782,1.0,2/16,2.65%,EYA4;BCL2
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.6760258854331469,1.164452721517457,0.34285714285714286,0.8340676804628078,1.0,4/6,27.87%,FOXP3;RC3H1;SMAD7;RC3H2
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.7027760838316046,1.1642354596758777,0.2972972972972973,0.8339610005011248,1.0,2/8,8.36%,APOE;ABL1
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.7362419079260156,-1.163969234980385,0.2711864406779661,1.0,1.0,3/6,20.27%,SLC19A3;ACP3;SLC25A19
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.4828373626224411,1.163888120683503,0.1956521739130435,0.8344093967562523,1.0,4/39,5.40%,GCK;FOXO1;SIRT1;ZBTB20
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.5744432802504278,-1.1637583419744129,0.2542372881355932,1.0,1.0,7/31,16.90%,GPSM2;CHMP3;DCTN1;EML3;ANKRD53;BORA;PSRC1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.7438910373821084,1.1636899862880798,0.35,0.834274882756643,1.0,2/6,15.02%,SLC25A37;ABCB10
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.48966650427837677,1.1636727509186857,0.24,0.8335728645012609,1.0,13/35,22.78%,THEM4;SIRT1;ARRB2;MAGI2;DRD3;BANK1;OTUD3;PKHD1;PTPRJ;PTEN;CIB1;PHLPP2;TRIB3
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.7143035908861243,1.1636148751273867,0.3409090909090909,0.8330796227709008,1.0,3/5,22.55%,TDO2;KYNU;AFMID
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.49882381028221306,-1.1632041678953067,0.19047619047619047,1.0,1.0,1/39,0.19%,EPN1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),0.6819204493687008,1.1630388177138238,0.3829787234042553,0.8343842195573546,1.0,3/6,20.69%,RAB11FIP3;RAB11FIP1;IL11
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.6479480986633812,-1.1630080185235967,0.3333333333333333,1.0,1.0,2/10,6.90%,NODAL;PLAC1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.7101280813512243,-1.162815138189983,0.2982456140350877,1.0,1.0,2/6,16.14%,TGFB1;SMAD3
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.7082870845950883,1.1627990155070678,0.375,0.8343745006100575,1.0,3/6,8.71%,FGF10;EPB41;SGK1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5556287032764796,-1.1626270364609037,0.30158730158730157,1.0,1.0,9/37,20.21%,ACTC1;C3AR1;STAT1;COL4A3;TRDN;F5;SCPEP1;PLN;SGCG
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.33806770547067194,1.1625210303288365,0.0,0.8344061935971406,1.0,445/1778,19.78%,ERG;TEAD2;NPAS4;ZSCAN4;SKAP1;FOXO1;CD38;ZNF607;ESRRG;FANK1;POU3F1;KIT;MKX;BAMBI;TGFBR1;MLF1;ZNF496;PKNOX1;TSHZ2;PER2;POU6F2;ZNF347;PRICKLE1;OR7D2;HDAC3;ZNF195;ZNF808;HDAC10;KLF10;ZNF117;TWIST2;ZNF692;ZNF239;NEUROD2;MITF;ZNF408;OSR1;TLE2;TSHZ3;BCL6;ZNF518A;CDK14;ARX;MAFB;CREB3L4;ZNF485;ZNF212;ZBTB7B;LBHD1;RORA;NFATC3;ZNF623;ZBTB9;APOE;POU3F2;SLC39A8;PROX1;DMRT3;TULP3;PCGF1;URI1;SIRT1;ZFPL1;TPRX1;CREB3L2;ATOH7;ZNF99;BHLHA9;PRDM5;ZNF835;BCL11B;SMARCD3;ATXN1;MTERF3;ZNF33B;ZNF561;ZNF701;PHC2;SFMBT1;WNT4;SOX12;FSTL3;E2F6;ZNF534;GATAD2A;TGIF1;ZNF263;BACH2;LHX2;IFI16;APBB3;ZBTB20;ZNF780B;PPARG;PYHIN1;ZEB2;CBFB;ELP4;RORB;ERBB2;NRG1;ZNF70;WNT3A;RFX6;SNX5;BCL11A;ZBTB40;GPBP1L1;ZNF470;RFPL2;TGFA;CTBP2;MED17;ZFP3;HIF3A;CTDSP1;ZNF641;PAX3;NR4A2;PML;CRY1;ZNF300;HMGB1;TOX;ARID3B;ZFHX4;SAFB2;ZBTB4;SPIN2B;ZNF274;HIC2;HIVEP2;HEXIM2;DHFR;BATF2;SMARCAL1;KDM7A;NCOA2;ZNF860;CRK;SEC14L2;FOXD4L5;PLCB1;ZBTB1;ETV1;WWP2;TEAD4;FOXP2;HP1BP3;ZNF215;PCGF5;STAT5B;ATF3;TESMIN;SP1;KDM8;SMARCB1;CIART;ABL1;ZFX;TCF20;FOXN3;MGA;NKAP;ELOA;PLAGL1;ZNF331;ZNF688;ZNF703;ZNF251;ZNF786;MAMLD1;FADS1;LCORL;FZD1;IKZF4;NAT14;ZNF33A;RFX7;ZEB1;ZNF575;MAP3K10;LRP6;HIVEP3;NR4A1;HDX;SLTM;TENM1;SP7;MLXIPL;ATF1;EFEMP1;POFUT1;CEP290;ZSCAN21;RPS6KA3;BCOR;CDK18;RFX1;ZNF311;EBF4;ZSCAN12;HCLS1;ZNF133;CCNH;TESC;SPEN;SRCAP;RNF10;TWIST1;GDF6;ZNF729;ZNF519;NOTCH4;WBP2NL;ASCL1;KDM2A;TFE3;NPAS3;ZNF514;TIMELESS;HES1;ZNF652;SMARCA4;RGS14;RET;ZNF782;BPTF;ZFP82;DACH1;MYC;MYT1L;TIAL1;ARID1A;MDFIC;CHD4;DMTF1;ZNF41;TRIM44;LIMS1;BICRAL;NSD1;WWTR1;HDAC1;ZNF774;ZNF569;SMARCA2;RBFOX2;ZNF761;BMP4;JUNB;NFIC;CREM;ZNF771;NOTCH1;EPC2;ZNF2;NR4A3;USP16;KDM3B;PIM2;KAT6A;NR3C2;SCMH1;SCRT1;NFIB;ZNF202;GFI1B;ZNF337;ZNF594;ZSCAN31;CUX1;ZNF704;PPM1A;BARX2;ZNF852;ZNF846;ZNF611;DLX1;BRD3;CARM1;ZNF131;ZNF155;MAGED1;PRMT5;SOX5;MXI1;DPF1;SOX13;TFCP2;RPS6KA4;MYOCD;RUNX1;ZNF165;NFKB1;ZNF384;ZXDC;NR3C1;SP2;MYBL2;SMAD2;ZNF75A;NR2F2;HDAC4;ARRB1;MAP2K7;RYBP;NFYC;MLLT3;FOXO6;ZNF599;ZNF646;MECP2;MBTD1;KLF12;RLF;TP53INP2;INSR;ZNF586;ZMYND11;BAZ1B;HES6;CDK16;DBX2;ZNF438;ZNF765;ZNF283;DPF3;NFAT5;MED13L;BAZ2B;BRD4;NR1H3;ZNF273;PRDM14;NR6A1;ZNF777;HSF1;PPARGC1B;ZBTB2;CXXC1;CREB3L1;ASCC2;FOXF2;PBX1;FZD7;ARID1B;ZFP28;TTC21B;ZNF48;ATF7IP;ZNF845;F2R;SPINDOC;MSC;ZNF589;HIVEP1;GABPA;ZNF549;ARID5B;ZNF609;ZNF12;NR2C1;BCL3;ZNF292;BRIP1;ZNF665;ZNF276;UBE2L3;MYPOP;GMEB1;SHH;THAP7;RCOR2;FUS;CHD1;CAMTA1;HSF4;ATF6;SATB2;ZNF675;ETV5;ERC1;ZGLP1;SUPT3H;DPRX;ZNF706;NIPBL;VRTN;RBPJ;MPHOSPH8;ZBTB5;POLR3G;DPF2;ZNF627;BAZ2A;FOXJ2;HDAC5;TCF4;SP3;ZNF79;ZHX3;ZNF445;ZBTB41;ZNF132;KLF6;ZNF66;CREB3L3;ZFP62;ELF2;ZNF69;KHDRBS1;SREBF2;ZNF717;ZNF142;KAT6B;NFIX;ZNF708;TBL1X;CHD7;JMJD1C;DMRT1;UXT;ZNF157;FOXP3;YAF2;EGR1;ZKSCAN2;TFDP1;DENND4A;SMAD7;SPIN1;PA2G4;EP300;WWC1;QRICH1;CREB1;ZNF785;GLI4;NFX1;PAX6;POU2F1;ZNF322;PRRX2;MEN1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5373341559946412,1.1625005101670207,0.17647058823529413,0.8337209593528576,1.0,1/18,1.52%,FGF10
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.718699185357071,1.1623246925070312,0.38636363636363635,0.83369808049153,1.0,4/6,23.13%,PLSCR4;PLSCR1;ANO7;PLSCR2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.4693591765425002,-1.1622087873001403,0.22058823529411764,1.0,1.0,30/90,20.89%,GMFG;ITGB2;JCHAIN;HCK;ARHGAP9;CYTIP;GPR183;TAGAP;PTPRC;LY86;PARVG;IL3RA;DOCK8;IKZF1;SPI1;NFAM1;WAS;MYO1F;ITM2C;CLEC4C;ITGAM;SERPINF1;TRAF3IP3;CD37;CD86;PSTPIP1;ITGAX;NIBAN3;CD300LF;LAMP5
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.4437144097329262,-1.1621776381282354,0.11940298507462686,1.0,1.0,20/183,14.29%,NEK2;MCM2;POLQ;BUB1;TGFB1;HMGB3;TRAIP;MCM3;CCND1;CDC25A;H2AZ1;SUV39H1;TTK;CHAF1A;SAP30;CCNF;ATF5;INCENP;HSPA8;CDC6
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.7207893154901868,1.1619584006875825,0.3023255813953488,0.8343220354310306,1.0,2/6,19.74%,FER;PTK6
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.5229000130115635,-1.1618403511308157,0.2537313432835821,1.0,1.0,11/35,23.84%,IFNK;SCIMP;CYBA;LY86;SH2D1B;DDX60;GRN;DHX58;LY96;USP17L2;BMP6
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.7240531085626051,-1.1617368603592564,0.3728813559322034,1.0,1.0,4/7,22.34%,DDX60;DHX58;TKFC;USP17L2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5342655150071756,-1.1617266130546555,0.19696969696969696,1.0,1.0,4/25,7.34%,ITGB2;CXCL13;ANXA1;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.5492985672586066,-1.1617113430768482,0.2647058823529412,1.0,1.0,1/32,0.31%,NEK2
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.45264335572706327,1.161550293605561,0.18518518518518517,0.8349448860255054,1.0,8/69,10.38%,ATP6V0D2;KPTN;TCIRG1;MLST8;MAPK8;EIF2AK3;DAPL1;RNF152
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.7054182098496802,1.1613486369603543,0.39473684210526316,0.8340461720952917,1.0,3/5,24.50%,KHDRBS1;CPSF6;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.7054182098496802,1.1613486369603543,0.39473684210526316,0.8340461720952917,1.0,3/5,24.50%,KHDRBS1;CPSF6;NRDE2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.38089681035009865,1.1607370541654096,0.2222222222222222,0.8352298489161823,1.0,14/216,7.18%,IL7R;CTDNEP1;CHRM2;HIP1;APOB;TOR1B;BIN1;KIAA0319;PACSIN2;LPCAT2;ARRB2;TGFA;UBXN2A;LDLR
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.559831209944228,1.160692645172545,0.2682926829268293,0.8346440243587594,1.0,7/23,12.64%,TGFBR1;ROBO2;PROX1;SLIT2;HES1;BMP4;NOTCH1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.7065667537693008,1.1604803797449093,0.2857142857142857,0.8344562075997687,1.0,2/6,4.95%,EPHX2;TET2
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.5860971070492604,1.160087510673658,0.2978723404255319,0.8347747616472955,1.0,3/20,10.20%,DAPK2;SLIT2;MCU
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.589772278977603,-1.1600612238095036,0.25,1.0,1.0,2/19,3.79%,PKP2;SCN5A
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7797480423670018,1.1599473420620323,0.3404255319148936,0.8344368482264143,1.0,2/6,7.37%,SNCA;WWP2
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.42185494013246433,1.159206967699644,0.23076923076923078,0.8362157009198523,1.0,8/82,8.68%,HGFAC;PRSS3;CPN1;HTRA2;HJV;KLKB1;TMPRSS2;F12
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.592447573557833,1.1589977856371196,0.3488372093023256,0.835999882396445,1.0,5/15,14.13%,DSCAML1;BSG;DSCAM;CNTN6;EMB
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.7490493585145335,-1.158937517409886,0.2727272727272727,1.0,1.0,1/5,0.43%,C1QB
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.4561132928715812,-1.158891113080333,0.19480519480519481,1.0,1.0,18/97,19.68%,MCM2;TICRR;CDK2AP1;MCM3;PCLAF;RPA3;DONSON;GRWD1;BRCA1;CDC6;RAD1;SET;POLE2;PIF1;TOPBP1;RMI2;POLE3;PTMS
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.7030709567612043,1.1587902319609844,0.2916666666666667,0.8359071014499676,1.0,1/5,5.16%,SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.6528439162135886,-1.1587547649101,0.35384615384615387,1.0,1.0,2/11,16.28%,DAB2;MSN
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.42749584043786265,-1.1579972058017265,0.15789473684210525,1.0,1.0,65/184,26.99%,RPL37A;PWP2;NOB1;SENP3;RPL15;EIF6;RPL3;RPL38;RPL35A;RPS9;RPL7A;EMG1;RPL13;RPS27;RPL13A;RPS16;NOP53;RPL27A;RPL9;LAS1L;RPL5;RPL21;RPL34;RPL4;RPL23;WDR12;RPS14;EXOSC2;RPL18A;RPL32;IMP3;RPL36;EXOSC8;RPL18;RPL29;RPS7;RPS15;RPL41;RPS28;RPLP1;SBDS;RPL12;RPL11;RPL35;RPL22;RPL27;RPL24;PDCD11;RPLP2;SURF6;RPS19;RPL28;RPL19;RPL26L1;RPS24;RPL10;RPS25;PIH1D2;DDX49;RAN;DHX37;RPS6;EBNA1BP2;RPL8;RPLP0
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.43863497010971814,1.1578800710674175,0.24242424242424243,0.8379250913826719,1.0,14/64,13.03%,GABRE;SLC26A7;GABRR2;GABRA5;SLC12A1;GABRG3;ANO5;SLC12A9;ANO8;TTYH3;GABRG1;GABRR1;ANO10;ANO4
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.6940637189677603,-1.1576778997527872,0.3,1.0,1.0,2/7,11.48%,STAT1;IFIT1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5942706497753649,1.1574810866922327,0.2222222222222222,0.8383749832521411,1.0,6/12,15.77%,CEP135;CEP120;CEP290;KIAA0586;SPIDR;CORO2B
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.6853925779575275,1.1573241553633706,0.27906976744186046,0.8381308448613812,1.0,3/8,17.40%,MID1;MAPRE1;MID2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6176298341425698,1.1573007324223055,0.35714285714285715,0.8375204430744861,1.0,5/12,21.01%,SCRIB;RAP2A;FSCN1;CAMSAP3;MYO9A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.5746439678551113,-1.1570282630646989,0.2786885245901639,1.0,1.0,4/24,3.79%,PKP2;CTNNA3;CAV3;SCN5A
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.4119434665503454,1.1569534649618327,0.2692307692307692,0.8377388322116106,1.0,44/161,18.24%,TBC1D10A;SNX18;SCRIB;TBC1D16;ASAP3;SIPA1;TBC1D12;ERBB2;ARHGAP42;SYDE2;SRGAP2;RGS16;RAPGEF1;RALGAPA2;SIPA1L2;TBC1D22B;PLXNB1;RGS7;LIMS1;TBC1D4;RGS6;RAP1A;RAP1GDS1;SNX9;RAPGEF3;NF1;EVI5L;CD40;DOCK9;PKP4;SIPA1L3;ARHGAP27;CCDC125;F11R;DOCK11;BCR;F2R;RSU1;SGSM3;SLC27A4;TBC1D2;ARHGAP11A;TBCK;TBC1D8
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.6433427879127116,-1.1569007390709727,0.3125,1.0,1.0,4/10,28.22%,CCDC39;ZMYND10;CFAP73;DNAAF1
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.7542111989855965,1.1567800206629841,0.38461538461538464,0.8376179047867026,1.0,1/5,3.82%,DCP1B
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7130011941328227,-1.1566770576491352,0.3064516129032258,1.0,1.0,1/5,12.06%,VDAC1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5602369850042563,1.1563677713407305,0.2619047619047619,0.8378900105413548,1.0,7/18,23.32%,ACACB;ABCD3;ABCD2;CPT1A;PRKAG2;PRKAA2;ACACA
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.7095173349909428,1.1563150707457972,0.3333333333333333,0.837322546769865,1.0,1/5,5.76%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.607522693705883,1.1560123980925439,0.2894736842105263,0.8373916056536889,1.0,5/17,20.96%,DAPK2;MCU;ADAM8;MOSPD2;THBS4
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.774289872891702,-1.1559373696000634,0.3269230769230769,1.0,1.0,1/7,4.12%,RIN3
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.5203266883288913,1.15584682572123,0.21951219512195122,0.837109277650856,1.0,7/23,14.52%,NMU;GRIK2;SYT1;RIMS2;WLS;PTPN23;CLSTN2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.6394375401971186,-1.155720016337932,0.2807017543859649,1.0,1.0,4/12,16.11%,WNT5A;CYBA;NOS2;RAC1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6825639073088383,-1.155468248913341,0.32727272727272727,1.0,1.0,3/7,26.61%,TRIM25;OAS3;PHB2
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.7126285404567589,1.1551110141584138,0.30303030303030304,0.8387712275511164,1.0,4/5,27.87%,FOXP3;RC3H1;SMAD7;RC3H2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.5680988432219325,1.154786730291331,0.3157894736842105,0.8390141775317382,1.0,3/12,4.76%,SIRT1;WNT4;AKR1C3
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5995485833871632,1.1545727731862936,0.35294117647058826,0.8388928781611703,1.0,3/16,5.67%,TGFBR1;ADGRG6;NRG1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.5023728101750331,1.154306635733679,0.2571428571428571,0.8389064233308686,1.0,9/42,21.51%,HTRA2;NEU4;RNASET2;NGLY1;FBXO27;PNPT1;FBXO17;XRN2;SIAH2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5212320983762091,1.1540027290479127,0.21621621621621623,0.8393504018442761,1.0,13/33,21.68%,KPTN;IFI16;EIF2AK3;IMPACT;MTMR3;TP53;SIK2;PRKAG2;SZT2;NIM1K;PRKAA2;PIK3R4;SESN2
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),0.6939920739773779,1.1539580634162772,0.32653061224489793,0.8387184011510789,1.0,3/5,8.31%,APOB;APOE;LPL
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.66951828017303,-1.1537998198597694,0.35,1.0,1.0,2/12,1.85%,WNT5A;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.4024632790690831,1.1534285767214056,0.16666666666666666,0.8396586300256264,1.0,18/80,16.69%,RASSF2;DUSP15;MID1;SH3RF1;TNFRSF19;HMGB1;PLCB1;CARD9;SH3RF3;CCN2;MAP3K10;GDF6;KLHDC10;GADD45G;FZD7;MAP4K2;MFHAS1;RELL1
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),0.7369083703753798,1.1533534367876987,0.2765957446808511,0.8391482070300615,1.0,3/5,20.01%,CRLS1;PGS1;PLA2G6
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.5926031684482849,1.1532252127513691,0.3170731707317073,0.8388129343769772,1.0,3/16,17.53%,MGARP;DST;DLG2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.4970512655133931,-1.15310973382354,0.2608695652173913,1.0,1.0,2/44,5.02%,POLQ;RPA3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6716790709952323,-1.152960583420942,0.35714285714285715,1.0,1.0,2/7,13.75%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.5961096129531113,-1.1527910974986355,0.3018867924528302,1.0,1.0,4/17,7.15%,OR51M1;OR51I2;SYT10;OR52A5
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.6359172869102605,-1.1526943209212372,0.3050847457627119,1.0,1.0,5/12,18.27%,HLA-DRB1;HLA-A;ERAP2;HLA-F;ERAP1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),0.6731047997435056,1.1526449083550425,0.4186046511627907,0.8391076442311414,1.0,1/5,0.71%,APOH
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),0.6731047997435056,1.1526449083550425,0.4186046511627907,0.8391076442311414,1.0,1/5,0.71%,APOH
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3284914783004211,1.1524514441886407,0.0,0.8390139454008325,1.0,427/1744,19.83%,ERG;TEAD2;NPAS4;ZSCAN4;SKAP1;FOXO1;SMYD2;ZNF607;ESRRG;POU3F1;KIT;MKX;ZNF496;PKNOX1;TSHZ2;PER2;POU6F2;ZNF347;HDAC3;GALR3;ZNF808;HDAC10;KLF10;TWIST2;ZNF692;ZNF239;NEUROD2;MITF;ZNF408;OSR1;TSHZ3;BCL6;ZNF518A;ARX;MAFB;CREB3L4;AASS;ZNF485;ZNF212;ZBTB7B;RORA;NFATC3;RARB;ZNF623;ZBTB9;APOE;POU3F2;PROX1;FRK;DMRT3;PCGF1;URI1;SIRT1;CDH13;GABPB2;TPRX1;PTOV1;CREB3L2;AUTS2;ATOH7;ZNF99;BHLHA9;PRDM5;CDK4;ZNF835;BCL11B;PID1;SMARCD3;ATXN1;ZNF33B;ZNF561;ZNF701;SOX12;FSTL3;E2F6;TET2;ZNF534;GATAD2A;HJV;TGIF1;ZNF263;FZD5;BACH2;LHX2;IFI16;MAML1;ZBTB20;ZNF780B;PPARG;ZEB2;CBFB;ELP4;RORB;SSBP3;ERBB2;ZNF70;KCNIP3;SNCA;SERPINE1;WNT3A;RFX6;MED25;SIRT7;BCL11A;ZBTB40;ZNF470;TGFA;PER3;CTBP2;MED17;RIPK2;PKD2;ZFP3;HIF3A;CTDSP1;ZNF641;NCOA3;PAX3;NR4A2;CRY1;ZNF300;HMGB1;TOX;GREM1;ARID3B;ZFHX4;SAFB2;ZBTB4;ZNF274;HIC2;HIVEP2;HEXIM2;BATF2;SMARCAL1;KDM7A;NCOA2;ZNF860;CRK;FOXD4L5;ZBTB1;ETV1;WWP2;TEAD4;FOXP2;ZNF215;PCGF5;STAT5B;ATF3;SP1;NRIP1;WWOX;SMARCB1;PLK3;ABL1;ZFX;TAF3;TCF20;RBL1;FHL2;MGA;NKAP;ELOA;PLAGL1;ZNF688;ZNF251;SENP1;ZNF786;MAMLD1;LCORL;IKZF4;BCLAF3;ZNF33A;RFX7;ZEB1;ZNF575;LRP6;HIVEP3;NR4A1;HDX;SLTM;MIER2;SP7;MLXIPL;JAG1;ATF1;ZSCAN21;RPS6KA3;BCOR;RFX1;ZNF311;EBF4;ZSCAN12;HCLS1;ZNF133;CCNH;GRIN1;SPEN;SRCAP;RNF10;JUP;TWIST1;ZNF729;NOTCH4;ZNF462;ASCL1;KDM2A;TFE3;NPAS3;ZNF514;HES1;TNIP3;ZNF652;SMARCA4;ZNF782;BPTF;ZFP82;RRP1B;NAMPT;MOV10;DACH1;MYC;MYT1L;TIAL1;ARID1A;CITED4;CHD4;TNRC6C;DMTF1;ZNF41;CCN1;NSD1;WWTR1;HDAC1;ZNF774;ZNF569;SMARCA2;ZNF761;BMP4;JUNB;NFIC;CREM;ZNF771;STING1;NOTCH1;EPC2;ZNF2;NR4A3;USP16;KDM3B;KAT6A;NR3C2;SCRT1;NFIB;ZNF202;GFI1B;ZNF337;ZNF594;ZSCAN31;CUX1;ZNF704;PPM1A;BARX2;ZNF852;ZNF846;ZNF611;DLX1;SIRT6;BRD3;ZNF131;GATAD2B;ZNF155;PLSCR1;SOX5;MXI1;DPF1;SOX13;TFCP2;RPS6KA4;MYOCD;RUNX1;ZNF165;NFKB1;ZNF384;ZXDC;NR3C1;SP2;MYBL2;SMAD2;ZNF75A;NR2F2;HDAC4;ARRB1;SAP130;NFYC;FOXO6;CDK8;ZNF599;MECP2;KLF12;RLF;THRB;ZNF586;BAZ1B;HES6;DBX2;CD40;ASXL3;ZNF438;OTUD7B;ZNF765;ZNF283;DPF3;NFAT5;MED13L;BAZ2B;BRD4;NR1H3;PRDM14;BCL9L;NR6A1;ZNF777;TNRC6A;HSF1;PPARGC1B;NCOA5;ZBTB2;CREB3L1;CXXC5;FOXF2;PBX1;ARID1B;ZFP28;IMPACT;TTC21B;ZNF48;ATM;ZNF845;MSC;ZNF589;HIVEP1;SKI;GABPA;ZNF549;ARID5B;ZNF609;ZNF12;NR2C1;GABPB1;ZNF292;BRIP1;ZNF665;ZNF276;ATAD2B;MYPOP;GMEB1;SHH;THAP7;RCOR2;AGO3;FUS;CHD1;CAMTA1;HSF4;ATF6;SATB2;ZNF675;FADD;ETV5;ZGLP1;SUPT3H;DPRX;NIPBL;ATN1;VRTN;RBPJ;ZBTB5;ZMYM5;DPF2;ZNF627;FOXJ2;KAT2B;HDAC5;TCF4;SP3;ZNF79;ZHX3;ZNF445;ZBTB41;ZNF132;KLF6;CREB3L3;ZFP62;ELF2;ZNF69;ASXL1;SREBF2;ZNF717;ZNF142;AGO2;KAT6B;NFIX;LPIN2;TBL1X;ACVR2A;JMJD1C;DMRT1;UXT;ZNF157;FOXP3;GADD45A;EGR1;ZKSCAN2;TFDP1;SMAD7;NCK2;EP300;WWC1;CREB1;ZNF785;NFX1;PAX6;POU2F1;ZNF322;PRRX2;MEN1;SLA2;ZNF324B
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.4060750036539877,1.1523559190695165,0.20689655172413793,0.8386265043487382,1.0,38/128,20.65%,TEAD2;ESRRG;HDAC3;HDAC10;RORA;RARB;MAML1;PPARG;RORB;MED17;NR4A2;TEAD4;TAF3;CCN2;NR4A1;TAF12;CCNH;NOTCH4;WWTR1;HDAC1;NOTCH1;NR4A3;NR3C2;NR3C1;THRB;NR1H3;NR6A1;GTF2F2;NR2C1;RBPJ;KAT2B;HDAC5;TBL1X;TAF4;POLR2F;ERCC3;MED27;HDAC7
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.6844280855583058,1.1518059428002034,0.32608695652173914,0.839561157875073,1.0,3/7,14.42%,SMYD5;NCOA3;MLLT3
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7121807343766153,1.1517845067790915,0.3333333333333333,0.8389205223751249,1.0,4/6,28.32%,PIH1D1;FBL;NOP58;ZNHIT6
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.45580940606875453,1.151592250280745,0.19230769230769232,0.8388539552063277,1.0,8/68,10.38%,ATP6V0D2;KPTN;TCIRG1;MLST8;MAPK8;EIF2AK3;DAPL1;RNF152
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.6929953445949073,1.151475330287424,0.325,0.8385345465062178,1.0,2/5,15.28%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.6606235031763398,1.1514709964467214,0.3829787234042553,0.8378299251479698,1.0,3/6,33.21%,GSTM2;CRYZ;GSTM4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.48049387683380107,1.151218568834319,0.17647058823529413,0.8379106591763771,1.0,6/25,17.69%,TXNL4A;KHSRP;SF3B1;SRRM1;SRSF4;SF3B4
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7464540193134632,1.1508777415504663,0.3684210526315789,0.8382435622076243,1.0,4/5,14.14%,ZBTB7B;CBFB;HMGB1;RUNX1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7307300238660966,-1.1504863491091808,0.2909090909090909,1.0,1.0,3/7,18.27%,HLA-A;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.8027470307048756,-1.1502077607287178,0.2833333333333333,1.0,1.0,3/5,15.59%,HTR2B;CSRP3;TTN
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.6355503089439664,1.1498935892893403,0.2631578947368421,0.840818184629313,1.0,7/11,27.16%,PTGIS;FAP;TP53;BCL2L1;DLC1;FZD3;DFFA
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.4691948614720035,1.1498905369521035,0.1935483870967742,0.8401140196254252,1.0,11/36,18.70%,NLGN1;CEL;UBXN2A;SPAST;NLGN4X;PTPRD;NLGN3;EMP2;NRXN1;NLGN4Y;UBXN2B
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.5882391038766046,1.149458430280095,0.23529411764705882,0.8408150627525719,1.0,1/9,7.28%,CHAC1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.6375041583298234,1.1492136786711635,0.43243243243243246,0.8409590805907036,1.0,3/9,22.32%,ZSWIM5;YTHDF1;TUBB2B
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.5815298735971377,-1.1490004048279379,0.25396825396825395,1.0,1.0,5/23,13.25%,MEIOB;SLC25A31;BTBD18;MEIOC;SYCP3
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.5810672828635802,1.148671361260121,0.2222222222222222,0.8420945639350212,1.0,6/15,10.64%,SLC30A10;SIRT1;MARCHF5;CDK6;RBL1;TWIST1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5616767958951788,1.1486635591663175,0.2619047619047619,0.8413784971289541,1.0,5/27,14.85%,ARC;APOE;ABL1;SCGN;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.6883532471251395,-1.1485360140921645,0.32786885245901637,1.0,1.0,2/6,9.91%,TIMP3;TIMP4
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6321361031125032,-1.1481936278776128,0.296875,1.0,1.0,4/14,8.82%,DUOX1;STAT1;KCNJ11;P2RY6
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.5481141575869041,1.1480188597777121,0.21621621621621623,0.8425116946761378,1.0,12/28,20.44%,CLC;SCRIB;ICOSLG;HMGB1;IL23A;LGALS9;FADD;FOXP3;RC3H1;BTN2A2;IL23R;TMIGD2
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6900593104439958,1.1477177347772265,0.3333333333333333,0.8427461071638723,1.0,3/8,16.45%,GLA;NEU4;NEU3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5994463857544299,1.1476312079836808,0.2571428571428571,0.8415547259663969,1.0,1/15,0.66%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5994463857544299,1.1476312079836808,0.2571428571428571,0.8415547259663969,1.0,1/15,0.66%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6986497465856772,1.1476190614925221,0.38235294117647056,0.8401833535030785,1.0,8/8,30.16%,PTBP1;LMCD1;CAMTA1;CIB1;AKAP6;SPPL3;SLC9A1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6986497465856772,1.1476190614925221,0.38235294117647056,0.8401833535030785,1.0,8/8,30.16%,PTBP1;LMCD1;CAMTA1;CIB1;AKAP6;SPPL3;SLC9A1;IGF1
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),0.6878474355562627,1.1475475659851042,0.4418604651162791,0.8396570067976799,1.0,1/5,12.52%,BMP4
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.6944611000520569,-1.1475319607183692,0.36065573770491804,1.0,1.0,2/6,19.15%,GUCY2C;GUCY2F
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.4955394455404825,1.1475058382540921,0.21621621621621623,0.8392102829755974,1.0,8/54,8.28%,TSKU;CYP7B1;APOB;CYP4V2;APOE;SOAT1;SULT2A1;ABCA1
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),0.6955614473853972,1.147419151634339,0.36363636363636365,0.8374034189088878,1.0,3/5,19.98%,NOP9;NOP14;TBL3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",0.6955614473853972,1.147419151634339,0.36363636363636365,0.8374034189088878,1.0,3/5,19.98%,NOP9;NOP14;TBL3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",0.6955614473853972,1.147419151634339,0.36363636363636365,0.8374034189088878,1.0,3/5,19.98%,NOP9;NOP14;TBL3
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5734160160526186,1.1465731711929437,0.3191489361702128,0.8388041103169518,1.0,4/15,14.27%,ITGA8;ITGB4;ITGA3;SMAD2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.43380815705713205,-1.1461951754888244,0.23809523809523808,1.0,1.0,23/94,12.81%,C1QB;ITGB2;FCGR3A;HCK;C3AR1;P2RY12;GPR183;IL21R;VSIG4;TNFRSF1B;MS4A4A;TAGAP;PTPRC;SLCO2B1;P2RY6;LY86;PARVG;PTAFR;SPI1;IGSF6;NFAM1;MYO1F;CLEC12A
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.6230434670247182,-1.1461433766350761,0.3148148148148148,1.0,1.0,2/14,3.26%,STAG3;SYCP1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.6230434670247182,-1.1461433766350761,0.3148148148148148,1.0,1.0,2/14,3.26%,STAG3;SYCP1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.3779502780051514,1.146115406511483,0.17857142857142858,0.8395360227624263,1.0,55/161,25.67%,TGFBR1;MAPKAPK2;SBK1;POGLUT3;GALNT1;VRK2;MAPK8;MAST1;POGLUT2;LATS1;EIF2AK3;SGK1;MAST2;AKT2;STK32C;MAP3K10;CLSPN;RPS6KA3;PKN2;GALNT13;MBOAT4;MAP3K13;MARK3;RPS6KA4;RPS6KA2;MAST4;RPS6KA6;CAMK1G;SGK2;ATM;MARK1;SMG1;MAPK12;DYRK3;CSNK1G1;MORC3;PRKCE;MARK2;PAK2;ATR;CDK5;CSNK1G3;PNCK;WNK1;DYRK1A;SRPK2;CDK1;CSNK1G2;GAS6;AKT3;IKBKB;RPS6KB1;STK38;STK39;DYRK2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7510868981962815,-1.1458040704263257,0.3508771929824561,1.0,1.0,1/5,9.75%,SLC6A12
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.7215798118744545,1.1455142807738645,0.3333333333333333,0.8406714452729092,1.0,2/6,11.55%,BNIP2;BNIPL
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.4229640598378151,1.1453427565333265,0.21212121212121213,0.8404613083774313,1.0,26/81,19.88%,ZNF804A;APOE;MAGI2;TOX;EPHA3;RAPGEF1;TENM3;STYXL1;ARSB;FZD1;RETREG3;ABL2;AVIL;COBL;RET;ARHGAP35;RAP1A;FUT9;LRP8;ROR1;RIT2;NTRK2;PTK7;EP300;PTK6;MARK2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5513233110671182,1.1452094340814605,0.3142857142857143,0.8402124213758907,1.0,5/17,14.72%,DDAH2;PKD2;AGXT2;DDAH1;INSR
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.6014935096670896,-1.1451901954127024,0.25,1.0,1.0,2/18,10.63%,CXCL13;DOCK8
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.6596596445961619,-1.1450613010268698,0.27692307692307694,1.0,1.0,4/9,16.03%,SP100;IFIT1;TRIM56;ISG15
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6489782476833068,1.1450393179362823,0.30952380952380953,0.8400551147385675,1.0,2/9,6.45%,RFWD3;CRY1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.5421914162090271,-1.1450104463802409,0.19047619047619047,1.0,1.0,3/26,9.51%,PLAAT4;PLA2G10;ALOX15
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.6567709905704274,1.144643855187079,0.17647058823529413,0.8398453033387369,1.0,3/12,11.55%,PLCB1;STAT5B;IL2RB
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.6567709905704274,1.144643855187079,0.17647058823529413,0.8398453033387369,1.0,3/12,11.55%,PLCB1;STAT5B;IL2RB
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5196273049759501,1.144601991923666,0.3181818181818182,0.8392470166307451,1.0,8/20,21.19%,CAPN10;IRS1;AKT2;IRS2;INSR;OCLN;OSBPL8;C1QTNF12
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.7464951866875996,1.1445630188462115,0.32,0.8387016486977797,1.0,3/5,18.89%,MOV10;AGO3;AGO2
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.696969164216604,1.1443112054114306,0.45714285714285713,0.8387926696958857,1.0,1/5,0.73%,SLC17A6
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7616002857328397,1.1443050776463866,0.3269230769230769,0.8381190090874199,1.0,4/5,22.30%,NOTCH1;RBPJ;NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.7481710224426662,1.1442476588971184,0.36585365853658536,0.8375888919139668,1.0,2/5,12.40%,CROCC;CCDC88A
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5444130322338092,1.1440925777632542,0.22580645161290322,0.837396007909735,1.0,4/25,6.78%,KIT;PTPRO;CDH13;SRGAP2
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.6331094622832167,1.1439835669964802,0.35,0.8371775932631262,1.0,5/8,14.10%,F2;DRD3;HES1;NOTCH1;NF1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.40768690143853176,1.1437083262091945,0.16666666666666666,0.8372049276029455,1.0,53/177,19.39%,FRMPD1;MRAP2;SCRIB;NLGN1;KCNB2;EHD4;ABHD17A;SPTBN4;SYNE3;NKD2;BSG;MAGI2;KCNIP3;TMEM150A;ITGA4;TNIK;DPP10;FLNA;LRP6;RAP2A;TESC;RAB3C;KCNIP4;PDZD11;JUP;TMEM88;ARL5A;TSPAN17;RAP1A;RAB40A;ANK2;RAB10;SMURF1;DPP6;EMP2;NRXN1;ARL3;F11R;EFR3B;ZDHHC3;RAB11B;PACS1;DLG2;BRAF;MYO5A;SLMAP;TTC7B;WNK3;BID;ANK1;RAB3D;LIN7A;TRARG1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.5360121013395481,1.1435904702675823,0.21951219512195122,0.8369354171999498,1.0,4/21,8.25%,MT1G;MT4;AKR1C3;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.49361874639706765,1.143552729732747,0.20930232558139536,0.8363311202566371,1.0,7/30,13.07%,CDK4;PKD2;CDK6;SLFN11;PLK3;RBL1;GFI1B
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.6214856587496149,1.1433165788821038,0.30952380952380953,0.8363848543229342,1.0,2/10,7.37%,SPEF2;WWP2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6003691565269695,1.1428270319253597,0.23684210526315788,0.8371336005978376,1.0,7/14,13.08%,VCAN;CSGALNACT1;CHST12;UST;CSPG5;B3GAT3;DSEL
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.5970424519996781,1.142651834353624,0.2553191489361702,0.8368650416589286,1.0,3/9,8.73%,PNP;NT5C1A;AMPD1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.6189959497908719,1.1426464145236936,0.3076923076923077,0.8361985474972133,1.0,2/15,10.20%,DAPK2;MCU
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.48107504362112163,1.1426343571780042,0.21951219512195122,0.8355074743174636,1.0,10/35,15.07%,PRSS3;KIT;CDH13;ZEB2;ABL1;KANK1;PKN2;FERMT1;PXN;PIK3CA
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.4964776132124715,1.1423154666935724,0.24242424242424243,0.8356514747554503,1.0,7/26,15.66%,PRPF39;PUF60;CELF4;CELF5;SFSWAP;CELF2;LUC7L
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.6973739865238794,1.142270621335086,0.37777777777777777,0.8351542804702468,1.0,4/6,28.65%,SLIT2;RNF113A;SLIT3;PADI2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.7010427635085608,-1.1418131437791719,0.36363636363636365,1.0,1.0,2/7,21.33%,CAV2;CAV1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.598024388716247,1.1417173696346945,0.2916666666666667,0.8362077433963834,1.0,4/12,13.45%,TCOF1;NRG1;NOTCH1;CDH2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.6606909058478446,1.1415394650915782,0.34146341463414637,0.8360820526713406,1.0,1/7,0.06%,ADRA1A
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.39700717109612826,1.141095124393305,0.14285714285714285,0.8368772681081722,1.0,30/125,16.96%,AUP1;CTDNEP1;FAM83H;TOR1B;CNTLN;PACSIN2;TULP3;STX5;MARCHF5;BICD1;GBF1;BBS9;GBP2;WASHC2C;CROCC;GCC2;WASHC2A;CEP250;RAB35;BANP;BMP4;TSPAN17;COG7;ANK2;ARFRP1;IFT140;ARL3;UBE2J2;TTC21B;ABCA7
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.5638040576439962,-1.1410919937969528,0.3484848484848485,1.0,1.0,3/21,11.52%,GPSM2;CHMP3;EML3
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.40224666412291055,1.1406728826096466,0.2608695652173913,0.8374284131237432,1.0,37/152,14.12%,FOXO1;TSKU;BAMBI;TGFBR1;SPRED3;USH2A;TWIST2;OSR1;RORA;SIRT1;ADAMTS12;PPARG;RORB;DTX1;ANKRD26;GREM1;IL17RD;TRIB2;CDK6;ANP32B;ABCA1;CRIM1;ADGRV1;JAG1;EFEMP1;SPRED2;TWIST1;NOTCH4;ASCL1;HES1;ADIPOR1;WWTR1;BMP4;NOTCH1;SPRED1;ENPP1;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.640636465653005,1.1403293403408912,0.27906976744186046,0.8375956581457159,1.0,3/12,11.36%,GMNC;SLFN11;TERF1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.7137531715135995,1.140303684148777,0.32558139534883723,0.835625142265446,1.0,1/6,0.41%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.7137531715135995,1.140303684148777,0.32558139534883723,0.835625142265446,1.0,1/6,0.41%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.7137531715135995,1.140303684148777,0.32558139534883723,0.835625142265446,1.0,1/6,0.41%,TACR3
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.5292572082110407,-1.1402830143793117,0.2807017543859649,1.0,1.0,6/25,23.37%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.6751900159431001,1.1398862149056355,0.3333333333333333,0.8362514037439167,1.0,1/6,0.47%,EGLN3
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),0.735437774305833,1.1395443773603917,0.37209302325581395,0.8324081029125587,1.0,1/5,1.53%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),0.735437774305833,1.1395443773603917,0.37209302325581395,0.8324081029125587,1.0,1/5,1.53%,NUDT4B
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),0.735437774305833,1.1395443773603917,0.37209302325581395,0.8324081029125587,1.0,1/5,1.53%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),0.735437774305833,1.1395443773603917,0.37209302325581395,0.8324081029125587,1.0,1/5,1.53%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),0.735437774305833,1.1395443773603917,0.37209302325581395,0.8324081029125587,1.0,1/5,1.53%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),0.735437774305833,1.1395443773603917,0.37209302325581395,0.8324081029125587,1.0,1/5,1.53%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),0.735437774305833,1.1395443773603917,0.37209302325581395,0.8324081029125587,1.0,1/5,1.53%,NUDT4B
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.6721948343235506,1.1394431168513177,0.30952380952380953,0.8320468432696804,1.0,4/9,17.37%,PROX1;BMP4;NF1;SHH
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5511652354249652,-1.1393992524583407,0.3103448275862069,1.0,1.0,6/28,16.43%,CCDC39;DRC1;ODAD1;DNAH17;ZMYND10;DNAI1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.5183703629874222,-1.139367393843323,0.25,1.0,1.0,6/28,13.25%,TOPAZ1;SOX30;MEIOC;GALNTL5;TNP1;SYCP3
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4168986739306442,-1.139195350662668,0.1518987341772152,1.0,1.0,20/164,14.55%,CD44;MICB;PTGES;CYP26B1;GPER1;WFS1;PLAC1;ACOX2;CCND1;CKB;PRSS23;COX6C;PDZK1;LAMC2;TPD52L1;ST6GALNAC2;DYNLT3;CDC6;PTGER3;IMPA2
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.7110060339499679,1.1388484187613641,0.37209302325581395,0.8331387986899199,1.0,2/5,4.61%,TGFBR1;DSP
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.6545787711891163,-1.138628238313602,0.30357142857142855,1.0,1.0,5/12,12.15%,ALOX12;ALOX5;ALOX15;ALOX12B;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.684200552732464,1.1385498434131438,0.34615384615384615,0.8327195175275763,1.0,1/6,13.97%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.684200552732464,1.1385498434131438,0.34615384615384615,0.8327195175275763,1.0,1/6,13.97%,ENPP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5907335467633283,-1.1383785952993,0.2413793103448276,1.0,1.0,12/23,34.21%,COPS5;COPS4;RBX1;RPS27A;DDB1;COPS7A;CETN2;UBB;COPS7B;RAD23B;GPS1;UBC
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.68546327263713,1.1382627664299931,0.34782608695652173,0.8327624032425892,1.0,4/5,30.68%,SYNCRIP;IGF2BP1;YBX1;HNRNPU
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),0.7685500246146502,1.1381622140416465,0.2708333333333333,0.8324400920584644,1.0,4/5,21.65%,HES1;BMP4;BMPR2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.45987654589038685,1.1381494389355735,0.30303030303030304,0.8318037927128445,1.0,15/60,16.23%,SKAP1;UTRN;CDH13;EPHA3;CDK6;ACER2;EFNA5;JAG1;JUP;ADAM15;MACF1;NF1;NEXMIF;EMP2;SLK
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.5179891904806266,-1.1380584649757735,0.28125,1.0,1.0,3/29,7.01%,IRF4;HLA-DRB1;PDCD1LG2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.39985553266598844,1.1380336968903968,0.2,0.8315456297756948,1.0,22/111,13.84%,SLC17A6;LHFPL4;KCNB2;NXPH1;HRH3;ELAVL3;PAK5;NR4A2;KCNJ6;ERC2;CELF4;CASKIN1;ADGRA1;MSI1;TENM1;CELF5;ABCC8;RIMS4;OLFM3;SCRT1;PRR36;SNAP91
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.6023894714111904,1.137775348317619,0.29545454545454547,0.8314260449522664,1.0,2/8,23.20%,SHMT2;METTL4
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.5871377396390448,-1.1376389057569465,0.35714285714285715,1.0,1.0,1/9,2.34%,JCHAIN
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.5705476738707118,1.1371316952877295,0.2702702702702703,0.8327498940367505,1.0,1/15,1.32%,KIT
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.6412406624413169,1.1368319967676055,0.36363636363636365,0.8329054056677068,1.0,1/7,2.37%,USH2A
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.4939080642320761,1.1366078317262935,0.29411764705882354,0.8328476619563276,1.0,10/41,19.88%,LAMA4;NOVA1;ALDH1A1;PLCL2;TFE3;NOTCH1;NR1H3;RBPJ;IP6K1;MAP2K6
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.5000248292041708,1.1365997239088137,0.25,0.8322266301580472,1.0,9/24,20.46%,PLEKHG2;COTL1;LATS1;HCLS1;ARHGAP35;FCHSD2;CXCL12;PAK3;GBA2
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),-0.7651542956779479,-1.1363647632333473,0.3559322033898305,1.0,1.0,1/5,2.76%,RFX4
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.5469722267137845,1.136356312125408,0.2857142857142857,0.832369677963652,1.0,5/15,14.36%,TELO2;SIK3;PIH1D1;CLEC16A;KLHL22
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.523705516446216,1.1362767188742997,0.2682926829268293,0.8319125226324136,1.0,7/23,19.79%,AUTS2;AVIL;WASF2;FSCN1;PIK3CA;OCLN;CARMIL2
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.6713795548353707,1.1362095897755218,0.3877551020408163,0.8314935704449694,1.0,3/7,23.59%,HPSE;ADIPOR2;SRF
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6236628276979362,1.1361687544111865,0.28205128205128205,0.830875621553279,1.0,4/11,11.84%,MFSD2A;NTNG2;MOV10;MACF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5905429874957772,1.1361087208291516,0.21428571428571427,0.8303210112636323,1.0,3/13,12.64%,HSPB1;SEMA5A;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.5520386149664789,1.136022329799967,0.20588235294117646,0.8299417212799965,1.0,2/16,7.53%,MAFB;CDK6
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5110025653621995,1.1359178298904125,0.2765957446808511,0.8295381404148081,1.0,6/20,17.75%,SMYD5;SIRT7;PIWIL1;MOV10;TEX15;PIWIL2
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.5069574886321455,1.1358476773053,0.2777777777777778,0.8290978876212869,1.0,6/27,9.82%,APOH;VCAN;FGFR1;TIMP1;LPL;JAG1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.6309558929153906,-1.1356690498016953,0.36507936507936506,1.0,1.0,3/6,22.90%,FBXL7;RBX1;SKP1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.5063230204613798,1.1355852791070593,0.25806451612903225,0.8290063635538615,1.0,7/21,16.61%,ITPR2;HTR2C;TRPM2;PKD2;LCK;SLC8B1;F2R
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.7108440571625918,-1.135544176034324,0.27586206896551724,1.0,1.0,1/6,0.48%,DBH
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.454762918988309,-1.1355019608194523,0.22857142857142856,1.0,1.0,28/78,17.91%,BHMT;SLC28A1;ITIH2;LECT2;TSHR;OIT3;IYD;CYP3A5;ABCC6;FMO5;ALDOB;SMLR1;SLC3A1;RORC;PLG;HNF1A;ACKR2;PDZK1;PON3;SERPINA10;SLC6A4;SLC22A7;TG;SLC5A9;PIK3C2G;CYP3A4;SLC16A11;ALB
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5606077593935415,1.1353041027695048,0.35135135135135137,0.8291385368880683,1.0,3/13,6.76%,MSH4;TOP2A;HFM1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.4440733775588693,-1.135251746823831,0.21621621621621623,1.0,1.0,29/79,26.00%,PSMB9;TRIM5;IL7;UBE2L6;IRF1;TRIM25;LPAR6;PROCR;OAS1;IFIT3;TXNIP;SP110;DDX60;IFI27;ISG15;C1S;WARS1;PSMA3;CASP8;DHX58;ISG20;CMTR1;IFITM3;MX1;EPSTI1;CMPK2;LAP3;TMEM140;PARP14
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6255246547505349,1.134500261441054,0.2682926829268293,0.8310574792828072,1.0,4/8,24.81%,NLGN1;NRXN1;PTEN;NLGN2
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.6756173274796924,1.1344161697564952,0.40425531914893614,0.8306546184067033,1.0,1/6,4.08%,METRNL
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.6570993207551803,1.1343178608949094,0.33962264150943394,0.82962798411581,1.0,3/6,22.23%,IWS1;SETD2;TPR
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.6570993207551803,1.1343178608949094,0.33962264150943394,0.82962798411581,1.0,3/6,22.23%,IWS1;SETD2;TPR
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.644240287828518,-1.1341688231996954,0.3898305084745763,1.0,1.0,4/10,24.48%,B3GNT9;B4GAT1;B3GALT2;B3GNT2
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.7337829518265028,1.1337320966754267,0.3541666666666667,0.8300878434970536,1.0,2/5,15.39%,PLSCR1;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.7337829518265028,1.1337320966754267,0.3541666666666667,0.8300878434970536,1.0,2/5,15.39%,PLSCR1;SETMAR
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.4484823425833238,1.1336471697922013,0.3055555555555556,0.8296997049899791,1.0,12/46,16.45%,ST6GALNAC3;ESYT3;GLA;STS;NEU4;SMPD4;ESYT2;GLB1;SMPD3;ST3GAL6;PGAP1;NEU3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.6567650668907902,1.133615854828666,0.32075471698113206,0.8291023930720862,1.0,2/7,16.15%,SLIT2;EMILIN1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.6591485930162518,-1.1332738544892957,0.38333333333333336,1.0,1.0,3/7,23.10%,SLC22A3;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.74683062390748,1.1331517347344764,0.34782608695652173,0.8298377549888576,1.0,2/5,14.20%,CEP135;SEPTIN9
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.4163336785690136,-1.132733354275397,0.15384615384615385,1.0,1.0,5/183,0.99%,SQOR;ENPP2;RAB34;COX6A1;CCNG2
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.43099435186152124,1.1324936536285455,0.2857142857142857,0.8310155071346378,1.0,12/66,19.59%,TOR1B;STX5;REEP6;EIF2AK3;SMPD4;STX18;RAB10;UBE2J2;MOSPD3;DOP1B;MIA3;TMCC1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5506061530519263,-1.132259115882399,0.3275862068965517,1.0,1.0,4/20,12.57%,PTPRC;TESPA1;NFAM1;PRKCH
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6434160087991521,1.132161495497569,0.38461538461538464,0.8315388964372012,1.0,3/8,10.40%,LAMB4;NTN4;NTNG2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.6650649032125029,1.1321333483676954,0.3409090909090909,0.8309297185305136,1.0,1/6,8.52%,GPHN
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.45370780568584157,1.1320058721345772,0.2692307692307692,0.8307025494514079,1.0,9/54,6.60%,TSKU;TGFBR1;FGF10;DCBLD2;CFLAR;DSP;ERBB2;NRG1;HPSE
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4615331328257042,1.1319218422564346,0.25,0.8302423804804279,1.0,17/59,20.39%,DGKD;SLC30A10;NRG2;ERBB2;NRG1;TGFA;PTPRR;EFEMP1;GAB1;PIK3CA;BRAF;MATK;ERBB3;SOS1;NCK2;PTK6;KIF16B
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4829223312147263,1.1315395684187028,0.2894736842105263,0.830703365019232,1.0,22/51,21.79%,ROBO2;DSCAML1;CDH13;BSG;SDK1;CADM1;DSCAM;PTPRM;TENM3;CNTN6;CDH2;PTPRT;EMB;CDH4;NECTIN3;AMIGO2;KIRREL3;SDK2;DSG2;ROBO4;PCDHB6;IGSF11
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.6180168350952073,1.131270065531694,0.3333333333333333,0.8309796818625618,1.0,2/9,9.48%,KIT;KITLG
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.547714511428995,1.1311758219758044,0.275,0.8307041780142873,1.0,6/21,6.51%,SMYD1;PROX1;MAML1;NRG1;WNT3A;GREM1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.44722013430061924,1.1311648541335786,0.32142857142857145,0.8300618081341126,1.0,15/61,23.13%,CPSF1;TRDMT1;METTL1;POP1;TRMT9B;CTU1;CDKAL1;TRMT61A;ANKRD16;FARS2;TSEN2;DTWD1;TRMT1;THUMPD1;ADAT2
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.6848088575959229,-1.1311450478813474,0.38596491228070173,1.0,1.0,3/10,19.17%,OLFM4;RAC1;BST1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.627392929644473,-1.1310773156822345,0.3684210526315789,1.0,1.0,4/9,28.38%,HTR2B;ADGRG1;FLOT1;AZU1
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.684193701937847,-1.1305389600892919,0.41818181818181815,1.0,1.0,3/5,24.30%,TEK;HIPK1;MFAP5
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.4396895382210877,1.1304713947782052,0.23684210526315788,0.8313533745934903,1.0,16/64,16.77%,FGF10;FGFR1;FGF18;ESRP1;FGF17;HNRNPF;TRIM71;HNRNPH1;SPRED2;FLRT2;TIAL1;RBFOX2;SPRED1;FGFR3;PTBP1;GTF2F2
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6108914661314045,1.1304697542079296,0.3023255813953488,0.8307237288228779,1.0,4/13,11.46%,IRS1;SIRT1;AKT2;IRS2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6679573594667971,-1.130055328717376,0.3157894736842105,1.0,1.0,1/10,3.78%,CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.5378423120842051,1.130039924733332,0.225,0.8312920906769952,1.0,5/20,14.12%,KIT;FGFR1;ABL2;PLA2G5;FGFR3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5100944215099102,-1.1300139554344688,0.2535211267605634,1.0,1.0,3/25,7.12%,CASQ2;CAV3;KCNS2
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.639157581395434,-1.1295217599197858,0.34328358208955223,1.0,1.0,3/15,3.25%,MYH7;STAC;MYH8
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5479550976253122,1.1294628094461188,0.2727272727272727,0.832652876161129,1.0,4/27,7.10%,TACR3;LHFPL2;PDE3A;PLCB1
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.6232956438353364,-1.1290236018065447,0.2916666666666667,1.0,1.0,4/15,20.02%,ERN2;SLFN14;EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.49650037320337603,1.128980156373486,0.28205128205128205,0.8332798079754636,1.0,3/31,4.21%,SMYD2;SMYD1;PRDM5
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.693031000492435,-1.128904364444316,0.3387096774193548,1.0,1.0,2/6,28.10%,SELP;PLA2G4A
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.5499297170287534,1.12879301128646,0.3142857142857143,0.8331989842856101,1.0,3/10,14.27%,PUS10;DGCR8;SMAD2
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7355836816978089,-1.1285459186076057,0.3387096774193548,1.0,1.0,1/5,5.60%,ATP6AP1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6521351926342491,-1.1284699655188342,0.35,1.0,1.0,3/8,16.40%,ALOX12B;SCIN;ACSL3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.6284498565131935,1.1279801345487255,0.3333333333333333,0.8349447136194791,1.0,2/9,4.43%,EGLN3;P3H2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.35089613660668084,1.12795677834319,0.11764705882352941,0.8343273805627824,1.0,131/459,22.03%,FOXO1;GMNC;CD38;PER2;PRICKLE1;HDAC3;HDAC10;KLF10;TWIST2;TLE2;TSHZ3;BCL6;SAMD4A;PROX1;SIRT1;PRDM5;ATXN1;MTERF3;PHC2;SFMBT1;WNT4;GATAD2A;IFI16;PPARG;RORB;NRG1;CTBP2;PML;CRY1;ZBTB4;HIC2;HEXIM2;DHFR;PLCB1;RIDA;WWP2;FOXP2;TRIM71;SLFN11;KDM8;CIART;PCIF1;EIF2AK3;FOXN3;NKAP;CNOT9;ZNF703;NANOS3;IKZF4;ZEB1;MAP3K10;MLXIPL;BCOR;SPEN;TWIST1;ASCL1;TIMELESS;HES1;SMARCA4;TERF1;DACH1;MDFIC;LIMS1;HDAC1;SMARCA2;RBFOX2;BMP4;NOTCH1;KAT6A;SCMH1;ENPP1;DPF1;SOX13;NR3C1;SMAD2;NR2F2;HDAC4;MECP2;MBTD1;PUS7;ZMYND11;DPF3;CREB3L1;ATF7IP;SPINDOC;ARID5B;ZNF12;BCL3;MALSU1;SYNCRIP;THAP7;RCOR2;ZNF706;NIPBL;RBPJ;MPHOSPH8;FXR2;DPF2;HDAC5;PATL2;SP3;ZHX3;KHDRBS1;KAT6B;FOXP3;YAF2;LSM14A;RAD17;PA2G4;POU2F1;MEN1;SAMD4B;TP53;LIN28A;EIF4A3;ATR;TRAF6;ZBTB7A;RSF1;ATP8B1;CDK5;MAGEL2;CEBPA;BMPR2;ZNF91;LARP1;PCGF6;SUV39H2;HINFP;DEAF1;IGF2BP1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.690570459616142,1.127932991045753,0.3404255319148936,0.8337353278396215,1.0,1/6,20.39%,LIN28A
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.46341353932069496,1.1277265920938067,0.25806451612903225,0.8336179579219943,1.0,12/46,16.52%,CRK;SPRY4;WASHC2C;ABL1;KANK1;EFNA5;FLNA;LIMS1;CSPG5;DOCK1;CASS4;CRKL
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.6318668861083618,1.1275216154189511,0.3191489361702128,0.8327894640008293,1.0,2/12,8.54%,PER2;GYS1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.6318668861083618,1.1275216154189511,0.3191489361702128,0.8327894640008293,1.0,2/12,8.54%,PER2;GYS1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.4830449750174901,1.1274000215134719,0.3333333333333333,0.8324428419554425,1.0,9/30,14.09%,SLC26A3;HCN1;PKD2;RAPGEF1;AANAT;AKAP9;HCN3;RAP1A;RAPGEF3
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6601645503053627,-1.12735777422148,0.24615384615384617,1.0,1.0,2/11,9.58%,ART1;ART3
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.4435768473496065,1.1273297243912057,0.25806451612903225,0.832084650497755,1.0,25/81,19.54%,GRID2;EPHA7;IGDCC3;UNC5D;PLEKHG4B;CNTNAP2;BCL11A;IL17RD;TRIM71;GRM4;MYO3A;MSI1;LIN28B;NLGN4X;CRABP1;RIMS4;ADAMTS19;FRAS1;ZNF663P;RCOR2;VRTN;WNK3;EPHA8;CXCL12;SYT6
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3989958920421517,1.127266563894962,0.21428571428571427,0.8316544151011889,1.0,48/195,19.44%,PLEKHG2;PCM1;LLGL1;BIN1;CNTRL;MID1;TOP2A;KPTN;ESPL1;FGD4;CNTROB;LMNB1;PKD2;RASA2;PCGF5;ABL1;EPB41;ALMS1;LATS1;MYO9B;MYO1E;FLNA;CEP250;MAPRE1;WASF2;CLIP2;RASAL2;FARP1;CCDC88A;FSCN1;DST;SYNPO;PXN;NF1;SEPTIN9;CLIP1;ARHGAP27;MARK4;BCR;FLNB;KIF3B;SAC3D1;ARHGAP10;DLGAP5;UXT;SOS1;ARHGAP5;NCK2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.535423646427342,1.127192618571405,0.21428571428571427,0.8312490311216953,1.0,3/28,3.82%,KIT;PTPRO;CDH13
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.6954212714770016,1.1269180712928757,0.27450980392156865,0.8313033743356061,1.0,3/6,23.09%,ZBTB1;TFCP2;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7240735898862208,1.126868888664955,0.3953488372093023,0.8308385325537517,1.0,4/5,24.76%,TENT4A;ELAVL4;LARP4B;RBM24
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.7055161638122524,1.1268063629334881,0.37209302325581395,0.8303623498429308,1.0,1/6,3.43%,SLC39A8
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.6749990427679672,1.1267870510017945,0.35294117647058826,0.8297904789745001,1.0,4/7,22.77%,TARBP2;AGO3;AGO2;ADAR
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.40951429108832327,1.1267173378712987,0.21875,0.8293158469760828,1.0,19/78,19.00%,ELOVL6;HDAC3;RORA;SMARCD3;PPARG;ACACB;NCOA2;SP1;IRS2;ADIPOR1;CARM1;CHD9;SC5D;NFYC;TM7SF2;OPA3;ABCA7;SREBF2;TBL1X
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5662270217379408,-1.126678253528838,0.36923076923076925,1.0,1.0,3/21,16.11%,TGFB1;THBS1;RAC1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.606665197810198,1.1264738915868675,0.3170731707317073,0.8293594424502597,1.0,2/10,12.15%,MED25;ZNF618
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),-0.7479056276865466,-1.1259810619152242,0.33962264150943394,1.0,1.0,1/5,5.98%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.5643357952447438,-1.1259534263179314,0.36363636363636365,1.0,1.0,2/16,6.27%,WNT5A;CYBA
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.6327500695608937,-1.1258875527780576,0.34545454545454546,1.0,1.0,2/11,5.98%,NMUR2;ANXA1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5249066404594268,-1.1256539014095137,0.25862068965517243,1.0,1.0,4/28,10.97%,MMP21;CCDC39;TBX6;GATA4
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.6200600016962576,-1.1254024939646543,0.32727272727272727,1.0,1.0,5/11,26.61%,OAS1;IFIT1;MX1;NLRP1;PHB2
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.7141828628720908,1.1249866478377542,0.32558139534883723,0.8330105865551116,1.0,3/5,15.64%,ANGPT1;TJP2;OCLN
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5554125884714027,1.1247500413392684,0.2631578947368421,0.8329190801489124,1.0,4/17,19.06%,TERF1;ATM;SMG5;SMG6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5743251346512098,-1.1244622961175104,0.2857142857142857,1.0,1.0,4/18,22.30%,RPA3;RBX1;RPA2;DDB1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5743251346512098,-1.1244622961175104,0.2857142857142857,1.0,1.0,4/18,22.30%,RPA3;RBX1;RPA2;DDB1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4270179681676584,1.1244084441104816,0.23684210526315788,0.8331999259954669,1.0,19/66,22.30%,GCK;NUP210;ZBTB20;NUP42;AAAS;MLXIPL;HDAC4;INSR;PFKFB4;PFKFB3;EP300;RANBP2;PRKAG2;GIT1;ZBTB7A;PRKAA2;NUP214;TPR;HIF1A
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4772965870597771,1.1241754993896649,0.3076923076923077,0.8331923974069358,1.0,21/59,23.30%,TBC1D10A;IFT88;TBC1D16;CEP120;SDCCAG8;TBC1D22B;CROCC;CCDC88A;ARHGAP35;EVI5L;IFT140;MARK4;SGSM3;TBC1D2;TBC1D8;DCDC2;USP6NL;TBC1D5;RABEP2;LIMK2;EVI5
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6288826973134006,1.124141283009137,0.3488372093023256,0.8326334199401931,1.0,3/7,24.30%,MTR;MTHFR;SMS
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.6700393604552983,1.1240442492070077,0.3695652173913043,0.8322549898566596,1.0,1/7,1.03%,TSKU
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.45370745784460353,-1.1240017752643334,0.2597402597402597,1.0,1.0,20/78,18.68%,PLEKHS1;CHST9;MS4A8;VWA3B;CCDC60;FUT2;MROH9;MAP3K19;MYO5B;DNAH3;AKAP14;BPIFB1;APOBEC4;DNAI1;FER1L6;ZBBX;MUC4;EYA2;CAPN13;SNTN
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.5026050625693242,1.1238182471591611,0.3103448275862069,0.8323798744597334,1.0,2/18,5.26%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5943076804573435,-1.1238149510938962,0.3870967741935484,1.0,1.0,3/21,9.29%,AIM2;STAT1;TRAF3IP2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5181018362948222,1.1233142434432701,0.27906976744186046,0.833329847158114,1.0,2/13,5.41%,PPP1R14D;MAGI2
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.5926511189778276,1.1232556752377225,0.30952380952380953,0.8322398618443902,1.0,5/10,29.86%,KLHL22;SESN2;RRAGD;SESN3;UBR2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.5926511189778276,1.1232556752377225,0.30952380952380953,0.8322398618443902,1.0,5/10,29.86%,KLHL22;SESN2;RRAGD;SESN3;UBR2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6365486681728126,1.1230684033617426,0.3684210526315789,0.8320541157160604,1.0,5/10,26.17%,NOTCH1;RBPJ;BMPR1A;ZFPM2;MEF2C
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.4730048934645851,-1.1229794241847177,0.2903225806451613,1.0,1.0,8/58,11.78%,ENPP2;PDXDC1;CYP3A5;PLA2G10;LVRN;PPT1;ERAP2;SIAH1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.5786671271914174,1.1227180894553264,0.2857142857142857,0.8324886958318071,1.0,6/12,13.15%,SPRED3;OSR1;ZEB1;SPRED2;NOTCH4;SPRED1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.44324955032368074,-1.122604991056597,0.29577464788732394,1.0,1.0,28/136,16.39%,F7;MPL;GMFG;ITGB2;FCGR3A;DAB2;HCK;C3AR1;P2RY12;ALOX12;GP1BA;HLA-A;TNFRSF1B;SMOX;LY86;SPI1;NFAM1;CDKN2D;ITGA2B;MYO1F;CLEC12A;THBS1;SELP;MFSD2B;RTL8B;ITGAM;F5;VWF
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.6549902258270046,-1.1225932124105908,0.3064516129032258,1.0,1.0,3/7,25.74%,DDX3X;PARP10;GPS2
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3600026948025003,1.122004303862883,0.18181818181818182,0.833732810644414,1.0,108/381,21.61%,NGF;SLITRK6;CHRM2;POU3F1;TGFBR1;VCAN;POU6F2;NEUROD2;ROBO2;ADGRG6;NLGN1;GRIK1;POU3F2;PROX1;DSCAML1;IL1RAPL2;ST8SIA4;ATXN1;FGF17;NRTN;SEMA5A;PTPRZ1;FZD5;SDK1;ZEB2;NRG1;ZC4H2;PKD2;CHST8;FKTN;DSCAM;CHAC1;TRIM71;EFNA5;SCD5;CRIM1;MSI1;ADGRV1;TENM1;JAG1;NAV3;RPS6KA3;SNTG2;FGF12;AVIL;ALDH1A2;ASCL1;HES1;TRAK2;MTR;EVL;MYT1L;ACHE;CSPG5;WWTR1;RBFOX2;CNTN6;FARP1;APBA1;RBFOX1;CDH2;DPF1;ADORA1;NF1;HDAC4;BTBD2;NAV1;EPHB2;RYK;CPNE6;NLGN3;NRXN1;DPF3;RPS6KA6;LIG4;SRRM4;NRSN1;SH3GL1;MARK4;NAV2;SHH;KIRREL3;ATN1;TYRO3;ERBB3;DPF2;LSAMP;SREBF2;NRCAM;CHD7;MNX1;EP300;UNC119B;PAX6;CDK5RAP2;LIMK1;ELP3;GBA2;LGI1;SZT2;ADGRL3;CDK5;SDK2;PTEN;NINJ1;PPP2R5D;PCDHB6;NTN5
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.6548415799450655,1.1216905019661358,0.34146341463414637,0.8341416271928773,1.0,6/6,34.53%,GABRB2;HRH1;GABRB1;GABRB3;GABRG2;DIAPH1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.60415456345236,1.121617688859531,0.3023255813953488,0.8336099959321274,1.0,2/10,6.01%,ZNF692;SIRT7
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.5294551042555312,1.1215126754798308,0.2916666666666667,0.8332812635724911,1.0,6/24,8.68%,APOH;F2;APOE;SERPINE1;HPSE;F12
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.6602215343261403,1.121484158280619,0.40540540540540543,0.8320793218408566,1.0,3/7,17.52%,ZEB2;TYRP1;OPN3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.6602215343261403,1.121484158280619,0.40540540540540543,0.8320793218408566,1.0,3/7,17.52%,ZEB2;TYRP1;OPN3
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.7163002583162013,-1.121338947715598,0.37037037037037035,1.0,1.0,3/5,26.61%,TRIM25;OAS3;PHB2
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.4077396789091335,1.1212164077615538,0.3333333333333333,0.8322031965605557,1.0,24/125,16.24%,KLHL17;ROBO2;MFSD2A;ADGRL2;EPHA7;PROX1;DSCAML1;DNAJC30;ATXN1;PITPNM1;CX3CR1;CNTNAP2;SPEF2;JHY;MAST1;SLC6A17;GRIN1;BPTF;NFIB;CDH2;NF1;SMG9;UTP3;PBX1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.5300993460444977,1.1211416418425884,0.3076923076923077,0.8318883913777942,1.0,4/18,12.93%,ACD;CTC1;TERF1;GNL3L
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5570271558394844,-1.1210446355399275,0.31666666666666665,1.0,1.0,6/15,14.22%,CXCL13;MSMP;GPR183;PIK3CG;HSD3B7;CXCL16
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.48325945431876327,-1.1210266426359148,0.38461538461538464,1.0,1.0,11/44,22.04%,HK2;TOMM20;PINK1;TIMM17A;TOMM7;PAM16;ROMO1;FIS1;CHCHD4;DNAJC19;TOMM34
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.7275327275079305,-1.1205834734687836,0.38181818181818183,1.0,1.0,1/6,7.84%,PSAP
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.7020634500642348,1.1202290449062842,0.37209302325581395,0.8338951124332915,1.0,1/5,7.11%,PTGIS
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.5642829437583711,1.1200309127492845,0.28888888888888886,0.8339581559152796,1.0,4/16,7.51%,CDH13;ERBB2;MVB12A;FER
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.489308495822189,1.120010021857037,0.2972972972972973,0.8333707807587917,1.0,9/28,11.55%,SKAP1;CD247;TRAC;PYHIN1;KLRC4-KLRK1;TRBC2;LCK;CD8A;IL2RB
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.6869018885423265,1.119979081231133,0.3076923076923077,0.8327842989485496,1.0,2/6,6.45%,RFWD3;CRY1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.39838204955406314,1.1199389381533464,0.21875,0.8322459327643796,1.0,41/154,19.50%,PCDH17;NOVA1;NMU;PARVA;LRRC4C;ELAVL3;CADM2;PCLO;PAK5;TOX;TAFA1;FSTL5;KCNIP1;ADGRA1;EFNA5;HIVEP3;GUCY1A2;BRINP1;ELAVL4;SCN7A;GOLGA7B;RGS7BP;RET;OLFM3;SCRT1;RBFOX1;MAP6;SNAP91;ANK2;TAFA5;PIK3CA;ASXL3;NRXN1;PPFIA2;LSAMP;TMEM196;ADGRB3;SLC7A14;NTRK2;CNTN1;ST8SIA3
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.7486691947457816,-1.1196767769350322,0.37254901960784315,1.0,1.0,2/5,16.11%,AIF1L;RAC1
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),-0.7332485157458328,-1.119572619308138,0.32142857142857145,1.0,1.0,3/5,21.90%,PKP2;NEFM;NEFL
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.4262169351691604,1.1194453415742147,0.16129032258064516,0.8331004436803884,1.0,15/57,20.51%,TGFBR1;BCL2;MFSD2A;ERBB2;SLC25A33;PLCB1;RPS6KA3;ADNP2;KLHL22;INSR;SLC44A4;BRAT1;ADAM10;DNPH1;LGI1
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.6942802706710653,-1.1193540134430064,0.41818181818181815,1.0,1.0,1/5,3.79%,SCN5A
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.36331052242784667,1.1192154647816202,0.2,0.8331638509342602,1.0,46/317,14.42%,ATP6V0D2;RAB20;TBC1D10A;APOB;RAB31;APOE;TCIRG1;STX5;TBC1D16;OLFM2;PPARG;TBC1D12;BLZF1;SCFD2;RAB28;RAB7A;GOLGA4;REP15;STX8;STX6;SCAMP4;TOM1;ABCA1;SYNDIG1;LTBP2;TICAM2;TBC1D22B;ACD;CEP290;GCC2;RAB3C;TMED3;RPGR;GGA1;MACF1;IL10RA;PREB;TBC1D4;ARL5A;WLS;SNX9;COG7;LRP1B;RAB10;ARFRP1;EVI5L
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.49410904386846627,1.1190785977340996,0.3103448275862069,0.8328737852414408,1.0,5/25,14.40%,GBF1;GCC2;ARL5A;COG7;ARFRP1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6140965287668725,1.1188049843265524,0.3409090909090909,0.8330432008624221,1.0,1/9,9.51%,METAP1D
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.6799305556124129,1.1187168153008007,0.3333333333333333,0.8325890061616097,1.0,2/6,7.69%,SLC8A1;DRD3
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.46404774924968917,-1.1186371434205313,0.30303030303030304,1.0,1.0,7/60,10.62%,FZD8;TCF7;WNT5A;FRAT1;WNT8B;TCF7L1;SFRP4
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.6480663763784487,1.1186096376408978,0.4146341463414634,0.8323000335412949,1.0,2/6,15.36%,DHFR;GCH1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.5707827168974668,-1.1184050774101935,0.328125,1.0,1.0,4/22,8.92%,MYBPH;CAV3;MYBPC3;C12ORF57
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),-0.672965920210394,-1.1183014731043666,0.375,1.0,1.0,3/7,23.93%,CYP21A2;HSD11B2;HSD11B1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3654299223327688,1.117822823765668,0.18181818181818182,0.8339139630804677,1.0,36/182,15.53%,GCK;PLCH1;FBP2;DUSP4;EPHX2;DUSP15;PLPPR1;ITPKB;EPHA7;DUSP23;BCKDK;PFKP;ALPL;PLCB1;G6PC3;LPL;ACYP2;DUSP18;PLPP2;PSPH;PLA2G5;AGPAT2;PLA2G4C;GPD2;PPM1A;PLCH2;INPP1;PTPRB;ENPP1;EPHB2;PTPRD;PIK3CA;PLPP3;ITPK1;PLA2G15;PIP4K2A
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.38816407080960985,1.1177767913624193,0.12903225806451613,0.8334132008733063,1.0,31/107,22.42%,FOXO1;NOX4;HTRA2;AKR1C3;SNCA;PKD2;VRK2;FER;SLC25A24;MAPK8;ABL1;ADNP2;HSPA1A;PXN;SLC4A11;PNPT1;RAD52;ETV5;ERMP1;GPX1;ERCC6L2;GSR;TP53;TMEM161A;PRKAA2;PLA2R1;SESN2;VKORC1L1;NFE2L2;HIF1A;FOS
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.7528912610076495,-1.1177504231957742,0.3269230769230769,1.0,1.0,2/5,19.16%,USP50;DDX3X
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),0.616665864054307,1.1174996543173863,0.38095238095238093,0.8334525853286006,1.0,2/7,7.69%,DRD5;DRD3
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.7093247991557018,-1.1173096472150457,0.36666666666666664,1.0,1.0,3/7,15.59%,CAV3;CSRP3;TTN
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.5980356564065419,1.1172049425233828,0.29411764705882354,0.8336090808184464,1.0,3/10,17.52%,ZEB2;TYRP1;OPN3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.42414075803522777,1.1171222999308195,0.2,0.8331799297411411,1.0,19/86,14.87%,GCK;MIDN;PER2;ITPR2;CAPN10;IRS1;KCNC2;DOC2B;RFX6;EFNA5;GLUD1;CELA2A;MCU;ABCC8;IRS2;RAP1A;RAPGEF3;SLC8B1;CDK16
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.6479503791948719,1.1170840541453422,0.3191489361702128,0.832692927987474,1.0,2/6,22.02%,SREBF2;NFE2L2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.5290844398760135,1.1169947547353543,0.3125,0.8323820180356101,1.0,3/20,7.44%,GCK;G6PC3;H6PD
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.614020550503392,-1.1160074691130168,0.36507936507936506,1.0,1.0,4/14,27.36%,PTPRC;TERT;EPCAM;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5340928708042776,-1.1159579820029504,0.3392857142857143,1.0,1.0,6/30,12.09%,HLA-DRB1;SFTPD;VSIG4;PDCD1LG2;CEACAM1;FGL1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5783907035685116,1.11582380653697,0.3333333333333333,0.8353541627005165,1.0,4/13,23.48%,USP44;CDK5RAP2;TPR;PCID2
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.4225960400040655,-1.1155034666210806,0.2702702702702703,1.0,1.0,17/128,12.34%,GPR62;TRIL;LMOD1;PPP1R1B;GFRA3;SOX10;SHISA6;LGI4;LRP4;DAAM2;CTHRC1;ART3;AQP4;MPZ;APOD;NDRG1;NTRK1
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.6667457444793801,1.1152954993996305,0.36585365853658536,0.8364191377927982,1.0,2/8,9.82%,SCUBE1;JAG1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.7509733573404147,-1.1148966533679374,0.2857142857142857,1.0,1.0,2/5,16.39%,P2RY12;VWF
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.4512760330817701,1.1148099528185558,0.2631578947368421,0.8370276075149476,1.0,11/47,20.84%,SLC19A1;DHFR;AADAT;ALDH18A1;IDH2;OGDH;ME3;MTHFR;FPGS;SHMT2;GLUD2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4391438087204017,1.1146884479285004,0.23333333333333334,0.8367027231896458,1.0,7/47,10.81%,TSKU;APOE;PTPRO;WNT3A;DCC;KANK1;PTPN9
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6016591635085217,-1.1145694773121062,0.3064516129032258,1.0,1.0,4/16,19.44%,SOX10;MYRF;EIF2B2;PLP1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.6208897459547454,-1.1145505490797785,0.42105263157894735,1.0,1.0,4/14,6.51%,WNT5A;TRIL;SCIMP;TNFRSF1B
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.6127250909580033,1.114144347505022,0.3877551020408163,0.837717705263894,1.0,5/7,36.72%,KMT2C;KMT2B;KMT2A;SETD4;KMT2D
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.6854503481485943,1.1140976037223602,0.3333333333333333,0.837229857994686,1.0,4/6,28.23%,CDK6;STAT3;DLL1;HES5
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.4162614510907888,-1.1137795922535876,0.22058823529411764,1.0,1.0,17/180,9.51%,CD44;TIMP3;TGFB1;NODAL;ROS1;ALKAL2;SCIMP;HLA-DRB1;GPER1;GPR183;FLT4;ATP6AP1;PTPRC;CEACAM1;P2RY6;HTR2B;ALOX15
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.5836256769754479,-1.1134811213477738,0.2807017543859649,1.0,1.0,1/21,0.24%,AQP3
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.6530054209165003,1.1134224640971158,0.43478260869565216,0.8384057368519154,1.0,1/6,7.91%,GMDS
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.6004417091713321,1.1132049040834109,0.358974358974359,0.8369798354271776,1.0,3/10,17.82%,SMARCAL1;TERF1;DNA2
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.6004417091713321,1.1132049040834109,0.358974358974359,0.8369798354271776,1.0,3/10,17.82%,SMARCAL1;TERF1;DNA2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.6004417091713321,1.1132049040834109,0.358974358974359,0.8369798354271776,1.0,3/10,17.82%,SMARCAL1;TERF1;DNA2
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.4824481088598553,-1.113126665851871,0.2714285714285714,1.0,1.0,20/60,17.20%,SLC28A2;SCTR;CLCA1;IYD;PBLD;CYP3A5;ABCC6;FMO5;ALDOB;SLC22A3;SLC3A1;SLC5A1;ACSM3;HNF1A;SLC6A4;SLC18A2;TFPI;SLC5A9;VIL1;CYP3A4
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.7090830448284737,-1.1131211362113669,0.40350877192982454,1.0,1.0,2/5,20.85%,GPER1;BAIAP3
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5465123825859195,1.113043282903498,0.325,0.836865387194168,1.0,2/14,7.10%,SMYD1;PLCB1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.6794543219327615,-1.112641528758358,0.38461538461538464,1.0,1.0,3/6,10.84%,ANXA1;HLA-A;STOML2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.6685758921261417,-1.112632564560426,0.42592592592592593,1.0,1.0,3/6,22.01%,CEACAM1;IL12A;CRTAM
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.64639269693695,-1.1126276400832336,0.36666666666666664,1.0,1.0,3/7,20.13%,COL1A1;OTOL1;COL4A6
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.5801765616220693,-1.1125547023894502,0.4307692307692308,1.0,1.0,6/14,23.30%,SFRP4;TMEM100;ATOH8;MESP1;SOX9;BTG1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.600521867393957,-1.1124314541812463,0.3389830508474576,1.0,1.0,2/11,6.29%,H1-3;H1-0
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.6914810671767966,1.1124259789960271,0.46511627906976744,0.8382572871385666,1.0,3/6,13.45%,CDK6;BMP4;CDH2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.6391876528591744,1.1122347558494372,0.3939393939393939,0.8381767896097094,1.0,2/5,24.35%,TRIP11;C17ORF75
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.39835597136266976,1.1121512305102252,0.22580645161290322,0.8377262127009079,1.0,10/67,9.74%,RORA;CDH5;AOAH;APOE;METRNL;IFI16;PPARG;PTGIS;LRFN5;SHARPIN
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4097678231966909,1.1120365625616657,0.3333333333333333,0.8374381479608815,1.0,14/62,14.27%,PHLDB2;BAMBI;TGFBR1;SPRED3;GREM1;IL17RD;EPHA3;ZNF703;SPRED2;TWIST1;ADIPOR1;WWTR1;SPRED1;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),0.6848571877130439,1.1120150774703457,0.4,0.8368963780371249,1.0,4/5,31.52%,F12;PLGRKT;ENO1;HPN
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.41256016212795515,1.1118115909756385,0.2413793103448276,0.837024903762743,1.0,25/82,22.03%,BIN1;SAMD4A;APOE;DHFR;RIDA;TRIM71;PCIF1;EIF2AK3;CNOT9;NANOS3;PUS7;RTN2;ABCA7;MALSU1;SYNCRIP;FXR2;PATL2;NTRK2;LSM14A;SAMD4B;LIN28A;EIF4A3;RTN1;LARP1;IGF2BP1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.40909078178587827,1.1117196612586668,0.22727272727272727,0.8366111231373117,1.0,26/92,14.05%,CBS;VCAN;PAPSS2;ANGPT1;CSGALNACT1;CHSY3;CHST6;CHST12;GSTM5;CHSY1;B4GALT2;CHAC1;UST;PRELP;B4GALT3;GSTO2;UGDH;MAT2A;CHST11;ST3GAL3;CSPG5;GSTZ1;CHPF2;DSEL;GSTA4;GSTM2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.34940619959112923,1.1115965949873805,0.17647058823529413,0.8364284727512743,1.0,50/247,14.18%,IRGM;SLC26A3;FOXO1;CPEB1;RORA;IRS1;BRINP3;KCNC2;PID1;HTRA2;PDE3A;CD14;AKR1C3;CX3CR1;DRD5;CAPN2;RORB;SERPINE1;WNT3A;HCN1;PKD2;NCOA3;HMGB1;EPHA3;RAPGEF1;SLIT2;FER;NRIP1;MAPK8;LPL;AANAT;ZNF703;TICAM2;PDE4B;ABL2;ADNP2;TESC;BRINP1;AKAP9;TNIP3;MTR;RET;HCN3;NR4A3;TICAM1;RAP1A;PXN;LBP;RAPGEF3;NFKB1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.45090439753296196,1.1115635223103812,0.3055555555555556,0.8358890577236664,1.0,12/51,18.68%,LLGL1;SNCAIP;RALA;SYT1;RAB3C;RIMS2;RAB10;VAMP8;SYN1;ARFIP1;DNAJC1;RAB3D
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),-0.7372821883252947,-1.1115327198843186,0.37037037037037035,1.0,1.0,2/5,19.93%,TNFRSF11A;CD81
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.33759974682026894,1.1115130734236656,0.0,0.8353849680518163,1.0,230/966,19.54%,ERG;TEAD2;NPAS4;SKAP1;FOXO1;CD38;ESRRG;FANK1;POU3F1;BAMBI;TGFBR1;ZNF496;HDAC3;GALR3;KLF10;MITF;OSR1;MAFB;CREB3L4;LBHD1;RORA;NFATC3;RARB;APOE;POU3F2;PROX1;SIRT1;CDH13;GABPB2;PTOV1;CREB3L2;AUTS2;BCL11B;PID1;SMARCD3;WNT4;SOX12;FSTL3;TET2;HJV;ZNF263;FZD5;LHX2;IFI16;MAML1;PPARG;PYHIN1;ZEB2;ELOF1;RORB;SSBP3;ERBB2;SERPINE1;WNT3A;RFX6;SNX5;MED25;SIRT7;RFPL2;CTBP2;MED17;RIPK2;PKD2;NCOA3;PAX3;NR4A2;PML;ZNF300;HMGB1;GREM1;CDCA4;NCOA2;SEC14L2;PLCB1;ETV1;PCGF5;STAT5B;ATF3;SP1;NRIP1;WWOX;KDM8;SMARCB1;ABL1;TCF20;EIF2AK3;RBL1;PLAGL1;SENP1;FZD1;NAT14;BCLAF3;LRP6;HIVEP3;NR4A1;SP7;MLXIPL;JAG1;ATF1;CEP290;ZSCAN21;RPS6KA3;HCLS1;GRIN1;TESC;RNF10;JUP;H1-10;TWIST1;GDF6;NOTCH4;ZNF462;WBP2NL;ASCL1;TFE3;NPAS3;HES1;TNIP3;SMARCA4;RET;BPTF;RRP1B;NAMPT;MYC;ARID1A;MDFIC;CITED4;CCN1;TRIM44;BICRAL;NSD1;WWTR1;HDAC1;SMARCA2;BMP4;JUNB;NFIC;STING1;NOTCH1;NR4A3;USP16;PIM2;KAT6A;NFIB;PPM1A;BARX2;DLX1;PLSCR1;DPF1;TFCP2;RPS6KA4;MYOCD;RUNX1;NFKB1;ZXDC;NR3C1;MYBL2;SMAD2;SERTAD2;NR2F2;HDAC4;ARRB1;MAP2K7;RYBP;MLLT3;CDK8;RLF;THRB;TP53INP2;CD40;ASXL3;DPF3;NFAT5;BRD4;NR1H3;BCL9L;HSF1;PPARGC1B;CXXC1;FOXF2;PBX1;FZD7;ARID1B;ATM;ATF7IP;F2R;HIVEP1;SKI;GABPA;ZNF609;BCL3;GABPB1;ATAD2B;SHH;ICE1;ATF6;SATB2;FADD;ETV5;ZGLP1;SUPT3H;RBPJ;DPF2;FOXJ2;KAT2B;HDAC5;TCF4;SP3;KLF6;CREB3L3;ELF2;ASXL1;SREBF2;AGO2;KAT6B;NFIX;LPIN2;TBL1X;ACVR2A;DMRT1;FOXP3;YAF2;EGR1;TFDP1;SMAD7;SPIN1;NCK2;EP300;QRICH1;CREB1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.4350174713020824,1.111481290793727,0.25,0.8348586241824817,1.0,13/46,15.28%,GRID2;NLGN1;CNTNAP2;ABL1;SYNDIG1;COL16A1;LIMS1;DLG5;CLSTN2;EPHB2;PTPRD;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4030933637283565,1.1114767961722365,0.34375,0.8342411252000982,1.0,21/95,22.23%,CTDNEP1;PRICKLE1;TOR1B;RANBP17;PML;GBP2;NOL8;TAF3;NXT1;BANP;BMP4;NUTF2;ABCA7;BCL3;MORC3;APPL2;ZBTB7A;PPP1R10;IPO8;NUP214;TPR
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.5698299606680806,1.1112649850964829,0.32608695652173914,0.8343020491314236,1.0,4/9,19.14%,PC;PDZD11;PCCA;MCCC1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.5469841715477183,-1.1111335021554565,0.328125,1.0,1.0,2/20,2.60%,BUB1;TERF2IP
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.5292876868643415,1.110876853534407,0.2777777777777778,0.8345350041951173,1.0,4/18,17.95%,CDH13;FARP2;EPS8;ELMO1
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.44139446934411347,-1.110816275739085,0.21518987341772153,1.0,1.0,29/115,20.50%,NEK2;TOPAZ1;C2ORF78;SLC25A31;SYCP1;BANF2;BCL2L14;DAZL;IQCF1;TAF7L;MEIOC;GALNTL5;BRCA1;TNP1;TEX101;GAPDHS;DNAH3;DEPDC4;TSSK3;GSG1;LDHC;SMC1B;AQP11;TULP2;SPATA17;MAEL;WDR87;GGNBP1;EFCAB10
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.6045460019073071,-1.1107673667932227,0.3709677419354839,1.0,1.0,1/15,2.41%,CXCL13
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),0.6429400386847195,1.1107587471567433,0.4,0.8337509814771535,1.0,5/5,35.72%,MAPRE1;MAPRE3;MAPRE2;GAS2L1;GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),0.6429400386847195,1.1107587471567433,0.4,0.8337509814771535,1.0,5/5,35.72%,MAPRE1;MAPRE3;MAPRE2;GAS2L1;GAS2L2
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.43381307736249763,1.1106248214338292,0.2857142857142857,0.8334457070633606,1.0,18/78,12.78%,CBS;HYKK;AASS;TDO2;HDC;HNMT;SARDH;ALDH7A1;CARNMT1;BCKDK;BCAT1;KYAT1;ECHS1;GLUD1;AADAT;OGDH;GSTZ1;DDAH1
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.6801513231782992,1.1104698403044013,0.4146341463414634,0.832584990498384,1.0,2/7,18.07%,MAP10;KIF4B
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.6801513231782992,1.1104698403044013,0.4146341463414634,0.832584990498384,1.0,2/7,18.07%,MAP10;KIF4B
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.58841553280786,1.1103529411781135,0.3684210526315789,0.8323726397719446,1.0,3/13,19.17%,ZBTB7B;NIPBL;FOXP3
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.5303647181065998,-1.1103476067953137,0.2711864406779661,1.0,1.0,8/24,23.29%,ALOX5;WFS1;CLU;CREB3;HERPUD1;AQP11;UBXN1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.6228264024463863,-1.1101854323264302,0.3684210526315789,1.0,1.0,3/11,17.37%,TGFB1;HLA-F;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5699876217888691,1.1100005715376156,0.3170731707317073,0.8328797916950477,1.0,5/16,16.92%,SAMSN1;PAG1;BANK1;PIBF1;LAPTM5
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.7265888641809636,-1.1098887421836232,0.40816326530612246,1.0,1.0,3/6,13.48%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),0.6492664941410173,1.1098706972136843,0.3488372093023256,0.8327473877386262,1.0,1/6,5.88%,RHCG
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.46096177280777495,1.1097872232673247,0.25,0.8323530016884728,1.0,7/34,15.12%,NLGN1;CEL;SNCA;SYT1;NLGN4X;SNAP91;NLGN3
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5890780427596233,1.1096047036840833,0.4411764705882353,0.8324262091684345,1.0,2/11,2.48%,DGKD;PARD3
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5824601361386731,-1.1095146132845848,0.3728813559322034,1.0,1.0,4/14,27.41%,COPS5;HSPA5;DDRGK1;UFL1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.676228986155053,1.1094934223163373,0.391304347826087,0.832123694437879,1.0,1/6,6.22%,TGFA
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.6159482549730859,1.1094753976620615,0.3333333333333333,0.8315600220409921,1.0,2/11,7.28%,SARDH;CHAC1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.6597601255764275,1.1092606493486676,0.4418604651162791,0.8315654552391483,1.0,3/8,15.37%,MCU;EFS;CASS4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.5850407913302023,1.1086450737805778,0.43902439024390244,0.8325362518435727,1.0,3/11,14.90%,NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5017020273292672,1.1086421024797677,0.325,0.8319848623245949,1.0,2/25,1.94%,SMYD2;SMYD1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.42337636449587124,-1.108168262225299,0.22857142857142856,1.0,1.0,23/130,12.36%,SLC28A2;SLC51A;SLC28A1;TREH;CLCA1;CDHR5;SOX10;DEGS2;ALDOB;NR1I3;TMC4;COL18A1;CA1;ASPN;CEACAM1;ACSL5;ART3;SLC5A1;ABCG2;RBP2;GATA4;HNF1A;PDZK1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.6940110046479868,-1.1080206118259306,0.4576271186440678,1.0,1.0,4/8,23.30%,STK17A;SFRP1;STK17B;BTG1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.3891206651879789,1.1079093675245322,0.27586206896551724,0.8334302462303003,1.0,17/98,14.51%,GCK;LLGL1;PER2;ITPR2;APOE;KCNC2;APBB3;RFX6;DRD3;DRD4;CELA2A;ABCC8;ACHE;UNC13B;RAP1A;RAPGEF3;SLC8B1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.6751249595870645,1.1078636616391373,0.45,0.832890341455833,1.0,3/6,21.05%,ERCC8;LIG4;ZBTB7A
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.5691034431002531,-1.1074608854064816,0.3235294117647059,1.0,1.0,2/16,2.36%,WNT5A;COL1A1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4033737315949212,-1.107295299725239,0.2328767123287671,1.0,1.0,20/306,7.43%,CD44;ENPP2;TBX1;FGF20;TGFB1;DAB2;TERF2IP;NODAL;CDK2AP1;SPDYA;BMP3;MMP9;HLA-DRB1;PINK1;GPER1;FLT4;TEC;CCND1;PTPRC;CARD14
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5237600803138931,-1.1071600704448907,0.31746031746031744,1.0,1.0,5/23,13.90%,STAC;ABCB1;PDZK1;GLRX;COX17
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.694540618888698,1.1066448952517938,0.475,0.8357371590073547,1.0,2/5,15.21%,ITGA4;PLPP3
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.6585761722812697,-1.1066047879113765,0.31746031746031744,1.0,1.0,3/9,17.95%,TICRR;CDC6;TOPBP1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7065947863574322,1.106441797837398,0.40476190476190477,0.835796105872086,1.0,3/5,19.57%,ADIPOR1;ADIPOR2;APPL2
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.6950008093508043,1.1062838649459787,0.42857142857142855,0.8355609663499053,1.0,2/5,18.94%,FRMPD4;CTNNA2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.41542590436074583,-1.1060219369924367,0.273972602739726,1.0,1.0,14/190,3.78%,CD44;INMT;C1QTNF1;TIMP3;LMOD1;COL1A1;DAB2;HCK;COL5A1;HHIP;ADAM33;ANGPTL2;DCN;CYP1B1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.5254491060757205,-1.1059309914632955,0.2638888888888889,1.0,1.0,2/20,5.43%,SCN5A;GPER1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.6122135356254702,-1.1059064244603987,0.3559322033898305,1.0,1.0,1/9,10.84%,STOML2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.6540685616470041,-1.1058044887183085,0.38333333333333336,1.0,1.0,1/8,4.60%,RAB11A
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.536360033224522,1.1057803029802227,0.3235294117647059,0.8363996204902276,1.0,6/18,22.33%,CPEB1;CPSF7;HSF1;ZC3H14;CPSF6;RNF40
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.5913991366548487,1.1057182023643168,0.3055555555555556,0.8358821021618051,1.0,6/12,25.38%,SEC14L2;H6PD;SREBF2;CLCN2;ABCA2;LPCAT3
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.6291143160369234,1.1056781554696824,0.3191489361702128,0.8353653354939903,1.0,1/8,1.32%,KIT
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.4628547307599998,1.105618088091284,0.35,0.8349620677623595,1.0,4/46,7.71%,GCK;NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.4843442036937136,-1.1053586142157954,0.25806451612903225,1.0,1.0,9/45,17.21%,KIF14;RAB11A;CEP55;CHMP3;EML3;NUF2;ANKRD53;PSRC1;BOD1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.6187840677558162,-1.1052336990929492,0.43333333333333335,1.0,1.0,1/11,5.82%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4690658637021419,1.104469788609348,0.3333333333333333,0.8377365985484496,1.0,15/49,21.27%,NGF;ROBO2;LRRC4C;SLIT2;PLXNB1;CHODL;ARHGAP35;CDH2;MAP6;PLXNA4;NTRK2;MARK2;PAK3;PAK2;PTEN
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5850585195833791,-1.1043644719481749,0.3333333333333333,1.0,1.0,5/18,15.59%,ACTC1;ALPK2;HEY2;CSRP3;TTN
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.667071657571453,1.1043490703717318,0.34285714285714286,0.8370633858086871,1.0,3/7,4.44%,HDC;HNMT;CARNMT1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.667071657571453,1.1043490703717318,0.34285714285714286,0.8370633858086871,1.0,3/7,4.44%,HDC;HNMT;CARNMT1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.5796444111940492,1.1042470871333752,0.325,0.8368174481940088,1.0,3/13,14.15%,MFSD2A;STAT5B;PPIB
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.5048230364455866,1.1040344253145356,0.2857142857142857,0.8368751877139577,1.0,14/24,30.63%,PITPNM1;LDLR;PITPNC1;PRELID2;SLC44A4;OSBPL8;NPC2;SCARB1;PRELID3A;PCTP;ABCA3;PITPNB;PITPNA;PRELID3B
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5906689698697154,-1.103934285350829,0.36507936507936506,1.0,1.0,5/15,17.71%,CAV3;SCN5A;KCNQ1;KCNE3;KCNE2
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.6460583632336708,1.103834371229781,0.391304347826087,0.8369328437952942,1.0,2/7,13.91%,DNAJC30;ATPSCKMT
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5338610596793532,1.1038000137992054,0.32,0.8363846496845126,1.0,7/12,24.97%,CBLB;CHMP6;GPRC5A;ZFYVE28;SOCS4;TSG101;CBL
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6914859208689532,-1.1035699613433416,0.3384615384615385,1.0,1.0,2/6,21.23%,SPI1;ABCA12
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6603859935655845,1.10320979816932,0.3611111111111111,0.83755234792534,1.0,5/7,30.13%,GALE;GALT;LRP5;PGM2;TKTL1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.6715377970587577,1.1031928060967855,0.3076923076923077,0.837015699369111,1.0,2/7,14.10%,DRD5;NF1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.4876037995030749,1.1030729496632021,0.35294117647058826,0.8367036972815883,1.0,6/27,11.63%,CDH5;SNCA;KANK4;SLIT2;KANK1;MAPRE1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.5445270131361979,1.1028098752809778,0.3902439024390244,0.8370297237097699,1.0,3/19,7.37%,CCN4;SERPINE1;SLIT2
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.6237552034363929,1.102432720999772,0.38235294117647056,0.8377688505335128,1.0,4/9,12.72%,GCK;SIRT1;LEPR;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.6012954201425539,-1.10239723510556,0.34545454545454546,1.0,1.0,1/12,2.49%,TRIM62
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.597419802824156,1.1011842089766997,0.325,0.8407743268619936,1.0,5/10,13.97%,KIT;MITF;LRMDA;TYRP1;ENPP1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5102282929338954,1.100513333186542,0.3170731707317073,0.8420454533600793,1.0,9/23,26.57%,AUP1;NGLY1;POMT2;RNF185;ZER1;FBXL17;BAG6;ZYG11B;LONP1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.6403493106716271,-1.100389786911871,0.3559322033898305,1.0,1.0,4/9,20.02%,ERI2;RPS21;EXOSC2;EXOSC8
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.43004531274124896,1.1003395029116931,0.2972972972972973,0.8419540300650179,1.0,31/100,21.14%,GRID2;PCDH17;NOVA1;ROBO2;UNC5D;ELAVL3;MAGI2;SLC35F1;KCNIP1;GUCY1A2;RAB3C;BRINP1;CPT1C;RBFOX1;SNAP91;DENND2A;ANK2;PTPRD;ASXL3;NRXN1;SRRM4;EFR3B;FAT3;LSAMP;ADGRB3;CTNNA2;CNTN1;ST8SIA3;PAK3;ADGRL3;MAGEL2
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.7070736658212591,-1.1001924504280056,0.41818181818181815,1.0,1.0,2/7,2.81%,F7;ANGPT2
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.3887125195012986,1.1001551995815093,0.18518518518518517,0.8417289921686071,1.0,20/115,10.17%,FIBIN;MXRA5;MRGPRF;PNPLA3;LAMA4;FGF10;TPM2;EDNRA;PARVA;SLC8A1;ADAMTS12;COL12A1;PPARG;MMP2;TIMP1;PAMR1;PLSCR4;CCN2;PDZRN3;COL16A1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.5913872551496115,1.0998400748460446,0.36585365853658536,0.8420611514617469,1.0,4/11,10.71%,KLRD1;BTN3A2;JAG1;CD8A
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5379162336089951,1.0996449297693796,0.32432432432432434,0.8418586182605664,1.0,5/13,17.35%,RORA;LRP6;OSBPL7;MLC1;GPLD1
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.6979683488876873,1.0995516792038476,0.43137254901960786,0.8415229164591933,1.0,2/5,12.64%,PROX1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.39958561006412924,1.0995427628735137,0.2647058823529412,0.8409209687364042,1.0,17/91,10.90%,IRGM;KIT;FGFR1;FGF18;PROX1;SIRT1;FLT3;ERBB2;SNCA;RALB;PKD2;DIPK2A;TELO2;CCND3;TENM1;PDGFD;PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.6887101145141952,-1.0995201542406807,0.42592592592592593,1.0,1.0,2/7,15.30%,CACTIN;NLRC3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.5307154332569461,-1.099225938409556,0.2777777777777778,1.0,1.0,4/22,7.15%,OR51M1;OR51I2;SYT10;OR52A5
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5528365141905691,-1.0991088790512817,0.3728813559322034,1.0,1.0,3/18,16.48%,RAB34;SFRP1;PDCL
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.5473160302394952,1.0990979127275369,0.3023255813953488,0.841430446247858,1.0,5/15,17.70%,DTNA;ERC2;CHRNA1;FCHSD2;ERC1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5970030145659561,-1.0990327889439508,0.3333333333333333,1.0,1.0,4/13,20.34%,PHKG1;CALM1;PYGL;MGAM
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4194501213298504,1.098995323762135,0.3055555555555556,0.8410513787872894,1.0,28/116,15.28%,SLC17A6;BCHE;POU3F1;PCDH17;PLPPR1;KCNB2;PROX1;UNC5D;RFX6;ETV1;RESP18;KCNIP1;ADGRA1;CFC1;LCORL;LEPR;RAB3C;ELAVL4;ABCC8;RGS7BP;SCGN;IAPP;MAP6;SNAP91;PTPRT;PTPRD;ASXL3;NRXN1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5858022571479914,-1.0989670953147195,0.3333333333333333,1.0,1.0,4/17,15.58%,DCN;CD63;IL12A;PIK3CB
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3921867874450943,1.0989198677406251,0.3125,0.8405952239137395,1.0,27/118,20.89%,NOVA1;PCBP3;ATXN1;BICD1;HNRNPF;RBMS1;RNASET2;HNRNPH1;ELAVL4;HNRNPL;RBFOX2;APOBEC1;WDR74;CELF2;TBRG4;PNPT1;PTBP1;GTF2F2;PAPOLA;SYNCRIP;AGO3;AGO2;LSM8;POLR2F;RBM6;XRN2;NUFIP1
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.7137941313850471,-1.0987328194786594,0.3448275862068966,1.0,1.0,1/5,0.90%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.7137941313850471,-1.0987328194786594,0.3448275862068966,1.0,1.0,1/5,0.90%,WNT5A
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5800167671366756,1.0985558694700281,0.40476190476190477,0.8409930247572633,1.0,4/10,22.84%,KDM7A;KDM3B;JMJD1C;KDM4C
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.5995272462428041,1.0984719282673752,0.4,0.8406150796230473,1.0,2/8,5.13%,SPTBN4;CNTNAP2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4015512101058671,1.0983386417384808,0.21739130434782608,0.8404036643259805,1.0,32/210,13.07%,ATP6V0D2;IRGM;FOXO1;DAPK2;HSPB1;BCL2;HTRA2;FZD5;IFI16;SNX5;HMGB1;MLST8;TRIM8;MAPK8;ABL1;ACER2;DEPP1;MTMR8;DHRSX;ERN1;ABL2;DAPL1;LEPR;RNF152;TRIM65;CASP3;IL10RA;OSBPL7;RASIP1;PIM2;TICAM1;USP36
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.6855956331677469,1.0982631972797348,0.4230769230769231,0.8400266766655718,1.0,2/5,13.05%,PACSIN2;MLC1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.507253114134877,1.098080698097623,0.35714285714285715,0.8399043834411454,1.0,7/22,19.85%,METTL8;PCIF1;PUS7;ZC3H13;TRMT61B;TRMT61A;METTL16
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5193585959216817,-1.0980394078111675,0.3333333333333333,1.0,1.0,3/28,4.99%,ARIH2;HSPA1L;PINK1
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6677108292491403,-1.0979028135579414,0.32727272727272727,1.0,1.0,3/5,30.17%,CALM1;CALM3;RACK1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.669165218547342,1.0978731261307364,0.4166666666666667,0.8400472840960304,1.0,3/6,16.96%,APOE;ABCA1;ABCA7
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.5738986589534079,-1.0977048342708677,0.43859649122807015,1.0,1.0,2/12,12.35%,CENPH;NUF2
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7333278077062015,1.0976118957427519,0.4791666666666667,0.8400686005164633,1.0,1/5,4.65%,SDC4
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.6941555411539437,1.0975739064858097,0.3488372093023256,0.8395716257827067,1.0,2/7,10.15%,SLC38A5;SFXN2
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.5259849642614671,1.0975618252416903,0.3333333333333333,0.8390312799490757,1.0,7/28,16.92%,KPTN;RAB7A;ZFYVE16;GCC2;RNF128;NEDD4;LAPTM5
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.6463803205318309,1.0973392245964493,0.4166666666666667,0.8390092263160681,1.0,3/6,21.21%,KYAT1;ASRGL1;PAH
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.6673860085226769,-1.0972644199013781,0.3684210526315789,1.0,1.0,3/6,7.86%,RAB34;DOCK2;MAPKAPK3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.545515823904996,-1.09705929272177,0.3793103448275862,1.0,1.0,3/15,18.82%,TERF2IP;TERT;TPP1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.6369989816231373,1.0969030464002063,0.3333333333333333,0.8396143976911371,1.0,1/6,4.68%,SLC38A5
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.44222085705284364,-1.0968675069183909,0.2727272727272727,1.0,1.0,20/110,22.36%,MCM2;PSMB9;MCM3;RPA3;NAP1L2;GRWD1;CHAF1A;CDC6;SMARCA5;PSMA7;RBX1;PSMB6;DAXX;PSMA3;RPS27A;PSMA5;SOX9;RPA2;DDB1;ORC6
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.7260628108657852,-1.0968029012213847,0.38181818181818183,1.0,1.0,2/5,11.40%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.7260628108657852,-1.0968029012213847,0.38181818181818183,1.0,1.0,2/5,11.40%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.5155975448759887,1.0962832776856979,0.3541666666666667,0.840713515039679,1.0,4/11,9.88%,NKD1;RORB;DSCAM;CEP290
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),-0.7361624489280119,-1.096266587467259,0.3968253968253968,1.0,1.0,1/5,6.93%,SLFN14
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.5497947754956646,1.0962415489399973,0.2727272727272727,0.8401958658780585,1.0,2/17,7.03%,APOE;SEC14L2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.5972904733756985,1.0958029928151083,0.36363636363636365,0.8408977362262485,1.0,4/10,31.71%,RESF1;MPHOSPH8;APOBEC3H;SETDB1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.37894202392733306,1.0955383927438769,0.24,0.8410499994103661,1.0,45/156,21.10%,TEAD2;ESRRG;HDAC3;HDAC10;RORA;RARB;TFB1M;MAML1;PPARG;RORB;MED17;NR4A2;TEAD4;TAF3;TAF1B;CCN2;NAT14;NR4A1;TAF12;CCNH;NOTCH4;POLR1H;WWTR1;HDAC1;NOTCH1;NR4A3;NR3C2;NR3C1;THRB;NR1H3;TBPL2;NR6A1;GTF2F2;NR2C1;RBPJ;KAT2B;HDAC5;TBL1X;TAF4;POLR2F;ERCC3;MED27;HDAC7;RSF1;NRBF2
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.6612465800848407,-1.095388429937618,0.39622641509433965,1.0,1.0,1/5,2.34%,JCHAIN
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.667008329939155,1.0952937927166357,0.32558139534883723,0.8410924019543327,1.0,4/6,29.99%,ATP10A;ASAP1;DNM2;SH3GLB1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.33939282772415086,1.0952512102133574,0.06666666666666667,0.840674557383957,1.0,89/604,13.08%,IL7R;ADRA1A;EGLN3;SMYD2;NOX4;NGF;KIT;BAMBI;GRK5;TGFBR1;FGF10;VEGFC;FGFR1;DUSP15;KLF10;KSR1;BCL2;BCL6;FGF18;IRS1;POU3F2;PROX1;FRK;ADAMTS1;SIRT1;CDH13;TCIRG1;CDK4;P3H2;AKR1C3;P3H3;FLT3;FGF17;MAGI2;ERBB2;NRG1;WNT3A;SLC25A33;TGFA;CTBP2;PKD2;PML;GREM1;FKTN;HP1BP3;TRIM71;FER;CDK6;STAT5B;TIMP1;CHRNA10;ACER2;SGK1;ZNF703;AKT2;KITLG;KLHL41;TENM1;MLXIPL;JAG1;WNK2;PDGFD;HCLS1;TESC;JUP;ALDH1A2;TIMELESS;HES1;IRS2;BNIPL;NAMPT;PBRM1;MYC;HSPA1A;LIMS1;WWTR1;HDAC1;SMARCA2;RBFOX2;CCDC88A;BMP4;JUNB;ACER3;NOTCH1;NR4A3;DDAH1;PIM2;UBE2A;ARID2
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.6201016112110791,1.0951421026261117,0.36585365853658536,0.8404653350056323,1.0,3/6,24.64%,AGO2;APELA;ACVR1B
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3840455522577324,1.0948505565944695,0.21428571428571427,0.840683122238285,1.0,16/99,10.90%,IRGM;CCNG1;KSR1;SIRT1;SLC8A1;CNPPD1;SLC8A3;SNCA;RALB;TRIB2;TELO2;CCND3;ABL1;LRP6;CCNH;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.6010959748281164,-1.09484586304406,0.34328358208955223,1.0,1.0,2/13,6.29%,TGFB1;H1-0
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.6571196033824738,1.094817629431418,0.4318181818181818,0.8401243096260256,1.0,2/8,4.06%,CHRM2;HRH3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),0.5872738901644324,1.094593479407425,0.391304347826087,0.8402764742500136,1.0,2/9,2.95%,APOB;LIPC
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.554581408780877,-1.0944104891212016,0.373134328358209,1.0,1.0,9/19,33.04%,THBS1;MTUS1;MST1;CCL5;CSF1R;C5;CXCL17;PTK2B;MAPK3
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.5414861800861602,1.0943338999418915,0.34375,0.8404611800342053,1.0,7/18,17.32%,SYT17;SYT3;SYT1;RIMS2;SMURF1;CPNE6;CPNE9
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.5402158157341407,1.0941817893622072,0.3695652173913043,0.8402310207802458,1.0,5/12,19.08%,SEMA5A;EPHA3;ARHGAP35;EPHB2;NRCAM
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.7190288898633305,1.0940932729435842,0.46,0.8399139604160597,1.0,3/6,21.42%,PROX1;NR2F2;BMPR2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4024100449802444,1.0940267006713964,0.21875,0.8395537632499367,1.0,17/96,15.50%,NUP210;HDAC10;SIRT1;P3H3;NUP42;SIRT7;BCL11A;LOXL1;AAAS;PLOD3;SENP1;P3H4;RNF212;ATPSCKMT;HDAC4;ESCO1;LIPT2
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),-0.7016336222127404,-1.0938980149903863,0.37254901960784315,1.0,1.0,1/5,2.84%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.4537055290425611,1.0938818023213928,0.3055555555555556,0.8394009379098204,1.0,12/35,16.61%,RAB27A;F2;APOE;WNT4;ZBTB20;MLXIPL;GRIN1;BMP4;RUNX1;SUCO;CREB3L1;F2R
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.6594289099434533,1.0938174991195162,0.4375,0.8389763238084053,1.0,4/7,30.93%,VCL;IKBKB;ROCK1;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.6201205248522748,1.0936466685574058,0.375,0.838889351435789,1.0,2/14,10.20%,DAPK2;MCU
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.5843424474624976,1.0932931464179874,0.35,0.8393674752509492,1.0,4/13,14.85%,TSKU;SPTBN4;NFIB;EPHB2
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.571660997096529,1.0932692002861688,0.36,0.8388460589862287,1.0,3/10,7.66%,HS3ST5;UST;SULT2A1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.7037676608109558,-1.0932572731619112,0.3469387755102041,1.0,1.0,3/8,13.48%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.6303916583521929,1.0931334327745066,0.43243243243243246,0.8385749145330995,1.0,2/6,12.30%,NPL;NAGK
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7202471034036138,-1.0930019567327816,0.37037037037037035,1.0,1.0,1/5,4.99%,PINK1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.4975069749927063,-1.092953560836342,0.3076923076923077,1.0,1.0,11/45,18.17%,DNAH11;TEKT5;CCDC39;TEKT3;DNHD1;ODAD1;DNAH17;CFAP61;DNAI1;ZBBX;RSPH9
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.6755936872620856,1.0927666808192205,0.4186046511627907,0.8390414146674396,1.0,1/5,10.95%,CTU1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.609219161158031,1.092597626283428,0.3783783783783784,0.8388030159140614,1.0,1/9,1.65%,GLYATL2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.615098117744075,-1.0925478233729786,0.38461538461538464,1.0,1.0,3/12,12.21%,COX6A1;COX6C;COX7C
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.6277089715746217,-1.0924101802667634,0.35,1.0,1.0,2/12,3.38%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.6676051840447723,-1.0920715075615726,0.4909090909090909,1.0,1.0,1/7,3.38%,CAV3
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.4776861608508499,1.0918997525092036,0.3076923076923077,0.8400915618350692,1.0,13/34,27.14%,IWS1;SAFB2;KHDRBS2;SLTM;PAPOLA;KHDRBS1;KHDRBS3;METTL16;PTCD2;SRPK2;RBM39;SON;SF1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.6171626882447614,1.0917841645040716,0.39473684210526316,0.8399825977970187,1.0,2/9,9.44%,RGN;GSTO2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.5426756436955933,-1.091596692437422,0.3620689655172414,1.0,1.0,4/18,9.63%,TRIL;ITGB2;SCIMP;OAS1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.4796843292001428,1.0912658291029376,0.3225806451612903,0.8408901105403882,1.0,10/32,11.17%,KSR1;ADGRG6;APOE;HTR2C;PDE3A;PDE7A;ADCY2;PDE9A;CAP2;RIMS2
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.4665511325851595,1.0912414380482456,0.2413793103448276,0.8403701736070747,1.0,21/67,18.93%,CBS;ALCAM;ACSS2;STX5;ANTXR2;PPARG;ADH4;LDLR;ATF3;LPL;JAG1;STARD4;CHKA;PLSCR1;GSTM2;SC5D;TM7SF2;NIBAN1;ETHE1;SREBF2;NSDHL
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5240487750201863,1.0910019522627319,0.3333333333333333,0.8404124003135401,1.0,11/18,30.74%,RIDA;DXO;LIN28B;YTHDF1;METTL16;RBM24;MEX3D;ROCK1;YTHDF3;FTO;CELF1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.46447510250522245,1.090803363143139,0.21052631578947367,0.840400621149328,1.0,8/27,17.46%,SHLD2;SHLD1;TIMELESS;ARID2;KMT5C;KMT5B;WRAP53;FUS
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.562227927665152,1.0907039311387294,0.3488372093023256,0.8401947831072681,1.0,3/9,18.41%,FARP2;ADGRB3;EPHA8
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4315929284054739,-1.0906261610350638,0.3466666666666667,1.0,1.0,15/115,7.02%,MYH1;NRAP;MYH7;ACTC1;CASQ2;LMOD1;MYH4;ANGPTL2;TMOD4;MYH8;CAV3;MMP9;NID1;KLHL38;CKMT2
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.6578656222403625,1.0905679255836214,0.375,0.8400107795147431,1.0,1/7,2.97%,ZBTB7B
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4407399413049266,-1.0902823129120676,0.25,1.0,1.0,15/81,13.63%,AQP3;WNT5A;TMEM184A;MISP;ESR1;EPN3;ANXA1;TMC4;ITGB6;ANKRD30A;LAMC2;MYO5B;SLC44A3;SERPINB5;CLDN1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.461969403988352,1.0900838759060045,0.37142857142857144,0.8407206930484904,1.0,14/41,22.61%,SDC4;RALB;CEP120;CROCC;STX18;CCDC88A;FSCN1;ARHGAP35;PIP4K2A;MARK4;LRSAM1;CNOT6;ASAP1;ELAPOR1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.623028612045965,1.0897036896810062,0.34285714285714286,0.8411821535152452,1.0,4/8,22.32%,WNK2;WNK3;DLG1;WNK1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.48638689541697927,1.0896527882499827,0.4,0.840793558531018,1.0,10/27,14.31%,APOH;APOE;SLIT2;VASH1;PTPRM;PTPRR;EVL;ADIPOR1;PTPN23;NR2F2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.5369234422444814,1.0895717831319127,0.3333333333333333,0.8403732669975174,1.0,5/13,13.84%,FHDC1;STX6;GCC2;VTI1A;PRMT5
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.6418623496293641,-1.0894401534607618,0.47619047619047616,1.0,1.0,5/10,27.24%,PINK1;IL10RB;ISCU;PARK7;NUPR1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.6784308399128793,1.089034680560126,0.425531914893617,0.8411883400745324,1.0,5/6,20.04%,PSAT1;SRR;PSPH;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3411656106406035,1.0889787840819647,0.10526315789473684,0.8407468967464033,1.0,76/421,14.71%,TEAD2;SKAP1;FOXO1;CD38;ESRRG;FANK1;POU3F1;BAMBI;TGFBR1;ZNF496;MITF;MAFB;LBHD1;RORA;APOE;CREB3L2;SMARCD3;WNT4;LHX2;PPARG;PYHIN1;RORB;WNT3A;RFX6;SNX5;RFPL2;MED17;PAX3;PML;SEC14L2;PLCB1;SP1;KDM8;FZD1;NAT14;LRP6;HIVEP3;MLXIPL;CEP290;TESC;RNF10;GDF6;NOTCH4;WBP2NL;TFE3;NPAS3;HES1;SMARCA4;RET;MYC;ARID1A;MDFIC;TRIM44;BICRAL;NSD1;HDAC1;SMARCA2;BMP4;NOTCH1;USP16;PIM2;KAT6A;NFIB;PPM1A;MYOCD;RUNX1;NFKB1;ZXDC;SMAD2;NR2F2;HDAC4;MAP2K7;RYBP;MLLT3;RLF;TP53INP2
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5897686559640863,1.0889491371073512,0.40476190476190477,0.8402524505792773,1.0,2/11,12.27%,TBCCD1;ARHGAP21
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.5922016599110519,1.0885560779095105,0.38461538461538464,0.8407123244802863,1.0,2/14,3.88%,LLGL1;ESPL1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.48372689975600414,1.0884740096358438,0.3076923076923077,0.8404006137134599,1.0,7/24,14.94%,SELPLG;PID1;PTGIS;FER;PTPRT;NFKB1;ST3GAL6
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.647756059560456,1.0884083423581918,0.47619047619047616,0.8400572314737105,1.0,4/7,19.66%,CDK6;BMP4;CDH2;PAX6
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6527782380838606,1.0883490992408456,0.3793103448275862,0.8395966998627847,1.0,3/7,14.45%,SLC30A10;NFKB1;CA2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5422342571908667,-1.0882832210818842,0.3220338983050847,1.0,1.0,1/25,0.71%,IHO1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.535614190152957,-1.0882509531250582,0.30985915492957744,1.0,1.0,2/18,4.12%,LRPAP1;RIN3
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.6334509271547852,-1.0882411349442174,0.4166666666666667,1.0,1.0,2/9,6.31%,ABCC6;SLCO2A1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.6054819435996127,-1.0880929129802188,0.38596491228070173,1.0,1.0,3/13,17.35%,PHKG1;CALM1;PYGL
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.4655039754134338,-1.088051705100074,0.352112676056338,1.0,1.0,12/54,13.63%,WNT5A;COL1A1;FLG;COL5A1;ALOX12;FLG2;ANXA1;CERS3;HRNR;ALOX12B;TXNIP;CLDN1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.6612117542358902,-1.088039726032603,0.4,1.0,1.0,3/8,15.59%,HTR2B;CSRP3;TTN
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.5591132131909076,-1.087871829145493,0.4098360655737705,1.0,1.0,3/17,17.02%,KIF14;STMN4;STMN1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4844980648045346,-1.0877176321913122,0.3728813559322034,1.0,1.0,6/37,10.74%,TGFB1;DAB2;NODAL;BMP3;TTK;GDF11
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.5176901027348935,-1.0877022590924537,0.3333333333333333,1.0,1.0,3/22,7.34%,ITGB2;CXCL13;PIK3CG
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.4450229239455232,1.0874266256142995,0.23529411764705882,0.8418723043466374,1.0,17/53,26.51%,IRGM;RAB7A;UBXN2A;STING1;TP53INP2;SMURF1;ATG16L2;UBXN2B;ATG2A;ATG12;ATG2B;ELAPOR1;VMP1;AMBRA1;ATG9B;TRAPPC8;ATG7
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.3970863253482645,-1.0871117076118806,0.28,1.0,1.0,23/205,10.97%,CD44;TBX1;TGFB1;NODAL;TRIM5;LPAR1;GFRAL;ALKAL2;SCIMP;HLA-DRB1;GSDME;GPER1;GPR183;FLT4;ATP6AP1;PIK3CG;PTPRC;P2RY6;HTR2B;ALOX15;CAV2;ALOX12B;GATA4
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.6367324032402599,1.086805047199918,0.45714285714285713,0.8429488209836867,1.0,5/8,31.48%,RPS6KA3;RGS14;TCIM;RELA;INO80
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6109692038949015,-1.0866597398736653,0.375,1.0,1.0,3/10,16.42%,COPS5;COPS4;TOR1A
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5279149409930026,1.0866597359059451,0.35555555555555557,0.8427113407510903,1.0,2/19,5.47%,IRGM;PPARG
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6167528563984342,1.0864767673462536,0.36585365853658536,0.8425168407249151,1.0,3/7,33.18%,NR1H3;ITGAV;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.4812001709046485,1.0862375519176264,0.23333333333333334,0.842599669781003,1.0,17/39,19.58%,GRID2;NLGN1;CX3CR1;SYNDIG1;NUMB;SPEN;RGS14;DLG5;CLSTN2;EPHB2;PTPRD;NLGN3;NRXN1;LIG4;FAIM;IL1RAP;SLITRK2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4515769893689825,1.0861910421033127,0.3157894736842105,0.8415305568090982,1.0,11/51,22.23%,NUP210;NUP42;TRIM71;AAAS;TNRC6A;AGO2;RANBP2;POLR2F;IPO8;NUP214;TPR
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4515769893689825,1.0861910421033127,0.3157894736842105,0.8415305568090982,1.0,11/51,22.23%,NUP210;NUP42;TRIM71;AAAS;TNRC6A;AGO2;RANBP2;POLR2F;IPO8;NUP214;TPR
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6241976366781518,1.086070254975171,0.37777777777777777,0.8412735913370714,1.0,2/8,8.05%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4100435607560153,1.0859555289468166,0.20689655172413793,0.8410063503047653,1.0,25/86,22.02%,FOXO1;NOX4;HTRA2;SNCA;PKD2;VRK2;SLC25A24;ABL1;ADNP2;HSPA1A;PIK3CA;SLC4A11;PNPT1;ATM;RAD52;ETV5;ERMP1;GPX1;GSR;TMEM161A;STOX1;PRKAA2;SESN2;VKORC1L1;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.6283029930773113,1.0857427913055173,0.37777777777777777,0.8409518710520331,1.0,4/7,26.10%,PTGIS;FAP;TP53;DLC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.54108731970802,-1.085725707581327,0.3484848484848485,1.0,1.0,3/24,3.38%,PKP2;CTNNA3;CAV3
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.647749038407005,1.0855920271503936,0.4186046511627907,0.8407276651308196,1.0,3/6,29.02%,IKBKB;ROCK1;NUAK1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.6190392651306718,-1.0854282310333208,0.37254901960784315,1.0,1.0,2/10,17.21%,NUF2;BOD1
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6333957418120243,1.0848309405830467,0.37777777777777777,0.8422112225021193,1.0,6/7,36.38%,IMPACT;BCL3;MAP3K4;POLH;YY1;CARD16
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6215897866063236,-1.0848299308485154,0.4576271186440678,1.0,1.0,3/10,8.69%,ANXA1;NLRP12;CEACAM1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4762895188468159,1.0845570139087108,0.358974358974359,0.8418467376761946,1.0,3/33,7.71%,NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.4762895188468159,1.0845570139087108,0.358974358974359,0.8418467376761946,1.0,3/33,7.71%,NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.542061622618109,1.0844156314048732,0.3333333333333333,0.8416860349957827,1.0,7/17,17.32%,SYT17;SYT3;SYT1;RIMS2;SMURF1;CPNE6;CPNE9
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.6243133337081705,1.0843593602835588,0.35294117647058826,0.8412505634954068,1.0,2/7,26.82%,PXN;STAT3
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.6958946837864775,1.084303254794404,0.36363636363636365,0.8408473922285131,1.0,2/6,16.74%,CARD9;IRAK4
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5160716559695218,1.0842950883811253,0.45161290322580644,0.8402969001876679,1.0,10/27,25.38%,APOE;SIRT1;PPARG;ABCA13;NR1H3;ABCA7;LIPG;RXRA;ABCA8;LPCAT3
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.489119499769614,1.0842801071644002,0.2972972972972973,0.8397471560979651,1.0,5/31,13.04%,LAMA3;CD151;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.6093219796158785,1.084026659568696,0.39473684210526316,0.8399681424179566,1.0,3/9,16.96%,APOE;ABCA1;ABCA7
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.7040722968177134,-1.083916397638729,0.4444444444444444,1.0,1.0,4/6,16.83%,SLC14A1;UPK3A;SLC14A2;AQP11
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6978200165040892,1.083874246434051,0.38095238095238093,0.8391241384296153,1.0,1/5,15.10%,DHRS7B
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6978200165040892,1.083874246434051,0.38095238095238093,0.8391241384296153,1.0,1/5,15.10%,DHRS7B
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4970866568453637,1.083625149191923,0.32558139534883723,0.8392398348159903,1.0,4/20,11.27%,BCL2A1;BCL2;DCC;CASP3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.6223360957156361,1.0830725271371664,0.39473684210526316,0.8401758690580798,1.0,2/6,12.72%,NR4A1;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5417196299027285,1.0825458626009998,0.35135135135135137,0.8410791005473263,1.0,6/18,29.84%,CUX1;LRP8;PTPRD;CUL7;IL1RAPL1;DBNL
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.44275117520651486,1.0824782802867636,0.3076923076923077,0.8406890035227738,1.0,11/40,17.20%,TGFBR1;IFT88;ITGA8;PROX1;WNT4;CEP290;BMP4;MYOCD;PYGO1;ARL3;HAS2
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.6987470703956916,-1.0824203394203393,0.4745762711864407,1.0,1.0,1/5,1.59%,TIMP3
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),0.6829845449750491,1.0824089697022243,0.4666666666666667,0.8403414250079102,1.0,2/5,12.64%,BNIPL;NOTCH1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.3884604552250067,-1.0822842440863365,0.3333333333333333,1.0,1.0,98/283,27.26%,MCM2;TICRR;RPL37A;MCM3;PCLAF;RPA3;DONSON;RPL15;GRWD1;RPL3;RPL38;COPS5;BRCA1;RPL35A;RPS9;RPL7A;EEF2;RPL13;RPS27;RPL13A;RPS4X;RPS16;GCNT1;CDC6;RAD1;YARS2;SET;TERT;RPS20;POLE2;RPS8;RPS21;RPS11;ABCF1;MRPL34;PIF1;RPL27A;RPL9;RPL5;TOPBP1;RPL21;RPL34;RPL4;RPL23;RPS14;RMI2;WARS1;RPL18A;RPL32;POLE3;PTMS;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;ALAS2;POLR2B;RPA2;RPL12;ORC6;EEF1A1;RPL11;PTMA;DRG1;RPL35;INHA;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;RPL28;RMI1;RPL19;RECQL4;RPS24;RPL10;RPS25;CREBL2;RPS3A;UPF1;ASMT;BLM;CHEK1;RAD9B;RPS6;RPL8;CDC7;RPLP0;XAB2;RPS12
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.4376819496188311,1.0822740768680175,0.32432432432432434,0.8400887326224746,1.0,26/57,28.02%,MITF;CDK4;CBFB;MED25;MED17;TWIST1;MOV10;TNRC6C;NFKB1;CDK8;MECP2;TNRC6A;AGO3;TP53;MED27;MED16;PTEN;MED13;CDK1;SETX;PPM1D;MED12;TNRC6B;MED23;MED4;RELA
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5202743526927719,1.0821572889943472,0.40540540540540543,0.8398783159354613,1.0,3/18,7.10%,CHRM2;HRH3;PLCB1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5101034339881165,-1.0821426884945833,0.3235294117647059,1.0,1.0,5/30,16.28%,RIN3;VAV3;NEB;RAC1;MSN
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6376605818393398,-1.081967827330999,0.3880597014925373,1.0,1.0,4/8,21.14%,TGFB1;HEY2;HEY1;SOX9
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.4928059144546329,1.0819453309704588,0.325,0.8399196214568878,1.0,3/20,3.38%,EPHX2;RORA;APOE
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.4791223019196096,-1.0819369585229197,0.3125,1.0,1.0,7/38,10.19%,SIRPG;TULP1;SFTPD;CYBA;PTPRC;DOCK2;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4651975200533703,1.0818138679340825,0.34285714285714286,0.8396572545974865,1.0,11/46,19.88%,LAMA4;NOVA1;ALDH1A1;PLCL2;TFE3;NOTCH1;NR1H3;RBPJ;BTN2A2;IP6K1;MAP2K6
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.6024244025565051,1.0818053636991078,0.4,0.839102291328446,1.0,4/9,14.82%,KIT;WHRN;ADGRV1;PDZD7
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.48737652782467666,-1.0817254161410719,0.3387096774193548,1.0,1.0,7/34,11.13%,IRF4;C1QB;C3AR1;HLA-DRB1;CLU;CPB2;C4BPA
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.3813633873025859,-1.0815020312038384,0.24285714285714285,1.0,1.0,50/182,28.37%,COX6A1;ATP6AP1;ATP6V1D;ATP5F1E;COX6C;NDUFA2;ACAA2;NDUFS2;PDHX;NDUFB4;ATP5MC3;VDAC1;COX7C;ATP5PF;TIMM17A;ATP5ME;ATP6V1E1;COX17;NDUFC1;NDUFA1;MRPL34;MRPS22;COX7A2;NNT;CASP7;COX4I1;ISCU;IDH3G;ETFB;ATP5PB;GPX4;COX7A2L;PDK4;ATP5F1A;VDAC3;SLC25A11;NDUFB2;COX6B1;ATP6V1G1;ECH1;SUPV3L1;MDH1;NDUFS6;PHB2;SDHC;COX5A;HCCS;GRPEL1;UQCRH;ATP6V1F
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.6727832418040076,1.0813989115739189,0.4583333333333333,0.8394681546629906,1.0,3/5,32.55%,GSTZ1;IL4I1;HPD
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6443806665742106,-1.0813893294772738,0.43103448275862066,1.0,1.0,4/9,24.48%,B3GNT9;B4GAT1;B3GALT2;B3GNT2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5045112525426952,1.081240081604607,0.3125,0.8394991764850991,1.0,8/21,27.52%,SAMD4A;CNOT9;CNOT4;SAMD4B;CNOT6;TUT7;CNOT2;PAN3
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4140800027864403,1.081224541160217,0.24390243902439024,0.8389663211247045,1.0,11/57,12.52%,MT1G;KIT;SIRT1;CDK4;IFI16;PPARG;PML;BATF2;FARP2;LGALS9;BMP4
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.49890877950758156,-1.08115975257484,0.3125,1.0,1.0,4/34,8.38%,WNT5A;GPR151;ACOX2;ARG2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.48656453175300995,1.081156257253176,0.35,0.8385802628843483,1.0,10/25,28.45%,ESPL1;USP44;ANAPC7;NSMCE2;DLGAP5;CDK5RAP2;RB1;PLK1;ANAPC4;HECW2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.6297838899569599,-1.0810966302033347,0.47368421052631576,1.0,1.0,1/10,2.33%,ITGB2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.5949509001664086,-1.0810611448909229,0.4,1.0,1.0,4/13,28.14%,MPV17L2;RCC1L;UQCC2;COA3
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),-0.6965727750565693,-1.0806973337184118,0.4423076923076923,1.0,1.0,2/5,9.93%,SLC5A2;SLC5A1
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.689471092898125,-1.0806439102301113,0.4262295081967213,1.0,1.0,1/6,2.84%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.6118003816080109,1.0806424467764724,0.4146341463414634,0.8393000253984728,1.0,5/7,32.37%,WNK2;WNK3;WNK1;WNK4;ATP1B3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.44793261612877144,-1.080606463203659,0.30434782608695654,1.0,1.0,13/82,20.75%,FBXO48;PSMB9;KIF14;FBXL7;FBXL13;CCNF;PSMA7;RBX1;PSMB6;FBXO39;PSMA3;FBXL18;PSMA5
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.6627633549563449,-1.0804839472373737,0.43103448275862066,1.0,1.0,2/7,19.15%,GUCY2C;GUCY2F
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.3451840862268831,1.0804819543189346,0.19047619047619047,0.8391539301452907,1.0,49/302,13.04%,COL22A1;COL8A1;LAMA3;PCM1;HIP1;TGFBR1;TPM2;CD151;CCDC88B;SNCAIP;RHOBTB3;P3H2;COL12A1;COL13A1;DSP;SNCA;COL9A2;RHOBTB1;COLGALT1;GREM1;LOXL1;CGNL1;PLK3;COLGALT2;SAMD14;PLOD3;KIF2B;LTBP2;MYO1E;MAP10;KLHL41;COL16A1;SPAST;RND3;P3H4;TPM4;AVIL;MYO1C;GGA1;MAP7D3;PLEC;EVL;KLHL24;CLIP2;CCDC88A;COL9A1;IAPP;ITGB4;DST
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.4098230979815108,1.0803293518258918,0.24324324324324326,0.8390600977546218,1.0,16/47,17.68%,TGFBR1;FGF10;PROX1;WNT4;NRG1;PRKCSH;PKD2;ZBTB1;COBL;NOTCH4;HES1;ARHGAP35;NF1;ARID5B;SHH;FADD
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),-0.6537830746799242,-1.0802483676262664,0.45098039215686275,1.0,1.0,2/8,12.87%,ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),-0.6537830746799242,-1.0802483676262664,0.45098039215686275,1.0,1.0,2/8,12.87%,ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.5120383609543239,1.0798957282727908,0.2972972972972973,0.8396428090139865,1.0,6/21,16.61%,F2;TRPC3;SNCA;GRIN1;CEMIP;F2R
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5018070572909678,-1.079714234413699,0.3939393939393939,1.0,1.0,3/28,10.19%,TENT5B;MEIOC;SLC11A1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),0.6427328572209328,1.079690476449154,0.3902439024390244,0.8391119140214183,1.0,3/5,26.08%,BMP4;SHH;PKD1
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),0.6427328572209328,1.079690476449154,0.3902439024390244,0.8391119140214183,1.0,3/5,26.08%,BMP4;SHH;PKD1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.4190563031598418,1.0795749690115517,0.36363636363636365,0.8388625771819507,1.0,10/53,12.91%,BAMBI;APOE;WNT3A;RALB;RIPK2;ABL1;EPB41;BMP4;STING1;MARK3
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),0.6608029366938132,1.079197777886991,0.4411764705882353,0.8392155336476868,1.0,2/5,26.99%,SLC30A8;SLC30A3
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.6131712612966335,-1.079115812185539,0.40384615384615385,1.0,1.0,2/7,16.11%,JCHAIN;RAC1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.6946351170641893,1.0790815450277347,0.4375,0.8390079473117861,1.0,2/6,14.20%,CEP135;SEPTIN9
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.4967626965812377,1.079005942793094,0.4090909090909091,0.8386555310703854,1.0,4/16,10.09%,PNP;HLA-DRA;NKAP;IL23A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6365714627674316,1.0789655144477632,0.47058823529411764,0.838210363916871,1.0,4/8,21.40%,TICAM2;LBP;NR1H3;NINJ1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5348640184943803,-1.0787621094552204,0.38333333333333336,1.0,1.0,4/26,13.34%,TERF2IP;H1-3;H1-0;CDKN1A
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.43625003614632546,1.078572418955959,0.24242424242424243,0.8385938672098021,1.0,12/51,23.27%,IRGM;RAB7A;UBXN2A;STING1;TP53INP2;ATG16L2;UBXN2B;ATG2A;ATG12;ATG2B;ELAPOR1;VMP1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4628509880869822,1.07840550915348,0.3953488372093023,0.8385424087120309,1.0,9/29,22.65%,CDK14;DHFR;CDK18;CDK16;BRD4;TFDP1;CDK5;HINFP;POLA1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.47280574753373805,-1.07836500857586,0.3333333333333333,1.0,1.0,1/49,0.31%,NEK2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.5937300746730728,1.0782913065302324,0.3541666666666667,0.8383152864190244,1.0,1/7,0.54%,FOXO1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5759010471990972,1.078217525504024,0.3181818181818182,0.8379851629583717,1.0,3/11,8.28%,LIPC;APOE;ABCA1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.41008189584661536,1.0782007008322343,0.28125,0.8374903029168285,1.0,19/104,16.87%,ATP6V0D2;EPM2A;SIRT1;SNX5;MLST8;MAPK8;MTMR8;ERN1;GPSM1;CASP3;CLEC16A;STING1;USP36;PIK3CA;QSOX1;SNX32;EXOC7;NEDD4;SMG1
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),0.6860974364976806,1.077905320544543,0.37735849056603776,0.8377492118828436,1.0,3/6,10.96%,APOH;KLKB1;F11
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6298384014474104,1.077887236301037,0.375,0.8372654749144463,1.0,1/6,4.86%,CX3CR1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.5934059595672477,1.0777742987391716,0.38636363636363635,0.8369781349455955,1.0,5/12,28.35%,SLC25A33;AKT3;LONP1;MEF2A;MPV17
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.6566783996925338,1.0777110982192184,0.475,0.8365985110001274,1.0,2/7,4.25%,RP1L1;NKD1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5620039765319971,1.0775966139961013,0.41025641025641024,0.8364663323855424,1.0,1/12,3.17%,RARB
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.45786626354761445,-1.077500597103629,0.3384615384615385,1.0,1.0,7/89,6.74%,MCM2;POLQ;MEIOB;MCM3;RPA3;MCMDC2;RAD51AP2
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.4551060766775287,1.0772233359817251,0.4,0.83697184136972,1.0,6/24,12.32%,MEGF10;XKR7;RHOBTB1;HMGB1;XKR6;XKR4
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.5723820323856537,1.0770220068270802,0.475,0.8369937256043073,1.0,3/12,14.90%,NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5856936349341335,-1.0769717496827296,0.37037037037037035,1.0,1.0,1/10,4.74%,HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.4994837892329866,1.076553923777388,0.37142857142857144,0.8376522508408987,1.0,7/14,30.16%,PDE9A;NR4A3;EDN1;MEF2A;SLC9A1;ROCK1;IGF1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6591189382151119,-1.0764968640591956,0.45098039215686275,1.0,1.0,3/11,17.96%,STAT1;IFNGR2;CDC37
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5068029172016872,-1.0764498895867984,0.40625,1.0,1.0,5/27,17.02%,KIF14;CFL1;STMN4;VIL1;STMN1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5721807021484921,-1.0763299086464808,0.390625,1.0,1.0,3/12,12.34%,SEMA3F;SEMA3A;NTRK1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5353319316255255,-1.0760201535220368,0.36065573770491804,1.0,1.0,8/23,17.57%,OGN;GPER1;SOD2;APOD;IL12A;CDKN1A;TGFB3;IGFBP3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.7099902678099381,-1.0759896133313465,0.41379310344827586,1.0,1.0,2/5,18.64%,ALOX5;GRN
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.49601419836781,-1.0758752959805105,0.3968253968253968,1.0,1.0,8/32,27.00%,TERF2IP;ESR1;BOD1;TPP1;RPA2;SLF1;MRNIP;FAM47E
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5001383683143465,-1.0758594685441276,0.3448275862068966,1.0,1.0,4/22,22.75%,RPA3;RPS27A;RPA2;PCNA
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3778988693018785,1.0751566111313584,0.2857142857142857,0.8409370004950019,1.0,19/96,13.71%,EGLN3;NGF;HIP1;SIRT1;CFLAR;HTRA2;PPARG;SNCA;HMGB1;CARD9;ANP32B;ACER2;EIF2AK3;SENP1;LCK;MYC;LGALS9;CRADD;CASP8AP2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.4720708704994058,-1.0750766922875261,0.3561643835616438,1.0,1.0,10/48,12.15%,ELOVL2;CYP1B1;PTGR1;ALOX12;ALOX5;PLA2G10;CYP2J2;ALOX15;ALOX12B;ALOX15B
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6797405512264069,1.075028333657417,0.46808510638297873,0.8406998412882399,1.0,2/5,13.74%,SIRT7;PRIMPOL
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4394711994933816,1.0748219309754756,0.3235294117647059,0.8407294572267954,1.0,20/72,21.13%,STX5;CAPN2;ZEB2;SIRT7;STX18;PLXNB1;AKAP9;CLEC16A;PREB;MIEF2;F11R;MYO5A;CAMSAP3;EP300;USP6NL;MARK2;PAK2;PDE4DIP;MTM1;STOX1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.683187365541621,1.074715520349517,0.43243243243243246,0.840380087776713,1.0,3/5,27.90%,SNCA;CDK5;ROCK1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.5480536576913013,1.0746596872761054,0.4489795918367347,0.839980003398131,1.0,1/16,1.32%,KIT
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.44887337634021424,-1.0746170731142868,0.38271604938271603,1.0,1.0,13/57,11.23%,PTPRH;CAPN8;TMEM184A;MS4A8;PTGR1;MISP;SMIM22;ITGB6;ANXA10;LIPH;SLC5A1;PGC;GPR39
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),-0.7024960849782451,-1.0744758714191385,0.43859649122807015,1.0,1.0,2/7,5.70%,CYP26B1;CYP24A1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.5646281088164989,1.074338768043144,0.3783783783783784,0.8402964273630902,1.0,3/9,20.36%,NXF5;RBFOX1;SIDT1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.4930136085180244,1.0737752797495177,0.3333333333333333,0.8414812691953134,1.0,3/22,7.25%,IBA57;HSCB;CIAO3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3927234806186686,1.0736484091791472,0.30303030303030304,0.8412140431156537,1.0,15/61,17.46%,MITF;NOVA1;RBM20;ESRP1;PCBP3;HNRNPF;HNRNPH1;FASTK;HNRNPL;RRP1B;USP36;PCBP4;SRRM4;PTBP1;FUS
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.6394694932141347,1.073504118462629,0.4772727272727273,0.8410492496594403,1.0,2/7,7.69%,DRD5;DRD3
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.5255637722627775,1.0729899546528856,0.32653061224489793,0.8416599823965493,1.0,4/16,8.31%,APOB;SIRT1;PLIN5;LPL
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.4585997466039481,-1.0729206751216172,0.375,1.0,1.0,7/42,12.29%,TBX1;TGFB1;CYP1B1;FLT4;ID1;LOX;HEY2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.5891817046622656,-1.0726697245174037,0.40350877192982454,1.0,1.0,3/14,5.87%,TRIM62;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.5752386895123233,1.0725646097506152,0.358974358974359,0.8421169923865697,1.0,3/12,10.01%,AASS;DNMT1;BCOR
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4541807147823353,-1.072553902854216,0.4084507042253521,1.0,1.0,10/63,13.34%,DISC1;DAB2;LRPAP1;ZFPM1;EFHB;TMC8;MITD1;IFIT1;CTSZ;CDKN1A
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4371711895129376,1.0725096974764672,0.38235294117647056,0.8417583577695159,1.0,19/36,32.48%,DCPS;RIDA;TRIM71;KHSRP;MOV10;YTHDF1;RC3H1;METTL16;TUT7;RBM24;MEX3D;RC3H2;ROCK1;YTHDF3;FTO;TARDBP;CELF1;ZFP36L2;TUT4
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.41744397658758475,1.0724748523459624,0.34210526315789475,0.8413289234596218,1.0,19/83,16.36%,RHOBTB3;TRPM2;RHOBTB1;CRK;MLST8;EPHA3;ABI3;ABL1;EFNA5;ABL2;RND3;EPS8;CCDC88A;FSCN1;ARHGAP35;RAPGEF3;PIK3CA;CORO2B;F11R
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.5598919772430833,-1.0723137138731669,0.4,1.0,1.0,7/17,23.65%,PWP2;RPS27;RPS14;RPS15;RPSA;RPS28;RPS19
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.6180487741022197,-1.071763948339963,0.39655172413793105,1.0,1.0,2/9,19.24%,PPP2R3A;SFRP2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.46889023000272684,-1.071666440551822,0.36363636363636365,1.0,1.0,4/36,3.79%,KCNA5;PKP2;CTNNA3;SCN5A
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5527845961015361,1.071572081902782,0.37142857142857144,0.8429349959494267,1.0,3/13,7.12%,PCM1;SYNE3;CEP120
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.5678839331516241,-1.0714402251029893,0.484375,1.0,1.0,3/11,9.88%,PTGES;OSMR;NLRP3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.572798947168516,1.0714315618147634,0.46153846153846156,0.8428408997500272,1.0,6/9,17.97%,NLGN1;CEL;NLGN4X;NLGN3;NRXN1;NLGN4Y
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.626718334172673,-1.0713437012088294,0.33962264150943394,1.0,1.0,1/7,8.38%,ARG2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.725348116606917,-1.0711556171110561,0.44642857142857145,1.0,1.0,1/5,4.60%,RAB11A
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.3803830795924592,1.0703063919311924,0.30434782608695654,0.8453584097056687,1.0,41/173,15.56%,KIT;HIP1;THEM4;TGFBR1;FGF10;FGFR1;ANGPT1;FGF18;IRS1;NRG2;SIRT1;AKR1C3;CX3CR1;FLT3;FGF17;SEMA5A;ARRB2;MAGI2;ERBB2;NRG1;TGFA;HPSE;DRD3;MYORG;AKT2;KITLG;HCLS1;LCK;BANK1;GRM2;RET;IRS2;GAB1;IAPP;FGFR3;PIK3R5;OTUD3;INSR;PIK3CA;CASS4;RASD2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.5570320483367162,1.070247023716547,0.38636363636363635,0.8450191380663347,1.0,7/13,29.77%,EIF3E;AGO2;EIF4EBP1;LARP1;TPR;FMR1;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.41016910858499284,1.07017042116164,0.2727272727272727,0.8446904577681837,1.0,18/62,16.94%,GPR174;APOE;ABCA1;ABL1;KANK1;MYO9B;ABL2;EPS8;RASIP1;ARHGAP35;ITGA3;ARRB1;RIT2;CCDC125;F11R;BCR;F2R;EPS8L2
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.6340750998745235,1.0701582221186698,0.4791666666666667,0.844189800811653,1.0,2/6,7.41%,NLGN1;PHACTR1
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),0.6782993351470711,1.0701066339245144,0.4878048780487805,0.8437303366236827,1.0,1/5,1.02%,CYP1A2
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.6860561278348802,-1.070041386646295,0.38461538461538464,1.0,1.0,4/7,12.15%,ALOX12;ALOX5;ALOX15;ALOX15B
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.4580604516771489,1.070024863810064,0.35,0.8433423695210346,1.0,5/34,11.36%,ZSCAN4;TELO2;ACD;CTC1;TERF1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.7219501634231117,1.069451205247091,0.46511627906976744,0.8445642572364642,1.0,1/5,9.25%,PLEKHM1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.5714309879327543,-1.0693359456218643,0.36363636363636365,1.0,1.0,4/14,15.29%,PLAAT4;SFRP4;PRKCH;ETV4
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.6438832005976488,1.069232860648923,0.4375,0.8444898206128808,1.0,1/5,0.43%,SKAP1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.39651433850952067,1.068686695665717,0.4,0.8455274183947843,1.0,9/82,10.23%,MCOLN3;TRPC3;SLC8A1;TRPM2;SLC8A3;PKD2;MICU1;MCU;GRIN1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.6159079733139425,1.0683159918965495,0.38636363636363635,0.8459070401036819,1.0,3/7,7.20%,CLC;HMGB1;ZBTB1
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.6480596540461103,1.0683094783517673,0.3469387755102041,0.8454078698374436,1.0,2/6,11.19%,FGF10;HES1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.4785392266614119,-1.068301227997593,0.45614035087719296,1.0,1.0,3/48,8.69%,ENPP2;RAB11A;CEACAM1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.5789485394627754,1.0682589381646654,0.34146341463414637,0.8449295255067104,1.0,2/6,24.90%,PIBF1;PRLR
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.4025505792912344,1.068188273181221,0.28125,0.8445828716948643,1.0,16/102,8.63%,COL22A1;EYA4;APOH;GHRLOS;APOB;ADAMTS6;F2;ARX;PROX1;COL12A1;RGN;SLC7A9;ITGA4;CGNL1;AGXT2;SLC6A16
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.43021824840061745,1.0681864120376128,0.32142857142857145,0.8440452283280536,1.0,4/47,7.10%,PLCH1;NUDT4B;ITPKB;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3680749496590981,-1.068141508557056,0.3068181818181818,1.0,1.0,39/381,12.93%,CD44;CLEC5A;CRLF1;TBX1;WNT5A;FGF20;KIF14;DAB2;HCK;MMP9;ALOX12;IL7;PINK1;BCL2L2;FLT4;BEX3;ANXA1;WFS1;CARD14;RNF213;PRAME;SOD2;PPT1;HTR2B;SMAD6;PTRH2;DNAJA1;IFIT3;LRP2;COPS5;GATA4;VDAC1;CFL1;NTRK1;CDKN2D;ATF5;PRKCH;CLCF1;TAF9B
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.5226571285485578,1.0681200232966495,0.325,0.843052532436907,1.0,4/17,13.89%,PRSS3;MTR;TCN2;ABCC1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.5226571285485578,1.0681200232966495,0.325,0.843052532436907,1.0,4/17,13.89%,PRSS3;MTR;TCN2;ABCC1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.476180327167239,-1.0678301674229271,0.36619718309859156,1.0,1.0,12/37,21.40%,TBX1;ACTC1;MYBPC3;ZFPM1;HTR2B;ALPK2;HEY2;TTN;HEY1;MESP1;SOX9;ENG
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.3995410889357734,-1.0675147777484228,0.32894736842105265,1.0,1.0,40/181,21.35%,CD44;PKP2;HK2;COL5A1;DCN;TGFBI;ALDOB;ENO2;SDC2;DEPDC1;SAP30;GPC3;PGAM1;GLRX;DDIT4;GAPDHS;CHST4;GPR87;BIK;B3GALT6;SLC16A3;TXN;LDHC;XYLT2;STMN1;PYGL;PRPS1;IGFBP3;ARPP19;LCT;TPI1;TPBG;IL13RA1;AURKA;CASP6;CLDN9;ISG20;SOX9;NT5E;PFKFB1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.6351953961376289,1.0673096159353619,0.3488372093023256,0.8446488339793196,1.0,3/5,35.84%,SLC15A4;XIAP;SLC15A2
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.4729624448790509,1.0672956661312287,0.3023255813953488,0.8441828867390877,1.0,5/25,16.36%,PHLDB2;CGNL1;WASF2;TMEFF2;F11R
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4194842521228519,1.0672677541959943,0.21875,0.8437175418870139,1.0,7/63,11.32%,MGAT4C;SLC39A8;DERL3;DPM3;UBE2J1;GAL3ST1;ALG12
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.6236271549769092,1.0669911396211222,0.4444444444444444,0.8439955135046279,1.0,3/8,12.64%,BIN1;HES1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.6115147573038302,-1.0669068555054444,0.3559322033898305,1.0,1.0,3/8,18.58%,HCK;LCP1;KIF9
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.5387335571157237,1.066569089169945,0.3404255319148936,0.8447946972981875,1.0,2/8,16.45%,NEU4;NEU3
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.6158269508265743,1.0665309628553892,0.41304347826086957,0.8443298583970795,1.0,6/9,32.01%,ABL1;ABL2;SZT2;SIRT4;SLAMF8;ECSIT
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4789645155515666,1.0664839063003138,0.4,0.8439157052974965,1.0,11/27,24.91%,CD14;TICAM2;TNIP3;TANK;TICAM1;CD40;FADD;UBE2D2;TRAF3;UBE2D3;IKBKB
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.583450788057738,1.0664565698309125,0.4,0.8434219993020491,1.0,1/11,0.78%,SMYD2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6079893081394476,1.066268833946031,0.44,0.8433691217774228,1.0,2/9,7.10%,SOAT1;PLCB1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.4391737126922575,1.0662552482680157,0.2631578947368421,0.8428664049682291,1.0,1/45,0.05%,ATP6V0D2
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.6045230982818535,-1.0660143899982095,0.4166666666666667,1.0,1.0,1/7,0.48%,DBH
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),-0.635107870299755,-1.0659660469265835,0.47540983606557374,1.0,1.0,4/7,28.40%,CYP21A2;HSD11B2;HSD11B1;YWHAH
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.689394961066621,1.0659309155230396,0.4888888888888889,0.8432236047120013,1.0,3/5,29.12%,AGBL4;AGBL1;AGBL2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5668498681110458,1.0658993241842656,0.42857142857142855,0.8427515828583999,1.0,5/14,26.82%,STAT5B;PXN;LYN;PRLR;STAT3
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.6653463692491124,-1.0658435907928479,0.48214285714285715,1.0,1.0,2/5,11.09%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.6653463692491124,-1.0658435907928479,0.48214285714285715,1.0,1.0,2/5,11.09%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5490396685254524,-1.0658349344683447,0.35714285714285715,1.0,1.0,6/16,14.34%,ESR1;GPER1;H2AZ1;FAM210B;SSTR1;SFRP1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.4428079860725228,1.065786798397122,0.3,0.8424697621898254,1.0,12/55,20.19%,AUP1;IFT88;RAB7A;DYNC1I2;STING1;KLHL3;ARL13B;ATM;LGALS8;ATG2A;CALCOCO2;RETREG1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.4382861369839899,-1.0656437680122852,0.3870967741935484,1.0,1.0,13/69,17.33%,DENND1C;IRF1;DTX2;FOXO4;LRP10;MMP25;ST6GALNAC2;SYTL1;CXCL16;DEF6;HLA-F;VASP;NFKB2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.39616344648258167,1.0652553125350146,0.3333333333333333,0.8433849759564557,1.0,10/112,7.71%,GCK;HSPB1;NUP210;CDH5;SIRT1;NUP42;PML;DSCAM;FER;AAAS
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.5472617154512058,1.0649946362755993,0.40476190476190477,0.8436711654561796,1.0,5/14,19.60%,CD14;TICAM2;TICAM1;ITPK1;TRPM7
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.5906878143567786,-1.064968771125547,0.423728813559322,1.0,1.0,2/11,11.56%,POU2F3;REST
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.49602147296419086,-1.0648315637076315,0.3709677419354839,1.0,1.0,8/38,15.59%,ERN2;H1-3;BANF2;GPER1;H1-0;INCENP;SET;TTN
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.4794611145191928,-1.0644438083547483,0.3770491803278688,1.0,1.0,5/33,12.15%,WNT5A;IL7;OAS1;TLR2;ALOX15B
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.49057280947586424,-1.0642424369578602,0.375,1.0,1.0,9/40,17.95%,TICRR;DTL;DONSON;ABRAXAS1;BRCA1;CDKN1A;CDC6;NOP53;TOPBP1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3695331549557859,1.064011680795756,0.2692307692307692,0.845670019849165,1.0,15/103,8.36%,ADRA1A;GPR33;ADRA1B;GPR174;EDNRA;TRPC3;HTR2C;SLC8A1;CYSLTR1;CX3CR1;JPH1;HMGB1;DRD3;CHRNA10;ABL1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.638289605758392,1.0639768537006602,0.4318181818181818,0.8452875206699928,1.0,4/7,35.84%,ZDHHC5;SLC15A4;XIAP;SLC15A2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.5704143694087527,1.0639299804820925,0.4444444444444444,0.8448856177764887,1.0,4/11,17.37%,NR4A2;LRP6;RYK;SHH
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.561058423259245,1.0637766645714248,0.48,0.8447227980611863,1.0,2/15,11.82%,INTS11;INTS9
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.3787183444481462,-1.0633174871118838,0.3333333333333333,1.0,1.0,109/355,26.99%,NOTUM;APOL1;SFTPA1;ITIH2;RPL37A;PIGH;UBE2L6;SFTPD;PAPPA2;WFS1;GNMT;SDC2;RPL15;SERPIND1;PRSS23;PAPPA;PHEX;RPL3;RPL38;STOML2;COPS5;RPL35A;PLG;GPC3;RPS9;LOX;CP;RPL7A;RPL13;RPS27;SERPINA10;RPL13A;PCMT1;RPS4X;RPS16;RABGGTB;YARS2;CSF2RA;USP6;RPS20;RABGGTA;MFGE8;RPS8;PLAT;RPS21;RPS11;F5;FN1;ABCF1;MRPL34;RPL27A;IGFBP3;RPL9;RPL5;ALB;RPL21;RPL34;RPL4;RPL23;RPS14;WARS1;RPL18A;RPL32;LAMB2;RPL36;RPS27A;RPL18;UBE2M;RPL29;RPS7;CHGB;RPS15;RPSA;TGOLN2;RPL41;RPS28;RPLP1;RPL12;EEF1A1;RPL11;SPCS2;RPL35;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;YES1;FBXO2;RPL28;RPL19;SFTPA2;RPS24;RPL10;RPS25;GGCX;PARP4;RPS3A;SCG3;ASMT;FUCA2;UBL5;RPS6;SPCS1;RPL8;NAGPA;AMBN;RPLP0
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.6072081601038308,-1.0632579366476786,0.4642857142857143,1.0,1.0,4/10,17.66%,PRDX4;GPX3;PXDN;PRDX1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.3934873913092682,1.063257912739266,0.3125,0.8455039180174491,1.0,21/91,16.12%,GALNT12;GALNT7;MUC13;POGLUT3;TMTC2;DPM3;TET2;GALNT1;FKTN;POGLUT2;PLOD3;FKRP;POFUT1;ST3GAL3;GALNT13;TMTC3;MUC7;XXYLT1;B3GALNT2;GALNT8;POMT2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.4269124872740324,1.0628828451162287,0.2222222222222222,0.8457578733451109,1.0,2/36,2.73%,PCM1;IFT88
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5946580049496796,-1.0627740924308648,0.43103448275862066,1.0,1.0,7/11,26.09%,SCIMP;OAS1;SCARA3;COLEC12;CASP8;TNIP2;RFTN1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.5108707969125046,-1.0627725634399818,0.4142857142857143,1.0,1.0,3/23,16.55%,F7;ZNF580;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.6420650856657777,1.0627493415666667,0.4418604651162791,0.8455055165946385,1.0,4/6,14.34%,AUTS2;SMARCB1;PIH1D1;ARRB1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5049369386743204,1.062623040210972,0.43243243243243246,0.8452633969300459,1.0,4/18,17.46%,PAPSS2;SULT2A1;ENPP1;SLC35B2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5382838793186054,-1.0625096071529987,0.453125,1.0,1.0,4/22,8.47%,DTL;RAB11A;CCND1;CDC25A
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.6240274318148942,1.0619137547119366,0.38,0.8466366998746137,1.0,2/7,17.35%,PLIN5;GPLD1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.41111445576536165,1.0617846383065266,0.36363636363636365,0.8463347537317633,1.0,5/45,9.68%,TRIM67;REEP6;FER;EFNA5;ADGRE2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.49523207899221405,-1.0617377497633573,0.36764705882352944,1.0,1.0,6/43,6.76%,MYH7;STAC;CASQ2;MYH8;SCN5A;MYBPC3
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.6863373063719448,-1.0616778127232278,0.4807692307692308,1.0,1.0,2/5,18.64%,CYBA;GRN
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.4977312135599863,-1.0609568759497259,0.4,1.0,1.0,5/35,13.75%,ARIH2;HSPA1L;PINK1;ATP5IF1;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.561532907139753,-1.0608270361578083,0.39655172413793105,1.0,1.0,7/12,28.54%,ANXA1;NLRP3;CD86;IL18;CD80;TNFSF4;RARA
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.6271185959232093,1.0606746439113526,0.4186046511627907,0.8485467891881019,1.0,3/6,33.22%,ETF1;PEX14;TRMT112
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.39157171486832476,1.0605035588243454,0.34285714285714286,0.8485110349007146,1.0,26/98,20.42%,TGFBR1;PER2;PRICKLE1;HDAC3;ANGPT1;SPOPL;COMMD1;ARRB2;SIRT7;RIPK2;CRY1;DCUN1D1;HSPA1A;N4BP1;GNL3L;ARRB1;FOXF2;MINAR1;LAPTM5;UBE2L3;MALT1;HSPBP1;FBXO4;SMAD7;U2AF2;SPRTN
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5891388561771816,1.0602304612764268,0.391304347826087,0.84870264569618,1.0,5/13,18.77%,FGFR1;CELF4;STOX2;RAI2;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5032459629294255,-1.0601109928880479,0.4032258064516129,1.0,1.0,4/20,4.90%,TGFB1;DAB2;NODAL;PBLD
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5097617083844056,1.0595516992070884,0.35555555555555557,0.8500990285115226,1.0,10/22,24.97%,PPARG;CBLB;CHMP6;GPRC5A;EPHB2;ZFYVE28;SOCS4;CALCR;TSG101;CBL
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.4164853619839429,1.0595324817264156,0.2727272727272727,0.8495984237921954,1.0,14/79,13.02%,IRGM;FOXO1;EPM2A;SIRT1;HMGB1;PLK3;TRIM8;DHRSX;GPSM1;RNF152;TRIM65;STING1;PIM2;TICAM1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.659889105874481,1.0594937243788574,0.38461538461538464,0.8491477779362343,1.0,2/5,16.13%,SIRT1;MTHFR
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5692061822944976,-1.0585556263467797,0.3508771929824561,1.0,1.0,2/14,2.54%,TGFB1;HCK
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.6969779165757242,-1.0583689931209888,0.4166666666666667,1.0,1.0,2/5,12.29%,ZFPM1;HEY2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.6345936902282814,-1.0581721187686928,0.5,1.0,1.0,2/9,4.86%,TGFB1;ESR1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.6588675267869588,1.0580966546371835,0.4791666666666667,0.852217144083846,1.0,3/6,29.97%,DDAH1;ENO1;CD34
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.3862551837769347,1.0580014035157317,0.32142857142857145,0.8518934867962831,1.0,22/112,16.57%,GPRIN3;TTC29;NLGN1;APOE;GPRIN1;NRTN;CNTNAP2;PKD2;HMGB1;PTPRM;SAMD14;TTC17;MNS1;RAB35;FAM161B;BICDL1;CDK16;RYK;PPP1R9A;FRY;NEDD4;MARK4
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.45073702816845285,1.0579336070990086,0.35,0.8516096232443765,1.0,15/46,20.35%,PER2;SPOPL;ARRB2;SIRT7;CRY1;ABL1;HSPA1A;N4BP1;GNL3L;ARRB1;MINAR1;SMAD7;MARCHF7;LIMK1;U2AF2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.48261203784986206,-1.057904416954746,0.4,1.0,1.0,9/33,16.55%,DUOX1;ALOX5;GP1BA;ANXA1;ACTG1;PLAU;CLDN1;VTN;VIL1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.42301421048203924,-1.0578591433752342,0.373134328358209,1.0,1.0,6/85,7.34%,ENPP2;WNT5A;MMP9;RAB11A;FLT4;PIK3CG
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.4758406060410687,1.0577330994367828,0.35555555555555557,0.8514835535672423,1.0,9/26,32.21%,SGIP1;SNAP91;FCHSD2;DNAJC6;FNBP1L;DLL1;ITSN2;ITSN1;LMBRD1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5562025583434858,-1.0576093176288592,0.38095238095238093,1.0,1.0,2/13,11.90%,SP100;APOD
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.6227351058678617,1.0572081623179905,0.4878048780487805,0.8522819847421198,1.0,1/5,3.85%,PDE10A
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.5188668769604029,1.056855855227813,0.375,0.8527747627452071,1.0,4/13,19.16%,NGF;CASP3;NTRK2;SOS1
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.6826657719983044,-1.0567749797786772,0.42857142857142855,1.0,1.0,1/6,5.53%,BLK
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.610405924586008,-1.0566892971928936,0.38461538461538464,1.0,1.0,4/8,26.80%,HTR2B;PTGER3;EDNRB;HTR1D
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5866611165096466,-1.05667169734721,0.47540983606557374,1.0,1.0,7/13,21.04%,CLDN5;CLDN6;CLDN1;CLDN18;CLDN2;CLDN20;CLDN9
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.6250189993435931,-1.0565596315677612,0.47761194029850745,1.0,1.0,1/8,2.26%,CDHR5
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.39318052772875833,1.0564670546285915,0.3076923076923077,0.8531785288919989,1.0,13/75,7.97%,APOH;TGFBR1;VEGFC;ANGPT1;FGF18;APOE;PROX1;SIRT1;CDH13;SEMA5A;ECM1;VASH1;PTPRM
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5624583777699805,1.0564577109452786,0.42857142857142855,0.8526690101752117,1.0,3/15,17.69%,TRA2A;CELF4;SF3B4
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.40989822287773603,1.0564430563931715,0.3235294117647059,0.8522287948914684,1.0,23/68,23.48%,TBC1D10A;IFT88;TBC1D16;TBC1D12;TRAPPC12;SDCCAG8;ALMS1;TBC1D22B;STX18;IFT140;MTMR3;SGSM3;TBC1D2;TBC1D8;RAB5A;DCDC2;USP6NL;TBC1D5;NPRL2;RABEP2;SENP6;EVI5;TSG101
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.6722313762135845,-1.0562404149813067,0.46875,1.0,1.0,1/5,12.57%,PRKCH
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.6470628497987083,-1.0558773547015396,0.45,1.0,1.0,2/8,7.23%,SLC7A7;SLC3A1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.6401509751593729,-1.0555666974712243,0.4032258064516129,1.0,1.0,4/8,16.65%,GPR183;ZFPM1;RORC;LEF1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6871765826540359,1.055480939853438,0.42857142857142855,0.853994674526907,1.0,2/5,24.68%,PGAP1;PIGU
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.5457356889899565,-1.0553361918248592,0.43103448275862066,1.0,1.0,3/16,8.69%,TGFB1;FLT4;CEACAM1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.3674198944409998,1.0550529663591528,0.27586206896551724,0.8548668715861301,1.0,24/124,13.60%,MATN1;FIBIN;MXRA5;MRGPRF;LAMA4;EMP1;FGF18;EDNRA;CREB3L2;ADAMTS12;COL12A1;SEMA5A;MMP2;PAMR1;LTBP2;OLFML2B;PDZRN3;COL16A1;CCDC80;IL10RA;COL9A1;CHODL;SDC3;EFS
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),0.6968815068996276,1.0549807982286932,0.4594594594594595,0.8545337940372568,1.0,2/5,17.63%,DRD3;PPP1R9B
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.605222868031199,1.0548831240731775,0.46511627906976744,0.8541913521023795,1.0,3/7,15.87%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3522874790566264,1.0547716685631574,0.36666666666666664,0.85392756295822,1.0,51/151,25.67%,TGFBR1;MAPKAPK2;SBK1;VRK2;MAPK8;MAST1;LATS1;EIF2AK3;SGK1;MAST2;AKT2;STK32C;MAP3K10;ERN1;CLSPN;RPS6KA3;PKN2;MAP3K13;MARK3;RPS6KA4;RPS6KA2;MAST4;RPS6KA6;CAMK1G;SGK2;ATM;MARK1;SMG1;MAPK12;DYRK3;CSNK1G1;MORC3;PRKCE;MARK2;PAK2;ATR;CDK5;CSNK1G3;PNCK;WNK1;DYRK1A;SRPK2;CDK1;CSNK1G2;GAS6;AKT3;IKBKB;RPS6KB1;STK38;STK39;DYRK2
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.3463626335462141,1.0547272036759108,0.2222222222222222,0.8535175320387142,1.0,63/298,20.69%,RAB20;TBC1D10A;RAB31;PRICKLE1;NLGN1;RANBP17;STX5;TBC1D16;NUP42;TBC1D12;SCFD2;RAB28;RAB7A;STX8;STX6;SYNDIG1;NXT1;ANKLE1;LTBP2;AKT2;TICAM2;TBC1D22B;ACD;TMED3;RPGR;MYO1C;GGA1;TRAK2;PREB;TBC1D4;ARL5A;WLS;XPO7;SNX9;COG7;ARFRP1;EVI5L;SMURF1;NUTF2;RTN2;HERC2;AP4S1;XPO5;VPS26C;LAPTM5;SGSM3;TBC1D2;ARFIP1;TBCK;TBC1D8;TECPR2;CLIP3;RAB5A;CAMSAP3;GRTP1;TRARG1;USP6NL;APPL2;TBC1D8B;TBC1D5;RASSF9;XPO1;SNF8
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3961748544960675,1.0546727080379867,0.3225806451612903,0.8531666091407512,1.0,26/76,23.36%,NLGN1;AUTS2;DEF8;CEP120;RALA;PLEKHM1;CROCC;TENM1;AVIL;EPS8;WASF2;CCDC88A;FSCN1;ARHGAP35;PIK3CA;OCLN;DOCK11;MARK4;EPS8L2;CDC42EP5;CARMIL2;MIEN1;TENM2;PLPPR5;GPM6A;PALM
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.37535925900790607,1.0545328352627699,0.26666666666666666,0.8530601095139003,1.0,12/77,8.36%,HSPB1;FGFR1;ANGPT1;ANXA3;FGF18;PROX1;RIN2;SIRT1;SEMA5A;HMGB1;SP1;ABL1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.6990776974059532,-1.0544604841665728,0.4426229508196721,1.0,1.0,3/5,27.63%,MAF;BFSP1;WNT5B
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.42925783292427977,1.054373049545854,0.40625,0.8529049777457381,1.0,14/49,22.61%,IRGM;EPM2A;SIRT1;RALB;GPSM1;STING1;PIP4K2A;LRSAM1;BNIP3L;CALCOCO2;PRKAA2;SESN2;LARP1;ELAPOR1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.4142355689403151,1.054158467545795,0.36363636363636365,0.8529352346004841,1.0,14/55,14.72%,GCK;IRS1;ACSM2A;PPARG;RFX6;CRY1;CYB5R4;MLXIPL;LEPR;MCU;ADIPOR1;ADIPOR2;SLC8B1;INSR
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.6665971491745336,-1.0541057019530264,0.46774193548387094,1.0,1.0,1/6,0.90%,WNT5A
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.6502222986967224,-1.0537323564270127,0.4642857142857143,1.0,1.0,2/7,18.49%,WAS;NTN1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.48136176145299825,1.0534553385898116,0.3225806451612903,0.8541928120166336,1.0,7/33,11.46%,GCK;CAPN10;DOC2B;RFX6;GLUD1;MCU;IRS2
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.6414402127574991,1.0534224521318731,0.47368421052631576,0.8537549518591834,1.0,2/5,15.34%,DUT;DTYMK
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6371031387845447,1.0533504425363904,0.5476190476190477,0.8534246562108836,1.0,3/5,26.03%,HMGB1;SLC15A4;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.6629844723319821,-1.0530271304930128,0.43859649122807015,1.0,1.0,3/5,14.34%,TIMP3;THBS1;SFRP1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6466559233772327,-1.0530057226319731,0.515625,1.0,1.0,3/8,20.47%,TMSB10;SCIN;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.6159817750150567,1.0527650091907255,0.42105263157894735,0.8542809376590508,1.0,3/7,19.06%,ATM;RAD50;SMG6
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6089672088402562,-1.0526382710656044,0.39655172413793105,1.0,1.0,2/10,3.38%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.4371880249999235,1.0526201656737344,0.3235294117647059,0.8541450576498686,1.0,19/65,17.96%,LAMB4;USH2A;ITGA8;PROX1;PARVA;NTN4;SRGAP2;ITGA4;FER;NTNG2;RILPL1;PXN;ANTXR1;ARL13B;SIPA1L3;TMEFF2;SRCIN1;FERMT3;TYRO3
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4720648083331439,-1.0523916862588771,0.3880597014925373,1.0,1.0,4/44,2.36%,TBX1;WNT5A;TGFB1;COL1A1
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.6450682457368576,1.0523754023573622,0.4634146341463415,0.8542812414919684,1.0,3/5,27.48%,ABCG8;LPCAT3;CYP8B1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.6653221871381495,-1.0523679856513115,0.44285714285714284,1.0,1.0,6/7,30.25%,SFTPD;TAFA4;EDNRB;CCL5;AZU1;CXCL17
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6074843021705683,-1.0519957106450923,0.45614035087719296,1.0,1.0,2/9,5.07%,PINK1;ALOX5
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.6118752152799464,-1.0519786846821984,0.4,1.0,1.0,3/10,12.14%,SLC5A2;SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.5618165368868009,1.0516727996041,0.5161290322580645,0.85579528494845,1.0,2/10,6.83%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5776913294963982,1.0512790541619008,0.46153846153846156,0.8563085053747251,1.0,3/9,15.67%,SNCAIP;HSPA1A;SACS
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.3354556094287545,1.0510041457629353,0.3076923076923077,0.8565884696296993,1.0,53/290,18.54%,RAB20;FGF10;TBC1D10A;GRID2;RAB31;ANGPT1;SEPTIN10;CNTLN;ABHD17A;STX5;TBC1D16;CNTNAP2;TBC1D12;SCFD2;RAB28;BICD1;STX8;STX6;SYNDIG1;TICAM2;FLNA;TBC1D22B;RAP2A;CROCC;ACD;TMED3;RPGR;GGA1;CEP250;TBC1D4;ARL5A;WLS;SNX9;COG7;SEPTIN9;SEPTIN8;ANK2;ARFRP1;EVI5L;SMURF1;EMP2;OCLN;HERC2;VPS26C;LAPTM5;SGSM3;TBC1D2;ARFIP1;TBCK;NIPBL;TBC1D8;CEP68;RAB5A
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.3831283671227541,1.050909059936101,0.2727272727272727,0.8563837705853344,1.0,16/99,11.20%,CYP7B1;EPHX2;ABCA9;ALDH1A1;ATXN1;ABCA6;PEX13;ISOC1;ABCA1;SLC27A2;FADS1;ABCD3;ABCD2;LCK;ACSL1;IDH2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5140682454405485,1.0506689716646112,0.38235294117647056,0.8563632513537224,1.0,6/19,20.92%,BIN1;APOE;RTN2;ABCA7;NTRK2;RTN1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.5392668034292543,-1.0505894784140108,0.42105263157894735,1.0,1.0,6/17,33.04%,THBS1;BST1;CCL5;CSF1R;CXCL17;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.35995606135935776,1.0504497461873596,0.3333333333333333,0.8563330834536113,1.0,32/118,21.65%,PHLDB2;MITF;MAGI2;SERPINE1;SRGAP2;SLIT2;TIMP1;PTPRR;KANK1;RAP2A;JAG1;NAV3;EVL;ADAM15;ADIPOR1;DACH1;ARID2;PTPRT;NF1;PTPN23;DLG5;NEXMIF;TMEFF2;SHH;RECK;SMAD7;MIA3;VCL;PTPRJ;PTEN;SCAI;BMPR1A
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.38242304698960766,1.0501034693699398,0.2777777777777778,0.8567380221739528,1.0,34/108,24.90%,ALCAM;TBC1D16;SLC19A1;TNFRSF19;KCNIP3;MPDZ;PLXNB1;CAP2;RBFOX2;FARP1;DDAH1;PTPRF;SDC3;KIAA1549L;FGFR3;SRRM3;DOCK1;ANTXR1;FOXF2;FAM43B;ZNRF3;NAV2;TYRO3;DZIP1;CHST3;GNA11;PTPN21;FAT1;SHC3;AGAP1;KAZN;NLGN2;FMNL2;EPN2
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.4975501881343112,1.0499757986832183,0.38461538461538464,0.8565627258931768,1.0,2/15,3.25%,MIDN;IRS1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.6144118056175245,1.0497067973256857,0.41304347826086957,0.8567063015794347,1.0,5/9,29.16%,TARBP2;AGO3;AGO2;ADAR;CLP1
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.7021500136674046,-1.0496382786187908,0.4745762711864407,1.0,1.0,1/6,6.59%,OLFM4
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6758042460149409,1.0494792567338125,0.5192307692307693,0.856675995555954,1.0,3/5,17.03%,SETMAR;ASH1L;SETD2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.3718423771955278,1.0494575267527473,0.25,0.8561538731503155,1.0,12/89,10.47%,NPAS4;GPC4;FGFR1;DUSP15;SPTBN4;DNAJB5;RFX6;KCNIP1;CFC1;PDZRN3;SPRED2;ABCC8
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.5864808071674502,1.0494289433426376,0.3333333333333333,0.8557191424602261,1.0,2/7,11.51%,APOE;STARD4
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.6025219675442196,1.0494112344977198,0.4864864864864865,0.8552560540895181,1.0,1/8,0.84%,AUP1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.620291467838095,1.0493731236545703,0.4883720930232558,0.8547935395581789,1.0,1/5,8.72%,KANK1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.48835679469963195,1.0492989448547092,0.3902439024390244,0.8544181805870354,1.0,4/27,9.12%,GPC4;GPC6;STX8;GPC5
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3314945592352897,1.0492443306336485,0.25,0.854004828743152,1.0,89/384,19.21%,FOXO1;CD38;PER2;PRICKLE1;HDAC3;HDAC10;KLF10;TWIST2;TLE2;TSHZ3;BCL6;PROX1;SIRT1;PRDM5;ATXN1;MTERF3;PHC2;SFMBT1;WNT4;GATAD2A;IFI16;PPARG;RORB;NRG1;CTBP2;PML;CRY1;ZBTB4;HIC2;HEXIM2;PLCB1;WWP2;FOXP2;KDM8;CIART;FOXN3;NKAP;ZNF703;IKZF4;ZEB1;MAP3K10;MLXIPL;BCOR;SPEN;TWIST1;ASCL1;TIMELESS;HES1;SMARCA4;DACH1;MDFIC;LIMS1;HDAC1;SMARCA2;RBFOX2;BMP4;NOTCH1;KAT6A;SCMH1;DPF1;SOX13;NR3C1;SMAD2;NR2F2;HDAC4;MECP2;MBTD1;ZMYND11;DPF3;CREB3L1;ATF7IP;SPINDOC;ARID5B;ZNF12;BCL3;THAP7;RCOR2;ZNF706;NIPBL;RBPJ;MPHOSPH8;DPF2;HDAC5;SP3;ZHX3;KHDRBS1;KAT6B;FOXP3;YAF2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.4708048556620361,1.0492398547880992,0.40625,0.8534862956394598,1.0,4/24,7.37%,ALCAM;AUTS2;SEMA5A;SLIT2
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.6009498315789655,1.049091935114713,0.46,0.8533236949640082,1.0,4/6,36.72%,KMT2B;KMT2A;SETD4;KMT2D
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.5598562304644501,-1.0490531638587286,0.43548387096774194,1.0,1.0,2/19,9.31%,BUB1;TTK
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.5598562304644501,-1.0490531638587286,0.43548387096774194,1.0,1.0,2/19,9.31%,BUB1;TTK
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.5598562304644501,-1.0490531638587286,0.43548387096774194,1.0,1.0,2/19,9.31%,BUB1;TTK
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.5114214541513818,1.0490149628323373,0.38461538461538464,0.852462021267418,1.0,10/19,26.81%,BCKDK;BCAT1;ECHS1;HIBADH;HIBCH;MCCC1;BCKDHB;AUH;ACADSB;DBT
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.5114214541513818,1.0490149628323373,0.38461538461538464,0.852462021267418,1.0,10/19,26.81%,BCKDK;BCAT1;ECHS1;HIBADH;HIBCH;MCCC1;BCKDHB;AUH;ACADSB;DBT
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.3571560510402824,1.0487768611541495,0.36666666666666664,0.8525687250203633,1.0,26/137,10.59%,FIBIN;MXRA5;MRGPRF;LAMA4;TPM2;CLEC14A;EDNRA;ITGA8;PARVA;COL12A1;PDE3A;PER3;NR4A2;PML;MMP2;NCOA2;ECM1;PAMR1;PLSCR4;LTBP2;CCN2;CRIM1;FLNA;EFEMP1;COL16A1;CCDC80
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3249173796821239,1.048596811304905,0.35714285714285715,0.8524358274112118,1.0,148/567,19.80%,SMYD2;PER2;HDAC3;HDAC10;KLF10;ZNF692;ZNF239;MITF;OSR1;BCL6;AASS;ZBTB7B;NFATC3;RARB;PROX1;FRK;PCGF1;URI1;SIRT1;PRDM5;ATXN1;E2F6;GATAD2A;HJV;TGIF1;ZNF263;IFI16;PPARG;ZEB2;CBFB;KCNIP3;SNCA;MED25;SIRT7;BCL11A;PER3;CTBP2;NR4A2;CRY1;HMGB1;ZBTB4;ZNF274;HEXIM2;ZBTB1;WWP2;FOXP2;ATF3;NRIP1;WWOX;PLK3;TAF3;FHL2;NKAP;ZNF688;ZEB1;MIER2;BCOR;ZNF133;SPEN;TWIST1;NOTCH4;ASCL1;HES1;SMARCA4;BPTF;DACH1;MYC;HSPA1A;MYT1L;NSD1;HDAC1;SMARCA2;BMP4;NFIC;CREM;NOTCH1;NR4A3;SCRT1;NFIB;ZNF202;GFI1B;ZNF337;CUX1;PPM1A;ZNF846;DLX1;SIRT6;GATAD2B;MXI1;SOX13;RUNX1;NFKB1;NR3C1;SP2;SMAD2;ZNF75A;NR2F2;HDAC4;SAP130;ZNF599;MECP2;KLF12;THRB;OTUD7B;NR1H3;NR6A1;HSF1;NCOA5;ZBTB2;CXXC5;IMPACT;NEDD4;ZNF589;HIVEP1;SKI;ARID5B;NR2C1;MYPOP;SHH;THAP7;HSF4;ZNF675;ETV5;ZGLP1;NIPBL;ATN1;RBPJ;ZBTB5;ZMYM5;DPF2;HDAC5;ZNF79;ZNF69;SREBF2;NFIX;TBL1X;DMRT1;UXT;FOXP3;GADD45A;SMAD7;EP300;WWC1;ZNF785;NFX1;PAX6;MEN1;SLA2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.5712084166913324,-1.0483907881029033,0.4,1.0,1.0,1/14,1.85%,TGFB1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.626325725934657,1.0483896122005005,0.36,0.8524754055855016,1.0,2/7,20.39%,LIN28B;LIN28A
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),0.6053883082589965,1.048376731912026,0.4418604651162791,0.8519887502866744,1.0,2/6,5.24%,CYP1A2;CYP2U1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.5528591783668364,-1.0483161877524396,0.4032258064516129,1.0,1.0,1/12,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.5245630610515858,-1.0482339435066923,0.38571428571428573,1.0,1.0,2/20,6.29%,WNT5A;PLA2G10
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4534643829031042,1.0481001537891268,0.3333333333333333,0.8520763604124344,1.0,17/34,23.28%,ITPKB;PI4KB;TMEM150A;PIK3C2B;PI4K2B;PIK3CA;PIP4K2A;EFR3B;SMG1;TTC7B;IP6K1;SLA2;SOCS7;SOCS4;PIK3CD;IP6K2;EFR3A
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.5748439962728591,-1.0480577670231337,0.4461538461538462,1.0,1.0,5/12,17.61%,PDE6B;GNGT1;RP1;PDE6A;CNGB1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.4250839384709524,1.0478139994347044,0.3902439024390244,0.8522020836870497,1.0,7/46,12.23%,FOXO1;MID1;GREM1;CARD9;RAP2A;MYC;LGALS9
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.6950403702815175,-1.0478108357736882,0.44642857142857145,1.0,1.0,2/5,11.14%,TRIM62;SPI1
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5803347188164346,-1.0473074773318394,0.423728813559322,1.0,1.0,4/12,16.03%,HK2;PINK1;DNAJA1;ISG15
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.5884469817877845,-1.0471865277063555,0.41935483870967744,1.0,1.0,2/11,13.34%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4690211920993963,1.04702175421103,0.4146341463414634,0.853683660780817,1.0,8/22,23.48%,MVB12A;UBAP1L;UBAP1;PTPN23;NEDD4;SNF8;MVB12B;TSG101
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.43331358349595483,1.046964337798128,0.3611111111111111,0.8533787853145327,1.0,5/27,9.89%,ARC;ABHD17A;LZTS3;ABI3;ABHD17C
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5622828405593907,1.0467877763269382,0.45098039215686275,0.8532745743985597,1.0,7/9,35.59%,SREBF2;ARHGEF10L;INSIG1;ERLIN1;NPC1L1;ERLIN2;SCAP
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.38806550034890036,1.0464380416046903,0.36363636363636365,0.8534659765034961,1.0,20/99,14.14%,TGFBR1;ROBO2;URI1;PID1;HTRA2;FLT3;ERBB2;NCOA3;NCOA2;DCPS;SLIT2;STAT5B;MAPK8;HCLS1;KHSRP;PTPN9;STING1;PTPN20;NDOR1;PTPN23
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.4313144110297248,1.0463796133867997,0.32558139534883723,0.8531617952804222,1.0,8/35,25.63%,TEFM;SLC25A33;LARS2;NOA1;QRSL1;MRPL2;MRPS7;FOXO3
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.37514607666136557,1.0462360141872589,0.35,0.8530293485939616,1.0,36/123,19.68%,SPHKAP;GRM3;LRRTM3;NXPH1;LRRC4C;PDE10A;KCNC2;ATXN1;ELAVL3;CADM2;NEGR1;PAK5;KCNIP1;CELF4;ADGRA1;RAB3C;BRINP1;ELAVL4;RGS7BP;GABRG1;OLFM3;SCRT1;RBFOX1;SNAP91;DPF1;NRXN1;RIT2;CXCL14;PPFIA2;LSAMP;TMEM196;ADGRB3;GRM5;VSTM2B;ST8SIA3;MMD2
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.6180622822797704,-1.0461556484432244,0.5283018867924528,1.0,1.0,2/9,10.19%,IRF4;SLC11A1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.4544953116369985,-1.0459328690638436,0.43283582089552236,1.0,1.0,11/41,28.10%,TOMM20;SEC62;TIMM17A;PAM16;ROMO1;CHCHD4;DNAJC19;HSPA5;PEX1;TIMM21;GRPEL1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5547468651494051,1.045494980878923,0.3902439024390244,0.8545430325296278,1.0,4/13,13.05%,NFATC3;PPARG;BMP4;NFIB
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5141511345561873,-1.0451705518514822,0.3968253968253968,1.0,1.0,4/22,15.97%,BHMT;PCMT1;EEF1AKMT2;ETFBKMT
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.577076407363696,1.0450738448698649,0.4418604651162791,0.8550374600542537,1.0,4/7,34.02%,XYLB;RPIA;FGGY;G6PD
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.7192536260990599,-1.0450153617685234,0.5396825396825397,1.0,1.0,1/5,0.40%,MYH7
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5024055732902791,1.0446829511481932,0.2727272727272727,0.8554647643644714,1.0,3/21,10.64%,MITF;MED17;TWIST1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.47277556928798603,-1.0445127571608215,0.39655172413793105,1.0,1.0,5/37,7.34%,CLIC1;P2RY12;GP1BA;ACTG1;PIK3CG
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.6022487531734543,-1.0444957264616144,0.44642857142857145,1.0,1.0,2/9,6.29%,H1-3;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.6022487531734543,-1.0444957264616144,0.44642857142857145,1.0,1.0,2/9,6.29%,H1-3;H1-0
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.6022487531734543,-1.0444957264616144,0.44642857142857145,1.0,1.0,2/9,6.29%,H1-3;H1-0
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.3967531208615682,-1.0443565762641407,0.3561643835616438,1.0,1.0,28/150,13.77%,TBX1;OLFML1;C1QTNF1;TIMP3;PTGES;LMOD1;COL1A1;DAB2;ECM2;ADAM33;ANGPTL2;DCN;CYP1B1;TRIP10;APOL6;NQO1;ACOX2;ASPN;PLAC9;CAVIN1;CFD;TLR2;AOX1;LOX;GPX3;COX7A1;STEAP4;METRN
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.5802080304991825,-1.04408994500529,0.4067796610169492,1.0,1.0,2/10,6.29%,H1-3;H1-0
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.6523898582668306,-1.044018426470704,0.5087719298245614,1.0,1.0,2/6,3.37%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.6523898582668306,-1.044018426470704,0.5087719298245614,1.0,1.0,2/6,3.37%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5492928855078294,1.0440178272029454,0.4166666666666667,0.856575317450121,1.0,2/11,4.34%,NOVA1;PCBP3
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.5443375104518127,1.0433584987071083,0.358974358974359,0.8577604418823863,1.0,6/10,17.97%,NLGN1;CEL;NLGN4X;PTPRD;NLGN3;NLGN4Y
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.3932759941285249,1.0433484285601338,0.35294117647058826,0.8572557490608131,1.0,10/62,20.24%,ELP4;ELOF1;IWS1;ELOA;CCNH;MLLT3;GTF2F2;SETD2;POLR2F;ERCC3
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3619397837638304,1.0433215067720025,0.25,0.8568275076036228,1.0,25/99,16.74%,BAMBI;TGFBR1;DUSP15;PARD3;CDH5;SIRT1;PDE3A;WNT4;ARRB2;WWOX;HPGD;LTBP2;LIMS1;TWSG1;DLX1;PXN;SOX5;NR3C1;SMAD2;CGN;SMURF1;FNTA;F11R;CRKL;SKI
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.49337598278367867,-1.0431684340263867,0.40789473684210525,1.0,1.0,3/25,17.40%,AIM2;USP50;VSIR
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.3725616053778947,1.0431306896595498,0.2962962962962963,0.8569587342483824,1.0,9/75,4.76%,MLPH;PDLIM3;LAMA3;MUC13;GOLT1A;PERP;DSP;SDC4;AKR1C3
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.6499758917759906,-1.0429726690757226,0.4576271186440678,1.0,1.0,2/7,3.37%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4972599524939808,1.0428049373875035,0.35135135135135137,0.8572791586677689,1.0,3/20,7.03%,EPHX2;APOE;SEC14L2
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.391597129753363,1.0424382754190753,0.3225806451612903,0.8576843518763239,1.0,6/55,7.24%,SLC26A3;PPP1R14D;MUC13;GOLT1A;DSP;TMPRSS2
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.5287797290308497,1.0423888235447047,0.37142857142857144,0.8573136302995042,1.0,6/16,20.44%,ICOSLG;HMGB1;IL23A;FADD;IL23R;TMIGD2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.4801160230500684,-1.042228307101885,0.36507936507936506,1.0,1.0,15/39,26.59%,PWP2;NOB1;EMG1;RPS27;RPS16;RPS14;RPS7;RPS15;RPSA;RPS28;SURF6;RPS19;RPS24;RPS25;RPS6
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.5433084029665545,1.0422213782109357,0.47368421052631576,0.8572268779716699,1.0,3/11,6.69%,SIRT1;DNMT1;ZNF274
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4881894314000616,-1.0421400747387068,0.4153846153846154,1.0,1.0,11/38,26.83%,PINK1;ATG14;GABARAPL1;FUNDC1;GABARAPL2;FIS1;MAP1LC3B2;SPATA18;BNIP3;PHB2;MAP1LC3B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.46538463026745247,1.0421214008997108,0.3684210526315789,0.8569324441259378,1.0,6/27,13.07%,CDK4;PKD2;CDK6;SLFN11;RBL1;GFI1B
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.5760378995425252,1.0419160854011786,0.42857142857142855,0.8569215417928846,1.0,1/12,4.38%,STX5
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.4804534273507146,1.0418723646562542,0.3235294117647059,0.8565050167528152,1.0,9/17,27.68%,CRY1;ADCY2;PRKAR2A;ADCY3;CREB1;ADCY6;PRKACB;ADCY9;ADCY5
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.5577555172121551,-1.041697829755807,0.45161290322580644,1.0,1.0,2/20,9.31%,BUB1;TTK
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6208069887746863,-1.0416750150989624,0.4827586206896552,1.0,1.0,4/7,26.79%,TRDN;CALM1;CAV1;CALM3
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3448402986258951,1.041589036944863,0.3,0.856777217110428,1.0,44/258,14.35%,ADRA1A;GPR3;ADRA1B;ESRRG;TSKU;BAMBI;TGFBR1;ELOVL6;PER2;HDAC3;NLGN1;ZBTB7B;CCDC88B;APOE;SIRT1;IFI16;SERPINE1;CADM1;NCOA3;PLCB1;CARD9;UCN;ABCA1;ALMS1;ZNF703;SHLD2;IL23A;LEPR;TWIST1;SHLD1;ACSL1;ADIPOR1;AGPAT2;ACHE;WWTR1;MAP3K13;BMP4;SIRT6;LBP;ADIPOR2;SOX5;PPIB;SMAD2;KMT5C
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.38783492454072827,1.0413625361415317,0.38461538461538464,0.8567664287458495,1.0,26/106,19.45%,EYA4;HDAC10;SIRT1;PRDM5;SIRT7;MIER2;NSD1;HDAC1;USP16;KAT6A;UBE2A;USP36;CARM1;RPS6KA4;HDAC4;CPA4;BAZ1B;EYA3;HDAC11;RCOR2;SUPT3H;BAZ2A;HDAC5;KAT6B;TBL1X;EP300
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.5905233691640339,1.0408357755329734,0.4523809523809524,0.8575560340678773,1.0,4/7,22.49%,SGSM3;DENND4A;DENND4B;DENND1A
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.62026450229728,1.040822949748218,0.4772727272727273,0.8570742600922396,1.0,1/6,1.69%,FHIT
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.6051869257037678,1.0407567791106282,0.4146341463414634,0.8567905710739121,1.0,3/6,21.70%,CYP4F3;UBIAD1;VKORC1L1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.4285967831365452,-1.0406184999460946,0.3125,1.0,1.0,9/67,15.30%,EOLA1;WNT5A;SCIMP;CYBA;NLRP12;TLR2;C1QTNF4;NOS2;NLRC3
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.39151553486946433,-1.0399108818095508,0.38235294117647056,1.0,1.0,16/148,13.26%,BUB1;ERCC6L;SPC25;ZWILCH;MISP;RAB11A;GPSM2;ITGB3BP;CENPU;ABRAXAS1;TTK;DYNLL1;CENPH;NUF2;INCENP;RPS27
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.6308707228264376,1.0396596812392107,0.42857142857142855,0.8593457695328758,1.0,4/7,23.96%,PYHIN1;RO60;TPR;GAS6
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.530601887040987,1.0396516076450832,0.3902439024390244,0.8588450003857249,1.0,6/15,19.85%,METTL8;PCIF1;ZC3H13;TRMT61B;TRMT61A;METTL16
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3707437405519168,1.0391475280020634,0.36363636363636365,0.8597060666155054,1.0,5/38,4.97%,RAB27A;F2;PID1;AKR1C3;AKR1C1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.5724553268560028,1.0391316398848303,0.42105263157894735,0.8591963025656605,1.0,5/12,19.60%,CD14;TICAM2;TICAM1;ITPK1;TRPM7
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.39082268296478356,1.0389926416696866,0.2962962962962963,0.8590622123426135,1.0,34/133,15.56%,KIT;HIP1;THEM4;TGFBR1;FGF10;FGFR1;ANGPT1;FGF18;IRS1;NRG2;AKR1C3;CX3CR1;FLT3;FGF17;SEMA5A;ERBB2;NRG1;TGFA;HPSE;MYORG;AKT2;KITLG;HCLS1;LCK;RET;IRS2;GAB1;IAPP;FGFR3;PIK3R5;INSR;PIK3CA;CASS4;RASD2
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5999598835246287,-1.0388812966893577,0.5283018867924528,1.0,1.0,1/9,0.84%,ACTC1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.4977819841777595,1.038867181450794,0.4642857142857143,0.8588533174029593,1.0,3/24,5.36%,SIRT1;AUTS2;DNMT1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5247985790308074,-1.0385622944756843,0.4576271186440678,1.0,1.0,2/17,4.99%,HK2;PINK1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.5762725351283683,1.0385553548846151,0.5,0.8590942019650316,1.0,2/7,14.88%,ZBTB7B;SMURF1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.5739741979858337,-1.0384615770765302,0.3888888888888889,1.0,1.0,4/12,17.37%,WNT5A;LEF1;WNT8A;TGFB3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.5143050769453743,1.038158160357162,0.4489795918367347,0.8596904579931488,1.0,2/16,2.65%,THEM4;BCL2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.3578172179341862,1.038042775776729,0.40476190476190477,0.8594254388143211,1.0,35/125,19.74%,SH2D6;NGF;KIT;FGFR1;EPHA7;FRK;SHC4;FLT3;ERBB2;EPHA3;RAPGEF1;FER;LCK;CD8A;MPZL1;RET;PTPRF;EFS;PTPRT;FGFR3;INSR;EPHB2;RYK;PTPRD;CASS4;ROR1;EPHA6;TYRO3;ERBB3;EPHA8;NTRK2;ACVR2A;EPHB4;MUSK;PTK6
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.40174186168975,1.0378980593785008,0.4482758620689655,0.8593290071443166,1.0,16/83,15.08%,KIT;FGFR1;KSR1;FGF18;APOE;FLT3;ERBB2;TRIB2;SPRY4;TENM1;PDGFD;RGS14;BMP4;NF1;PIK3R5;CD40
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5906611795526291,-1.0377834887137687,0.4520547945205479,1.0,1.0,1/12,1.44%,CASQ2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.5528865719136845,1.0375787787039663,0.4418604651162791,0.8595036278287593,1.0,1/11,5.84%,PEX13
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.6535337157137558,1.0375565108427263,0.4166666666666667,0.8590431213219125,1.0,1/5,6.50%,DCC
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.6188859801652205,-1.0374625229666685,0.45161290322580644,1.0,1.0,4/8,17.61%,PDE6B;GNGT1;PDE6A;CNGB1
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.6412340445326806,-1.0373004653899072,0.4642857142857143,1.0,1.0,1/6,8.08%,SOD2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4512547317975601,1.037120710066621,0.34210526315789475,0.8595816290017216,1.0,11/35,25.26%,CPNE7;CRLS1;FADS1;NUS1;CPNE6;AGPAT5;CPNE1;SAMD8;HDHD5;PCYT2;ABCA8
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.4577842972790307,1.0370979667819704,0.47619047619047616,0.8591029768836476,1.0,10/33,23.79%,STX5;GBF1;PLK3;STING1;MRRF;DYRK3;ATG2A;RETREG1;ATG2B;CDK1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6343356358738673,1.0368880224370598,0.43902439024390244,0.8591375109132815,1.0,4/7,29.36%,PRIMPOL;DNA2;LONP1;LIG3
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3507736099500679,1.0368658127441273,0.46153846153846156,0.8586690136047982,1.0,38/164,18.98%,DGKD;PNPLA3;PLD6;SLC44A5;MFSD2A;LPCAT2;PITPNM1;PI4KB;ABHD3;CPNE7;PIK3C2B;CRLS1;MTMR8;GPD1;PI4K2B;PGS1;CHPT1;PLA2G5;AGPAT2;ACHE;CEPT1;PLA2G4C;CHKA;PLSCR1;PIK3R5;CPNE6;PIK3CA;AGPAT5;DGKZ;PIP4K2A;DGKH;MTMR3;MTMR14;LCLAT1;SLC44A4;RAB5A;CPNE1;LPIN2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.4223160149443279,1.0368344868235997,0.34285714285714286,0.858247622943996,1.0,16/61,10.96%,CYP1A2;GPC4;APOB;CYP4V2;ALDH1A1;APOE;SDC4;AKR1C3;GPC6;AKR1C1;ADH4;LPL;RPE65;GPC5;CYP2S1;ALDH1A2
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.5133922021877437,1.0364509471469292,0.34210526315789475,0.858691959940723,1.0,2/14,1.61%,VEGFC;ITGA11
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.4855539816214942,-1.0362047937550314,0.3968253968253968,1.0,1.0,3/32,9.48%,AMBP;PINK1;DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4346021153151224,-1.0360323724143456,0.4375,1.0,1.0,14/65,16.12%,EPN1;CLDN5;DCN;ALOX5;STAT1;CNMD;FOXO4;CD160;COL4A3;TEK;THBS1;ISM1;PIK3CB;SERPINF1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5273473679126808,-1.035827348209406,0.4166666666666667,1.0,1.0,4/16,23.52%,OAS1;CACTIN;ISG15;OAS3
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.5802593155526363,-1.0354575956725596,0.4827586206896552,1.0,1.0,5/13,21.47%,ADSS1;RFK;PAICS;IMPDH2;PFAS
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.6301018712346673,1.035441583440273,0.5,0.860995346213648,1.0,1/5,4.86%,CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.6714441750342797,-1.0354146610878356,0.5370370370370371,1.0,1.0,3/7,9.17%,PLA2G10;POMZP3;IQCF1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),-0.6597383668500204,-1.0353725637758484,0.4897959183673469,1.0,1.0,4/5,30.42%,RAC1;NOXA1;RAC2;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.6271272622834532,1.0353669976090645,0.46511627906976744,0.8606755360792646,1.0,3/7,9.56%,APOH;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5847891196947039,1.035103007256255,0.525,0.8607090062933734,1.0,2/8,5.42%,SIRT1;ERCC8
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.59600444000879,-1.0349018853519083,0.4838709677419355,1.0,1.0,3/12,17.95%,TICRR;CDC6;TOPBP1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.655266739618733,1.0346137357552236,0.5,0.8614478109549671,1.0,3/6,12.98%,ZBTB7B;LGALS9;TWSG1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.47512192685459853,1.0344818984817012,0.45714285714285713,0.861248887606617,1.0,7/33,19.56%,SLC26A3;SLC4A7;CA2;GPR89A;GPR89B;SLC9C2;SLC9A9
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4594836791038661,1.0343528938898856,0.3548387096774194,0.8610687419711798,1.0,5/30,7.55%,FGF10;LSM10;ADAMTS1;PLCB1;CCND3
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.6677083525960525,1.034320380149664,0.4878048780487805,0.8606664598357594,1.0,2/6,14.74%,PUS10;PUS7
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.3845387876070135,1.0343152184083133,0.3870967741935484,0.8601628068800006,1.0,24/77,21.65%,BAMBI;TGFBR1;DUSP15;PARD3;CDH5;SIRT1;ARRB2;HPGD;LTBP2;TWSG1;PXN;SMAD2;CGN;SMURF1;FNTA;F11R;SKI;SMAD7;APPL2;USP15;ACVR1;FURIN;ZFYVE9;BMPR1A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5215791667270702,-1.0342523121065204,0.40350877192982454,1.0,1.0,4/19,20.00%,CNMD;TMEM204;VTN;ITGA5
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.38797582804975667,1.0340967633299658,0.39285714285714285,0.8602149700709171,1.0,21/96,22.23%,CPSF1;NUP210;NXF5;NUP42;IWS1;AAAS;U2AF1;NXT1;SRRM1;NXF1;SRSF4;SMG1;SMG5;SYMPK;SMG6;RANBP2;U2AF2;EIF4A3;NUP214;EIF4E;TPR
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.4931331954873525,1.033934577093967,0.3829787234042553,0.8601930864005463,1.0,3/21,7.25%,IBA57;HSCB;CIAO3
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.6715753706887712,1.0337947664642613,0.5365853658536586,0.8600418324543422,1.0,2/6,4.94%,FBP2;PFKP
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.5908607087298001,-1.0335855000491347,0.5,1.0,1.0,4/12,21.33%,CASQ2;KCNQ1;KCNE2;CAV1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.49111725638334863,1.0335704636590695,0.4,0.8600477890367509,1.0,9/27,16.08%,SIRT7;SHLD2;SHLD1;KMT5C;SMCHD1;SETMAR;KMT5B;HSF1;WRAP53
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.6691968575651943,-1.033541214169385,0.5,1.0,1.0,1/6,15.76%,PTX3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.5244944654376047,1.0334044008364618,0.42857142857142855,0.8600168120995783,1.0,7/14,29.89%,PANK1;PPCS;SLC25A16;ACOT7;PANK3;PPCDC;CROT
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4648293646849734,1.0331859018242837,0.4186046511627907,0.8599950980804264,1.0,9/16,19.52%,MAML1;NOTCH4;NOTCH1;PBX1;RBPJ;KAT2B;DLGAP5;EP300;WWC1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.6406028755863766,1.0329999418547346,0.42857142857142855,0.8592882540746777,1.0,2/6,15.58%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.6406028755863766,1.0329999418547346,0.42857142857142855,0.8592882540746777,1.0,2/6,15.58%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.5220161852058829,-1.0329776497470111,0.4411764705882353,1.0,1.0,3/16,11.90%,CTNNA1;LATS2;APOD
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.6152401874741664,-1.0329754729946674,0.45614035087719296,1.0,1.0,4/9,8.75%,RAB34;DOCK2;MAPKAPK3;PPT1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.527483643462632,1.032925906986282,0.3870967741935484,0.8589538800066899,1.0,6/17,20.92%,BIN1;APOE;RTN2;ABCA7;NTRK2;RTN1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.4953170671609443,-1.0329095401203063,0.4153846153846154,1.0,1.0,5/23,10.63%,MYH7;PKP2;TGFB1;MYBPC3;LRP2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.47366074241635825,1.0326901485721323,0.3870967741935484,0.8590248897961255,1.0,5/25,7.55%,FGF10;LSM10;ADAMTS1;PLCB1;CCND3
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.5252766406186355,-1.0326729972178532,0.46153846153846156,1.0,1.0,1/10,2.34%,JCHAIN
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.414732381551365,-1.0322976308100387,0.31746031746031744,1.0,1.0,14/50,27.15%,NDUFA2;NDUFS2;NDUFB4;NDUFB9;NDUFC1;NDUFA1;TMEM126A;NDUFB11;NDUFS5;NDUFB10;NDUFAF5;NDUFB2;NDUFS6;TIMM21
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.414732381551365,-1.0322976308100387,0.31746031746031744,1.0,1.0,14/50,27.15%,NDUFA2;NDUFS2;NDUFB4;NDUFB9;NDUFC1;NDUFA1;TMEM126A;NDUFB11;NDUFS5;NDUFB10;NDUFAF5;NDUFB2;NDUFS6;TIMM21
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5616207520340998,1.0322598952270967,0.4186046511627907,0.8597213349824574,1.0,6/14,26.05%,SIRT1;HP1BP3;SMCHD1;SETD7;PRDM16;BAHD1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5397441033386658,1.0321491129179712,0.35135135135135137,0.8594976186909001,1.0,6/13,27.10%,TNRC6C;TNRC6A;AGO2;TNRC6B;TOB1;PABPC1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.4820045529333135,1.0318365296026037,0.43333333333333335,0.859807067293958,1.0,2/21,6.26%,IRGM;RIPK2
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.663686039112132,1.0317509288941438,0.5238095238095238,0.8595284697375284,1.0,4/7,24.99%,PEX13;SLC27A2;PECR;SLC25A17
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3635544007591107,1.0315047663642891,0.2692307692307692,0.8596998783232549,1.0,17/106,10.96%,ARC;TDO2;EHD4;VSTM5;KCNC2;TRPM2;CLYBL;HCN1;PKD2;ACACB;ZBTB1;CARD9;MICU1;C9;IKZF4;SPAST;ALDH1A2
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.654997732955003,-1.0315043226582579,0.41304347826086957,1.0,1.0,2/5,15.83%,AOX1;HAAO
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.41086923582765456,1.031300798864615,0.3793103448275862,0.8597793678901516,1.0,19/65,21.95%,FRMPD1;PARD3;ZDHHC11B;SYNE3;ZDHHC12;MYO1C;GOLGA7B;ZDHHC18;RAB10;NECTIN3;ZDHHC14;ZDHHC3;RAB11B;BRAF;BID;ZDHHC11;ZDHHC9;ZDHHC23;GRIN3B
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.5741790016028802,1.0310949681362942,0.4166666666666667,0.8593059672229956,1.0,3/9,19.86%,STAT5B;IL2RB;IL2RA
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.5741790016028802,1.0310949681362942,0.4166666666666667,0.8593059672229956,1.0,3/9,19.86%,STAT5B;IL2RB;IL2RA
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),0.5649827455588188,1.0310225911469113,0.509090909090909,0.8590010194530335,1.0,2/6,18.51%,AGXT2;ALDH4A1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.5849643451458595,1.030835831302907,0.45,0.8590075328715333,1.0,6/11,26.88%,PACSIN2;SNX9;BIN3;SNX33;FNBP1L;WHAMM
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6841049756218757,1.0306001782024943,0.4634146341463415,0.8591786427435174,1.0,1/5,3.15%,GLA
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.5895413888552776,1.0302290185264833,0.43902439024390244,0.8594775014280147,1.0,2/10,3.71%,RNLS;SPTBN4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.3869783108024853,1.0301665948413397,0.3793103448275862,0.8592462412873622,1.0,17/93,11.37%,FIBIN;MXRA5;MRGPRF;LAMA4;ITGA11;SSC5D;EDNRA;ITGA8;ADAMTS1;COL12A1;MMP2;SLIT2;PAMR1;COL16A1;CCDC80;MSRB3;RBMS3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.5374073319263049,1.030084199282296,0.46875,0.8589148387962294,1.0,3/12,11.63%,CDH5;SNCA;MAPRE1
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.5946119921714773,1.0298490648311998,0.4878048780487805,0.8590582316126466,1.0,2/6,25.83%,FRRS1L;FYN
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.463155497707582,1.0295970676002997,0.39473684210526316,0.8591376312447088,1.0,7/18,19.86%,BCL6;SOX12;CBFB;TNFRSF18;RUNX1;FOXP3;IL2RA
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3609241048371765,1.0295415250408013,0.32142857142857145,0.858834213045502,1.0,18/165,11.85%,IL7R;NGF;EMP1;MAFB;DCBLD2;SPON1;RGS16;ETV1;TRIB2;SDCCAG8;PTPRR;USP12;AKT2;MAP3K1;JUP;ALDH1A2;CFH;IL10RA
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.531641027840159,-1.0293329020471085,0.47619047619047616,1.0,1.0,4/18,20.96%,LMOD1;SCIN;LMOD3;ARPC5L
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.38455174619719,-1.0293311957304878,0.36363636363636365,1.0,1.0,36/189,23.06%,CDCA3;MCM2;HMGB3;SPC25;MCM3;RPA3;DONSON;DEPDC1;CDC25A;H2AZ1;PRDX4;SUV39H1;BRCA1;RBBP7;CDKN1A;NAA38;TUBB;PSMC3IP;RAD1;ANP32E;CDKN3;STMN1;PAICS;PRPS1;CENPM;HMGA1;EXOSC8;AURKA;TK1;DCK;RPA2;ORC6;CDKN1B;CKS1B;PCNA;PTTG1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.45778458314749193,-1.028500868911803,0.4117647058823529,1.0,1.0,5/39,10.19%,TENT5B;BOLL;DAZL;MEIOC;SLC11A1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3822335040197792,1.028418555252339,0.4,0.8609627599434718,1.0,15/84,10.22%,ARC;EHD4;VSTM5;KCNC2;SNCA;PKD2;ZBTB1;CARD9;MICU1;C9;IKZF4;UGDH;MAT2A;MCU;SPAST
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.42352141111551045,1.0283859571717693,0.42857142857142855,0.8605494062473866,1.0,12/43,16.81%,LLGL1;RAB31;COMMD1;BLZF1;GOLGA4;GCC2;GGA1;MACF1;RAB10;ARFRP1;ARL3;EXOC6B
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.4923968949885729,1.0280009638684575,0.35,0.8609188344679501,1.0,7/12,35.79%,CDA;CTPS2;DPYSL5;DPYSL2;DPYS;DPYSL4;ALDH6A1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.4268305553867874,-1.0278526060447861,0.43661971830985913,1.0,1.0,2/59,1.26%,ENPP2;PLAAT4
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.50099928185107,1.027851186326701,0.41935483870967744,0.8607969074747268,1.0,3/11,14.10%,SOX12;PKD2;NF1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.648123772951999,-1.0275483269989305,0.4666666666666667,1.0,1.0,2/6,23.52%,DDX3X;OAS3
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.505815714556314,-1.0273317063307505,0.4,1.0,1.0,3/19,7.39%,IFNK;IL21R;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.48324307208702777,1.0271195142879768,0.4,0.8622924040294037,1.0,5/22,16.36%,PHLDB2;CGNL1;WASF2;TMEFF2;F11R
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.40777091032033774,1.0270518950044927,0.43478260869565216,0.861997286552864,1.0,12/37,20.91%,RP1L1;JHY;AAAS;SPAG16;SPAST;NAV1;CLIP1;MARK4;TPPP3;CFAP46;CDK5RAP2;NCKAP5L
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.5831842436814124,-1.0266768923390641,0.49206349206349204,1.0,1.0,3/9,22.50%,AGT;SOX9;SIX4
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.4591374910928816,1.0262721710719034,0.4,0.8632997549686905,1.0,10/24,23.36%,NLGN1;RALA;TENM1;FSCN1;DOCK11;MIEN1;TENM2;PLPPR5;GPM6A;PALM
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.6509234995314472,-1.0258224287599202,0.5084745762711864,1.0,1.0,2/8,7.99%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.58915102280763,1.025756014053562,0.47368421052631576,0.8639930169970703,1.0,3/7,14.02%,ZC4H2;MDGA2;SOX13
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3459605037416771,1.0256403151198978,0.3888888888888889,0.8637155531609082,1.0,63/202,21.98%,PCM1;TTC29;FHDC1;IFT88;EHD4;PARVA;DZIP1L;SCLT1;PKD2;GBF1;BBS9;CILK1;TTC36;SPAG16;FLNA;CEP290;TTC17;RAB11FIP3;AVIL;RPGR;MNS1;CEP250;NOTCH1;MKS1;RILPL1;CDC14B;FAM161B;PTPN23;PIBF1;KIAA0586;ARL13B;CEP20;TTC39C;SSTR3;BBIP1;EXOC7;CEP162;IFT140;ARL3;NEK1;MARK4;KIF3B;CFAP70;RP2;CFAP221;TMEM138;DZIP1;CNGA4;PTPDC1;CFAP43;CEP41;DCDC2;POC1B;UNC119B;TCTN2;TMEM67;WDR19;PKHD1;EXOC4;IQCB1;EXOC6;ASAP1;CDC14A
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.29275180233373566,1.025602648680495,0.21052631578947367,0.8633387599526607,1.0,199/857,19.66%,TEAD2;ESRRG;TSKU;NGF;CCN4;RAB27A;POU3F1;TGFBR1;FGF10;MLF1;ACTG2;EPHX2;POU6F2;OR7D2;PC;ZNF195;HDAC10;ZNF117;ZNF804A;MITF;OSR1;NOVA1;RBM20;BCL6;ANGPT1;MAFB;FGF18;ZNF212;ZBTB7B;RORA;CDH5;ICOSLG;APOE;SLC39A8;PROX1;TULP3;PCGF1;SIRT1;ZFPL1;ESRP1;PRDM5;CDK4;PCBP3;SLC8A1;PID1;ATXN1;WNT4;SOX12;BTN3A2;FGF17;ZNF263;IFI16;APBB3;DNMT1;RORB;WNT3A;GPBP1L1;HNRNPF;UBAP2;PML;ZBTB4;SPIN2B;ZNF274;NCOA2;CIAO3;WWP2;HP1BP3;TRIM71;CDK6;TESMIN;SP1;OPRD1;MAPK8;ABL1;EIF2AK3;FOXN3;RBL1;NKAP;ZNF331;ZNF703;FADS1;FEZF2;ZNF33A;MLXIPL;EFEMP1;POFUT1;ZSCAN21;HNRNPH1;ADNP2;HCLS1;TESC;FASTK;HNRNPL;KHSRP;TWIST1;ZNF519;ZNF462;ASCL1;RIMS2;RBMS3;RRP1B;MOV10;MYC;HSPA1A;TNRC6C;DMTF1;TRIM44;LIMS1;NSD1;WWTR1;HDAC1;LGALS9;SMARCA2;BMP4;CREM;NOTCH1;ZNF2;TICAM1;SCRT1;USP36;CARM1;MAGED1;PLSCR1;PRMT5;SOX13;RPS6KA4;RUNX1;NFKB1;RAG2;NR3C1;MYBL2;ANK2;HDAC4;RYBP;NFYC;ZNF646;MECP2;INSR;HES6;EPHB2;PCBP4;ZNF273;PRDM14;OCLN;TOB2;TNRC6A;RNF207;PPARGC1B;CXXC1;CREB3L1;EMILIN1;SRRM4;ASCC2;FZD7;PTBP1;TRIM14;CRKL;ATM;MSC;GABPA;ADNP;UBE2L3;SHH;THAP7;AGO3;FUS;BRAF;TRIM4;ZNF675;ERC1;SUPT3H;RBPJ;BAZ2A;HDAC5;GPX1;SP3;ZNF66;EPB41L4B;NTRK2;CPNE1;AGO2;KAT6B;ZNF708;CHD7;JMJD1C;FOXP3;YAF2;EGR1;MUSK;DENND4A;RC3H1;SPIN1;EP300;WWC1;GLI4;NFX1;BTN2A2;PAX6;ADAM10
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.5231858972388679,-1.0255708353071749,0.3968253968253968,1.0,1.0,4/21,14.68%,CYP1B1;FUT2;ALOX12B;SERINC1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.43006375252241225,1.025398193072866,0.34285714285714286,0.8634332180207487,1.0,6/38,9.15%,BCL2;PID1;SLC25A33;OPRD1;ABL1;AKT2
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6012029172266002,-1.0253090925306219,0.5,1.0,1.0,3/10,18.17%,CCDC39;ZMYND10;RSPH9
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.364321783546113,1.02514148683739,0.45454545454545453,0.8635637612863639,1.0,10/82,8.80%,LETM2;CDH5;HTR2C;SLC8A1;DRD5;RGN;SLC8A3;DRD3;TESMIN;DRD4
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.4610863071204719,1.024948653058729,0.38095238095238093,0.8635132817999516,1.0,11/26,21.11%,FGF10;ADGRG6;PTPRZ1;SLC8A3;NFIB;CDH2;MMP24;SHH;ERBB3;GPR157;CDK5
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),0.5563151522402678,1.0249409370127438,0.44680851063829785,0.8630109471392187,1.0,2/5,22.56%,SLC44A4;SLC44A2
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.4487600496337797,-1.0248582186299342,0.4393939393939394,1.0,1.0,1/43,0.31%,NEK2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.584505690572658,-1.0247005998514294,0.44642857142857145,1.0,1.0,2/8,6.00%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.6413385174990239,-1.024582874044753,0.5344827586206896,1.0,1.0,5/7,34.21%,TLR2;RPS27A;UBB;B2M;UBC
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.6413385174990239,-1.024582874044753,0.5344827586206896,1.0,1.0,5/7,34.21%,TLR2;RPS27A;UBB;B2M;UBC
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5292269969158571,-1.0244628580930344,0.4461538461538462,1.0,1.0,6/15,28.66%,PTPRC;TERT;ZFP36L1;EPCAM;KDM1A;YAP1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.46679544630206493,-1.0243310405077746,0.45454545454545453,1.0,1.0,10/39,19.98%,IRF1;OAS1;TLR2;TRIM56;OAS2;CACTIN;NLRC3;ISG15;DDX3X;DHX58
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.5984165836870924,1.0243068446372077,0.5531914893617021,0.8640448105492203,1.0,4/8,26.44%,KLHL41;MYOCD;MEF2C;NR1D2
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5981064814390128,-1.024286939882846,0.43859649122807015,1.0,1.0,4/9,27.26%,SVIP;HERPUD1;CAV1;USP14
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.6461875841635202,1.0242515032898454,0.42857142857142855,0.8636871952038471,1.0,1/7,0.41%,TACR3
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.5973144013216458,1.024142663414484,0.4716981132075472,0.8634202205271245,1.0,3/8,29.05%,PDSS2;MVK;MVD
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.5361035263747171,1.0238129589101546,0.425,0.8636134378138706,1.0,3/10,9.30%,NKD2;ASTL;RHBDD1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5422337705052297,-1.0237192987024089,0.42592592592592593,1.0,1.0,1/16,0.79%,TBX1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.5519348007826611,1.0237089684476484,0.4411764705882353,0.8633828638952882,1.0,5/11,15.07%,VEGFC;NUS1;MYO1C;GAB1;PIK3CA
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.46586402622883843,-1.023619144659455,0.4852941176470588,1.0,1.0,4/33,4.20%,DNAH11;TBX1;MMP21;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.41937059006392985,-1.0231679610433557,0.42028985507246375,1.0,1.0,13/59,16.90%,LMOD1;HCK;CAV3;PINK1;C15ORF62;ALOX15;DCTN1;BAIAP2L1;ANKRD53;CDK5R1;RAC1;VASP;PSRC1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.3820250654559861,1.0230282041489627,0.41379310344827586,0.8646657065332476,1.0,25/101,24.34%,RHEBL1;KSR1;RIN2;DNMT1;RALB;RRAS2;RALA;CCDC88A;RASSF1;NF1;RIT2;ARL3;ARHGAP33;CRKL;BCR;BRAP;SOS1;TP53;SHOC2;TNK2;SIAH2;SHC3;ARHGAP18;CCNA2;PLD2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.546772122852909,-1.0229935971940833,0.4696969696969697,1.0,1.0,2/9,14.09%,IL12A;THBS1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.5996364127634136,1.0229464024866766,0.4186046511627907,0.8644257885121422,1.0,1/7,1.16%,MEGF10
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.5277524318028423,1.0229287709303823,0.4090909090909091,0.8639612380846834,1.0,5/13,16.29%,ELOF1;CDCA4;ARID1A;SERTAD2;ARID1B
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.6367641014799046,1.0228539723418444,0.5306122448979592,0.8636770494062446,1.0,1/5,6.50%,HMGB1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.41456525049928067,1.0225392846231556,0.3125,0.8641390277511617,1.0,11/57,16.64%,PNPLA3;APOE;SIRT1;ZBTB20;PPARG;ABCA1;MLXIPL;IRS2;TLCD3B;NR1H3;ACOX1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.5570210324563855,1.0224880704339612,0.375,0.8637472951344681,1.0,2/10,7.69%,RNLS;DRD3
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.5647668937442617,-1.0224379353107103,0.49122807017543857,1.0,1.0,2/13,13.01%,GAD1;ACOT4
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.5826124534100336,1.0223282776738032,0.5454545454545454,0.8634457713369308,1.0,3/9,8.05%,SIRT1;PTGIS;PLIN5
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.5606822157962579,1.0223040179704714,0.40816326530612246,0.8630190095755242,1.0,6/11,32.84%,DDAH1;BMPR2;SLC2A5;PLCB3;ACE;GPR37L1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.44277328716850073,1.0221957529646606,0.42857142857142855,0.8627989413658734,1.0,13/34,24.38%,CAPN10;DNAJC30;REEP6;AAAS;MLC1;ATPSCKMT;TTC21B;RAB11B;WWC1;NUP214;GAS1;RNF139;MAP2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4822594180544505,1.0221458601580407,0.3333333333333333,0.8624805659679993,1.0,13/36,27.53%,ROBO2;MAML1;JAG1;NOTCH4;NOTCH1;RBPJ;KAT2B;EP300;JAG2;EPN2;CREBBP;STAT3;DLL1
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),-0.6713359575200614,-1.0221323267987044,0.6,1.0,1.0,2/5,29.47%,CHRNB2;CHRNA3
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.6152689376299385,-1.0217652759666411,0.48484848484848486,1.0,1.0,1/7,1.44%,CASQ2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.6152689376299385,-1.0217652759666411,0.48484848484848486,1.0,1.0,1/7,1.44%,CASQ2
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.5322098204208283,1.021284199665565,0.391304347826087,0.8644729289963655,1.0,4/10,18.02%,NRG1;NR1H3;VAMP8;ERBB3
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.5876922991954414,1.0209332773168704,0.5476190476190477,0.8649683851478992,1.0,1/8,3.15%,GLA
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4124373101444356,1.0208754182370294,0.4594594594594595,0.864586698340643,1.0,11/26,25.37%,CD14;SARM1;NLRP2B;TICAM2;TICAM1;MFHAS1;TYRO3;GPR108;LYN;NR1D1;IRAK3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.38547051963096945,-1.020874224542432,0.39436619718309857,1.0,1.0,63/160,27.77%,RPL37A;RPL15;RPL3;RPL38;RPL35A;RPS9;RPL7A;RPL13;RPS27;RPL13A;RPS4X;RPS16;RPS20;RPS8;RPS21;RPS11;RPL27A;RPL9;RPL5;RPL21;RPL34;RPL4;RPL23;RPS14;RPL18A;RPL32;RPL36;RPS27A;EXOSC8;RPL18;RPL29;RPS7;RPS15;RPSA;RPL41;RPS28;RPLP1;RPL12;RPL11;RPL35;ZFP36L1;RPL22;RPL27;RPL24;RPLP2;RPS13;RPS19;RPL28;RPL19;RPS24;RPL10;RPS25;RPS3A;PNLDC1;UPF1;CNOT11;RPS6;RPL8;RPLP0;RPS12;ZFP36;MRTO4;RPS3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.423610088215128,1.020817316313463,0.42857142857142855,0.864223329700107,1.0,5/54,3.02%,PNP;CD38;FGF10;BCL2;CCDC88B
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6088421304888154,1.0208131131724048,0.5111111111111111,0.8632388987464702,1.0,3/6,15.87%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6088421304888154,1.0208131131724048,0.5111111111111111,0.8632388987464702,1.0,3/6,15.87%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.40401392501972144,-1.0207569448164655,0.43283582089552236,1.0,1.0,19/90,17.33%,AQP3;MICB;TGFB1;ESR1;CYP24A1;ANXA1;MAPKAPK3;WNT8B;SMAD6;SLC11A1;PALM3;GPX3;IL12A;CDKN2D;NOS2;SELP;RXRG;TNFRSF11A;WNT8A
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.6459393445435244,-1.0203363042096296,0.5,1.0,1.0,1/5,7.39%,PTPRC
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5877224142524586,1.0202485276874418,0.46511627906976744,0.8643850976635366,1.0,5/10,21.56%,CSGALNACT1;B3GAT3;DSEL;B3GAT2;CSGALNACT2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.5642540572146829,-1.020217995035106,0.5084745762711864,1.0,1.0,4/11,21.52%,ERH;SLC19A3;SLC25A19;DCK
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.6530589426396816,1.0200568601367814,0.5227272727272727,0.8642724095495631,1.0,2/5,17.82%,PRIMPOL;DNA2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.5823406662569202,1.0197447243112614,0.4166666666666667,0.8645520591174155,1.0,2/9,6.45%,PER2;CRY1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3195688970210823,1.0196890078707919,0.2857142857142857,0.8642255953228409,1.0,128/446,21.65%,ERG;DAPK2;KIT;GRK5;TGFBR1;FGFR1;MAPKAPK2;SBK1;CDK14;LMTK3;FRK;CDK4;BCKDK;CSK;FLT3;MAML1;ERBB2;PAK5;CRY1;CILK1;EPHA3;VRK2;TRIB2;FER;CDK6;ABI3;MAPK8;MAST1;ABL1;SIK3;LATS1;EIF2AK3;SGK1;MAST2;AKT2;MYO3A;MAP3K1;TNIK;STK32C;MAP3K10;ERN1;MAP3K9;ABL2;EFEMP1;WNK2;CLSPN;RPS6KA3;PKN2;CDK18;CCNH;FASTK;LCK;TSSK4;GDF6;RET;MAP3K21;MAP3K13;PXK;BMP4;MARK3;PIM2;MELK;FAM20B;RPS6KA4;FGFR3;SMAD2;CDK8;RPS6KA2;INSR;BAZ1B;EPHB2;CDK16;RYK;MAST4;RPS6KA6;CAMK1G;SLK;NEK1;MAP4K2;SGK2;ATM;MARK4;BCR;MARK1;SMG1;EEF2K;MAPK12;DYRK3;CSNK1G1;BRAF;TBCK;ERC1;MATK;TYRO3;WNK3;MORC3;EPHA8;NTRK2;PRKCE;ACVR2A;EPHB4;MUSK;SMAD7;CREB1;ADAM10;USP15;PTK6;MARK2;MAP2K6;PDK1;PPP4R1;SIK2;PAK3;PAK2;LIMK1;CLK2;PRKAG2;ATR;ACVR1;NIM1K;CDK5;PRKAA2;PIK3R4;BMPR2;PIK3CD;CSNK1G3;PNCK;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.4524090136567028,1.0193166156390352,0.3333333333333333,0.864487143982353,1.0,5/34,7.75%,CSTA;F2;ECM1;CHAC1;TIMP1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.4038377257385876,1.0190361322465034,0.45714285714285713,0.864721697511546,1.0,12/50,19.46%,OLFM2;ABCA1;CYB5R4;LTBP2;RAB3C;RIMS2;PREB;WLS;RAB10;TVP23B;RAB3D;MIA3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.4316219496099776,1.0189835391693085,0.3404255319148936,0.8643512301409134,1.0,7/34,17.31%,RASSF2;EPHA7;RAP2A;PDGFD;ENPP1;IMPACT;RAD50
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.32533495382852023,1.0188181377530052,0.4074074074074074,0.8642567248623815,1.0,53/366,12.72%,IL7R;MEGF10;CCN4;BAMBI;GRK5;TGFBR1;FGF10;VEGFC;FGFR1;OSR1;BCL2;FGF18;IRS1;POU3F2;PROX1;SIRT1;CDH13;TCIRG1;CDK4;PID1;AKR1C3;FLT3;FGF17;ERBB2;NRG1;WNT3A;SLC25A33;TGFA;TOX;GREM1;HPSE;FER;CDK6;TIMP1;ACER2;ZNF703;AKT2;KITLG;MLXIPL;PDGFD;HCLS1;HES1;IRS2;NAMPT;MYC;SAAL1;CCN1;WWTR1;HDAC1;BMP4;ACER3;NOTCH1;NR4A3
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.553839033790191,1.0186836796457965,0.46,0.8635797388925621,1.0,5/10,30.88%,ASCC2;MGMT;ASCC3;FTO;ALKBH3
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.553839033790191,1.0186836796457965,0.46,0.8635797388925621,1.0,5/10,30.88%,ASCC2;MGMT;ASCC3;FTO;ALKBH3
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5586895520057622,1.0186238130040812,0.5581395348837209,0.8631841506926228,1.0,5/14,23.96%,ANP32B;RAPGEF3;TP53;TPR;GAS6
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.513437353750291,1.018225393198567,0.4444444444444444,0.8638443104293497,1.0,8/18,27.26%,MSTO1;TRAK2;MARK1;BRAT1;MARK2;MTM1;TRAK1;MEF2A
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.46948734317543034,-1.0181749819593897,0.44285714285714284,1.0,1.0,8/29,19.98%,IRF1;OAS1;TLR2;TRIM56;OAS2;ISG15;DDX3X;DHX58
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31853693731588356,1.017628228521151,0.2222222222222222,0.864831647167339,1.0,101/396,19.76%,TEAD2;ESRRG;TGFBR1;MLF1;POU6F2;OR7D2;ZNF195;HDAC10;ZNF117;MITF;MAFB;TCOF1;ZNF212;RORA;SLC39A8;TULP3;PCGF1;ZFPL1;ATXN1;SOX12;ZNF263;APBB3;RORB;GPBP1L1;PML;ZBTB4;SPIN2B;ZNF274;NCOA2;HP1BP3;TESMIN;SP1;ABL1;PCIF1;FOXN3;RBBP6;ZNF331;ZNF703;NANOS3;FADS1;ZNF33A;MLXIPL;EFEMP1;POFUT1;ZSCAN21;HCLS1;ZNF519;DMTF1;NSD1;WWTR1;SMARCA2;CCDC88A;CREM;NOTCH1;ZNF2;SCRT1;CARM1;MAGED1;PRMT5;SOX13;RPS6KA4;NR3C1;MYBL2;RYBP;NFYC;ZNF646;DSCC1;INSR;HES6;GEMIN5;ESCO1;PUM3;ZNF273;PPARGC1B;CXXC1;ASCC2;FZD7;MSC;UBE2L3;THAP7;FUS;ZNF675;ERC1;SUPT3H;BAZ2A;SP3;ZNF66;GRM5;KAT6B;ZNF708;CHD7;JMJD1C;FOXP3;YAF2;DENND4A;SPIN1;EP300;WWC1;GLI4;NFX1;PRRX2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.37888428074358893,-1.0175075897865902,0.3974358974358974,1.0,1.0,29/180,13.43%,CD44;ITGB2;COL1A1;COL5A1;ECM2;MMP21;DCN;TGFBI;MMP9;ICAM3;COL27A1;NID1;ITGA9;MMP19;ITGB6;COL18A1;HRNR;COL4A4;MATN4;VIT;COL4A3;COL24A1;LOX;ITGA2B;LAMC2;MMP25;ACAN;COL23A1;PXDN
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4179790749979063,1.0170984008739616,0.4444444444444444,0.8658267160185532,1.0,11/32,15.33%,RAB31;BLZF1;RAB7A;GOLGA4;GCC2;GGA1;MACF1;RILPL1;RAB10;ARFRP1;NECTIN3
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.4168857467977433,1.016830298570081,0.3684210526315789,0.8660681562977597,1.0,8/44,14.10%,MARVELD1;PARD3;ADGRG6;SLC8A3;GAL3ST1;ABCD2;ACER3;NF1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.5031516121109683,-1.0167296703265178,0.4868421052631579,1.0,1.0,2/18,7.41%,BOLL;DAZL
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.47583545903038604,1.0165334695206227,0.3888888888888889,0.8661942997196187,1.0,6/25,12.62%,CBS;TDO2;SARDH;KYAT1;AADAT;GSTZ1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.586361034074126,1.0163709826080027,0.5609756097560976,0.8660373299433178,1.0,1/8,6.02%,ARMC10
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.4765231749028243,1.016305986757139,0.4666666666666667,0.8656772700292937,1.0,8/22,14.09%,KSR1;ADGRG6;PDE3A;PDE7A;ADCY2;CAP2;RIMS2;RAPGEF3
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.647023926851826,-1.0160640067334572,0.4745762711864407,1.0,1.0,1/7,4.20%,CCDC39
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.5997553729148046,1.016002888661171,0.4716981132075472,0.8659094134834859,1.0,2/9,6.39%,PPP1R3A;PPP1R3E
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.5677326808188209,1.0159670706877526,0.4888888888888889,0.8655498354082618,1.0,2/10,8.74%,F2;RBL1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6652267399758264,-1.015580163882383,0.5409836065573771,1.0,1.0,2/5,21.12%,ZNF473;CPSF2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.36368059721275986,1.0152905731510289,0.5,0.8668846268788013,1.0,33/129,18.73%,GPRIN3;NLGN1;RP1L1;APOE;POU3F2;GPRIN1;NRTN;CNTNAP2;HMGB1;ETV1;PTPRM;TENM3;SAMD14;TENM1;UGDH;ASCL1;RAB35;MYT1L;RUNX1;BICDL1;CDK16;RYK;PPP1R9A;SRRM4;FRY;PBX1;ARL3;NEDD4;PPP1R9B;SLC44A4;EPHA8;ATP8A2;NTRK2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.5495939491202149,-1.0151910707557088,0.5,1.0,1.0,1/13,2.84%,NODAL
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.4086620489285636,-1.0151487668940657,0.4225352112676056,1.0,1.0,13/95,13.14%,AQP3;PTGES;EPN3;SLCO2A1;SMIM22;TMC4;ITGB6;SLC5A1;AQP4;SCNN1G;PROM2;MYO5B;SLC44A3
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.5359919499236924,1.01505491274294,0.45454545454545453,0.8669305180124846,1.0,4/7,27.16%,PAK2;BCL2L1;FZD3;DFFA
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.5372780200754121,1.0150192045821147,0.46153846153846156,0.8665357218030609,1.0,6/11,17.97%,NLGN1;CEL;NLGN4X;PTPRD;NLGN3;NLGN4Y
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5406568871787023,1.0146356347137606,0.37142857142857144,0.8669781056386011,1.0,4/12,21.27%,SPTBN4;ARHGAP35;EPHB2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.5899098879741508,-1.014532815579714,0.5076923076923077,1.0,1.0,3/10,15.29%,PLAAT4;PRKCH;ETV4
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.6215212965036816,-1.0144208676567597,0.47368421052631576,1.0,1.0,6/9,23.14%,PLA2G10;POMZP3;IQCF1;SERPINA10;SPINK13;ZP3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4638744596667703,1.0143787688192567,0.41379310344827586,0.8671383011625297,1.0,7/23,21.03%,RIPK2;ALPK1;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.5709771171429998,1.0143423255703188,0.4878048780487805,0.8667176647522343,1.0,5/8,33.52%,HMGB1;SLC15A4;RSAD2;PTPRS;GRAMD4
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.4346931931748103,1.014333547361567,0.42424242424242425,0.8662447479075218,1.0,8/32,18.62%,CPSF1;LSM10;PCF11;SNRPB;CPSF7;PAPOLA;TTF2;SYMPK
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.42046149815798517,-1.013983255458855,0.4444444444444444,1.0,1.0,1/50,0.22%,DENND1C
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5152425879265915,1.013955956088549,0.40476190476190477,0.8667653854982694,1.0,6/13,26.15%,RAD9A;MUS81;RAD17;EME2;MDC1;NEK11
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.5619875920211657,1.0139041384741545,0.39473684210526316,0.8663544560551689,1.0,5/7,38.83%,DPYSL5;DPYSL2;DPYS;DPYSL4;CRMP1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.4734977813593704,1.0138921940595726,0.40476190476190477,0.8654287146030655,1.0,3/14,5.57%,SLC8A1;TRPM2;SLC8A3
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.4734977813593704,1.0138921940595726,0.40476190476190477,0.8654287146030655,1.0,3/14,5.57%,SLC8A1;TRPM2;SLC8A3
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.3142244004481466,1.0136031420807277,0.375,0.8657382067543092,1.0,51/264,18.02%,KIT;FGF10;FGFR1;MAPKAPK2;KSR1;ANGPT1;FGF18;IRS1;ABHD17A;NRG2;SPTBN4;PSME4;FLT3;FGF17;NRTN;PSMA1;ERBB2;NRG1;TGFA;IL17RD;PPP5C;RASA2;MAPK8;TNIK;KITLG;ABHD17C;GRIN1;RET;IRS2;IL2RB;MYC;LGALS9;RASAL2;MARK3;SPRED1;NF1;FGFR3;NFKB1;ABHD17B;MAP2K7;PIK3CA;FNTA;NCAM1;HSF1;RIT2;DUSP6;MAPK12;DLG2;BRAF;BRAP;ERBB3
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.4389556818984532,1.0135076637925384,0.3684210526315789,0.8654164137450735,1.0,15/45,17.96%,LAMB4;USH2A;ITGA8;PARVA;NTN4;SRGAP2;ITGA4;FER;NTNG2;PXN;ANTXR1;TMEFF2;SRCIN1;FERMT3;TYRO3
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.5384806558328176,-1.013114251789558,0.47058823529411764,1.0,1.0,4/14,17.57%,HHIP;NLRP12;OPRM1;IGFBP3
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.6378503438858429,1.013062885265089,0.5,0.8659532734940867,1.0,2/7,12.15%,MED25;ZNF618
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5522856263770214,1.0129149802866244,0.48936170212765956,0.8658680563278025,1.0,2/11,2.76%,PARD3;ADGRG6
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.44006183514776087,1.012413664973068,0.3684210526315789,0.8666490067524644,1.0,3/37,7.71%,NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.49607302917995205,-1.0124110062624818,0.46875,1.0,1.0,6/28,14.61%,NRAP;TBX1;NEB;TMEM204;HEY2;POPDC2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.42213087517270387,1.011935040381863,0.5333333333333333,0.8674378214985801,1.0,2/28,5.28%,CPEB1;CAPN2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.5665394000378144,1.0117700886885896,0.40540540540540543,0.8674829885305992,1.0,6/8,38.83%,DPYSL5;DPYSL2;DPYS;DPYSL4;ALDH6A1;CRMP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.47808932369942514,-1.0117484031636905,0.4696969696969697,1.0,1.0,3/27,10.02%,PINK1;CLU;ACAA2
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.5423304347739639,1.011680801513268,0.34210526315789475,0.8672311676275243,1.0,3/8,6.30%,OSR1;WNT4;PKD2
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.6314454949964647,1.011571427983742,0.525,0.8669534440511844,1.0,2/5,7.60%,HS3ST5;UST
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.6635527762303486,1.0115052382932486,0.5344827586206896,0.8665887959641352,1.0,3/5,29.46%,MVK;MVD;PMVK
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.6897173410643795,-1.0114178358245582,0.6326530612244898,1.0,1.0,3/5,14.83%,CEACAM1;SPI1;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5383846140868498,-1.011266731733763,0.5245901639344263,1.0,1.0,5/13,33.04%,THBS1;CCL5;CSF1R;CXCL17;MAPK3
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.49050069894547893,-1.0111829153955256,0.49230769230769234,1.0,1.0,8/30,17.95%,TICRR;DTL;DONSON;ABRAXAS1;BRCA1;CDKN1A;NOP53;TOPBP1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5361874242110237,-1.0109389271843838,0.5185185185185185,1.0,1.0,3/18,5.87%,TRIM62;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4492064774538978,1.010856653809959,0.4473684210526316,0.8679247120242976,1.0,6/27,12.64%,NGF;FGF10;EPOR;RAPGEF1;IRS2;NOTCH1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.5834675623786318,-1.0107825681097984,0.5166666666666667,1.0,1.0,2/8,8.38%,AZIN1;ARG2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4297898143087345,1.0106611696852832,0.4,0.8679781931754343,1.0,12/35,25.03%,ARC;PHACTR1;FARP1;MAP6;EPHB2;CTNNA2;DCDC2;PAK3;PTEN;MAP2;TAOK2;CTNND2
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6060464193975718,1.0103618227223403,0.5121951219512195,0.8678151489291606,1.0,2/7,23.48%,TPR;PCID2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6060464193975718,1.0103618227223403,0.5121951219512195,0.8678151489291606,1.0,2/7,23.48%,TPR;PCID2
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.524551290681938,1.0103611990669679,0.42424242424242425,0.8673466486218907,1.0,2/7,7.42%,SIRT1;TMEM106A
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5111365742008848,-1.0101287770994838,0.5285714285714286,1.0,1.0,5/18,9.81%,PSMB9;AIM2;BEX3;NLRP12;USP50
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.594552198262125,-1.010128082066709,0.48333333333333334,1.0,1.0,3/9,12.29%,ZFPM1;GATA4;HEY2
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.48743551330348767,1.0101212156606296,0.5405405405405406,0.8674785826770294,1.0,7/21,11.52%,NLGN1;DEF8;ABI3;KANK1;PLEKHM1;EPS8;EVL
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.37928298524132775,1.009817599533735,0.4375,0.867636437611423,1.0,19/51,21.65%,TGFBR1;RAB31;KLF10;TGIF1;SERPINE1;LTBP2;WWTR1;HDAC1;JUNB;PPM1A;SMURF1;FNTA;SKI;PMEPA1;SMAD7;ACVR1;FURIN;BMPR2;BMPR1A
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.34264059791245527,1.009745491001378,0.45,0.867299092258501,1.0,33/148,15.00%,PER2;FGFR1;NEUROD2;KIAA0319;POU3F2;AUTS2;ATOH7;WNT4;CX3CR1;FZD5;LHX2;SH3RF1;ERBB2;WNT3A;PEX13;NR4A2;TAFA1;CDK6;SDCCAG8;FZD1;ADNP2;NLGN4X;ASCL1;HES1;CASP3;MYT1L;SNPH;FUT9;RUNX1;NAV1;HES6;RYK;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.32884057362363645,1.0095417499222659,0.35,0.8673266744439899,1.0,50/246,18.42%,FOXO1;RASSF2;NGF;FANK1;DAPK2;PLEKHG2;BCL6;SCRIB;BIN1;TOP2A;SIRT1;FGD4;HTRA2;SNCA;TRIM35;HMGB1;SLIT2;NLRP2B;MAPK8;ABL1;LATS1;MAP3K10;FGD1;CASP3;RRP1B;UNC13B;BMP4;IAPP;MELK;CRADD;NF1;RYBP;VAV2;RPS6KA2;GADD45G;UBE2Z;ATM;MARK4;DUSP6;LAPTM5;PAWR;FAF1;SLC27A4;GPLD1;AIFM2;ATF6;FADD;CALHM2;BID;CLIP3
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.4365140812758462,1.0092910335396972,0.3548387096774194,0.8674930247125555,1.0,5/39,10.24%,LLGL1;NLGN1;RHOBTB3;RHOBTB1;RND3
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.37979062392010093,-1.0091587160142195,0.4605263157894737,1.0,1.0,32/175,16.26%,CLEC5A;APOL1;TRIM58;JCHAIN;TRIM62;HCK;TRIM5;SP100;SFTPD;BLK;TRIM25;CYBA;CIITA;PIK3CG;RNF39;OAS1;CFD;TRIM77;TLR2;SLC11A1;MASP1;IFIT1;RNF187;TRIM56;NOS2;CXCL16;BPIFB1;MASP2;IFI27;PTX3;ISG15;NLRP9
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3519910828338189,-1.0091341064602244,0.45569620253164556,1.0,1.0,75/436,17.72%,CD44;IRF4;CRLF1;DUOX1;PSMB9;TGFB1;AIM2;ITGB2;CXCL13;TRIM62;HCK;TRIM5;SP100;IFNK;MMP9;IL7;HLA-DRB1;ALOX5;IRF1;STAT1;TXNDC17;IL21R;TRIM25;ANXA1;HLA-A;TEC;TNFRSF1B;CIITA;CCND1;IL27;CARD14;CA1;SOD2;CEACAM1;OSMR;TRAF3IP2;ALOX15;OAS1;INPP5D;IFIT3;IL3RA;PTAFR;SPI1;IFIT1;RORC;CFL1;HLA-DPB1;IL12A;CLCF1;CDKN1A;HSPA8;IL10RB;OPRM1;NOS2;OAS2;IL18BP;HLA-F;LCP1;HLA-DPA1;CSF2RA;IFI27;PIK3CB;ITGAM;ISG15;MSN;FN1;TNFSF18;CAMK2A;TNFRSF11A;IFNGR2;CD27;IFI6;PSMA7;RBX1;PSMB6
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.4741520909151337,1.0090592116028343,0.41025641025641024,0.8675117978037936,1.0,4/17,11.44%,SDC4;RAB7A;CHMP6;SMPD3
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5326951024559021,1.0088506598616975,0.38461538461538464,0.867591206731242,1.0,4/13,22.30%,MGARP;SPAST;UXT;HIF1A
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6127237142189235,-1.0086915797711105,0.5161290322580645,1.0,1.0,3/6,33.46%,TRNT1;PTCD1;SSB
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.6024520122464976,1.0084204677056936,0.5,0.8679736419600763,1.0,4/6,34.42%,NR4A3;HAVCR1;NECTIN2;CRLF2
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.6363995217012144,-1.0081314539584882,0.41509433962264153,1.0,1.0,2/6,23.79%,RMI2;MSH6
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5216566477559514,-1.0080425324858031,0.4918032786885246,1.0,1.0,6/18,23.10%,SLC22A3;ABCG2;ABCB1;SLC22A4;SLC47A1;SLC22A1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.6326972082785761,1.0078226303670739,0.5609756097560976,0.8690913769859657,1.0,1/6,3.58%,PARVA
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.4220139142792245,1.0074419639809986,0.36363636363636365,0.869602312749531,1.0,10/40,20.39%,DGKD;SLC30A10;TGFA;EFEMP1;GAB1;PIK3CA;BRAF;SOS1;NCK2;KIF16B
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.4025184678163993,1.0073886323589176,0.42105263157894735,0.8692999590983208,1.0,12/37,19.27%,TNFSF14;MAP3K14;MAPK8;MAP3K1;TLR5;CRADD;CASP8AP2;NFKB1;CD40;F11R;FADD;GADD45A
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.46648181761791546,-1.0072417718967313,0.46153846153846156,1.0,1.0,4/46,7.13%,PSMB9;BHMT;NQO1;AZIN1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.4412975600095765,1.0071129218843318,0.4634146341463415,0.869490487711538,1.0,2/22,3.09%,MT1G;MT4
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5214460743964131,-1.0069339832335054,0.4528301886792453,1.0,1.0,5/15,16.55%,AHR;TNFRSF1B;IL27;IL12A;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.3951328190739206,1.0067823008888943,0.4146341463414634,0.869818986165742,1.0,8/58,10.05%,KIT;FGFR1;FGF18;FLT3;ERBB2;MAP3K10;TENM1;PDGFD
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.4496064806088901,-1.006749034434184,0.4696969696969697,1.0,1.0,22/46,27.86%,PWP2;MPV17L2;EIF6;RPL3;RPS27;BRIX1;MRPL20;NOP53;RPL5;RPS14;DDX3X;RPS15;RPSA;RPS28;SBDS;RPL11;RPL24;RPS19;RPL10;DHX37;RPLP0;MRPS2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.4212060862158281,1.0067142369305215,0.4,0.869491121396376,1.0,8/28,17.88%,OSR1;LRP6;TWIST1;HDAC1;SKI;MYH3;SHH;NIPBL
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.5560966911882819,-1.0063249696055367,0.375,1.0,1.0,9/11,24.39%,AIM2;GSDMA;GSDME;NLRC4;NLRP9;NAIP;CASP8;APIP;NLRP1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.622981099540239,-1.0063069105202047,0.47540983606557374,1.0,1.0,1/9,1.13%,AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.622981099540239,-1.0063069105202047,0.47540983606557374,1.0,1.0,1/9,1.13%,AHR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5964836635636757,-1.0061150981550595,0.5370370370370371,1.0,1.0,1/7,16.28%,MSN
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5964836635636757,-1.0061150981550595,0.5370370370370371,1.0,1.0,1/7,16.28%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5964836635636757,-1.0061150981550595,0.5370370370370371,1.0,1.0,1/7,16.28%,MSN
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.44023010199662166,1.0059526784800676,0.4666666666666667,0.8710097479901835,1.0,8/19,20.18%,TFB1M;METTL15;FBLL1;FBL;BUD23;ZCCHC4;METTL16;NSUN4
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.3744765707306337,1.005849941651435,0.4230769230769231,0.8707591840911657,1.0,35/95,24.58%,SIRT1;SMARCD3;ZBTB1;SMARCB1;SRCAP;PIH1D1;SMARCA4;BPTF;PBRM1;MYC;ARID1A;CHD4;HDAC1;SMARCA2;GATAD2B;HDAC4;BAZ1B;BAZ2B;ARID1B;SATB2;BAZ2A;KAT2B;HDAC5;FOXP3;NUDT5;ZBTB7A;RSF1;SMARCAD1;SUV39H2;PADI4;RBBP4;KDM4C;KDM5B;TADA2A;KDM5C
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5328863649781883,1.005724376676845,0.5,0.8705692184884908,1.0,3/15,14.63%,INTS11;INTS9;INTS14
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.5992289392519131,-1.0055475567237826,0.5576923076923077,1.0,1.0,2/7,24.59%,ADCK1;BNIP3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.37608128052410056,1.0055430325882324,0.3793103448275862,0.8705517118285307,1.0,20/90,22.23%,CPSF1;NUP210;NXF5;NUP42;AAAS;U2AF1;NXT1;SRRM1;NXF1;SRSF4;SMG1;SMG5;SYMPK;SMG6;RANBP2;U2AF2;EIF4A3;NUP214;EIF4E;TPR
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.6377130624076446,-1.0054751322888418,0.5,1.0,1.0,2/5,28.66%,WBP2;YAP1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.3495590751514199,1.00521952098791,0.4375,0.8709646068400111,1.0,23/98,15.13%,LGR5;FREM1;GPC4;SPON1;TMEM132C;TNFRSF19;PARM1;PDE9A;MSI1;PDZRN3;WNK2;COBL;HID1;VWA2;NEO1;ZNF704;PTPRT;RALGPS1;RAI2;LRRN1;EPHB2;PPP1R9A;ASXL3
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.5193994728890696,1.0051977043448705,0.45,0.870542565308266,1.0,3/12,12.52%,TGFBR1;PKD2;BMP4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.5876745239516368,-1.0050311113092751,0.4067796610169492,1.0,1.0,1/8,0.90%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.43540948881307745,1.0045495530753021,0.4,0.8715224842053517,1.0,6/33,10.44%,MIDN;IRS1;APOE;DRD3;DRD4;RAB11FIP3
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.35117155452846105,-1.0045390559398428,0.4470588235294118,1.0,1.0,30/304,14.34%,CD44;CLEC5A;WNT5A;KIF14;DAB2;HCK;MMP9;IL7;BCL2L2;FLT4;ANXA1;WFS1;CARD14;PRAME;PPT1;HTR2B;SMAD6;DNAJA1;IFIT3;LRP2;COPS5;VDAC1;CFL1;NTRK1;ATF5;TAF9B;TEK;NAA38;THBS1;SFRP1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.6213974970878018,-1.004462468515421,0.5333333333333333,1.0,1.0,3/7,18.12%,CYP3A5;CYP3A4;NIT1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.4140788778312386,-1.0042792893950732,0.391304347826087,1.0,1.0,3/65,5.82%,SLC28A2;GAD1;SLC22A3
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.48257803355260004,1.0038399906745026,0.4772727272727273,0.8729825474421896,1.0,1/18,0.78%,SMYD2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5549680375189303,1.0037341640247868,0.47619047619047616,0.8727490397886037,1.0,4/10,26.82%,STAT5B;LYN;PRLR;STAT3
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.6508847458017976,-1.0035852649679198,0.5645161290322581,1.0,1.0,2/5,14.43%,HTR2B;PTGER3
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.37736438070482714,1.0033816887272335,0.4482758620689655,0.873168164080225,1.0,31/113,17.65%,SNX18;ASAP3;ERBB2;SRGAP2;RGS16;RAPGEF1;PLIN5;MAPK8;PLXNB1;RGS7;LIMS1;RGS6;RAP1A;RAP1GDS1;SNX9;RAPGEF3;NF1;EVI5L;CD40;DOCK9;PKP4;FNTA;ARHGAP27;F11R;DOCK11;F2R;RSU1;SGSM3;MAPK12;TBC1D2;ARHGAP11A
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.540451337683201,-1.002882863898623,0.5192307692307693,1.0,1.0,4/11,22.42%,USP13;HERPUD1;AQP11;UBXN1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.6259187620889747,1.0023176698078073,0.5111111111111111,0.875439917067097,1.0,5/5,37.42%,FZD7;BMP2;FRS2;SMAD4;SOX6
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.49725951453621525,-1.0022313837502415,0.5,1.0,1.0,2/17,6.29%,SLC28A1;PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4750661497088604,1.002195583344682,0.5,0.8752654606021669,1.0,4/23,12.93%,ACD;CTC1;TERF1;GNL3L
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.575129555078526,1.0017227160208988,0.4594594594594595,0.8759653022731083,1.0,4/12,8.31%,LIPC;SNCA;PLIN5;LPL
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3870188202945749,1.001708589828174,0.5151515151515151,0.8754995405850554,1.0,10/62,8.74%,FGF10;LSM10;ADAMTS1;CDK4;PKD2;PLCB1;CDK6;CCND3;SLFN11;RBL1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.3470359591640052,1.0016070383188138,0.4230769230769231,0.8752568578640899,1.0,16/123,9.82%,IRGM;HIP1;SNCAIP;APOE;PACSIN2;URI1;CDH13;PAK5;WNT3A;RAPGEF1;NRG3;ABL1;LATS1;SGK1;ZFYVE16;ABL2
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.648283305258952,-1.0013734714056266,0.5370370370370371,1.0,1.0,2/5,22.95%,SFRP1;INHA
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.38434018104834816,1.0013493476365576,0.43333333333333335,0.8753994402139996,1.0,29/111,17.10%,MEGF10;PCDH17;NOVA1;NLGN1;LRRC4C;PTPRZ1;DOK5;SLC35F1;SLIT2;KCNIP1;SYNDIG1;ADGRA1;GUCY1A2;PDZRN3;PDGFD;BRINP1;RGS7BP;NPAS3;EFS;MAP6;SNAP91;ANK2;CDH4;PTPRD;ASXL3;CORO2B;MARK1;PPFIA2;FAT3
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.3626593954111367,-1.0010433600216768,0.4266666666666667,1.0,1.0,63/192,26.99%,RPL37A;PWP2;NOB1;SENP3;RPL15;INTS5;RPL3;RPL38;RPL35A;RPS9;RPL7A;EMG1;RPL13;RPS27;RPL13A;RPS16;SMAD3;NOP53;RPL27A;RPL9;LAS1L;RPL5;RPL21;RPL34;RPL4;RPL23;WDR12;RPS14;EXOSC2;RPL18A;RPL32;IMP3;RPL36;EXOSC8;RPL18;RPL29;RPS7;RPS15;RPL41;RPS28;RPLP1;SBDS;RPL12;RPL11;RPL35;RPL22;RPL27;RPL24;PDCD11;RPLP2;RPS19;RPL28;RPL19;RPS24;RPL10;RPS25;PIH1D2;DDX49;DHX37;RPS6;EBNA1BP2;RPL8;RPLP0
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5031863170698561,-1.000732202461244,0.4153846153846154,1.0,1.0,1/17,1.04%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5031863170698561,-1.000732202461244,0.4153846153846154,1.0,1.0,1/17,1.04%,MGST1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.6343004115585386,1.0001550551070568,0.5238095238095238,0.8780729018466777,1.0,2/6,29.93%,RAB11B;RAB11FIP2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.49851136647374483,-0.9999301217880705,0.4126984126984127,1.0,1.0,5/15,22.74%,KCNA5;KCNQ1;KCNE2;ATP1A1;KCNJ5
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.5278696810146869,0.9997534196838463,0.43478260869565216,0.8786838135669452,1.0,3/8,12.64%,LRP6;PHACTR4;NOTCH1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.397904384980458,0.9997243566521807,0.4186046511627907,0.8782776274136118,1.0,14/53,14.85%,KIT;FGFR1;FLT3;ERBB2;EPHA3;FER;ABI3;ABL1;ABL2;EFEMP1;LCK;FGFR3;INSR;EPHB2
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),0.6391556582202317,0.9996856485773621,0.48936170212765956,0.877906034432035,1.0,1/5,12.52%,BMP4
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3873941943059575,0.9996743241379767,0.4411764705882353,0.877440997400576,1.0,15/67,16.36%,PHLDB2;TGFBR1;ASAP3;SORBS3;CGNL1;ABL1;ALMS1;CCN2;EVL;WASF2;CCDC88A;PXN;RAPGEF3;TMEFF2;F11R
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.4985503006182453,-0.9995820681069282,0.4666666666666667,1.0,1.0,7/25,23.11%,EIF6;RPL7A;LAS1L;WDR12;NSA2;RPL35;DDX18
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.46822101977872815,0.9995741955543863,0.5238095238095238,0.8772152361518261,1.0,8/25,15.12%,GPC4;SDC4;GPC6;HPSE;GPC5;GLB1;SDC3;HPSE2
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.31499099159942323,0.9995717413991845,0.38095238095238093,0.8767340429339698,1.0,91/359,19.76%,TEAD2;ESRRG;TGFBR1;MLF1;POU6F2;OR7D2;ZNF195;HDAC10;ZNF117;MITF;MAFB;ZNF212;RORA;SLC39A8;TULP3;PCGF1;ZFPL1;ATXN1;SOX12;ZNF263;APBB3;RORB;GPBP1L1;PML;ZBTB4;SPIN2B;ZNF274;NCOA2;HP1BP3;TESMIN;SP1;ABL1;FOXN3;ZNF331;ZNF703;FADS1;ZNF33A;MLXIPL;EFEMP1;POFUT1;ZSCAN21;HCLS1;ZNF519;DMTF1;NSD1;WWTR1;SMARCA2;CREM;NOTCH1;ZNF2;SCRT1;CARM1;MAGED1;PRMT5;SOX13;RPS6KA4;NR3C1;MYBL2;RYBP;NFYC;ZNF646;INSR;HES6;ZNF273;PPARGC1B;CXXC1;ASCC2;FZD7;MSC;UBE2L3;THAP7;FUS;ZNF675;ERC1;SUPT3H;BAZ2A;SP3;ZNF66;KAT6B;ZNF708;CHD7;JMJD1C;FOXP3;YAF2;DENND4A;SPIN1;EP300;WWC1;GLI4;NFX1;PRRX2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.3856484392884542,-0.9992328210850615,0.44776119402985076,1.0,1.0,5/109,1.85%,ENPP2;DUOX1;FGF20;KIF14;TGFB1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.4866199897341681,0.9991472527207357,0.4857142857142857,0.8772414633097856,1.0,4/16,12.23%,TRPM2;FLT3;BATF2;LGALS9
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.37143765783435334,0.9990485111290293,0.38235294117647056,0.8769736159336239,1.0,32/106,18.77%,ZSWIM5;PLPPR1;HDC;DSCAML1;ZDHHC11B;ASAP3;TMPRSS2;PPP1R13B;PIK3C2B;USP54;PDE9A;KIAA1671;WNK2;PLXNB1;EBF4;COBL;HID1;NEO1;ZNF704;PTPRT;FGFR3;RALGPS1;RAI2;CGN;PPP1R9A;SRCIN1;SGK2;MYRIP;SHH;ERBB3;EPB41L4B;CAMSAP3
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),0.613862060550987,0.998990716870886,0.47368421052631576,0.8766039580940895,1.0,1/6,12.60%,APOBEC1
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.6251046549922354,0.9989834364068756,0.5116279069767442,0.8756873695186929,1.0,1/6,3.15%,GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.6251046549922354,0.9989834364068756,0.5116279069767442,0.8756873695186929,1.0,1/6,3.15%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.5426746839367689,0.9986567344476902,0.5588235294117647,0.8761345121312653,1.0,7/15,19.66%,PCM1;ROBO2;WNT3A;NOTCH1;ELAPOR2;APPL2;PAX6
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.38402575125230737,0.9985576387464142,0.3,0.8758849815792593,1.0,10/57,15.21%,VEGFC;HSPB1;MAPKAPK2;CLEC14A;CRK;WASF2;PXN;VAV2;PIK3CA;DOCK1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.45923063695973687,0.9973932631148521,0.42857142857142855,0.878368028135108,1.0,2/14,12.28%,KPTN;RNF128
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.4666693194891435,0.997381429439853,0.35714285714285715,0.8779055311765982,1.0,5/18,16.61%,F2;SNCA;ANK2;CEMIP;F2R
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.4154573501577141,0.9969148465919091,0.46153846153846156,0.8786641057971237,1.0,7/20,22.35%,TFB1M;FBLL1;FBL;BUD23;ZCCHC4;NSUN4;THUMPD1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.5906375772865308,-0.9967892124085163,0.5517241379310345,1.0,1.0,2/7,5.34%,GLYCTK;ALDOB
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.3954506281524436,0.996774916615984,0.43243243243243246,0.8785323417279741,1.0,9/51,12.76%,FBP2;PER2;PC;ENO3;CRY1;G6PC3;IRS2;SLC25A1;SLC25A12
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5226824988369216,-0.9962939979292476,0.5081967213114754,1.0,1.0,3/13,2.84%,TGFB1;DAB2;NODAL
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.6114924054420228,-0.9960469968833021,0.4827586206896552,1.0,1.0,2/6,13.45%,DCTN1;HSPA8
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.6323487113242927,-0.9958877914165372,0.5454545454545454,1.0,1.0,2/5,5.34%,GLYCTK;ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.6323487113242927,-0.9958877914165372,0.5454545454545454,1.0,1.0,2/5,5.34%,GLYCTK;ALDOB
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.37579267533044436,0.9956126946217971,0.3333333333333333,0.8807714591566265,1.0,21/93,22.23%,CPSF1;NUP210;NXF5;NUP42;AAAS;U2AF1;NXT1;SRRM1;NXF1;SRSF4;XPO5;SMG1;SMG5;SYMPK;SMG6;RANBP2;U2AF2;EIF4A3;NUP214;EIF4E;TPR
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.31750655197610456,0.995578993836287,0.35714285714285715,0.8803594346149184,1.0,63/256,20.00%,GMNC;GRK5;TGFBR1;FGF10;MLF1;PER2;BIN1;PROX1;SIRT1;CDK4;HTRA2;SIPA1;MAGI2;MED25;PKD2;PML;GBF1;PPP1R13B;CDK6;NLRP2B;ABL1;HPGD;MAEA;PLAGL1;ZNF703;NANOS3;AKT2;ERN1;LRP6;NR4A1;MLXIPL;PHACTR4;LIN52;BRINP1;MYC;BMP4;JUNB;NOTCH1;PIM2;RASSF1;CDC14B;MYBL2;RPS6KA2;TBRG4;GADD45G;SETMAR;PNPT1;ATM;FBXL22;PES1;MAPK12;PPP1R9B;CDC26;KAT2B;DLGAP5;GADD45A;FAP;EP300;ADAM10;PTK6;MEN1;MAP2K6;TP53
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.4484433535390339,-0.9954903395761675,0.45161290322580644,1.0,1.0,5/32,13.34%,CASQ2;GRK7;ANXA1;MTCH1;TRDN
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.33610593658713456,0.9952138222126493,0.3684210526315789,0.8808443751558339,1.0,56/264,19.53%,FOXO1;RASSF2;NGF;FANK1;DAPK2;PLEKHG2;TGFBR1;BCL6;SCRIB;BIN1;TOP2A;EPHA7;SIRT1;FGD4;HTRA2;SNCA;TRIM35;HMGB1;PTGIS;SLIT2;NLRP2B;MAPK8;ABL1;LATS1;MAP3K10;FGD1;CASP3;RRP1B;UNC13B;BMP4;IAPP;MELK;CRADD;NF1;RYBP;VAV2;RPS6KA2;GADD45G;UBE2Z;ATM;DUSP6;PAWR;FAF1;SLC27A4;GPLD1;AIFM2;ATF6;FADD;CALHM2;BID;CLIP3;BNIP3L;SOS1;GADD45A;FAP;QRICH1
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.5773256183882114,-0.9950467681586259,0.5833333333333334,1.0,1.0,1/11,0.48%,DBH
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.4498708947627321,0.9948814166458263,0.4523809523809524,0.8810160232681487,1.0,4/19,12.11%,ACSM2A;THEM5;SCD5;SLC25A1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.5227539478061027,-0.9947548387148482,0.4642857142857143,1.0,1.0,5/15,28.68%,SFRP1;CD27;ZFP36L1;INHA;BTK
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4309817713466624,0.9947286429165553,0.42857142857142855,0.8809255810604659,1.0,11/31,21.75%,KPTN;EPM2A;SIRT1;DEPTOR;RNF152;ATM;MINAR1;SZT2;PRKAA2;SESN2;NPRL2
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),0.6387051669610847,0.9946365971545912,0.5263157894736842,0.8806916906371208,1.0,3/5,24.10%,SLC25A42;SLC25A41;SLC17A9
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.41155645067243624,-0.9946007689104381,0.5151515151515151,1.0,1.0,7/59,14.82%,NEK2;GPER1;FOXO4;BRCA1;RBBP7;MAX;TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5758314409371525,0.9944065344018933,0.4666666666666667,0.880736552078655,1.0,2/9,9.84%,SLC30A10;ABCD2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.5408549232470674,0.9942963057894495,0.5121951219512195,0.8806126699130581,1.0,3/10,20.16%,MFSD2A;MTMR3;MTMR1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.5383406597376251,-0.9942497163217235,0.509090909090909,1.0,1.0,6/12,22.95%,CYP26B1;CYP3A5;CYP3A4;SCPEP1;ALDH8A1;ALDH1A3
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.6367069058431897,-0.9941232939759364,0.559322033898305,1.0,1.0,2/5,5.52%,P2RY12;GPR183
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5119643463371595,0.9940827796732215,0.5806451612903226,0.8806238048746955,1.0,4/19,25.67%,JADE3;MSL2;JADE2;KMT2A
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5529265305998907,0.9939344865906626,0.45454545454545453,0.880567522986819,1.0,6/11,22.79%,RGN;FADS1;UGDH;SLC35D1;PAH;CYP2C8
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.6637075361143671,-0.9936078310640248,0.6122448979591837,1.0,1.0,2/5,5.29%,HLA-DRB1;HLA-DMA
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4108315755112062,0.9934360296232422,0.43243243243243246,0.8813618261239333,1.0,3/26,2.65%,CD38;SH2B2;BCL2
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.5577258514091168,-0.9932882726096265,0.46875,1.0,1.0,1/12,0.48%,DBH
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.4467650684198747,-0.9932209354664293,0.4666666666666667,1.0,1.0,11/32,15.77%,F8;C1QTNF1;F7;GP1BA;CPB2;PLG;PLAU;VTN;A2M;TFPI;PLAT
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.5576334224203057,0.9932001575732765,0.4791666666666667,0.8814735347799235,1.0,6/8,35.59%,SREBF2;ARHGEF10L;INSIG1;ERLIN1;ERLIN2;SCAP
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.31567474351080527,0.9929671394109035,0.4375,0.8815851224736443,1.0,95/362,21.65%,ERG;DGKD;DAPK2;GRK5;TGFBR1;FGFR1;MAPKAPK2;CDK14;LMTK3;EPHA7;FRK;CDK4;BCKDK;CSK;MAML1;ERBB2;PAK5;CILK1;VRK2;TRIB2;FER;CDK6;MAPK8;MAST1;ABL1;SIK3;LATS1;EIF2AK3;SGK1;MAST2;MAP3K1;TNIK;ERN1;MAP3K9;WNK2;PKN2;CDK18;FASTK;LCK;TSSK4;RET;MAP3K21;MAP3K13;PXK;MARK3;PIM2;MELK;FAM20B;RPS6KA4;CDK8;INSR;EPHB2;CDK16;RYK;PIK3CA;DGKZ;DGKH;NEK1;MAP4K2;SGK2;ATM;MARK4;BCR;MARK1;DYRK3;BRAF;TBCK;MATK;WNK3;MORC3;PRKCE;ACVR2A;CREB1;ADAM10;PTK6;MARK2;PDK1;PPP4R1;SIK2;XYLB;PAK3;PAK2;LIMK1;CLK2;PRKAG2;ACVR1;TNK2;PNKP;NIM1K;CDK5;PRKAA2;PIK3R4;BMPR2;PIK3CD;BMPR1A
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.5700383522116762,-0.9927949491802868,0.5396825396825397,1.0,1.0,6/10,34.38%,TLR2;RPS27A;UBB;B2M;UBC;PGK1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.5769182698456172,0.992543513075674,0.5238095238095238,0.8822094383216081,1.0,3/7,29.05%,PDSS2;MVK;MVD
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.48163509649833247,0.9922178499595573,0.4666666666666667,0.8825221748107931,1.0,3/17,4.45%,HSPB1;SIRT1;HTRA2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.39081327491059353,0.9916497926047428,0.425,0.883548426182785,1.0,12/70,10.20%,GCK;FOXO1;IRS1;SIRT1;ACSM2A;PPARG;RFX6;CRY1;CYB5R4;MLXIPL;LEPR;MCU
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.593591132387664,0.9915180876119853,0.5128205128205128,0.8834068397844713,1.0,3/6,10.90%,DNMT1;SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.4339598137833906,0.9912629624482794,0.4411764705882353,0.8830654327287406,1.0,2/24,4.25%,CPSF1;PCF11
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.4339598137833906,0.9912629624482794,0.4411764705882353,0.8830654327287406,1.0,2/24,4.25%,CPSF1;PCF11
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5594017325609918,-0.9910558390331503,0.5294117647058824,1.0,1.0,4/11,26.90%,SEC62;SGTB;HSPA5;CHMP4B
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.47104100276393046,0.9902457916594919,0.45714285714285713,0.8848852912978691,1.0,11/26,13.08%,VCAN;CSGALNACT1;CHSY3;CHST12;CHSY1;ARSB;UGDH;CHST11;CSPG5;CHPF2;DSEL
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.38262665780613964,0.9902052992439984,0.43243243243243246,0.8844836448878182,1.0,3/41,2.03%,DGKD;PNPLA3;PLD6
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3585588196245117,0.9900010913337071,0.4642857142857143,0.8845009873228374,1.0,42/122,24.60%,HDAC3;HDAC10;SIRT1;SMARCD3;HIRIP3;ZBTB1;HP1BP3;SMARCB1;PIH1D1;SMARCA4;BPTF;PBRM1;MYC;ARID1A;HDAC1;SMARCA2;HDAC4;BAZ1B;BAZ2B;HDAC11;SETD2;CHD1;SATB2;BAZ2A;KAT2B;HDAC5;FOXP3;NUDT5;PHF1;ZBTB7A;RSF1;BRWD1;SMARCAD1;SUV39H2;PADI4;RBBP4;SETD7;KDM4C;KDM5B;TADA2A;KDM5C;EZH2
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5519564619254026,0.9898367391488162,0.5277777777777778,0.8843928118871193,1.0,5/8,39.40%,NIPBL;PDGFRA;EPHB3;FGFR2;AGR2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.5726886304812062,-0.9898359943437813,0.5409836065573771,1.0,1.0,4/9,31.91%,FIS1;BNIP3;VPS35;CCAR2
prerank,PanglaoDB_Augmented_2021__Neurons,0.31667302337271985,0.9896838942488541,0.43333333333333335,0.884351649772958,1.0,73/267,19.99%,SLC17A6;LHFPL4;RORA;GRM3;PROX1;LRRTM3;NXPH1;ELAVL3;CADM2;CNTNAP2;CACNB4;PCLO;PAK5;SAFB2;NCALD;RIN1;RESP18;ERC2;PDE1A;CELF4;LUZP2;ADGRA1;SLC6A17;PNISR;CACNG2;CTTNBP2;CELF5;TESC;RAB3C;BRINP1;ELAVL4;GPATCH8;RGS7BP;SFSWAP;SGIP1;OLFM3;NWD2;CHODL;GNL3L;SCRT1;RBFOX1;SNAP91;MECP2;ZMYND11;CPNE6;PPP1R9A;CSPP1;NRXN1;SACS;SRRM4;RIT2;HDAC11;FRRS1L;RHBDD2;PPFIA2;SYN1;MYO5A;MATK;SLC36A4;TMEM196;ADGRB3;ZCCHC7;ZNF445;DZANK1;GRM5;VSTM2B;CTNNA2;UNC79;B3GAT2;ST8SIA3;MMD2;TRIP11;NBEA
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.5537063034628977,0.9894801020733172,0.4878048780487805,0.8843439623895759,1.0,2/6,24.73%,MYO1C;JCAD
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.4404994298656414,0.989376275829754,0.41379310344827586,0.8840856897226393,1.0,4/45,6.50%,PNP;CCDC88B;ICOSLG;HMGB1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.45356077214924784,0.9889163954656658,0.4772727272727273,0.8845957685613521,1.0,10/26,24.91%,CD14;TICAM2;TANK;TICAM1;CD40;FADD;UBE2D2;TRAF3;UBE2D3;IKBKB
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.35503212016927,0.9888725874439316,0.48148148148148145,0.884237508320995,1.0,13/90,9.60%,RASSF2;HDAC3;DUSP15;SH3RF1;TNFRSF19;HMGB1;FKTN;PLCB1;CARD9;SH3RF3;CCN2;MAP3K10;RAP2A
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.6121755798042732,0.9887378004903639,0.45652173913043476,0.8840797847001888,1.0,2/6,17.42%,STAT5B;CSAD
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.4496657395115898,0.9886426280919574,0.48936170212765956,0.8837888672199833,1.0,10/25,25.01%,ACD;CTC1;TERF1;DACH1;GNL3L;MEN1;TP53;BMPR2;STN1;XRN1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5787254990680601,-0.9886021977998598,0.559322033898305,1.0,1.0,2/10,11.56%,PINK1;REST
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.43666204152418886,-0.9885898696499162,0.4918032786885246,1.0,1.0,7/46,10.74%,TGFB1;DAB2;NODAL;BMP3;SMAD6;TTK;GDF11
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.454663339540092,0.9885470159395904,0.5135135135135135,0.8835815689546231,1.0,5/18,26.73%,GPSM1;RRP1B;F11R;WNK1;LRCH1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.5098036812758447,-0.9885381884323887,0.5084745762711864,1.0,1.0,3/21,4.35%,CASQ2;CAV3;HTR1B
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.45243178705719433,0.9884120078711449,0.47368421052631576,0.8834993867651578,1.0,2/18,1.43%,GPR33;SH2B2
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),0.6291423770691189,0.9882092242906474,0.4634146341463415,0.8835005106094926,1.0,3/5,22.67%,SRGAP2;NEXMIF;TNN
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.5715997451120607,0.9880336325674267,0.5272727272727272,0.8833685557338861,1.0,1/8,2.49%,LYPD1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.5278378583485305,0.9879912900227745,0.43243243243243246,0.8825317863699695,1.0,4/9,24.94%,NFATC3;NFAT5;PPP3CC;NFATC1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.5278378583485305,0.9879912900227745,0.43243243243243246,0.8825317863699695,1.0,4/9,24.94%,NFATC3;NFAT5;PPP3CC;NFATC1
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),0.5969592683472871,0.9877827816109398,0.6111111111111112,0.8826662891059023,1.0,2/6,26.17%,BMP4;MEF2C
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.553066602726964,-0.9877453960140425,0.45161290322580644,1.0,1.0,1/11,6.65%,RTP5
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.4255127421350711,0.9876482347578784,0.44680851063829785,0.8825018635255499,1.0,6/28,17.03%,SMYD5;TET2;ATPSCKMT;KMT5C;KMT5B;SETD2
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.5128135961708906,-0.9875290664582185,0.47761194029850745,1.0,1.0,1/14,1.01%,TICRR
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.3348435572592886,0.987382377735341,0.5666666666666667,0.8827606657374364,1.0,29/120,16.27%,TGFBR1;USH2A;NEUROD2;POU3F2;ATOH7;WNT4;FZD5;LHX2;RORB;ERBB2;WNT3A;NR4A2;TENM3;FZD1;LRP6;TENM1;UGDH;ADNP2;NLGN4X;ASCL1;CASP3;MYT1L;SNPH;FUT9;RUNX1;RYK;PTPRD;PBX1;FZD7
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5549312852056321,0.987278527076197,0.5142857142857142,0.8826212374221571,1.0,6/11,29.81%,ADAMTS1;NR4A3;PRKG1;MEF2C;DOCK7;DOCK4
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.34761433601773767,0.9872420613879447,0.5384615384615384,0.8822665142027407,1.0,11/74,10.23%,CDH5;TMTC2;HTR2C;SLC8A1;DRD5;RGN;SLC8A3;SNCA;DRD3;DRD4;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.5185004126760954,0.9871513351639748,0.4864864864864865,0.8819701422876671,1.0,3/10,7.10%,BCL6;SOX12;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.380284428231454,0.9869469395579156,0.45454545454545453,0.882030017121103,1.0,6/80,2.97%,GPR3;ESRRG;ELOVL6;PER2;HDAC3;ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.47496106945387023,-0.9865129708469411,0.5074626865671642,1.0,1.0,1/25,1.85%,TGFB1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.6353808349312471,-0.9862769753277634,0.5806451612903226,1.0,1.0,1/6,10.97%,GATA4
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.5371487832859644,-0.9862513927232516,0.453125,1.0,1.0,4/10,29.89%,MOAP1;BLOC1S2;BNIP3;VDAC2
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.5864697251931503,-0.9860167035912437,0.5357142857142857,1.0,1.0,3/9,25.63%,TAS1R1;GNAT3;PKD1L3
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.3715823267803339,0.9860044926863459,0.45714285714285713,0.883909900616043,1.0,9/67,5.28%,APOH;CPN1;APOB;F2;ADGRG6;PROX1;GOLT1A;DSP;FZD5
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.4405018157352367,0.985513836125962,0.4166666666666667,0.8848286193555753,1.0,2/17,7.34%,SIRT1;POLD3
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.60509656239325,-0.985501327130023,0.5454545454545454,1.0,1.0,1/6,0.84%,ACTC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6207845867152324,0.9854422729077089,0.5526315789473685,0.8839786712227138,1.0,1/6,16.38%,ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6207845867152324,0.9854422729077089,0.5526315789473685,0.8839786712227138,1.0,1/6,16.38%,ANAPC7
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5161885574738193,-0.9853681821475123,0.543859649122807,1.0,1.0,1/17,0.70%,POLQ
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.374949199526166,0.9853311060488806,0.5172413793103449,0.8837814000915624,1.0,11/81,7.91%,FIBIN;MXRA5;MRGPRF;ACTG2;CLEC14A;EDNRA;PARVA;COL12A1;SEMA5A;MMP2;PAMR1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.4005227475673853,0.9851891130614876,0.5,0.8836338450213235,1.0,15/65,22.23%,ARC;NXF5;U2AF1;SRRM1;NXF1;SRSF4;RBFOX1;PNPT1;XPO5;U2AF2;SIDT1;EIF4A3;NUP214;EIF4E;TPR
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.6636267227262564,-0.985135813398537,0.5357142857142857,1.0,1.0,2/5,19.59%,MRLN;PLN
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.6000658359495576,-0.9840023450941897,0.5555555555555556,1.0,1.0,2/6,18.49%,RNF26;HOOK2
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.3220946711491419,0.9834435416987976,0.42105263157894735,0.8876180478844783,1.0,38/238,15.23%,TEAD2;MATN1;CD247;LLGL1;QRICH2;MITF;PARD3;NLGN1;RP1L1;LRRTM3;PARVA;FSCN3;PCLO;WNT3A;JHY;SLC7A9;PML;TRIP13;SPAG16;FZD1;FLNA;ACD;CEP290;P3H4;NLGN4X;WASF3;EPS8;HES1;IL2RB;LIMS1;FSCN1;MAGI1;SNX9;CALD1;GEMIN5;CD40;NLGN3;QSOX1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.3704285249281016,0.9834149011424911,0.5,0.887213101652487,1.0,45/127,21.40%,MRAP2;KCNB2;EHD4;SPTBN4;NKD2;BSG;KCNIP3;TMEM150A;TNIK;DPP10;FLNA;LRP6;RAP2A;TESC;RAB3C;KCNIP4;PDZD11;JUP;TMEM88;TSPAN17;RAP1A;RAB40A;ANK2;RAB10;SMURF1;DPP6;EMP2;ARL3;F11R;EFR3B;ZDHHC3;PACS1;MYO5A;SLMAP;TTC7B;WNK3;ANK1;RAB3D;LIN7A;TRARG1;RAB40C;WDR19;DLG1;PLEKHF1;ZDHHC23
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.47271402105256916,0.9833293128265954,0.48936170212765956,0.8868992024476762,1.0,9/16,28.51%,LRRTM3;SP1;CASP3;GSAP;SLC2A13;ABCA2;ABCG1;RELA;EPHA4
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.33383499919075654,0.9832306051339731,0.5263157894736842,0.8866350375294819,1.0,28/225,10.23%,KLHL17;VCAN;POU6F2;ROBO2;MFSD2A;GRIK1;ADGRL2;EPHA7;PROX1;DSCAML1;IL1RAPL2;DNAJC30;ATXN1;PITPNM1;SOX12;CX3CR1;CNTNAP2;PTPRZ1;SLC8A3;JHY;PKD2;NR4A2;CHST8;MAST1;SLC6A17;RPS6KA3;SNTG2;GRIN1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.5063494147947719,-0.9830840160106589,0.5692307692307692,1.0,1.0,4/12,19.91%,KCNQ1;KCNE3;KCNE2;ATP1A1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.48819171834518416,0.9828662844814577,0.45714285714285713,0.8870706376197662,1.0,2/23,1.66%,NOX4;CBS
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4435408624456781,0.9828163913581724,0.5,0.8867079630635586,1.0,10/20,28.51%,LRRTM3;SP1;CASP3;GSAP;LYN;SLC2A13;ABCA2;ABCG1;RELA;EPHA4
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6046233517407382,0.9826307067181793,0.4857142857142857,0.8867402576886195,1.0,3/6,30.94%,ARFIP1;EIPR1;ATP9A
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3945240993466498,0.9825248120473433,0.5714285714285714,0.8865013841531062,1.0,15/33,25.62%,UTRN;OSR1;WNK2;FGF12;FGF14;NEDD4;SLMAP;NETO1;WNK3;PRKCE;DMD;WNK1;ANK3;FGF13;STK39
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.36551714450617084,-0.9823983665343871,0.46153846153846156,1.0,1.0,28/180,13.43%,CD44;ITGB2;COL1A1;COL5A1;ECM2;MMP21;DCN;TGFBI;MMP9;ICAM3;COL27A1;NID1;ITGA9;MMP19;ITGB6;COL18A1;COL4A4;MATN4;VIT;COL4A3;COL24A1;LOX;ITGA2B;LAMC2;MMP25;ACAN;COL23A1;PXDN
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.5103217759397958,-0.9818788421388481,0.5362318840579711,1.0,1.0,4/16,17.57%,HHIP;NLRP12;OPRM1;IGFBP3
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.6061873134693687,0.981734850073928,0.5384615384615384,0.8878230126053652,1.0,3/6,31.52%,EGR1;HIF1A;HPN
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.457426954796402,0.9817234205678506,0.4634146341463415,0.8873868394345702,1.0,4/25,13.23%,FGF10;PROX1;BMP4;ITGA3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),0.6033211783618222,0.9816163432597907,0.49019607843137253,0.8872956599012572,1.0,1/5,1.03%,TSKU
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5712288320499185,0.9815481888261262,0.5263157894736842,0.8869996056224305,1.0,4/8,33.06%,CHD1;ST3GAL2;ST3GAL4;SETD5
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.4611545796445411,0.9812945514149958,0.5,0.8870316442293958,1.0,2/20,8.29%,TRA2A;CELF4
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.45018991288317267,0.9811012131790297,0.5789473684210527,0.886973556912264,1.0,5/22,13.15%,SPRED3;IL17RD;SPRED2;ADIPOR1;SPRED1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5528836097553396,-0.9810049832946184,0.5490196078431373,1.0,1.0,6/11,36.41%,CCT8;CCT6A;CCT7;CCT2;MEPCE;CCT5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5528836097553396,-0.9810049832946184,0.5490196078431373,1.0,1.0,6/11,36.41%,CCT8;CCT6A;CCT7;CCT2;MEPCE;CCT5
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.5547244137210114,0.980934799281815,0.5121951219512195,0.8869564602036659,1.0,4/6,19.54%,KDM2A;DACH1;SMAD7;CREB1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.5555378677759114,0.9809332285448636,0.4772727272727273,0.8864893951903939,1.0,2/8,14.50%,PCGF5;MECP2
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.49900345552464587,0.9808018586667104,0.4523809523809524,0.8864071531947211,1.0,4/12,14.27%,FZD5;CXXC4;COBL;SMAD2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.5545747718487004,0.9803372009989537,0.38,0.8873547908903368,1.0,2/7,3.30%,SCRIB;GRIP1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.46033661790153924,0.9801700609811107,0.4864864864864865,0.8873130237046821,1.0,9/26,19.17%,SLC3A2;SLC38A5;SLC7A2;SLC25A29;SLC7A8;SLC25A12;SLC6A20;SLC36A4;SLC1A3
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.5428334655391884,0.9800570690246738,0.5227272727272727,0.8871814923222713,1.0,6/9,38.66%,DLGAP5;POGZ;CENPE;CENPT;CENPF;CENPC
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.4241494596037008,-0.9799957250908352,0.44776119402985076,1.0,1.0,1/57,0.31%,NEK2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.5084647689915053,-0.979920556949828,0.5161290322580645,1.0,1.0,5/18,18.51%,ZFPM1;SMAD6;GATA4;HEY2;HEY1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.3946915945964894,0.9799157311262003,0.42424242424242425,0.8870582591871489,1.0,15/42,21.27%,NRG1;SNCA;RAB7A;EPHA3;WWP2;PXK;PLSCR1;NR1H3;ABCA7;LRSAM1;ERBB3;RUBCN;PIP4P2;SNX33;PTEN
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.5833330879612614,0.979884849007487,0.5833333333333334,0.8866578582115024,1.0,3/7,19.29%,PDZD11;RAB10;LIN7A
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5595957398695774,-0.9795753474223238,0.47540983606557374,1.0,1.0,2/10,15.59%,LCP1;TTN
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.5547898942033276,-0.9794990148312539,0.5081967213114754,1.0,1.0,1/10,6.65%,RTP5
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.41906581423570266,-0.9793489913574472,0.5166666666666667,1.0,1.0,10/57,16.33%,AQP3;HAMP;ZACN;TRPV6;NDRG1;THBS1;HVCN1;TTN;HAAO;CALM1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.32309919633630935,0.9792014199780363,0.4827586206896552,0.8879126362582536,1.0,47/137,24.42%,ELOVL6;SLC44A5;MFSD2A;APOE;LPCAT2;ABHD3;GSTM5;GPHN;ACER2;ELOVL4;GSTO2;PLPP2;HACD1;CHPT1;ACHE;CEPT1;ACER3;PLA2G4C;GSTZ1;GSTA4;CHKA;GSTM2;PPM1L;PLPP3;GCH1;CERS4;FA2H;ELOVL1;PAM;SLC44A4;ELOVL5;LPIN2;SAMD8;DMD;ST3GAL2;FURIN;CERS5;PAH;LARGE1;CPS1;SLC44A2;ASL;GAL3ST2;PEMT;CSNK1G2;ACER1;GSTT2B
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.4244507848431959,-0.9785149891399043,0.47540983606557374,1.0,1.0,14/46,23.84%,HAMP;ATP6AP1;FTH1;NUBP1;SLC11A1;ABCG2;CP;FRRS1;CYB561A3;ISCU;HEPH;ALAS2;SKP1;BMP6
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.43906797987539764,-0.9783385605724314,0.49206349206349204,1.0,1.0,6/33,7.39%,AHR;IL7;GPR183;BLK;VAV3;PTPRC
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.45480612659681924,0.9781129936855787,0.5277777777777778,0.8902170932002706,1.0,9/28,19.17%,SLC3A2;SLC38A5;SLC7A9;SLC7A2;SLC7A8;SLC25A12;SLC6A20;SLC36A4;SLC1A3
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.49407445215260853,-0.9778338262548913,0.5396825396825397,1.0,1.0,4/22,23.29%,SP100;APOD;USP17L2;PARK7
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.6026436893706195,0.9777859755721785,0.525,0.8906218209332727,1.0,1/6,1.47%,THEM4
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3066719542967899,0.9777140258123239,0.5714285714285714,0.8902936406191296,1.0,194/787,19.80%,FOXO1;SMYD2;CD38;PER2;PRICKLE1;HDAC3;HDAC10;KLF10;TWIST2;ZNF692;ZNF239;MITF;OSR1;TLE2;TSHZ3;BCL6;AASS;ZBTB7B;RARB;PROX1;FRK;PCGF1;URI1;SIRT1;PRDM5;ATXN1;MTERF3;PHC2;SFMBT1;WNT4;E2F6;GATAD2A;HJV;TGIF1;ZNF263;IFI16;PPARG;ZEB2;CBFB;RORB;NRG1;KCNIP3;SNCA;MED25;SIRT7;BCL11A;PER3;CTBP2;NR4A2;PML;CRY1;HMGB1;ZBTB4;ZNF274;HIC2;HEXIM2;PLCB1;ZBTB1;WWP2;FOXP2;ATF3;NRIP1;WWOX;KDM8;PLK3;CIART;TAF3;FOXN3;FHL2;NKAP;ZNF688;ZNF703;IKZF4;ZEB1;MAP3K10;FLNA;MIER2;MLXIPL;BCOR;ZNF133;SPEN;TWIST1;NOTCH4;ASCL1;KDM2A;TIMELESS;HES1;SMARCA4;BPTF;DACH1;MYC;MYT1L;MDFIC;LIMS1;NSD1;HDAC1;SMARCA2;RBFOX2;BMP4;NFIC;CREM;NOTCH1;NR4A3;KAT6A;SCMH1;SCRT1;ZNF202;GFI1B;ZNF337;CUX1;PPM1A;ZNF846;DLX1;SIRT6;GATAD2B;MXI1;DPF1;SOX13;RUNX1;NFKB1;NR3C1;SP2;SMAD2;ZNF75A;NR2F2;HDAC4;SAP130;ZNF599;MECP2;MBTD1;KLF12;THRB;ZMYND11;OTUD7B;DPF3;NR1H3;NR6A1;HSF1;NCOA5;ZBTB2;CREB3L1;CXXC5;IMPACT;ATF7IP;SPINDOC;ZNF589;HIVEP1;SKI;ARID5B;ZNF12;NR2C1;BCL3;MYPOP;SHH;THAP7;RCOR2;HSF4;ZNF675;ETV5;ZGLP1;ZNF706;NIPBL;ATN1;RBPJ;MPHOSPH8;ZBTB5;ZMYM5;DPF2;HDAC5;SP3;ZNF79;ZHX3;ZNF69;KHDRBS1;SREBF2;KAT6B;NFIX;TBL1X;DMRT1;UXT;FOXP3;YAF2;GADD45A;SMAD7;PA2G4;EP300;WWC1;CREB1;ZNF785;NFX1;PAX6;POU2F1;MEN1;SLA2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.5831252873513081,0.9774012688208398,0.5111111111111111,0.8907223078271752,1.0,3/6,24.51%,PPARG;FAM120B;RXRA
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.589520643651747,-0.9773870943344442,0.5,1.0,1.0,4/7,18.98%,HLA-DRB1;IL18BP;LEF1;IL18
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5479701627429677,-0.9772529401361283,0.5294117647058824,1.0,1.0,4/12,16.83%,ALOX5;WFS1;CLU;AQP11
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.5051035620389366,0.9771247524080776,0.5789473684210527,0.8909066205943028,1.0,3/10,19.97%,CX3CR1;LBP;PLCG2
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.545624754205747,0.9768920810293453,0.5348837209302325,0.8910338589754251,1.0,5/11,13.08%,VCAN;CHST12;UST;CSPG5;DSEL
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.6123391657465337,-0.976780669361445,0.6333333333333333,1.0,1.0,1/6,6.27%,CYBA
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.4964812015239881,-0.9766956737722788,0.46153846153846156,1.0,1.0,1/17,1.85%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.46711692994885484,-0.9766131844885126,0.578125,1.0,1.0,9/35,18.71%,WNT5A;ITGB2;CLU;REST;DDIT4;CDK5R1;ITGAM;GRN;DAXX
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.5330720710814291,0.9765422084702418,0.4782608695652174,0.8914289802241027,1.0,2/10,4.94%,FBP2;PFKP
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.5099392639360353,0.9764962334723897,0.5121951219512195,0.8910606482599686,1.0,1/12,4.95%,TET2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.4838849992780986,0.9764192076506172,0.4186046511627907,0.8908306255726816,1.0,3/13,15.92%,ATF3;GSTO2;HSF1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.6146873151342787,-0.9762990165776377,0.5272727272727272,1.0,1.0,2/7,15.78%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.3944041400856933,0.976274814305115,0.40540540540540543,0.8907792404881983,1.0,16/64,19.14%,PRSS3;PC;SLC19A1;DHFR;GSTO2;PDZD11;MTR;TCN2;ABCC1;ENPP1;MTHFR;PCCA;PNPO;FPGS;SHMT2;MCCC1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5825959871555265,-0.9762071536164706,0.5357142857142857,1.0,1.0,2/7,6.00%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4853680853530039,0.976149093311185,0.4473684210526316,0.8905901283139576,1.0,3/24,6.90%,FGF10;GREM1;RSPO2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.40847470819835996,0.9760836914381202,0.45161290322580644,0.8902797055157643,1.0,2/23,1.45%,DGKD;HIP1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.35705217451836996,0.976003523733957,0.5,0.889945317342573,1.0,38/150,17.65%,SNX18;FGD4;ASAP3;ERBB2;SRGAP2;RGS16;CRK;EPHA3;RAPGEF1;EFNA5;FGD5;GPSM1;PLXNB1;FGD1;RGS7;RRP1B;LIMS1;RASIP1;RGS6;RAP1A;RAP1GDS1;SNX9;RAPGEF3;NF1;EVI5L;VAV2;CD40;DOCK9;PKP4;ARHGAP27;F11R;PLXNA4;DOCK11;F2R;RSU1;SGSM3;TBC1D2;ARHGAP11A
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.3515422480932968,0.9759438367608573,0.4523809523809524,0.8896517379072513,1.0,26/76,22.82%,NGF;FGF10;LZTR1;EPOR;RAPGEF1;SPRY4;KANK1;MYO9B;EPS8;IRS2;NOTCH1;RALGPS1;EPHB2;STAMBP;CRKL;BCR;SGSM3;EPS8L2;DENND4A;MMD2;SHOC2;RAF1;DENND4B;SPRY3;DENND1A;LYN
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.5774864641627727,0.9758447433618991,0.5526315789473685,0.8893908156084004,1.0,2/7,7.44%,WNT4;H6PD
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.4052112177086621,0.9757679880141084,0.5,0.8891705831352316,1.0,5/53,7.71%,GCK;NUP210;NUP42;SLC25A33;AAAS
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.6539003297865151,-0.9756995860687887,0.5833333333333334,1.0,1.0,2/5,21.55%,MSN;AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.6539003297865151,-0.9756995860687887,0.5833333333333334,1.0,1.0,2/5,21.55%,MSN;AR
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.6646932269008171,0.9756550361098014,0.6111111111111112,0.888950579712997,1.0,2/5,25.01%,TOE1;XRN1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5617464855969164,-0.9754605124149949,0.5172413793103449,1.0,1.0,4/9,24.95%,PPT1;PROM2;CAV1;AXL
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4689562892290532,0.975327498040534,0.38636363636363635,0.8891426432401113,1.0,3/19,6.44%,SIRT1;IFI16;PML
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5763044877117252,-0.9753199782306852,0.5846153846153846,1.0,1.0,3/9,15.81%,SCIN;PITHD1;FAXDC2
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.5593820352689277,0.9752513918452486,0.574468085106383,0.888404876425568,1.0,1/8,5.86%,SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.5593820352689277,0.9752513918452486,0.574468085106383,0.888404876425568,1.0,1/8,5.86%,SLC25A33
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.5912524763101826,0.9752443095934145,0.5555555555555556,0.8879519090792509,1.0,1/6,8.27%,NOL8
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5571345984967058,-0.9752220974657695,0.5862068965517241,1.0,1.0,2/13,5.43%,ESR1;GPER1
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5766968225670481,-0.9750767318720088,0.5087719298245614,1.0,1.0,1/8,2.41%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5262465313161502,-0.9750216333405198,0.5172413793103449,1.0,1.0,1/12,5.98%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.38962110939620714,0.9749823630286351,0.5121951219512195,0.8880635070543937,1.0,18/47,21.53%,TBC1D10A;APOE;PERP;NKD2;ASTL;RHBDD1;TANK;SNX9;GPLD1;MAPK12;FADD;CTSC;ADAM8;AURKAIP1;SH3D19;FURIN;SNX33;ASPH
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.37158290853743053,0.9748720350823625,0.3783783783783784,0.8878608705045072,1.0,12/58,11.76%,EGLN3;CPEB1;RORA;SIRT1;MGARP;SLC8A3;PTGIS;HP1BP3;OPRD1;KCND2;TWIST1;MYC
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.3250023687235662,0.9747495604602963,0.5,0.8877630959618973,1.0,21/114,15.08%,F2;BCL2;CDH5;TRPC3;HTR2C;HCRTR1;SLC8A1;DRD5;RGN;SLC8A3;PML;DRD3;DRD4;MICU1;MCU;WBP2NL;SCGN;PDZD8;ANK2;SLC8B1;CD40
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.5522687510433779,0.9747188555085147,0.43243243243243246,0.8873757671709555,1.0,2/7,5.47%,DNMT1;PPARG
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.48083538469825965,0.9737236355934825,0.5111111111111111,0.8893129258947983,1.0,4/13,17.37%,TCOF1;NRG1;CDH2;SHH
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.3445166058710058,0.9736315994307323,0.41379310344827586,0.8890939869792696,1.0,7/69,7.80%,PRICKLE1;HDAC3;ANGPT1;COMMD1;RIPK2;CRY1;DCUN1D1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.43844134551018166,0.9735784858689339,0.4883720930232558,0.8887226378654223,1.0,8/29,23.43%,BCL2;PPP1R13B;MAPK8;BID;TFDP1;TP53;ZNF205;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.529821674355897,0.9735702538952864,0.5116279069767442,0.8878286115867483,1.0,3/9,20.01%,NSMAF;SMPD3;PLA2G6
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.529821674355897,0.9735702538952864,0.5116279069767442,0.8878286115867483,1.0,3/9,20.01%,NSMAF;SMPD3;PLA2G6
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.5954986353403812,0.9735489207459866,0.475,0.8874023434342979,1.0,1/6,3.73%,SIRT1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.4548830046073648,-0.9735423033498134,0.5454545454545454,1.0,1.0,4/27,14.75%,MISP;GPSM2;DCTN1;NDEL1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.46744803822432857,0.9735298034399315,0.42857142857142855,0.8869684982623597,1.0,6/28,12.64%,TGFBR1;ROBO2;PROX1;SLIT2;HES1;NOTCH1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.5455043973034152,0.9734029186109121,0.5581395348837209,0.8867915098684859,1.0,5/12,13.08%,VCAN;CHST12;UST;CSPG5;DSEL
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.40022318505424725,0.9733322215869561,0.5,0.8864945740394052,1.0,12/34,20.05%,IL16;RIPK2;HMGB1;PLCB1;MAST2;IL23A;LGALS9;PIBF1;CD40;LAPTM5;PLCG2;IL23R
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.3580014504292254,0.973157181290152,0.48484848484848486,0.886494111921991,1.0,20/64,15.63%,GRIN3A;NEUROD2;KIAA0319;SFMBT1;MARCHF5;BCL11A;DCC;GREM1;CDK6;VASH1;ANP32B;KANK1;NOTCH4;BMP4;NOTCH1;NFIB;RAPGEF3;FGFR3;ELAPOR2;RPS6KA6
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.6345831154910443,-0.9727937605089501,0.6428571428571429,1.0,1.0,2/5,22.15%,PDCD5;SGTB
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.43160902754319835,-0.9726324871107418,0.5352112676056338,1.0,1.0,3/40,6.71%,PKP2;SCN5A;WFS1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.5996416931974892,0.972567834198508,0.5909090909090909,0.8870209445463986,1.0,2/6,19.96%,USP44;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.5996416931974892,0.972567834198508,0.5909090909090909,0.8870209445463986,1.0,2/6,19.96%,USP44;CDK5RAP2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.3955972022339995,0.97228289972366,0.45714285714285713,0.8871321029109092,1.0,12/53,18.77%,PCM1;CCDC88B;PLK3;MAP10;SPAST;CLIP2;CCDC88A;DST;CLIP1;SLK;CLIP3;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4591816456945206,-0.9721031129955401,0.4714285714285714,1.0,1.0,2/27,4.58%,TCF7;IL7
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.3712452333945141,-0.9720212048588375,0.4927536231884058,1.0,1.0,22/123,21.33%,AMBP;APOL1;ITGB2;JCHAIN;DAB2;SFTPD;PPT1;CAV2;LRP2;MASP1;HPR;CXCL16;ITGAM;M6PR;AMN;ALB;HSPH1;ASGR1;COLEC12;CD81;STAB2;CAV1
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.5498485656919279,0.9719225915594057,0.42105263157894735,0.8876425505745976,1.0,2/7,4.53%,CFLAR;EYS
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.5632641012658539,-0.9718058723073093,0.4666666666666667,1.0,1.0,2/10,8.75%,NOTUM;PPT1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3978707223903162,0.9715689185230012,0.4375,0.8879927942831065,1.0,16/64,16.37%,NGF;ROBO2;SMARCD3;CX3CR1;SLIT2;PLXNB1;NUMB;SPEN;RGS14;DCT;CHODL;CUX1;MAP6;PTPRD;LIG4;PLXNA4
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.6068769076670556,-0.9714616651454879,0.5510204081632653,1.0,1.0,3/5,27.66%,SFRP4;ZFP36L1;ZFP36
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.5441419819313015,0.9714029479639902,0.4,0.8878638862238838,1.0,1/6,3.73%,SIRT1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.48021269596805505,0.9712848105490824,0.5,0.8872238264137355,1.0,7/14,28.61%,NANOS3;TNRC6C;AGO2;TNRC6B;TOB1;PABPC1;NANOS1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.48021269596805505,0.9712848105490824,0.5,0.8872238264137355,1.0,7/14,28.61%,NANOS3;TNRC6C;AGO2;TNRC6B;TOB1;PABPC1;NANOS1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.5548571917325746,-0.9706548152419817,0.5,1.0,1.0,1/9,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.5548571917325746,-0.9706548152419817,0.5,1.0,1.0,1/9,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.5903836854152048,-0.9705413218876278,0.5263157894736842,1.0,1.0,2/6,14.06%,ARG2;NOS2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.4973774015308389,0.970407369113899,0.42857142857142855,0.888840413179101,1.0,4/10,12.64%,SLC8A1;ALPK3;JAG1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.34713281980808675,0.9701051429686446,0.5428571428571428,0.889101546748222,1.0,14/143,7.42%,ADRA1A;ADRA1B;KIT;FGF10;FGFR1;KSR1;EPHA7;FLT3;ERBB2;PAK5;HMGB1;GREM1;VRK2;TMEM106A
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4877561503408616,0.9700395820455057,0.5294117647058824,0.888789334071254,1.0,1/11,1.95%,PER2
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.5674826478473801,0.9699192014157304,0.5238095238095238,0.8886445034869018,1.0,3/6,30.09%,SLC4A11;STK39;TRPV4
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.4578171134295144,0.9697457799279788,0.4444444444444444,0.8885634313783682,1.0,5/21,23.14%,TENM1;ICE1;POLR3G;CEBPA;ICE2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.5242792509701344,0.9694121934484827,0.4666666666666667,0.8890149054330475,1.0,4/14,13.83%,PUDP;UPP2;CDA;UCK2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.3288581474949314,0.9693884218398175,0.3684210526315789,0.8886080577311062,1.0,26/194,11.76%,ADRA1A;EGLN3;FOXO1;DAPK2;HIP1;TNFSF14;BCL2;ESPL1;CFLAR;CD14;TP53AIP1;TNFRSF19;PAK5;PAX3;DCC;PLK3;EFNA5;PLAGL1;MAP3K10;RNF152;GDF6;CASP3;BNIP2;BNIPL;ADAM15;MYC
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.4817524959771673,0.9691103068314332,0.5128205128205128,0.8886938494261526,1.0,7/16,33.41%,ATG2A;ATG12;ATG2B;ATG9B;ATG7;ATG3;WDR45
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.37687951806246295,0.9690727266777931,0.4827586206896552,0.8883431265209013,1.0,7/51,8.25%,APOE;SIRT1;AKR1C3;PKD2;FER;PLK3;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.5260446938292994,0.9687028623458245,0.5128205128205128,0.8887303433055744,1.0,3/10,12.73%,APOE;LDLR;IAPP
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.4262250923697329,0.9685872299549381,0.42424242424242425,0.8884909368048881,1.0,13/36,21.48%,ATXN1;BACH2;ANP32A;AAAS;NXT1;SNRPB;RGS14;GEMIN5;NUTF2;MALT1;XPO1;NEMF;SNRPF
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.4912898601398833,0.9685763436454361,0.6176470588235294,0.888061624955532,1.0,3/13,5.52%,VEGFC;CDH13;IL16
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5380644139059758,0.968521752875024,0.46153846153846156,0.8868554204374632,1.0,5/11,24.92%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.5380644139059758,0.968521752875024,0.46153846153846156,0.8868554204374632,1.0,5/11,24.92%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5380644139059758,0.968521752875024,0.46153846153846156,0.8868554204374632,1.0,5/11,24.92%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.356477824074398,0.9683469476541618,0.46875,0.8868152464849633,1.0,17/111,9.69%,MT1G;NEUROD2;NLGN1;CPNE4;MT4;ITPKB;SYT17;TRPM2;AKR1C3;SNCA;PKD2;CPNE7;SLC25A24;MAPK8;SYT3;SYT1;ADGRV1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.4018278361902917,-0.9679753980029134,0.5405405405405406,1.0,1.0,20/52,26.63%,CCNG2;CCND1;CDC25A;CCNF;CDKN2D;CDKN1A;CDC6;CDK5R1;CDKN3;CDC37;CCNI2;CCNE2;CCND2;GTPBP4;CDKN1B;CCNI;CDK7;HSP90AB1;BLM;CDK5R2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.43063125329899493,0.9678900493923822,0.5142857142857142,0.8875100688471415,1.0,10/22,20.05%,IL16;RIPK2;HMGB1;PLCB1;IL23A;LGALS9;CD40;LAPTM5;PLCG2;IL23R
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3670803704766796,0.9677833531573614,0.4,0.8872879321584065,1.0,38/123,18.68%,MRAP2;KCNB2;EHD4;SPTBN4;NKD2;BSG;KCNIP3;TMEM150A;TNIK;DPP10;FLNA;LRP6;RAP2A;TESC;RAB3C;KCNIP4;JUP;TMEM88;CCDC88A;TSPAN17;RAP1A;RAB40A;ANK2;RAB10;SMURF1;DPP6;EMP2;NECTIN3;F11R;EFR3B;ZDHHC3;PACS1;MYO5A;SLMAP;TTC7B;WNK3;ANK1;RAB3D
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.5541347009369275,-0.9676721440691387,0.5428571428571428,1.0,1.0,1/12,1.48%,ELOVL2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.47727918445632206,0.9676655786315906,0.4888888888888889,0.8871212842267273,1.0,4/19,12.23%,KLRD1;ARRB2;CADM1;LGALS9
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5506734208053108,0.9673895606164267,0.5476190476190477,0.8872309802759544,1.0,3/9,14.33%,HDAC3;HDAC1;HDAC4
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.5943253537040569,-0.9673619125928332,0.5517241379310345,1.0,1.0,2/6,10.40%,ABCG2;ABCB1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.6092818176882674,0.9673581588938096,0.5813953488372093,0.886883136327055,1.0,2/6,14.53%,SIRT1;SMCHD1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.42127496042074425,0.9671465463929765,0.47058823529411764,0.8868430706078505,1.0,9/33,15.50%,CYP1A2;CSGALNACT1;CARNMT1;PTGIS;GLUD1;GSTO2;CYP2S1;CYP4F3;LIPT2
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),-0.6315240247973504,-0.9671218691524508,0.5344827586206896,1.0,1.0,2/6,25.36%,BCL2L12;CARD8
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.49691993213669816,0.9669076519395052,0.4883720930232558,0.8869606195604973,1.0,2/12,7.37%,SERPINE1;SLIT2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.35868136226468794,-0.9668624753331532,0.48484848484848486,1.0,1.0,22/137,14.10%,IRF4;TGFB1;ITGB2;CXCL13;MMP9;IL7;STAT1;HLA-DMA;HLA-A;PTPRC;LY86;CARTPT;TLR2;NLRP3;SPI1;BRCA1;RPS9;IGSF6;IL12A;WAS;NOS2;GCNT1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.41517513799695965,0.9668267983871667,0.5588235294117647,0.8866843139254424,1.0,6/27,9.48%,LHFPL2;KIT;WNT4;AKR1C3;MAMLD1;KITLG
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.34933168192458974,0.9663154824762852,0.48484848484848486,0.887455093913957,1.0,29/97,22.40%,NGB;NXPH1;HRH3;ELAVL3;PPFIA3;CASKIN1;ADGRA1;GRIN1;BRINP1;B4GALNT4;CSPG5;RIMS4;FBLL1;SCRT1;PRR36;MAP6;SNAP91;SRRM3;MPP2;SYN1;CLIP3;GRM5;VSTM2B;MMD2;PNCK;JPH3;HPCA;TUBB2B;KCNQ2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.29696924324514545,0.9662676431506642,0.75,0.8871001503731759,1.0,175/735,19.78%,ERG;NPAS4;SKAP1;FOXO1;HDAC3;GALR3;KLF10;MITF;OSR1;CREB3L4;RORA;NFATC3;RARB;POU3F2;PROX1;SIRT1;CDH13;GABPB2;PTOV1;AUTS2;BCL11B;PID1;SMARCD3;SOX12;FSTL3;TET2;HJV;ZNF263;FZD5;IFI16;MAML1;PPARG;ZEB2;RORB;SSBP3;SERPINE1;WNT3A;RFX6;MED25;SIRT7;CTBP2;MED17;RIPK2;PKD2;NCOA3;PAX3;NR4A2;ZNF300;HMGB1;GREM1;NCOA2;ETV1;PCGF5;STAT5B;ATF3;SP1;NRIP1;WWOX;SMARCB1;ABL1;TCF20;RBL1;PLAGL1;SENP1;BCLAF3;LRP6;NR4A1;SP7;MLXIPL;JAG1;ATF1;ZSCAN21;RPS6KA3;HCLS1;GRIN1;RNF10;JUP;TWIST1;NOTCH4;ZNF462;ASCL1;TFE3;HES1;TNIP3;SMARCA4;BPTF;RRP1B;NAMPT;MYC;CITED4;CCN1;WWTR1;HDAC1;SMARCA2;BMP4;JUNB;NFIC;STING1;NOTCH1;NR4A3;USP16;KAT6A;NFIB;BARX2;DLX1;PLSCR1;DPF1;TFCP2;RPS6KA4;MYOCD;RUNX1;NFKB1;NR3C1;MYBL2;SMAD2;NR2F2;HDAC4;ARRB1;CDK8;RLF;THRB;CD40;ASXL3;DPF3;NFAT5;BRD4;NR1H3;BCL9L;HSF1;PPARGC1B;FOXF2;PBX1;ATM;HIVEP1;SKI;GABPA;ZNF609;GABPB1;ATAD2B;SHH;ATF6;SATB2;FADD;ETV5;ZGLP1;RBPJ;DPF2;FOXJ2;KAT2B;HDAC5;TCF4;SP3;KLF6;CREB3L3;ASXL1;DLGAP5;SREBF2;AGO2;KAT6B;NFIX;LPIN2;TBL1X;ACVR2A;DMRT1;FOXP3;EGR1;TFDP1;SMAD7;NCK2;EP300;WWC1;CREB1;PAX6;POU2F1;MEN1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.5246386668738339,0.9661803547890564,0.47368421052631576,0.8868792328892348,1.0,3/13,12.73%,APOE;LDLR;IAPP
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.5356121196567799,0.9660977447578318,0.5454545454545454,0.8865642335813668,1.0,3/9,14.44%,DHFR;MTR;NREP
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.38088394745009807,-0.9660853592696876,0.5733333333333334,1.0,1.0,23/126,13.35%,NRAP;MYH7;ACTC1;CASQ2;HAMP;C14ORF180;OBSCN;LMOD1;CTNNA3;CAV3;KLHL38;MYBPC3;CKMT2;GPIHBP1;CKB;ART3;SLC5A1;GATA4;LOX;HEY2;COX7A1;TRDN;CSRP3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.6374336664261283,-0.9653307270661055,0.578125,1.0,1.0,1/6,16.11%,RAC1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.36058729789736527,0.9653244327530461,0.34375,0.887938335392925,1.0,10/89,12.11%,RFWD3;HDAC3;HDAC10;TOP2A;SIRT1;ABL1;LATS1;SMARCA4;MYC;HDAC1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.6390190246627117,0.9651839987584291,0.6571428571428571,0.8879371526080566,1.0,2/6,19.87%,SPATA7;TCTN2
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.5614637116398167,0.9648468878339145,0.5238095238095238,0.8877151892062534,1.0,2/6,11.51%,LDLR;STARD4
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.5614637116398167,0.9648468878339145,0.5238095238095238,0.8877151892062534,1.0,2/6,11.51%,LDLR;STARD4
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.415691641547343,0.9645674782911887,0.5151515151515151,0.8878238661063281,1.0,8/29,14.14%,OSR1;CREB3L2;EIF2AK3;BMP4;NFIB;SOX5;FGFR3;RUNX1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.5717902001785882,-0.9639657712728524,0.5535714285714286,1.0,1.0,4/10,23.39%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.6359632488686378,-0.9638981035159669,0.5818181818181818,1.0,1.0,1/5,8.43%,EIF6
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.5165814891309155,-0.9638516068346831,0.5423728813559322,1.0,1.0,7/14,25.84%,SCN5A;GATA4;HEY2;HEY1;ENG;DAND5;TMEM65
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.6368998011171261,-0.9638305863917312,0.5818181818181818,1.0,1.0,1/5,1.85%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.6368998011171261,-0.9638305863917312,0.5818181818181818,1.0,1.0,1/5,1.85%,TGFB1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3942532015986009,0.9638030862926442,0.41379310344827586,0.8892017029952893,1.0,9/32,17.37%,KPTN;TELO2;SIK3;RNF152;PIH1D1;CLEC16A;KLHL22;ATM;DYRK3
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.6002690182289924,-0.963698391430489,0.5882352941176471,1.0,1.0,2/7,9.60%,HAT1;CHAF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.6002690182289924,-0.963698391430489,0.5882352941176471,1.0,1.0,2/7,9.60%,HAT1;CHAF1A
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.47587132371882024,0.9633603152136381,0.6,0.8897089045607441,1.0,2/21,5.76%,DDAH2;SNCA
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.4594152258395815,-0.9631333935213038,0.4857142857142857,1.0,1.0,3/24,3.37%,PKP2;ITGB2;CTNNA3
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.3676580934700747,0.9630899658692453,0.5277777777777778,0.8900120904057863,1.0,28/101,19.75%,RASSF2;KIT;FGFR1;F2;EPHA7;FLT3;ERBB2;EPHA3;DRD4;RET;CCN1;RAP1A;SNX9;FGFR3;INSR;EPHB2;RYK;ROR1;RAD50;EPHA6;TYRO3;ERBB3;EPHA8;NTRK2;EPHB4;MUSK;MMD2;TAB2
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.5821801850835974,0.9630598870277757,0.5952380952380952,0.8896187094944583,1.0,1/8,1.83%,RAB31
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.5046339338070042,0.9627718971309245,0.4722222222222222,0.8899841893626295,1.0,6/12,16.26%,MFSD2A;RP1L1;RORB;CEP290;CDHR1;ARL3
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.5040690798127163,0.9624727464327303,0.5111111111111111,0.8902789639187334,1.0,5/12,12.64%,ROBO2;SLIT2;JAG1;BMP4;NOTCH1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.3337336637732807,0.9624027446084835,0.5517241379310345,0.8900110239678791,1.0,23/109,15.21%,ADGRL2;APOE;HTR2C;GPC6;CGNL1;BCAM;CLIC6;MPDZ;PDZRN3;PLXNB1;COBL;UNC13B;RNF128;FARP1;DDAH1;NEO1;PTPRF;EFS;MAGI1;MAP6;FGFR3;PRICKLE2;PLPP3
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.5133805808558919,-0.9618349135296378,0.5081967213114754,1.0,1.0,3/14,8.69%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.405126386894755,-0.9618225999756027,0.5161290322580645,1.0,1.0,6/46,14.06%,WNT5A;SCIMP;CYBA;TLR2;C1QTNF4;NOS2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.4982650650739271,-0.9616509814714927,0.5423728813559322,1.0,1.0,6/17,21.33%,TGFB1;UBE3A;THBS1;TGFB3;WBP2;CAV1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.5788244728573361,-0.9615581485722188,0.576271186440678,1.0,1.0,3/7,21.09%,TGFB1;SMAD3;AGT
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5417050304942559,0.9614407807828316,0.5897435897435898,0.8918045167301248,1.0,5/11,13.43%,DOC2B;SYT1;RIMS2;UNC13B;UNC13C
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.4773727281230423,-0.9612316517144367,0.5555555555555556,1.0,1.0,2/17,4.35%,CASQ2;HTR1B
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.373416826834649,0.9609852647938668,0.43243243243243246,0.8924490910613324,1.0,17/65,20.27%,HNRNPF;ANKLE1;HNRNPH1;DXO;HNRNPL;RBFOX2;POLG;ENPP1;WDR74;SETMAR;PTBP1;GTF2F2;RAD50;DNA2;LSM8;POLR2F;XRN2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4086417380745456,0.9609780105549607,0.5121951219512195,0.892024473244644,1.0,5/23,14.40%,PCGF1;RNF168;UBE2E1;BCOR;RYBP
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.3912107786705497,0.9609287624213961,0.46153846153846156,0.8916938297563571,1.0,12/50,18.09%,SLC16A9;SLC3A2;SLC38A5;SLC16A7;SLC16A5;SLC6A17;SLC25A29;SLC7A8;SLC7A6;SLC6A20;SLC16A6;SLC36A4
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4439724178029816,0.9609162354192275,0.5333333333333333,0.8908388404535251,1.0,6/21,20.00%,BCL2;PPP1R13B;MAPK8;BID;TFDP1;TP53
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4439724178029816,0.9609162354192275,0.5333333333333333,0.8908388404535251,1.0,6/21,20.00%,BCL2;PPP1R13B;MAPK8;BID;TFDP1;TP53
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5903482651801104,-0.9606498744166526,0.5483870967741935,1.0,1.0,3/8,20.02%,ERI2;EXOSC2;EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5903482651801104,-0.9606498744166526,0.5483870967741935,1.0,1.0,3/8,20.02%,ERI2;EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.5976891347823112,-0.9605863570857027,0.5806451612903226,1.0,1.0,1/7,6.51%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.540680373705881,0.9604952366143533,0.5681818181818182,0.8913966602776293,1.0,4/7,21.75%,GREM1;LEPR;SUCO;SYT7
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.45179998362200596,0.960476221084376,0.5675675675675675,0.8910125329567996,1.0,5/21,18.98%,PNPLA3;PLA2G15;AWAT2;MOGAT2;LPIN2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.3952599132911724,0.9600093992307505,0.5769230769230769,0.891647469231642,1.0,20/57,21.49%,KIT;ADGRG3;FLT3;TOX;ITGA4;LEPR;LCK;RAG2;HDAC4;GPR89A;PBX1;GPR89B;HDAC5;KLF6;CHD7;PLCG2;IL11;ZBTB7A;PTPRJ;PIK3CD
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.4333609731304887,0.9598084506699798,0.4375,0.8916444427858724,1.0,6/20,14.51%,SLC8A3;MICU1;MCU;PDZD8;RAP1GDS1;SLC8B1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5281340224476522,-0.9594397617615953,0.559322033898305,1.0,1.0,2/10,10.09%,SYNE2;DCTN1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.3700283362095189,0.9593678577956557,0.47058823529411764,0.8922551229694164,1.0,8/80,9.84%,PRICKLE1;APOE;RANBP17;GDAP1;PEX13;NXT1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.328616574846762,0.9593557528874346,0.5,0.891840276431346,1.0,26/111,17.02%,ARC;PHLDB2;BCL6;LRRC4C;PID1;MARCHF5;ERBB2;SARM1;LZTS3;VASH1;ABI3;EFNA5;TNIK;RAP2A;PDZD8;ARHGAP35;CDH2;BMPER;NF1;EMP2;BCL9L;ZMYM4;SRCIN1;TSPAN12;NEDD4;PPFIA2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5145784215875874,0.959335203350603,0.5,0.891472408161763,1.0,5/12,8.31%,CDH13;PPARG;LDLR;ABCA1;LPL
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.4593933071628627,-0.9591732938997787,0.5606060606060606,1.0,1.0,1/30,1.26%,KIF14
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4438360647926423,0.9587745690427355,0.4411764705882353,0.8920247534697372,1.0,10/23,21.40%,ZDHHC11B;ZDHHC12;GOLGA7B;ZDHHC18;ZDHHC14;ZDHHC3;CLIP3;ZDHHC11;ZDHHC9;ZDHHC23
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4438360647926423,0.9587745690427355,0.4411764705882353,0.8920247534697372,1.0,10/23,21.40%,ZDHHC11B;ZDHHC12;GOLGA7B;ZDHHC18;ZDHHC14;ZDHHC3;CLIP3;ZDHHC11;ZDHHC9;ZDHHC23
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.5364621154509384,-0.9586707067008301,0.543859649122807,1.0,1.0,1/11,0.79%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5636430665199678,-0.9585484096553356,0.5818181818181818,1.0,1.0,3/10,16.33%,CASQ2;TRDN;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5636430665199678,-0.9585484096553356,0.5818181818181818,1.0,1.0,3/10,16.33%,CASQ2;TRDN;CALM1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5431977868960616,-0.958421588996057,0.5714285714285714,1.0,1.0,3/10,15.58%,DCN;IL12A;PIK3CB
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.3771158074059684,0.9582300958209328,0.46875,0.8929514312050891,1.0,15/57,20.18%,TRDMT1;TFB1M;METTL1;METTL8;PCIF1;MTO1;FBLL1;FBL;ZC3H13;TRMT61B;BUD23;TRMT61A;ZCCHC4;METTL16;NSUN4
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.34417186671392613,0.9581682162542617,0.5,0.892622468378511,1.0,32/113,21.73%,BAMBI;TGFBR1;DUSP15;PARD3;CDH5;SIRT1;HJV;ARRB2;HPGD;LTBP2;ZFYVE16;GDF6;BMP4;TWSG1;PXN;SMAD2;CGN;SMURF1;FNTA;F11R;HIVEP1;SKI;ACVR2A;SMAD7;APPL2;USP15;ACVR1;FURIN;ZFYVE9;BMPR2;BMPR1A;AMH
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.5944620073182498,-0.9576539416093908,0.6,1.0,1.0,1/6,10.40%,ABCB1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.3865280163794602,0.9573804659256377,0.48484848484848486,0.894113040152189,1.0,15/61,16.87%,SKAP1;UTRN;CDH13;CRK;CDK6;ABL1;FLNA;JUP;LIMS1;CSPG5;EMP2;DOCK1;CASS4;CRKL;RSU1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5571469207820453,-0.9571254081332132,0.5471698113207547,1.0,1.0,3/8,26.83%,ATG14;PHB2;MAP1LC3B
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.3995204443272959,-0.9571144404000812,0.5441176470588235,1.0,1.0,9/62,9.32%,IRF4;AHR;SIRPG;GMFG;CYTIP;TAGAP;PTPRC;CD5;KLRB1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5507861636060232,0.9570581313088659,0.4888888888888889,0.8943950850559103,1.0,2/6,11.49%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.5300915460660498,0.957014999512739,0.40476190476190477,0.8940658948697644,1.0,2/9,4.39%,EDNRA;SLC8A1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.39753164091639165,0.956542328357419,0.5681818181818182,0.89473417015115,1.0,11/40,20.27%,RIDA;RNASET2;ERN1;DXO;HSPA1A;LSM2;PNPT1;AGO3;DNA2;METTL16;XRN2
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.5861836911375043,0.956464391509897,0.5454545454545454,0.8944437682771077,1.0,3/6,33.59%,RPUSD1;RPUSD2;RPUSD4
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.5128776622271689,0.956416063046318,0.4473684210526316,0.8940996005995068,1.0,2/7,4.25%,RSPO3;NKD1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5046596291140197,-0.9562872191679792,0.543859649122807,1.0,1.0,6/17,20.75%,PSMB9;ENC1;PSMA7;PSMB6;PSMA3;PSMA5
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.603673638661951,-0.956091314154291,0.5517241379310345,1.0,1.0,2/6,8.92%,CAV3;C12ORF57
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.5238234745832625,-0.9555556303300915,0.5396825396825397,1.0,1.0,1/12,1.04%,MGST1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.6225972933489372,-0.9554340528694543,0.603448275862069,1.0,1.0,1/7,0.90%,WNT5A
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.485845466569941,0.955418741208874,0.4523809523809524,0.8958782885380611,1.0,3/14,3.73%,SKAP1;SAMSN1;SIRT1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.521390676869695,0.9554126725115575,0.55,0.895433463171359,1.0,5/12,26.61%,PATL1;PATL2;LSM14A;RC3H1;ATXN2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.47727337260777497,-0.9553707345023444,0.5645161290322581,1.0,1.0,6/28,17.78%,ATP6AP1;SLC9A2;ATP1A4;SLC9B1;SLC9C1;LACC1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.3630926604213617,-0.95529318856075,0.5076923076923077,1.0,1.0,8/87,6.38%,ENPP2;TREH;CLCA1;ANGPTL2;DCN;ALDOB;PIEZO2;SMLR1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.5324015109467739,-0.9551761239825788,0.5357142857142857,1.0,1.0,2/11,6.29%,GPER1;PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.5813771189927603,-0.9549344505109432,0.5925925925925926,1.0,1.0,1/5,3.38%,CAV3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.37787013399686015,0.9547932795298835,0.5142857142857142,0.8964772194745056,1.0,3/42,2.03%,DGKD;PNPLA3;PLD6
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),0.5488906493774915,0.9546717234323934,0.5882352941176471,0.896294567680356,1.0,3/7,12.52%,OSR1;WNT4;BMP4
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.4080830451005363,-0.9545603121918396,0.5277777777777778,1.0,1.0,9/60,8.03%,AQP3;CLCA1;CAPN8;MS4A8;MISP;PLA2G10;SMIM22;TMC4;BACE2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.4097585237025565,-0.9544655745022388,0.5,1.0,1.0,13/51,24.47%,PSMB9;FBXL7;ATF5;PSMA7;RBX1;PSMB6;PSMA3;AURKA;PSMA5;SKP1;PSMD8;RFPL1;PSMD6
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.5054278315891325,-0.9543392731885502,0.5555555555555556,1.0,1.0,2/13,4.74%,MMP9;HLA-DRB1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.36731626699584824,0.9543100564341906,0.48148148148148145,0.8966513017606088,1.0,22/117,12.10%,FIBIN;MXRA5;MRGPRF;LAMA3;OSR1;EDNRA;PARVA;COL12A1;DSP;SDC4;NTN4;GBP2;PLSCR4;CRLS1;LRIG3;FZD1;EFEMP1;COL16A1;RND3;CCDC80;MIR22HG;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.46396161120926394,0.9542127276361058,0.5675675675675675,0.896399452751716,1.0,10/20,28.02%,NOTCH1;RBPJ;EP300;SESN2;NFE2L2;CARF;HIF1A;SMAD5;BMP2;RELA
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.6266423996229097,-0.9540790654260081,0.6101694915254238,1.0,1.0,2/5,20.02%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.6266423996229097,-0.9540790654260081,0.6101694915254238,1.0,1.0,2/5,20.02%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.6266423996229097,-0.9540790654260081,0.6101694915254238,1.0,1.0,2/5,20.02%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.6266423996229097,-0.9540790654260081,0.6101694915254238,1.0,1.0,2/5,20.02%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.42365510822737795,0.95405246466642,0.5882352941176471,0.8962632826428267,1.0,8/22,16.61%,KIT;F2;OCIAD2;HES1;IL10RA;NOTCH1;PIBF1;F2R
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.42283497420650645,-0.9540051366709973,0.5161290322580645,1.0,1.0,10/62,20.75%,PSMB9;HLA-A;CYBA;SNAP23;HLA-F;PSMA7;PSMB6;ITGB5;PSMA3;PSMA5
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.5673477129861129,-0.9539024842873035,0.6101694915254238,1.0,1.0,2/8,14.76%,DARS2;YARS2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.5187142082885992,0.9530493465757162,0.5333333333333333,0.8981885653852616,1.0,5/13,24.38%,ARHGAP35;NTRK2;GBA2;PTEN;MAP2
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.3234343215577487,0.9529942016256221,0.5,0.8979363295794376,1.0,33/153,15.70%,PHLDB2;PLD6;FGFR1;NEUROD2;NLGN1;GRIP1;APOE;SIRT1;MARCHF5;NCOA3;PLCB1;RALA;ZNF703;CCN2;SHLD2;RPS6KA3;MCU;COBL;SHLD1;MAP3K13;BMP4;DLX1;MIEF2;SOX5;RAPGEF3;DLG5;KMT5C;LRP8;FOXO6;INSR;ELAPOR2;NRXN1;KMT5B
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.49498595880155727,0.9525916243023731,0.5609756097560976,0.89837589222967,1.0,4/10,19.01%,TOX;BMP4;SHH;ADAM8
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4862076467593698,0.9525524630190975,0.5106382978723404,0.8979932518482321,1.0,4/9,28.32%,PIH1D1;NUFIP1;ZNHIT6;NAF1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.39596365231137903,0.9524321188466932,0.5,0.8978336018239427,1.0,25/54,26.76%,MAML1;DTX1;GMDS;JAG1;POFUT1;NOTCH4;ASCL1;HES1;MYC;NOTCH1;PBX1;RBPJ;KAT2B;DLGAP5;EP300;WWC1;ADAM10;NRARP;MIB1;JAG2;NOTCH3;SNAI2;CREBBP;BMP2;SORBS2
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.5829931145004273,-0.9524205197474703,0.6129032258064516,1.0,1.0,1/8,6.21%,DRC1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3565704359495843,0.9523355523751885,0.38461538461538464,0.8975897120461964,1.0,18/85,12.97%,CCN4;AKR1C3;SNCA;SARM1;RIPK2;DCC;RRAS2;SRGAP2;SLFN11;SLC25A24;ACER2;CCN2;ADNP2;HSPA1A;CCN1;BMP4;ACER3;RILPL1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5464849514750645,0.9522928212591611,0.59375,0.8972463698393343,1.0,2/10,14.29%,AKAP9;ANK2
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.5499201376124033,-0.95219974438497,0.5344827586206896,1.0,1.0,3/7,23.29%,OSMR;PTGER3;PARK7
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.5499957794651502,-0.9521397790311147,0.5849056603773585,1.0,1.0,3/13,11.90%,GPER1;CEACAM1;APOD
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.5289877126912027,-0.9519865181418367,0.5344827586206896,1.0,1.0,1/15,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.4640059471728889,0.9519278650032345,0.55,0.8976928535288177,1.0,6/16,19.45%,SP1;SMARCB1;SMARCA4;RRP1B;CHD1;EP300
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.3720014682870359,0.9518586373736188,0.6052631578947368,0.8973881047851183,1.0,21/74,21.96%,PRR16;SAMD4A;LRRTM3;ERBB2;SP1;PCIF1;NSMAF;CASP3;SMPD3;EIF3E;NIBAN1;BCL3;PIWIL2;YTHDF1;FXR2;GSAP;ZCCHC4;PLA2G6;EIF4A3;LARP4B;UPF3A
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.618825330321304,0.9516946255614315,0.5581395348837209,0.8968330832055872,1.0,2/5,22.07%,FER;PDE1B
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.618825330321304,0.9516946255614315,0.5581395348837209,0.8968330832055872,1.0,2/5,22.07%,FER;PDE1B
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.38635141114060484,0.9514132374443652,0.5,0.8970723456985737,1.0,10/29,25.01%,KIAA0319;NKD1;DCC;FGFR3;DIP2B;WWC1;PTEN;WWC2;MAP2;FGF13
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.4997829235666927,0.9513014803546604,0.47619047619047616,0.8967837943480588,1.0,4/15,11.97%,GREM1;HPSE;PLXNB1;CCN1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.37819985591760413,-0.9511388285486347,0.5072463768115942,1.0,1.0,19/102,12.36%,AMBP;SLC22A8;BHMT;SLC28A1;F7;OIT3;TGFBI;SLC22A6;ALDOB;SMLR1;SLC5A2;DAO;SLC5A1;C3P1;LRP2;SCIN;CYP2E1;HNF1A;PDZK1
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),-0.6363778614474387,-0.9511039757306791,0.631578947368421,1.0,1.0,1/5,5.98%,ANXA1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.44537997567688514,-0.9510362807455989,0.5161290322580645,1.0,1.0,3/25,10.97%,CCDC39;TBX6;GATA4
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.672262507406173,0.9509997814627646,0.6111111111111112,0.8969617072902785,1.0,1/5,3.45%,PROX1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5430635163073257,-0.9507754055553254,0.576271186440678,1.0,1.0,1/7,8.75%,PPT1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.38988834769475145,-0.9507676814496033,0.559322033898305,1.0,1.0,4/67,3.18%,ACTC1;OBSCN;LMOD1;TMOD4
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.40086920040714413,-0.950587090034817,0.5454545454545454,1.0,1.0,15/59,18.64%,CRLF1;FGF20;KIF14;PINK1;WFS1;SOD2;PPT1;NTRK1;CLCF1;SET;FOXB1;TGFB3;NAIP;MAG;GRN
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.49344492119757266,0.9505564623535387,0.5263157894736842,0.8975901194352509,1.0,3/11,11.67%,CPT1C;CPT1A;ACADM
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.5241500149196892,0.9505379780818167,0.5319148936170213,0.8971719475830556,1.0,2/6,11.46%,BCL6;IRS2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.38127764436663963,0.9501326855689964,0.5,0.8976699114638744,1.0,12/55,15.50%,GCK;CAPN10;DOC2B;APBB3;GLUD1;MCU;IRS2;ACHE;UNC13B;WLS;PTPN23;FRMD4A
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.5728663289150298,-0.9499784806287835,0.55,1.0,1.0,1/8,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.5089787547677906,0.9499460286211436,0.5405405405405406,0.897618221180241,1.0,4/9,25.38%,SEC14L2;SREBF2;ABCA2;LPCAT3
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.4193530317443378,-0.9499333913417746,0.5079365079365079,1.0,1.0,14/58,12.77%,SIRPG;GMFG;ITGB2;ARHGAP9;CYTIP;GPR183;TBC1D10C;TNFRSF1B;TAGAP;PTPRC;CD5;PARVG;IKZF1;MYO1F
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",-0.6282422035646166,-0.9494603741511827,0.5818181818181818,1.0,1.0,1/5,0.69%,F8
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",-0.6282422035646166,-0.9494603741511827,0.5818181818181818,1.0,1.0,1/5,0.69%,F8
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.35576249979588886,0.9494057761438551,0.6052631578947368,0.8985119021378098,1.0,14/71,20.45%,AUP1;DERL3;UBE2J1;MAN1A1;FBXO27;UBE2J2;UBE4B;RHBDD2;FBXO17;RNF185;TMUB2;EDEM1;TMEM67;UBXN4
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.4152125756052502,-0.9493944082035944,0.5873015873015873,1.0,1.0,6/43,12.72%,FOXM1;CYP1B1;PINK1;EIF6;STK17A;STUB1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.5642182174483565,0.9493468723432489,0.6,0.8981931561343884,1.0,4/7,26.51%,ATG2A;ATG2B;ATG9B;ATG7
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.5825750574497754,-0.9492642788215795,0.5862068965517241,1.0,1.0,2/8,6.76%,SCN5A;MYBPC3
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.5278043154775729,-0.949253032291142,0.5483870967741935,1.0,1.0,1/12,4.90%,GPR151
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.40539295368171635,-0.9492087953830334,0.4745762711864407,1.0,1.0,6/52,9.05%,AMBP;HHIP;ALOX5;WFS1;NLRP12;CLU
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.5838035135403286,0.9492087273042826,0.6097560975609756,0.8975489888095387,1.0,3/6,29.05%,NUS1;DOLPP1;MVD
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.5838035135403286,0.9492087273042826,0.6097560975609756,0.8975489888095387,1.0,3/6,29.05%,NUS1;DOLPP1;MVD
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.4696146081786307,-0.9491774204181745,0.546875,1.0,1.0,3/24,19.90%,B3GNT5;GCNT1;TPI1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.41583846737610614,-0.9491129773353717,0.5223880597014925,1.0,1.0,8/51,12.61%,WNT5A;ITGB2;ACOX2;CIDEB;CLU;NTRK1;HPR;DDIT4
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5344494122940524,0.9491075902031106,0.5,0.8972616171213128,1.0,4/9,21.23%,SIRT1;MYOCD;DIP2B;PRKAA2
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.5560186868797433,0.948921131753463,0.5853658536585366,0.8972787225482509,1.0,3/7,20.07%,DRD5;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.44861303444247774,0.9485505612465358,0.5757575757575758,0.8977898875612289,1.0,13/31,21.40%,ZDHHC11B;ZDHHC12;GOLGA7B;ZDHHC18;ZDHHC16;ZDHHC14;ZDHHC3;ZDHHC13;CLIP3;ZDHHC11;ZDHHC5;ZDHHC9;ZDHHC23
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.3272026440960673,0.9484290809513138,0.5555555555555556,0.8976547687912254,1.0,36/115,22.30%,SCRIB;EDNRA;PARVA;COL12A1;ERBB2;NTN4;PAX3;CDCP1;LRIG3;KITLG;EFEMP1;COL16A1;RND3;CAP2;WWTR1;RBFOX2;DDAH1;BARX2;RUNX1;NR2F2;DOCK1;PLPP3;ANTXR1;NCAM1;FZD7;CHST3;ADCY6;DMD;SH3D19;GNA11;CSPG4;HTRA1;FSTL1;PTPN21;BOC;LAMC1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.33962258631705533,0.9483851969373063,0.42857142857142855,0.897314751016129,1.0,38/139,19.68%,SLC17A6;SPHKAP;NOVA1;LRRTM3;ELAVL3;NKAIN2;CADM2;GDAP1;MAGI2;PAK5;LRFN5;ERC2;PARM1;ADGRA1;RAB3C;BRINP1;ELAVL4;SCN7A;AVIL;RGS7BP;OLFM3;RBFOX1;MAP6;SNAP91;ANK2;PTPRD;ASXL3;NRXN1;DGKZ;DGKH;PPFIA2;DLG2;LSAMP;TMEM196;ADGRB3;GRM5;ST8SIA3;MMD2
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.36236095734252577,-0.9481083365838577,0.5217391304347826,1.0,1.0,16/126,16.11%,RASGRF2;OBSCN;ARHGAP15;FOXM1;ARHGAP9;TRIP10;VAV3;TAGAP;ARHGDIG;RHOQ;ARHGAP12;ARAP3;ARHGAP28;A2M;TGM2;RAC1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.4495926146586895,-0.9480666694927827,0.5151515151515151,1.0,1.0,5/33,8.94%,TBX1;SOX10;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.42120307896584286,0.9479002595534799,0.46153846153846156,0.8979769499704578,1.0,4/27,8.95%,DGKD;HIP1;TGFA;CNOT9
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.5321277788916441,0.9474877610431093,0.5384615384615384,0.8985247073237136,1.0,3/10,7.11%,PTGS1;AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5463224288240314,-0.9473882612734402,0.543859649122807,1.0,1.0,1/10,6.56%,CNMD
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.4537435793337086,0.947273259192599,0.5,0.898692798733418,1.0,7/22,20.57%,MYC;HSF1;LIG4;ATM;MEN1;TP53;ATR
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.4964303201031994,0.9472100673799545,0.5833333333333334,0.898459043027675,1.0,2/8,6.88%,HMGB1;BATF2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.42647871516311675,-0.9471869399107642,0.5416666666666666,1.0,1.0,7/33,17.65%,WNT5A;PDE6B;CALM1;LEF1;CAMK2A;PDE6A;PLCB2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.5015498688992867,0.9471700295009307,0.5581395348837209,0.8981194620222709,1.0,2/11,3.38%,PC;APOE
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.34136975291124944,0.947088805717939,0.4827586206896552,0.897825641232484,1.0,11/89,8.11%,FIBIN;MXRA5;MRGPRF;LAMA4;TPM2;EDNRA;PARVA;COL12A1;MMP2;PAMR1;PLSCR4
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.604291366146237,-0.9469625760012615,0.6226415094339622,1.0,1.0,1/6,8.93%,SMOX
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.49596836193382665,-0.946927869413485,0.5263157894736842,1.0,1.0,4/18,14.83%,HLA-DRB1;HLA-A;IL12A;HLA-F
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5930729948551533,0.946595218814523,0.5853658536585366,0.8983494346898575,1.0,2/5,32.34%,CAMSAP3;TJP1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4695998861143101,0.9465704844610597,0.5405405405405406,0.897949889687751,1.0,3/16,11.05%,CBS;SRR;PSPH
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4370308266368792,0.9465008114779925,0.3870967741935484,0.8976338988904147,1.0,6/21,21.03%,RIPK2;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.46944667211216606,-0.9462714124619783,0.53125,1.0,1.0,1/15,1.44%,CASQ2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.44784819549537414,0.9458689762871714,0.6111111111111112,0.8986935547831602,1.0,8/17,24.24%,TICAM2;LBP;NR1H3;MFHAS1;APPL2;NINJ1;LYN;NR1D1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.4781787543450089,0.9457356448414878,0.4375,0.8985134661335176,1.0,5/21,14.14%,NKD2;ASTL;CHAC1;RHBDD1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.3618577419799419,-0.9456477016299683,0.582089552238806,1.0,1.0,23/133,17.40%,UBE2L6;HLA-DRB1;SFTPD;TRIM25;ANXA1;VSIG4;PDCD1LG2;PTPRC;NLRP12;ZFPM1;CEACAM1;SLC11A1;APOD;IL12A;ADCY7;THBS1;CACTIN;NLRC3;ISG15;RAC1;FN1;LEF1;VSIR
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.556534361353774,0.9449801950546312,0.5405405405405406,0.8997302036212563,1.0,5/12,15.46%,PUDP;UPP2;CDA;UCK2;HPRT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.5598441318684382,-0.9447463265142167,0.5471698113207547,1.0,1.0,5/9,27.24%,GATA4;CAMK2A;ENG;LTK;NUPR1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.42396744311295037,-0.944363797155375,0.6031746031746031,1.0,1.0,10/60,20.75%,PSMB9;HLA-A;CYBA;SNAP23;HLA-F;PSMA7;PSMB6;ITGB5;PSMA3;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.5354541942660012,-0.944095657055458,0.5384615384615384,1.0,1.0,1/9,3.38%,CAV3
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),0.5737127214634611,0.9440550926718237,0.6136363636363636,0.9013834155768122,1.0,1/5,1.02%,CYP1A2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.35994936736869354,0.9440265306510024,0.4827586206896552,0.900998645763672,1.0,22/97,17.32%,SLC10A3;ABCA9;MFSD2A;APOE;PITPNM1;ABCA6;AKR1C1;NCOA2;LDLR;ABCA1;ABCD3;ABCD2;ACSL1;ABCA13;LBP;CHKA;ABCA10;ABCA7;PITPNC1;SLC27A4;PRELID2;ABCG8
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.33742749504717695,0.9436753144881992,0.5833333333333334,0.9014434817475299,1.0,12/60,18.21%,PNPLA3;ZBTB20;PPARG;WNK2;SLC4A7;IRS2;KLHL3;TLCD3B;SLC4A11;NR1H3;ACOX1;WNK3
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.43771790565446755,0.9436041287836759,0.6470588235294118,0.9011570086727017,1.0,4/27,12.23%,IRGM;GBF1;RRP1B;LGALS9
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.47758949368997006,-0.943534699909207,0.55,1.0,1.0,2/12,5.98%,MSMP;ANXA1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.517899127087659,0.9433976128177997,0.4897959183673469,0.901149466547382,1.0,4/7,32.03%,SPAST;TMCC1;SH3GLB1;CORO1C
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.5262185973714315,-0.9432332288886357,0.509090909090909,1.0,1.0,1/12,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.3756439317961806,-0.9431178946563006,0.5789473684210527,1.0,1.0,12/116,11.23%,AMBP;SCTR;FCGR3A;HCK;TSHR;PTGDR;HLA-DRB1;CGA;GPR27;ALOX15;SPI1;GPR39
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.44929380525332907,-0.9431044783713206,0.5230769230769231,1.0,1.0,2/26,4.99%,WNT5A;PINK1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3028567065858009,0.9430656479916404,0.7894736842105263,0.9016086379340547,1.0,99/372,23.27%,IRGM;AUP1;PCM1;HDAC3;FHDC1;IFT88;EHD4;PARVA;DZIP1L;SCLT1;BICD1;MVB12A;RAB7A;STARD9;UBXN2A;GBF1;BBS9;CILK1;PRRC2C;TTC36;SPAG16;FARP2;FLNA;KLHL41;CEP290;RAB11FIP3;AVIL;RPGR;CEP250;CHMP6;MAPRE1;PLA2G4C;STING1;NOTCH1;MKS1;RILPL1;CDC14B;SYNPO;GOLGA8H;PTPN23;PIBF1;KIAA0586;TP53INP2;VTA1;ARL13B;CEP20;TTC39C;SSTR3;BBIP1;PATL1;EXOC7;CEP162;IFT140;ARL3;NEK1;ATG16L2;KIF3B;SAC3D1;CFAP70;YTHDF1;RP2;CFAP221;TMEM138;DZIP1;CNGA4;PATL2;PTPDC1;CFAP43;UBXN2B;ATG2A;DLGAP5;STAM2;CEP41;DCDC2;POC1B;LSM14A;RC3H1;UNC119B;TCTN2;TMEM67;WDR19;GOLGA8S;SNF8;PKHD1;EXOC4;IQCB1;EXOC6;ASAP1;CDS1;CDC14A;ATG12;ATG2B;ELAPOR1;POGZ;KIF27;KASH5;CFAP410;FAM161A;VMP1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.3671213352364344,-0.9429384263699623,0.6052631578947368,1.0,1.0,6/117,6.68%,MCM2;PSMB9;CDK2AP1;MCM3;RPA3;MCMDC2
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5893918467532447,-0.942852550151954,0.6274509803921569,1.0,1.0,4/7,23.39%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.4017797862917185,0.9428487216455111,0.5384615384615384,0.9017137425187003,1.0,4/31,3.16%,CD247;KLRD1;GPR174;TOP2A
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.5162720537307204,-0.942757782534775,0.559322033898305,1.0,1.0,1/10,0.79%,TBX1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.40070881752556964,-0.9427361034763612,0.5333333333333333,1.0,1.0,10/68,12.69%,AMACR;SLC22A24;CYP1B1;CYP26B1;CYP3A5;CYP24A1;CYP21A2;LRP2;CYP2E1;CYP2A6
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.5983892494506162,0.9426791002593843,0.6511627906976745,0.9016608204766791,1.0,4/6,39.73%,ACE;N4BP2L2;PDCD2;EIF2AK2
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.5361807365322447,0.9425213850654288,0.6052631578947368,0.9015327836999496,1.0,2/5,6.67%,HMGB1;CDH26
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4367602213347108,0.9420636977806311,0.5581395348837209,0.9022087574074182,1.0,4/26,9.49%,BCL2;TMEM117;CHAC1;ERN1
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.5445713154209454,-0.9419373326080707,0.576271186440678,1.0,1.0,4/11,21.47%,ADSS1;PAICS;IMPDH2;PFAS
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.45627064064201295,0.9417912086464698,0.525,0.9024184993353237,1.0,9/20,12.72%,VCAN;CSGALNACT1;CHSY3;CHST12;CHSY1;UGDH;CHST11;CSPG5;CHPF2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3344222829795355,0.9417499907862419,0.5333333333333333,0.9020651110751611,1.0,48/140,22.82%,RASSF2;HSPB1;SPRED3;PARD3;SAMSN1;PID1;CEP85;SNCA;DEPTOR;GREM1;SLIT2;TRIB2;NLRP2B;LRP6;MLXIPL;SPRED2;TWIST1;WWTR1;SPRED1;ENPP1;UBASH3B;NF1;TAB1;EPHB2;PPP1R15B;PLPP3;OCLN;EMILIN1;TARBP2;NIBAN1;IMPACT;CRKL;DNAJC3;PMEPA1;SMAD7;NCK2;MEN1;GNAQ;PAK2;DMD;PRKAG2;NCK1;PTEN;PDE4D;DUSP19;CIB1;TRIB3;LYN
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3921767570026893,0.9413797098605489,0.46153846153846156,0.9025522966366553,1.0,8/32,15.18%,PRSS3;CDH5;CDH13;ABL1;NR4A1;PXN;PIK3CA;EMP2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5064856607634608,-0.9412329102745982,0.5517241379310345,1.0,1.0,2/15,8.75%,CAV3;PPT1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5906241545357406,-0.9409871632012194,0.6229508196721312,1.0,1.0,3/8,28.31%,SMUG1;OGG1;TDG
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.31320874909172924,0.9409144004233926,0.47619047619047616,0.9032114764213865,1.0,54/243,20.94%,TEAD2;MATN1;CD247;LLGL1;MITF;PARD3;TLE2;STX5;SEC24C;SLC7A9;TGFA;PML;CNIH3;TRAPPC1;FARP2;BET1;COL16A1;MCU;PDZD11;WASF3;HES1;SMARCA4;IL2RB;MYC;HDAC1;PREB;STING1;MAGI1;SNX9;GEMIN5;CD40;SEC22B;BCL9L;OCLN;HSF1;PYGO1;NDUFAF1;FERMT3;FADD;PARD6B;CTSC;SKAP2;LIN7A;IL1RAP;EP300;CXCL12;ADAM10;MEN1;TP53;WDR19;DMD;PPP6R3;PDE4DIP;MDM4
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.44438096221282397,0.9409075733762043,0.4857142857142857,0.9027832686662738,1.0,6/22,8.31%,CYP1A2;GLYATL2;LIPC;CEL;STS;LPL
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.6068619597956882,-0.9408461837165142,0.6428571428571429,1.0,1.0,1/5,17.43%,RAD54L
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.4448830078349677,0.940713034097788,0.5135135135135135,0.9027749824249393,1.0,7/22,15.58%,APOB;PPARG;ABCA1;LPL;PLA2G5;NFKB1;NR1H3
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.4028061009221735,0.9405718581230961,0.6153846153846154,0.9025944890370083,1.0,3/32,10.23%,CPEB1;CAPN2;GRIN1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.5924577601791983,0.9404812669146165,0.6041666666666666,0.9023393294573867,1.0,1/7,3.82%,DCP1B
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3583146722526917,0.9402039570387277,0.5,0.902600563485935,1.0,19/82,16.28%,HSPB1;PTPRO;SLC8A1;CEP85;SLC8A3;SNCA;DEPTOR;TRIB2;ABL1;LRP6;WWTR1;SPRED1;PTPRB;PTPRT;UBASH3B;NF1;TAB1;SRCIN1;TARBP2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.32712059656067155,0.9400273174833221,0.4827586206896552,0.9026148115325519,1.0,21/161,15.21%,IRGM;RASSF2;HIP1;PARVA;PYHIN1;PER3;TELO2;FLNA;CCNH;TESC;TMEM88;HSPA1A;TRIM44;PIM2;USP36;SWSAP1;COG7;PPIB;ANK2;OTUD3;PLPP3
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.5716106829741308,-0.9399566211160799,0.6268656716417911,1.0,1.0,1/7,4.86%,SHISA6
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.3492080348749095,0.9397917148533728,0.53125,0.9028308224968539,1.0,28/90,21.49%,MITF;MAGI2;SERPINE1;SRGAP2;CRK;SLIT2;KANK1;RAP2A;JAG1;NAV3;ADAM15;DACH1;FRMD5;ARID2;PTPRT;NF1;DLG5;TMEFF2;CCDC125;SHH;RECK;SMAD7;MIA3;VCL;PTPRJ;PTEN;SPINT2;SCAI
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.351057466059108,0.9397686011859696,0.59375,0.9024490565247439,1.0,18/91,15.96%,GPR3;ESRRG;ELOVL6;PER2;HDAC3;ZBTB7B;ACACB;ALMS1;LEPR;ACSL1;ADIPOR1;ACHE;SIRT6;ADIPOR2;INSR;GADD45G;HSF1;PPARGC1B
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.36038922271512497,0.9389519048693744,0.4375,0.9039789601107937,1.0,23/69,25.51%,CDH5;APOE;SNCA;KANK4;LDLR;SLIT2;KANK1;NAV3;MAPRE1;IAPP;PIK3CA;SSH1;EMILIN1;CLIP3;CAMSAP3;ATXN7;CIB1;TRIM54;DYRK1A;MAP2;CORO1A;FGF13;TWF2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.5214596718760556,0.9387166620781155,0.5454545454545454,0.9040223684895331,1.0,1/6,3.73%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5470672075609103,-0.9385436294093126,0.5660377358490566,1.0,1.0,3/8,20.88%,SLIRP;PHAX;ZCCHC17
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),-0.598594574148875,-0.9385079555277389,0.559322033898305,1.0,1.0,1/5,3.71%,GFRAL
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.360203258642688,-0.9384607997351794,0.5555555555555556,1.0,1.0,22/102,19.25%,MS4A8;ANGPTL2;VWA3B;CFAP126;DRC1;CCDC60;VWA3A;MAP3K19;AQP4;DRC3;AKAP14;BPIFB1;APOBEC4;ZMYND10;CFAP61;DNAI1;PVALB;DNAH2;ZBBX;SNTN;MYO16;FAM81B
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.5647071116428396,0.9384485465977546,0.5686274509803921,0.9042745831982177,1.0,4/6,19.08%,PROX1;SMCHD1;SKI;CHD7
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.61414831124506,0.9384006640292142,0.5918367346938775,0.9034965939581577,1.0,3/5,35.90%,KIF3B;KIF5C;KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.61414831124506,0.9384006640292142,0.5918367346938775,0.9034965939581577,1.0,3/5,35.90%,KIF3B;KIF5C;KIF17
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.40973460006989626,-0.9383815821372751,0.5507246376811594,1.0,1.0,24/53,31.17%,EIF6;RPL3;RPL35A;RPL7A;BRIX1;MRPL20;NOP53;LAS1L;RPL5;WDR12;NSA2;RPL11;RPL24;SURF6;RPL26L1;RPL10;EBNA1BP2;RPLP0;MRTO4;RPL10A;RPL14;RSL24D1;ZNF622;RPL6
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.4662368439106512,0.9382973900602919,0.5555555555555556,0.9033092582958555,1.0,6/14,10.94%,PTGS1;AKR1C3;AKR1C1;HPGD;CES2;CYP2S1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.4989545595311842,-0.9376450653582971,0.603448275862069,1.0,1.0,6/14,22.17%,PINK1;COX7A1;NOP53;COX7A2;ACTN3;COX7A2L
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.47885153801727565,0.9372782356760222,0.5675675675675675,0.9052884695872916,1.0,4/13,16.22%,PACSIN2;PID1;CSPG5;PNPT1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.4491419629418495,0.9372317889765217,0.6176470588235294,0.9049144302822121,1.0,6/18,21.11%,BCL2;LIG4;ATN1;ERBB3;BID;CDK5
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.4955068786063338,-0.9368096049072677,0.5862068965517241,1.0,1.0,3/17,16.94%,GPR183;OSCAR;TNFRSF11A
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.5790211022621782,0.9367715076179256,0.6444444444444445,0.9054778657917604,1.0,3/6,35.77%,SHH;EML1;RACGAP1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.549029050168598,0.9367473435424242,0.5897435897435898,0.9050669244206724,1.0,2/6,21.27%,NLGN4X;PTEN
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.4929916108629415,0.9365088261179594,0.45454545454545453,0.9052062198205622,1.0,5/10,29.15%,PSMG2;PSMD4;PSMD5;PSMD10;PSMD13
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.4548177018083471,-0.9364064455953912,0.5538461538461539,1.0,1.0,3/18,15.44%,MCM3;MCMDC2;TERT
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.42855184752271774,-0.9362251013075444,0.5303030303030303,1.0,1.0,3/35,9.91%,TIMP3;AZIN1;TIMP4
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4868972530711239,-0.9361975026354833,0.5645161290322581,1.0,1.0,6/16,24.51%,HCK;BAIAP2L1;TEK;NTRK3;BAIAP2L2;HAX1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.48077752114575434,0.9361288423983886,0.5135135135135135,0.9057687078654512,1.0,2/16,3.25%,MIDN;IRS1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.5664101175376292,-0.9358453829374929,0.5846153846153846,1.0,1.0,3/6,39.52%,DHX58;SEC14L1;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5732905704604282,0.9357434319974396,0.5882352941176471,0.9062118868911089,1.0,5/11,20.00%,ATF3;CREB3L1;ATF6;CREB3L3;TP53
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.44514864556191713,-0.9356851283329501,0.47368421052631576,1.0,1.0,1/21,0.79%,TBX1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.5040799074902982,-0.9355536028222237,0.6065573770491803,1.0,1.0,6/20,14.54%,DUOX1;ALOX12;CYBA;SOD2;NOS2;TAFA4
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5418669341706449,-0.93552578312757,0.6666666666666666,1.0,1.0,2/12,2.84%,DAB2;NODAL
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.5072435613213624,-0.935429976543291,0.5901639344262295,1.0,1.0,3/11,13.48%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.4995339255138196,0.9354052321107422,0.5319148936170213,0.9065581868532541,1.0,3/11,5.76%,BCL2;ACO1;SNCA
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.5008136159914999,0.9348791678773878,0.5526315789473685,0.9075196953147318,1.0,3/8,15.51%,JMJD4;MTRF1;ETF1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.4847154301648807,-0.9347676935484401,0.5483870967741935,1.0,1.0,1/14,0.79%,TBX1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.4501041226609711,0.9347539188136846,0.6052631578947368,0.9074351103472212,1.0,7/24,10.94%,PTGS1;AKR1C3;AKR1C1;PTGIS;HPGD;CES2;CYP2S1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.40780704560014175,-0.9345893621361613,0.6119402985074627,1.0,1.0,2/62,1.26%,ENPP2;PLAAT4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.347239549619262,0.9345746139452192,0.5,0.9074098785368473,1.0,10/64,20.24%,ELP4;ELOF1;IWS1;ELOA;CCNH;MLLT3;GTF2F2;SETD2;POLR2F;ERCC3
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.40059659842644824,0.9345714990574808,0.53125,0.9069995832659613,1.0,14/42,25.01%,RIDA;NBDY;ERN1;DXO;HSPA1A;LSM2;PNPT1;AGO3;RC3H1;METTL16;XRN2;LSM6;TUT7;XRN1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.5407568921919728,0.9342470274145619,0.5365853658536586,0.9067350507132702,1.0,4/11,13.83%,PUDP;UPP2;CDA;UCK2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.5407568921919728,0.9342470274145619,0.5365853658536586,0.9067350507132702,1.0,4/11,13.83%,PUDP;UPP2;CDA;UCK2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4095699054890205,0.9342045363707926,0.4358974358974359,0.9063700322220472,1.0,6/35,14.40%,FHIT;QRICH2;PML;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.4347835955359685,0.9339954707814132,0.5476190476190477,0.9064710215526871,1.0,11/31,27.75%,BICD1;TRAK2;ARHGAP21;BICDL1;UXT;NDE1;BICDL2;PEX14;TRAK1;RAB6A;LRPPRC
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.4463679340184281,-0.9339404598548346,0.5625,1.0,1.0,9/34,29.05%,PINK1;GABARAPL1;FUNDC1;GABARAPL2;FIS1;MAP1LC3B2;BNIP3;MAP1LC3B;ULK1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.5472762647420105,0.9337843308127272,0.5531914893617021,0.9061705722952784,1.0,3/6,31.07%,IQSEC1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.5472762647420105,0.9337843308127272,0.5531914893617021,0.9061705722952784,1.0,3/6,31.07%,IQSEC1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.5608733229268101,-0.9333472286732156,0.5714285714285714,1.0,1.0,3/10,10.97%,TGFB1;GPER1;GATA4
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.42924374018371947,-0.9331871792041481,0.5666666666666667,1.0,1.0,3/33,4.08%,F7;TGFB1;P2RY12
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.32395441214220133,0.932715841169804,0.53125,0.9083086415841002,1.0,34/171,14.14%,RSPO3;FRMPD1;GRK5;LLGL1;RORA;TULP3;SIRT1;RFNG;CSK;AKR1C3;SEMA5A;CBFB;SLC8A3;DTX1;DOK5;RGS11;RGS16;KCTD8;CRK;PLCB1;TIMP1;SHARPIN;POFUT1;RGS14;IGFBP4;MDFIC;WWTR1;VWA2;RGS6;ITGA3;PXN;PLSCR1;UBASH3B;RUNX1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.4406509610276009,-0.9325773444518468,0.5272727272727272,1.0,1.0,2/28,10.02%,PLPP6;ACAA2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.48006535541654355,0.9324156470212831,0.5454545454545454,0.9085191795540587,1.0,7/15,21.42%,SEMA5A;ERN1;BMP4;BMPER;DLG1;NRARP;BMPR2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.43295659906444556,0.9323793469112464,0.5333333333333333,0.908235466607641,1.0,7/24,18.23%,NGF;BCL2;CRADD;CASP8AP2;ZDHHC3;FADD;BID
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4518200161043813,-0.9323687872200339,0.559322033898305,1.0,1.0,5/24,18.82%,TGFB1;PPT1;SIAH1;CLN8;TPP1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.41277950823165477,0.9321464339349195,0.5428571428571428,0.908416357945126,1.0,6/26,13.72%,MITF;SIRT1;CX3CR1;AVIL;ADIPOR1;ADIPOR2
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.5926729756886797,-0.9316240931774498,0.6226415094339622,1.0,1.0,1/5,23.46%,SLF1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.4550156941567982,-0.9316183461644117,0.5925925925925926,1.0,1.0,3/22,6.76%,NMUR2;MYBPH;MYBPC3
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.5606439208729034,0.9310482705172094,0.6097560975609756,0.910681911510146,1.0,1/6,7.75%,TIMP1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5118601222752468,0.9310154747427517,0.5348837209302325,0.9103165794196926,1.0,3/8,14.44%,DHFR;MTR;NREP
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3425125265439768,-0.9309803869926471,0.7123287671232876,1.0,1.0,32/250,12.52%,IRF4;WNT5A;TGFB1;NODAL;CYP1B1;S100A13;SCIMP;IL7;IRF1;FLT4;ANXA1;HLA-A;CYBA;IL27;PIK3CG;PTPRC;ZFPM1;POLR1C;POLR3H;HTR2B;TLR2;NLRP3;SLC11A1;STOML2;GATA4;C1QTNF4;BRCA1;ALOX15B;HLA-DPB1;NFAM1;IL12A;ZNF580
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.48009755989499825,0.9307133643455462,0.5277777777777778,0.9106949457998758,1.0,3/13,15.07%,SLC8A1;GSTM2;PIK3CA
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.5678456675149394,-0.9306757891507442,0.6428571428571429,1.0,1.0,1/6,6.27%,CYBA
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.4544963942967495,-0.9306492690973676,0.5384615384615384,1.0,1.0,1/21,1.85%,TGFB1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3506850488651421,0.9305823504564236,0.71875,0.9105874288762936,1.0,7/57,7.83%,TGFBR1;FGFR1;CFLAR;SH3RF1;DEPTOR;PML;WWOX
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.4271178828454843,0.9302624398473874,0.6428571428571429,0.9108403086575884,1.0,8/27,18.94%,MEGF10;ABL1;BNIP2;CDH2;MYOCD;PTBP1;MAPK12;CTNNA2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.35878489159699783,0.9302531890334979,0.5,0.9104388455032044,1.0,15/62,20.51%,CPSF1;PCF11;TENT4A;U2AF1;LIN28B;SRRM1;SRSF4;CPSF7;PNPT1;PAPOLA;SYMPK;RPRD2;U2AF2;LIN28A;EIF4A3
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.3831796955599512,0.9302328338114207,0.5185185185185185,0.9100451079877718,1.0,24/81,20.33%,TBC1D10A;SCRIB;TBC1D16;SIPA1;TBC1D12;ARHGAP42;SYDE2;RALGAPA2;SIPA1L2;TBC1D22B;TBC1D4;EVI5L;SIPA1L3;CCDC125;BCR;SGSM3;SLC27A4;TBC1D2;TBCK;TBC1D8;GRTP1;USP6NL;TBC1D8B;TBC1D5
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.5648136592466991,-0.9301757409596348,0.5818181818181818,1.0,1.0,5/8,28.66%,TEK;ZFP36L1;NUPR1;ZFP36;YAP1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.5657456409646984,0.9298659235117511,0.5,0.9104814488670625,1.0,2/6,3.30%,SCRIB;GRIP1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.5466283539706454,-0.9296510660792611,0.6290322580645161,1.0,1.0,3/9,12.15%,ALOX12;ALOX15;ALOX15B
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.5578507665164482,-0.929595580235918,0.6101694915254238,1.0,1.0,2/6,28.68%,CD27;BTK
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.4638489940409817,-0.9293863218453363,0.6857142857142857,1.0,1.0,12/27,28.81%,ATP6V0E2;ATP1A4;HVCN1;ATP4A;NNT;ATP1A1;NOX5;UCP1;SLC36A3;DMAC2L;ATP6V1F;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.45577773340581446,0.9292257766038109,0.4883720930232558,0.9114017557940779,1.0,2/13,6.34%,KLRD1;CADM1
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.5099872508247457,0.9291156413817038,0.5681818181818182,0.9111695045410876,1.0,3/8,20.00%,LGALS9;ADAM8;TP53
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.3737972226499179,0.9289422687548007,0.5862068965517241,0.9110914473909901,1.0,2/33,5.28%,CPEB1;CAPN2
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.5874392572660675,-0.9287644204685963,0.5961538461538461,1.0,1.0,2/6,16.86%,IRF1;GLI3
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.46118741486144466,0.9287522844541177,0.5,0.9111014080310681,1.0,5/17,14.18%,APOB;PLIN5;LPL;OSBPL11;NFKB1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.34553548985428134,0.9287215514970085,0.5862068965517241,0.9107304476315159,1.0,18/80,16.96%,FOXO1;DUSP4;SPRED3;APOE;SPRY4;PTPRR;WNK2;SPRED2;RGS14;MYC;BMP4;SPRED1;NF1;EPHB2;RPS6KA6;EMILIN1;DUSP6;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.5035775454831884,0.928613923865883,0.525,0.9104989505317652,1.0,3/12,14.10%,DRD5;MAPK8;NF1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.5107821190524795,-0.928595188407795,0.546875,1.0,1.0,4/12,18.73%,TNFRSF1B;PTPRC;GRN;TAFA3
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.5584849033116591,-0.9285414515222185,0.5862068965517241,1.0,1.0,1/8,4.98%,DYDC2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.36094621694536055,0.9281669589322625,0.5945945945945946,0.9112190535279341,1.0,25/87,19.32%,KIT;FGFR1;EPHA7;FLT3;ERBB2;EPHA3;RBL1;DRD4;RET;IRS2;FGFR3;INSR;EPHB2;RYK;EMP2;ROR1;ANKRD54;RAD50;EPHA6;TYRO3;ERBB3;EPHA8;NTRK2;EPHB4;MUSK
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.4353775103143841,0.9280772554459217,0.5,0.91093634022658,1.0,2/14,4.45%,DNAJC30;PID1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.5488171803929818,0.9279413379604853,0.5454545454545454,0.9107562531029291,1.0,3/6,9.15%,DOC2B;SNCA;AKT2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.4627973115957789,-0.9279219110184659,0.5873015873015873,1.0,1.0,12/29,26.70%,HSPA1L;HSPA8;HSPE1;DNAJB4;CHCHD4;DNAJB1;HSPA5;HSPA2;SDF2L1;ENTPD5;HSPA13;BAG1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.47490437052662404,-0.9278574563131309,0.5344827586206896,1.0,1.0,6/11,28.54%,NLRP3;CD86;IL18;CD81;TNFSF4;RARA
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4485669419832719,0.9278044588231543,0.5882352941176471,0.9105836433895886,1.0,1/12,5.60%,RNF168
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.3624578229806555,0.9274480352609183,0.47368421052631576,0.911090520101344,1.0,8/47,11.56%,RAB27A;SNCA;RALA;SYT1;RAB3C;CHMP6;RIMS2;RAB27B
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.5832542989995059,-0.9274258957665986,0.6724137931034483,1.0,1.0,1/6,5.53%,BLK
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.4418047938791769,0.9274184090605662,0.5135135135135135,0.9107353873384795,1.0,9/18,15.12%,NLGN1;LRRTM3;CEL;PCLO;WNT3A;FZD1;NLGN4X;PTPRD;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.4767427564254201,-0.9273684817986999,0.5151515151515151,1.0,1.0,4/21,9.55%,LILRB3;ZFPM1;CEACAM1;CARTPT
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.42762423643743513,0.9272864535554604,0.5,0.9105922214462734,1.0,16/38,27.65%,CCN4;WNT4;CCN1;WWTR1;BMP4;SUCO;ZHX3;ACVR2A;ACVR1;BMPR2;BMPR1A;LRP3;LRP5;MEF2C;BMP2;NPNT
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.35242225136591926,0.9272788235766017,0.6153846153846154,0.9101938904504255,1.0,20/46,22.72%,FGFR1;KIAA0319;AUTS2;SH3RF1;PEX13;NR4A2;SDCCAG8;NAV1;MARK1;CEP85L;ASTN2;NTRK2;DCDC2;NRCAM;MARK2;ELP3;ADGRL3;CDK5;TUBB2B;GPM6A
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.5243491427520357,-0.9272366974138647,0.5263157894736842,1.0,1.0,4/10,14.83%,AHR;PTPRC;CEACAM1;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.5531483208108283,0.9271512658355012,0.55,0.9100365313289972,1.0,3/6,23.96%,HCLS1;CXCL12;GAS6
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.3995957039052135,0.9270508298883762,0.4523809523809524,0.9098355952459397,1.0,11/30,22.77%,TRIM71;NOTCH4;MOV10;TNRC6C;TNRC6A;TARBP2;XPO5;AGO3;AGO2;CNOT6;ADAR
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.38190307257477113,0.9269811469357699,0.6,0.9095547234251269,1.0,13/63,9.69%,NEUROD2;NLGN1;CPNE4;ITPKB;SYT17;TRPM2;AKR1C3;PKD2;CPNE7;SLC25A24;SYT3;SYT1;ADGRV1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.44360916302626174,0.9268334009101924,0.5,0.9095580582334016,1.0,2/23,5.16%,SLC26A7;SLC19A1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.3696686658461652,-0.9268016938527514,0.6470588235294118,1.0,1.0,8/122,10.71%,GPR62;TRIL;SOX10;LRRTM1;TMEM179;MATN4;TCEAL5;AQP4
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.42619818836166934,-0.9266181031768349,0.5294117647058824,1.0,1.0,8/43,20.75%,PSMB9;NQO1;AZIN1;OAZ2;PSMA7;PSMB6;PSMA3;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.41618300460116886,-0.9263981871361786,0.515625,1.0,1.0,13/43,23.39%,KIF14;CLU;SMAD6;SVIP;TMC8;RPL13A;THRA;NLRC3;NOP53;DDX3X;HSPA5;PARK7;TFIP11
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.42415557091536665,-0.9263743707931615,0.5079365079365079,1.0,1.0,7/28,24.02%,HLA-A;ERAP2;HLA-F;ERAP1;TAPBPL;SEC24D;SEC13
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.3517599831001463,0.9262852287765203,0.5714285714285714,0.9102672773215011,1.0,16/66,20.83%,CPN1;NAALADL1;CARNMT1;GSTM5;TRHDE;GSTZ1;THOP1;GSTA4;GSTM2;ADAMTS13;ETHE1;GPX1;HM13;GSR;DMD;FURIN
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.40826178606453345,0.9262434706987964,0.47368421052631576,0.9099065862743718,1.0,6/19,21.23%,BRCC3;USP16;USP36;SUPT3H;USP15;ATXN7
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5135324499483824,-0.9253925859654513,0.6415094339622641,1.0,1.0,4/13,19.37%,TEC;NTRK1;TXK;BMX
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.40034189022426264,-0.9252627621417178,0.6031746031746031,1.0,1.0,5/44,15.06%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ROMO1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.4757127088139673,0.9252368689491712,0.5365853658536586,0.9117273465159065,1.0,3/14,12.87%,AK3;IMPDH1;EFL1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.512821793582376,0.9251785626027264,0.62,0.9114825816212849,1.0,2/8,15.26%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.4657495778739815,-0.9244351969603277,0.5441176470588235,1.0,1.0,8/26,21.24%,HLA-A;TLR2;LYG2;IL12A;ROMO1;LYG1;PGLYRP1;STAB2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.5462166411859514,0.9243821072050818,0.5581395348837209,0.9125382266110884,1.0,2/6,12.90%,ADAM15;PTPRF
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.5269156660737983,-0.9243314373100932,0.603448275862069,1.0,1.0,6/15,23.14%,ANXA1;RAC1;TNFSF18;BST1;CD81;ZP3
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.39923362180301347,0.9239795364883575,0.5128205128205128,0.9131354932389509,1.0,8/23,13.91%,CSGALNACT1;ADAMTS12;CHST12;HPSE;CHST8;CHST11;HS3ST4;FAM20B
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.36047965368641927,0.9238959159619858,0.5641025641025641,0.9129412111787382,1.0,16/76,13.09%,FRMPD1;MRAP2;GRK5;TULP3;KLK14;RGS11;CRY1;RGS16;KCTD8;PLCB1;SAG;CAMKMT;RGS14;RPGRIP1L;KLK5;RGS6
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.49514148965811955,-0.9236381905616121,0.64,1.0,1.0,5/15,29.77%,NOP10;CCT8;CCT6A;CCT7;CCT2
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5035628134982422,-0.923636211472908,0.5671641791044776,1.0,1.0,5/12,27.18%,DCTN1;CLDN1;CBLN1;MYADM;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.5578167684157695,-0.9232956325963059,0.5081967213114754,1.0,1.0,4/7,25.74%,OTUB1;PARP10;OTUB2;GPS2
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5493514449579375,-0.9232812313934268,0.6,1.0,1.0,1/9,0.90%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.29312648396155383,0.9231534086596841,0.7894736842105263,0.914161525093445,1.0,68/486,13.60%,IL7R;RAB27A;BAMBI;GRK5;TGFBR1;FGF10;VEGFC;FGFR1;PARD3;BCL2;CAPN10;MFSD2A;FGF18;TRPC3;IRS1;POU3F2;PROX1;SIRT1;TCIRG1;CDK4;AKR1C3;FLT3;FGF17;ERBB2;NRG1;WNT3A;SLC25A33;TGFA;RIPK2;ACACB;GREM1;FER;SLFN11;TIMP1;MAPK8;ACER2;ANKLE1;ZNF703;CCN2;AKT2;KITLG;LRP6;MLXIPL;RPS6KA3;PDGFD;ADNP2;HCLS1;GRIN1;TNFRSF18;RNF10;TFE3;HES1;IRS2;IL2RB;NAMPT;PLA2G5;MYC;FRMD5;WWTR1;HDAC1;BMP4;ACER3;NOTCH1;UBE2A;MLC1;SMC5;DLX1;LBP
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3867003402027099,-0.9231432516372173,0.5522388059701493,1.0,1.0,23/56,32.58%,PSMB9;FBXL7;PSMA7;RBX1;PSMB6;PSMA3;AURKA;PSMA5;SKP1;PSMD8;RFPL1;PSMD6;CHEK1;PSMB4;PSMC5;PSMB7;GPR132;VPS4A;PSMC1;PSMD3;FHL1;PSMD7;PSMD12
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.4803446265647833,0.9230931708545963,0.4418604651162791,0.913807445054076,1.0,4/12,5.48%,IRGM;HTRA2;IFI16;PYHIN1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.5199734412298443,-0.9230508017467834,0.532258064516129,1.0,1.0,1/11,5.25%,DEGS2
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.5810456240256998,0.9230273868759472,0.5918367346938775,0.9134971751642008,1.0,2/5,24.57%,SAMHD1;RRM2B
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.32404299642510404,0.9228563585967865,0.5769230769230769,0.9134986548980559,1.0,17/104,11.35%,FIBIN;MXRA5;MRGPRF;KIT;LAMA4;SSC5D;CLEC14A;EDNRA;MMP2;ITGA4;PAMR1;LTBP2;OLFML2B;COL16A1;SNED1;CCDC80;CFH
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5067406817434399,0.922623284397617,0.5555555555555556,0.9136666506813994,1.0,1/10,6.51%,GREM1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.5454261048107412,0.9223373992569571,0.55,0.913943037712774,1.0,5/7,33.29%,FSCN1;CARMIL2;CLASP2;PDPN;CLASP1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.3939616884814967,0.9221506322527259,0.625,0.9139660072503849,1.0,2/26,3.05%,PER2;EDNRA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.37938360869609133,0.9220847089647718,0.5588235294117647,0.9137142237206001,1.0,7/56,10.33%,NLGN1;CACNG4;DLGAP4;CNIH3;CACNG2;GRIN1;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.3771024571884216,0.9220130109653402,0.5757575757575758,0.9134048630589446,1.0,7/43,14.02%,ZBTB7B;METRNL;PPARG;LPL;TFE3;CARM1;SOX13
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.40867754105063614,-0.9219878585566438,0.5625,1.0,1.0,13/51,12.67%,SIRPG;GMFG;ITGB2;ARHGAP9;CYTIP;TBC1D10C;TAGAP;PTPRC;CD5;KLRB1;PARVG;IKZF1;WAS
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.5089817106321838,-0.9217340026814059,0.5645161290322581,1.0,1.0,6/12,29.67%,PINK1;PHF23;FEZ1;CHMP4B;NUPR1;FEZ2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.48896466612745426,0.9216926546469058,0.5365853658536586,0.9138469881847715,1.0,3/12,3.57%,TGFBR1;OSR1;DSCAML1
prerank,MSigDB_Hallmark_2020__Coagulation,-0.36208755936990045,-0.9216273762913918,0.6290322580645161,1.0,1.0,22/98,16.96%,F8;TIMP3;S100A13;MMP9;GP1BA;ANXA1;ACOX2;PRSS23;CLU;CPB2;CFD;PLG;PLAU;THBS1;A2M;MASP2;PLAT;RAC1;FN1;VWF;C1S;CTSO
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.3876857227053172,-0.9213403264328398,0.6119402985074627,1.0,1.0,8/43,9.93%,ST6GALNAC1;CLCA1;GUCY2C;OLFM4;CEACAM1;ACSL5;CFD;SLC5A1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.5486376404038263,-0.9212082049180345,0.5862068965517241,1.0,1.0,1/7,7.61%,HAT1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.37814122827739827,0.921205812659665,0.6,0.9144475358716323,1.0,15/51,21.91%,MFSD2A;APOE;PITPNM1;LDLR;ABCA1;ABCC1;ABCA7;PITPNC1;PRELID2;ATP8A2;ATP10A;OSBPL8;ATP8B1;NPC2;SCARB1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.4706501910867057,0.9211357344292088,0.5641025641025641,0.9142032128181923,1.0,5/12,26.51%,AGBL4;GPLD1;ATG12;AGBL1;ATG7
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.32352029625381645,0.9210439252114071,0.7096774193548387,0.9139951816154809,1.0,16/95,12.72%,TGFBR1;FGF10;VEGFC;OSR1;PROX1;SIRT1;CDH13;SEMA5A;ERBB2;TGFA;ECM1;ZNF703;NR4A1;MYC;BMP4;NR4A3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.3552470540811305,0.9210111249050552,0.5217391304347826,0.9136359407890485,1.0,7/90,5.88%,ATP6V0D2;SLC5A8;ESRRG;FRK;TP53AIP1;CYP4Z1;RHCG
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5272095640438913,-0.9209957459915497,0.6065573770491803,1.0,1.0,1/11,7.43%,CARD14
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3846043022378429,-0.9208939375581636,0.5652173913043478,1.0,1.0,18/82,18.64%,CRLF1;FGF20;KIF14;PINK1;TNFRSF1B;WFS1;SOD2;PPT1;REST;NTRK1;CLCF1;HLA-F;SET;FOXB1;TGFB3;NAIP;MAG;GRN
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3475464055977727,-0.9208853648182479,0.6129032258064516,1.0,1.0,14/104,8.33%,MYH7;ACTC1;CASQ2;LMOD1;MYH4;TMOD4;MYH8;CAV3;MYOT;LTB4R;MYBPC3;CKMT2;CHRNE;NEB
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.4167982554439569,-0.9208721124291356,0.6031746031746031,1.0,1.0,11/40,18.54%,TIMP3;SERPIND1;TIMP4;SERPINB7;SERPINB5;SERPINE3;SERPINA10;SPOCK3;VTN;SERPINF1;SERPINB1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.4497232698165051,0.920830928147502,0.6046511627906976,0.9136805864587748,1.0,6/22,9.56%,TGFBR1;FGFR1;DSCAML1;SPEF2;WWOX;LRP6
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.5865281780301894,-0.9204614036966312,0.5538461538461539,1.0,1.0,1/5,9.55%,CARTPT
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.509305795967931,-0.9202871639577901,0.6,1.0,1.0,2/10,11.90%,F7;APOD
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3575879886423078,-0.9200365278488041,0.625,1.0,1.0,18/111,15.29%,SLC22A25;SLC22A24;SLC22A6;SLC22A3;CHMP3;SLCO2A1;TCN1;SLCO2B1;PPT1;ABCG2;LRP2;TXNIP;SLC6A4;SLC22A4;SLCO1A2;SLC18A2;CLN8;MFSD2B
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),-0.5822653958234647,-0.9197085426834863,0.6470588235294118,1.0,1.0,1/6,10.64%,POLR2M
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.5376660661980928,-0.9196649064416506,0.6415094339622641,1.0,1.0,2/9,9.21%,ZFPM1;SMAD6
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.41352729576003544,-0.9193892610586694,0.640625,1.0,1.0,2/32,8.03%,TGFB1;BACE2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.5183231683839937,0.919367179375182,0.52,0.9164623182371007,1.0,2/11,6.39%,PPP1R3A;PPP1R3E
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.47143124811735165,-0.9191550906942765,0.5490196078431373,1.0,1.0,6/21,19.15%,GRK7;PDE6B;CALM1;PDE6A;CNGB1;GUCY2F
prerank,MSigDB_Hallmark_2020__DNA Repair,0.3155026392997639,0.9191344730144928,0.5652173913043478,0.9165272116971099,1.0,27/140,20.75%,PNP;AK3;ERCC8;DUT;POLD3;BCAM;AAAS;RALA;ELOA;PDE4B;TAF12;HCLS1;CDA;REV3L;DGCR8;NT5C3A;HPRT1;TARBP2;RAD52;SAC3D1;APRT;NFX1;POLR2F;TP53;ADCY6;ERCC3;GTF3C5
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.4493915434226785,-0.9190526193596817,0.5806451612903226,1.0,1.0,4/23,14.94%,SOX10;TLR2;MYRF;EIF2B2
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),-0.6212778898952055,-0.919048407988996,0.6666666666666666,1.0,1.0,2/5,10.19%,IL27;SLC11A1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5098891302216428,-0.9189930658660295,0.5614035087719298,1.0,1.0,3/12,18.29%,SEMA3F;SEMA3A;PLXNA3
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.37631898996210705,-0.9189899011392677,0.5970149253731343,1.0,1.0,17/82,15.86%,C1QB;ANKUB1;APOL6;FMO5;VSIG4;CPM;SOD2;SLCO2B1;MAP3K19;CP;HLA-DPB1;GAS7;OMG;APOBEC4;HLA-DPA1;HVCN1;LDHC
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.36746939336870604,-0.9189160702494474,0.6119402985074627,1.0,1.0,14/85,19.90%,FZD8;TCF7;WNT5A;FRAT1;WNT8B;TCF7L1;SFRP4;SFRP1;LEF1;WNT8A;RBX1;DDX3X;SFRP2;RPS27A
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.3027256534629466,0.91859255545282,0.75,0.9175131707534011,1.0,51/234,19.97%,MCOLN3;KCNK6;SLC30A10;KCNB2;TRPC3;SLC39A8;SLC12A1;KCNH8;KCNC2;SLC8A1;TRPM2;SLC39A11;SLC8A3;RHCG;HCN1;PKD2;KCNH7;KCNK2;TMEM175;KCND2;SLC6A16;SLC6A17;KCNH4;ABCC8;SCN7A;HCN3;KCNH5;KCNQ5;KCNK12;SLC6A20;SLC4A11;ATP12A;KCNJ10;SCNN1B;KCNK10;KCND3;KCNG1;NALCN;SLC9C2;KCNJ8;KCNC3;CACNA1A;SLC24A2;SCNN1D;SLC1A3;TRPV2;SLC9A9;TRPM7;KCNAB3;TRPC4AP;SLC25A27
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.44414061204516897,0.918559679501886,0.5526315789473685,0.9171315539152911,1.0,2/22,2.76%,NGF;ADGRG6
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5471163077396172,-0.9182878902528917,0.6530612244897959,1.0,1.0,3/8,29.07%,VTN;ITGA5;PRKD2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.4726024584583412,0.9182579668104061,0.5813953488372093,0.9174836329777278,1.0,4/10,19.08%,SEMA5A;ARHGAP35;EPHB2;NRCAM
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.5649190927646035,-0.9182564237328904,0.5964912280701754,1.0,1.0,3/9,6.27%,DUOX1;ALOX12;CYBA
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.5254158205225454,-0.9180810998005308,0.6363636363636364,1.0,1.0,3/11,19.91%,ATP1A4;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),-0.5839852291228904,-0.9180459563641422,0.576271186440678,1.0,1.0,2/5,14.46%,NOS2;BPIFB1
prerank,PanglaoDB_Augmented_2021__B Cells,-0.3520291699770479,-0.9179585879325401,0.6231884057971014,1.0,1.0,15/111,11.02%,IRF4;GMFG;JCHAIN;ARHGAP9;CYTIP;IL21R;TBC1D10C;TAGAP;PTPRC;LY86;CD5;PARVG;IFIT3;TMC8;IKZF1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4316752289612332,0.9179550821823259,0.6046511627906976,0.9177922684885639,1.0,4/20,6.51%,PROX1;SMARCD3;CX3CR1;TOX
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.41674893594191,0.9179220184336006,0.6176470588235294,0.9174326008658938,1.0,8/26,26.48%,LSM10;SNRPB;ATM;SNRPF;ERI1;TUT7;XRN1;SNRPG
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.35977678698321747,-0.917733180237622,0.5753424657534246,1.0,1.0,24/120,21.55%,WNT5A;AIM2;TRIM62;TERF2IP;TRIM5;TRIM25;CARD14;CLU;TLR2;NLRP3;NTRK1;PRKCH;NLRC4;TNFSF18;CAMK2A;TNFRSF11A;NFKB2;TRIM22;IL18;RPS27A;ALK;AGT;CAV1;AR
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.3624629167523014,0.9176053793059666,0.6756756756756757,0.9176763577078006,1.0,4/54,5.16%,DUSP2;TCOF1;CDK4;SLC19A1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5936866211137652,-0.9175464858980371,0.5925925925925926,1.0,1.0,1/7,8.43%,EIF6
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2653362691088789,0.9175225323364792,1.0,0.917453426550445,1.0,162/908,17.22%,ERG;EGLN3;CSTA;ASB18;CTDNEP1;DAPK2;DUSP2;CD247;GRK5;TGFBR1;APOB;DUSP4;VCAN;FGFR1;MAPKAPK2;KLHL20;CDK14;LMTK3;APOE;FRK;PTPRO;CEL;SIRT1;LORICRIN;CDK4;PTAR1;ST8SIA4;BCKDK;DSP;CSK;PSME4;FSTL3;PSMA1;COMMD1;PTPRZ1;MAML1;ERCC8;ERBB2;PAK5;PDIA6;JMJD4;PRKCSH;SIRT7;HS3ST5;HIF3A;CTDSP1;LOXL1;PPP5C;CILK1;VRK2;WWP2;TRIB2;FER;CDK6;UST;TIMP1;DCUN1D1;MAN2A1;CTDSP2;PTPRM;FBXO15;MAPK8;MAST1;ABL1;LTBP1;SIK3;ANO8;LATS1;EIF2AK3;PTPRR;SGK1;LGALS1;KTN1;MAST2;UBE2E1;AKT2;MAP3K1;TNIK;RHBDD1;ERN1;METAP1D;KLHL41;MAP3K9;DCAF13;ABL2;WNK2;PKN2;PPP2R1B;CDK18;WDTC1;NUS1;ST3GAL3;FASTK;LCK;TSSK4;NTAQ1;GAN;PTPN9;RET;IGFBP4;UBE2E2;CCN1;MAP3K21;FBXL20;MAP3K13;PXK;BMP4;PGGT1B;PTPRF;KLHL3;MARK3;PIM2;PPM1A;MELK;CDC14B;CDH2;PTPRB;NGLY1;FBXL14;SIRT6;FUT9;KLHL42;FAM20B;PTPRT;COG7;RPS6KA4;KLHL22;PPM1L;CDK8;KLHL5;ASB7;TAB1;INSR;CDK16;RYK;DCAF5;ST3GAL6;PTPRD;QSOX1;PGAP1;B3GALNT2;FBXO27;PTPRE;SSH1;NEK1;MAP4K2;SGK2;ATM;MARK4;BCR;MARK1;MTMR3;DUSP6;RAB11B;ABCA7;DNAJC3;ALG3;FBXO17;FBXL22;SENP8;UBE2L3;PPEF1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5155616676531444,0.9174385734062281,0.625,0.9167644107444902,1.0,2/8,9.46%,SNCA;PDE4B
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5155616676531444,0.9174385734062281,0.625,0.9167644107444902,1.0,2/8,9.46%,SNCA;PDE4B
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.48500773479220727,-0.9167968449579672,0.5737704918032787,1.0,1.0,2/14,7.95%,P2RY12;KCNJ11
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.5474093683060016,0.9166943405264164,0.5681818181818182,0.9180399906367699,1.0,2/7,18.68%,RHCG;SLC12A4
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.5309696811320147,-0.9164947019660225,0.5892857142857143,1.0,1.0,3/8,13.04%,OGN;OMD;ACAN
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.3937029219994402,0.9164785617806521,0.5675675675675675,0.9181754587856986,1.0,8/38,19.45%,MFSD2A;HRH3;HLA-DRA;NF1;NIPBL;GRM5;CHD7;DOP1B
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.3746113748713652,0.9163622353987176,0.6,0.9180458888982289,1.0,14/43,20.39%,RBM20;SIRT7;RIOK1;ERN1;DXO;LIN28B;HSPA1A;BMP4;NFKB1;BUD23;PNPT1;TP53;U2AF2;LIN28A
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5592466773059672,-0.9161144706293237,0.7017543859649122,1.0,1.0,3/7,23.29%,NOS2;CHCHD4;PARK7
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.3616236962087692,0.9160187473087695,0.5151515151515151,0.9185318989029835,1.0,8/39,12.72%,CCN4;ADAMTS1;CDH13;DNMT1;MMP2;ERN1;BMP4;NR4A3
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.40079691884764573,0.9158881611456573,0.5277777777777778,0.9184094374408042,1.0,8/24,21.03%,CD14;MAP3K1;TLR5;TAB3;TAB1;IRAK4;TAB2;TRAF6
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.5856382954715535,0.9158879220271736,0.6222222222222222,0.9179867915883233,1.0,2/5,30.53%,NIPBL;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.537734932272274,0.915675962435508,0.6666666666666666,0.9181291192857232,1.0,3/7,10.09%,ZBTB1;CARD9;IL23A
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.47985852978817356,-0.9156004344034411,0.6326530612244898,1.0,1.0,3/16,11.08%,CEP55;CHMP3;MITD1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.4205005516522943,-0.9154404769346743,0.6229508196721312,1.0,1.0,7/35,16.55%,SIRPG;TNFRSF1B;IL27;FGL1;HLA-DPB1;HLA-DPA1;TNFSF18
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.574937302022343,0.9154095650915645,0.6585365853658537,0.9178635965684941,1.0,2/7,2.76%,PARD3;ADGRG6
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.574937302022343,0.9154095650915645,0.6585365853658537,0.9178635965684941,1.0,2/7,2.76%,PARD3;ADGRG6
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.3664418400568203,0.9152097201276839,0.6,0.9179558271650301,1.0,9/31,18.13%,BCL2;SNCA;KCNJ3;WWP2;KCNJ6;OCLN;KCNJ10;NEDD4;KCNJ8
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.4174095474688671,-0.9151408141996997,0.5909090909090909,1.0,1.0,6/33,11.13%,C1QB;CXCL13;C3AR1;CLU;CPB2;C4BPA
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.40937731193092647,0.9150533480815101,0.5555555555555556,0.917891035694169,1.0,4/17,25.25%,SMPD4;PLA2G4C;PNPLA6;ABHD12
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.5533440739383269,0.9149951508226238,0.5909090909090909,0.9176337871241717,1.0,4/5,33.18%,NR1H3;ITGAV;PTPN2;NR1H2
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.5878199310328579,0.9147754565626496,0.6470588235294118,0.9176689804349618,1.0,3/6,18.09%,SLC6A17;SLC6A20;SLC36A4
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.43478808467424734,-0.9146440082127956,0.5909090909090909,1.0,1.0,3/30,8.79%,KCNA5;CASQ2;CD63
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.5379902251231181,0.9143284049997519,0.6170212765957447,0.9182384193298067,1.0,2/8,12.23%,HTRA2;LGALS9
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.4497005703141732,-0.9142880481374792,0.578125,1.0,1.0,7/26,13.25%,SLC25A31;SYCP1;TTC6;BANF2;TNP1;TEX101;SYCP3
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3427144413396756,0.914249770858992,0.7142857142857143,0.9179600039228967,1.0,10/67,14.36%,KIFC1;KIFC2;ESPL1;AAAS;FLNA;SPAST;SGO2;EPS8;PIBF1;KLHL22
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.35579246377139845,0.9140353276064704,0.6296296296296297,0.9180946399291906,1.0,13/45,20.57%,SIRT1;IFI16;TANK;SPIDR;HSF1;LIG4;ATM;EEF1D;RAD9A;NIPBL;GADD45A;TP53;ATR
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),0.5029304443467144,0.9138861121259965,0.5813953488372093,0.9179161401867637,1.0,2/6,2.81%,OSR1;ANGPT1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.44318694090544425,0.9137549328393801,0.5121951219512195,0.9177591358217748,1.0,3/16,12.11%,CSTA;ECM1;HDAC1
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.5741870618472149,-0.9136020087241897,0.6666666666666666,1.0,1.0,2/6,33.04%,CSF1R;MAPK3
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.48130645913280057,0.9136019290114519,0.6176470588235294,0.9176875640320841,1.0,4/10,17.37%,FZD5;WLS;SKI;SHH
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.33224470460253025,0.9132280673695778,0.6,0.9181346614462703,1.0,12/75,15.44%,SMYD5;PSME4;PSMA1;CBFB;ABL1;SP7;JAG1;HES1;NOTCH1;RUNX1;PUS7;SLC4A11
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5361451189932642,-0.9131347140601352,0.5573770491803278,1.0,1.0,2/11,14.77%,SLC22A6;SLC22A4
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.3196142328588714,0.9131123807880756,0.625,0.9179422679091941,1.0,42/170,22.03%,HSPB1;PRR16;TCOF1;SAMD4A;ERBB2;DHFR;RIDA;TRIM71;PCIF1;EIF2AK3;CNOT9;NANOS3;RPS6KA3;MTRF1;EIF3H;EIF3E;PUS7;GEMIN5;PUM3;ETF1;NIBAN1;IMPACT;BCL3;MALSU1;SYNCRIP;PIWIL2;YTHDF1;FXR2;PATL2;SHMT2;GRM5;ZCCHC4;LSM14A;SAMD4B;LIN28A;EIF4A3;LARP4B;NEMF;LARP1;EIF4E;UPF3A;IGF2BP1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.46850416337082035,0.9131008286301683,0.6153846153846154,0.9175655107289866,1.0,5/16,17.98%,TGFBR1;BMP4;NOTCH1;HAS2;RBPJ
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.34200000958304444,0.9128786709618986,0.6296296296296297,0.9176289522331912,1.0,28/109,17.03%,SLITRK6;EDIL3;EDNRA;ADGRL2;PARVA;ALDH7A1;ASAP3;GPC6;PCDH7;IL17RD;SLIT2;TENM3;MPDZ;PDZRN3;COL16A1;CAP2;RBFOX2;FARP1;SDC3;EFS;MAGI1;DENND2A;ANK2;PRICKLE2;ANTXR1;PBX1;CDH11;NAV2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.3470196828431614,-0.9128385486055323,0.6075949367088608,1.0,1.0,12/141,5.91%,MYH7;ACTC1;PLAG1;SNN;STAG3;ZC2HC1C;PDE6B;HTR1B;MYOT;SOX10;NRIP2;GP1BA
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.34866380445982187,-0.9126656824612361,0.6621621621621622,1.0,1.0,38/155,19.98%,IRF4;PSMB9;IL7;UBE2L6;HLA-DRB1;APOL6;IRF1;STAT1;HLA-DMA;TRIM25;HLA-A;CIITA;RNF213;SOD2;LATS2;P2RY14;IFIT3;IFIT1;ARL4A;TXNIP;CDKN1A;SELP;OAS2;IL18BP;SP110;DDX60;IFI27;ISG15;C1S;NUP93;CD86;WARS1;CASP7;PSMA3;MT2A;CASP8;FPR1;DHX58
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.3670396123815535,0.9126529742636738,0.5384615384615384,0.9177065182089325,1.0,15/64,14.85%,KIT;FGFR1;FLT3;ERBB2;EPHA3;FER;ABI3;ABL1;ABL2;EFEMP1;LCK;FGFR3;PIBF1;INSR;EPHB2
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.5447049602093172,0.9124350030577032,0.5909090909090909,0.917826541150223,1.0,3/6,30.09%,SLC4A11;STK39;TRPV4
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.3972213054936513,-0.912339460291863,0.5166666666666667,1.0,1.0,23/48,25.70%,JCHAIN;FCGR3A;HCK;POU2F3;ALOX5;PTPRC;ASIC5;PTAFR;SPI1;NFAM1;TUBB;ITGAM;PLCB2;IL13RA1;CD300LF;SOX9;ADGRE3;HK3;CD24;GNG13;GNAT3;IL17RB;FGL2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.4232101421194485,-0.9123222126075701,0.5970149253731343,1.0,1.0,5/27,12.29%,NRAP;CAV3;NEB;ALPK2;HEY2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3458975905853419,0.9122055172927139,0.5666666666666667,0.9179606240797772,1.0,8/58,12.10%,HDAC3;F2;PYHIN1;EIF2AK3;FLNA;HCLS1;JUP;WWTR1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.4256072269348009,-0.9121934692773372,0.5909090909090909,1.0,1.0,3/42,5.02%,TERF2IP;SP100;RPA3
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.4939353440399359,-0.9120550528987855,0.6833333333333333,1.0,1.0,4/14,19.91%,KCNQ1;KCNE3;KCNE2;ATP1A1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.4134977720305636,0.912044433551299,0.5208333333333334,0.9180591773073162,1.0,3/17,3.16%,CHRM2;KCNB2;NMU
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.4828793726008974,-0.912041216596714,0.5666666666666667,1.0,1.0,2/16,11.52%,CHMP3;EML3
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.4520290965261049,0.9119820036725803,0.6388888888888888,0.9178037272956362,1.0,7/16,29.79%,GDF6;BMP4;SOX5;BMPR2;BMP2;ZBTB16;BMPR1B
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.34080791379436265,0.9119760429704663,0.6428571428571429,0.9173928589316912,1.0,21/87,12.57%,MGAT4C;ADRA1B;CDH7;RP1L1;SV2C;GABRG3;PDE10A;SLC2A11;HCN1;SAG;KCNJ6;OPRD1;AANAT;CATSPER2;CATSPERG;DRD4;RGR;MYT1L;ZNF774;XKR4;CREM
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.4485027313144872,-0.9116198700245477,0.5873015873015873,1.0,1.0,4/20,19.58%,UBE2U;ATXN7L3;RNF20;RNF8
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.5671379998165984,-0.9115727688939864,0.6271186440677966,1.0,1.0,1/8,3.38%,CAV3
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.32604372087055117,0.911456771276271,0.7586206896551724,0.9179724201293724,1.0,15/121,8.11%,ARC;FIBIN;MXRA5;RNF182;CLEC14A;EDNRA;CDH5;RIN2;PARVA;SLC12A1;SMARCD3;CDH6;CGNL1;PAMR1;PLSCR4
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.4921272867468684,0.9114140264544592,0.5641025641025641,0.9171799126078518,1.0,3/8,14.19%,ABHD17A;ABHD17C;ABHD17B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.4921272867468684,0.9114140264544592,0.5641025641025641,0.9171799126078518,1.0,3/8,14.19%,ABHD17A;ABHD17C;ABHD17B
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.49723403984465075,0.9114051155367043,0.5952380952380952,0.9167841991931291,1.0,3/8,15.87%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.3703843125723209,-0.9113741125986013,0.6617647058823529,1.0,1.0,24/103,17.91%,F8;TIMP3;TGFB1;BLK;A1BG;PSAP;CD63;CLU;CFD;PLG;TUBA4A;ITGA2B;THBS1;SELP;A2M;TTN;ITIH4;F5;CALM1;FN1;VWF;ITIH3;TGFB3;ALB
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.5655487389255787,-0.9112809352214079,0.6612903225806451,1.0,1.0,2/7,22.89%,SEC62;HSPA5
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.48221142873953843,0.9112287668873738,0.5641025641025641,0.916819442721277,1.0,1/11,0.34%,NPAS4
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.5564600518452595,-0.9111549918802417,0.6379310344827587,1.0,1.0,2/7,18.82%,ADAD2;ADARB2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.428688811756197,-0.9111494491654442,0.6268656716417911,1.0,1.0,3/38,5.28%,FZD8;TCF7;FRAT1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.4907655399781515,-0.9110195730392873,0.6296296296296297,1.0,1.0,3/12,11.56%,GPER1;ANXA1;REST
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3852928608955692,0.9109526397629312,0.6410256410256411,0.9170239926593641,1.0,9/46,14.34%,PER2;SPOPL;ARRB2;SIRT7;CRY1;HSPA1A;N4BP1;GNL3L;ARRB1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.3376484255282678,0.9106234860626993,0.6451612903225806,0.9172918299786482,1.0,11/63,16.79%,DAPK2;HSPB1;IFI16;ABL1;ACER2;DEPP1;ABL2;OSBPL7;PIP4K2A;ATM;MTMR3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.38077495458181015,0.9104404476270688,0.4230769230769231,0.9173408939418122,1.0,15/47,19.66%,PCM1;PER2;CX3CR1;WNT3A;NUMB;SPEN;ASCL1;HES1;RGS14;NOTCH1;HES6;LIG4;FAIM;APPL2;PAX6
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.5473141116632961,0.910418618532514,0.6363636363636364,0.9169882818360123,1.0,3/6,22.50%,AMPD1;HPRT1;AMPD3
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.4190239212239825,0.9103744310435407,0.5121951219512195,0.9166500753622874,1.0,7/14,33.13%,ATM;ERI1;TUT7;XRN1;EXOSC10;TUT4;TENT4B
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.40445343119981503,-0.9101050421516486,0.5757575757575758,1.0,1.0,6/37,10.84%,IRF4;SFTPD;ANXA1;VSIG4;PTPRC;STOML2
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.5434278506336818,0.9100992877190971,0.6511627906976745,0.9168683181947169,1.0,1/5,1.58%,VEGFC
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.4839840617000106,0.9100044408872398,0.5813953488372093,0.9166923140662178,1.0,3/9,12.90%,GREM2;ADAM15;PTPRF
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3724988301068359,0.9100001940135196,0.5294117647058824,0.9162773333898637,1.0,7/44,8.36%,BCL2A1;BCL2;SIRT1;HTRA2;IFI16;PML;ABL1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5256944911241404,0.9098234889052461,0.6046511627906976,0.9162283000280469,1.0,1/9,0.43%,SKAP1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.43562782346226153,-0.9096756501219019,0.6153846153846154,1.0,1.0,3/19,10.63%,TBX1;SMAD6;LRP2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.341731298263331,0.9096430057173344,0.4827586206896552,0.9162917437661333,1.0,18/66,21.03%,PRICKLE1;HDAC3;ANGPT1;COMMD1;RIPK2;CRY1;DCUN1D1;TANK;HDAC4;RASD2;LAPTM5;UBE2L3;MALT1;HSPBP1;FBXO4;SMAD7;SPRTN;TRAF6
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.3317050331567854,0.9094350334976639,0.5151515151515151,0.91638322562032,1.0,14/87,10.64%,TEAD2;FGF10;TWIST2;EDNRA;PARVA;ADAMTS1;COL12A1;PPARG;MMP2;SLIT2;LRIG3;EFEMP1;RND3;TWIST1
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.5682457982908736,0.9094031490118433,0.6136363636363636,0.9160112588669606,1.0,3/5,27.44%,IAPP;CALCR;RAMP1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5388866447393107,-0.9090961573027165,0.6323529411764706,1.0,1.0,2/6,5.27%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5388866447393107,-0.9090961573027165,0.6323529411764706,1.0,1.0,2/6,5.27%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),-0.5547236456164502,-0.9090376067528558,0.5789473684210527,1.0,1.0,3/5,19.13%,GNMT;ENPP4;ACP3
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.42210437051994243,-0.9086188463951957,0.625,1.0,1.0,5/38,14.30%,STAC;KCNJ15;KCNQ1;PDZK1;KCNJ4
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.47649738355469884,-0.908590869625393,0.59375,1.0,1.0,2/18,6.68%,MCM3;MCMDC2
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.33587204186345865,0.9081651981513582,0.5833333333333334,0.9183624277783148,1.0,6/62,10.50%,TGFBR1;SBK1;GALNT1;MAPK8;MAP3K10;GALNT13
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.43402353834838414,0.9079198119153344,0.5405405405405406,0.9185229944501772,1.0,10/22,28.82%,APOE;ABL1;PIK3CA;GPX1;CAMSAP3;GBA2;MAP2;AEBP1;C9ORF72;MAPRE3
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.47562831532069816,-0.9074843217147354,0.6037735849056604,1.0,1.0,1/12,5.07%,ALOX5
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),0.5757813103767604,0.9074734918548583,0.627906976744186,0.9189428302869052,1.0,2/5,6.77%,CYP4V2;ADH4
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.4704115415558151,0.9073484687528522,0.4375,0.9187876290114877,1.0,4/14,10.78%,LAMB4;NTN4;NTNG2;FLRT2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4240303014891237,0.9070961434500993,0.5454545454545454,0.9189267721930585,1.0,3/18,11.77%,TGFBR1;DCUN1D1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.4604904558152951,0.907056095061476,0.5405405405405406,0.9185896735128447,1.0,1/9,3.73%,SIRT1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.4801882972272331,0.9068738252422512,0.5897435897435898,0.918560815103151,1.0,3/12,15.07%,SLC8A1;GSTM2;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.5805535675775663,-0.9068297594990419,0.6181818181818182,1.0,1.0,2/5,33.04%,CSF1R;MAPK3
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.40025284749779566,0.9063187651969542,0.6052631578947368,0.9194203994336825,1.0,8/26,23.96%,SLC8A1;MICU1;MCU;CACNA1I;CACNA1A;TRPC4;SLC25A23;CACNA1B
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.5032505615758126,0.9062581699675903,0.5,0.9191464640610536,1.0,4/7,14.10%,DRD3;HES1;NOTCH1;NF1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.5466129330240778,-0.905748335419493,0.6065573770491803,1.0,1.0,2/6,19.16%,DDX1;DDX3X
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4377191566151389,0.9055420713695943,0.5405405405405406,0.9202496305710371,1.0,1/13,5.60%,RNF168
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.509793660649358,0.9053814800472609,0.6530612244897959,0.9201781618538547,1.0,3/10,5.35%,KLRD1;CX3CR1;ARRB2
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.46498564330942194,0.9053684089385763,0.4444444444444444,0.9197995127925106,1.0,4/11,22.61%,RALB;PIP4K2A;LRSAM1;ELAPOR1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5290354130715902,-0.9051178167119918,0.6333333333333333,1.0,1.0,4/9,26.83%,GABARAPL1;GABARAPL2;MAP1LC3B2;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5290354130715902,-0.9051178167119918,0.6333333333333333,1.0,1.0,4/9,26.83%,GABARAPL1;GABARAPL2;MAP1LC3B2;MAP1LC3B
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.46159258163236305,-0.9049916061420742,0.5932203389830508,1.0,1.0,2/20,3.01%,CXCL13;SP100
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.38861457263953536,-0.9049815347136666,0.5846153846153846,1.0,1.0,9/49,22.08%,CASQ2;CHMP3;GAS7;WAS;RAC1;VIL1;PSTPIP1;CATIP;GPX4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.29019766223584775,0.9048288512171844,0.6666666666666666,0.9204472190361058,1.0,70/283,20.13%,PCM1;CEP152;FHDC1;IFT88;CNTRL;RP1L1;CEP135;EHD4;PARVA;DZIP1L;SCLT1;JHY;GBF1;BBS9;CILK1;SDCCAG8;TTC36;ALMS1;SPAG16;DYNC1I2;C2CD3;FLNA;CEP290;AKAP9;RAB11FIP3;AVIL;RPGR;CEP250;RPGRIP1L;MAPRE1;NOTCH1;MKS1;RILPL1;CDC14B;PTPN23;PIBF1;KIAA0586;ARL13B;CEP20;TTC39C;SSTR3;BBIP1;EXOC7;CEP162;IFT140;ARL3;NEK1;TTC21B;MARK4;KIF3B;CFAP46;CFAP70;RP2;CFAP221;TMEM138;DZIP1;CNGA4;PTPDC1;CFAP43;CEP41;DCDC2;POC1B;UNC119B;NDE1;DNAAF3;TCTN2;TRIP11;CDK5RAP2;TMEM67;WDR19
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.4045281921179275,-0.9045471084915865,0.6268656716417911,1.0,1.0,4/28,10.33%,WNT5A;DTX2;CCND1;SAP30
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.44602184359420705,0.904415114158132,0.6486486486486487,0.921136202957271,1.0,6/17,17.22%,URI1;AKR1C3;MGARP;BMP4;NR3C1;UBE2L3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.37910262616761287,-0.9039138106072768,0.6307692307692307,1.0,1.0,6/40,11.07%,LMOD1;HCK;C15ORF62;ALOX15;BAIAP2L1;SCIN
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.5855469514875467,-0.9038685748756862,0.631578947368421,1.0,1.0,2/5,30.42%,BAG3;HDAC6
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.454601672611056,0.9038118321203402,0.525,0.9220895587073934,1.0,4/17,5.48%,IRGM;HTRA2;IFI16;PYHIN1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.43682271438734593,0.9037299584029519,0.4418604651162791,0.9218571079416602,1.0,3/13,8.71%,FGF10;NRG1;SGK1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.5503400206560783,-0.9036719281915813,0.6666666666666666,1.0,1.0,1/8,15.44%,TERT
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),-0.557128654655967,-0.9036682534575708,0.6326530612244898,1.0,1.0,1/5,9.05%,CHCHD2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.35546117428848606,0.9033453503226936,0.5384615384615384,0.9222588785697107,1.0,13/75,10.80%,PCDH15;LHFPL3;KIT;USH2A;LHFPL4;SPTBN4;ALDH7A1;PAX3;WHRN;GRM7;MYO3A;ADGRV1;CCDC50
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.40878294253556435,0.90320195667237,0.6170212765957447,0.9221170929687521,1.0,6/24,19.03%,RHEX;STAT5B;HSPA1A;ABCB10;ANKRD54;ACVR2A
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.513301576161375,-0.9030760119996993,0.559322033898305,1.0,1.0,1/10,0.79%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.4831029345484857,0.9029829801408618,0.5714285714285714,0.9221216139863988,1.0,1/10,5.11%,SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.4876924666173921,0.9028732993541198,0.6153846153846154,0.9219521855889758,1.0,2/7,11.46%,BCL6;IRS2
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4130684609256636,0.9027222888703447,0.5641025641025641,0.9218315917740522,1.0,3/20,8.37%,PPP1R14D;BOD1L1;STYXL1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.35828432977560737,0.9026150800592083,0.7058823529411765,0.9216832995194593,1.0,9/50,13.06%,ACADS;ACAD10;BDH2;SLC27A2;ECHS1;ABCD3;ABCD2;ACADM;MECR
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.4520727829483273,-0.9024878071950069,0.6190476190476191,1.0,1.0,4/26,16.77%,HMGB3;ANXA1;DDX1;PIF1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.44676268657684926,0.9024784917963831,0.5116279069767442,0.9216254701385037,1.0,3/13,9.69%,KIT;WHRN;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.4363970829486831,0.9024614404161628,0.5581395348837209,0.9212482052883582,1.0,5/12,27.24%,MARK3;DLG5;WWC1;WWC2;WWC3
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.5051100587687513,-0.9022721097796395,0.5806451612903226,1.0,1.0,2/13,10.40%,PSAP;ABCB1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.40814676281887924,0.9021715714883011,0.4594594594594595,0.9214127746363195,1.0,7/24,11.61%,SYT17;DOC2B;SDF4;SYT3;SYT1;RIMS2;SYT12
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.5763900916268201,-0.9021130097037343,0.6363636363636364,1.0,1.0,2/5,22.01%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.5763900916268201,-0.9021130097037343,0.6363636363636364,1.0,1.0,2/5,22.01%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.3852833089226065,-0.901995796763761,0.6571428571428571,1.0,1.0,9/85,11.23%,SCTR;FCGR3A;HCK;TSHR;PTGDR;HLA-DRB1;CGA;GPR27;GPR39
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4471463194343042,0.9019830634160643,0.6122448979591837,0.9214037177491264,1.0,6/16,29.05%,NUS1;ALG12;ALG3;ALG13;DOLPP1;MVD
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.36432192040859057,-0.9018397129735191,0.6376811594202898,1.0,1.0,16/73,21.27%,SCTR;CAPN8;MISP;SMIM22;TMC4;ITGB6;AQP4;MYO5B;SLC44A3;MUC5B;SOWAHB;ALB;CAPN13;TJP3;SOX9;LGALS4
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.49173080705403377,0.9013330849074981,0.6129032258064516,0.9222963582383676,1.0,1/11,2.97%,ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.5370230262743897,-0.9011016178886369,0.6379310344827587,1.0,1.0,3/11,14.96%,VSIG4;C4BPA;A2M
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5240285616855218,0.9008856008605916,0.6363636363636364,0.9229386149330562,1.0,3/8,16.98%,ADIPOR1;PTPRT;BCL3
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.4860572263000367,0.900315616511013,0.5813953488372093,0.923822844638071,1.0,3/16,7.11%,PTGS1;AKR1C3;PTGIS
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.349886430637752,-0.9002739838649674,0.589041095890411,1.0,1.0,12/128,12.20%,C1QTNF1;TIMP3;LMOD1;TMEM184A;DOCK6;AARD;SLCO2A1;ACOX2;COL18A1;CLU;GATA4;GPX3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.39807777056717647,-0.8999240832845182,0.6029411764705882,1.0,1.0,3/30,11.09%,PKP2;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),-0.5598479923196659,-0.8998423918115009,0.5873015873015873,1.0,1.0,2/6,25.01%,NOS2;AGER
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.49176863584648456,0.8997672858837568,0.5853658536585366,0.9248586753873067,1.0,1/10,7.28%,CHAC1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.3911838647141162,0.8997595274531596,0.5428571428571428,0.9244534517352057,1.0,12/41,17.24%,HRH3;PCLO;SNCA;PPFIA3;SYT1;GRM4;PDZD11;RIMS2;SNPH;SYN2;NRXN1;SYN1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.36533135096386193,0.8996574997157964,0.5294117647058824,0.924339255277026,1.0,7/50,12.05%,PHLDB2;EPHA3;ABL1;EFNA5;COL16A1;MACF1;LIMS1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.5058433872499037,0.899576686439895,0.5490196078431373,0.9241006447456538,1.0,1/6,2.46%,MITF
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.473976281900489,0.8992458388818522,0.47619047619047616,0.924498377261786,1.0,2/11,8.02%,RFWD3;PLK3
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.5489456622603627,0.8991578623092334,0.5918367346938775,0.9242737310094276,1.0,2/5,25.85%,NOTCH1;SNAI2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.3644234488723621,0.8990937080624103,0.6578947368421053,0.9240147429572212,1.0,9/42,15.27%,SLC3A2;SLC38A5;SLC7A9;SLC7A11;SFXN2;SLC7A8;SLC25A12;SLC7A6;SLC6A20
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.39127293220211445,-0.8990699991352229,0.6065573770491803,1.0,1.0,3/48,5.07%,NOTUM;TGFB1;ALOX5
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.32760142962396843,0.8989117067240949,0.6333333333333333,0.9240667211180689,1.0,16/89,14.72%,CACNG4;KCNB2;IGDCC3;POU3F2;GRM8;RHBDL3;CASKIN1;MSI1;LIN28B;ACHE;CRABP1;CSPG5;RIMS4;FBLL1;SNAP91;MPP2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.40754436416007495,-0.8986059099804894,0.5932203389830508,1.0,1.0,3/34,5.07%,WNT5A;TGFB1;ALOX5
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.5437002048720271,-0.898504788840744,0.6382978723404256,1.0,1.0,2/9,9.89%,DBH;DAO
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.41000487000507574,-0.8981337351383094,0.6111111111111112,1.0,1.0,11/40,20.21%,ACTC1;SCN5A;ZFPM1;GATA4;HEY2;CSRP3;TTN;HEY1;AKAP13;MESP1;SGCG
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.5250583190718999,-0.8978159458528646,0.6615384615384615,1.0,1.0,2/9,6.88%,TAF7;CIITA
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.4143945922876502,0.8976970335921387,0.5555555555555556,0.9265137084610006,1.0,6/15,26.77%,MAGI2;PPP1R15B;GPLD1;MEF2C;BMP2;MTMR9
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.3292412453641721,0.8974296034225113,0.6666666666666666,0.9267439077053571,1.0,18/75,20.31%,SMYD5;IFI16;DNMT1;TAF1B;MYO1C;SF3B1;POLR1H;HDAC4;MECP2;BAZ1B;MPHOSPH8;KAT2B;HDAC5;GPX1;EP300;POLR2F;PHF1;MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.5713383272712034,-0.897304683509236,0.6938775510204082,1.0,1.0,1/5,5.47%,GPSM2
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.43032487671720004,0.8969757027535835,0.6190476190476191,0.9273669774360204,1.0,2/18,5.13%,URI1;PPP1R35
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.3160141856914409,0.8968120335764518,0.6785714285714286,0.9272933022923299,1.0,10/119,4.47%,FIBIN;MXRA5;MRGPRF;ESRRG;MAFB;EDNRA;CDH5;ALDH1A1;PARVA;COL12A1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.34737053790279177,0.8968073986790416,0.625,0.9268820857502934,1.0,10/51,9.53%,CHRM2;HTR1F;HRH3;GRM8;DRD3;ADCY2;DRD4;GRM7;GRM4;FLNA
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.38073226679206906,0.8965523845866549,0.6285714285714286,0.9269188809271413,1.0,13/64,16.36%,RHOBTB3;RHOBTB1;CRK;MLST8;EPHA3;ABL1;EFNA5;RND3;CCDC88A;FSCN1;ARHGAP35;CORO2B;F11R
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.4936441631916897,0.8963823315689372,0.6111111111111112,0.926852386076766,1.0,7/12,26.08%,PKD2;FAF1;CCDC22;PSMD10;SUFU;NFKBIB;PKD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4414186635075041,-0.8961359406114614,0.5873015873015873,1.0,1.0,1/18,1.44%,CASQ2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.4840407786490548,-0.895909827271892,0.6333333333333333,1.0,1.0,1/11,0.79%,TBX1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.5004762108604474,0.8956739077052366,0.6216216216216216,0.9281070597842473,1.0,1/11,3.38%,APOE
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.46376549588868654,-0.8956134696310071,0.6811594202898551,1.0,1.0,4/21,8.52%,ERN2;GPER1;H1-0;ENDOG
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.502672032199076,0.895569151857911,0.6382978723404256,0.9279231763591086,1.0,1/7,4.68%,SLC38A5
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.41390359501037466,0.8955429681510014,0.575,0.9275813377858196,1.0,4/24,4.88%,KIT;F2;IRS1;FLT3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.37140921333281113,0.8953897686379398,0.5476190476190477,0.9275284108800212,1.0,9/31,18.02%,NYAP2;IRS1;ERBB2;PIK3C2B;NF1;PIK3R5;PIK3CA;TYRO3;ERBB3
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3782413807564479,0.8953884729656053,0.5384615384615384,0.9271183629530186,1.0,10/45,16.52%,CRK;ABL1;FLNA;LIMS1;CSPG5;CUX1;PTPRD;DOCK1;CASS4;CRKL
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.3048887188280672,0.8953794388459023,0.625,0.9267292741493353,1.0,16/153,10.49%,SKAP1;CD38;CD247;SH2B2;BCL2;ICOSLG;CSK;PSME4;BTN3A2;PSMA1;RIPK2;HLA-DRA;PDE4B;PAG1;DENND1B;LCK
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.525601407879117,0.8953702056283275,0.5909090909090909,0.926326803975273,1.0,3/7,19.23%,HAS2;MARS1;SYAP1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.4230167128897109,-0.8949856383572729,0.6545454545454545,1.0,1.0,5/28,12.83%,CYP1B1;P2RY12;PIK3CG;ADA;PLAU
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.3797943341385881,-0.894689201568055,0.6571428571428571,1.0,1.0,9/86,11.23%,SCTR;FCGR3A;HCK;TSHR;PTGDR;HLA-DRB1;CGA;GPR27;GPR39
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.4247982356122808,0.8946674417725808,0.6,0.9272348564300034,1.0,10/28,23.13%,MFSD2A;PLSCR4;ABCA1;PLSCR1;ABCC1;ABCA7;ATP8A2;ATP10A;ATP8B1;PLSCR2
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.5480451027179987,-0.8946606139933234,0.6551724137931034,1.0,1.0,1/5,4.08%,P2RY12
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.40165474644283783,-0.894448772862505,0.6285714285714286,1.0,1.0,8/49,11.72%,TBX1;PDXDC1;SOX10;SEMA3F;SEMA3A;FAT2;HTR2B;GPC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.3976760680031249,-0.8944152167760007,0.6229508196721312,1.0,1.0,12/36,31.89%,RPA3;RBX1;RPS27A;OGG1;RPA2;DDB1;PCNA;POLD4;UBB;GTF2H5;RFC5;ERCC4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.36685555010734733,-0.8944058652032386,0.6875,1.0,1.0,3/68,3.31%,GML;SP100;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.4371953407117004,0.8944058157605956,0.5882352941176471,0.9274633151900749,1.0,4/23,16.27%,SNCA;DSCAM;BTBD10;FZD7
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),0.5696441301769612,0.8941947189812502,0.673469387755102,0.9275545031433655,1.0,2/5,2.91%,FGFR1;FGF18
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.5187029574950031,-0.8941731439915567,0.6470588235294118,1.0,1.0,4/9,22.48%,RPL5;RPL23;RPS7;RPL11
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4143294919249615,-0.8938849731066487,0.6491228070175439,1.0,1.0,2/28,9.58%,ART1;ART3
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.34864639861755603,0.8938376455593519,0.6764705882352942,0.927994983172404,1.0,16/60,19.67%,SH3RF1;ERCC8;MARCHF5;WWP2;TRIM71;SH3RF3;RNF10;UBE3D;KLHL24;UBE2A;RNF146;CNOT4;LRSAM1;RNF185;NFX1;MARCHF7
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.44410822951506895,-0.8937575182564839,0.6166666666666667,1.0,1.0,3/18,9.91%,TIMP3;TNFRSF1B;TIMP4
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5842500298482821,0.8936145344745889,0.5897435897435898,0.9280790090084794,1.0,4/5,41.21%,VPS13A;SORL1;VPS13D;VPS13C
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.31580154828130197,0.8934784830367203,0.75,0.9279713174640679,1.0,19/118,16.12%,MGAT4C;GALNT7;SLC39A8;DPM3;ST8SIA4;TET2;GALNT1;FKTN;PLOD3;GAL3ST1;POFUT1;NUS1;ST3GAL3;ALG12;FUT9;COG7;ST3GAL6;B3GALNT2;POMT2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.45680666073173704,-0.8931443134673235,0.6176470588235294,1.0,1.0,10/24,26.70%,HSPA1L;HSPA8;HSPE1;DNAJB4;DNAJB1;HSPA5;HSPA2;SDF2L1;HSPA13;BAG1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.36638010371621993,0.8930018914531561,0.5945945945945946,0.9285273357347736,1.0,13/45,18.57%,SLC3A2;SLC38A5;SLC7A9;SLC6A17;SLC7A11;SLC7A2;SLC16A10;SLC25A29;SLC7A8;SLC7A6;SLC6A20;SLC36A4;SLC7A14
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.4062850619092606,0.8929573568007774,0.7037037037037037,0.9282759356757662,1.0,5/29,6.85%,COL8A1;LAMA3;COL12A1;MMP2;ITGA4
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),-0.6061464858673371,-0.8928162634993744,0.6545454545454545,1.0,1.0,2/5,5.43%,ERN2;GPER1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.37016978130928585,0.892490684262196,0.5625,0.9288996844110443,1.0,4/51,4.65%,PNP;CLC;CCDC88B;SDC4
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.4724266310356242,0.8922448930667489,0.6153846153846154,0.9290309542093399,1.0,3/9,21.20%,PPP1R15B;ABCA7;NCK1
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),0.5491480855452053,0.8922358130975917,0.6458333333333334,0.9286294183174117,1.0,4/6,17.37%,FLT3;BMP4;LIG4;SHH
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.43608558390451746,-0.8919261604626066,0.5636363636363636,1.0,1.0,9/26,30.87%,RPA3;RBX1;RPS27A;RPA2;DDB1;CDK7;CETN2;UBB;GTF2H5
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5388101125811023,0.8918428581669099,0.5675675675675675,0.9290678778036531,1.0,4/6,38.02%,KIF3B;FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.32919541987734785,0.891749263891899,0.5862068965517241,0.9288372624870452,1.0,16/75,20.95%,EFNB1;EPHA7;MMP2;CRK;EPHA3;EFNA5;GRIN1;VAV2;EPHB2;EPHA6;EPHA8;EPHB4;NCK2;PAK3;ARPC3;GIT1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.4292229905813579,0.8916878137397918,0.5853658536585366,0.9285318255856413,1.0,4/17,4.61%,CSTA;CD247;LORICRIN;DSP
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.47093135368781014,-0.8915924840339893,0.639344262295082,1.0,1.0,7/14,22.95%,CYP1B1;DHRS13;RDH13;BCO1;RDH10;ALDH8A1;ALDH1A3
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.28093845944322243,0.8914905274829271,0.9473684210526315,0.9286084297890503,1.0,69/272,22.30%,SMYD5;PC;SAMD4A;APOE;SIRT1;WNT4;DNMT1;DHFR;RIDA;WWP2;TRIM71;OPRD1;PCIF1;EIF2AK3;RBL1;CNOT9;NANOS3;ERN1;DXO;RBMS3;MOV10;HSPA1A;TNRC6C;HDAC1;N4BP1;LGALS9;LSM2;BMP4;NOTCH1;TWSG1;RPS6KA4;RUNX1;NFKB1;MECP2;PUS7;OCLN;TNRC6A;CREB3L1;EMILIN1;PNPT1;PTBP1;CRKL;MALSU1;SYNCRIP;AGO3;MPHOSPH8;FXR2;KAT2B;PATL2;CPNE1;AGO2;FOXP3;LSM14A;BTN2A2;ADAM10;METTL16;SAMD4B;PHF1;MACROH2A2;LIN28A;EIF4A3;STOX1;PRKAA2;BMPR1A;LARP1;HINFP;IGF2BP1;RBBP4;HIF1A
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.4961398181350134,0.8913956973850776,0.575,0.9283238043379617,1.0,2/10,10.49%,PAG1;LCK
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.35930906375958443,-0.8910060431910994,0.6521739130434783,1.0,1.0,8/77,8.37%,WNT5A;ARIH2;RASGRP4;TGFB1;FLT4;PTPRC;PLD4;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.27839015753042556,0.890996955209829,0.8571428571428571,0.9287137569044486,1.0,50/378,12.64%,NGF;RAB27A;POU3F1;TGFBR1;FGF10;ACTG2;EPHX2;PRR16;ZNF804A;MITF;OSR1;RBM20;ANGPT1;FGF18;ZBTB7B;CCDC88B;CDH5;SAMD4A;PID1;FGF17;IFI16;DNMT1;ERBB2;TENT4A;WNT3A;CADM1;SP1;CARD9;MAPK8;PCIF1;EIF2AK3;TAF1B;ERN1;TESC;ELAVL4;MYO1C;TWIST1;SF3B1;POLR1H;RIMS2;RBMS3;MOV10;MYC;HSPA1A;AGPAT2;TNRC6C;LIMS1;LGALS9;BMP4;NOTCH1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.3970262874798869,-0.8909546519486324,0.5909090909090909,1.0,1.0,6/36,15.33%,PIGH;B3GNT5;MPPE1;A4GALT;PIGC;PIGL
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.4399482566862193,-0.8907514135604553,0.5789473684210527,1.0,1.0,2/16,11.14%,STAT1;SPI1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.3558137098579377,-0.8907450905773957,0.6,1.0,1.0,20/72,19.81%,CRYBB1;COL1A1;TULP1;ROM1;WFS1;FSCN2;COL18A1;CABP4;SLC24A1;GPR179;RDH12;RABGGTB;PDE6C;RABGGTA;CRYBA4;TULP2;CNGB1;CRYBB3;GUCY2F;CRYBG3
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.46077588285099863,0.8903960848073265,0.5348837209302325,0.9297229333541404,1.0,2/8,11.49%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.3328608973226035,0.8898572856205815,0.6756756756756757,0.9305270627801453,1.0,12/86,9.49%,BCL2A1;FHIT;BCL2;TMEM117;HTRA2;IFI16;PML;CHAC1;PPP1R13B;ZNF385B;ABL1;ERN1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.31471035728762764,0.8897995495968581,0.5555555555555556,0.9302625031211017,1.0,58/220,19.32%,IRGM;KIT;FGF10;VEGFC;FGFR1;HDAC3;F2;ANGPT1;FGF18;EPHA7;SIRT1;FLT3;FGF17;ZBTB20;ERBB2;WNT3A;RALB;EPHA3;DSCAM;CCND3;ABL1;DRD4;EFNA5;AKT2;TNIK;RAP2A;MLXIPL;LEPR;BTBD10;RET;CCN1;BMP4;FGFR3;ARRB1;INSR;EPHB2;RYK;CD40;ROR1;FZD7;PELI2;NIBAN1;CRKL;PFKFB4;RAD50;PFKFB3;FBH1;EPHA6;TYRO3;ERBB3;FXR2;EPHA8;CLIP3;NTRK2;BRAT1;ACVR2A;EPHB4;MUSK
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.3762411227273229,0.8897520955662561,0.59375,0.929970977124652,1.0,8/39,13.89%,SLC38A5;SLC19A1;SLC7A9;SLC16A7;SLC7A11;SLC7A8;SLC7A6;ABCC1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3424212377687129,-0.8897353585855303,0.6666666666666666,1.0,1.0,12/136,11.79%,NEK2;PSMB9;KIF14;DTL;RAB11A;FBXL7;CCND1;CDC25A;DYNLL1;DCTN1;CEP72;TUBA4A
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.31788426065306147,0.8896673765731581,0.75,0.929781653688606,1.0,18/95,14.14%,VEGFC;HSPB1;ANXA3;FGF18;CDH5;SIRT1;SEMA5A;SERPINE1;PTGIS;ECM1;SP1;JUP;TWIST1;GAB1;SIRT6;BMPER;RAPGEF3;RUNX1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.44106363041543883,0.8896125047451037,0.5675675675675675,0.9295177670020455,1.0,3/13,14.62%,CPSF1;ERN1;CPSF7
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.5815018535368606,-0.8895515365836763,0.6451612903225806,1.0,1.0,1/5,9.05%,CLU
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.35810341623954917,-0.8893809319523447,0.65,1.0,1.0,18/84,17.93%,TRIM5;IRF1;STAT1;AGBL5;PLA2G10;PTPRC;OAS1;TLR2;IFIT3;IFIT1;DDIT4;TRIM56;OAS2;IFI27;ISG15;NLRP9;IFI6;SERINC3
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.43912804390420235,0.8893165107787558,0.7,0.9298992141355331,1.0,3/19,12.23%,FGF10;MYC;LGALS9
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.4438889977029741,0.8892563799212749,0.5757575757575758,0.9295812059165766,1.0,3/12,21.46%,H6PD;PGLS;RPIA
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.5554265070320528,-0.8886006242151371,0.62,1.0,1.0,2/5,25.74%,ATG14;GPS2
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.3791591685498024,0.8885840152123401,0.6222222222222222,0.9307018167508208,1.0,4/33,7.62%,RHEX;MAFB;CDK6;STAT5B
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.5048544370515183,0.8882603707336317,0.6538461538461539,0.9310483392262933,1.0,4/9,14.18%,APOB;PLIN5;LPL;NFKB1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.5211921641758775,-0.8881451733021881,0.6851851851851852,1.0,1.0,1/7,10.45%,SLC24A1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.30662411383817223,0.8878477545774395,0.7894736842105263,0.9316182567093773,1.0,38/179,23.56%,CTDNEP1;TOR1B;REEP6;BLZF1;UBXN2A;GBF1;TRAPPC12;EIF2AK3;TICAM2;SMPD4;TMED3;PI4K2B;ARHGAP21;FAM174B;GOLGA8H;COG7;COG4;GOLGB1;UBXN2B;DOP1B;MIA3;USP6NL;TMCC1;TRIP11;GOLGA8S;PLEKHF1;ATP8B1;SNX33;COG2;ZNF501;MYO18A;SYNE1;COG3;SEC61A1;VMP1;BNIP1;ANK3;TRAPPC11
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.36207367457252465,-0.8878371063956245,0.6619718309859155,1.0,1.0,12/67,19.98%,IRF1;STAT1;POLR1C;POLR3H;OAS1;TLR2;TRIM56;OAS2;ISG15;NFKB2;DDX3X;DHX58
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.47617584572873867,0.8877570965108266,0.6052631578947368,0.9313678110682786,1.0,4/15,13.45%,TCOF1;NRG1;LRP6;CDH2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.43800349460043925,-0.8877549532021134,0.6470588235294118,1.0,1.0,4/20,16.33%,STAC;P2RY6;TRDN;CALM1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.512483871652115,0.8873215074334609,0.6904761904761905,0.9320251387929211,1.0,2/9,15.26%,TIMELESS;SPIDR
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5046455312517839,-0.8869800279996151,0.6785714285714286,1.0,1.0,2/10,4.74%,IRF4;HLA-DRB1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.40719393387992303,0.8868530394586199,0.6129032258064516,0.9327428223106812,1.0,3/32,5.11%,ALCAM;AUTS2;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.4735586698622373,-0.8867249296100184,0.582089552238806,1.0,1.0,1/13,7.99%,SEMA3A
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.48651745121874146,0.8866516183817569,0.6190476190476191,0.9328440928608266,1.0,2/9,14.10%,TWIST1;RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.44724808453003867,-0.8864250683725404,0.6521739130434783,1.0,1.0,5/17,28.00%,PINK1;VSIR;GRN;DDRGK1;APH1A
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.5251427191490973,-0.8861089351437792,0.6212121212121212,1.0,1.0,2/9,13.34%,IL12A;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.43937621421185924,-0.886049261702998,0.676923076923077,1.0,1.0,7/32,18.66%,CAV3;PINK1;TCHP;BRCA1;PHF23;TBC1D7;FEZ1
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),-0.5542987610350132,-0.8858739770744307,0.6363636363636364,1.0,1.0,4/5,42.53%,TCAF2;ARL6IP5;GOPC;SLC43A1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.4222934739952967,-0.8857327034899215,0.5961538461538461,1.0,1.0,11/29,26.83%,CHMP3;ATG14;GABARAPL1;CALM1;GABARAPL2;RUBCNL;VAMP7;LAMP2;MAP1LC3B2;ATP2A2;MAP1LC3B
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.3828273501727181,-0.8854290989896385,0.6,1.0,1.0,8/49,12.97%,HAMP;ATP6AP1;FTH1;NUBP1;SLC11A1;ABCG2;CP;FRRS1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.3187841693677644,0.885354157624939,0.64,0.9352991308833994,1.0,19/103,15.27%,FIBIN;MXRA5;LAMA4;EDNRA;ADGRL2;MMP2;SLIT2;PAMR1;MPDZ;GUCY1A2;PDZRN3;COL16A1;ALDH1A2;EFS;MAGI1;ANK2;CALD1;PLPP3;ANTXR1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.5427502764081745,0.8851436131304251,0.7441860465116279,0.935487094014603,1.0,2/6,14.29%,GALE;GALT
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),-0.5933644931390047,-0.8847022525004471,0.6949152542372882,1.0,1.0,3/5,33.68%,CAV1;FLOT1;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.5542239791771997,-0.8846088647902364,0.671875,1.0,1.0,1/6,12.57%,PRKCH
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.3795182198395087,0.8846070432271992,0.5675675675675675,0.9363169101604366,1.0,5/51,10.42%,NUP210;NUP42;BCL11A;AAAS;RNF212
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.45748206485166476,-0.8845638496707096,0.7333333333333333,1.0,1.0,7/19,32.38%,PTPRC;CLCF1;CD86;PHB2;TNFSF4;SUPT6H;TNFRSF4
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4254620177748244,0.8844044309137443,0.6153846153846154,0.9363961852452483,1.0,2/13,6.35%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.627084042882738,0.8843526200860384,0.7058823529411765,0.9361040207150393,1.0,1/5,5.16%,SLC19A1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.3785098376177709,0.8843458803338051,0.75,0.9357041218355248,1.0,12/36,21.16%,KIT;ADGRG3;FLT3;ITGA4;RAG2;HDAC4;HDAC5;KLF6;PLCG2;IL11;ZBTB7A;PTPRJ
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.4692264276631667,-0.8841491918598152,0.6363636363636364,1.0,1.0,2/13,11.56%,ANXA1;REST
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.48050719278924814,0.884139985005964,0.6176470588235294,0.9357768134044867,1.0,4/11,19.56%,SERPINE1;HMGB1;CXCL12;MOSPD2
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.39899184979332214,0.8840957841412402,0.5555555555555556,0.9354380943017617,1.0,2/19,6.03%,PLD6;PIWIL1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.31886457490477643,0.8840554311819891,0.6428571428571429,0.9351603333937694,1.0,15/90,12.77%,PCM1;CEP152;CNTRL;CEP135;SCLT1;SDCCAG8;ALMS1;DYNC1I2;C2CD3;CEP290;AKAP9;CEP250;RPGRIP1L;MAPRE1;MKS1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.48648700405492507,-0.8837763130015351,0.5357142857142857,1.0,1.0,1/10,3.76%,IYD
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.39671853833542187,0.8836427543993441,0.6904761904761905,0.9354824557157324,1.0,5/27,9.15%,CYP1A2;ELOVL6;EPHX2;HPGD;FADS1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.45993936821472886,-0.8835099933345066,0.6271186440677966,1.0,1.0,4/17,21.71%,EIF6;LAS1L;WDR12;NSA2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.38040933210857375,0.8834803038289709,0.6666666666666666,0.9353732822209248,1.0,8/27,15.45%,PCM1;IFT88;C2CD3;CEP290;CEP250;RPGRIP1L;PIBF1;ARL13B
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.42788285134194975,0.8832174068221541,0.6666666666666666,0.9354998133836261,1.0,4/11,18.36%,SMARCB1;PIH1D1;RAPGEF3;HDAC5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.5239799202868414,-0.8830448802290499,0.6896551724137931,1.0,1.0,3/9,27.18%,IL12A;IL5RA;CSF1R
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.31356413687467594,0.8829329839181339,0.8148148148148148,0.9357675397560283,1.0,14/111,8.57%,EGLN3;CPEB1;RORA;SIRT1;PSME4;PSMA1;MGARP;SLC8A3;HIF3A;PTGIS;HP1BP3;PLK3;OPRD1;KCND2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.2949008741711381,0.8825613112169035,0.7931034482758621,0.9361897297426837,1.0,30/121,15.27%,LAMA4;HSPB1;EMP1;MITF;RAI14;PARVA;COL12A1;PPARG;RASSF8;PAX3;MMP2;ECM1;PMEL;PPFIBP1;TYRP1;COL16A1;RND3;CCDC80;EPS8;CRABP1;WWTR1;RASAL2;DCT;DST;ENPP1;CALD1;PRICKLE2;DOCK1;PLPP3;ANTXR1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.3314108722390957,0.8825409045286835,0.696969696969697,0.9358182430575347,1.0,4/84,7.38%,TEAD2;FAM83H;REEP6;TEAD4
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.42302588263836727,-0.8821673894442776,0.6612903225806451,1.0,1.0,8/29,25.10%,HSPA1L;STUB1;HSPA8;DAXX;HSPA5;HSPA2;OPTN;HSPA13
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.32882541204133253,0.8819480673365931,0.6842105263157895,0.9365693292899869,1.0,16/85,13.28%,SLC26A7;SLC10A3;SLC3A2;MFSD2A;SLC38A5;AKR1C1;SLC19A1;SLC7A9;NCOA2;SLC7A11;SLC7A2;ACSL1;SLC16A10;SLC25A29;SLC7A8;SLC7A6
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.4920517213821646,0.8818671320948452,0.6666666666666666,0.9362853228360384,1.0,1/9,0.66%,PHLDB2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.4580514381573491,0.88183965425417,0.5135135135135135,0.9359545620227119,1.0,4/16,23.78%,APOE;ACHE;ADAM10;TMCC2
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.3481796429245315,0.8817466034721946,0.6521739130434783,0.935812005064098,1.0,8/86,4.42%,FIBIN;MXRA5;MRGPRF;LAMA4;ITGA11;SSC5D;ANGPT1;ADAMTS12
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5264244287521395,0.8816197705453483,0.6829268292682927,0.9352657431705732,1.0,3/7,26.51%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5264244287521395,0.8816197705453483,0.6829268292682927,0.9352657431705732,1.0,3/7,26.51%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4863494764143826,0.8815486032251475,0.5882352941176471,0.9349896143777384,1.0,7/13,23.38%,DRD4;WNK2;TESC;WNK3;DMD;WNK1;ANK3
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.2915698960824597,0.8811231101150021,0.6666666666666666,0.9355310974289929,1.0,66/277,25.94%,CPSF1;SNRPN;NOVA1;PCF11;TRA2A;HNRNPF;RBM41;PRPF40B;PUF60;U2AF1;ERN1;HNRNPH1;CCNH;SPEN;HNRNPL;TXNL4A;SF3B1;SRRM1;SNRPB;ZMAT5;CWC27;LSM2;SRSF4;CPSF7;TBRG4;GEMIN5;LSM7;SRRM4;PTBP1;GTF2F2;PAPOLA;SYNCRIP;FUS;SF3B4;SYMPK;RPRD2;LSM8;AURKAIP1;POLR2F;RBM6;ERCC3;U2AF2;EIF4A3;CPSF6;RALY;SNRPF;CDC5L;SNRNP48;PPIH;LSM6;DDX46;CWF19L1;RNF113A;PSPC1;GPATCH1;WDR33;RBM10;DDX39A;TCERG1;PDCD7;HNRNPUL1;CCAR1;SCAF11;SNRPA;THOC1;SON
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.558228565803057,-0.8809547869447812,0.6909090909090909,1.0,1.0,1/7,6.27%,CYBA
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.319987465604983,-0.8807725340797983,0.7662337662337663,1.0,1.0,33/251,13.43%,CD44;TGFB1;ITGB2;COL1A1;COL5A1;ECM2;MMP21;DCN;CYP1B1;TGFBI;MMP9;ICAM3;COL27A1;P4HA3;NID1;ITGA9;MMP19;SCUBE3;ITGB6;COL18A1;COL4A4;MATN4;VIT;COL4A3;COL24A1;PLG;LOX;ITGA2B;LAMC2;MMP25;ACAN;COL23A1;PXDN
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.45678654712196887,-0.8807238356641193,0.6833333333333333,1.0,1.0,4/22,11.56%,AIM2;HTR1B;KCNQ1;REST
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4434990477186591,-0.8805642516629155,0.6428571428571429,1.0,1.0,8/20,34.21%,RBX1;RPS27A;DDB1;CETN2;UBB;GTF2H5;RAD23B;UBC
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.4213823320288839,-0.880547235172611,0.7213114754098361,1.0,1.0,4/27,15.78%,ITGB2;CLU;SLC11A1;ITGAM
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.39296964740265894,-0.8804412045673321,0.6290322580645161,1.0,1.0,8/35,23.65%,PWP2;NOB1;TSR2;RPS16;RPS8;RPS14;RPS28;RPS19
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.43809472976803293,0.8800494597473553,0.5531914893617021,0.9373914023113681,1.0,2/10,14.41%,COBL;LRP8
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.5478114086962065,-0.8798082867584,0.676923076923077,1.0,1.0,1/7,4.35%,HTR1B
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.4591746156392019,-0.8797947426767566,0.65,1.0,1.0,1/13,8.03%,BACE2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.4302703139529809,-0.8797057756508836,0.6515151515151515,1.0,1.0,2/27,6.93%,ERN2;SLFN14
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.4170287497154884,0.8794207108799187,0.625,0.9383865767244928,1.0,1/17,1.25%,RAB27A
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.3335391985999359,-0.8794076701865194,0.7567567567567568,1.0,1.0,20/140,16.55%,NRAP;ACTC1;LMOD1;TMOD4;ELMO3;FHOD1;NEB;BAIAP2L1;ARHGAP12;SCIN;SVIL;NLRP5;WAS;MYO1F;MYO5B;VILL;LCP1;TTN;RAC1;VIL1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.5116732044434227,-0.8791712397155403,0.603448275862069,1.0,1.0,6/10,33.37%,PARP10;PARP14;PARP2;PARP15;ZC3HAV1;PARP9
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5129150705890329,-0.8787559974740717,0.7058823529411765,1.0,1.0,1/8,0.80%,MICB
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.42526391229076826,0.8786075848228618,0.625,0.939835890696666,1.0,12/26,30.16%,ITGA4;GRIN1;ABCC1;CACNA1A;GRM5;CDK5;FYN;FPR2;CACNB1;EPHA4;GRIN2A;IGF1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.36421279825189107,0.8785541040299232,0.68,0.9396052066291634,1.0,15/42,26.61%,TCOF1;TRIM71;PCIF1;NANOS3;GEMIN5;PUM3;GRM5;RC3H1;METTL16;LARP1;EIF4E;ZC3H7B;FOXO3;MEX3D;ATXN2
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.46360377021928934,-0.8780861544018952,0.5882352941176471,1.0,1.0,2/9,7.39%,IFNK;PTPRC
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.4215974703150628,0.8780847163201779,0.6097560975609756,0.9403307290068056,1.0,2/22,3.58%,QRICH2;PARVA
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.33907242466604204,-0.8779994165428503,0.7878787878787878,1.0,1.0,7/133,5.55%,NEK2;PLAAT4;TGFB1;ROS1;HLA-DRB1;PINK1;FLT4
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4261565200859571,-0.8776417264569869,0.6567164179104478,1.0,1.0,6/25,16.90%,CAV3;DCTN1;ANKRD53;CDK5R1;RAC1;PSRC1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.4439664221017034,-0.8770240756816615,0.6727272727272727,1.0,1.0,10/24,34.63%,RBX1;RPS27A;DDB1;CETN2;UBB;GTF2H5;ERCC4;RAD23B;UBC;RNF111
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.4615286288283597,-0.8769740601665972,0.6349206349206349,1.0,1.0,4/17,22.34%,DDX60;NOP53;DHX58;USP17L2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.5025414526262206,-0.8768981109525057,0.6,1.0,1.0,1/9,4.32%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.3679106051235486,-0.876607582381643,0.676923076923077,1.0,1.0,11/52,16.11%,FOXM1;CYP1B1;PINK1;ALOX5;EIF6;STK17A;BRCA1;CDKN1A;THBS1;ROMO1;RAC1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.316427041847368,0.8765215069812202,0.8125,0.9432274380420135,1.0,10/59,12.93%,F2;PYHIN1;BICD1;TRAPPC12;EIF2AK3;CROCC;CEP250;WWTR1;CCDC88A;GNL3L
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.368197910643199,0.8764973705792758,0.6857142857142857,0.942835282479719,1.0,13/37,17.46%,SHLD2;SHLD1;TIMELESS;ARID2;KMT5C;SMCHD1;SPIDR;SETMAR;SPIRE2;KMT5B;WRAP53;MGMT;FUS
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.46300410062564734,0.8764779975351427,0.6666666666666666,0.9424568174680349,1.0,4/11,20.31%,ACD;PIH1D1;NIPBL;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.4877863319984159,-0.8762960405745358,0.6229508196721312,1.0,1.0,2/15,12.52%,F7;ZNF580
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3649393651081093,0.8759113208494238,0.6060606060606061,0.9434001064702674,1.0,8/32,16.52%,CRK;ABL1;FLNA;LIMS1;CSPG5;DOCK1;CASS4;CRKL
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.34730555382442946,0.8757413600469135,0.6451612903225806,0.9433419327894194,1.0,12/54,16.61%,NGF;FGF10;GPR174;AUTS2;EPOR;RAPGEF1;IRS2;NOTCH1;ARRB1;F11R;CRKL;F2R
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.5464280725977216,-0.8756047784107983,0.6551724137931034,1.0,1.0,1/6,9.55%,CARTPT
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.3765997432792268,0.8755280114926376,0.5,0.9433971676702004,1.0,3/25,4.45%,HSPB1;SIRT1;HTRA2
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.4854296025403994,0.8752698571741552,0.6153846153846154,0.9435723304495425,1.0,6/10,33.96%,RAB11B;EHD1;EIPR1;ATP9A;SORL1;PLA2G4E
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.5533569064147065,0.8749645529643283,0.6511627906976745,0.9434493753473475,1.0,1/5,3.62%,PTPRO
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.5533569064147065,0.8749645529643283,0.6511627906976745,0.9434493753473475,1.0,1/5,3.62%,PTPRO
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.44912654849272277,0.8749277306742967,0.5853658536585366,0.9431050659323116,1.0,1/14,3.27%,SNCAIP
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.4104711272116921,-0.8747203642834616,0.6470588235294118,1.0,1.0,8/35,13.49%,ENO4;HK2;ALDOB;ENO2;ENOSF1;PKLR;PGAM1;GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.536347576177137,-0.8744431823708645,0.6557377049180327,1.0,1.0,4/8,24.64%,KCNE3;KCNE2;CAV1;KCNAB1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.31397735090497175,0.8743543723306264,0.75,0.943998672334121,1.0,29/111,17.49%,PNPLA3;THEM4;PER2;LIPC;AOAH;CEL;ACSM2A;PPARG;LPL;HPGD;SLC27A2;ELOVL4;ABCD3;ABCD2;CPT1C;ACSL1;CPT1A;ADIPOR1;ACADM;AASDH;MECR;LTC4S;ADIPOR2;PLA2G15;FA2H;ACOX1;NUDT19;SLC27A4;OXSM
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4365929158726862,0.8735003889029022,0.6153846153846154,0.9453437835270835,1.0,1/12,1.74%,CPSF1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.5313065693878547,-0.8732052589909827,0.7166666666666667,1.0,1.0,3/8,7.34%,ALOX5;GPR183;PIK3CG
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.5651252615886153,-0.8729981181603507,0.6774193548387096,1.0,1.0,3/5,27.11%,CAV1;RFTN1;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.28643336206585174,0.8725234726373252,0.7619047619047619,0.9470533935568481,1.0,53/290,16.92%,NGF;RAB27A;POU3F1;TGFBR1;FGF10;ACTG2;EPHX2;ZNF804A;MITF;OSR1;SCRIB;ANGPT1;FGF18;ZBTB7B;CDH5;PID1;FGF17;ARRB2;DNMT1;MAGI2;SNCA;WNT3A;GREM1;SP1;MAPK8;EIF2AK3;TESC;TWIST1;RIMS2;RBMS3;MOV10;MYC;HSPA1A;TNRC6C;LIMS1;LGALS9;BMP4;NOTCH1;RESF1;TICAM1;PLSCR1;ANK2;ARRB1;INSR;EPHB2;OCLN;TNRC6A;RNF207;EMILIN1;ATM;ATF7IP;GABPA;LAPTM5
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.5466045970049094,-0.8725195075953092,0.6166666666666667,1.0,1.0,3/6,21.00%,ITGB2;ITGAM;CHRNB2
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.4475096453269372,-0.8724131071688287,0.6031746031746031,1.0,1.0,2/16,9.92%,LGI4;MTCH1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5613965468895674,-0.8724113174596663,0.6825396825396826,1.0,1.0,3/5,27.36%,RNF20;CDK9;KDM1A
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5157463987845692,-0.8723613716485921,0.6274509803921569,1.0,1.0,1/6,9.21%,SMAD6
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.4966800249742748,-0.8723072161216071,0.6724137931034483,1.0,1.0,2/12,11.90%,OAS1;APOD
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.33982846797779964,-0.8721753220003206,0.7536231884057971,1.0,1.0,17/111,9.94%,NMUR2;CHRNA9;WNT5A;C1QTNF1;CXCL13;C3AR1;XCR1;LPAR1;CAV3;PTGDR;ESR1;GPER1;CALB2;ACKR4;TAC4;TRPC7;CAV2
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.49944536598380224,0.8721626902506376,0.6153846153846154,0.9474789909116463,1.0,2/6,18.43%,SDF4;GPX1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.34998729651216026,-0.8721278396384108,0.6842105263157895,1.0,1.0,18/91,17.93%,TRIM5;IRF1;STAT1;AGBL5;PLA2G10;PTPRC;OAS1;TLR2;IFIT3;IFIT1;DDIT4;TRIM56;OAS2;IFI27;ISG15;NLRP9;IFI6;SERINC3
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.49507251047845957,0.8720050463914234,0.5625,0.9474658195620832,1.0,3/6,21.42%,EIF2AK3;SULF2;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.3884636010673623,0.8718229611598836,0.7586206896551724,0.947472578444536,1.0,9/37,17.68%,CD14;SERPINE1;HMGB1;HSPA1A;LGALS9;TLR5;LBP;F2R;FADD
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.2729570015179061,0.8717241258356274,1.0,0.9473200478269854,1.0,98/441,16.74%,ADRA1A;ADRA1B;KIT;HIP1;THEM4;TGFBR1;FGF10;FGFR1;HDAC3;TNFSF14;NEUROD2;KSR1;BCL2;ANGPT1;NLGN1;FGF18;IRS1;NRG2;SIRT1;CDH13;MAP3K14;CFLAR;CD14;AKR1C3;CX3CR1;FLT3;FGF17;SEMA5A;TNFRSF19;ERBB2;NRG1;TGFA;RIPK2;HMGB1;HPSE;PPP5C;EPOR;MLST8;ECM1;TMEM106A;CARD9;TRIM8;STYXL1;MYORG;LGALS1;GRM4;AKT2;TICAM2;KITLG;FLNA;ADGRV1;SHARPIN;PLXNB1;PDGFD;IL23A;HCLS1;APOL3;LCK;RET;IRS2;TRIM44;LIMS1;LGALS9;GAB1;IAPP;PIM2;NR3C2;TICAM1;ALPK1;WLS;PPM1A;FGFR3;DLG5;TAB3;PIK3R5;INSR;RYK;PELI1;PIK3CA;CD40;GPR89A;CASS4;IQCJ-SCHIP1;TSPAN6;NFAT5;ROR1;BRD4;RASD2;CXXC5;RIT2;PELI2;TRIM14;ZCCHC3;NEDD4;EEF1D;F2R;MFHAS1;IRAK4
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.5336392787176087,-0.8716603211115787,0.6785714285714286,1.0,1.0,2/7,21.33%,HERPUD1;CAV1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.38748724774543636,-0.8714374357289083,0.6712328767123288,1.0,1.0,1/44,0.31%,NEK2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3526105506679868,0.8714214908325058,0.6285714285714286,0.9477514384167894,1.0,19/62,19.13%,KIT;FGFR1;SIRT1;FLT3;EPOR;PLXNB1;PDGFD;HCLS1;IRS2;GAB1;PIK3R5;INSR;PIK3CA;ROR1;NEDD4;F2R;ERBB3;NTRK2;FSHR
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.3855539950964837,0.8712568446972533,0.6190476190476191,0.9477779602120529,1.0,8/25,14.40%,RAB31;BLZF1;GOLGA4;GCC2;GGA1;MACF1;RAB10;ARFRP1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.33828518626284326,0.87124962934127,0.6764705882352942,0.9474001313895607,1.0,5/69,8.83%,PRICKLE1;RANBP17;CBLB;KPNA6;NXT1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.523559768748045,0.8712132659456552,0.6511627906976745,0.9466785534433395,1.0,1/5,16.08%,WRAP53
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.523559768748045,0.8712132659456552,0.6511627906976745,0.9466785534433395,1.0,1/5,16.08%,WRAP53
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.539236471521985,-0.8709188982240074,0.6290322580645161,1.0,1.0,2/5,26.11%,SPINK6;SPINK5
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.48625555822080674,-0.8708627623897548,0.6666666666666666,1.0,1.0,4/14,29.98%,AIF1L;RAC1;CSF1R;TPM1
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.546099047178471,0.8707720567549104,0.6410256410256411,0.9471622571741811,1.0,1/5,3.73%,SIRT1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.2950748271343222,0.8706649083253032,0.7241379310344828,0.9469772282752125,1.0,36/225,14.42%,LGR5;BAMBI;FGF10;PRICKLE1;TLE2;CDK14;APOE;PTPRO;NKD1;NKD2;PSME4;PSMA1;SEMA5A;ZEB2;WNT3A;GREM1;DACT3;LATS1;KANK1;ZNF703;GPC5;LRP6;WNK2;LZTS2;JUP;TMEM88;RBMS3;IGFBP4;WWTR1;HDAC1;WLS;PPM1A;SOX13;RNF146;NFKB1;MLLT3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.41177565096604174,0.8706211661793338,0.6111111111111112,0.9466799151942785,1.0,3/23,9.49%,PCF11;POP1;ERN1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.43972773366140805,-0.8705352493175343,0.6379310344827587,1.0,1.0,5/23,17.28%,CASQ2;MMP9;TRDN;CALM1;KCNE3
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.36709077796920286,0.8702403711554711,0.6571428571428571,0.9471167210215237,1.0,6/30,14.14%,CBFB;SAFB2;NCOA2;LATS1;CARM1;RUNX1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4296616910417709,-0.8699671023968771,0.6461538461538462,1.0,1.0,1/24,1.26%,KIF14
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.5163734023880459,0.869840354439604,0.7297297297297297,0.9475333294808946,1.0,5/9,28.17%,CARM1;PRMT5;PRDM14;PRDM4;PRMT1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.38262623704078436,-0.869772200291301,0.6301369863013698,1.0,1.0,3/47,2.46%,CLCA2;AQP3;FLG
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.4735299825578374,0.8696227854033289,0.6,0.9475400251760565,1.0,3/10,24.62%,TENM4;TPPP;ABCA2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.3826335738419432,0.8695497154154729,0.6923076923076923,0.9472759932068039,1.0,7/31,18.39%,SARM1;TNIK;RAP2A;CUX1;PTPRD;NEDD4;ADGRB3
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.45779988450865133,0.8694266432518178,0.6153846153846154,0.9472101906624096,1.0,5/11,16.61%,CX3CR1;CARD9;OCIAD2;NOTCH1;F2R
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.40374893959985847,-0.869328452828376,0.6060606060606061,1.0,1.0,10/34,23.65%,VSIG4;OAS1;CACTIN;A2M;NLRC3;ISG15;GRN;DHX58;OAS3;RPS19
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.5602925894108091,-0.8691010807651758,0.7037037037037037,1.0,1.0,3/7,18.51%,ZFPM1;GATA4;HEY1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.5045561439633911,-0.8690184906093643,0.6666666666666666,1.0,1.0,3/12,14.06%,GAD1;DAO;NOS2
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.5297420955531599,-0.8688273272783327,0.6470588235294118,1.0,1.0,3/6,37.51%,TBCC;VBP1;TBCE
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.38570925499126085,0.8687683574031106,0.5897435897435898,0.948285788550138,1.0,5/28,9.58%,GJB6;MFSD2A;CDH5;TJP2;CLDN12
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.3888370694247023,-0.8685698751833372,0.5909090909090909,1.0,1.0,4/30,9.48%,RAB11A;PINK1;ACTG1;DNAJA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3898814335031796,-0.8685265513040161,0.6721311475409836,1.0,1.0,11/34,31.89%,RPA3;RBX1;RPS27A;RPA2;DDB1;PCNA;POLD4;UBB;GTF2H5;RFC5;ERCC4
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5110333062143603,-0.8677465207459296,0.6136363636363636,1.0,1.0,2/8,12.72%,CLU;STUB1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.43520654331658165,-0.867534338209758,0.6,1.0,1.0,6/24,17.78%,WNT5A;SCIMP;HLA-A;CD160;HLA-F;LACC1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.35881884025920163,-0.8675230503423067,0.6842105263157895,1.0,1.0,10/101,10.42%,ENPP2;ELOVL2;PDXDC1;DEGS2;PRKD3;CERS3;PSAP;PPT1;ORMDL3;ALOX12B
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.46672499228171527,-0.8673113689910159,0.671875,1.0,1.0,1/15,1.31%,ADSS1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.4145871591778964,0.8671445045361972,0.5789473684210527,0.9513652217631192,1.0,2/19,8.61%,CBLB;KPNA6
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.4567749223202128,0.8668611527650294,0.5813953488372093,0.951554847043039,1.0,2/11,14.18%,APOE;NFKB1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.421081958047957,0.8667777419338417,0.5789473684210527,0.9513226171680792,1.0,4/18,16.13%,NAALAD2;SLC25A12;ASPG;MTHFR
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.3244583217858192,0.866336843277013,0.6896551724137931,0.9518150640492602,1.0,28/123,15.71%,SLC17A6;ALCAM;ARX;LHFPL4;PLPPR1;KCNB2;UNC5D;CNGA3;ELAVL3;PAK5;RFX6;INSL5;KCNIP1;CELF4;ADGRA1;CFC1;RAB3C;ELAVL4;ABCC8;SCGN;OLFM3;IAPP;SCRT1;SNAP91;PTPRT;ASXL3;NRXN1;VWA5B2
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.41772786712884946,0.8661994252842239,0.7272727272727273,0.9516882549556158,1.0,8/20,19.46%,CDH5;GREM1;SLIT2;NR4A1;EMP2;GPLD1;EPHB4;MIA3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.4721259469652498,-0.8660122922298233,0.6206896551724138,1.0,1.0,5/17,14.38%,C1QTNF1;BLK;TEC;TXK;SELP
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.4548237312235961,-0.8660112637745148,0.7142857142857143,1.0,1.0,1/22,5.80%,CYP21A2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.39187482177927235,0.8659872092955784,0.6410256410256411,0.9517721325288547,1.0,10/19,26.78%,HEXIM2;LATS1;MYOCD;NR2F2;MEN1;CEBPA;PTEN;IPO7;TFAP4;PLK1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.3874323566801984,0.8659602264003579,0.5714285714285714,0.9514546923376673,1.0,8/26,21.15%,PROX1;SPEF2;BMP4;ITGA3;SMCHD1;SHH;CHD7;CEBPA
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.5116215658601806,-0.8659358634421018,0.6727272727272727,1.0,1.0,1/7,6.13%,CHMP3
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.40720615053244635,-0.8656581175637921,0.65625,1.0,1.0,5/21,22.75%,RPA3;POLE2;RPS27A;RPA2;PCNA
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.5393992728353111,-0.8656525345921867,0.7288135593220338,1.0,1.0,1/7,5.04%,ABCC6
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.4140920910690855,-0.8656496685302045,0.6507936507936508,1.0,1.0,5/21,17.40%,TGFB1;UBE3A;THBS1;TGFB3;WBP2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.4646522015281552,0.8656408528922024,0.6904761904761905,0.9518147490943681,1.0,3/11,12.64%,JAG1;HES1;NOTCH1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.34808184846999174,-0.8655922403364298,0.7534246575342466,1.0,1.0,8/97,6.13%,ENPP2;C1QB;GALNT15;FCGR3A;LYVE1;P2RY12;SHISA6;VSIG4
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.512460202071096,0.8654808707455367,0.6458333333333334,0.9517341604541241,1.0,1/6,3.73%,SIRT1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.3422651865831477,-0.8653893275371675,0.7323943661971831,1.0,1.0,15/120,13.35%,MYH7;TBX1;PKP2;TGFB1;MMP21;MYBPC3;ZFPM1;HTR2B;ALPK2;HEG1;GATA4;GPC3;TEK;CDKN1A;CSRP3
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.4993954239849771,-0.8651951013892639,0.6491228070175439,1.0,1.0,2/10,4.96%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.4993954239849771,-0.8651951013892639,0.6491228070175439,1.0,1.0,2/10,4.96%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.4993954239849771,-0.8651951013892639,0.6491228070175439,1.0,1.0,2/10,4.96%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.5085651719824884,0.8650465156902338,0.5581395348837209,0.9521923366270868,1.0,4/6,26.32%,NRG1;HDAC5;RBM24;HDAC9
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.35440169258054033,0.8649716241455581,0.6388888888888888,0.9519343557585197,1.0,10/49,12.41%,LAMA3;EMP1;KLK14;DSP;STS;KLK7;CCN2;HDAC1;KLK5;DCT
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.3757700568763225,-0.8648719492074499,0.6521739130434783,1.0,1.0,7/50,12.74%,DTL;UVSSA;PCLAF;GPR88;SLC24A1;CDKN2D;RRH
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4195160771732247,-0.8647435866548654,0.6792452830188679,1.0,1.0,6/25,18.62%,TGFB1;SPI1;GNL3;TERT;SMAD3;ATOH8
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4620477269342734,0.8641885687270484,0.6060606060606061,0.9533832122286148,1.0,2/9,4.25%,RSPO3;NKD1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.31028658148977223,0.8640160988187101,0.59375,0.9532889750627295,1.0,12/119,10.58%,LGR5;BAMBI;FGF10;PSME4;PSMA1;SEMA5A;ZEB2;WNT3A;KANK1;GPC5;WNK2;JUP
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.3995536162416094,0.8638159450282058,0.6571428571428571,0.9533325434164122,1.0,4/17,13.54%,DTX1;ASCL1;HES1;DLX1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.4767679166342676,0.8637802412133565,0.6486486486486487,0.9530024051283877,1.0,2/9,14.29%,GALE;GALT
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.35744625826597237,0.863756712211675,0.7142857142857143,0.9527053095552259,1.0,8/34,12.11%,CSTA;USH2A;LORICRIN;DSP;AKR1C3;JAG1;CASP3;HDAC1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.32347899947365666,0.8636239086618008,0.8,0.9525787666772721,1.0,16/74,14.05%,CYP1A2;PNPLA3;ELOVL6;GLYATL2;EPHX2;CYP4Z1;HPGD;SLC27A2;FADS1;AIG1;ACSL1;CPT1A;PLA2G4C;LTC4S;CYP4F3;GSTM2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.5447069804939582,-0.8634206004027161,0.6610169491525424,1.0,1.0,2/7,17.40%,IL12A;VSIR
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.39553235139319143,-0.8634029282392685,0.7,1.0,1.0,2/43,2.60%,POLQ;TERF2IP
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3292707111881,-0.8631349029048253,0.75,1.0,1.0,23/153,12.58%,SQOR;C1QTNF1;TIMP3;LMOD1;COL1A1;COL5A1;ANGPTL2;DCN;CYP1B1;UACA;ITGA9;SLCO2A1;PROCR;BACE2;COL4A4;SMAD6;ITGBL1;ENPP4;COL4A3;AFAP1L1;LOX;HEY2;COX7A1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.43408599492102745,0.8629645744315806,0.6363636363636364,0.9535588282232654,1.0,5/18,18.50%,SLC19A1;DHFR;MTHFR;FPGS;SHMT2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4553107316477317,-0.8629469961285106,0.7164179104477612,1.0,1.0,1/17,2.02%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.5125448455987577,-0.8628329784329493,0.7101449275362319,1.0,1.0,1/8,5.98%,ANXA1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.500364269816916,-0.8628160286287849,0.7017543859649122,1.0,1.0,2/10,17.44%,ADA;PRPS1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.4786174977205553,0.8627257186815666,0.7272727272727273,0.953562923748235,1.0,4/9,16.74%,TENM3;LRP6;NF1;SKI
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.41719444125666805,-0.862715835617071,0.704225352112676,1.0,1.0,5/26,15.17%,DAB2;NODAL;BRCA1;SFRP1;ZNF366
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.5431966835296903,-0.8626017840805368,0.671875,1.0,1.0,2/6,17.68%,TCN1;AMN
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.3288028909473215,0.8625178915707813,0.6842105263157895,0.9535539322032279,1.0,19/57,21.49%,KIT;BCL2;ADGRG3;FLT3;ITGA4;BANK1;RAG2;HDAC4;EPHB2;CD40;CD22;HDAC5;KLF6;MALT1;PLCG2;IL11;ZBTB7A;PTPRJ;PIK3CD
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.5387875537746374,0.862232319280206,0.6481481481481481,0.9534183182962018,1.0,2/5,14.82%,WHRN;PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.5387875537746374,0.862232319280206,0.6481481481481481,0.9534183182962018,1.0,2/5,14.82%,WHRN;PDZD7
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.35223609572749853,-0.8622178922389143,0.6909090909090909,1.0,1.0,3/48,4.99%,ARIH2;HSPA1L;PINK1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.37462920217911827,0.8620812607067023,0.6944444444444444,0.9533767311160911,1.0,11/33,22.61%,IFT88;TBC1D12;RALB;SEC22B;PIP4K2A;MTMR3;LRSAM1;RAB5A;MTM1;NPRL2;ELAPOR1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.39044919071654705,-0.8620495312500361,0.6551724137931034,1.0,1.0,3/29,10.97%,CCDC39;TBX6;GATA4
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.46892092286682824,0.8620426660828682,0.6341463414634146,0.9530347615782759,1.0,2/10,1.96%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.565421097710703,0.8620307451175818,0.6470588235294118,0.952660439073533,1.0,4/5,38.02%,KIF3B;FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.38971616693826916,-0.8619823116659125,0.6349206349206349,1.0,1.0,3/36,4.99%,AMBP;FOXM1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.38191956603992694,0.8617935117823786,0.6923076923076923,0.9526648998737965,1.0,2/25,6.44%,QRICH2;PML
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.3740713907383666,0.8616818645919877,0.5882352941176471,0.9525976084816172,1.0,11/40,17.24%,HRH3;PCLO;SNCA;PPFIA3;SYT1;GRM4;PDZD11;SNPH;SYN2;NRXN1;SYN1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.47242744349872207,-0.8613499070724863,0.7,1.0,1.0,2/11,6.13%,TRIM5;CHMP3
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.3860183309206738,-0.8612894244637996,0.7142857142857143,1.0,1.0,6/37,15.71%,LPAR1;ANXA1;NDUFS2;PRDM12;ROGDI;METTL14
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.47963986364631905,0.8612296114566741,0.6274509803921569,0.9531106401231123,1.0,1/9,2.85%,BIN1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.4428951708366884,0.8610770701831985,0.6875,0.9530823208966086,1.0,6/16,19.46%,GREM1;SLIT2;NR4A1;GPLD1;EPHB4;MIA3
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5392872277551579,0.8610044380925536,0.6756756756756757,0.9528390508256845,1.0,3/5,41.18%,CLUH;LRRK2;MAPT
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),0.440774458528968,0.8605541558857308,0.5897435897435898,0.9535401741121238,1.0,2/15,6.77%,CYP1A2;ADH4
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.33354920907572194,-0.860445465778856,0.76,1.0,1.0,13/105,15.44%,DISC1;DAB2;CLDN5;LRPAP1;ZFPM1;EFHB;TMC8;MITD1;IFIT1;CTSZ;CDKN1A;VTN;TERT
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.35584149388449693,0.860442023444688,0.7241379310344828,0.9533489874461042,1.0,22/62,28.10%,TRDMT1;METTL1;PUS10;TRMT9B;CTU1;MTO1;PUS7;CDKAL1;TRMT61B;TRMT61A;ANKRD16;TPRKB;DTWD1;TRMT1;THUMPD1;ADAT2;PUSL1;ALKBH8;THG1L;THADA;URM1;QTRT1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.31907277917338905,0.8603790130152922,0.8125,0.9530798865306962,1.0,13/83,10.64%,VEGFC;HSPB1;ANXA3;FGF18;CDH5;SIRT1;SEMA5A;SERPINE1;PTGIS;ECM1;SP1;JUP;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.45057503148264816,0.8602222626684894,0.6136363636363636,0.9530646463958085,1.0,1/14,0.43%,SKAP1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3608833347243284,0.8601435470760553,0.6060606060606061,0.9528348941596125,1.0,11/43,16.82%,DUSP4;SPRED3;PTPRR;WNK2;SPRED2;RGS14;SPRED1;EPHB2;RPS6KA6;EMILIN1;DUSP6
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.4194822406578269,-0.8599338459884989,0.5964912280701754,1.0,1.0,5/21,21.45%,CYP24A1;LRP2;RBP2;CYP3A4;VDR
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3378894657695119,-0.8599157381647305,0.6493506493506493,1.0,1.0,13/114,11.14%,AIM2;SP100;CYP1B1;ESR1;ID1;PLA2G10;WFS1;TBX6;NLRP12;NLRP3;ID3;SFRP4;SPI1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.4579242098329821,-0.8598190078617011,0.6507936507936508,1.0,1.0,1/12,7.77%,DOCK2
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.5641214175940827,0.8597288680542273,0.6956521739130435,0.9532941257428096,1.0,2/5,32.84%,NTRK2;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.5131022222264068,-0.8594816734695736,0.7142857142857143,1.0,1.0,2/10,11.40%,CCNF;BRCA1
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.5383026213308227,-0.8592824678380584,0.6551724137931034,1.0,1.0,1/6,1.85%,PKP2
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.4909749003992724,0.8592205883069867,0.65,0.9539088609792571,1.0,4/10,10.22%,PCM1;WNT3A;CEP120;NUMB
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4833299895620793,0.8589709843201215,0.660377358490566,0.9536246460601999,1.0,2/7,10.09%,CARD9;IL23A
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4833299895620793,0.8589709843201215,0.660377358490566,0.9536246460601999,1.0,2/7,10.09%,CARD9;IL23A
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),-0.5774128317984365,-0.8588107956113264,0.7241379310344828,1.0,1.0,1/5,4.18%,MMP9
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.47133495062535724,0.858778897773168,0.6590909090909091,0.9537649090079936,1.0,5/8,23.98%,KYAT1;AADAT;KYNU;KYAT3;ACSM1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.3851820193855602,0.8586662798876065,0.6451612903225806,0.953561377744709,1.0,10/23,14.33%,HDAC3;HDAC10;ABHD17A;SIRT1;SIRT7;ABHD17C;HDAC1;SIRT6;ABHD17B;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.489628009220739,-0.8585923006902515,0.6666666666666666,1.0,1.0,2/14,9.55%,LILRB3;CARTPT
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.47436187491675236,-0.8583278821479826,0.6964285714285714,1.0,1.0,3/13,13.72%,SP100;WAS;SPOCK3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.3525394102880433,0.8582222035138101,0.7142857142857143,0.9539673025804445,1.0,8/39,14.09%,TGFBR1;SORBS3;ABL1;CCN2;EVL;CCDC88A;PXN;RAPGEF3
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),-0.5777534402756891,-0.8581370940240145,0.7254901960784313,1.0,1.0,4/5,35.94%,ALOX15B;CNR1;DAGLB;CNR2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.3600898974384234,-0.8581245994255778,0.7142857142857143,1.0,1.0,9/52,16.03%,TRIM62;TRIM5;STAT1;CHMP3;OAS1;IFIT1;OAS2;PTX3;ISG15
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.5559509200128363,0.8581201196911531,0.6585365853658537,0.9537120241396675,1.0,3/5,23.96%,BCL11B;GPLD1;GAS6
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3298598971468943,0.8576483743662631,0.75,0.9542276459763066,1.0,4/64,6.34%,EGLN3;PSME4;PSMA1;HIF3A
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.5683508155132352,-0.8576274122706079,0.711864406779661,1.0,1.0,3/6,32.73%,SYT11;SYT4;ADRA2A
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.47628858193563794,0.8575993668045261,0.6363636363636364,0.9539206824575733,1.0,2/9,6.21%,SNCA;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.40740931760164867,-0.8575719869482586,0.6774193548387096,1.0,1.0,4/24,10.35%,TGFB1;DAB2;MRAP;RHOQ
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.5455970317826536,-0.857448382712453,0.6904761904761905,1.0,1.0,3/5,30.17%,ACSL3;CNST;RACK1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.3564150125416541,-0.8570611226547153,0.6666666666666666,1.0,1.0,10/52,20.17%,IFNK;IRF1;SH2D1B;CACTIN;NLRC3;CDC37;ERAP1;CASP8;DHX58;TKFC
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4802477177837258,-0.8569932613993467,0.7,1.0,1.0,2/12,3.37%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.4430274495572022,0.8568528389292737,0.6086956521739131,0.9550570010476396,1.0,1/10,1.52%,FGF10
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.38346762358185493,-0.8565010678447478,0.6666666666666666,1.0,1.0,1/40,0.20%,CLIC1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.3879601275675036,-0.8563251742859184,0.676056338028169,1.0,1.0,7/33,18.99%,CASQ2;KCNJ15;KCNJ11;KCNQ1;KCNJ4;KCNE2;KCNJ13
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.4696369839584828,-0.8563188284466592,0.65,1.0,1.0,5/10,26.29%,MSMP;MSN;CRTAM;CCL5;ZAP70
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.5207881342645082,0.8561508035207427,0.6666666666666666,0.9562311831527996,1.0,2/5,21.26%,DSCAM;SDK2
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.4647217895094482,0.8560570654964232,0.6666666666666666,0.9559948905263586,1.0,1/11,0.43%,SKAP1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.4044963823794725,-0.8560118723748376,0.6333333333333333,1.0,1.0,3/24,6.51%,KIF14;LGI4;TNFRSF1B
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.5178044076787722,0.8557787765547864,0.7435897435897436,0.9562435116231697,1.0,2/5,4.25%,RSPO3;NKD1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.30266431555866663,-0.8557618896600732,0.8902439024390244,1.0,1.0,52/341,16.65%,IRF4;CRLF1;DUOX1;TCF7;WNT5A;TGFB1;AIM2;ITGB2;HCK;IFNK;MMP9;IL7;ALOX5;IRF1;STAT1;GSDME;GPER1;ANXA1;TEC;TNFRSF1B;CCND1;NLRP12;OSMR;ALOX15;OAS1;INPP5D;TLR2;IL3RA;DOCK8;AQP4;PTAFR;BRCA1;IFIT1;RORC;IL12A;CLCF1;CDKN1A;HSPA8;RPL13A;IL10RB;OPRM1;NOS2;SFRP1;IL18BP;CACTIN;HLA-DPA1;CSF2RA;PIK3CB;ITGAM;SMAD3;FN1;LEF1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3486173616047977,0.855648476818414,0.6571428571428571,0.9561301543223677,1.0,3/29,5.11%,KIAA0319;SEMA6C;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3449617112946873,0.8556288083873675,0.6666666666666666,0.955784420426382,1.0,9/45,14.09%,TGFBR1;SORBS3;ABL1;CCN2;EVL;CCDC88A;SYNPO;PXN;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3998024588060363,0.8554887935590625,0.6511627906976745,0.9557746254882556,1.0,6/16,16.32%,KANK1;ABL2;RASIP1;ARHGAP35;ITGA3;CCDC125
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.45712004105808435,0.8553207297705212,0.6170212765957447,0.9557519343664628,1.0,2/9,6.35%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.2911469856235356,0.855306441663756,1.0,0.9554067880261615,1.0,66/464,13.08%,ADRA1A;GMNC;SMYD2;NOX4;NGF;CCN4;SMYD5;KLF10;BCL2;BCL6;ANGPT1;PROX1;FRK;DCBLD2;ADAMTS1;SIRT1;CDH13;P3H2;HTRA2;P3H3;ASTL;SEMA5A;SIPA1;MAGI2;MARCHF5;SIRT7;PIWIL1;CTBP2;PKD2;PML;ST7L;SRGAP2;FKTN;DSCAM;SLIT2;PPP1R13B;CDK6;NLRP2B;DACT3;ANP32B;HPGD;EIF2AK3;CCN2;NR4A1;TENM1;WNK2;PLXNB1;ADNP2;TESC;BRINP1;NOTCH4;ALDH1A2;SMARCA4;CDA;BNIPL;PBRM1;ADAM15;MYC;HSPA1A;CCN1;SMARCA2;BMP4;NOTCH1;DDAH1;PIM2;ARID2
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4301327391038488,-0.8551567353138169,0.6981132075471698,1.0,1.0,5/18,29.77%,NOP10;CCT8;CCT6A;CCT7;CCT2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.4278388268330835,0.8551116672838228,0.5853658536585366,0.9554745236349587,1.0,3/14,11.60%,TRIM71;KHSRP;MOV10
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.3721185001594359,0.8550156219117833,0.6486486486486487,0.9548819414438231,1.0,4/28,8.18%,THEM4;ACSM2A;THEM5;ACOT9
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.3721185001594359,0.8550156219117833,0.6486486486486487,0.9548819414438231,1.0,4/28,8.18%,THEM4;ACSM2A;THEM5;ACOT9
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.5066233815676124,-0.8549557467351534,0.7115384615384616,1.0,1.0,2/9,14.09%,ATP6AP2;THBS1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.4026132526561137,0.8543936126376902,0.5833333333333334,0.9558254857760473,1.0,7/15,27.68%,ADCY2;PRKAR2A;ADCY3;ADCY6;PRKACB;ADCY9;ADCY5
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.31749470575230065,0.8543718476631561,0.7857142857142857,0.9554810238517742,1.0,20/97,17.55%,CPN1;THEM4;PC;ACSM2A;SLC19A1;THEM5;DHFR;ACOT9;NSMAF;PDZD11;PLPP2;SMPD3;PM20D1;THOP1;PLPP3;PLA2G15;MTHFR;PCCA;OXSM;FPGS
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.34137980837315146,0.8543472082590352,0.8181818181818182,0.9550918129930664,1.0,13/77,12.39%,SLC5A8;SLC5A12;SLC12A1;SLC8A1;SLC8A3;HCN1;PKD2;SLC6A16;SGK1;SLC6A17;SCN7A;HCN3;SLC9B2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.33069280725308764,0.8537244302358614,0.7058823529411765,0.9559312061225974,1.0,16/96,10.59%,FIBIN;MXRA5;MRGPRF;LAMA4;SSC5D;EDNRA;ADAMTS12;COL12A1;MMP2;TIMP1;PAMR1;LTBP2;CCN2;OLFML2B;COL16A1;CCDC80
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.505600766520992,-0.8535008308712956,0.6226415094339622,1.0,1.0,2/6,22.88%,ATF5;ZFP36L1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.3680830082592977,-0.8531880673124013,0.7096774193548387,1.0,1.0,8/30,18.53%,HK2;SOD2;CLU;BIK;CAMK2A;FIS1;IFI6;BBC3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.3533554150640631,-0.853152178244095,0.7049180327868853,1.0,1.0,3/48,5.47%,STAC;GPER1;GPSM2
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.415369321666189,-0.8530257659557691,0.6290322580645161,1.0,1.0,2/26,5.80%,ALOX5;CYP21A2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.3859664117369916,-0.8527157062886842,0.7166666666666667,1.0,1.0,7/35,21.14%,NAP1L2;HAT1;GRWD1;CHAF1A;SMARCA5;DAXX;SOX9
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.5497784221378073,-0.8526257724906633,0.7,1.0,1.0,2/6,15.40%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.34898754291591144,-0.852572645356236,0.7121212121212122,1.0,1.0,5/68,9.30%,NEK2;MISP;RAB11A;ABRAXAS1;GOLGA8B
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.48737654317833323,0.8524861424858459,0.65625,0.9582226629799515,1.0,3/7,19.45%,COL16A1;FERMT3;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.423909244922974,-0.8522473250194731,0.7230769230769231,1.0,1.0,4/19,10.35%,TGFB1;DAB2;MRAP;RHOQ
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.31811999299052984,0.8522339369847752,0.75,0.9583147118395619,1.0,23/88,19.13%,KIT;FGFR1;SIRT1;FLT3;DIPK2A;EPOR;PLXNB1;PDGFD;HCLS1;TWIST1;IRS2;GAB1;PIK3R5;INSR;PIK3CA;ROR1;PIP4K2A;STAMBP;NEDD4;F2R;ERBB3;NTRK2;FSHR
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.5378562406769825,0.8521057436809699,0.6382978723404256,0.9578308841452667,1.0,1/5,6.51%,TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.5378562406769825,0.8521057436809699,0.6382978723404256,0.9578308841452667,1.0,1/5,6.51%,TOX
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.55838575094817,-0.8520649260650724,0.7580645161290323,1.0,1.0,2/7,18.82%,IL7;TPP1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.35461655947816667,-0.8519302143003001,0.746268656716418,1.0,1.0,24/70,32.16%,UVSSA;RPA3;COPS5;COPS4;RBX1;RPS27A;XRCC1;POLR2B;RPA2;DDB1;PCNA;CDK7;COPS7A;POLD4;XAB2;TCEA1;POLR2K;PRPF19;UBB;COPS7B;GTF2H5;RFC5;ERCC4;POLR2I
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.3750141952592069,-0.8518772703911989,0.65625,1.0,1.0,15/60,12.77%,SIRPG;GMFG;ITGB2;TSHR;ARHGAP9;CYTIP;TBC1D10C;TAGAP;PTPRC;CD5;PARVG;TMC8;IKZF1;WAS;MYO1F
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),0.5622145286237963,0.851678040986566,0.8108108108108109,0.9583529541684955,1.0,1/5,2.76%,ADGRG6
prerank,PanglaoDB_Augmented_2021__NK Cells,0.3367910950207257,0.8516328389766784,0.6486486486486487,0.9580470756576979,1.0,12/81,6.61%,PCDH15;DUSP2;KIT;CD247;SELPLG;KLRD1;AOAH;TRAC;PYHIN1;IL16;SAMD3;CHSY1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.5503712135374481,-0.8516150475077618,0.75,1.0,1.0,2/7,17.40%,UBE3A;WBP2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.37816052048016374,-0.8514231407848348,0.7794117647058824,1.0,1.0,14/54,24.47%,PSMB9;NQO1;AZIN1;OAZ2;PSMA7;PSMB6;FGFR4;PSMA3;PSMA5;PANK2;CAV1;PDK4;PSMD8;PSMD6
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.287832539392733,0.851332381561293,0.7777777777777778,0.9583570223899838,1.0,42/168,20.23%,LAMA4;TNNT1;SPRED3;NOVA1;ALDH1A1;PTPRO;SFMBT1;HS3ST5;CHSY1;IL17RD;TIMP1;PLCL2;PTPRR;SPRED2;RAB11FIP3;TFE3;EVL;ADIPOR1;N4BP1;BMP4;NOTCH1;TWSG1;NFIB;SPRED1;DLX1;RPS6KA4;MYOCD;PTPN23;ELAPOR2;NR1H3;RPS6KA6;F2R;SHH;ZNF706;RBPJ;FOXP3;SMAD7;WWC1;BTN2A2;IP6K1;MAP2K6;RAB11FIP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.4331376839335753,-0.851222233613593,0.6507936507936508,1.0,1.0,2/20,15.68%,MPV17L2;RCC1L
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.3976955359528488,-0.8511160767980988,0.6949152542372882,1.0,1.0,2/27,6.13%,RAB11A;CHMP3
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.3869937045572045,0.8510928965270071,0.675,0.9584295592641213,1.0,6/29,12.02%,CYP7B1;OSBPL3;OSBPL6;AKR1C1;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3225563302449249,-0.8508095471829502,0.676056338028169,1.0,1.0,24/143,21.33%,NOTUM;PSMB9;WNT5A;DAB2;SHISA6;LRP4;LATS2;SFRP4;DRAXIN;SFRP1;GLI3;PSMA7;RBX1;PSMB6;MCC;MESP1;SFRP2;PSMA3;TPBG;DKK2;BICC1;PSMA5;SOX9;CAV1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.5157706108319909,-0.8503979948687072,0.6417910447761194,1.0,1.0,3/7,25.68%,DOCK8;JAM2;CCL5
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.410067804201846,0.8503168629684874,0.5714285714285714,0.9596296556182713,1.0,6/20,19.69%,SLC3A2;SLC7A2;SLC7A8;SLC6A20;SLC1A3;SLC16A2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.3338116251441856,0.8503131383355061,0.5945945945945946,0.9592340951666561,1.0,6/57,9.95%,PROX1;CDK4;PKD2;CCND3;LRP6;PKN2
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.5256717809274173,0.8502507447756498,0.6938775510204082,0.9589860985891956,1.0,1/5,5.13%,CNTNAP2
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.34139774694419234,-0.8499862747377452,0.7466666666666667,1.0,1.0,11/101,7.07%,ACTC1;C1QTNF1;TIMP3;LMOD1;COL1A1;COL5A1;ANGPT2;ANGPTL2;SYNC;UACA;FBXL7
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.3265218056296066,0.8498522247957252,0.7586206896551724,0.9594805916334718,1.0,7/70,6.41%,TGFBR1;BCL2;URI1;CFLAR;CX3CR1;SH3RF1;NR4A2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.3473405638691094,-0.8498142129878914,0.7313432835820896,1.0,1.0,13/64,19.33%,SIRPG;ECM2;NODAL;P2RY12;ALOX15;VIT;IL12A;TGM2;RAC1;TNFSF18;RNASE10;SFRP2;FBLN2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.4905787008129697,-0.8493694422975067,0.7058823529411765,1.0,1.0,2/9,8.82%,CASQ2;P2RY6
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.3917427165342081,0.8492552372395787,0.717948717948718,0.9603712529027018,1.0,8/29,12.82%,PCM1;SIRT7;PLK3;TENM1;CEP290;GCC2;BMP4;B3GAT3
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3639678495205403,0.849206965181288,0.7073170731707317,0.9601103070379372,1.0,5/42,13.07%,CTDNEP1;BIN1;IRAG2;CHMP6;USP36
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4356420963758128,0.8489263418329199,0.7142857142857143,0.960373647268476,1.0,10/26,12.82%,VCAN;CSGALNACT1;CHSY3;CHST12;CHSY1;UGDH;CHST11;CSPG5;CHPF2;B3GAT3
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.3964552824192631,0.8488303086940117,0.6190476190476191,0.9601895768552882,1.0,6/15,12.45%,MFSD2A;GRIP1;NTNG2;MOV10;MACF1;MAP3K13
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.35945030433800984,0.8486023774827608,0.7666666666666667,0.9602802497811669,1.0,8/34,13.58%,DOC2B;PCLO;SNCA;SYT1;RIMS2;UNC13B;UNC13C;SNPH
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.3177099253315754,0.8485737835272854,0.8125,0.9599687042393273,1.0,14/64,11.72%,CYP1A2;ELOVL6;EPHX2;LIPC;ACSM2A;ABHD3;LPL;HPGD;ELOVL4;SCD5;FADS1;ABCD3;HACD1;TECR
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.4951608431207417,-0.8484986720818118,0.6833333333333333,1.0,1.0,2/12,11.90%,DOCK8;APOD
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.4336550646606078,0.8481361378252099,0.6756756756756757,0.9605570814495701,1.0,3/12,10.94%,CYP1A2;CYP2U1;CYP2S1
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.5487557486083636,-0.8480022570329749,0.7543859649122807,1.0,1.0,1/6,10.96%,PRDM12
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.4628251404967044,-0.8477477482452842,0.6307692307692307,1.0,1.0,2/11,17.47%,TCHP;TBC1D7
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.3532792749260553,0.8475023229795114,0.6923076923076923,0.9614192294515623,1.0,10/45,21.27%,PLCH1;ITPKB;PLCB1;PLCH2;INPP1;ITPK1;IP6K1;PLCG2;IPPK;PTEN
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.3924899305755569,0.8474615456589232,0.5897435897435898,0.9610884739206941,1.0,3/30,3.58%,QRICH2;PACSIN2;PARVA
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.27036271323625205,0.8474299170846726,0.9545454545454546,0.9607962263108669,1.0,46/198,21.08%,MLF1;PKNOX1;ZBTB7B;TEFM;ARRB2;CBFB;IWS1;SLC25A33;DTX1;NR4A2;PPP5C;TRIP13;TAF3;ELOA;TAF1B;NAT14;TAF12;CCNH;NFIC;PRMT5;SOX5;NFKB1;MLLT3;SNAPC3;THRB;TBPL2;GTF3C4;HSF1;GTF2F2;BCL3;POLR3G;POLR3K;BAZ2A;TTF2;NFIX;TAF4;TFDP1;NFX1;POLR2F;TRIP11;TP53;ERCC3;RO60;GTF3C5;RSF1;MED16
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.45869127348607636,0.8474223299395683,0.6666666666666666,0.9604277765257007,1.0,4/11,10.98%,NLGN1;DEF8;PLEKHM1;EPS8
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.4741289666167437,-0.8474049959710283,0.6666666666666666,1.0,1.0,1/7,5.94%,SENP3
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.4059603634768463,0.8473734374579013,0.8333333333333334,0.960129671699702,1.0,3/15,7.16%,CDK4;PML;JAGN1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4496517640950965,-0.8473575490475242,0.6379310344827587,1.0,1.0,3/11,23.89%,RAC1;STMN1;MST1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.34389454203209074,0.8470211745996002,0.7307692307692307,0.9605255887571797,1.0,16/51,25.37%,ADAMTS12;SNCA;GBP2;PTGIS;LGALS9;TANK;NFKB1;HDAC4;CD40;HAS2;RC3H1;TRAF6;HIF1A;NR1D1;IGBP1;IRAK3
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.4253497372011044,0.8465757237058399,0.673469387755102,0.9610802397080644,1.0,1/11,1.52%,FGF10
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.554210345956449,-0.8464631308660379,0.7924528301886793,1.0,1.0,1/5,11.56%,REST
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.4973352942648045,-0.8462714408120783,0.6617647058823529,1.0,1.0,2/7,27.06%,PRDM7;STRA8
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.4164643895860387,0.8461620471464377,0.6666666666666666,0.9615136018733244,1.0,2/14,8.29%,PUF60;CELF4
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.32182371267722676,0.8461301023793404,0.7,0.9611901121838503,1.0,15/105,10.46%,FIBIN;MXRA5;MRGPRF;LAMA4;TPM2;CLEC14A;EDNRA;PARVA;COL12A1;MMP2;PAMR1;PLSCR4;EFEMP1;COL16A1;TPM4
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.5548101519416049,-0.8459344699719337,0.723404255319149,1.0,1.0,2/6,16.55%,SCIN;VIL1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.38342536191465776,-0.8457958322955766,0.6451612903225806,1.0,1.0,10/31,14.78%,SLC22A25;SLC22A24;SLC22A6;SLC22A3;SLCO2B1;ABCG2;SLC13A4;VDAC1;SLC17A8;SLCO1A2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.3553854144919681,-0.8457842907891123,0.7638888888888888,1.0,1.0,20/85,17.75%,HAMP;JCHAIN;CXCL13;GSDMA;SFTPD;HLA-A;OAS1;TLR2;SLC11A1;LYG2;DEFB109B;IL12A;NLRC4;NOS2;SELP;OAS2;ROMO1;ISG15;LYG1;NAIP
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.38719449945909995,-0.8455839509154774,0.6557377049180327,1.0,1.0,4/28,14.75%,MISP;GPSM2;DCTN1;NDEL1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.515866216818436,0.8454033289275077,0.6190476190476191,0.9620678912850104,1.0,1/5,12.64%,TANK
prerank,MSigDB_Hallmark_2020__Complement,-0.3091568887665414,-0.8453503821213378,0.7777777777777778,1.0,1.0,23/158,16.96%,F8;PSMB9;F7;S100A13;IRF1;GP1BA;PIK3CG;CPM;CLU;PHEX;ERAP2;PLG;CP;WAS;CDK5R1;PLAT;ITGAM;F5;CALM1;FN1;C1S;ATOX1;CTSO
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3372366140878422,0.8453430328878139,0.6551724137931034,0.9618460702345913,1.0,8/77,5.22%,EGLN3;NGF;GRID2;SLC30A10;BCL2;EPHA7;APOE;PTPRZ1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.5598616278189862,-0.8451276957727349,0.7678571428571429,1.0,1.0,1/5,11.90%,APOD
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.580795873850878,-0.8451276144191139,0.7450980392156863,1.0,1.0,3/5,37.20%,PANK2;FITM2;MBOAT7
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.37945045343714845,0.8449156883172755,0.696969696969697,0.9623038083381853,1.0,5/33,8.18%,THEM4;ACSM2A;THEM5;ACACB;ACOT9
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4222664958413742,-0.8446709466932115,0.6268656716417911,1.0,1.0,2/18,14.09%,DAB2;THBS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4222664958413742,-0.8446709466932115,0.6268656716417911,1.0,1.0,2/18,14.09%,DAB2;THBS1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4280805002283728,0.8446448884266791,0.5909090909090909,0.9625580770469545,1.0,3/12,16.98%,ADIPOR1;PIBF1;BCL3
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3435296018775515,0.8446318155987551,0.6578947368421053,0.9621840681956564,1.0,5/40,9.53%,KIFC1;KIFC2;AAAS;MAP10;FLNA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.39377125977386934,-0.8446117255206567,0.6206896551724138,1.0,1.0,8/28,15.78%,HLA-DRB1;HLA-A;CD160;SPI1;IL12A;NOS2;HLA-F;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.3144200274521937,0.8445962469315709,0.7741935483870968,0.9618801217192567,1.0,38/130,22.45%,IRGM;RASSF2;NOX4;PAK5;SNCA;RALB;TELO2;TNIK;CLSPN;IL23A;PIH1D1;CCN1;CCDC88A;RAP1A;SNX9;LRP8;INSR;EMP2;CASS4;SRCIN1;ERBB3;GRM5;SYAP1;EGR1;MMD2;TAB2;MARK2;IL23R;PAK3;PAK2;PRKAG2;TRAF6;PARP16;STOX1;CACUL1;DUSP19;CIB1;AXIN1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.44418845572049986,-0.8444809792058511,0.7358490566037735,1.0,1.0,6/19,14.83%,HLA-DRB1;HLA-A;PTPRC;CEACAM1;IL12A;HLA-F
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.3874733807817849,-0.844451646032177,0.6865671641791045,1.0,1.0,6/43,14.34%,AHR;CTNNA1;GLRA2;BRCA1;ADCY7;SFRP1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.3646135548963876,-0.8439986511445962,0.6833333333333333,1.0,1.0,16/64,18.22%,SIRPG;ITGB2;CYTIP;GPR183;TNFRSF1B;TAGAP;PTPRC;CD5;KLRB1;PARVG;HLA-DPB1;HLA-F;TRAF3IP3;MAF;CNGB1;PSTPIP1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.5298039600720679,-0.8439068338992708,0.6909090909090909,1.0,1.0,1/7,14.29%,CDC6
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.48157146959614827,-0.843628199003669,0.7213114754098361,1.0,1.0,1/10,3.80%,CYP26B1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.33563007626534846,0.843598172647183,0.7037037037037037,0.9634083837756742,1.0,13/67,17.35%,PNPLA3;PIGQ;ABHD3;PLCB1;CPNE7;CRLS1;SMPD4;PLA2G4C;CPNE6;PLA2G15;DGKH;SERINC5;GPLD1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3601472741174566,0.8430784862618405,0.6818181818181818,0.9642447340327334,1.0,7/31,12.64%,KIT;F2;OCIAD2;HES1;ADIPOR1;IL10RA;NOTCH1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.33403975901770966,0.8430673070430992,0.7142857142857143,0.9638896488580097,1.0,7/37,8.80%,CHRM2;GALR3;HTR1F;HTR2C;HRH3;OPRD1;DRD4
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.41043450220023303,0.842937701958724,0.7105263157894737,0.9637247895074619,1.0,7/17,20.75%,TCOF1;SIRT7;TAF1B;GTF3C4;MARS1;SPIN1;GTF3C5
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.4901656416807246,-0.8425363505990773,0.7,1.0,1.0,1/13,0.79%,TBX1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.48213500927147407,0.842509891024145,0.6046511627906976,0.9643195007179787,1.0,2/9,3.30%,SCRIB;GRIP1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5398882049442981,-0.8423624027611333,0.7222222222222222,1.0,1.0,1/5,9.85%,TLR2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.3486407594537675,-0.8422677965345069,0.746268656716418,1.0,1.0,9/50,14.44%,WNT5A;CYBA;PTPRC;CLU;OAS1;TLR2;C1QTNF4;THBS1;OAS2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.31517085277239787,0.8420063422547811,0.7575757575757576,0.9649833142812547,1.0,6/58,6.02%,HSPB1;BCL2;URI1;SIRT1;HTRA2;ARMC10
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.3631854335375174,0.8419311384529441,0.7380952380952381,0.9647233588426074,1.0,9/38,19.05%,KIT;FLVCR1;HCLS1;CASP3;ABCB10;ACIN1;MFHAS1;DYRK3;CDIN1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3612237683562215,0.8418300239621224,0.717948717948718,0.964558428591904,1.0,6/45,4.76%,CYP7B1;PER2;OSBPL3;OSBPL6;PSAT1;AKR1C3
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.45956448701542074,0.8417921925343076,0.6875,0.9642293556240854,1.0,2/7,7.10%,ZBTB7B;HLA-DRA
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.38403379248185093,-0.8415627672103515,0.7183098591549296,1.0,1.0,5/35,17.67%,DTL;TRIM25;ATXN7L3;RNF20;RBX1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.47786833065068174,-0.8415475135563849,0.7377049180327869,1.0,1.0,1/10,0.83%,RAB34
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.4198620301914361,-0.8415044614476699,0.6774193548387096,1.0,1.0,4/16,18.64%,ITGB2;CLU;ITGAM;GRN
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3936010072530397,-0.8412507236584288,0.6792452830188679,1.0,1.0,7/32,19.81%,SP100;TMC8;BRCA1;THBS1;SFRP1;DDX3X;CASP8
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5005203801266076,-0.8412211056396333,0.6896551724137931,1.0,1.0,2/9,10.62%,CYP26B1;SFRP4
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.340536576652328,0.841204450360643,0.7777777777777778,0.9649552841839336,1.0,7/38,11.19%,NGF;IFI16;PPARG;PYHIN1;HMGB1;MAPK8;HES1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.42331776381621383,0.8410935881017313,0.6944444444444444,0.9647904607456685,1.0,5/12,10.47%,NLGN1;LRRTM3;WNT3A;FZD1;NLGN4X
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.3918771653550928,-0.8409694941160444,0.7096774193548387,1.0,1.0,3/33,10.19%,TENT5B;MEIOC;SLC11A1
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3515740733993532,0.8409633142743984,0.6875,0.9646825669773994,1.0,25/59,28.02%,CDK4;CBFB;MED25;MED17;MOV10;TNRC6C;NFKB1;CDK8;MECP2;TNRC6A;ATF7IP;AGO3;TP53;MED27;MED16;PTEN;MED13;SRF;CDK1;PPM1D;MED12;TNRC6B;MED23;MED4;RELA
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.5215196843841448,-0.840807088595246,0.7377049180327869,1.0,1.0,2/5,25.16%,RTF1;PAF1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5020473067357955,-0.8407034230672253,0.7413793103448276,1.0,1.0,4/10,21.33%,CASQ2;TRDN;CALM1;CAV1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.4823179639579732,-0.8406828943689035,0.65,1.0,1.0,1/12,6.65%,RTP5
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.5499403139958585,-0.8406801921154882,0.7115384615384616,1.0,1.0,2/6,8.82%,GPER1;P2RY6
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.3165459993739933,0.8403652396704718,0.7142857142857143,0.9655966697171685,1.0,7/62,10.99%,MLPH;PERP;ESRP1;DSP;CTSV;RND3;FERMT1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.3815640145837166,-0.8403470400319301,0.6923076923076923,1.0,1.0,5/36,20.80%,NARS1;DARS2;YARS2;WARS1;PPA1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.4530883956673166,0.8401412419360138,0.6097560975609756,0.9653741877159626,1.0,4/10,11.10%,EYS;REEP6;RPE65;CEP250
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.4530883956673166,0.8401412419360138,0.6097560975609756,0.9653741877159626,1.0,4/10,11.10%,EYS;REEP6;RPE65;CEP250
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.3401007319151949,-0.8400732964262917,0.71875,1.0,1.0,17/59,21.45%,TGFB1;ALOX5;STAT1;CNMD;CEACAM1;CAV2;ATP5IF1;THBS1;SFRP1;NLRC3;AQP11;ATOH8;MCC;SFRP2;SOX9;CAV1;VDR
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4567023173507655,-0.8399873683025966,0.7678571428571429,1.0,1.0,2/12,7.89%,CYP26B1;PRAME
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.4648713279366499,-0.83939890762383,0.7142857142857143,1.0,1.0,3/9,29.02%,ISG15;RPS27A;UBB
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.39463506148775174,-0.8393175384529871,0.7076923076923077,1.0,1.0,3/21,16.33%,CASQ2;TRDN;CALM1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3320153287119554,-0.8390224741934592,0.8260869565217391,1.0,1.0,12/94,11.72%,NOTUM;DISC1;ESR1;SOX30;ATP6V1C2;DAAM2;HIC1;TCF7L1;TLR2;SFRP4;ATP6AP2;GPC3
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.37108605552692575,-0.8390166607403188,0.6779661016949152,1.0,1.0,4/50,6.29%,POLQ;TERF2IP;H1-3;H1-0
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2890033154596611,0.8389769117801417,0.8571428571428571,0.9673138640497608,1.0,55/172,22.95%,DGKD;THEM4;BCL2;RORA;EPM2A;ADGRG3;URI1;SIRT1;PDE10A;PDE3A;ARRB2;MAGI2;DEPTOR;SLIT2;CGNL1;DRD3;TWIST1;BANK1;TNIP3;ADIPOR1;TANK;MARK3;SPRED1;PPM1A;NF1;DLG5;OTUD3;ZMYND11;OTUD7B;TSPAN6;STAMBP;PDE3B;MINAR1;CD22;ABCA7;CPNE1;WWC1;SLA2;CCDC22;HDAC7;PKHD1;OTUD7A;PTPRJ;PRKAA2;PTEN;PDE4D;NPRL2;NOC2L;SPRY3;CIB1;WWC2;PHLPP2;TRIB3;LYN;CDC34
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.3736794952337564,0.8389066832590665,0.7272727272727273,0.9670603155039754,1.0,4/17,14.12%,SLC8A1;NRG1;ALPK3;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.5791754045629453,-0.838882795978434,0.7755102040816326,1.0,1.0,3/5,27.41%,HSPA5;DDRGK1;UFL1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.3899959641250877,0.8388558459834579,0.625,0.9667880865274258,1.0,1/18,0.19%,PKD1L1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.36923395085656674,-0.838825847001721,0.7301587301587301,1.0,1.0,8/52,11.02%,ITGB2;IFNK;HLA-DRB1;GPR151;CYBA;PTPRC;NLRP3;SH2D1B
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.569085715698161,-0.8385745789237621,0.7457627118644068,1.0,1.0,3/5,22.16%,EIF6;DDX3X;SBDS
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.398176098516424,0.8382922199097288,0.6153846153846154,0.9675166253392506,1.0,8/22,18.94%,OLFM2;NRG1;ABL1;BNIP2;CDH2;MYOCD;MAPK12;CTNNA2
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.39768316924667546,0.8381364861047095,0.6857142857142857,0.9674268479214959,1.0,1/14,0.94%,DGKD
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.3619001697800273,0.8381138527199176,0.782608695652174,0.9670793492377998,1.0,7/29,21.23%,ZBTB20;ERN1;MLXIPL;UNC13B;RAB11B;LIN28A;PRKAA2
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.3677394907259169,0.837985622419685,0.6428571428571429,0.9669709660072291,1.0,15/53,19.75%,BCL2;SNCA;MTMR8;DAPL1;LEPR;IL10RA;RASIP1;USP36;KLHL22;TAB3;PIK3CA;QSOX1;SMG1;RUBCN;TAB2
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.4869197831767289,0.8379588128478405,0.6511627906976745,0.9666741932757619,1.0,4/9,18.70%,BICD1;CEP250;MARK4;UBXN2B
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.4358000591915989,-0.8378722006134596,0.6949152542372882,1.0,1.0,1/20,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.4358000591915989,-0.8378722006134596,0.6949152542372882,1.0,1.0,1/20,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.4223429315384656,0.837830961965637,0.7222222222222222,0.9664969810725255,1.0,3/15,14.33%,PID1;MLXIPL;HDAC4
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.5360887399801315,-0.8377995227784324,0.7333333333333333,1.0,1.0,3/6,21.40%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.5360887399801315,-0.8377995227784324,0.7333333333333333,1.0,1.0,3/6,21.40%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.3568264447337431,-0.8376433317944056,0.7971014492753623,1.0,1.0,13/69,21.09%,CASQ2;CAV3;KCNJ11;CYP2J2;KCNQ1;ATP1A4;TRDN;KCNG2;CALM1;ITPR3;PLN;ATP1A1;AGT
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.5449916984264871,-0.8375413758627078,0.7,1.0,1.0,3/6,29.40%,GATA4;NUPR1;BAG3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3163186219636271,0.8374680895407587,0.7878787878787878,0.966840944154312,1.0,5/74,7.69%,EGLN3;PSME4;PSMA1;HIF3A;ATF3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.3440390559131881,0.8372873931748541,0.7297297297297297,0.9668206817391785,1.0,5/43,5.35%,KIT;PARVA;CX3CR1;SEMA5A;ARRB2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.5424766270741421,0.8372392672773321,0.631578947368421,0.9665244489250282,1.0,3/5,14.14%,HCLS1;TESC;RUNX1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.3004263187837619,0.8369745471668893,0.6666666666666666,0.9667175070193893,1.0,48/230,16.52%,IRGM;FGF10;VEGFC;HSPB1;HDAC3;F2;ANGPT1;FGF18;CDH5;EPHA7;SPTBN4;SIRT1;PID1;FGF17;ERBB2;WNT3A;RALB;PML;SLIT2;FER;CCND3;ATF3;ABL1;EIF2AK3;EFNA5;AKT2;TNIK;LRP6;RAP2A;LEPR;CCN1;NSD1;WWTR1;CCDC88A;BMP4;BMPER;ARRB1;INSR;EPHB2;CD40;PPP1R15B;PLPP3;BRD4;OCLN;PELI2;NIBAN1;IMPACT;CRKL
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.3686479060072873,0.8369738593978034,0.8055555555555556,0.9663275443299906,1.0,5/29,12.32%,MEGF10;XKR7;RHOBTB1;XKR6;XKR4
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4485584863464399,-0.8368260207821322,0.7246376811594203,1.0,1.0,1/11,9.48%,DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.3139918352181372,-0.8366829668787849,0.75,1.0,1.0,12/162,10.62%,NOTUM;PSMB9;WNT5A;DAB2;SHISA6;SOX30;LRP4;RNF213;LATS2;HIC1;ALPK2;SFRP4
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.3128288158098781,-0.8366173559489818,0.7761194029850746,1.0,1.0,16/147,11.72%,SLC28A2;CLEC5A;AHR;C3AR1;LPAR1;ROS1;IRF1;GPR183;GP1BA;TNFRSF1B;OSMR;TLR2;NLRP3;PTAFR;ADGRE1;GPC3
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.3458525991439784,-0.83656373441646,0.7391304347826086,1.0,1.0,9/64,14.22%,AQP3;PLEKHG6;CYP24A1;TCN1;SPINT1;ST6GALNAC2;RDH12;SERPINB5;CXCL16
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3235188225548488,0.836238617246583,0.7241379310344828,0.9673600145203739,1.0,17/64,21.75%,HDAC3;EPM2A;SIRT1;DEPTOR;MLST8;TELO2;PIH1D1;PIK3CA;MINAR1;DYRK3;TBCK;LIN28A;PKHD1;GNA12;PRKAA2;HTR6;NPRL2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.44250905938447416,0.8357770126289694,0.5476190476190477,0.9678343064976003,1.0,2/10,5.86%,SNCA;SLC25A33
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3173216268351885,0.8357525978110918,0.7083333333333334,0.9674944435218078,1.0,17/67,22.18%,CPSF1;LSM10;PCF11;TAF1B;CCNH;SNRPB;POLR1H;PRMT5;CPSF7;PAPOLA;POLR3K;TTF2;SYMPK;POLR2F;ERCC3;SNRPF;MTERF2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.38605660379513623,0.8353122397542538,0.725,0.9679682993278882,1.0,3/23,4.94%,GCK;ENO3;PFKP
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5383453221374586,0.8351894478970916,0.7058823529411765,0.9669939372620261,1.0,2/5,17.52%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5383453221374586,0.8351894478970916,0.7058823529411765,0.9669939372620261,1.0,2/5,17.52%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5383453221374586,0.8351894478970916,0.7058823529411765,0.9669939372620261,1.0,2/5,17.52%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.3211109716107006,-0.8348792563030779,0.8243243243243243,1.0,1.0,16/111,19.36%,FZD8;PSMB9;WNT5A;PDE6B;SFRP4;SFRP1;RAC1;CALM1;LEF1;CAMK2A;PDE6A;PSMA7;PLCB2;PSMB6;SFRP2;PSMA3
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.3689552174639184,0.8347630562896081,0.5757575757575758,0.9676109179111725,1.0,3/24,8.31%,PNPLA3;LIPC;LPL
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.46270464943300005,-0.8346509531468523,0.6610169491525424,1.0,1.0,2/13,8.93%,DBH;SMOX
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.35397274475447166,-0.8344036403047527,0.7428571428571429,1.0,1.0,4/37,10.01%,TGFB1;CTNNA1;LATS2;ORMDL3
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.3427157674994997,0.8343521908961614,0.7941176470588235,0.9680962640093448,1.0,7/35,17.37%,KIT;OSR1;LRP6;SP7;MLLT3;SETD2;SHH
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.44051002387666727,-0.8343382561952808,0.6274509803921569,1.0,1.0,2/15,10.55%,CEACAM1;CD160
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.4397659310951056,-0.834218388499922,0.6885245901639344,1.0,1.0,4/15,15.71%,ANXA1;NDUFS2;METRN;METTL14
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.36010643011619714,0.8341838255685378,0.7837837837837838,0.9680506343347701,1.0,3/30,6.35%,DERL3;DPM3;UBE2J1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3173167500557528,0.8341628111796886,0.78125,0.9677055367308238,1.0,10/74,8.36%,APOH;ANGPT1;ANXA3;APOE;PROX1;RIN2;SLIT2;VASH1;PTPRM;ABL1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.4647618148550511,0.834106534071948,0.6857142857142857,0.9674106135932719,1.0,2/7,3.91%,HDC;PSAT1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.4212669272168049,0.8338913043987018,0.5526315789473685,0.967415191358513,1.0,4/11,12.78%,ANGPT1;PDE3A;SLIT2;DDAH1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.38858766864423416,-0.8336126343926353,0.7241379310344828,1.0,1.0,3/34,6.94%,ESR1;GPER1;UBE3A
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.45497335816386897,-0.8334327650494235,0.75,1.0,1.0,1/12,0.83%,RAB34
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.5366286906598142,-0.8332712443398961,0.75,1.0,1.0,2/7,20.02%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.5366286906598142,-0.8332712443398961,0.75,1.0,1.0,2/7,20.02%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3771686836191875,-0.8332220973142138,0.6935483870967742,1.0,1.0,3/36,2.44%,TGFB1;COL1A1;DAB2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.37993608802181256,0.8328250355759715,0.7586206896551724,0.9692894164828596,1.0,11/28,30.42%,AKAP9;MAP7D3;TPPP3;NDE1;TPPP;FGF13;CLASP2;ZNF207;PIN1;TRPV4;CCDC57
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.3770181123530864,0.8327380977912259,0.7222222222222222,0.9690378207270914,1.0,9/24,27.22%,P3H2;CWC27;PPIB;NKTR;FKBP7;PPIL2;PPIH;PPIA;PPIL6
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.5019944767846016,0.8326148344965926,0.7,0.9689171973132217,1.0,1/6,5.86%,SLC25A33
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.45047697666606534,0.8324816166909534,0.66,0.9688028952322446,1.0,2/9,3.07%,TGFBR1;RORA
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.28165025444211655,-0.8323600509568839,0.9659090909090909,1.0,1.0,88/602,19.24%,CD44;CLEC5A;WNT5A;KIF14;RASGRF2;OBSCN;DAB2;HCK;CYP1B1;MMP9;IL7;BCL2L14;PINK1;BCL2L2;STAT1;GPER1;FLT4;VAV3;ANXA1;ITGB3BP;OLFM4;PXT1;WFS1;CARD14;PRAME;CIDEB;LATS2;RTKN;PPT1;HTR2B;CLU;SMAD6;DDX20;DNAJA1;STK17A;IFIT3;MOAP1;ALPK2;MTCH1;SFRP4;LRP2;COPS5;SCIN;BEX2;REST;SIAH1;VDAC1;TFPT;CFL1;NDRG1;NTRK1;ATF5;TAF9B;TEK;NLRC4;NAA38;THBS1;RABGGTB;SFRP1;PNMA1;ANP32E;RABGGTA;PAX7;PNMA2;TGM2;TNFSF18;LEF1;SAP18;TGFB3;TP53I3;NOP53;ECT2;CD27;IGFBP3;IFI6;SUDS3;NAIP;ALB;GADD45B;CAPN13;DAXX;RNF144B;EGR3;CASP10;AKAP13;DDX3X;FIGNL1;SFRP2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.35072002643393935,0.8321635469176997,0.6756756756756757,0.9690931268352407,1.0,6/41,9.42%,ZBTB7B;IRS1;SIRT1;CRY1;STAT5B;CELA2A
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.38083817352255345,-0.8321147121737198,0.6923076923076923,1.0,1.0,3/26,11.05%,MGST1;ABCG2;SLC13A4
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.470718153266394,0.8320999452489034,0.675,0.9687860352716333,1.0,3/9,14.28%,IL23A;TICAM1;PIBF1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.44262056145423323,-0.8319943645025077,0.6851851851851852,1.0,1.0,3/13,21.33%,USP13;HERPUD1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4110932169188025,-0.8319275626132451,0.6349206349206349,1.0,1.0,6/17,28.68%,IL7;CD27;AXL;XRCC6;ZAP70;BTK
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.4849494105581772,0.8314805435740794,0.717391304347826,0.96966667599974,1.0,3/6,18.40%,MYC;SETD2;TCF4
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4356330556797884,0.8314447006473746,0.6511627906976745,0.9693596006897177,1.0,2/12,12.87%,AK3;EFL1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.46630723951474534,0.8314062479061654,0.7441860465116279,0.9690279220011787,1.0,3/7,28.32%,PIH1D1;NUFIP1;ZNHIT6
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.3861830753459154,-0.8312750645175386,0.6944444444444444,1.0,1.0,8/30,21.50%,TAF7;TAF6;TBPL1;TERT;TCEA2;SMARCA5;TAF13;TAF10
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.43373983562335183,-0.831045993630073,0.7049180327868853,1.0,1.0,4/15,14.09%,GPER1;CD160;SFRP4;THBS1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.3032554227527177,-0.8301348168415,0.8571428571428571,1.0,1.0,16/237,8.08%,ENPP2;F7;TGFB1;COL1A1;DAB2;MMP9;RAB11A;GPER1;SYNE2;ACTG1;SMIM22;CGA;SEMA3F;PTPRC;SEMA3A;SOD2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3160109051727171,0.8297699026536426,0.75,0.9720932429117963,1.0,23/93,19.27%,TGFBR1;CD151;NEUROD2;CDH5;APOE;NRG1;SNCA;PIH1D1;FRMPD4;GNL3L;RAPGEF3;RUNX1;PTPN23;INSR;SPIDR;NRXN1;FAF1;ICE1;BID;CLIP3;GPX1;ATP10A;ADD1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.4761209994603853,0.8295517539753281,0.6458333333333334,0.9720152352253074,1.0,2/9,7.83%,SIRT1;ABI3
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.3091183559531566,0.8294690594891813,0.782608695652174,0.9717635556591621,1.0,34/120,19.72%,KCNK6;KCNB2;SLC12A1;KCNH8;KCNC2;HCN1;PKD2;KCNH7;KCNJ3;KCNJ6;KCNK2;SLC12A9;TMEM175;KCND2;KCNH4;ABCC8;HCN3;KCNH5;KCNQ5;KCNK12;ATP12A;KCNJ10;KCNK10;KCND3;KCNG1;NALCN;SLC9C2;KCNJ8;KCNC3;SLC12A4;SLC24A2;SLC1A3;SLC9A9;KCNAB3
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.367243176500322,0.8294296306988352,0.7878787878787878,0.9714624585116001,1.0,6/33,12.78%,DDAH2;GLA;APOE;DHFR;NUS1;DDAH1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.44197884410320604,0.8290229678207701,0.5526315789473685,0.9719427815569524,1.0,3/9,25.94%,PPCS;PDHA1;DLAT
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.5025297348737012,0.8290199514448615,0.660377358490566,0.9715612873481433,1.0,1/5,3.76%,HTR2C
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.3608249722356221,-0.8289155495787156,0.6724137931034483,1.0,1.0,3/42,4.03%,BUB1;TGFB1;ZWILCH
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.5216159870475728,0.8287535562481243,0.6842105263157895,0.971681883966407,1.0,3/5,13.28%,SLC7A2;SLC25A29;SLC7A6
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.36495975778770895,-0.8284921913207812,0.676923076923077,1.0,1.0,7/53,13.34%,TICRR;DTL;DONSON;ABRAXAS1;CCND1;BRCA1;CDKN1A
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.45272008685430387,0.8281516376441768,0.6190476190476191,0.9724835514554356,1.0,3/11,12.09%,VCAN;ARSB;CSPG5
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.3940211888132377,0.8281476275652129,0.6666666666666666,0.9721022977696258,1.0,9/26,14.42%,KIT;MLF1;FSTL3;FLT3;PRRC2C;SP7;ARMC6;BMP4;MLLT3
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),0.5659866958715107,0.8281352366837234,0.8,0.971739910235783,1.0,2/5,15.27%,SLC7A8;SLC6A20
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.43224623745983426,0.8280405547207621,0.7368421052631579,0.9715942873427079,1.0,3/13,9.18%,RPP25;POP1;RPP25L
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.4596895184431361,0.827970492564987,0.6285714285714286,0.9713869546386741,1.0,2/8,15.53%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.5080849437509082,0.8279125609952969,0.675,0.9711674266543151,1.0,2/5,19.27%,PTPN23;ADD1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.37938787928901374,-0.8278882580507352,0.7627118644067796,1.0,1.0,4/31,11.40%,LRPAP1;RIN3;PINK1;BRCA1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.40706497732337155,-0.827716126567986,0.7258064516129032,1.0,1.0,5/16,18.53%,SOD2;CLU;FIS1;IFI6;BBC3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.37151467011074596,-0.8275504001279345,0.6857142857142857,1.0,1.0,6/36,9.88%,WNT5A;AIM2;S100A13;NLRP12;USP50;NLRP3
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.4685480180185173,0.8272279919012735,0.6923076923076923,0.9720415180213754,1.0,2/8,3.88%,TOP2A;ESPL1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.48439030106062303,0.8271834090245288,0.6153846153846154,0.9717478019971574,1.0,2/9,13.85%,GDF6;SOX5
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.3474081981592902,0.827009552261532,0.7741935483870968,0.9717197474092407,1.0,5/44,7.38%,MKX;ITGA11;UTRN;FKTN;TEAD4
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.4521617007258055,0.8269560729046868,0.7045454545454546,0.9714695845236919,1.0,4/10,11.19%,TGFBR1;FGF10;ZBTB1;HES1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.5058424011679514,0.8269351536359892,0.6956521739130435,0.9711085990595263,1.0,2/10,15.07%,SEMA5A;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.45213745353914336,0.8268337388434814,0.6956521739130435,0.9708835388225531,1.0,7/12,21.09%,APOE;SNX9;GPLD1;ADAM8;SH3D19;FURIN;SNX33
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.49000333206298785,-0.8267529489043368,0.6727272727272727,1.0,1.0,1/8,0.84%,ACTC1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.39271465529161914,0.8267448082526503,0.6923076923076923,0.970664820085202,1.0,5/16,14.10%,SMARCD3;CX3CR1;TAFA1;DCT;NF1
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.529839302300166,-0.8264618631615064,0.6935483870967742,1.0,1.0,2/6,25.36%,CACTIN;CARD8
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.4589315109711445,-0.8262742653355682,0.7407407407407407,1.0,1.0,2/10,27.40%,GRN;SCARF1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.32841944037122067,-0.8259319756257896,0.7741935483870968,1.0,1.0,23/86,18.15%,AIM2;GMFG;ARHGAP9;CYTIP;ZBTB32;IL7;ALOX5;BLK;TBC1D10C;TAGAP;PTPRC;LY86;PARVG;TMC8;IKZF1;WAS;CLCA3P;HVCN1;TRAF3IP3;CD37;CD27;CD86;TMEM156
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.4708167363847757,0.8258615931246205,0.6410256410256411,0.9719247966114904,1.0,3/7,32.11%,MECP2;DNMT3A;CTCF
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.3907674755188958,0.8257381274406506,0.6551724137931034,0.9717920514693444,1.0,5/25,9.53%,SCRIB;NLGN1;MAGI2;ITGA4;FLNA
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.27439118789097866,0.8256714679760557,0.88,0.971511676489061,1.0,24/152,13.28%,KCNK6;SLC5A8;SLC3A2;KCNB2;SLC5A12;CNGA3;SLC8A1;TRPM2;SLC38A5;SLC8A3;RHCG;KCNJ3;KCNJ6;SGK1;SLC6A17;KCNH4;GRIN1;ABCC8;SCN7A;SLC25A29;SLC9B2;SLC7A8;ANO10;SLC7A6
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.2999210331259788,0.825014605840184,0.8333333333333334,0.9724683144056306,1.0,30/109,19.72%,KCNK6;KCNB2;KCNH8;KCNC2;HCN1;PKD2;KCNH7;KCNJ3;KCNJ6;KCNK2;TMEM175;KCND2;KCNH4;ABCC8;HCN3;KCNH5;KCNQ5;KCNK12;KCNJ10;KCNK10;KCND3;KCNG1;NALCN;SLC9C2;KCNJ8;KCNC3;SLC24A2;SLC1A3;SLC9A9;KCNAB3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.4216399414267433,-0.8248620197445992,0.639344262295082,1.0,1.0,7/25,13.49%,ENO4;HK2;ALDOB;ENO2;PKLR;PGAM1;GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.3209143858266522,0.8248325967962594,0.7714285714285715,0.9724154715273705,1.0,17/65,16.37%,ANGPT1;PTPRO;CDH13;SEMA5A;SIPA1;SERPINE1;DSCAM;ACER2;JAG1;PLXNB1;NOTCH1;EPHB2;NEXMIF;CORO2B;PDE3B;FZD7;PLXNA4
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.5231068340189375,0.8248053502430986,0.7777777777777778,0.9720552545621006,1.0,2/5,17.68%,BMP4;FADD
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.30182121989770866,0.8247373740402251,0.84,0.9717998026423864,1.0,20/139,14.18%,LGR5;RSPO3;BAMBI;FGF10;PSME4;PSMA1;SEMA5A;ZEB2;WNT3A;RSPO2;KANK1;GPC5;WNK2;JUP;SMARCA4;MACF1;WLS;PPM1A;RNF146;NFKB1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.289198022491577,0.8246099347245491,0.9545454545454546,0.9716797087714808,1.0,35/154,14.22%,IRGM;RORA;IRS1;BRINP3;URI1;PID1;HTRA2;CD14;CX3CR1;MGARP;RORB;SERPINE1;WNT3A;NCOA3;HMGB1;EPHA3;NRIP1;MAPK8;LPL;ADCY2;ZNF703;TICAM2;PDE4B;ABL2;ADNP2;TESC;BRINP1;TNIP3;RET;ADAM15;ADCY3;TICAM1;LBP;NFKB1;NR3C1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.44193497629775363,-0.8245195454035144,0.6271186440677966,1.0,1.0,1/12,1.85%,PKP2
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.28844268975894255,0.8244461302142791,0.8571428571428571,0.9715781329195315,1.0,16/151,8.88%,FANK1;DAPK2;HIP1;BCL6;SIRT1;PERP;FLT3;TP53AIP1;DCPS;ANP32A;PPP1R13B;ANP32B;ABL1;ACER2;SGK1;LGALS1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.47328301841665144,-0.8244186095891577,0.7413793103448276,1.0,1.0,1/8,9.85%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4856332171051269,0.8243652039565893,0.71875,0.9713231722986719,1.0,2/9,8.80%,DRD3;DRD4
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.46114602107889735,0.8240172468899776,0.7073170731707317,0.9711880140131927,1.0,6/11,18.89%,TRIM71;NOTCH4;TNRC6C;TNRC6A;AGO3;AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.46114602107889735,0.8240172468899776,0.7073170731707317,0.9711880140131927,1.0,6/11,18.89%,TRIM71;NOTCH4;TNRC6C;TNRC6A;AGO3;AGO2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4496501658710592,-0.8239879543441253,0.7384615384615385,1.0,1.0,5/16,19.91%,ATP6AP1;ATP1A4;ATP4A;LACC1;ATP1A1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.34721680546450284,0.8238483709699318,0.6829268292682927,0.9711664998814918,1.0,5/19,19.69%,SFXN2;SLC7A8;SLC6A20;SLC1A3;SLC16A2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.43732583115262413,0.8238181045656366,0.7,0.9708569437083123,1.0,5/11,26.67%,NAGK;UAP1;GNPNAT1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.43594844493840657,0.8237536570845176,0.696969696969697,0.9706456556398282,1.0,4/11,12.46%,GAS2L3;FLNA;EPS8;GAS2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3203229275506935,0.8237141161288501,0.6944444444444444,0.9703610451335303,1.0,9/50,8.31%,HSPB1;CX3CR1;FZD5;IFI16;PYHIN1;RIPK2;TMEM106A;NLRP2B;LPL
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.43218282997202273,-0.8236489623763866,0.6721311475409836,1.0,1.0,6/16,29.91%,NLRP12;NLRC3;SYT11;GHRL;CD200R1;PTPN6
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.37245781357683233,0.8236461151712102,0.7333333333333333,0.9701807273073925,1.0,7/23,21.71%,RHEBL1;MLST8;CCDC88A;SMG1;EIF4EBP1;SYAP1;LARP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.3719934128314668,0.8234594574133203,0.7045454545454546,0.9701229367113077,1.0,8/35,19.74%,NOX4;LRP8;CASS4;SRCIN1;ERBB3;GRM5;NCK2;PTK6
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.4043583704486807,-0.823396058978128,0.7166666666666667,1.0,1.0,1/23,0.90%,WNT5A
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.39508621569186,0.8233920878193487,0.6923076923076923,0.9699061535086497,1.0,5/15,14.44%,SARM1;DHFR;MORN4;MTR;NREP
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.4401035083224639,-0.8232493797314282,0.7285714285714285,1.0,1.0,2/14,12.89%,TGFB1;CLCF1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.41818234880122496,0.823113831085411,0.7428571428571429,0.9700992086260507,1.0,2/16,5.28%,CLC;FZD5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.3927162356622197,-0.8230871921423271,0.7833333333333333,1.0,1.0,1/31,0.70%,POLQ
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.3491111295059639,0.8230368002408915,0.7777777777777778,0.9698275969787967,1.0,5/54,9.88%,TRIM67;DZIP1L;STX6;MAPK8;CEP290
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.42014037871881926,0.82301665660844,0.7380952380952381,0.9694828833348553,1.0,5/15,15.45%,PROX1;PKD2;TRIM71;ALDH1A2;ARL13B
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.3837253368259401,0.8229924144404117,0.7209302325581395,0.9691506551576721,1.0,8/17,32.02%,EMP2;ATM;SMG6;LDB2;HMBOX1;SLAMF8;FEM1A;SPTSSB
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.34073725363363416,-0.8228734457649111,0.7419354838709677,1.0,1.0,11/67,16.35%,ITGB2;DAB2;HCK;TEC;ITGB6;CEACAM1;ITGBL1;ITGA2B;TXK;ISG15;FN1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.3736968996155777,-0.82231901371114,0.7014925373134329,1.0,1.0,3/35,5.27%,DUOX1;AHR;STAT1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.46849970443410355,0.8222445809381,0.6764705882352942,0.9703143721569691,1.0,2/6,16.61%,ABCA1;F2R
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.44831432718629316,-0.8222356621984599,0.7101449275362319,1.0,1.0,4/16,16.15%,SLC5A2;SLC5A1;SLC9A2;SLC9C1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.37077843120052967,-0.8217472011489809,0.7272727272727273,1.0,1.0,5/40,8.94%,TBX1;SOX10;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.5453676271749278,-0.8216198076011971,0.7142857142857143,1.0,1.0,1/5,3.14%,GAD1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.3439236601441208,-0.8216183806655563,0.7966101694915254,1.0,1.0,10/75,11.72%,SIRPG;DAB2;TULP1;SFTPD;ANXA1;CYBA;DOCK2;SLC11A1;SCIN;GPC3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.3755744571197802,-0.8211347471359601,0.6896551724137931,1.0,1.0,1/24,0.90%,WNT5A
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.48317172743425496,0.8207724637917775,0.6136363636363636,0.9726549450007332,1.0,2/5,30.88%,FTO;ALKBH3
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.5373559477814825,-0.8207334995799894,0.75,1.0,1.0,1/5,10.52%,PDHX
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.482281435275707,-0.8207114600659157,0.7457627118644068,1.0,1.0,2/8,10.63%,TBX1;LRP2
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.41479708586070485,0.8206007748376087,0.7,0.9725841644191479,1.0,3/15,14.18%,TMEM106A;MAPK8;NFKB1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.3132539109356892,0.8205048189640654,0.8809523809523809,0.9723792912000294,1.0,12/63,11.52%,PLEKHG2;BIN1;KANK4;SLIT2;FER;COTL1;LATS1;KANK1;CRACD;TENM1;HCLS1;EVL
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.389736315285504,-0.8204349462555692,0.6923076923076923,1.0,1.0,2/29,10.02%,PLPP6;ACAA2
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.4978216419717217,0.820421891451209,0.6666666666666666,0.9721319119573449,1.0,1/5,28.63%,NAA16
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.4229416390656243,-0.8198750549337062,0.71875,1.0,1.0,1/17,3.38%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.42543160039995537,-0.8198707197086152,0.7222222222222222,1.0,1.0,4/26,7.01%,HLA-DRB1;SFTPD;VSIG4;PDCD1LG2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.37720810503292973,-0.8198562203778462,0.7352941176470589,1.0,1.0,5/52,7.38%,ELOVL2;B3GNT5;DEGS2;PRKD3;CERS3
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.38009202949873866,0.8198290392440982,0.6842105263157895,0.9728656776441406,1.0,6/21,16.74%,TSKU;TENM3;EFEMP1;CEP290;NF1;SKI
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.4177966959213546,0.8197652095806209,0.7272727272727273,0.9726487540550838,1.0,7/18,30.01%,TRIM71;TARBP2;AGO3;AGO2;ZC3H7B;DROSHA;PRKRA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.52605179810173,-0.8197536862623179,0.75,1.0,1.0,1/6,5.53%,BLK
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.29763017316812956,0.8195205121590997,0.896551724137931,0.9727424929467795,1.0,22/147,10.76%,FIBIN;MXRA5;MRGPRF;NOX4;LAMA4;ACTG2;TPM2;ANGPT1;CLEC14A;EDNRA;ITGA8;COL12A1;MMP2;WWP2;PAMR1;PLSCR4;FHL2;AKT2;PDGFD;COL16A1;CCDC80;MSRB3
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.39072025271183514,0.8193512626176995,0.717948717948718,0.972315335162167,1.0,3/22,4.94%,GCK;ENO3;PFKP
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.39072025271183514,0.8193512626176995,0.717948717948718,0.972315335162167,1.0,3/22,4.94%,GCK;ENO3;PFKP
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.3670480874604738,0.8192384634121134,0.6857142857142857,0.9721840997288264,1.0,3/23,7.28%,NAALADL1;TRHDE;CHAC1
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.27134936462332554,0.8189801250031646,1.0,0.9723204236358851,1.0,38/171,19.27%,SLC10A3;PC;SLC30A10;PIGQ;SLC25A37;HTRA2;BSG;SNCA;TENT5C;KDM7A;EPOR;CCND3;BCAM;DCUN1D1;EPB41;SLC7A11;TRAK2;ADIPOR1;OSBP2;MARCHF8;MARK3;XPO7;MXI1;NR3C1;CA2;GMPS;CDR2;PGLS;MFHAS1;GYPA;DCAF10;ACKR1;FOXJ2;ANK1;KAT2B;BNIP3L;LPIN2;ADD1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.3269331053972558,0.8189652889942595,0.7692307692307693,0.9719887748196727,1.0,13/57,15.20%,IGLL3P;CD38;HTRA2;IL16;ATXN8OS;MAST1;AMPD1;MAN1A1;ENPP1;PPIB;ZNF165;CD40;GNG7
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.37656790126596656,-0.8186569148234033,0.7681159420289855,1.0,1.0,6/30,18.80%,PWP2;TSR2;RPS16;RPS8;RPS21;RPS14
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.42589304472781775,-0.8185154126748336,0.7142857142857143,1.0,1.0,3/16,19.16%,STAT1;NLRC3;DDX3X
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.333854893861106,-0.8185087115301117,0.8055555555555556,1.0,1.0,7/95,7.34%,AQP3;WNT5A;CASQ2;SCN5A;SYT10;TRPV6;SYT2
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.4673152856093511,0.8184997152339809,0.7021276595744681,0.9725137921910559,1.0,2/10,7.83%,SIRT1;ABI3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.3097883572197702,0.818473864179926,0.7419354838709677,0.9721641127100757,1.0,20/98,17.39%,IRGM;CDH5;APOE;NRG1;RALB;OPRD1;ABCA1;LATS1;FARP2;PIH1D1;PREB;IAPP;GNL3L;SEPTIN8;SPIDR;HSF1;IMPACT;ATF7IP;FAF1;ICE1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.46831829597657093,0.8183545382703385,0.627906976744186,0.9720149854796262,1.0,3/8,23.14%,SNAPC3;ICE1;ICE2
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.5497830251736492,0.8182799708355777,0.7,0.971805307782068,1.0,1/5,16.22%,PNPT1
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.4549351962516116,-0.8181618223336679,0.6833333333333333,1.0,1.0,2/12,9.50%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3164888383225155,0.8180975696446274,0.7878787878787878,0.9717292089123754,1.0,7/76,6.46%,MT1G;SLC30A10;MT4;ACO1;SLC39A8;HJV;FLVCR1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.3498925714111448,0.8180373993201415,0.8125,0.9715016204585721,1.0,6/31,7.98%,ANGPT1;ARRB2;MAGI2;WNT3A;GREM1;ANKRD13D
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.2903333707905807,0.8179528868534847,0.9,0.9712923883141004,1.0,22/90,21.96%,EIF2S3B;PRR16;SAMD4A;ERBB2;JMJD4;PCIF1;USP16;EIF3E;NIBAN1;BCL3;PIWIL2;EIF5AL1;YTHDF1;FXR2;KHDRBS1;AGO2;ZCCHC4;LIN28A;EIF4A3;LARP4B;LARP1;UPF3A
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.2904564327271795,0.817619514686528,0.896551724137931,0.9717011569773067,1.0,40/149,20.57%,DAPK2;KIT;GRK5;FGFR1;MAPKAPK2;FLT3;ERBB2;VRK2;FER;ABL1;EIF2AK3;MYO3A;TNIK;MAP3K10;ERN1;MAP3K9;WNK2;MAP3K21;MAP3K13;MARK3;PIM2;MELK;FGFR3;INSR;SLK;ATM;SMG1;EEF2K;TYRO3;WNK3;EPHA8;NTRK2;EPHB4;MUSK;PTK6;MARK2;SIK2;PAK2;CLK2;ATR
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.48700845305270346,-0.8173766051223536,0.7241379310344828,1.0,1.0,1/6,9.55%,CARTPT
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.3005318207240121,-0.8173561616043297,0.9166666666666666,1.0,1.0,8/169,8.15%,CD44;SNN;TRIP10;IRF1;GPR183;CCND1;SOD2;DRAM1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.37798663999557347,-0.8172497735640974,0.7571428571428571,1.0,1.0,4/26,7.38%,WNT5A;FLG;ANXA1;CERS3
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.26031129942483366,0.8171839365657074,1.0,0.972273088565156,1.0,69/317,20.57%,FOXO1;RFWD3;BCL2A1;MAPKAPK2;BCL2;BCL6;TOP2A;SIRT1;HTRA2;PSME4;ERCC8;RNF168;SIRT7;ZBTB40;PML;CRY1;ZBTB4;SMARCAL1;ZBTB1;SLFN11;BOD1L1;PLK3;ABL1;FANCL;ACER2;RBBP6;TIMELESS;UBE2E2;MYC;ZDHHC16;TANK;USP16;UBE2A;SMC5;SUSD6;KMT5C;BAZ1B;PAXX;SHPRH;SPIDR;KMT5B;HERC2;ATM;RAD52;BCL3;MGMT;RAD50;MAPK12;FBH1;MACROD2;RAD9A;NIPBL;BID;H2AX;BRAT1;MUS81;GADD45A;RAD17;SAMHD1;MEN1;MAP2K6;TP53;RAD51B;FBXO31;SMC6;PHF1;ERCC3;SPRTN;ATR
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.40093719428837593,-0.8169988863975917,0.7213114754098361,1.0,1.0,1/17,1.13%,AHR
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.46716137985641865,-0.8169838638138602,0.6964285714285714,1.0,1.0,2/9,14.40%,CLU;MYRF
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.34556736304481017,-0.8168459516190162,0.8095238095238095,1.0,1.0,9/56,12.38%,AMACR;LIPI;ACMSD;ACSM6;ALOX5;ACOX2;LIPH;ACSM3;HSD3B7
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.325484038466019,-0.8165781230237182,0.7916666666666666,1.0,1.0,11/94,11.55%,WNT5A;TGFB1;IFNK;P2RY12;SCIMP;CYBA;NLRP12;LY86;TLR2;SH2D1B;PLG
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.4473575050078802,-0.8165459928491817,0.7704918032786885,1.0,1.0,2/11,14.85%,FHOD1;LCP1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.35356088129096874,0.8164829705359833,0.7948717948717948,0.9732803554635047,1.0,6/32,8.96%,APOE;HRH3;SNCA;DRD3;DRD4;GRM7
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.35382985004987366,0.8164408556990732,0.7954545454545454,0.9729921045466922,1.0,4/24,8.37%,URI1;PPP1R35;BOD1L1;STYXL1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.387843228000427,0.8164001309828965,0.6363636363636364,0.972722221439164,1.0,11/29,25.26%,APOE;SIRT1;PPARG;NR1H3;ABCA7;SHH;SREBF2;YJEFN3;RXRA;ABCA2;ABCA8
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.4167234382525163,0.8162546968795187,0.7619047619047619,0.9725674118598827,1.0,6/15,17.35%,TGFBR1;LRP6;OSBPL7;MLC1;SMAD2;GPLD1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.388509358444338,0.8158174711669995,0.8125,0.9731197649518005,1.0,1/17,5.26%,GDAP1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.46428690353304375,-0.8157474172372152,0.746031746031746,1.0,1.0,1/15,2.60%,TERF2IP
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.37480764029501745,-0.8156650517977959,0.765625,1.0,1.0,7/36,9.32%,SIRPG;CYTIP;TBC1D10C;TAGAP;PTPRC;CD5;KLRB1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.292260330130169,0.815540407075102,0.8529411764705882,0.9733394474721099,1.0,16/75,12.52%,SCUBE1;SCRIB;PROX1;AKR1C1;PPARG;RHCG;BDH2;LATS1;ZNF703;AKT2;JAG1;PIH1D1;ASCL1;CPT1A;HDAC1;BMP4
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.4924278489712112,0.8151980102837153,0.7428571428571429,0.9735831128277282,1.0,4/6,25.01%,PEX13;EFHC1;HTR6;FGF13
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.32377251121314377,0.815090034553529,0.8,0.9734040651546777,1.0,5/50,6.83%,MGARP;GDAP1;IMMP2L;TIMM29;IMMP1L
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4398716767873015,0.8147670045911507,0.717391304347826,0.9736776847052355,1.0,2/10,6.35%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.40153088867261566,-0.8147605571908214,0.7384615384615385,1.0,1.0,3/24,7.34%,FGF20;SYT10;SYT2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.4924478617448047,-0.8146731618302046,0.7321428571428571,1.0,1.0,2/7,12.50%,SOD2;IL12A
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.29314354282888155,0.8145973772886351,0.8461538461538461,0.9736133352949367,1.0,25/142,14.73%,ACADS;ALDH1A1;TDO2;CEL;ENO3;REEP6;BPHL;HPGD;LGALS1;ECHS1;UGDH;AADAT;SLC22A5;GPD1;ACSL1;CPT1A;ACADM;GSTZ1;GPD2;RAP1GDS1;LTC4S;ADIPOR2;CA2;TP53INP2;ODC1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.5181295276044543,-0.8144869635905955,0.7796610169491526,1.0,1.0,1/6,5.27%,STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.5181295276044543,-0.8144869635905955,0.7796610169491526,1.0,1.0,1/6,5.27%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.3679508904400607,0.8137757997690834,0.71875,0.974797044213644,1.0,6/24,11.19%,NGF;PPARG;PYHIN1;HMGB1;TWIST1;HES1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.3772052015634635,-0.8137606146457425,0.7619047619047619,1.0,1.0,9/29,29.91%,ARG2;CACTIN;NLRC3;VSIR;SYT11;GHRL;NR1H4;RARA;PTPN6
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.2965832368651647,0.8137277590637005,0.8695652173913043,0.9745093230952869,1.0,21/100,15.58%,IRGM;MAPKAPK2;CD14;CX3CR1;SNCA;SERPINE1;HMGB1;FER;SRR;MAPK8;TICAM2;PDE4B;RPS6KA3;TNIP3;LGALS9;TICAM1;LBP;NFKB1;PELI1;GCH1;NR1H3
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.43807015727697707,-0.8134364665592944,0.7538461538461538,1.0,1.0,5/14,24.64%,KCNS2;KCNE3;KCNE2;KCNS1;KCNAB1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.32424392923240636,0.8133373906263239,0.7428571428571429,0.9748182358076488,1.0,5/40,7.69%,RAB31;ARRB2;SNCA;SAG;DRD3
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.4654668104613561,0.8132850893896768,0.7551020408163265,0.9746029937015065,1.0,2/9,3.38%,PC;APOE
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.2858284896074295,0.8130403217569568,0.8461538461538461,0.9746889025011534,1.0,32/215,11.49%,TSKU;BCL2;IRS1;TULP3;KCTD21;KLK14;NKD1;NKD2;ADAMTS12;PID1;FSTL3;CX3CR1;CXXC4;ERBB2;SNCA;NR4A2;CRY1;DCC;CHAC1;WWP2;SPRY4;WWOX;NLRP2B;DACT3;PLIN5;KANK1;BEND6;PHACTR4;NLGN4X;DLK2;RGS14;RPGRIP1L
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.3283378876939528,-0.8128699653742797,0.8382352941176471,1.0,1.0,14/64,19.58%,H1-3;H1-0;NAP1L2;GRWD1;CHAF1A;TNP1;SET;ANP32E;SMARCE1;SMARCA5;DAXX;HMGA1;POLE3;RNF8
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.4394592919137994,0.8126914318688551,0.6666666666666666,0.9749011091257134,1.0,2/12,7.11%,PTGS1;PTGIS
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.320250026627723,0.8126310694447838,0.75,0.9745958596064511,1.0,12/72,10.80%,PCDH15;LHFPL3;USH2A;LHFPL4;SPTBN4;ALDH7A1;PAX3;WHRN;GRM7;MYO3A;ADGRV1;CCDC50
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),0.5122724257981736,0.8124560210968567,0.7959183673469388,0.9745012906218559,1.0,1/5,9.88%,CEP290
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.31943953700033223,0.8123781379612913,0.7931034482758621,0.9742565356164303,1.0,13/65,14.18%,IRGM;CD14;CX3CR1;FZD5;SERPINE1;HMGB1;MAPK8;TICAM2;PDE4B;TNIP3;TICAM1;LBP;NFKB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.4860998580705671,-0.8122344978163103,0.7096774193548387,1.0,1.0,5/9,23.30%,CEACAM1;APOLD1;TMEM100;ATOH8;BTG1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.35449505106401513,0.8122106285938527,0.7419354838709677,0.9741922112034987,1.0,5/33,10.66%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.29368386530722945,0.8122073608031355,0.8928571428571429,0.9738216447515735,1.0,29/112,22.23%,PERP;TMEM117;DSP;SDC4;ERBB2;BCAM;PARM1;PTGFRN;PLXNB1;JUP;COBL;OGDH;HID1;UNC13B;RNF128;PTPRF;TMEM63B;DOCK1;HDAC11;EPB41L4B;CAMSAP3;ARHGEF10L;ST14;ADCY6;GNA11;SYT7;CDS1;PTPN21;PCDH1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.43569207917043784,-0.8121431975148444,0.7121212121212122,1.0,1.0,1/12,0.79%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.31195221368556214,0.8120494835312797,0.9142857142857143,0.97373952788867,1.0,7/74,8.02%,FOXO1;APOE;NKD1;STX5;RAB7A;WWP2;PLK3
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.36479585384648266,-0.8118680959811335,0.7457627118644068,1.0,1.0,5/30,12.29%,TGFB1;TNFRSF1B;SMAD6;GATA4;HEY2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.36058122321261943,0.8117729243286909,0.8611111111111112,0.9738975177220315,1.0,3/29,6.35%,DERL3;DPM3;UBE2J1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.40102854841722035,-0.8115973826872317,0.7313432835820896,1.0,1.0,5/24,16.55%,ACTG1;FHOD1;WAS;RAC1;VIL1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.47534258371646165,0.8115544434044785,0.7368421052631579,0.9739354102653858,1.0,2/7,17.78%,PLA2G15;MOGAT2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3557077006132798,0.8115489173751538,0.7777777777777778,0.9735595185593783,1.0,5/25,18.64%,CFLAR;SERPINE1;FADD;GPX1;FAIM
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.3526219512835015,0.8110754961662663,0.7647058823529411,0.9741789434411269,1.0,3/33,3.43%,SLC30A10;TRPC3;SLC39A8
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4041907918124357,0.8110043515210799,0.717948717948718,0.973947051523773,1.0,4/12,27.74%,ABCA7;ADAM10;DYRK1A;ABCG1
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.5380936208282288,-0.810894452437302,0.7017543859649122,1.0,1.0,2/5,17.71%,KCNQ1;KCNE2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.49045801166302166,0.8108934963908483,0.7567567567567568,0.9737632545117452,1.0,2/6,15.98%,RNF168;LIG4
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.32137131581814615,0.8108259187918124,0.8095238095238095,0.9734778166491543,1.0,27/92,26.48%,SNRPN;NOVA1;U2AF1;TXNL4A;KHSRP;SF3B1;SRRM1;SNRPB;ZMAT5;SRSF4;PTBP1;SYNCRIP;FUS;PPP1R9B;SF3B4;YJU2;SNRPF;SNRNP48;LSM6;SRPK2;RNF113A;NRDE2;TCERG1;PDCD7;SCAF11;MAGOHB;SNRPG
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.3389761376891669,-0.810650412136023,0.7619047619047619,1.0,1.0,8/76,9.85%,TRIL;SFTPA1;ITGB2;SCIMP;SFTPD;MAPKAPK3;OAS1;TLR2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.46394936739314896,-0.8105370547184718,0.7192982456140351,1.0,1.0,3/7,25.64%,ATG14;CALM1;ATP2A2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.3621316575996215,-0.8103489769727361,0.7049180327868853,1.0,1.0,5/46,9.60%,H1-3;H1-0;NAP1L2;GRWD1;CHAF1A
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.3837661374843531,0.8103191920878269,0.6666666666666666,0.9742519259701444,1.0,7/15,16.61%,F2;WNT4;BMP4;RUNX1;SUCO;CREB3L1;F2R
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.4007309140135026,0.8096438538615641,0.75,0.9750015087532324,1.0,2/27,5.36%,SMYD5;DNMT1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.4742379306940563,0.8095442041662505,0.7,0.9748295494359557,1.0,3/8,17.27%,SLC27A2;ACSL1;SLC27A4
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.4208885062402803,0.8093566156939821,0.6923076923076923,0.9748370621928663,1.0,5/12,26.67%,NAGK;UAP1;GNPNAT1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.38975481581126203,0.8093491408890455,0.71875,0.9744681005535892,1.0,3/15,8.31%,PNPLA3;LIPC;LPL
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3748032810982132,-0.8092442391173814,0.6785714285714286,1.0,1.0,6/30,15.30%,ALOX5;PLD4;APOD;ADCY7;NOS2;NLRC3
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.46335663863971255,-0.8090958571776914,0.7457627118644068,1.0,1.0,2/8,12.56%,STOML2;GLRX
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.4932172608178005,0.8088968500060125,0.7380952380952381,0.9750611391968833,1.0,2/5,10.90%,SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.43825640345868755,0.8087981099727591,0.7142857142857143,0.9749073346094465,1.0,3/9,20.48%,AKR1C3;ADCY6;PTGFR
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.38288491190916296,-0.8087957883168436,0.7333333333333333,1.0,1.0,10/28,21.55%,TGFB1;SOX30;UBE3A;THBS1;TFPI;TGFB3;WBP2;ATP1A1;CAV1;AR
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.48044106707380974,-0.8086116468655525,0.7321428571428571,1.0,1.0,1/8,5.75%,AGBL5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.5009626276836601,-0.8084384664474222,0.7377049180327869,1.0,1.0,2/5,27.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.5009626276836601,-0.8084384664474222,0.7377049180327869,1.0,1.0,2/5,27.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.5009626276836601,-0.8084384664474222,0.7377049180327869,1.0,1.0,2/5,27.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.32786795931714907,-0.8083617976682762,0.8026315789473685,1.0,1.0,16/96,18.98%,WNT5A;KIF14;PINK1;CARD14;SLC11A1;STRADB;ADCY7;TOM1L1;PRRC1;TXN;BORA;ECT2;STRADA;CD86;NTRK3;IL18
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.34843392133989487,0.8083090551470646,0.7073170731707317,0.9754818424376964,1.0,11/27,25.67%,TET2;DPY30;SETMAR;DYDC1;CXXC1;MEN1;KMT2C;WDR5B;TET3;KMT2B;KMT2A
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.32992741905865475,0.8081954657203372,0.75,0.9753279944193587,1.0,6/32,12.59%,SEMA6C;SEMA5A;FARP2;FLNA;PLXNB1;SEMA4A
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.5023143247430129,-0.8081175144304006,0.7758620689655172,1.0,1.0,4/7,30.71%,KCNE3;KCNE2;KCNAB1;KCNE4
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.4539140493837637,0.8079193746831304,0.6851851851851852,0.9755022967657156,1.0,3/7,19.08%,ATOH7;ERBB3;CHD7
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.32496373680427404,0.8077872285129389,0.7307692307692307,0.97540817831086,1.0,10/78,12.38%,PARD3;ZDHHC11B;ZDHHC12;GDAP1;PEX13;ABCD3;ABCD2;MYO1C;GOLGA7B;ZDHHC18
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.38898911975797473,0.80743496653799,0.6842105263157895,0.9756180740641414,1.0,7/24,16.82%,PROX1;WNT4;PRKCSH;PKD2;COBL;NF1;ARID5B
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.3498667626101609,0.8066845541868068,0.7692307692307693,0.9767571573250219,1.0,2/24,9.84%,ABCD3;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3470819787459467,0.8066764924283646,0.8214285714285714,0.9764006426615083,1.0,16/55,20.06%,FGF10;LSM10;ADAMTS1;ESPL1;CDK4;PLCB1;CCND3;KLHL18;UBE2E2;MECP2;BRD4;ANAPC7;NSMCE2;DLGAP5;TFDP1;RAD51B
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3165329400327654,-0.8064245339669253,0.7878787878787878,1.0,1.0,7/89,5.92%,TBX1;TGFB1;UPK1A;SOX10;PPP2R3A;STAT1;UPK1B
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.3913508372160467,0.8064067864740186,0.6857142857142857,0.9764908609615088,1.0,11/21,27.90%,EPHA3;EFNA5;MACF1;SLK;CAMSAP3;VCL;PTPRA;PEAK1;GPM6B;SLC9A1;ROCK1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.33886009121475275,0.8062780094130759,0.6666666666666666,0.9763072863699201,1.0,5/37,9.30%,TRPM2;DHFR;DRD3;DRD4;RHBDD1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.29501619815381747,-0.8061825137317904,0.9014084507042254,1.0,1.0,13/141,9.88%,WNT5A;PTGES;HCK;MMP9;ALOX5;GPER1;LRRC19;ANXA1;TNFRSF1B;NLRP12;ALOX15;TLR2;NLRP3
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.48234498802756,-0.8061347262554656,0.7288135593220338,1.0,1.0,1/8,6.71%,WFS1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.4697000804122456,0.8060808710474576,0.7368421052631579,0.9762844547917859,1.0,2/8,9.90%,GREM1;PLXNB1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.43436678542289303,-0.8059599693663684,0.7708333333333334,1.0,1.0,2/13,11.09%,SLC5A1;KCNQ1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.425434137440437,-0.80579277126973,0.7076923076923077,1.0,1.0,1/21,2.60%,TERF2IP
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.4433490495952108,0.8053579746828247,0.75,0.9772308325802765,1.0,2/9,14.12%,NRG1;MYOCD
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.3023343391403818,0.8053149931045976,0.8275862068965517,0.9769164244579146,1.0,21/114,16.96%,ELOVL6;HDAC3;APOE;SMARCD3;PSME4;PSMA1;PPARG;ACACB;NCOA2;LDLR;SP1;IRS2;ADIPOR1;CARM1;CHD9;SC5D;NFYC;ODC1;TM7SF2;OPA3;ABCA7
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4689201093392046,-0.8052897832104804,0.7586206896551724,1.0,1.0,3/11,19.16%,USP50;NLRC3;DDX3X
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.34635937878454903,-0.805174568249299,0.8620689655172413,1.0,1.0,11/44,12.69%,PTGES;CYP1B1;ALOX12;ALOX5;PLA2G10;CYP2J2;ALOX15;ALOX12B;CYP2E1;ALOX15B;CYP2A6
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.4024666870427388,0.8051660397052672,0.6756756756756757,0.9768280305684411,1.0,2/14,7.28%,SERPINE1;CHAC1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.37114539155742154,-0.8050839715587373,0.734375,1.0,1.0,6/40,20.80%,NARS1;DARS2;YARS2;TARS3;WARS1;PPA1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.3690996917498605,0.8047359638228189,0.7777777777777778,0.9771257486027054,1.0,6/19,13.97%,GREM1;CHSY1;ECM1;BCOR;NOTCH1;ENPP1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.45155075596240396,0.804687533443308,0.6818181818181818,0.9768354885539524,1.0,3/8,21.97%,ZNF703;GPX1;DEAF1
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.5135706004574196,0.8043549355669333,0.7727272727272727,0.977103303267202,1.0,2/6,15.36%,DHFR;GCH1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4625652062885356,-0.8042895329229803,0.7538461538461538,1.0,1.0,2/10,7.39%,BLK;PTPRC
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.35635086583868403,0.8041553808008138,0.6944444444444444,0.9769971760048881,1.0,3/35,7.71%,NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.34491572552227956,0.8039065690666256,0.8484848484848485,0.9770927523521136,1.0,15/49,20.05%,MAPKAPK2;CD14;FZD5;SNCA;FER;SRR;RPS6KA3;LGALS9;LBP;PELI1;GCH1;F2R;OTUD5;TAB2;IL23R
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.5342722637854728,0.8039010739705728,0.7333333333333333,0.9767318141025114,1.0,1/5,12.13%,UNC13B
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.3523184616930032,0.8037726474937966,0.8461538461538461,0.9765311411002242,1.0,5/30,10.55%,CACNG4;CACNB4;ABL1;CACNG2;SCN7A
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.4752229207045323,-0.8037635197329748,0.7575757575757576,1.0,1.0,5/12,19.03%,ACTG1;FHOD1;WAS;RAC1;AKAP13
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.3656406828346402,0.8034936540671169,0.7575757575757576,0.976644555688426,1.0,8/31,15.12%,ARC;PKD2;STAC2;ATPSCKMT;GSTM2;ANK2;EPHB2;NLGN3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.5212040407642395,-0.8033626319097545,0.7868852459016393,1.0,1.0,2/5,41.62%,TMEM33;RAB3GAP2
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.372211425539515,-0.8032598086259565,0.828125,1.0,1.0,5/31,11.13%,C1QB;C3AR1;CLU;CPB2;C4BPA
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.5387691266288155,0.8030030288191524,0.7291666666666666,0.9768178566026647,1.0,1/5,3.43%,SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.5387691266288155,0.8030030288191524,0.7291666666666666,0.9768178566026647,1.0,1/5,3.43%,SLC39A8
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.48838196134202116,-0.8027509040282631,0.7884615384615384,1.0,1.0,1/9,0.90%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.27395421806428916,0.8025904942033372,1.0,0.9772268587934418,1.0,41/303,14.17%,ADRA1A;SMYD2;NOX4;NGF;PER2;KLF10;PROX1;FRK;ADAMTS1;CDH13;P3H2;P3H3;MAGI2;PPARG;MED25;CTBP2;PKD2;PML;GREM1;FKTN;CDK6;TENM1;WNK2;PLXNB1;TESC;ALDH1A2;HES1;BNIPL;PBRM1;MYC;HSPA1A;SMARCA2;BMP4;NOTCH1;DDAH1;PIM2;ARID2;MAGED1;NF1;MYOCD;DLG5
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.3765198434144526,0.8023572729877654,0.7435897435897436,0.9772984359333929,1.0,7/20,18.98%,CEL;AGXT2;CYP4F3;PLA2G15;ACOX1;NUDT19;LPIN2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.40346755068243034,-0.8023330353541244,0.7246376811594203,1.0,1.0,2/18,4.99%,DCN;PINK1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.31083081117832,0.8022342003752961,0.8333333333333334,0.9771039175035012,1.0,17/65,23.03%,SIRT1;MMP2;OPN5;ZBTB1;TIMP1;RHBDD1;MYC;N4BP1;IMPACT;NEDD4;OPN3;EP300;TP53;ATR;TMEM161A;NOC2L;MME
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.4951782267736551,-0.8022048308407208,0.7346938775510204,1.0,1.0,1/5,8.75%,POLR3H
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.4057259839614367,0.8020073911793179,0.7027027027027027,0.9773055020183505,1.0,4/15,12.62%,TDO2;KYAT1;AADAT;GSTZ1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.4881918444605553,0.8019794359800161,0.75,0.9769811631965112,1.0,3/5,33.12%,DOCK11;DLL1;DOCK10
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.27467998854989667,0.8019098431047209,0.9473684210526315,0.976757460740646,1.0,41/160,24.11%,F2;GOLT1A;SPTBN4;STX5;SEC24C;TGFA;GBF1;TRAPPC12;CNIH3;TRAPPC1;DYNC1I2;TICAM2;BET1;SPAST;TMED3;PREB;VTI1A;COG7;ANK2;SEC22B;PGAP1;COG4;GOLGB1;COG5;TMEM115;YIF1A;ANK1;CTSC;MIA3;TRIP11;COG2;CD55;TFG;COG3;ANK3;TRAPPC11;CAPZB;GAS6;SEC31A;SPTB;CAPZA1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.39900098805753775,-0.8015991490109029,0.75,1.0,1.0,6/23,21.09%,CAV3;CYP2J2;KCNQ1;KCNG2;PLN;AGT
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.3761617700547162,-0.8014180556601493,0.8166666666666667,1.0,1.0,4/28,3.72%,TGFB1;ANGPT2;SP100;DCN
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.410030166178748,-0.8013841470461306,0.8208955223880597,1.0,1.0,7/19,20.47%,UACA;NLRP12;NLRP3;SPI1;NLRC3;DDX3X;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.33302941795878194,-0.8011731422248467,0.8153846153846154,1.0,1.0,9/53,14.44%,WNT5A;CYBA;PTPRC;CLU;OAS1;TLR2;C1QTNF4;THBS1;OAS2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.32841637632055365,0.8011075455466555,0.7647058823529411,0.9778857243263984,1.0,15/43,21.03%,APOB;MAPKAPK2;CD14;HMGB1;RPS6KA3;TLR5;ALPK1;LBP;TAB3;TAB1;IRAK4;CNPY3;TAB2;PLCG2;TRAF6
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3219069889496416,-0.801100702012842,0.8285714285714286,1.0,1.0,6/96,7.43%,PSMB9;AIM2;STAT1;TXNDC17;TNFRSF1B;CARD14
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.3642160132544128,-0.8007999754828519,0.7454545454545455,1.0,1.0,15/41,23.29%,TIMP3;SERPIND1;TIMP4;SERPINB7;SERPINB5;SERPINE3;SERPINA10;SPOCK3;VTN;SERPINF1;SERPINB1;SPINK6;AGT;UBXN1;PARK7
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.46906723085152285,0.8007689813030311,0.7045454545454546,0.9781752176358572,1.0,1/8,1.66%,CBS
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.3280320048938744,0.7997733115404082,0.7272727272727273,0.9795970141447543,1.0,5/62,7.71%,NUP210;NUP42;PPARG;TRIM71;AAAS
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.48561436393801616,0.7997415664791084,0.7777777777777778,0.9792960063977816,1.0,1/5,1.25%,RAB27A
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3639149865903113,0.7996118533131643,0.7058823529411765,0.9792074139839299,1.0,5/22,14.42%,SLIT2;ABI3;KANK1;EVL;EVI5L
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.35064515333605994,0.7995004895876453,0.7777777777777778,0.9790128355190812,1.0,7/20,24.46%,SMARCB1;PIH1D1;RPS6KA4;ARRB1;FOXP3;NOS1;TADA2A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.35992403837059,-0.7993108046320135,0.8,1.0,1.0,5/38,8.69%,SIRPG;TGFB1;NODAL;ADA;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.334028700873496,0.7986391897613723,0.9333333333333333,0.9803614832771101,1.0,6/46,10.49%,TGFBR1;BCL2;PML;WWOX;STYXL1;LCK
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.38996916788297675,-0.7986170366033535,0.8133333333333334,1.0,1.0,3/32,7.34%,RAB34;S100A13;PIK3CG
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.33426183350876065,-0.7978980260033057,0.7288135593220338,1.0,1.0,12/63,22.75%,IHO1;RPA3;REXO4;DDX1;RBX1;RPS27A;ISG20;RNASE1;OGG1;RPA2;DDB1;PCNA
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.28517903585855536,0.7977101665968334,0.9411764705882353,0.9815030505887364,1.0,53/234,25.13%,CPSF1;SNRPN;NOVA1;PCF11;TRA2A;HNRNPF;RBM41;PRPF40B;PUF60;U2AF1;HNRNPH1;SPEN;HNRNPL;TXNL4A;SF3B1;SRRM1;SNRPB;ZMAT5;CWC27;LSM2;SRSF4;CPSF7;GEMIN5;LSM7;PTBP1;GTF2F2;PAPOLA;SYNCRIP;FUS;SF3B4;SYMPK;LSM8;POLR2F;RBM6;U2AF2;EIF4A3;RALY;SNRPF;CDC5L;SNRNP48;PPIH;LSM6;DDX46;CWF19L1;RNF113A;PSPC1;GPATCH1;WDR33;RBM10;DDX39A;PDCD7;HNRNPUL1;CCAR1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3674933742950893,-0.7975432834086911,0.7014925373134329,1.0,1.0,5/32,9.88%,WNT5A;AIM2;NLRP12;USP50;NLRP3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.35510291006268535,0.7975393405776322,0.7368421052631579,0.9814431821619406,1.0,3/22,4.88%,KIT;IRS1;FLT3
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.38731266493857924,-0.7971458433168362,0.78125,1.0,1.0,3/29,5.98%,MMP9;STAT1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.336485949062619,-0.7970159917965245,0.8142857142857143,1.0,1.0,15/52,25.00%,DCN;MMP9;PINK1;GPER1;CIDEB;MOAP1;BIK;FIS1;BBC3;PDCD5;AURKA;PARK7;ADCK1;BNIP3;CAMKK2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.34502674440601844,-0.796906578766758,0.8387096774193549,1.0,1.0,12/33,26.93%,SLC51A;SLCO2B1;CEACAM1;SLC16A8;SLCO1A2;STARD5;SLC27A5;SLC10A1;GHRL;NR1H4;ABCC11;SLC10A4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.4418861021953806,0.7968508690824296,0.7317073170731707,0.9823069780093789,1.0,3/8,13.31%,MICU1;MCU;RAP1GDS1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.3586759893850639,-0.7966911028743804,0.7666666666666667,1.0,1.0,4/29,16.65%,TCF7;TCF7L1;TERT;LEF1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.3389945357578059,0.796541075213227,0.7804878048780488,0.9824938398673985,1.0,7/25,19.45%,TRPC3;GRIN1;ANK2;F2R;WNK3;STIM2;CXCL12
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.3160406878598303,-0.796488195642734,0.8181818181818182,1.0,1.0,7/72,12.57%,STAC;TGFB1;DAB2;GPER1;MRAP;RHOQ;PRKCH
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.4995672323557171,-0.7963759229309713,0.7547169811320755,1.0,1.0,1/6,23.68%,CELSR1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.44597855018842364,-0.7962988626234254,0.7903225806451613,1.0,1.0,4/12,15.27%,TAF7;SPI1;BRCA1;SET
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.4087564104704626,0.7962436384902024,0.8,0.9826570464382421,1.0,4/13,22.39%,STING1;ATG2A;RETREG1;ATG2B
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.3338814293102691,0.7962309983094935,0.7741935483870968,0.9822971434706577,1.0,2/19,5.37%,GJB6;MAML1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.3821048989156329,0.7961609179746945,0.6875,0.9820256230388104,1.0,6/22,21.27%,DRD3;NLGN4X;ACHE;GRIK3;SLC24A2;PTEN
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.30175096098624976,-0.7960755829679289,0.8985507246376812,1.0,1.0,23/139,14.06%,AQP3;AMBP;AHR;SLC28A1;F7;ITIH2;HAMP;OIT3;ALDOB;NR1I3;SMLR1;SDC2;CPB2;C3P1;CYP2E1;GPC3;FOXA3;CP;FGL1;HPR;CYP2A6;PON3;NOS2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.304932759685883,0.7960627892246706,0.8787878787878788,0.9818776157749101,1.0,16/95,14.68%,RASSF2;HSPB1;SIRT1;CEP85;SNCA;DEPTOR;TRIB2;LRP6;CCN1;WWTR1;SPRED1;RAP1A;SNX9;UBASH3B;NF1;TAB1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.3184815969029952,0.7959927744241142,0.8285714285714286,0.9816710244588005,1.0,14/41,24.50%,HDAC3;ANP32B;FLNA;HCLS1;JUP;RAPGEF3;NEDD4;KHDRBS1;TP53;CPSF6;UBR5;TPR;GAS6;NRDE2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.3164969909797133,0.7958779184983121,0.75,0.9815819366110007,1.0,16/61,24.24%,ADAMTS12;CAPN2;RHBDD1;CTSV;RSPRY1;NGLY1;OTUD7B;CTSC;MALT1;HM13;FAP;OTUD7A;ZER1;FBXL17;BAG6;NR1D1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.3757044447272194,0.7958608800659607,0.8,0.9812583097570822,1.0,6/23,20.10%,SIRT1;PML;KAT6A;SMC5;NSMCE2;SMC6
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.358001072186382,-0.7957263702861654,0.8333333333333334,1.0,1.0,5/39,13.67%,ARIH2;TRIM5;TRAF3IP2;STUB1;TRIM56
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.49875394563511644,-0.7956846171975842,0.7258064516129032,1.0,1.0,3/6,33.68%,CAV1;FLOT1;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),-0.4342823192059861,-0.7956404911213986,0.8095238095238095,1.0,1.0,1/7,6.29%,PLA2G10
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.48035876126581756,0.7953280065833839,0.7567567567567568,0.9818788610410492,1.0,1/6,19.69%,USP15
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.4008177651892746,-0.795298542648697,0.7857142857142857,1.0,1.0,6/17,23.10%,SLC22A3;PDZK1;SLC22A4;SLC47A1;SLC25A19;SLC22A1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.3333444070557129,-0.7948347091317562,0.8169014084507042,1.0,1.0,2/77,0.90%,PSMB9;WNT5A
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.2898803468900502,-0.7945862377300525,0.9333333333333333,1.0,1.0,49/252,27.12%,MCM2;POLQ;TICRR;HMGB3;TERF2IP;SP100;MCM3;RPA3;UBE2U;ENDOG;BRCA1;REXO4;CDC6;RAD1;DNASE2;TERT;POLE2;SMUG1;RAD54L;NOP53;NUDT15;TOPBP1;RMI2;POLE3;RPS27A;XRCC1;NT5E;OGG1;RPA2;DDB1;ORC6;PCNA;FANCC;PARK7;MSH6;RECQL4;PARP4;RAN;XRCC6;POLD4;UPF1;SUPV3L1;BLM;CHEK1;RAD9B;NUDT1;CDC7;PARP2;ZRANB3
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.45363466370030114,0.7942552687362616,0.7380952380952381,0.9834132183260565,1.0,2/10,8.31%,HMGB1;LPL
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.5317602311011427,-0.7940442377068395,0.8113207547169812,1.0,1.0,1/5,8.10%,RFK
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.5317602311011427,-0.7940442377068395,0.8113207547169812,1.0,1.0,1/5,8.10%,RFK
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.40053363985592666,-0.793629936422914,0.7142857142857143,1.0,1.0,3/16,19.24%,CLU;CDKN2D;SFRP2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.29220297999525013,-0.7935920792453383,0.9014084507042254,1.0,1.0,14/182,9.29%,WNT5A;TRIM62;TERF2IP;TRIM5;LPAR1;S100A13;HLA-DRB1;ESR1;PINK1;STAT1;TRIM25;NLRP12;HTR2B;TRAF3IP2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.363460087510271,0.7933035110751767,0.8387096774193549,0.9847706628219433,1.0,4/19,14.51%,SLC8A3;MICU1;MCU;SLC8B1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.45753803776747726,-0.7931344693665723,0.7580645161290323,1.0,1.0,4/12,18.49%,SEMA3A;LAMC2;RAC1;NTN1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.3813898118517805,0.7929105477243248,0.7647058823529411,0.9851373669856545,1.0,4/20,19.25%,BICD1;PRRC2C;YTHDF1;LSM14A
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.4664374770287326,0.7928854296474298,0.7450980392156863,0.9848247183924896,1.0,4/6,26.36%,FSCN1;SPIRE2;ESPN;FMN2
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.47270922941993876,-0.792607046920955,0.7205882352941176,1.0,1.0,2/6,7.34%,GPR183;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.30666117996879827,-0.792271447751185,0.8153846153846154,1.0,1.0,14/79,16.90%,LMOD1;HCK;CAV3;C15ORF62;CLU;ALOX15;DCTN1;BAIAP2L1;ANKRD53;CDK5R1;RAC1;VASP;VIL1;PSRC1
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4336278050506668,-0.7921368888125954,0.8153846153846154,1.0,1.0,1/14,9.05%,CLU
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.382164690093442,-0.792055747262617,0.819672131147541,1.0,1.0,2/22,12.14%,ESR1;HNF1A
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.4428786990199414,0.7919511199424303,0.7446808510638298,0.9861625417080478,1.0,1/8,1.16%,MEGF10
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.45863224827910676,0.7918144867272312,0.6585365853658537,0.9860135341256121,1.0,3/6,21.18%,ABHD3;OXSM;ACOT7
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.39119722664758444,0.7913915808495602,0.7096774193548387,0.9862798110069777,1.0,7/18,30.09%,PKD2;SLC4A11;WNK3;STK39;SERPINB6;AQP1;TRPV4
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3894836764212818,0.7913692214528418,0.75,0.9859613578051892,1.0,3/13,20.69%,CHMP6;VTA1;SNF8
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.34892650934992814,-0.791352948593535,0.7936507936507936,1.0,1.0,4/71,6.74%,POLQ;MEIOB;RPA3;RAD51AP2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.4960327822994925,0.7913398230439085,0.6904761904761905,0.98563730103301,1.0,1/6,1.32%,KIT
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.5355331587886348,-0.7912461006958804,0.7547169811320755,1.0,1.0,1/5,5.07%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.28009556138558206,0.7904743937629032,0.9117647058823529,0.9869080542357799,1.0,21/100,16.68%,MT1G;BCL6;DCBLD2;SIRT1;SIPA1;PML;ST7L;SLIT2;DACT3;SMARCA4;CDA;ADAM15;HSPA1A;SMARCA2;NOTCH1;ENPP1;FGFR3;SERTAD2;CGRRF1;PNPT1;MINAR1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.3862376304509459,-0.790460894444114,0.7538461538461538,1.0,1.0,8/26,18.51%,TBX1;ATP6AP2;GATA4;HEY2;BHLHE41;WNT8A;HES7;HEY1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3496466202847273,-0.7900613514887938,0.7575757575757576,1.0,1.0,8/33,28.31%,RPA3;SMUG1;XRCC1;OGG1;RPA2;PCNA;POLD4;TDG
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.46767525539185867,0.7896491388161313,0.68,0.988142820100391,1.0,1/8,11.53%,AK9
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.3560219178749696,-0.7895912549640416,0.746031746031746,1.0,1.0,5/31,17.90%,MAB21L1;SALL2;ITGAM;HIPK1;FREM2
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.2644511232372972,0.7895771473343149,0.9666666666666667,0.9879408758411893,1.0,25/178,12.23%,TGFBR1;BCL2;BCL6;MFSD2A;DCBLD2;URI1;SIRT1;SIPA1;ERBB2;PAK5;SLC25A33;PML;ST7L;SLIT2;NRG3;DACT3;SGK1;RPS6KA3;ADNP2;SMARCA4;CHPT1;CDA;ADAM15;HSPA1A;SMARCA2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.4160618015099361,-0.7894533632619278,0.7777777777777778,1.0,1.0,2/13,7.41%,BOLL;DAZL
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.4311128270777729,-0.7892863681826477,0.7575757575757576,1.0,1.0,1/11,8.37%,BTBD18
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4070869451687414,-0.7892090527594184,0.7397260273972602,1.0,1.0,3/21,7.57%,C3AR1;LPAR1;LPAR6
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.31198793809472347,0.789203832192271,0.8857142857142857,0.9881999947041258,1.0,5/54,7.37%,FOXO1;NKD1;STX5;RAB7A;WWP2
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.43559908184257334,0.7889977655106374,0.725,0.9881498160289339,1.0,3/11,9.18%,RPP25;POP1;RPP25L
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.38134552059348154,0.7889832743374949,0.7777777777777778,0.9878023478804391,1.0,3/15,11.70%,PRPF39;DCPS;SFSWAP
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.47125997514262125,0.7888930450395629,0.7954545454545454,0.987612489836317,1.0,3/6,23.70%,SLC4A7;PDZD7;JAG2
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.4656596149699151,0.7887563832553778,0.5476190476190477,0.987099262783528,1.0,3/7,26.82%,AGO2;TNRC6B;STAT3
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.4656596149699151,0.7887563832553778,0.5476190476190477,0.987099262783528,1.0,3/7,26.82%,AGO2;TNRC6B;STAT3
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.3219002622374517,-0.7884202348381084,0.84375,1.0,1.0,15/50,21.97%,SLC51A;SLCO2A1;SLCO2B1;CEACAM1;SLC6A12;ABCG2;SLC16A8;SLCO1A2;SLC16A3;SLC16A4;SLC16A11;STARD5;SLC16A12;SLC27A5;SLC10A1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.4547803300341001,0.7882935838223899,0.6829268292682927,0.9874163265324166,1.0,2/8,2.86%,GRID2;NLGN1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.34485854046008263,0.7882856063136015,0.8055555555555556,0.987063964762261,1.0,7/34,12.24%,RAB27A;SYT17;SYT3;SYT1;RIMS2;SYT12;RIMS4
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.2896954484340799,0.7882541520127418,0.9142857142857143,0.9867525847682378,1.0,27/117,19.50%,PCDH17;UNC5D;DOC2B;PCLO;SERPINE1;KCNIP1;ERC2;ADGRA1;GUCY1A2;RAB3C;BRINP1;ELAVL4;RGS7BP;DST;RBFOX1;MAP6;SNAP91;ANK2;PTPRD;ASXL3;NRXN1;AKAP12;LSAMP;TMEM196;ADGRB3;CNTN1;ST8SIA3
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.4671755992857606,-0.7882416275450361,0.7288135593220338,1.0,1.0,2/8,19.17%,OLFM4;BST1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.41434100806307494,-0.7882345610103979,0.7241379310344828,1.0,1.0,4/13,28.63%,DDX20;SRSF10;CD2BP2;PRPF19
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),0.4870095024977946,0.7878062406075192,0.7631578947368421,0.9871159396426313,1.0,2/6,16.27%,BMP4;FZD7
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.31756699521433823,0.7876393183485461,0.9090909090909091,0.9871128354394632,1.0,7/31,24.46%,ZBTB7B;RPS6KA4;ARRB1;NIPBL;FOXP3;NOS1;TADA2A
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.4416403214935017,-0.787602429475235,0.75,1.0,1.0,3/11,22.56%,CFL1;VIL1;DSTN
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.47776361640751136,-0.787560263965196,0.7424242424242424,1.0,1.0,2/8,30.59%,FIS1;PEX11B
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.5143495681256312,-0.7875497495836759,0.8,1.0,1.0,3/6,27.11%,LMOD3;ACTN3;FLOT1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.34950425534232915,-0.7874998742753664,0.75,1.0,1.0,2/39,0.90%,TBX1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.36978690541823145,-0.787459666047844,0.7580645161290323,1.0,1.0,9/30,29.91%,ARG2;CACTIN;NLRC3;VSIR;SYT11;GHRL;NR1H4;RARA;PTPN6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.38414093400517724,-0.7874140086847191,0.7049180327868853,1.0,1.0,4/21,10.84%,IRF4;ANXA1;PTPRC;STOML2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.2893309810618262,-0.7872308218945637,0.9,1.0,1.0,18/157,11.41%,WNT5A;HK2;CXCL13;NODAL;SP100;CLDN5;DCN;CYP1B1;ALOX5;STAT1;CNMD;FOXO4;CEACAM1;CD160;COL4A3;GATA4;BRCA1;CEMIP2
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.3329411213407739,-0.7871846201638951,0.8307692307692308,1.0,1.0,9/67,15.25%,LIPI;ACSM6;ALOX5;CYP21A2;ACSL5;LIPH;ACSM3;CLN8;OLAH
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),-0.5260381196673389,-0.7866846008727716,0.7547169811320755,1.0,1.0,2/5,10.63%,TBX1;LRP2
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.381576564367436,0.7866646954138071,0.7666666666666667,0.9883647630328873,1.0,5/20,10.23%,TMTC2;SLC8A1;SNCA;CNNM2;GRIN1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.2985954816808894,0.78652527576997,0.8064516129032258,0.9882450313095562,1.0,6/76,7.71%,NUP210;MAPKAPK2;SIRT1;NUP42;MLST8;AAAS
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.3632041510830487,-0.7864562599810295,0.8412698412698413,1.0,1.0,6/40,16.35%,WNT5A;FTH1;CDKN1A;SFRP1;NLRC3;FN1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.4391547880162511,0.7863816128337692,0.7021276595744681,0.9880731352599146,1.0,3/6,19.85%,METTL15;BUD23;METTL16
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.39670086612283906,0.786339102665399,0.7727272727272727,0.9877852914294165,1.0,2/15,9.84%,F2;ABCD2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.3961681568942951,0.7862807884097023,0.7441860465116279,0.9875324724264376,1.0,3/18,4.88%,TNFSF14;BCL2;FLT3
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.4951870840870519,-0.785984853922104,0.8070175438596491,1.0,1.0,2/6,10.74%,BHMT;CHDH
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3217589469376216,0.7859485300353001,0.9,0.9876742066309776,1.0,18/47,22.46%,ABL1;ACER2;CLSPN;ATM;BCL3;BRIP1;RAD9A;BID;H2AX;GADD45A;RAD17;TP53;ATR;MDM4;SESN2;CDC5L;HINFP;ATRIP
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.32557367066829046,-0.7857842188168422,0.8169014084507042,1.0,1.0,9/71,16.07%,ST6GALNAC1;CHST9;B3GNT5;FUT2;GALNTL5;ST6GALNAC2;GCNT1;B3GALT6;B3GNT9
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.3594058433127415,-0.7855605297969819,0.8064516129032258,1.0,1.0,3/23,8.69%,SLC51A;SLCO2B1;CEACAM1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.3840234270407439,-0.7851577921020884,0.8412698412698413,1.0,1.0,4/21,14.73%,H1-0;ENDOG;REXO4;DNASE2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.32572641112190853,-0.7847092275403967,0.8513513513513513,1.0,1.0,6/69,7.01%,WNT5A;TGFB1;CXCL13;HCK;TNFRSF1B;PDCD1LG2
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),0.48586279765256835,0.7845121184230018,0.7446808510638298,0.9899492464169759,1.0,1/6,24.45%,HSD3B2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.33140509265187074,-0.7842226147849906,0.8115942028985508,1.0,1.0,9/70,15.77%,PIGH;UBE2L6;GNMT;PHEX;LOX;RABGGTB;USP6;RABGGTA;PLAT
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.4279345783855519,-0.7840196086899439,0.7419354838709677,1.0,1.0,4/10,22.75%,LOX;SUMF1;CHCHD4;LOXL4
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.2942914297689461,0.78389772743645,0.8888888888888888,0.9908665236902696,1.0,16/84,20.45%,AUP1;DERL3;UBE2J1;RHBDD1;MAN1A1;FBXO27;POMT2;UBE2J2;UBE4B;RHBDD2;FBXO17;RNF185;TMUB2;EDEM1;TMEM67;UBXN4
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.33682418879211745,0.7835239141173617,0.7619047619047619,0.990919961379162,1.0,4/23,12.59%,SEMA6C;SEMA5A;DSCAM;SEMA4A
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.3103046063246028,0.7832417317118192,0.8125,0.9910370583768212,1.0,13/49,20.57%,ZSCAN4;POLD3;ACD;CTC1;TERF1;SMC5;ATM;RAD50;NSMCE2;DNA2;TPRKB;SMC6;ATR
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.4197800352331646,-0.7832018044007905,0.6792452830188679,1.0,1.0,1/12,0.84%,ACTC1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3102339378963518,-0.7830448832130986,0.7777777777777778,1.0,1.0,17/79,20.91%,CCNG2;SPDYA;CCND1;LATS2;CDC25A;CCNF;CDKN2D;CDKN1A;CDC6;CDK5R1;CDKN3;PSRC1;CDC37;CCNI2;CCNE2;CCND2;GTPBP4
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.4675084358876501,0.7829638301393383,0.8095238095238095,0.99120616618173,1.0,1/9,14.41%,LRP8
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.47328070682218726,0.7828210018548521,0.7352941176470589,0.9910973951713334,1.0,2/7,15.98%,RNF168;LIG4
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3268390197814176,0.7824209213278915,0.7941176470588235,0.9914398854966345,1.0,13/50,17.68%,SSC5D;CD14;SERPINE1;HMGB1;HSPA1A;LGALS9;TLR5;LBP;ARRB1;OTUD7B;F2R;BCL3;FADD
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.2883614385271303,-0.7824203322897223,0.9571428571428572,1.0,1.0,29/153,17.91%,F8;TIMP3;TGFB1;SYT10;BLK;A1BG;SYT2;PSAP;CD63;CLU;CFD;SCIN;PLG;TUBA4A;ITGA2B;THBS1;SELP;A2M;STEAP2;TTN;ITIH4;F5;CALM1;FN1;VWF;ITIH3;TGFB3;VAMP7;ALB
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.3809999859251553,0.7822500153524854,0.7692307692307693,0.9914236238363935,1.0,5/14,13.00%,TOP2A;HMGB1;ABL1;TOP1MT;KAT6A
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.5106955710858264,0.7821089598930869,0.7073170731707317,0.9912513126677297,1.0,1/5,10.54%,SGO2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.37658587309612185,0.782086978897023,0.7941176470588235,0.9909231260882729,1.0,6/23,13.02%,FGF10;CCDC88B;IL23A;SH3KBP1;LCK;TICAM1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.3404236828798177,-0.7819295648557583,0.75,1.0,1.0,8/41,12.15%,ALOX12;CYP3A5;ALOX5;PLPP6;ALOX15;ALOX12B;CYP2E1;ALOX15B
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4134876709044862,0.781914642649905,0.7428571428571429,0.9908839716191465,1.0,6/10,26.78%,CDC14B;PTEN;FZR1;GORASP1;BTRC;PLK1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.3398324825076334,0.7818763952442185,0.7948717948717948,0.9905850335400876,1.0,4/31,7.37%,EPHA7;SEMA6C;UNC5C;SLIT2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.40778456690404014,-0.7818367911793999,0.75,1.0,1.0,2/14,2.41%,KIF14;CXCL13
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.30054954593889804,0.7816913720637509,0.9512195121951219,0.9905344908099437,1.0,12/58,14.68%,HSPB1;CEP85;SNCA;DEPTOR;TRIB2;LRP6;IRS2;WWTR1;SPRED1;UBASH3B;NF1;TAB1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.43247819789355924,0.7815059416827703,0.7441860465116279,0.9905416788953165,1.0,5/12,30.71%,ATM;PIK3R4;TRAPPC8;PIK3C3;PJVK
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.3196990395962628,-0.781334792055288,0.8235294117647058,1.0,1.0,4/59,6.29%,TGFB1;GPER1;ATP6AP1;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.34988815246513466,0.7812468267156399,0.6857142857142857,0.9905892319488919,1.0,8/22,20.29%,HTRA2;PML;WWOX;PPP2R1B;RET;FADD;BID;PAK2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4049352533906292,0.7808283562695555,0.7631578947368421,0.9909480622187246,1.0,4/14,15.70%,SHLD2;SHLD1;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.3783171695706956,-0.7805895519648332,0.8360655737704918,1.0,1.0,2/21,9.41%,DUOX1;CAVIN1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.36209575492175894,0.7805339018649372,0.8235294117647058,0.9909666147197059,1.0,7/27,24.38%,SKA1;ABL1;MAPRE1;CAMSAP3;GBA2;SKA3;MAP2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.46361530446025634,0.7805084256730632,0.6857142857142857,0.9906625502725717,1.0,3/6,31.32%,NUTF2;PLK1;TOR1AIP2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.3625432378726308,0.7804748351413667,0.8620689655172413,0.9899975323030741,1.0,5/30,10.66%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.3625432378726308,0.7804748351413667,0.8620689655172413,0.9899975323030741,1.0,5/30,10.66%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.4567688353096463,-0.7802789622270959,0.7636363636363637,1.0,1.0,4/9,24.12%,PTPRC;GRN;TAFA3;SYT11
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.47107089869882757,-0.7800313380909999,0.8421052631578947,1.0,1.0,4/10,26.53%,ATP1A4;ATP4A;ATP1A1;SLC4A4
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.44302152135072037,-0.7800204723378805,0.6964285714285714,1.0,1.0,2/11,5.43%,C1QTNF1;GPER1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.42652081447632895,0.7798872990556278,0.75,0.9901963351713287,1.0,2/9,16.76%,ABL1;GABPA
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.42652081447632895,0.7798872990556278,0.75,0.9901963351713287,1.0,2/9,16.76%,ABL1;GABPA
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.3966859481289742,-0.7796463990155478,0.7966101694915254,1.0,1.0,4/14,14.79%,GPER1;CIITA;CEACAM1;SLC18A2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.46650352477057133,0.7793520693655134,0.8043478260869565,0.9906291326824019,1.0,1/7,2.74%,CAPN10
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.4395255184661171,0.779012782460164,0.7297297297297297,0.9909179103648267,1.0,3/13,28.98%,DHRS7B;PLA2G6;NCEH1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.4454797386302455,0.7788459679753015,0.8372093023255814,0.99080426439324,1.0,1/8,6.26%,RIPK2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.4811793397074253,-0.7786116798040297,0.7704918032786885,1.0,1.0,2/7,18.86%,SERINC1;TLCD1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.328509734363787,-0.7783442511730984,0.8253968253968254,1.0,1.0,12/58,16.12%,CLDN5;DCN;ALOX5;STAT1;CNMD;FOXO4;CD160;COL4A3;TEK;THBS1;ISM1;SERPINF1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.40486335984026245,0.7780920998349469,0.7333333333333333,0.9917934993480426,1.0,5/14,25.68%,NRG1;JAG1;MAPK12;HINFP;RB1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.37547595000484113,0.7779425570709712,0.7058823529411765,0.991685355410097,1.0,2/24,6.77%,CYP1A2;ADH4
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4084977530990024,-0.7777676821708548,0.8448275862068966,1.0,1.0,3/15,18.51%,TGFB1;HEY2;HEY1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.4249877394207572,0.7776032401937882,0.7333333333333333,0.9914807818856727,1.0,1/9,15.03%,VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.4249877394207572,0.7776032401937882,0.7333333333333333,0.9914807818856727,1.0,1/9,15.03%,VTA1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.39442093637341497,0.7775524436824984,0.75,0.9911721392938826,1.0,5/13,20.35%,SFSWAP;SRSF4;PCBP4;PTBP1;U2AF2
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.4604069786505701,-0.777512959809924,0.7627118644067796,1.0,1.0,3/8,29.89%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.4306268567589227,0.7773694357694646,0.7631578947368421,0.9911217156277199,1.0,1/10,6.55%,TIMM29
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.31005467426572997,-0.7773589641756735,0.8611111111111112,1.0,1.0,4/67,8.06%,HK2;RAB11A;PINK1;RANBP6
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.3558993178144655,-0.7772854948260574,0.8548387096774194,1.0,1.0,2/21,6.13%,HLA-DRB1;CHMP3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.29067762563361454,-0.7771390516417704,0.918918918918919,1.0,1.0,29/188,19.07%,DUOX1;F7;TGFB1;COL1A1;DAB2;MMP9;GPER1;SYNE2;ACTG1;SMIM22;CGA;SEMA3F;SEMA3A;SOD2;CAVIN1;PIK3R3;LAMC2;PLAU;CLDN1;THBS1;CXCL16;SEMA3B;VIL1;LEF1;VSIR;NTN1;GRN;NTRK3;ITGAX
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3306669897772145,-0.7768435997447121,0.8333333333333334,1.0,1.0,5/61,10.61%,EPN1;MMP9;GPER1;CEACAM1;PDE6H
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.31464023948437475,0.776721614574656,0.7586206896551724,0.9919481754947334,1.0,9/53,10.30%,BIN1;KCNIP3;KCNJ3;WWP2;KCNJ6;KCNIP1;DPP10;FLNA;KCNIP4
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.46323216365163183,-0.7766920477198425,0.7192982456140351,1.0,1.0,1/6,5.82%,SLC22A3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.45669014510423556,0.7766529864906421,0.7647058823529411,0.991702719973358,1.0,2/8,17.98%,BMP4;RBPJ
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.38216344878708775,-0.7765756847889487,0.819672131147541,1.0,1.0,7/25,25.10%,HSPA1L;HSPA8;DAXX;HSPA5;HSPA2;OPTN;HSPA13
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.3064012073649923,-0.7765663169590287,0.9076923076923077,1.0,1.0,21/76,28.14%,NDUFA2;NDUFS2;NDUFB4;NDUFB9;COX17;NDUFC1;NDUFA1;TMEM126A;COX20;NDUFB11;NDUFS5;NDUFB10;CHCHD4;NDUFAF5;NDUFB2;COX16;NDUFS6;LYRM7;TIMM21;UQCC2;COA3
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.37041347614259756,-0.7765309085325228,0.8688524590163934,1.0,1.0,2/28,2.84%,DAB2;NODAL
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.31381418905420855,-0.7763773303682151,0.8507462686567164,1.0,1.0,6/69,8.94%,NMUR2;XCR1;P2RY12;PTPRC;ACKR4;HTR2B
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.39532693822865983,0.7762059933231933,0.8571428571428571,0.9920587590773662,1.0,4/11,19.92%,SERPINE1;F12;RUNX1;PLGRKT
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.42189220926102733,-0.7761196753746387,0.7580645161290323,1.0,1.0,3/15,15.33%,PIGH;PIGC;PIGL
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5029819085092389,-0.7759640168166374,0.7796610169491526,1.0,1.0,2/5,11.14%,TAF7;SPI1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.3724102230704748,-0.7759078121880351,0.8813559322033898,1.0,1.0,4/20,19.12%,PPP1R1B;TIPRL;BOD1;ARPP19
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.3298706899025959,-0.7758564444281908,0.8333333333333334,1.0,1.0,11/51,15.53%,DBH;AMBP;F7;ALDOB;FTCD;DAO;C3P1;FGL1;SLC18A2;SLC22A7;SHD
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.5161027639291569,-0.7757355114534402,0.8076923076923077,1.0,1.0,3/5,21.40%,HEY2;MESP1;ENG
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.42755889260681545,-0.7756472961462173,0.7868852459016393,1.0,1.0,1/11,7.61%,HAT1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.254316466556162,0.7755372394648091,1.0,0.9927236688982913,1.0,44/201,19.38%,MLF1;SPTBN4;CNPPD1;PCLO;NRG1;SPEF2;ABHD3;PCOLCE2;IMPDH1;LRRC73;FSTL5;CASKIN1;EFNA5;NAT14;TESC;FGF12;CAP2;MORN4;GOLGA7B;CSPG5;RNF128;PTPRF;H2BC21;PRR36;MAP6;FAM81A;SRRM3;CLSTN2;KLHL5;MPP2;LRRC45;OSCP1;IFT140;SRCIN1;ARL3;MARK1;LRRIQ1;TRIM66;CNGA4;CFAP43;FAIM;EPB41L4B;DCDC2;RIC8B
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.35833840673344064,0.7752380013773231,0.7962962962962963,0.9928329988198853,1.0,2/16,7.87%,MID1;CARD9
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.3178709176122946,-0.7751226460853102,0.875,1.0,1.0,2/75,0.90%,PSMB9;WNT5A
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.42995743800284203,0.7751103155202403,0.7291666666666666,0.9927191498524238,1.0,3/9,24.27%,HES1;ACVR1;APELA
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.31532938725124954,0.7748791459591656,0.7894736842105263,0.9927483438366553,1.0,6/40,14.18%,APOE;LDLR;FLNA;BANP;IAPP;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.43866918982504277,-0.7748022024155841,0.71875,1.0,1.0,1/11,1.76%,DISC1
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.49039352040479733,-0.7747852756410327,0.75,1.0,1.0,2/5,26.57%,ALG10B;GOLGA2
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.3453205264683944,-0.7744472954876999,0.7719298245614035,1.0,1.0,4/35,11.14%,TCF7;ANXA1;PTPRC;SPI1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.46976521686091877,-0.7743392400373945,0.8301886792452831,1.0,1.0,4/9,24.54%,NLRP12;CAV1;ENG;MVP
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.41224627090339394,0.7743223999351488,0.8095238095238095,0.993200519725745,1.0,2/11,12.57%,FBLL1;FBL
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.287223553603668,-0.7742964209285664,0.9487179487179487,1.0,1.0,22/112,18.78%,SLC22A8;TMEM213;MACC1;IYD;SLC22A6;CYP3A5;ITGB6;SLC3A1;SLC5A1;SCIN;ATP5MK;SCNN1G;PROM2;MYO5B;ATP10B;PVALB;SGMS2;PIK3C2G;MUC4;COL28A1;RASSF6;ADGRF5
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3293978685491147,-0.7742714338427985,0.8253968253968254,1.0,1.0,12/47,24.26%,SCIN;SVIL;CFL1;GAS7;WAS;VILL;RAC1;VIL1;PSTPIP1;CATIP;DSTN;GHRL
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.3082653760791244,0.7742467130826889,0.8205128205128205,0.9929723780126214,1.0,3/38,5.47%,CCN4;CDH13;PPARG
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.44176716333932753,-0.7742227015609151,0.746031746031746,1.0,1.0,1/13,6.93%,SLFN14
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.36104444947294306,0.773827070372805,0.8055555555555556,0.9932927617003785,1.0,6/23,26.66%,MAN1A2;MAN1A1;RNF185;EDEM1;RNF139;EDEM3
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.41754090324286997,0.7738026834021516,0.8113207547169812,0.9929905243020317,1.0,2/11,5.35%,KLRD1;ARRB2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.39822146996874636,-0.7736053470781693,0.7413793103448276,1.0,1.0,3/15,16.35%,ITGB6;SMAD3;FN1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.4056458360332243,0.7734588716164282,0.725,0.9931051828919643,1.0,1/7,11.36%,TERF1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3022883827165871,0.7734028588761906,0.8387096774193549,0.9928659997919662,1.0,12/37,20.00%,SIRT1;IFI16;OPN5;RGR;TANK;SPIDR;LIG4;EEF1D;OPN3;RAD9A;GADD45A;TP53
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3934515909210278,0.7733868563240125,0.8367346938775511,0.9925414372371629,1.0,2/12,11.57%,MYORG;IGFBP4
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.3802103452285572,-0.7728588161378632,0.8484848484848485,1.0,1.0,2/23,3.79%,CAV3;SCN5A
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.4911931755092001,-0.7725883032964584,0.7761194029850746,1.0,1.0,5/9,19.40%,HLA-DRB1;HLA-A;NLRC4;NAIP;PGLYRP1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.34205471595102194,-0.7725870270409319,0.8787878787878788,1.0,1.0,12/47,15.86%,ENO4;HK2;ALDOB;ENO2;PDHX;SLC16A8;PKLR;PGAM1;VDAC1;GAPDHS;SLC16A3;LDHC
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.3340920890788377,-0.7723568786188976,0.8596491228070176,1.0,1.0,6/46,16.86%,RAB34;HHIP;GPC3;SFRP1;PDCL;GLI3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.375056350008388,-0.7720646452721948,0.8,1.0,1.0,2/24,4.99%,DCN;PINK1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.4480962509203402,-0.771827632368735,0.746031746031746,1.0,1.0,1/8,4.99%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.33327235173520575,0.7717427088258835,0.8863636363636364,0.9950336924295067,1.0,7/33,10.99%,APOH;F2;SERPINE1;HPSE;F12;KANK1;FERMT1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.3606801028032317,-0.7717406387594141,0.7592592592592593,1.0,1.0,3/32,15.81%,PLPP6;ACAA2;FAXDC2
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.39574970930949505,-0.7712731481824788,0.7887323943661971,1.0,1.0,2/22,9.55%,LILRB3;CARTPT
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3190491030189519,0.771254097240847,0.7272727272727273,0.9953640137488126,1.0,11/58,14.39%,BCL2;MFSD2A;TIMP1;PLIN5;MTMR8;DAPL1;LEPR;IL10RA;RASIP1;KLHL22;TAB3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.34120321931032455,0.7710998424984332,0.7878787878787878,0.9952212089043251,1.0,5/27,7.41%,FOXO1;RORA;SIRT1;ANKRD26;TRIB2
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.418569672176521,0.7709284823586777,0.7555555555555555,0.9951297665269719,1.0,5/12,17.37%,BMP4;NF1;CSRP2;CSRP1;SHH
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.2740245055822388,0.7709071223901731,0.9428571428571428,0.994804969104466,1.0,10/86,11.17%,HIP1;PACSIN2;CDH13;RALA;ABL1;SYT1;ZFYVE16;ABL2;RAB3C;RIMS2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.3294772339385798,0.7707722825373599,0.8809523809523809,0.9946397614244061,1.0,4/28,15.03%,RAB27A;MVB12A;CHMP6;VTA1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.31269233428839255,-0.7707229100168184,0.864406779661017,1.0,1.0,21/73,19.81%,CRYBB1;COL1A1;TULP1;ROM1;WFS1;FSCN2;COL18A1;CABP4;SLC24A1;GPR179;RDH12;RABGGTB;PDE6C;RABGGTA;CRYBA4;TULP2;CNGB1;CRYBB3;GUCY2F;USH1C;CRYBG3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.3284768118935386,0.7706842614569748,0.8461538461538461,0.994423473266392,1.0,5/29,7.97%,APOH;APOE;PPARG;VASH1;PTPRM
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.4406938700293329,-0.7706534253137807,0.8032786885245902,1.0,1.0,1/15,2.92%,TRAIP
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.3818609563145513,-0.770457227614886,0.7833333333333333,1.0,1.0,3/21,14.53%,IRF1;TLR2;CACTIN
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.47487953579821796,0.7703508823816505,0.7,0.9946850488647521,1.0,1/5,1.16%,MEGF10
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.3230634000428143,0.7703307834908705,0.7105263157894737,0.9943552046465197,1.0,8/34,20.92%,UNC5C;PML;CDK6;ACHE;NF1;SHH;NRCAM;RTN1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.404560926440221,-0.7703183870777031,0.75,1.0,1.0,3/11,14.09%,GPER1;CD160;THBS1
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),0.48861887311853314,0.770287428099372,0.7857142857142857,0.9940881126189365,1.0,3/6,24.60%,CEMIP;HAS2;ABCC5
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3407909040549284,0.770275680615992,0.9117647058823529,0.9937360049361307,1.0,13/40,22.25%,SMARCB1;SRCAP;SMARCA4;PBRM1;ARID1A;CHD4;HDAC1;SMARCA2;GATAD2B;ARID1B;NASP;SMARCAD1;RBBP4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.29775171788764415,-0.7702584881036586,0.9066666666666666,1.0,1.0,14/146,11.23%,SCTR;FCGR3A;HCK;TSHR;PTGDR;HLA-DRB1;ALOX5;GPER1;TNFRSF1B;CGA;NLRP12;GPR27;NLRP3;GPR39
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.46460731956034207,-0.7702379603346906,0.7543859649122807,1.0,1.0,3/5,21.14%,GPIHBP1;SFRP1;SOX9
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.2631592861436856,0.7699831945223575,1.0,0.993844125696763,1.0,32/150,18.40%,RFWD3;BRCC3;SEM1;RNF168;TENT4A;HMGB1;SMARCAL1;PPP5C;POLM;TRIP13;MAPK8;KDM2A;REV3L;MMS22L;SMC5;SWSAP1;AP5Z1;BAZ1B;PAXX;SPIDR;SETMAR;LIG4;HERC2;EYA3;ATM;RAD52;BRIP1;RAD50;NSMCE2;FBH1;DNA2;H2AX
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.37695253304332965,-0.7698505106301003,0.8,1.0,1.0,1/21,1.33%,STAC
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.35643923112747344,0.7696631183116126,0.7142857142857143,0.9939521674506282,1.0,7/16,16.61%,F2;WNT4;BMP4;RUNX1;SUCO;CREB3L1;F2R
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.40268975842679733,0.7695811847498211,0.8055555555555556,0.9936969618384767,1.0,4/12,24.57%,SPEF2;CTNNA2;PTEN;VPS51
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.4906483765913693,-0.7694945060820787,0.8333333333333334,1.0,1.0,2/6,27.94%,SFRP1;TNFSF4
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.41439200049406766,0.7694185352931383,0.8529411764705882,0.9935724085859066,1.0,2/13,11.47%,DUT;UPP2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.41077482783162816,0.769414639205005,0.723404255319149,0.9932097909185394,1.0,3/11,15.07%,CDH5;NOTCH4;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.3835503704467462,-0.7693347728366904,0.819672131147541,1.0,1.0,4/19,10.35%,TGFB1;DAB2;MRAP;RHOQ
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.4504546084130939,-0.76896510813399,0.8103448275862069,1.0,1.0,1/10,1.85%,TGFB1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.3299487066660521,-0.7687578742879547,0.8805970149253731,1.0,1.0,8/47,15.81%,GP1BA;ZFPM1;EIF6;SCIN;PITHD1;ITGA2B;THBS1;FAXDC2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.34939075187841506,-0.7687254561874532,0.8405797101449275,1.0,1.0,4/38,15.97%,BHMT;PCMT1;EEF1AKMT2;ETFBKMT
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.40522688158825115,-0.7686290366134326,0.7833333333333333,1.0,1.0,3/18,20.02%,INTS5;EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.32703335040022624,0.7685975071565441,0.8378378378378378,0.9940944630181578,1.0,6/33,12.09%,VCAN;CHAC1;PRELP;ARSB;GLB1;CSPG5
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.30360191747282816,-0.7684028366381846,0.9466666666666667,1.0,1.0,23/124,16.41%,C1QTNF1;TIMP3;LMOD1;COL1A1;ECM2;ANGPT2;ADAM33;ANGPTL2;PDE5A;DCN;GPIHBP1;ASPN;DAAM2;P2RY14;COX7A1;TEK;STEAP4;VTN;ACTA2;ATP13A5;MFGE8;PCDH18;C1S
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.48836524478958665,-0.7683715367350666,0.7777777777777778,1.0,1.0,4/6,26.61%,CD86;ITGA5;TNIP2;PHB2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.42169937638896304,-0.7683473887149758,0.7714285714285715,1.0,1.0,1/12,1.31%,ADSS1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.4492346428576588,0.7683121316929701,0.7428571428571429,0.9941908840038846,1.0,6/10,25.26%,SMPD4;SMPD3;SAMD8;SMPDL3A;ABCA2;ABCA8
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.3378131569386815,-0.7682711848650788,0.8260869565217391,1.0,1.0,6/41,19.02%,SCN5A;GPER1;KCNQ1;KCNE3;KCNE2;GNA15
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.5126844166340168,-0.768155660109917,0.75,1.0,1.0,1/5,18.30%,SSU72
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5151896796767998,-0.7679902866876118,0.7666666666666667,1.0,1.0,2/6,12.36%,ABCB1;PDZK1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.36163623858066835,-0.7679435577359622,0.835820895522388,1.0,1.0,1/23,1.85%,TGFB1
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.49185591602284545,-0.7674947388859551,0.7941176470588235,1.0,1.0,3/6,29.77%,CDKN1A;HYAL1;STK11
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.44169960680725384,-0.7670764881363991,0.8214285714285714,1.0,1.0,3/10,10.74%,BHMT;SMOX;CHDH
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.43329170555982505,-0.767035765259782,0.8245614035087719,1.0,1.0,2/10,5.98%,BLK;ANXA1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.4653997057266485,0.7667261499798255,0.7358490566037735,0.9963829751262833,1.0,2/6,19.80%,CARD9;SLA2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.38905153409034043,0.7660417259139848,0.7608695652173914,0.997033377545332,1.0,2/15,6.34%,KLRD1;CADM1
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.5314254750399656,-0.7659158514701457,0.8214285714285714,1.0,1.0,2/5,39.67%,SLX4;ERCC1
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),-0.4781562016468729,-0.7656053757914747,0.7843137254901961,1.0,1.0,2/5,31.72%,NOX5;RAB3A
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.35608363970314577,0.7655651240529793,0.7857142857142857,0.9973210637496319,1.0,5/25,12.02%,CYP7B1;OSBPL3;OSBPL6;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.4760204769973458,-0.7654875238571837,0.8392857142857143,1.0,1.0,4/7,26.79%,TRDN;CALM1;JPH2;CALM3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.403349724959147,-0.765403739354808,0.7457627118644068,1.0,1.0,1/16,1.85%,TGFB1
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.4810876992512849,0.7650906777013659,0.8181818181818182,0.9978405174086181,1.0,2/5,20.06%,NUDT5;XYLB
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.3090170575670263,-0.7650678116574282,0.9206349206349206,1.0,1.0,16/90,12.77%,GMFG;STAG3;ARHGAP9;CYTIP;BLK;TBC1D10C;TAGAP;PTPRC;P2RY14;LY86;PARVG;TMC8;DOCK8;IKZF1;WAS;MYO1F
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.4514057737871414,-0.7650601929139494,0.7936507936507936,1.0,1.0,1/8,9.05%,CLU
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.46715753766763635,0.764823382470731,0.84,0.9978958077937525,1.0,2/6,31.80%,EPHA4;PTPRS
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.40964191966916197,-0.7647954318921165,0.8166666666666667,1.0,1.0,9/22,26.99%,RPL3;BRIX1;MRPL20;NOP53;RPL5;RPL11;RPL24;RPL10;RPLP0
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.3859822654793173,-0.7647286422893684,0.8307692307692308,1.0,1.0,3/20,21.21%,MOAP1;ROMO1;HSPA4
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.4879190765222078,0.7646273091377901,0.8,0.9978492885056418,1.0,1/6,8.66%,EIF2AK3
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.2877106177490996,0.76437463131402,0.8648648648648649,0.9978706246702221,1.0,17/56,26.22%,TGFBR1;SBK1;MAPK8;MAP3K10;DYRK3;WNK3;MARK2;ACVR1;CDK5;WNK1;CDC42BPA;DYRK1A;CDK1;ACVR1B;STK39;DYRK2;CDK10
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.28217506873624487,0.7643215712928076,0.9583333333333334,0.9975529605887351,1.0,13/94,11.78%,SLC26A3;CPEB1;PDE3A;TRPM2;CAPN2;HCN1;PKD2;RAPGEF1;SLIT2;AANAT;AKAP9;JUP;HCN3
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.39817829231339064,0.7639777733538333,0.6923076923076923,0.9977438197114274,1.0,1/10,2.27%,HDAC10
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.38524084256630575,-0.7637226520194509,0.8461538461538461,1.0,1.0,2/19,11.56%,NODAL;REST
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.39793808401104674,0.7636996429298858,0.85,0.9977933991393302,1.0,3/12,12.30%,BCKDK;NPL;NAGK
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.43384247945249765,0.7635811271914027,0.7291666666666666,0.9976115554063785,1.0,4/8,25.60%,PLSCR1;MILR1;LYN;HAVCR1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.32703213730665226,-0.7633403615754784,0.90625,1.0,1.0,8/49,12.23%,SIRPG;IL7;ANXA1;HLA-A;PDCD1LG2;PTPRC;DOCK8;HLA-DPB1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.366095199640488,-0.7633278148541547,0.8571428571428571,1.0,1.0,2/26,2.81%,TGFB1;ANGPT2
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.27918395185137757,0.7630571507971337,0.9473684210526315,0.9980560546275027,1.0,14/55,19.45%,MAFB;CBFB;CDK6;MOV10;TNRC6C;HDAC1;NR4A3;RUNX1;DPY30;CNOT4;TNRC6A;AGO3;KAT2B;EP300
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.2792415631833835,0.7629101589432892,1.0,0.9979419214690878,1.0,13/88,17.24%,FOXO1;NKD1;STX5;RAB7A;WWP2;FLNA;CHMP6;BANP;ODC1;SMURF1;SEC22B;NEDD4;FAF1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.28565771958441355,0.7627851350154184,0.8620689655172413,0.9977376720063024,1.0,14/74,18.23%,CDH5;SDC4;NRG1;RAB7A;STX18;PIH1D1;SMPD3;GNL3L;SYNPO;SPIDR;EMILIN1;FAF1;ICE1;BID
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.41465235245173127,-0.7627499006528203,0.8032786885245902,1.0,1.0,2/12,9.05%,LRPAP1;CLU
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.5113050518515158,-0.7626482474985212,0.8333333333333334,1.0,1.0,2/5,23.08%,SDS;SDSL
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.26540177933449477,0.7624288638142757,1.0,0.9979562257732488,1.0,61/257,25.59%,CPSF1;SNRPN;NOVA1;PCF11;TRA2A;HNRNPF;RBM41;DCPS;PRPF40B;PUF60;U2AF1;CELF4;HNRNPH1;SPEN;HNRNPL;TXNL4A;SF3B1;SRRM1;SNRPB;ZMAT5;CWC27;LSM2;SRSF4;PRMT5;CPSF7;GEMIN5;LSM7;PTBP1;GTF2F2;PAPOLA;SYNCRIP;FUS;SF3B4;SYMPK;LSM8;POLR2F;RBM6;U2AF2;EIF4A3;RALY;SNRPF;CDC5L;SNRNP48;PPIH;LSM6;DDX46;CWF19L1;SRPK2;RNF113A;CLNS1A;PSPC1;GPATCH1;WDR33;RBM10;DDX39A;PDCD7;CDK13;HNRNPUL1;CCAR1;SCAF11;SNRPA
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.4031243126248653,0.7622931006508576,0.717948717948718,0.9974411656613024,1.0,4/10,25.42%,CLYBL;PNPT1;SCARA5;SLC1A2
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.4031243126248653,0.7622931006508576,0.717948717948718,0.9974411656613024,1.0,4/10,25.42%,CLYBL;PNPT1;SCARA5;SLC1A2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.35581196867163445,-0.7621657199585259,0.7931034482758621,1.0,1.0,6/24,25.97%,RPA3;RPS27A;XRCC1;RPA2;PCNA;POLD4
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.4156816239041609,-0.7615464306325037,0.7868852459016393,1.0,1.0,1/11,5.04%,ABCC6
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.39697071721521937,-0.7614204875374484,0.8153846153846154,1.0,1.0,1/17,3.14%,GAD1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.424138852035015,0.7607515348691247,0.7560975609756098,0.9996298356856601,1.0,5/12,15.18%,TIMP1;FLNA;PHACTR4;LIMS1;EMP2
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.4121532280350068,0.7605625146633075,0.8,0.9994872443662636,1.0,4/8,25.40%,GLUD1;KYNU;GLUD2;MTHFD1L
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.4421310169351443,-0.7604876558593003,0.8125,1.0,1.0,5/9,15.77%,GP1BA;CPB2;PLG;PLAU;PLAT
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.43606913521558677,-0.7601423066723525,0.7941176470588235,1.0,1.0,2/13,8.97%,AZIN1;ACSL5
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.4021523176528125,-0.7600777202609867,0.7192982456140351,1.0,1.0,1/13,5.27%,STAT1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3098580028207337,0.7599470949840235,0.75,0.9999916542021848,1.0,6/42,10.49%,DAPK2;BCL2;URI1;STYXL1;EIF2AK3;LCK
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3838036021384975,0.7598896332271523,0.8611111111111112,0.9997309487179664,1.0,4/13,25.56%,NOP9;NOP14;TBL3;RRS1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.4236003901732641,-0.7598058688421956,0.847457627118644,1.0,1.0,2/13,24.12%,AHNAK2;SYT11
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.41470392518680316,-0.7592361735749446,0.7413793103448276,1.0,1.0,1/13,4.86%,SHISA6
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.37576151483614845,0.7590593097896436,0.7142857142857143,1.0,1.0,7/11,25.67%,SGK1;NR1H3;SGK2;WNK3;RXRA;STK39;KMT2A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.299503368281872,-0.7587092324203738,0.8611111111111112,1.0,1.0,7/85,9.21%,HTRA4;TGFB1;DAB2;PBLD;ASPN;LATS2;SMAD6
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.3805869578373498,0.7580032041449515,0.8536585365853658,1.0,1.0,4/12,17.20%,AKR1C3;SGK1;KLHL3;HAS2
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.42244333635864406,-0.7577825173435987,0.7321428571428571,1.0,1.0,1/10,3.31%,FOXM1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.27431421301438774,0.7575092795431122,1.0,1.0,1.0,29/127,16.47%,SLC26A3;RORA;URI1;PDE3A;TRPM2;DRD5;MGARP;HCN1;PKD2;NCOA3;RAPGEF1;NRIP1;AANAT;ADCY2;ZNF703;AKAP9;JUP;CASP3;HCN3;ADCY3;STING1;NR4A3;RAP1A;RAPGEF3;NR3C1;SPIDR;SSH1;GABRB2;IMPACT
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.28116096459689127,0.7572299852413971,0.9642857142857143,1.0,1.0,30/109,19.66%,ANGPT1;EPHA7;CDH13;SEMA5A;SIPA1;ERBB2;DSCAM;ABL1;EFNA5;ABL2;PLXNB1;TESC;TNFRSF18;TFE3;RET;FRMD5;EPHB2;PKP4;PDE3B;PLXNA4;ATM;RSU1;ERBB3;EPHA8;PPP1CB;EPB41L4B;ADAM8;CXCL12;MIA3;ADAM10
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.2540612792068358,0.7571655535486821,1.0,1.0,1.0,21/154,11.98%,TSKU;NOVA1;APOE;PROX1;PRDM5;CDK4;PCBP3;SLC8A1;TBC1D16;UBAP2;LDLR;CIAO3;CDK6;NKAP;FEZF2;ADNP2;KHSRP;ZNF462;ASCL1;MYC;TRIM44
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.47983630021416646,-0.7571623689106853,0.8214285714285714,1.0,1.0,2/6,25.16%,RTF1;PAF1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.31540504064478275,0.7571063617703216,0.9142857142857143,1.0,1.0,5/49,6.97%,RAB31;ARRB2;SNCA;MVB12A;REP15
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.33523691328427,-0.7569662321994259,0.88,1.0,1.0,10/45,21.04%,CTNNA1;CLDN5;MARVELD2;CLDN6;CLDN1;CLDN18;ECT2;CLDN2;CLDN20;CLDN9
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.3674959759068435,0.7569555001831924,0.7560975609756098,1.0,1.0,5/23,17.37%,PROX1;HECA;BMP4;ITGA3;SHH
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.3267745233262841,0.7569544057205387,0.8571428571428571,1.0,1.0,1/38,1.25%,RAB27A
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.3464534508939631,0.7568241864469478,0.8333333333333334,1.0,1.0,7/27,14.94%,CHST6;B4GALT2;PRELP;B4GALT3;ST3GAL3;GLB1;ST3GAL6
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.35754414685530445,-0.7563310727140166,0.8305084745762712,1.0,1.0,4/36,14.62%,SNRPD2;DDX20;GEMIN4;STRAP
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.356944311433667,-0.756210137259428,0.8148148148148148,1.0,1.0,4/24,10.91%,SOX10;FLG2;ACTG1;ARHGAP12
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),0.46547109923251034,0.7558594965260621,0.7674418604651163,1.0,1.0,2/5,14.27%,CFC1;SMAD2
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.46287957041217365,-0.7555883629906306,0.8125,1.0,1.0,1/8,11.40%,BRCA1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.33608787106440585,0.7554841661396577,0.75,1.0,1.0,8/22,14.10%,TGFBR1;PKD2;HPGD;JAG1;HES1;BMP4;NOTCH1;NF1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.47074282607386037,-0.7554192036532245,0.7868852459016393,1.0,1.0,1/7,5.53%,BLK
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.48411198122840166,0.7551131774368257,0.7346938775510204,1.0,1.0,1/5,10.31%,GPD1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.4342557856248397,0.7549265887874065,0.6595744680851063,1.0,1.0,1/7,12.27%,ARHGAP21
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.39506340074710333,-0.7547406650516204,0.8448275862068966,1.0,1.0,5/13,14.34%,RNF213;DAAM2;SFRP4;GPC3;SFRP1
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),0.4509557392530524,0.7546647707431506,0.6976744186046512,1.0,1.0,1/5,7.69%,DRD3
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.29427562803195606,0.7543623654260782,0.9285714285714286,1.0,1.0,7/56,8.36%,SIRT1;TRPM2;AKR1C3;PKD2;FER;MAPK8;ABL1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.318524897718191,0.7542407873110328,0.9333333333333333,1.0,1.0,11/46,15.87%,ST6GALNAC3;ACER2;SMPD4;NSMAF;PLPP2;ACER3;TLCD3B;PLPP3;PLA2G15;CERS4;FA2H
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.43640475659804345,-0.7541650374909423,0.8307692307692308,1.0,1.0,3/12,22.09%,FTCD;CALM1;GCHFR
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.4831213787231629,-0.7541512724683695,0.8166666666666667,1.0,1.0,1/6,3.28%,LRPAP1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.35620092370305023,-0.7538717319766675,0.8142857142857143,1.0,1.0,5/32,17.22%,TULP1;ATP6V1D;ROPN1B;FSIP2;TULP2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.38377374921876345,-0.7538298596879698,0.7741935483870968,1.0,1.0,1/14,6.29%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.2619415194989899,-0.7537673449573837,0.9871794871794872,1.0,1.0,39/348,16.70%,ENPP2;FGF20;KIF14;F7;TGFB1;COL1A1;DAB2;CLDN5;CYP1B1;MMP9;GPER1;SYNE2;ANXA1;ACTG1;SMIM22;CGA;SEMA3F;SEMA3A;SOD2;CEACAM1;PIK3R3;TMSB10;IGSF10;ALOX15B;LAMC2;PLAU;CLDN1;THBS1;CXCL16;FGF22;SFRP1;RNF20;SEMA3B;NEXN;RAC1;BEX4;VIL1;LEF1;CAMK2A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4151725025980906,0.7535536262170216,0.8292682926829268,1.0,1.0,1/8,3.08%,NFATC3
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.42113114276447994,-0.7534833170004427,0.8923076923076924,1.0,1.0,3/14,14.73%,H1-0;ENDOG;DNASE2
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.4044735372037982,-0.7534760411409482,0.8070175438596491,1.0,1.0,4/14,20.45%,SLC5A2;SLC5A1;SLC5A9;SLC23A1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.4534916527627938,0.753380475507142,0.8181818181818182,1.0,1.0,2/8,11.46%,AKT2;IRS2
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.3768015532710006,-0.7533598171083722,0.8070175438596491,1.0,1.0,7/19,25.20%,ABCG2;ATP5IF1;UROS;ALB;PGRMC1;ALAS2;NFE2L1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.241322931471209,0.7533302033266083,1.0,1.0,1.0,84/393,21.27%,RASSF2;SMYD2;DAPK2;PLEKHG2;CCNG1;HSPB1;NLGN1;FGD4;MOB3B;RGN;PAK5;DIPK2A;PML;SYDE2;SRGAP2;CRK;MLST8;VRK2;TELO2;PPP1R13B;PLK3;ARHGAP20;STYXL1;TAF3;SGK1;MYO9B;TNIK;PRKAR2A;TAF12;FGD1;AKAP7;GRM2;BANP;CHD4;HDAC1;ARHGAP21;ARHGAP35;KAT6A;SPRED1;PRMT5;VAV2;PIP4K2A;RASD2;RIT2;ARHGAP33;ATM;BCR;ARAP2;BCL3;BRIP1;ANKRD54;RAD50;ARHGAP11A;TBCK;RAD9A;DNA2;AKAP12;ZFAND6;ARHGAP10;NTRK2;CPNE1;TAF4;FSHR;SOS1;RAD17;ARHGAP5;EP300;WWC1;MAP2K6;PLCG2;TP53;PAK3;PAK2;DLG1;PRKAG2;ATR;PKHD1;MDM4;GNA12;MYO9A;TRAF6;CDK5;PRKAA2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),-0.4805944185526772,-0.7531522418263147,0.8163265306122449,1.0,1.0,3/5,18.64%,CYBA;PGC;GRN
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.34180750791733944,-0.7523572379537646,0.803030303030303,1.0,1.0,3/31,8.75%,ALOX12;ALOX5;PPT1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.3466231780902745,-0.7520519955121996,0.8412698412698413,1.0,1.0,8/29,30.99%,RAB6D;RAB6B;GABARAPL2;RAB6C;COG8;TRAPPC3L;COPG1;COPG2
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.4732677728687742,0.7518270709466364,0.7948717948717948,1.0,1.0,1/5,23.22%,NAPEPLD
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.4732677728687742,0.7518270709466364,0.7948717948717948,1.0,1.0,1/5,23.22%,NAPEPLD
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.46171038229566613,0.7516130524424586,0.8367346938775511,1.0,1.0,1/5,6.04%,DOK5
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.41739454384982433,-0.7516106586615762,0.782608695652174,1.0,1.0,3/10,20.47%,PINK1;NOS2;TMSB4X
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.36276492467523885,-0.7511220392830383,0.9122807017543859,1.0,1.0,2/21,8.39%,TGFB1;LATS2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.3008186312849437,-0.7509543109297883,0.9027777777777778,1.0,1.0,16/102,15.68%,TRIL;PPP1R1B;TSPAN11;GFRA3;SOX10;SHISA6;LGI4;DAAM2;TCEAL5;AQP4;MPZ;APOD;TSPAN7;NOS2;SLC18A2;RXRG
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.30944787249764427,-0.750928373632498,0.8813559322033898,1.0,1.0,7/66,12.86%,ARHGAP15;ARHGAP9;VAV3;PPP1R17;ARHGAP12;ATP5IF1;PROM2
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.41513036011838217,0.7508190421512365,0.8,1.0,1.0,5/10,19.62%,SCRIB;LGALS9;FOXP3;RC3H1;BTN2A2
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),-0.4633035651523487,-0.7507042359899138,0.7368421052631579,1.0,1.0,2/7,26.64%,AKR1B15;HSD17B2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.46061293253911917,0.7506852572037443,0.78125,1.0,1.0,3/5,39.90%,DCAF1;PKN1;PRKCA
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.29257697144684364,-0.7504947499574212,0.9130434782608695,1.0,1.0,8/86,15.02%,HLA-DRB1;HLA-DMA;HLA-A;DYNLL1;DCTN1;HLA-DPB1;HLA-F;HLA-DPA1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.31894455547884276,0.7503802548580578,0.9166666666666666,1.0,1.0,8/55,12.82%,PCM1;APBB3;PLK3;TENM1;CEP290;ACHE;UNC13B;B3GAT3
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.33916766498838524,0.7503392598408991,0.9148936170212766,1.0,1.0,7/23,23.96%,ZBTB20;ERN1;UNC13B;LIN28A;PRKAA2;SLC2A5;GAS6
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),-0.5225508778458227,-0.7503196275900798,0.8490566037735849,1.0,1.0,1/5,5.60%,ATP6AP1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.3410241722985819,0.7500896996108075,0.7666666666666667,1.0,1.0,5/23,10.35%,CHST6;B4GALT2;PRELP;B4GALT3;ST3GAL3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.3584477148899553,0.7497850888534542,0.8461538461538461,1.0,1.0,4/17,18.49%,APOE;RNF128;FAF1;CTSC
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3467090186294565,0.7496557482930394,0.8125,1.0,1.0,8/22,17.95%,ELOVL6;THEM5;HACD1;ACSL1;TECR;ELOVL1;FAR2;ELOVL5
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.27188189532668877,0.7496172109178895,0.9642857142857143,1.0,1.0,33/169,18.98%,HGFAC;CYP1A2;DDAH2;PC;PAPSS2;TDO2;APOE;AKR1C3;SERPINE1;BCAT1;BPHL;ABCD2;UGDH;JUP;CYP2S1;F11;CDA;IGFBP4;MAN1A1;LEAP2;CA2;MPP2;HES6;GCH1;HPRT1;ACOX1;CSAD;SLC35D1;ELOVL5;KYNU;SHMT2;SLC12A4;LPIN2
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3153017152929105,0.749584701987405,0.8648648648648649,1.0,1.0,8/38,15.39%,RFWD3;SMARCAL1;SLFN11;BOD1L1;TIMELESS;MMS22L;PRIMPOL;SETMAR
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4265104320868879,0.7494786627258099,0.7954545454545454,1.0,1.0,5/8,40.22%,EDN1;ACE;ECE1;EDN3;CORIN
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.40976435321454463,0.7493781838965284,0.813953488372093,1.0,1.0,3/10,21.20%,HSPA1A;IMPACT;NCK1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.37240896554921255,0.7492175055521971,0.8157894736842105,1.0,1.0,2/14,6.51%,DSCAML1;GREM1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.32450654272719415,0.7490959558293194,0.8837209302325582,1.0,1.0,8/27,21.75%,ABL1;TERF1;IRS2;SMAD7;MEN1;TP53;LIMK1;NPRL2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.3285260450294714,-0.7490906318465346,0.8852459016393442,1.0,1.0,6/49,12.67%,C15ORF62;ARHGDIG;RTKN;ROPN1B;CFL1;WAS
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.4670524937318393,0.748979411267611,0.7368421052631579,1.0,1.0,2/5,21.61%,PDE4B;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.46262043461912883,-0.74893876763888,0.847457627118644,1.0,1.0,1/7,23.79%,MSH6
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.26996494059092824,0.7486653224632314,1.0,1.0,1.0,29/130,20.95%,KSR1;CDH13;DNMT1;RALB;RRAS2;RAPGEF1;RALA;MYO9B;FARP2;RAP2A;PHACTR4;EPS8;RAP1A;RASSF1;RAPGEF3;NF1;RIT2;CRKL;SGSM3;EPS8L2;BRAP;ELMO1;CDC42EP5;SOS1;ARHGAP5;TP53;LIMK1;SHOC2;GNA12
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.39023784064325406,0.748569327289517,0.8285714285714286,1.0,1.0,6/10,31.92%,DXO;PCID2;XRN1;EXOSC5;EXOSC9;EXOSC10
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.35354510568247083,0.7481270516529618,0.8529411764705882,1.0,1.0,2/14,11.38%,COMMD1;COX19
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.32759806579221595,0.7480735056533122,0.8709677419354839,1.0,1.0,9/31,18.21%,NKAIN3;SPTBN4;NKAIN2;WNK2;FGF12;NKAIN4;NEDD4;SLMAP;WNK3
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.2945044089104448,-0.7480055886936823,0.8970588235294118,1.0,1.0,5/76,7.04%,TBX1;TGFB1;NODAL;SCN5A;FUT2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.3603344346402103,0.7477107901867052,0.8333333333333334,1.0,1.0,2/19,4.39%,SLC12A1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.41587013365852965,-0.7475273650140153,0.7903225806451613,1.0,1.0,1/9,5.53%,BLK
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5151270257591277,-0.7474404393615974,0.7894736842105263,1.0,1.0,1/5,5.27%,STAT1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.24256614404966395,0.7472074972974398,1.0,1.0,1.0,86/461,18.01%,RFWD3;RNF182;NEUROD2;KLHL20;BCL2;LZTR1;UBE2E3;SIRT1;PSME4;PSMA1;COMMD1;ZNRF1;SH3RF1;ARRB2;ERCC8;MARCHF5;CBFB;RNF168;PEX13;DTX1;TRIM69;HIF3A;TRIM35;UBE2J1;WWP2;TRIM71;RNF166;FBXO15;UBE2O;FANCL;SH3RF3;RBBP6;UBE2E1;KLHL41;PDZRN3;RNF152;RNF10;GAN;KLHL18;UBE3D;UBE2E2;ANAPC16;KLHL24;TRIM44;UBE2D4;FBXL20;RNF217;TSPAN17;RNF38;MARCHF8;KLHL3;THOP1;FBXO28;UBE2A;MSL2;FBXL14;KLHL42;RNF146;ARRB1;KLHL22;SMURF1;PELI1;SHPRH;UBE2Z;UBE2QL1;CNOT4;FBXO27;HERC2;PELI2;ANAPC7;ARIH1;TRIM14;UBE2J2;UBE4B;NEDD4;ZNRF3;FBXO17;FBXL22;UBE2L3;LRSAM1;FBH1;RNF185;TRIM4;MARCHF3;BRAP;LONRF1
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.2637628299915719,0.7469596294814681,0.9583333333333334,1.0,1.0,13/134,10.49%,SKAP1;CD247;ICOSLG;CSK;PSME4;BTN3A2;PSMA1;RIPK2;HLA-DRA;PDE4B;PAG1;DENND1B;LCK
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),-0.5125917436808286,-0.746849448670624,0.92,1.0,1.0,3/5,25.96%,GPIHBP1;LDLRAP1;ANXA2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3817429214403518,0.7468162233196235,0.7608695652173914,1.0,1.0,5/15,12.64%,ROBO2;SLIT2;JAG1;BMP4;NOTCH1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.3990783753816551,0.7467746672528801,0.7777777777777778,1.0,1.0,3/10,10.16%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.3990783753816551,0.7467746672528801,0.7777777777777778,1.0,1.0,3/10,10.16%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.3606744511016906,-0.7466547142262596,0.8412698412698413,1.0,1.0,3/28,7.34%,FGF20;SYT10;SYT2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3442981150994079,-0.7464689910624952,0.8923076923076924,1.0,1.0,5/34,8.82%,MMP9;HTR1B;GPER1;SOD2;P2RY6
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3932786727531174,0.7462454894147968,0.8043478260869565,1.0,1.0,4/11,22.37%,SPRY4;CREB3L1;SULF2;SPRY3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.3600510520156426,-0.7462226200995211,0.8873239436619719,1.0,1.0,3/20,8.82%,MMP9;HTR1B;P2RY6
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.44206159020744673,-0.745665943335098,0.7903225806451613,1.0,1.0,4/8,23.79%,GPR183;C17ORF99;RNF8;MSH6
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.4473865474236954,0.7455815287862135,0.7924528301886793,1.0,1.0,2/5,12.64%,HES1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.2903899223122439,-0.7454887483537959,0.9571428571428572,1.0,1.0,12/81,15.30%,WNT5A;CYBA;PTPRC;ARG2;CLU;OAS1;TLR2;C1QTNF4;THBS1;OAS2;CACTIN;NLRC3
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.3086297856945503,0.7454007154994166,0.9354838709677419,1.0,1.0,5/52,8.12%,BCL2;MGARP;GDAP1;FLVCR1;SLC25A24
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.38692451860193905,0.7453786856432137,0.6944444444444444,1.0,1.0,5/14,13.23%,FSTL3;DOK5;SLIT2;TWSG1;ITGA3
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4083526306550762,-0.7453096371289973,0.7971014492753623,1.0,1.0,2/9,20.17%,DHX58;TKFC
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.2570518330876121,0.7451562886263857,1.0,1.0,1.0,19/103,15.73%,BCL6;KIAA0319;DCBLD2;SIRT1;SIPA1;PML;ST7L;DCC;SLIT2;DACT3;SMARCA4;CDA;ADAM15;HSPA1A;SMARCA2;ENPP1;SERTAD2;DIP2B;CGRRF1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.31523060068789455,0.745130684418943,0.775,1.0,1.0,5/28,12.64%,SMYD1;PLCB1;KLHL41;BMP4;NOTCH1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.38247422326074904,0.7449806082266088,0.868421052631579,1.0,1.0,5/12,26.67%,NAGK;UAP1;GNPNAT1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.4538599664014812,-0.744541390259825,0.847457627118644,1.0,1.0,1/6,12.29%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.38387707413290545,-0.7445065499266034,0.8461538461538461,1.0,1.0,3/21,9.88%,NLRP12;CEACAM1;NLRP3
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.4563103245437393,0.7443338185836303,0.8363636363636363,1.0,1.0,1/7,4.73%,CSK
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.2722931006826696,0.7442063544845986,1.0,1.0,1.0,17/121,11.63%,PCM1;CEP152;CDK14;CNTRL;CEP135;PLCB1;KDM8;PLK3;SDCCAG8;ALMS1;LATS1;DYNC1I2;CEP290;CCNH;AKAP9;CEP250;MAPRE1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.30093230018674944,0.744196035053271,0.7647058823529411,1.0,1.0,11/41,19.66%,MAFB;ASCL1;ZDHHC16;SMCHD1;SMG9;SIPA1L3;PBX1;ADAMTS18;ATF6;CHD7;PAX6
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.2866461112524499,0.7441203310715566,0.972972972972973,1.0,1.0,21/60,21.71%,RASSF2;TNFSF14;ADGRG3;CD14;IL23A;ADIPOR1;TRIM44;LIMS1;LGALS9;NR3C2;PPM1A;TSPAN6;NFAT5;LAPTM5;BCL3;CPNE1;EP300;DLG1;HDAC7;TRAF6;TCIM
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.3244400766736009,-0.7439806959010975,0.9629629629629629,1.0,1.0,6/47,8.26%,GMFG;ICAM3;FRAT1;GYPB;SLFN14;FAM110A
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.28782980887317794,0.7438786673575869,0.9,1.0,1.0,14/67,18.28%,SNX18;SEPTIN10;ESPL1;SPAST;RAB35;SNX9;SEPTIN9;SEPTIN8;SPIRE2;STAMBP;ARL3;KIF4B;EFHC1;BIN3
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.42082031282730614,0.743861134382489,0.7446808510638298,1.0,1.0,2/8,9.84%,LRP6;EFEMP1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.42549527737573023,-0.7438545349715842,0.7857142857142857,1.0,1.0,1/9,3.76%,IYD
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.47237015632139057,-0.7436238262831802,0.7857142857142857,1.0,1.0,2/5,21.33%,PROM2;CAV1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.35848940225772674,0.7433381280919793,0.851063829787234,1.0,1.0,3/18,9.84%,SLC30A10;PLIN5;ABCD2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.36279619917068356,0.7432573424150322,0.8285714285714286,1.0,1.0,4/19,9.56%,FZD5;WNT3A;FZD1;LRP6
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.3692155468772289,0.7431967373832499,0.8653846153846154,1.0,1.0,3/18,15.07%,BCL2;NOTCH1;PIK3CA
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.46997839855410795,0.7429703792717957,0.7674418604651163,1.0,1.0,1/5,20.06%,XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.46997839855410795,0.7429703792717957,0.7674418604651163,1.0,1.0,1/5,20.06%,XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.46997839855410795,0.7429703792717957,0.7674418604651163,1.0,1.0,1/5,20.06%,XYLB
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.37785035062127714,0.7428740022876287,0.8378378378378378,1.0,1.0,2/10,15.36%,DHFR;GCH1
prerank,MSigDB_Hallmark_2020__UV Response Up,0.259411930462967,0.7428244265450425,1.0,1.0,1.0,21/142,15.36%,TACR3;PDLIM3;RAB27A;FGF18;BSG;LHX2;ARRB2;CCND3;ATF3;CTSV;NR4A1;NXF1;CASP3;RET;HTR7;JUNB;CHKA;CA2;PTPRD;CYB5B;GCH1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.35521470677423816,-0.742762233252659,0.8450704225352113,1.0,1.0,4/22,16.28%,CAV3;VAV3;RAC1;MSN
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.2760338276397973,-0.7426569222824562,0.9866666666666667,1.0,1.0,20/182,20.42%,ARIH2;DTL;UBE2L6;PINK1;TRIM25;FBXL7;RNF213;SIAH1;STUB1;RNF20;ISG15;UBL7;HERPUD1;FEM1C;RBX1;RNF144B;RNF8;KCTD10;RPS27A;AURKA
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.38410941814550886,0.7423600714661095,0.7755102040816326,1.0,1.0,5/17,14.10%,TGFBR1;ROBO2;PKD2;HES1;NF1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.3011059957711348,-0.742124977684333,0.9,1.0,1.0,11/79,17.52%,NEK2;KIF14;DYNLL1;DCTN1;CEP72;TUBA4A;ATF5;TUBB;ATAD5;CEP76;TUBB4A
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.364160188796751,-0.74167030234436,0.8333333333333334,1.0,1.0,6/26,16.90%,CAV3;DCTN1;ANKRD53;CDK5R1;RAC1;PSRC1
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.4356808220222532,0.7415537561049389,0.7959183673469388,1.0,1.0,3/6,20.94%,NOTCH1;ANK2;MDM4
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4103430433723991,-0.7415499528492787,0.8703703703703703,1.0,1.0,4/14,17.37%,GPER1;SOD2;CDKN1A;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.2670619140775206,0.7414377317276709,0.9142857142857143,1.0,1.0,23/90,20.52%,BCL2;NKD2;ERBB2;EPHA3;PPP1R13B;MAPK8;AKT2;DPP10;MYO1C;PTPN9;STAC2;ITGA3;MIEF2;EPHB2;CEMIP;WNK3;BID;CLIP3;PRKCE;TFDP1;TP53;ZDHHC5;DLG1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.37745970544020435,-0.7412673240915825,0.8448275862068966,1.0,1.0,2/19,18.27%,BACE2;ERAP1
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),-0.4577775216301669,-0.7410913998290276,0.7741935483870968,1.0,1.0,2/5,18.77%,SLC7A3;SLC47A1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.27107750177691803,0.7409539841254528,0.96,1.0,1.0,17/122,11.63%,PCM1;CEP152;CDK14;CNTRL;CEP135;PLCB1;KDM8;PLK3;SDCCAG8;ALMS1;LATS1;DYNC1I2;CEP290;CCNH;AKAP9;CEP250;MAPRE1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.41932960837436695,0.7409475735733715,0.8409090909090909,1.0,1.0,3/10,12.23%,ZBTB7B;HLA-DRA;LGALS9
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.36502423769480863,0.7409434695796018,0.7906976744186046,1.0,1.0,2/16,7.03%,SERPINE1;CRK
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.380179687327064,0.7408769515019175,0.7777777777777778,1.0,1.0,6/12,17.95%,ELOVL6;ELOVL4;HACD1;TECR;ELOVL1;ELOVL5
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.37308923637850244,0.7407243507904511,0.825,1.0,1.0,5/23,20.84%,TRAK2;BICDL1;KIF3B;NDE1;BICDL2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.27727271092025996,-0.7407240399761795,0.9866666666666667,1.0,1.0,10/139,9.29%,TRIM62;TERF2IP;TRIM5;LPAR1;S100A13;HLA-DRB1;PINK1;TRIM25;HTR2B;TRAF3IP2
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.4718931268384492,0.7406481233741565,0.7441860465116279,1.0,1.0,3/5,14.14%,TENM3;PTPRR;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2936957024855828,-0.7406423332125742,0.9452054794520548,1.0,1.0,10/78,18.72%,ARIH2;DAB2;CLU;USP13;STUB1;NOP53;RBX1;KCNE2;ELOB;RNF144B
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.29379513386151884,-0.7404559553716304,0.9180327868852459,1.0,1.0,15/91,20.29%,APOL1;AHR;CYBA;DTX2;LRP10;SPINT1;OAS1;CTSZ;CXCL16;MFGE8;FOSL2;MARCKSL1;GRN;PGLYRP1;IL13RA1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.38522769416666136,-0.7401686058245786,0.8703703703703703,1.0,1.0,3/16,12.89%,TGFB1;TNFRSF1B;CLCF1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.26567684654631957,0.7401029642759006,1.0,1.0,1.0,21/131,14.09%,PCM1;HDAC3;BCL2;HTRA2;FZD5;ERBB2;PPP1R13B;PLK3;ANP32B;MAPK8;AKT2;FLNA;TENM1;CEP290;HCLS1;JUP;MYO1C;B3GAT3;USP36;MIEF2;RAPGEF3
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.2882890141206089,-0.7400097721374005,0.9558823529411765,1.0,1.0,7/85,12.51%,DTL;UVSSA;PCLAF;CCND1;CDC25A;IL12A;CDKN2D
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.40912114752490925,-0.7399648054525845,0.7931034482758621,1.0,1.0,2/16,10.71%,CCDC39;AQP4
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.3848091006959479,0.7398356127827107,0.825,1.0,1.0,5/14,20.35%,SFSWAP;SRSF4;PCBP4;PTBP1;U2AF2
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.38575423198641656,-0.739821911440389,0.819672131147541,1.0,1.0,7/15,27.24%,PINK1;COX7A1;COX7A2;ACTN3;COX7A2L;UQCC2;NUPR1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.3812176465634612,0.7397185490696907,0.8653846153846154,1.0,1.0,3/14,15.07%,BCL2;NOTCH1;PIK3CA
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.33801209066598986,0.7395262546780961,0.8333333333333334,1.0,1.0,3/19,10.22%,TOR1B;UBXN2A;SPAST
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.4400748934965859,-0.7391648048902366,0.8333333333333334,1.0,1.0,3/8,16.87%,PIK3CG;PIK3CB;PIK3C2G
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.34698064491531877,0.7390277224886834,0.9333333333333333,1.0,1.0,4/22,18.68%,SLC12A1;SLC12A9;SCNN1B;SLC12A4
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.43173974928119124,-0.7390229858783155,0.8545454545454545,1.0,1.0,2/10,14.86%,ESR1;THRA
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.35067659846589794,-0.7390096887473281,0.7794117647058824,1.0,1.0,5/22,16.83%,SLC14A1;UPK3A;ABCG2;SLC14A2;AQP11
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.38367590104781096,-0.7388932975906367,0.8813559322033898,1.0,1.0,1/18,4.86%,ESR1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.4466333821640998,-0.7388703415716662,0.7636363636363637,1.0,1.0,1/7,5.20%,IRF1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.4304875837426093,0.7387328214158349,0.8043478260869565,1.0,1.0,2/8,9.15%,DOC2B;AKT2
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.37441998790098857,0.7386214985583781,0.717948717948718,1.0,1.0,4/10,19.88%,TOM1L2;BMP4;DMRT1;AURKAIP1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.2776583724042334,0.738506499464783,1.0,1.0,1.0,9/94,8.25%,FOXO1;APOE;SLC25A37;NKD1;STX5;RAB7A;WWP2;CARD9;MAPK8
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.35537634687611197,-0.7384662560378643,0.828125,1.0,1.0,3/22,16.28%,ITGB2;SELP;MSN
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.30393621305032503,-0.7383395118655414,0.8985507246376812,1.0,1.0,6/54,17.37%,TGFB1;NODAL;SMAD6;SMAD3;TMEM100;TGFB3
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.42543955766763053,0.7382738154914372,0.8,1.0,1.0,2/7,23.28%,ABCA7;DYRK1A
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.4319856016000114,0.7381591604461035,0.7608695652173914,1.0,1.0,3/7,16.92%,ABI3;RBMS3;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3758816763379918,0.7380562848516056,0.7021276595744681,1.0,1.0,4/13,14.18%,APOB;LPL;PLA2G5;NFKB1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.4986752777842099,0.7375960857758193,0.8372093023255814,1.0,1.0,2/5,19.21%,FBH1;MUS81
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.33866152611487244,0.7374396934269947,0.8333333333333334,1.0,1.0,2/21,5.13%,URI1;PPP1R35
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.4198242144514463,-0.7373714088011248,0.7368421052631579,1.0,1.0,2/8,11.14%,TAF7;SPI1
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.4283230521014208,-0.7370457183718472,0.7704918032786885,1.0,1.0,1/7,4.74%,HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.4283230521014208,-0.7370457183718472,0.7704918032786885,1.0,1.0,1/7,4.74%,HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.33254881164868083,-0.7369527386373081,0.819672131147541,1.0,1.0,8/40,19.33%,ECM2;ALOX15;VIT;PLG;PIK3CB;RAC1;BST1;FBLN2
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.2931728864079922,0.7369185784417441,0.9032258064516129,1.0,1.0,10/50,19.27%,EXTL1;PDIA6;CTDSP2;ERN1;PREB;CXXC1;DNAJC3;YIF1A;EDEM1;ADD1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.40219428103331534,-0.7366934577505398,0.8225806451612904,1.0,1.0,2/12,18.82%,ADAD2;ADARB2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.35958960330685463,-0.7366715584863519,0.8793103448275862,1.0,1.0,2/24,14.09%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.43868650988838953,-0.7365026148234098,0.8596491228070176,1.0,1.0,2/7,11.90%,OAS1;APOD
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.39822504255737,-0.736395481689271,0.8307692307692308,1.0,1.0,4/12,22.34%,TLR2;DDX60;DHX58;USP17L2
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.38513265771562566,-0.7363230243539635,0.8714285714285714,1.0,1.0,3/18,12.29%,TGFB1;ASPN;HEY2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.3063978995707564,0.7362699667210864,0.967741935483871,1.0,1.0,6/32,12.52%,HDAC3;FLNA;HCLS1;JUP;MDFIC;BMP4
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.4168115945227415,-0.7361392414695814,0.8620689655172413,1.0,1.0,4/13,14.06%,CYP1B1;NQO1;ARG2;NOS2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3998333219006382,0.735920577638358,0.8,1.0,1.0,4/14,17.46%,TIMELESS;ARID2;WRAP53;FUS
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),-0.4464107863983765,-0.735918369690936,0.8484848484848485,1.0,1.0,2/11,6.76%,WNT5A;LRP4
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.269554840789863,-0.7358285462172618,1.0,1.0,1.0,37/299,17.91%,NOTUM;PSMB9;APOL1;ITIH2;DTL;RAB11A;WFS1;ASB14;SDC2;FBXL7;SERPIND1;FBXL13;PRSS23;COPS5;CCNF;GPC3;RBBP7;CP;RAB8A;SERPINA10;RABGGTB;KLHL2;RABGGTA;MFGE8;COPS4;F5;FN1;ASB5;SUMF1;FEM1C;FBXO40;IGFBP3;PSMA7;RBX1;PSMB6;ELOB;ALB
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.4548819931599313,0.7357165599242745,0.8,1.0,1.0,2/6,5.76%,GLA;SNCA
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.44332688487829963,0.735695405426989,0.7884615384615384,1.0,1.0,2/8,16.37%,PLXNB1;PLXNA4
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),0.45006936323722224,0.7355053419324842,0.8421052631578947,1.0,1.0,2/5,38.00%,ABCA3;TRIAP1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.3225013915736619,0.7352622441522159,0.9655172413793104,1.0,1.0,11/42,15.70%,CD38;BCL2;SHLD2;SH3KBP1;SHLD1;TNFSF13B;IRS2;KMT5C;EPHB2;CD40;KMT5B
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.3490125183541527,0.7349791809982411,0.7878787878787878,1.0,1.0,2/22,9.62%,PMEL;TYRP1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.4564770475430885,-0.7349686520986648,0.7931034482758621,1.0,1.0,2/5,26.87%,RNF20;CDK9
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.2723272672138057,0.734507932620218,0.96875,1.0,1.0,20/114,20.63%,PARD3;NLGN1;ZDHHC11B;ZDHHC12;MGARP;GDAP1;LTBP2;MYO1C;GOLGA7B;TRAK2;ZDHHC18;MAN1A1;ZDHHC14;AP4S1;ZDHHC3;ZFAND6;EDEM1;ZDHHC11;ZDHHC9;RASSF9
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.4337633170682607,-0.7343789755517175,0.75,1.0,1.0,1/6,5.33%,SOX30
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3056402746588702,0.7343706427142375,0.8611111111111112,1.0,1.0,10/38,20.99%,ST6GALNAC3;ST8SIA4;SMPD4;TLCD3B;CERS4;FA2H;SAMD8;ST8SIA3;CERS5;ST6GALNAC5
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.3578132115814985,0.7343563713123066,0.782608695652174,1.0,1.0,8/15,24.99%,SLC19A1;SLC25A24;SLC25A42;SLC35B2;SLC25A41;SLC17A9;ABCC5;SLC25A17
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),-0.4587935188277321,-0.7341378785741017,0.8333333333333334,1.0,1.0,1/5,21.09%,AGT
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.3989596186912877,0.7340112357974807,0.868421052631579,1.0,1.0,3/13,15.36%,HDC;GPHN;GCH1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.28345172431678634,0.7338210223637203,0.9444444444444444,1.0,1.0,30/112,25.01%,HSPB1;MAPKAPK2;SAMD4A;PSME4;PSMA1;EXOSC1;ANP32A;CSDC2;KHSRP;MOV10;HSPA1A;PCBP4;PNPT1;ZC3H14;YTHDF1;FXR2;DIS3;RC3H1;SAMD4B;PSMD4;XPO1;NUP214;IGF2BP1;PCID2;PSMD5;PSMD10;DCP1A;RBM24;PKP1;XRN1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.43892088221981995,-0.7334556058096192,0.7903225806451613,1.0,1.0,2/9,7.99%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.457054548824878,-0.7334337621771135,0.8387096774193549,1.0,1.0,1/7,1.85%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.3503040937847852,-0.7333791251136573,0.85,1.0,1.0,5/31,17.51%,KIF14;HTR2B;SVIL;CDC6;ECT2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.4724601643531532,0.7333693101698721,0.78,1.0,1.0,1/5,1.62%,KLRD1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3392004976258583,0.7330847738361574,0.918918918918919,1.0,1.0,6/24,16.61%,F2;SNCA;PKD2;GSTM2;CEMIP;F2R
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.3765350399665974,-0.7327900396541425,0.8412698412698413,1.0,1.0,2/17,4.96%,CYP1B1;CYP3A5
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.45306929135483875,0.7327102138582139,0.7555555555555555,1.0,1.0,2/5,12.08%,SLC7A2;SLC25A29
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.342348038467654,0.7326044288043284,0.8648648648648649,1.0,1.0,4/22,12.64%,SIRT1;TIMP1;APBA3;NOTCH1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.4169327922633032,0.7324960255339128,0.8717948717948718,1.0,1.0,1/8,3.73%,SIRT1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.49017012562703743,0.7323575619305335,0.782608695652174,1.0,1.0,1/5,4.70%,CD14
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.3771596021723333,-0.7322448170552,0.7777777777777778,1.0,1.0,7/19,22.50%,SVIL;CSRP3;POPDC2;MYL6;BASP1;CAV1;SIX4
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.36389442459901844,-0.7321778528181812,0.7846153846153846,1.0,1.0,4/22,21.40%,TGFB1;HEY2;CAV1;ENG
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.45016870400005554,0.7320853335371739,0.775,1.0,1.0,1/5,5.57%,RORB
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.45016870400005554,0.7320853335371739,0.775,1.0,1.0,1/5,5.57%,RORB
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.45986890405045133,-0.7317600698683663,0.9433962264150944,1.0,1.0,4/7,24.12%,PTPRC;GRN;TAFA3;SYT11
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.4557551416786044,0.7316963424573963,0.8367346938775511,1.0,1.0,3/5,37.99%,AXIN1;GSK3B;APC
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.4240748754367263,0.7316398276075498,0.75,1.0,1.0,2/9,16.93%,REP15;RAB11B
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.2849077324412911,-0.7314739344014146,0.9452054794520548,1.0,1.0,14/117,13.63%,AQP3;CRLF1;COL1A1;SLCO2A1;ITGB6;SEMA3F;OSMR;COL4A4;COL4A3;A4GALT;SCNN1G;LAMC2;SLC44A3;CLDN1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.33219005619478037,0.7314192436554785,0.875,1.0,1.0,7/19,24.46%,RPS6KA4;ARRB1;DIP2B;FOXP3;PRKAA2;NOS1;TADA2A
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.3464005792484769,-0.7314189316036656,0.875,1.0,1.0,7/33,18.51%,KIF14;LGI4;TNFRSF1B;HEY2;BHLHE41;HES7;HEY1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.2971975057785391,0.7311516113113623,0.8666666666666667,1.0,1.0,10/45,18.10%,SNX18;ESPL1;CNTROB;SPAST;RAB35;SNX9;STAMBP;ARL3;KIF4B;EFHC1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.32833743860623327,-0.7311137264466117,0.9016393442622951,1.0,1.0,12/47,26.07%,TRAIP;PTPRC;OAS1;PALM3;CACTIN;ISG15;PELI3;OAS3;CARD8;GPS2;PARP14;OTUD4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.30814794992292344,0.730984739490689,0.8484848484848485,1.0,1.0,4/30,14.10%,PCM1;WNT3A;NOTCH1;NF1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.2861604233349576,0.7309385843382139,0.9666666666666667,1.0,1.0,13/59,23.69%,RAB7A;KPNA6;PKN2;MDFIC;TARBP2;GTF2F2;TYRO3;POLR2F;RSF1;LARP1;ADAR;PPIH;SRPK2
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.4830556557821075,-0.7309165300941362,0.8490566037735849,1.0,1.0,2/5,9.94%,CAV3;CAV2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.3963711856326088,0.7307112587826388,0.7714285714285715,1.0,1.0,1/9,11.36%,TERF1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.36985495611443603,0.7306714942072069,0.8108108108108109,1.0,1.0,6/16,13.08%,SMARCD3;SMARCB1;SMARCA4;MYC;ARID1A;ARID2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.29847734198288967,-0.7305368107542936,0.972972972972973,1.0,1.0,3/72,3.38%,ARIH2;DAB2;CAV3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.4023480434410007,0.7305158980656676,0.8125,1.0,1.0,1/9,8.77%,FHL2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4023480434410007,0.7305158980656676,0.8125,1.0,1.0,1/9,8.77%,FHL2
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.41028370034629913,-0.7301581490876929,0.9152542372881356,1.0,1.0,2/11,15.45%,NUCKS1;IFI27
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.2715630151638349,0.7298397179220907,0.9166666666666666,1.0,1.0,16/61,20.60%,TDO2;TRPM2;SNCA;HCN1;PKD2;ACACB;GRIN1;ALDH1A2;USP16;CPSF7;HPRT1;KCNC3;SHMT2;SAMHD1;APPL2;CPSF6
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.4471000876124228,0.7297224862706431,0.8043478260869565,1.0,1.0,1/5,2.97%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.27576644829807745,0.7296816624976441,0.9666666666666667,1.0,1.0,11/43,23.09%,KCNJ3;KCNJ6;FLNA;WNK2;AKAP9;ANK2;KCNJ10;WNK3;WNK1;KCNH2;AKAP6
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.2939374810056819,0.729527372058031,0.8918918918918919,1.0,1.0,4/52,4.76%,CYP7B1;OSBPL3;OSBPL6;AKR1C3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.3376303242815548,-0.7293672281918222,0.9230769230769231,1.0,1.0,2/41,1.85%,WNT5A;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.33674565392204037,0.7292781809427273,0.7692307692307693,1.0,1.0,5/18,20.35%,SFSWAP;SRSF4;PCBP4;PTBP1;U2AF2
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.3929659069671047,-0.7291695880664044,0.863013698630137,1.0,1.0,1/15,2.84%,NODAL
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.3722818231706801,0.7291360159195339,0.8717948717948718,0.9999482375560059,1.0,2/11,16.36%,TJP2;F11R
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2904930727213886,0.7288666527067265,0.918918918918919,0.9999247980289471,1.0,10/39,16.61%,F2;JPH1;SNCA;JSRP1;GSTM2;UBASH3B;ANK2;JPH4;CEMIP;F2R
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.2707869692916696,-0.7288314927012104,1.0,1.0,1.0,28/174,17.57%,CCNG2;HK2;COL5A1;DCN;TGFBI;PHKG1;ALDOB;ENO2;SDC2;CAVIN1;SAP30;PNRC1;PKLR;GPC3;LOX;CP;NDRG1;GLRX;DDIT4;LXN;CDKN1A;GAPDHS;B3GALT6;LDHC;TGM2;FOSL2;TGFB3;IGFBP3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.4240868697456191,0.728363209536811,0.8461538461538461,1.0,1.0,3/9,21.01%,RAP2A;CAMSAP3;MYO9A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),-0.4605672447472995,-0.7283463492054753,0.7931034482758621,1.0,1.0,1/5,6.97%,ITGB6
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.4246730058007261,0.7283106129634833,0.8095238095238095,0.9999854143547101,1.0,1/5,14.10%,RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3960554468831291,-0.7283098914998863,0.8524590163934426,1.0,1.0,1/12,4.74%,HLA-DRB1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.29706651887357516,0.7283077675269595,0.9545454545454546,0.9996397574537924,1.0,11/42,17.37%,KIT;TET2;IFI16;FLVCR1;HCLS1;CASP3;KAT6A;RUNX1;ACIN1;MFHAS1;DYRK3
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.3309565678050129,-0.7282256770142504,0.8571428571428571,1.0,1.0,1/38,2.49%,TRIM62
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.394265705837869,-0.7281565021316617,0.8181818181818182,1.0,1.0,3/11,26.29%,TMEM35A;HSP90AB1;GPD1L
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.46303669729408103,-0.7281275506162099,0.8301886792452831,1.0,1.0,1/5,3.38%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.2870441738372437,0.7280939800219945,0.9473684210526315,0.9995144530465786,1.0,12/78,12.52%,CCN4;HTRA2;SNCA;SRGAP2;DCPS;CCN2;ADNP2;BTBD10;PM20D1;HSPA1A;CCN1;BMP4
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.35294787379449843,0.7278181411978223,0.875,0.9994697367602292,1.0,2/20,5.81%,PCM1;WNT3A
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.2817218396188147,0.7275871117156297,0.95,0.9993928618523805,1.0,13/67,22.23%,PRICKLE1;RANBP17;BACH2;NXT1;SNRPB;GEMIN5;NUTF2;APPL2;PPP1R10;SNRPF;IPO8;NUP214;TPR
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.440279229162633,-0.7273723081884729,0.8,1.0,1.0,2/8,14.09%,SLFN14;THBS1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.307151299758554,0.7272298409386945,0.9696969696969697,0.9994769319745606,1.0,16/58,18.40%,BRCC3;ERCC8;RNF168;HMGB1;SMARCAL1;POLM;KDM2A;SMC5;PAXX;SETMAR;LIG4;HERC2;ATM;RAD50;NSMCE2;H2AX
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.4573446245624221,-0.7270583431320999,0.7924528301886793,1.0,1.0,2/5,16.03%,UBE2L6;ISG15
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.3085484068693923,-0.7270533999999405,0.8823529411764706,1.0,1.0,6/65,11.02%,WNT5A;IFNK;CYBA;NLRP12;TLR2;SH2D1B
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.3718044219673579,-0.7268536311309125,0.8305084745762712,1.0,1.0,2/15,3.98%,TULP1;PDE6B
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3777131745488713,-0.7262027278811083,0.9122807017543859,1.0,1.0,1/17,3.79%,SCN5A
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.44680660838709274,-0.7260626156591441,0.8245614035087719,1.0,1.0,2/6,21.33%,CAMK2A;CAV1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.31008479814023693,-0.7258863316016894,0.9701492537313433,1.0,1.0,13/60,18.98%,HLA-DRB1;HLA-A;PDCD1LG2;IL27;ZFPM1;SLC11A1;HLA-DPB1;IL12A;TXK;HLA-DPA1;ISG15;VSIR;IL18
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.3457650253577806,0.7257507140049858,0.8846153846153846,1.0,1.0,4/15,23.04%,GBF1;ANK2;MIA3;UBAC2
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),-0.46166009076160663,-0.7257415558187048,0.8135593220338984,1.0,1.0,3/5,18.98%,IL12A;HSPH1;IL18
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.426527044125696,0.7255290313540127,0.8260869565217391,1.0,1.0,1/6,4.21%,PRDM5
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.2698940973275465,-0.7254579474171029,0.9722222222222222,1.0,1.0,24/182,16.33%,TBX1;FGF20;TGFB1;DAB2;TERF2IP;CDK2AP1;MMP9;HLA-DRB1;PINK1;GPER1;FLT4;CCND1;CARD14;PIK3R3;SVIP;NTRK1;PROM2;TEK;ATG14;FGF22;TXN;FAXDC2;RAC1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.40419595146215853,0.725224658151852,0.782608695652174,1.0,1.0,3/7,32.07%,PIBF1;NF2;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.30510356941764344,0.7246422044864796,0.78125,1.0,1.0,9/28,27.10%,TOP2A;PKN2;TARBP2;LARP1;ADAR;PPIH;SRPK2;PPIA;PABPC1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3947807048818862,0.7245396736512445,0.8627450980392157,1.0,1.0,3/12,24.40%,ALG12;ALG3;ALG13
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.28514830232812843,-0.72445641130031,0.9117647058823529,1.0,1.0,7/66,11.49%,WNT5A;TGFB1;ALOX5;GPER1;ZFPM1;ADIRF;RORC
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.36847392573582705,-0.7241803722743475,0.8571428571428571,1.0,1.0,7/21,25.20%,ABCG2;ATP5IF1;UROS;ALB;PGRMC1;ALAS2;NFE2L1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.33158167134020444,0.7241308097984283,0.8378378378378378,1.0,1.0,7/23,16.36%,CBFB;RAPGEF1;MYO1C;RAP1A;RUNX1;OCLN;F11R
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3344772572772341,0.7238974836598648,0.8571428571428571,1.0,1.0,3/17,7.55%,PROX1;PKD2;CCND3
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.39035659999607664,0.7237544102065445,0.8611111111111112,1.0,1.0,3/12,9.01%,ANGPT1;PDE3A;TJP2
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.3025058194584021,-0.7236336750565896,0.9538461538461539,1.0,1.0,11/58,21.84%,TGFB1;NODAL;SMAD6;VSTM2A;SFRP1;SMAD3;TMEM100;TGFB3;SOX9;ENG;GDF15
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.3150456225152395,0.7235349307758613,1.0,1.0,1.0,10/34,20.57%,RFWD3;SMARCAL1;BOD1L1;MMS22L;PRIMPOL;SETMAR;FBH1;DNA2;SAMHD1;ATR
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.4532170967924408,-0.723513216784634,0.8333333333333334,1.0,1.0,1/8,4.20%,CCDC39
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.42285257855287617,0.7234774527409367,0.8055555555555556,1.0,1.0,3/8,7.75%,MMP2;OPN5;TIMP1
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.2646010358776323,-0.7234430354214825,0.9855072463768116,1.0,1.0,11/180,7.67%,NRAP;ACTC1;CTNNA1;CLDN5;TGFBI;MMP9;ACTG1;ITGA9;CALB2;PTPRC;TSPAN4
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.4261377745435332,-0.7233740775676919,0.7962962962962963,1.0,1.0,2/7,23.13%,SPI1;VCPIP1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.4196518501699349,-0.7230501323657426,0.8076923076923077,1.0,1.0,5/8,30.50%,TXNIP;ORC6;RFPL1;BLM;VPS4A
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.4388680186315971,0.7226217761778215,0.7551020408163265,1.0,1.0,1/5,14.41%,LRP8
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.40541099509495077,-0.7224757731881386,0.9310344827586207,1.0,1.0,4/14,14.06%,CYP1B1;NQO1;ARG2;NOS2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.41520913993540864,0.7223368994754562,0.7959183673469388,1.0,1.0,1/7,14.84%,CTPS2
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.4026143645176828,0.7222553021509351,0.813953488372093,1.0,1.0,1/7,2.48%,PARD3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4360472470356088,-0.7222290173875464,0.7916666666666666,1.0,1.0,1/7,7.78%,RNF213
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.3404445660016566,0.7219429451815337,0.8611111111111112,1.0,1.0,3/25,7.62%,PKD2;FER;STAT5B
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.2639048591995819,-0.7217537289898237,0.9861111111111112,1.0,1.0,12/143,12.58%,CASQ2;TGFB1;CCDC39;CHMP3;DRC1;CYBA;CLU;RPL38;HIGD1C;TMEM35A;TESPA1;COX7A1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.2453595888079082,0.7214861211203546,0.9642857142857143,1.0,1.0,33/142,22.46%,SMYD2;CCNG1;PML;MLST8;PPP1R13B;PLK3;TAF3;SGK1;TAF12;BANP;CHD4;HDAC1;KAT6A;PRMT5;PIP4K2A;ATM;BRIP1;RAD50;RAD9A;DNA2;TAF4;RAD17;EP300;MAP2K6;TP53;PRKAG2;ATR;MDM4;CDK5;PRKAA2;RBBP4;NOC2L;ATRIP
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.37033790847663584,-0.7214622321188914,0.8939393939393939,1.0,1.0,3/19,12.95%,SYNE2;MYO1F;MYO5B
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.3409184574787198,0.7214274022037653,0.8260869565217391,1.0,1.0,4/17,22.38%,TIMELESS;SPIDR;HSF1;CPS1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.4172659554500689,0.7210146991804114,0.8260869565217391,1.0,1.0,1/6,2.86%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.4243622768229811,-0.7209491413027592,0.8888888888888888,1.0,1.0,1/8,4.99%,PINK1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.31212331219005246,-0.7208652178204299,0.9841269841269841,1.0,1.0,13/49,23.71%,FRAT1;CHMP3;WNT8B;HSPA8;GABARAPL1;GABARAPL2;RUBCNL;WNT8A;VAMP7;RPL23;CAV1;LAMP2;MAP1LC3B2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.30599224516363605,-0.7207938043875783,0.90625,1.0,1.0,20/58,28.56%,RPL38;RPL35A;EMG1;RPS16;RPL5;WDR12;RPS7;RPS15;RPS28;RPL11;SURF6;RPS19;RPL26L1;RPS24;RPS25;DHX37;RPS6;EBNA1BP2;MRTO4;RBIS
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.25089373696845924,0.7202096282086022,1.0,1.0,1.0,13/94,12.64%,PDLIM3;TGFBR1;OSR1;RBM20;CDH5;PKD2;CFC1;ALPK3;BCOR;FGF12;NOTCH4;ZDHHC16;NOTCH1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.2768683492087293,0.720206847144961,0.9666666666666667,1.0,1.0,8/65,8.79%,THEM4;AK3;ACSM2A;THEM5;SULT2A1;ACOT9;AMPD1;PDE9A
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),0.4366257202375737,0.719902993576234,0.7916666666666666,1.0,1.0,1/5,7.90%,NLRP2B
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.31281202759760574,0.7198961329340324,1.0,1.0,1.0,2/24,5.34%,PER2;IFI16
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.3631208858987039,-0.7197605925562593,0.8852459016393442,1.0,1.0,2/20,7.01%,HLA-DRB1;PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.4074676584292666,0.7193708864075389,0.7674418604651163,1.0,1.0,1/7,1.32%,KIT
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.23463137186352878,0.7191273540642599,1.0,1.0,1.0,55/353,17.89%,RFWD3;RNF182;NUP210;NEUROD2;KLHL20;LZTR1;UBE2E3;SIRT1;COMMD1;ARRB2;NUP42;RNF168;PEX13;DTX1;BCL11A;TRIM69;HIF3A;TRIM35;WWP2;AAAS;DCUN1D1;UBE2E1;KLHL41;PDZRN3;RNF152;RNF212;GAN;KLHL18;ANAPC16;KLHL24;TRIM44;UBE2D4;TSPAN17;RNF38;KLHL3;UBE2A;MSL2;ARRB1;SMURF1;SHPRH;UBE2Z;CNOT4;HERC2;ANAPC7;ARIH1;TRIM14;UBE2J2;NEDD4;ZNRF3;UBE2L3;NSMCE2;FBH1;TRIM4;MARCHF3;BRAP
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.39887658377733043,-0.7189350483252577,0.8333333333333334,1.0,1.0,1/16,0.48%,DBH
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.3207447566787369,0.7188509047961261,0.8857142857142857,1.0,1.0,6/29,12.64%,ROBO2;SEMA6C;SEMA5A;SLIT2;SEMA4A;NOTCH1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.38378798617326426,0.7181098549526592,0.8571428571428571,1.0,1.0,3/11,10.16%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.4258974141809169,0.7178840879342404,0.7954545454545454,1.0,1.0,3/10,15.77%,WWP2;TERF1;CORO2B
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2740900187507045,0.717871616967483,0.9375,1.0,1.0,17/59,21.47%,RFWD3;PML;PLK3;PLAGL1;CNOT9;CRADD;CARM1;PCBP4;CNOT4;ATM;GADD45A;TFDP1;EP300;TP53;FBXO31;MDM4;CNOT6
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.4036703361014433,0.7175742852084347,0.7894736842105263,1.0,1.0,3/7,22.78%,BCAT1;MCCC1;HMGCLL1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.36453944824484763,-0.7172514551787467,0.8448275862068966,1.0,1.0,7/23,22.50%,SVIL;CSRP3;POPDC2;MYL6;SGCG;CAV1;SIX4
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.3445713125246928,0.7171778475924605,0.9024390243902439,1.0,1.0,3/23,3.91%,GPR161;TULP3;KCTD21
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.353204953297076,-0.7171118688401543,0.8307692307692308,1.0,1.0,3/23,11.62%,PINK1;UBE3A;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.4520029922750568,-0.7168591031077447,0.803921568627451,1.0,1.0,3/5,34.19%,PRKD2;SMOC2;NPTN
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.36376202859474227,0.7168375995963144,0.8717948717948718,1.0,1.0,6/12,35.34%,MLLT3;METTL4;SSRP1;HNRNPU;SETD5;TLK2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.3842005610994949,0.7167626438719933,0.725,1.0,1.0,6/11,24.18%,WNK2;WNK3;DMD;WNK1;ANK3;NOS1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.37477319316351865,-0.716708126952339,0.8709677419354839,1.0,1.0,3/17,22.09%,DEGS2;CALM1;GCHFR
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4218652741405999,0.7166071545283038,0.8,1.0,1.0,2/8,10.23%,RAB27A;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.350087301837985,-0.7157986628313798,0.9,1.0,1.0,4/23,19.59%,CASQ2;TRDN;CALM1;PLN
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.46441169256918774,-0.7157576804228551,0.8333333333333334,1.0,1.0,2/5,21.52%,PRPS1;DCK
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),-0.46382712895629286,-0.7157212158983591,0.7666666666666667,1.0,1.0,2/5,17.39%,TGM2;FIS1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.3942810518157123,-0.7156049718361478,0.765625,1.0,1.0,2/10,15.40%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3306129785305517,0.7155071373709873,0.78125,1.0,1.0,8/17,16.61%,F2;WNT4;BMP4;RUNX1;SUCO;CREB3L1;EMILIN1;F2R
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.27180957844394976,0.7154964803859287,0.967741935483871,1.0,1.0,19/96,18.23%,SKAP1;CDH5;NRG1;SNCA;MED25;ABCA1;PIH1D1;FERMT1;TERF1;RASIP1;UNC13B;FSCN1;GNL3L;SPIDR;ATM;FAF1;ICE1;TPPP3;BID
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.4422216256914585,-0.715438314352814,0.8135593220338984,1.0,1.0,1/6,15.47%,TXN
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.454206967622167,0.7152796522745919,0.875,1.0,1.0,2/6,13.60%,CD14;LBP
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.454206967622167,0.7152796522745919,0.875,1.0,1.0,2/6,13.60%,CD14;LBP
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.2953658332816425,-0.7151142102338195,0.9850746268656716,1.0,1.0,10/60,16.70%,CRLF3;SPDYA;CCND1;LATS2;CDC25A;CDKN2D;MAX;CDKN1A;CDKN3;CAMK2A
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.33087995568857176,-0.7150951245533549,0.8852459016393442,1.0,1.0,3/31,11.07%,POLR1C;CAVIN1;POLR1G
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.3934164544593033,0.714850058376453,0.8,1.0,1.0,3/10,21.42%,IRAK4;TRAF6;PIK3R4
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.4092752714773681,0.7145288164448224,0.8292682926829268,1.0,1.0,3/7,18.50%,GMPS;CTPS2;SHMT2
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.4556978216782447,-0.7143741875413933,0.8269230769230769,1.0,1.0,1/6,3.38%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3650611682409863,-0.7143161009430304,0.8235294117647058,1.0,1.0,2/18,10.55%,CEACAM1;CD160
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.39935080006146206,0.7141317293060869,0.7948717948717948,1.0,1.0,2/8,15.67%,HSPA1A;SACS
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.43664713770815267,-0.7140610719427621,0.873015873015873,1.0,1.0,1/6,11.86%,TNXB
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.32008110957841357,-0.713900143759675,0.8620689655172413,1.0,1.0,4/26,12.29%,TGFB1;SMAD6;GATA4;HEY2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.3106189786531755,0.7138452328514747,0.9444444444444444,1.0,1.0,3/27,8.54%,SIRT1;CEP120;ALMS1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.3877324414636654,0.7136010810989253,0.85,1.0,1.0,3/10,16.02%,SIRT7;RIOK1;BUD23
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.3135051652775377,-0.7133972867106191,0.9054054054054054,1.0,1.0,10/41,21.04%,CLDN5;ACTG1;MARVELD2;CLDN6;CLDN1;CLDN18;ECT2;CLDN2;CLDN20;CLDN9
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.30380707786754346,-0.7133937153724474,0.9577464788732394,1.0,1.0,5/62,6.02%,FCGR3A;HCK;BLK;VAV3;ACTG1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.44438839340598835,0.7131695756211957,0.8181818181818182,1.0,1.0,3/5,26.66%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.44438839340598835,0.7131695756211957,0.8181818181818182,1.0,1.0,3/5,26.66%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.44438839340598835,0.7131695756211957,0.8181818181818182,1.0,1.0,3/5,26.66%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.2919193262384003,-0.7130932339438777,0.9855072463768116,1.0,1.0,10/93,17.21%,KIF14;RAB11A;CEP55;CHMP3;EML3;ANKRD53;SET;TTN;PSRC1;BOD1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.44173206543992266,0.7129148675268622,0.8048780487804879,1.0,1.0,2/5,20.31%,FLNA;MACROH2A2
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.408066088500866,0.7123587657060554,0.8085106382978723,1.0,1.0,2/8,10.12%,ARX;PHACTR4
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.353773752151158,0.7122204162516514,0.8095238095238095,1.0,1.0,4/15,15.51%,CLEC16A;MTRF1;INSR;ETF1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.3950233055727275,0.712191234827825,0.8958333333333334,1.0,1.0,4/9,30.37%,IMPACT;RAB11B;SLC9A1;PKD2L1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.36945980875845585,0.7121186934105526,0.9130434782608695,1.0,1.0,3/12,12.23%,FER;ADGRE2;LGALS9
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.45543786382893503,-0.7120868046875528,0.9038461538461539,1.0,1.0,2/7,27.94%,SFRP1;TNFSF4
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.26553664171195296,-0.7119911130305813,1.0,1.0,1.0,32/197,20.42%,NEK2;CCNG2;FOXM1;CRLF3;SPDYA;FBXL7;CCND1;LATS2;CDC25A;DYNLL1;DCTN1;ABCB1;CEP72;CCNF;TUBA4A;CDKN2D;TPD52L1;MAX;CDKN1A;TUBB;CDKN3;CAMK2A;BORA;CEP76;TUBB4A;ARPP19;USH1C;CCNI2;YWHAG;CCNE2;CCND2;AURKA
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.42013473293318887,0.7118891330137888,0.7837837837837838,1.0,1.0,1/6,14.06%,UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.4265049669114182,-0.7117930631622721,0.8571428571428571,1.0,1.0,3/9,22.34%,DDX60;DHX58;USP17L2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.2786162992001291,-0.7117300259757123,0.975,1.0,1.0,3/150,1.85%,NEK2;PSMB9;TGFB1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.2680169458131352,0.71170647595652,0.9772727272727273,1.0,1.0,3/63,2.65%,NGF;BCL2A1;BCL2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.26501297833795084,-0.7114356670735509,1.0,1.0,1.0,35/188,27.79%,MCM2;ERH;SNRPD2;H2AZ1;PRDX4;COPS5;GNL3;VDAC1;SET;HSPE1;PSMA7;RPL34;EIF2S2;POLE3;IFRD1;RPL18;IMPDH2;SRPK1;PCNA;RPL22;DDX18;PSMD8;EIF1AX;VDAC3;DEK;RAN;XRCC6;HSP90AB1;SF3A1;CTPS1;RPS6;PHB2;RPLP0;RPS3;COX5A
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),0.45455185152255806,0.7112249086942309,0.8611111111111112,1.0,1.0,2/6,20.05%,IL23A;IL23R
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.3987040681689752,-0.7111632460800857,0.8301886792452831,1.0,1.0,3/13,24.61%,SLC25A18;SLC25A22;SLC25A11
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.32183964795967385,-0.7108585111884592,0.8769230769230769,1.0,1.0,1/31,2.57%,SLC25A31
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.3638896386108061,0.7105205695285014,0.8780487804878049,1.0,1.0,5/14,13.08%,SMARCD3;SMARCB1;SMARCA4;ARID1A;ARID2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.3638896386108061,0.7105205695285014,0.8780487804878049,1.0,1.0,5/14,13.08%,SMARCD3;SMARCB1;SMARCA4;ARID1A;ARID2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.245314808780458,0.7102975815569593,1.0,1.0,1.0,35/187,20.31%,PNP;EGLN3;ELOVL6;CCNG1;GLA;PSAT1;DHFR;LDLR;BCAT1;FADS1;SLC7A11;PSPH;STARD4;NAMPT;ADIPOR2;SC5D;NFYC;GMPS;CYB5B;HPRT1;ETF1;TM7SF2;NIBAN1;TES;ELOVL5;POLR3G;CTSC;SHMT2;SKAP2;EDEM1;PGM1;PDK1;GSR;PHGDH;ADD3
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.39643769737666673,0.7098538577615602,0.825,1.0,1.0,2/9,3.76%,HTR1F;HTR2C
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.36319583611826106,-0.7096523856289824,0.9298245614035088,1.0,1.0,1/18,3.01%,SP100
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3624598476526717,-0.7095514771091553,0.859375,1.0,1.0,1/12,6.29%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.4048332802736838,-0.7091222822256448,0.9272727272727272,1.0,1.0,1/11,1.85%,TGFB1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.34181428222550536,-0.7084622329356813,0.8275862068965517,1.0,1.0,5/23,20.80%,GNMT;DAO;ABHD14B;SULT4A1;PPA1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.3016331612010898,-0.708303016807376,0.9117647058823529,1.0,1.0,14/50,25.91%,FANCF;RPA3;RAD51AP2;DCLRE1C;NUCKS1;DCLRE1A;RNF8;RPS27A;RPA2;FANCC;MSH6;FANCI;CENPX;FAAP20
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.4336248475925831,-0.7081398086513805,0.8153846153846154,1.0,1.0,2/8,21.62%,EFHB;SARAF
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.330534627653881,0.7077526657442097,0.8863636363636364,1.0,1.0,2/26,9.04%,IFT88;DYNC1I2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.37936421376575336,0.7076566694560024,0.8181818181818182,1.0,1.0,2/11,16.08%,TERF1;WRAP53
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.316485146763663,0.7075949413062573,0.8979591836734694,1.0,1.0,10/29,21.23%,APOE;ZBTB20;MLXIPL;AVIL;ADIPOR1;ADIPOR2;ASXL3;CREB1;PRKAG2;PRKAA2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.29417720019914284,0.707523514373112,0.9705882352941176,1.0,1.0,6/34,18.21%,UTRN;WWP2;FGF12;ANK2;NEDD4;WNK3
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.35382651717296143,0.7073841314584938,0.8571428571428571,1.0,1.0,9/19,31.67%,CWC27;PPIB;NKTR;PPIL2;PPIH;PPIA;PPIL6;PIN1;PPIG
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.2775676375482241,0.7071854158350606,0.8846153846153846,1.0,1.0,11/45,19.57%,TDO2;TRPM2;HCN1;PKD2;ACACB;ALDH1A2;USP16;HPRT1;SHMT2;SAMHD1;APPL2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.4163050197041197,-0.7071225058533777,0.8245614035087719,1.0,1.0,1/11,2.60%,TERF2IP
prerank,MSigDB_Hallmark_2020__Androgen Response,0.25464515305565943,0.7068562263005761,1.0,1.0,1.0,20/96,19.91%,ADAMTS1;UBE2J1;TMPRSS2;CDK6;CCND3;HPGD;SGK1;FADS1;RPS6KA3;UAP1;CDC14B;NGLY1;ARID5B;PMEPA1;ELOVL5;AKAP12;PA2G4;ANKH;SAT1;GSR
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.26195344829118244,0.7066251137163541,1.0,1.0,1.0,34/115,23.71%,PIGQ;ITPKB;DPM3;PITPNM1;PI4KB;TMEM150A;PIK3C2B;MTMR8;PI4K2B;CWH43;PIK3R5;PIK3CA;PIP4K2A;EFR3B;MTMR3;SMG1;MTMR14;TTC7B;RAB5A;IP6K1;SLA2;PLCG2;MTMR1;SOCS7;MTM1;SOCS4;PTEN;PIK3R4;PIK3CD;CDS1;VAC14;IP6K2;EFR3A;PIGF
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3586811786011963,-0.7062695228193143,0.8032786885245902,1.0,1.0,4/18,16.55%,SCIN;SVIL;VILL;VIL1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3586811786011963,-0.7062695228193143,0.8032786885245902,1.0,1.0,4/18,16.55%,SCIN;SVIL;VILL;VIL1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.26634707751549785,0.7058652897488905,0.96875,1.0,1.0,20/74,22.23%,RANBP17;ATXN1;NUP42;U2AF1;ANKLE1;SRRM1;NXF1;SRSF4;XPO7;SMURF1;NUTF2;XPO5;MALT1;U2AF2;EIF4A3;XPO1;NEMF;NUP214;EIF4E;TPR
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.4639434939049312,-0.7055669812547413,0.8703703703703703,1.0,1.0,2/6,9.94%,CAV3;CAV2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.3428546774638515,0.7055448234366791,0.8484848484848485,1.0,1.0,4/17,15.52%,CRLS1;PGS1;PLA2G5;PLA2G15
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.30996493023659016,-0.7054018402296691,0.9027777777777778,1.0,1.0,6/39,16.28%,CA1;SOD2;CFL1;IL12A;LCP1;MSN
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.4089185626329551,-0.7051718303008301,0.8461538461538461,1.0,1.0,2/11,7.30%,MMP9;CCND1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.37669407177294595,-0.7051430187455332,0.8461538461538461,1.0,1.0,3/17,12.29%,TGFB1;H1-0;HEY2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.3393069071789675,-0.7047943049397551,0.8524590163934426,1.0,1.0,4/26,18.09%,PTPRC;C17ORF99;CLCF1;CD86
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.25597716204161414,-0.7047500046079491,1.0,1.0,1.0,25/174,20.39%,CLCA2;TGFB1;PROCR;MAPKAPK3;HINT1;DRAM1;ADA;ALOX15B;NDRG1;TXNIP;DDIT4;TPD52L1;CDKN1A;SERPINB5;DEF6;CDK5R1;EI24;NUDT15;RRAD;IER5;ISCU;RPL36;CD81;RPL18;CCND2
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.36284826577482154,0.7046914833674336,0.8125,1.0,1.0,8/14,24.99%,SLC19A1;SLC25A24;SLC25A42;SLC35B2;SLC25A41;SLC17A9;ABCC5;SLC25A17
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.35179753562824967,-0.7046169010597118,0.835820895522388,1.0,1.0,4/23,17.39%,ITGB2;PDZK1;ITGAM;FIS1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.3529514191451476,-0.7046077067045498,0.8870967741935484,1.0,1.0,1/13,1.85%,TGFB1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.34661114740533994,-0.7046072786309611,0.8275862068965517,1.0,1.0,1/22,8.37%,BTBD18
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.31785720244946636,-0.7045657990138539,0.9285714285714286,1.0,1.0,5/29,14.90%,SYT10;TRPV6;SYT2;REST;DOC2A
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.40696059126529205,0.7037667375427751,0.8157894736842105,1.0,1.0,2/6,21.16%,FAP;PTPRJ
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.30780025254702326,-0.7037341982677575,0.9305555555555556,1.0,1.0,9/68,16.66%,ELOVL2;DEGS2;PRKD3;CERS3;ALOX12B;A4GALT;HACD4;CLN8;SGMS2
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.43193939951677307,0.7035130221401756,0.8,1.0,1.0,1/5,11.20%,IDH2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.3506119060772268,0.7031587983114511,0.85,1.0,1.0,2/13,5.24%,CYP1A2;CYP2U1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.28146898185040303,0.7031219125720108,0.9705882352941176,1.0,1.0,6/45,11.77%,HSPB1;TOR1B;DNAJB5;RHBDD1;ERN1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3079630541958014,-0.7029929114964356,0.9661016949152542,1.0,1.0,7/35,18.62%,TGFB1;SPI1;REST;GNL3;TERT;SMAD3;ATOH8
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.286481759776974,-0.7027358511335442,0.9558823529411765,1.0,1.0,6/72,7.95%,FGF20;KCNA5;KCNJ15;SYT10;SYT2;KCNJ11
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.33514779631772346,0.7026792731852971,0.8809523809523809,1.0,1.0,5/18,16.50%,SLC3A2;RALB;STING1;TICAM1;ZCCHC3
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.37228933714508855,-0.7026175750013351,0.8545454545454545,1.0,1.0,1/11,5.07%,ALOX5
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.27011907045287553,-0.7025046308085783,0.9863013698630136,1.0,1.0,19/123,16.94%,TIMP3;SP100;STAT1;ANXA1;CIITA;NLRP12;MAPKAPK3;OSMR;TIMP4;SLC11A1;TRIM56;CXCL16;SELP;IL18BP;ISG15;SMAD3;ITIH4;LEF1;TNFRSF11A
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.3812919216808006,-0.7024775155282668,0.8490566037735849,1.0,1.0,2/13,11.40%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3450150793583898,0.702053385293691,0.9142857142857143,1.0,1.0,2/25,7.37%,LLGL1;WWP2
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.3092786459952272,0.70194828560485,0.9117647058823529,1.0,1.0,13/27,23.17%,KCNIP3;KCNIP1;DPP10;KCNIP4;FGF12;DPP6;SLMAP;WNK3;KCNAB3;DLG1;WNK1;KCNH2;SLC30A5
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.316225091214446,0.7016334887338249,0.9459459459459459,1.0,1.0,4/20,18.68%,SLC12A1;SLC12A9;ATP12A;SLC12A4
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.4001599525366037,-0.7010971169297817,0.8709677419354839,1.0,1.0,1/9,5.53%,BLK
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.30340620851076805,0.7008622972439056,1.0,1.0,1.0,12/31,17.95%,ELOVL6;SLC27A2;ELOVL4;ABCD3;ABCD2;HACD1;ACSL1;TECR;ELOVL1;ACOX1;SLC27A4;ELOVL5
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.2922347235296247,0.7007813271074212,0.9743589743589743,1.0,1.0,4/33,11.13%,TCOF1;TAF1B;CCNH;POLR1H
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.34647076798417653,0.7007199343158492,0.825,1.0,1.0,3/11,16.61%,SMR3B;ATPSCKMT;F2R
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.26544406168768037,0.7004570707645359,1.0,1.0,1.0,21/94,21.96%,TBC1D10A;PRR16;SAMD4A;PERP;ERBB2;PCIF1;EIF3E;NR1H3;NIBAN1;BCL3;FAF1;FADD;PIWIL2;YTHDF1;FXR2;ZCCHC4;AURKAIP1;EIF4A3;LARP4B;ASPH;UPF3A
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.36005847183315987,-0.7002681400925365,0.8545454545454545,1.0,1.0,4/15,16.35%,SOX10;SEMA3A;NTRK1;FN1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.34212745812283585,-0.7002206007596031,0.9047619047619048,1.0,1.0,6/27,14.80%,WNT5A;ADAM21;LRP2;GATA4;BIK;MEA1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.3938517275072993,-0.7001773769910712,0.9047619047619048,1.0,1.0,1/14,3.19%,CLDN5
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.32148371098123785,-0.6998926403784934,0.9104477611940298,1.0,1.0,6/46,16.66%,DEGS2;CERS3;ARG2;ALOX12B;CLN8;SGMS2
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.33070527815672646,-0.6998719553093525,0.8783783783783784,1.0,1.0,4/18,19.93%,HLA-A;NLRP3;IL18;CD81
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.30264368357914034,0.6998276124865169,0.9375,1.0,1.0,12/31,28.17%,GDF6;LGALS9;GADD45G;MFHAS1;RELL1;EMC10;GADD45A;DLG1;RELL2;BMP2;PHLPP1;PRMT1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.36712785069248294,0.6996745387522937,0.8974358974358975,1.0,1.0,2/13,13.87%,ENOX2;NDOR1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.37522164113995565,-0.6995688717638981,0.873015873015873,1.0,1.0,4/14,20.34%,PHKG1;CALM1;PYGL;MGAM
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.2848642278491956,0.6993618675460317,0.9142857142857143,1.0,1.0,11/45,17.88%,TSKU;EFEMP1;CEP290;ZDHHC16;SMG9;SIPA1L3;PBX1;ADAMTS18;SKI;ATF6;NIPBL
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.420182978945908,-0.6987767768650683,0.8333333333333334,1.0,1.0,2/6,19.81%,SPI1;CASP8
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.35867047276781533,-0.6984405288342477,0.896551724137931,1.0,1.0,3/18,12.57%,BLK;NFAM1;PRKCH
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.3200039507832817,-0.6978598347846384,0.9152542372881356,1.0,1.0,3/29,12.24%,CEACAM1;CD160;TESPA1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.35495902876540963,0.6978013555508288,0.875,1.0,1.0,4/15,15.36%,APOE;DHFR;NUS1;GCH1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.31348532786846495,0.697375788693434,0.85,1.0,1.0,3/20,7.55%,PROX1;PKD2;CCND3
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.3887161508719706,-0.6973331443988358,0.8909090909090909,1.0,1.0,5/12,21.40%,ZFPM1;GATA4;HEY2;MESP1;ENG
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.32178271639769285,0.6973275150226367,0.9117647058823529,1.0,1.0,10/29,26.66%,NLGN1;GRIN1;EPHB2;DLG2;DLG1;LRRC7;GRIA4;DLG3;MEF2C;GRIA1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.3607504793101399,-0.6973163760031584,0.8983050847457628,1.0,1.0,1/14,4.86%,ESR1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3101299938617559,-0.6973005586697867,0.9444444444444444,1.0,1.0,6/37,16.28%,CA1;SOD2;CFL1;IL12A;LCP1;MSN
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.3223200631344416,0.6972767813205905,0.8611111111111112,1.0,1.0,7/27,18.94%,SRGAP2;PHACTR1;NTNG2;NEXMIF;ZNF609;NIPBL;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),-0.45595801089176535,-0.6972223052299767,0.84,1.0,1.0,1/5,3.19%,CLDN5
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),-0.45595801089176535,-0.6972223052299767,0.84,1.0,1.0,1/5,3.19%,CLDN5
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.38854971665173194,-0.6970458429354397,0.8181818181818182,1.0,1.0,2/11,16.55%,SCIN;VIL1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.32603132053862577,0.696929521156006,0.9285714285714286,1.0,1.0,4/14,22.93%,CTC1;FAF1;DNA2;STN1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.3335023706386382,0.6969276282467719,0.8888888888888888,1.0,1.0,8/22,22.30%,ZBTB20;MLXIPL;NFKB1;INSR;PFKFB4;PFKFB3;PRKAA2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.32409989211918966,0.6968577389104459,0.8055555555555556,1.0,1.0,1/18,3.18%,EPHA7
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.35708375455025243,0.6967507790508248,0.7894736842105263,1.0,1.0,5/9,31.92%,DXO;XRN1;EXOSC5;EXOSC9;EXOSC10
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.3593669656085588,-0.6965116377417743,0.8852459016393442,1.0,1.0,2/21,5.34%,ENO4;ENO2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.29851588492085235,0.6964748053991268,0.9761904761904762,1.0,1.0,4/25,21.06%,MDFIC;GTF2F2;POLR2F;RSF1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.37198873181219083,-0.696172766553499,0.7833333333333333,1.0,1.0,4/16,20.63%,IL10RB;NOS2;NOP53;ACTN3
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.32501083445825507,-0.6960612250138325,0.8382352941176471,1.0,1.0,4/32,11.20%,TRMO;WDR6;TRMT10A;DALRD3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3150439501159074,0.6960284534707736,0.9210526315789473,1.0,1.0,10/21,26.78%,HEXIM2;LATS1;MYOCD;NR2F2;MEN1;CEBPA;PTEN;IPO7;TFAP4;PLK1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.4040741202052408,-0.6960017748647044,0.8666666666666667,1.0,1.0,3/14,15.59%,CAV3;CSRP3;TTN
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.4306889565235205,0.6959783280643618,0.8571428571428571,1.0,1.0,2/6,7.27%,ALDH1A1;BCAT1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.314951218989031,0.6958487898605713,0.9032258064516129,1.0,1.0,4/24,10.58%,HDAC3;FLNA;HCLS1;JUP
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.35275687910466563,0.6957769921232566,0.8444444444444444,1.0,1.0,5/16,14.10%,PTPRZ1;DRD3;HES1;NOTCH1;NF1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.3804609917381341,0.6953295714070661,0.9047619047619048,1.0,1.0,6/11,23.03%,SERPINE1;ATM;TP53;ATR;PLA2R1;MME
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.30755723137117325,-0.6951086230231104,0.9402985074626866,1.0,1.0,5/38,15.42%,F7;IL12A;ZNF580;THBS1;CREB3
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.3759363591967951,0.6949863169669164,0.9047619047619048,1.0,1.0,5/11,22.35%,HIRIP3;TP53;SUV39H2;RBBP4;NOC2L
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.319217262833621,-0.6948882325794506,0.8591549295774648,1.0,1.0,9/50,13.32%,AIM2;NODAL;UACA;GPER1;CIDEB;USP50;NLRP3;REST;NLRC4
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.36042331735810534,-0.6947158404230326,0.85,1.0,1.0,1/19,1.31%,ADSS1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.4264055522182957,-0.694542054158118,0.8448275862068966,1.0,1.0,2/7,18.98%,SLC11A1;IL18
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.2656855489574327,-0.6942167870989799,1.0,1.0,1.0,8/138,7.43%,PSMB9;AIM2;STAT1;GSDME;GPER1;TXNDC17;TNFRSF1B;CARD14
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.3667346823069611,0.6938769148209718,0.8372093023255814,1.0,1.0,1/11,6.26%,RIPK2
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.48126210123986757,-0.6935875824814363,0.896551724137931,1.0,1.0,2/5,26.11%,SLU7;SF3A1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3540796515391737,-0.6933958786964383,0.8805970149253731,1.0,1.0,5/16,28.14%,COX17;COX20;COX16;TIMM21;COA3
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.3711818950196434,-0.6930549546332034,0.8793103448275862,1.0,1.0,1/13,4.74%,HLA-DRB1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.31701406708299035,-0.6929408444693604,0.8787878787878788,1.0,1.0,6/30,16.65%,POU2F3;LRRC19;SAP30;REST;NUCKS1;LEF1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.40666060760692246,0.6928379372664756,0.8372093023255814,1.0,1.0,3/9,20.00%,TERF1;MEN1;TP53
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.38974219892907974,-0.692731934412137,0.9107142857142857,1.0,1.0,3/12,19.93%,HLA-A;IL18;CD81
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.4093733708217307,0.6926145055139313,0.8222222222222222,1.0,1.0,2/5,14.28%,SIRT1;PIBF1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.2573378876692005,-0.692430501041053,0.9726027397260274,1.0,1.0,15/119,14.79%,SLC22A3;CHMP3;SLC7A7;TCN1;SLC3A1;PPT1;SLC6A12;SLC11A1;ABCG2;LRP2;SLC7A3;TXNIP;SLC6A4;SLC22A4;SLC18A2
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.26616974771409824,-0.6922529555311085,0.9577464788732394,1.0,1.0,6/96,12.88%,MCM2;MCM3;DHX38;CHAF1A;DARS2;INCENP
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.32894953780475467,-0.6922388568984891,0.9253731343283582,1.0,1.0,6/24,16.12%,GPER1;ATP6AP1;LRP2;OPRM1;TGM2;SERPINF1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.308868989899945,-0.6914855878711722,0.9552238805970149,1.0,1.0,2/44,1.85%,WNT5A;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.35831968587280205,-0.6914012453703985,0.9130434782608695,1.0,1.0,2/11,9.94%,CHMP3;CAV2
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.3089685021194074,0.6909451068830068,0.925,1.0,1.0,3/26,7.05%,COMMD1;HJV;BDH2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.3005627809727451,0.6909329436175917,0.8604651162790697,1.0,1.0,8/33,25.91%,RNASET2;NUDT18;PNPT1;ADPRM;NUDT5;XRN2;PABPC4;ENTPD2
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.4374297363302586,-0.6908976109999173,0.8461538461538461,1.0,1.0,1/6,6.51%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.41612917918423376,-0.6903593067981467,0.9019607843137255,1.0,1.0,1/7,1.85%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.4210210229898482,-0.690209156755716,0.8653846153846154,1.0,1.0,1/10,4.12%,RIN3
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.40402460736478385,-0.689528513209246,0.9310344827586207,1.0,1.0,1/8,5.53%,BLK
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.285566755064001,0.6890368748591981,0.9302325581395349,1.0,1.0,8/27,27.80%,MAPK8;NFKB1;MAP2K7;CUL1;TAOK2;IKBKB;BTRC;MAP3K20
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.3608000683672498,0.6888605974481312,0.8064516129032258,1.0,1.0,2/18,7.90%,CX3CR1;NLRP2B
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.43830552436640285,0.6888439054876034,0.8958333333333334,1.0,1.0,1/5,14.84%,CTPS2
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),0.43511383981524254,0.6886355666956115,0.851063829787234,1.0,1.0,1/5,2.53%,SAMSN1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.36684700747865395,0.6880161163466043,0.8571428571428571,1.0,1.0,5/11,37.49%,ATG9B;TRAPPC8;PACS2;WDR45;WIPI1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.3077965502715162,0.687354900534707,0.9722222222222222,1.0,1.0,7/30,19.47%,TCOF1;PCIF1;NANOS3;GEMIN5;PUM3;GRM5;SAMD8
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.39983783206934986,0.6871153412454111,0.813953488372093,1.0,1.0,1/5,9.87%,GPSM1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.29488438474101086,-0.6870962826083687,0.9558823529411765,1.0,1.0,1/51,0.75%,GML
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.29946181222586593,0.6868466379887164,0.925,1.0,1.0,1/31,0.81%,FBP2
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.38129329940493445,-0.6867708949583918,0.8888888888888888,1.0,1.0,1/11,1.85%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.38450772817929535,-0.6867284821749139,0.8939393939393939,1.0,1.0,1/13,0.90%,WNT5A
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.385867036717401,0.6863434377668707,0.8958333333333334,1.0,1.0,4/8,28.83%,GSTZ1;PDK1;PDP2;PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.385867036717401,0.6863434377668707,0.8958333333333334,1.0,1.0,4/8,28.83%,GSTZ1;PDK1;PDP2;PDPR
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.3355436926908919,-0.6862801403651617,0.9016393442622951,1.0,1.0,2/21,12.89%,STAT1;CLCF1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.41655700634942294,0.6860461418971173,0.8205128205128205,1.0,1.0,3/8,12.59%,LPCAT2;CHPT1;PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3270541123176358,0.6859962560849877,0.8918918918918919,1.0,1.0,6/18,21.54%,SPRED3;SPRED2;SPRED1;ATM;ATR;PLA2R1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.2558254761844074,0.6859276231383172,1.0,1.0,1.0,12/68,18.19%,SIRT1;ADAMTS12;PID1;GBP2;SMPD4;CASP3;TANK;MAP2K7;CD40;GCH1;HAS2;ZFAND6
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.26493943503247913,0.6858290560657226,1.0,1.0,1.0,19/68,21.09%,EPHA3;WASHC2C;OPRD1;CRACD;HSPA1A;IAPP;RAPGEF3;SACS;HSF1;TMEFF2;IMPACT;ABCA7;LRSAM1;FAP;EP300;RUBCN;CARMIL2;RAF1;SNX33
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.43511652005922824,-0.6853732615589234,0.8620689655172413,1.0,1.0,1/6,6.00%,HLA-A
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.23132446398236386,0.6851158805477494,1.0,1.0,1.0,73/302,24.15%,AUP1;KLHL20;DERL3;SIRT1;CDC20B;PSME4;SPOPL;PSMA1;ZNRF1;ARRB2;ERCC8;UBXN2A;UBE2J1;PML;WWP2;TRIM71;MAEA;UBE2E1;SHARPIN;UBE3D;ANAPC16;DMAC2;FBXL20;UBE2A;USP44;FBXL14;MAN1A1;KLHL42;ARRB1;KLHL22;SMURF1;PELI1;FBXO27;ANAPC7;UBE2J2;UBE4B;NEDD4;RHBDD2;FBXO17;FBXL22;FAF1;RNF185;TMUB2;CDC26;UBXN2B;TBL1X;EDEM1;SPOP;FBXO4;TRIM9;FBXO31;TMEM67;AMN1;PSMD4;UBXN4;RNF216;NEMF;CUL1;HECTD3;SIAH2;FZR1;NFE2L2;FBXL2;CDC34;AGAP3;PSMD5;APPBP2;CDK1;FBXL17;PSMD10;BAG6;UBE4A;UBE2D3
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.39977524674621995,0.6847980570781477,0.8648648648648649,1.0,1.0,2/8,7.37%,ALCAM;SLIT2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.39977524674621995,0.6847980570781477,0.8648648648648649,1.0,1.0,2/8,7.37%,ALCAM;SLIT2
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.35109187045295687,0.6840458370726218,0.85,1.0,1.0,5/14,28.85%,SEC24C;MIA3;SEC31A;SEC24B;SAR1A
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.4021363430186491,0.6838162073205798,0.8717948717948718,1.0,1.0,1/7,17.02%,PPFIA2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.25991989222804956,0.6834127153241784,1.0,1.0,1.0,12/71,20.60%,CPSF1;PCF11;U2AF1;SRRM1;SRSF4;CPSF7;PAPOLA;SYMPK;RPRD2;U2AF2;EIF4A3;CPSF6
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2871846047337998,-0.6829291231164695,0.9733333333333334,1.0,1.0,7/63,15.30%,AIM2;CYP1B1;NLRP12;NLRP3;SPI1;CACTIN;NLRC3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.3621823399617431,0.6828645572789517,0.875,1.0,1.0,3/8,25.56%,NOP9;NOP14;RRS1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.28896251856592636,0.6827813823817901,0.9705882352941176,1.0,1.0,5/41,8.62%,QRICH2;COMMD1;PYHIN1;PML;LATS1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.3424613392551749,-0.6823753593486215,0.8636363636363636,1.0,1.0,2/16,15.40%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.34533696354438803,-0.6819342723069908,0.9305555555555556,1.0,1.0,1/22,3.38%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.29587352465307515,0.6817182625940693,0.9714285714285714,1.0,1.0,6/19,21.09%,EPHA3;NR1H3;ABCA7;LRSAM1;RUBCN;SNX33
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.3248445544147131,-0.6815090379592574,0.9090909090909091,1.0,1.0,4/25,19.03%,LPAR1;LPAR6;RAC1;AKAP13
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.3625880624801902,-0.6811536382937433,0.8793103448275862,1.0,1.0,5/14,16.55%,PIK3CG;SLC11A1;DOCK8;MSN;TNFSF18
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),0.431596006476584,0.6811519930687148,0.8888888888888888,1.0,1.0,1/5,6.50%,HMGB1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.3889873641589868,0.6809036472710313,0.9387755102040817,1.0,1.0,3/9,12.23%,TMPRSS2;LGALS1;LGALS9
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.3889873641589868,0.6809036472710313,0.9387755102040817,1.0,1.0,3/9,12.23%,TMPRSS2;LGALS1;LGALS9
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.39221122249179124,-0.6807813189641104,0.8333333333333334,1.0,1.0,1/11,10.63%,DOCK8
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.3715312720975898,0.6806586254362853,0.8421052631578947,1.0,1.0,6/12,20.64%,FSTL3;MAGI2;SKI;ACVR2A;SMAD7;ACVR1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.2975644399352007,0.6804010843977815,0.8846153846153846,1.0,1.0,1/24,5.26%,GDAP1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.3760427730005286,-0.6802397880331543,0.9074074074074074,1.0,1.0,5/13,30.17%,WFS1;HSPA5;DDRGK1;UFL1;RACK1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),0.43868122826536693,0.680156817943678,0.8823529411764706,1.0,1.0,2/5,9.49%,CELA2A;ERN1
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.3815953886988219,0.6801422140077346,0.8918918918918919,1.0,1.0,3/7,30.07%,EXOSC5;APOBEC3H;CDADC1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.32150125028517695,-0.6800803841491065,0.9538461538461539,1.0,1.0,3/25,10.62%,TGFB1;LATS2;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.4255844045321261,-0.6797539293984537,0.82,1.0,1.0,2/5,14.09%,CTSZ;THBS1
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.45696728762711813,-0.6797292289297182,0.8688524590163934,1.0,1.0,1/5,7.39%,PTPRC
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.3063559007691598,0.679200793244025,0.875,1.0,1.0,9/27,25.37%,RAPGEF1;TJP2;RAP1A;RAPGEF3;F11R;ROBO4;PDE4D;PPP1R16B;AFDN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.39416678246303977,0.6785635786089806,0.8372093023255814,1.0,1.0,3/7,16.61%,NMU;MYOCD;F2R
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.4355426350711574,-0.6785234247239023,0.7903225806451613,1.0,1.0,1/6,11.40%,BRCA1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.35495692214659924,-0.677975656274315,0.90625,1.0,1.0,3/17,19.15%,GUCY2C;ADCY7;GUCY2F
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.43112437335733933,-0.6777966646248903,0.8620689655172413,1.0,1.0,2/6,19.93%,NLRP3;CD81
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.43112437335733933,-0.6777966646248903,0.8620689655172413,1.0,1.0,2/6,19.93%,NLRP3;CD81
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.266793404650273,0.677767276145867,1.0,1.0,1.0,12/39,20.46%,CDH5;SNCA;ABL1;NAV3;AKAP9;MAPRE1;CLIP1;OCLN;CLIP3;CAMSAP3;CDK5RAP2;GBA2
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.27429888651238843,-0.6777070890537431,0.9523809523809523,1.0,1.0,9/67,16.55%,LMOD1;HCK;C15ORF62;GPSM2;ALOX15;BAIAP2L1;TEK;VASP;VIL1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.3690177454635966,0.6776473308632219,0.84,1.0,1.0,2/6,14.12%,OLFM2;MYOCD
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.3550781686852128,0.6774183213879125,0.9130434782608695,1.0,1.0,4/11,22.02%,EIF2AK3;IMPACT;QRICH1;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.2811611974828088,-0.6771065010385315,1.0,1.0,1.0,6/71,10.74%,TGFB1;DAB2;NODAL;BMP3;TTK;GDF11
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.38501752579059245,-0.6768810748721098,0.9047619047619048,1.0,1.0,3/10,29.89%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.343957026460028,0.6767172562143933,0.9428571428571428,1.0,1.0,5/11,21.65%,BMP4;NOTCH1;ACVR1;MDM4;BMPR1A
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.3924611606778752,0.6765243318532808,0.8372093023255814,1.0,1.0,2/7,18.55%,METAP1D;FKBP7
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.3194021128377578,-0.6765116904339211,0.967741935483871,1.0,1.0,6/32,14.80%,WNT5A;ADAM21;LRP2;GATA4;BIK;MEA1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.32383661591872875,-0.676390529199312,0.8852459016393442,1.0,1.0,3/18,15.88%,SLC5A2;SLC5A1;SLC5A9
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3162259100308691,0.6760873485490322,0.8611111111111112,1.0,1.0,5/20,16.92%,RAB7A;ZFYVE16;GCC2;NEDD4;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.34433539947713465,0.6759856089470839,0.8928571428571429,1.0,1.0,3/12,16.09%,DOC2B;SYT1;CACNA1I
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),0.3766628902297899,0.675855652880119,0.8888888888888888,1.0,1.0,3/7,22.38%,ALDH18A1;PAH;CPS1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.3531035345231609,-0.6757994849555647,0.8793103448275862,1.0,1.0,4/16,23.39%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.31099067142047876,0.6756407094900166,0.9459459459459459,1.0,1.0,7/32,19.03%,RHEX;STAT5B;TESC;HSPA1A;ABCB10;ANKRD54;ACVR2A
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.44662130341544237,-0.6749955894758575,0.9411764705882353,1.0,1.0,1/6,7.99%,SEMA3A
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.3826345418353706,0.6749094825367882,0.8095238095238095,1.0,1.0,2/7,10.96%,RPE65;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.2959743558347795,-0.6746355692614305,0.953125,1.0,1.0,10/72,15.78%,WNT5A;KIF14;ITGB2;TNFRSF1B;CLU;REST;DDIT4;CTSZ;HLA-F;ITGAM
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.4164963368248964,0.6746154137007653,0.8571428571428571,1.0,1.0,1/7,7.05%,FKTN
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3465074200157339,0.6744736308611731,0.8780487804878049,1.0,1.0,5/15,16.75%,F2;GALP;H2BC21;MUC7;CXCL14
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.3729114144560749,0.674239269893801,0.8181818181818182,1.0,1.0,1/8,7.05%,BDH2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2477457084067744,-0.6740934812765434,1.0,1.0,1.0,18/198,13.32%,WNT5A;BEX1;AIM2;TRIM62;TERF2IP;NODAL;TRIM5;ESR1;TRIM25;CARD14;CLU;TLR2;NLRP3;COPS5;NTRK1;NFAM1;PRKCH;NLRC4
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3295921645410445,-0.6739036921051997,0.8983050847457628,1.0,1.0,6/28,17.07%,TGFB1;P2RY12;PIK3R3;TEK;ATG14;TNFAIP8L3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.31519667097123144,0.673653967341234,0.9310344827586207,1.0,1.0,5/28,11.98%,IRGM;TICAM2;HSPA1A;AGPAT2;TRIM44
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.42742640081042943,-0.6732709815156521,0.9444444444444444,1.0,1.0,2/6,12.67%,NEB;WAS
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.28304679932549665,-0.6732636374752876,0.9824561403508771,1.0,1.0,2/48,5.43%,STAC;GPER1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.26780749553030186,0.673251314734707,1.0,1.0,1.0,27/79,22.95%,CDK14;CDK4;USP26;DHFR;BCAT1;TRIM71;CDK6;PLK3;LATS1;CDK18;CCNH;MYC;PIM2;CDK16;BRD4;KHDRBS1;EIF4EBP1;TFDP1;NASP;ACVR1;CDK5;CACUL1;CUL1;EIF4E;HINFP;POLA1;CDC34
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.3546925740677432,0.6729069058748014,0.8536585365853658,1.0,1.0,5/15,15.18%,BTN3A2;CADM1;JAG1;CD8A;EMP2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2912723725032045,0.6729005927933501,0.8857142857142857,1.0,1.0,7/30,18.50%,BRCC3;STAMBPL1;USP16;OTUD7B;STAMBP;OTUD5;SHMT2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.35751584802689723,0.6719746752906073,0.8709677419354839,1.0,1.0,3/14,13.95%,SCD5;SLC25A1;PPCS
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.3320843914069039,0.6718599700849207,0.8918918918918919,1.0,1.0,1/18,1.71%,LLGL1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.2987533172826151,0.67126895916964,0.9459459459459459,1.0,1.0,11/34,25.70%,SLC19A1;IL10RA;SLC7A8;SLC6A20;LRSAM1;SLC12A4;SLC1A3;SLC16A2;SLC7A5;SLC11A2;SLC29A2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.24314007688484146,0.6712543467577098,1.0,1.0,1.0,11/138,7.93%,HSPB1;MAPKAPK2;TENT5A;SAMD4A;PSME4;PSMA1;TENT5C;EXOSC1;RIDA;ANP32A;CSDC2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.43865941849468326,-0.6710580404681346,0.9104477611940298,1.0,1.0,1/6,17.67%,RBX1
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),0.38687524193159034,0.6709407120616117,0.8,1.0,1.0,2/5,13.84%,DRD3;PRMT5
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.4212155508268375,-0.6704936225835295,0.8775510204081632,1.0,1.0,2/5,38.13%,TMEM70;ATP5F1D
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.44004066103004574,-0.6703882193342032,0.8214285714285714,1.0,1.0,2/5,15.52%,RABGGTB;RABGGTA
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.3225245105236863,-0.670382359694003,0.9836065573770492,1.0,1.0,4/28,15.33%,PIGH;MPPE1;PIGC;PIGL
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.2878174808961541,-0.6702481524053797,0.96875,1.0,1.0,10/63,24.47%,PSMB9;CARD14;NFKB2;PSMA7;PSMB6;PSMA3;PSMA5;SKP1;PSMD8;PSMD6
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.29079336429427427,-0.670248044115454,0.96875,1.0,1.0,5/59,9.21%,HTRA4;TGFB1;PBLD;ASPN;SMAD6
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.331256180081378,-0.6701974179947114,1.0,1.0,1.0,3/29,11.07%,POLR1C;CAVIN1;POLR1G
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3202350959439624,0.6696664011699789,0.9473684210526315,1.0,1.0,10/19,27.67%,FHL2;PTBP1;LMCD1;CAMTA1;PLCG2;CIB1;AKAP6;DYRK2;SPPL3;SLC9A1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.3814067456283168,0.6696531680294308,0.8636363636363636,1.0,1.0,5/11,35.66%,LAPTM5;EHD3;CCDC91;CLN3;ANKFY1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.366005568691668,0.66960241202387,0.9310344827586207,1.0,1.0,3/11,15.13%,WASF3;WASF2;FCHSD2
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.30324445344183587,-0.6685363201646086,0.8888888888888888,1.0,1.0,11/35,26.84%,ATP10B;HOOK2;GRN;TPP1;ACP3;SNAPIN;VPS18;ACP2;LAMTOR1;HPS4;NAGPA
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.38909119459079017,0.6683795323583066,0.8431372549019608,1.0,1.0,4/7,37.71%,APPL2;SIRT2;HGF;APPL1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.38909119459079017,0.6683795323583066,0.8431372549019608,1.0,1.0,4/7,37.71%,APPL2;SIRT2;HGF;APPL1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.2850124369036756,-0.6683646662244555,0.9692307692307692,1.0,1.0,4/37,13.16%,FOXO4;BRCA1;RBBP7;MAX
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.26611994200633987,-0.6681511916653456,0.9701492537313433,1.0,1.0,19/116,17.31%,AMACR;CYP26B1;PTGR1;ALOX12;CYP3A5;CKMT2;ACOT6;CKB;CYP2J2;PDHX;SLC16A8;VDAC1;ACOT4;MCCC2;SLC16A3;LDHC;ACSL3;CYP3A4;SCPEP1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.4149042801662606,0.6679536937695469,0.8666666666666667,1.0,1.0,1/7,14.74%,PUS7
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.3212533421824843,0.6678525314697107,0.9117647058823529,1.0,1.0,3/15,12.21%,ADCY2;PRKAR2A;ADCY3
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.34538259349895073,-0.6678100999495991,0.873015873015873,1.0,1.0,2/16,12.57%,CLDN5;PRKCH
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.32220189781558506,-0.6677519877606967,0.9230769230769231,1.0,1.0,4/24,20.45%,TCN1;ABCG2;AMN;SLC23A1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.39910070304837875,-0.6676282076212312,0.8571428571428571,1.0,1.0,3/7,26.10%,TRMT10A;TRMT10B;SUPV3L1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.3815986669345426,-0.6676163551293461,0.8627450980392157,1.0,1.0,1/8,5.14%,DONSON
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.37721199722085186,-0.6675079742263935,0.8070175438596491,1.0,1.0,2/8,18.65%,MSN;JAM2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3694763076762084,-0.6674855581065525,0.8656716417910447,1.0,1.0,1/8,3.78%,CYP1B1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.3822551625777392,-0.6673915352738279,0.8970588235294118,1.0,1.0,2/10,19.24%,HEY2;SFRP2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.28499555799143633,-0.6670826205037969,0.96875,1.0,1.0,4/38,13.16%,FOXO4;BRCA1;RBBP7;MAX
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.36386709836404185,-0.6668299884203572,0.8245614035087719,1.0,1.0,3/12,19.09%,WNT8B;GPC3;MESP1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.385087854279051,0.6668118338934065,0.8571428571428571,1.0,1.0,3/8,20.93%,OTUD3;OTUD7B;OTUD7A
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.2967419342313514,-0.6667242627025988,0.9661016949152542,1.0,1.0,8/31,26.01%,RBBP7;STUB1;THBS1;DAXX;IER5;SLU7;HSBP1L1;HSP90AB1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.38631860374911736,0.6666524202721312,0.813953488372093,1.0,1.0,3/9,15.36%,PTAR1;PGGT1B;FNTA
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.29862698029614115,0.6665468454007305,0.9655172413793104,1.0,1.0,4/25,10.58%,HDAC3;FLNA;HCLS1;JUP
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.3052012513990968,0.6665164441179945,0.9411764705882353,1.0,1.0,5/32,18.79%,MGARP;SPAST;DST;KIF3B;AP3B2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.3480973986992115,0.6661718379868212,0.9111111111111111,1.0,1.0,8/16,30.74%,TARBP2;AGO3;AGO2;NRDE2;DROSHA;CLP1;PRKRA;CELF1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.25100685026004815,-0.6661407471182409,1.0,1.0,1.0,27/162,24.59%,HK2;TOMM20;PINK1;CHCHD2;CAV2;HIGD1C;SLIRP;STOML2;COX7A1;TIMM17A;TOMM7;BIK;TERT;FIS1;COX7A2;CHCHD4;DNAJC19;TOMM34;COX7A2L;ATAD3C;PARK7;ADCK1;MX1;DNAJA3;SPATA18;HAX1;BNIP3
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.37801911107899605,0.6653741760518437,0.8478260869565217,1.0,1.0,3/8,20.00%,SP7;MLLT3;TP53
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.32221485224704044,-0.6652683632970212,0.875,1.0,1.0,4/26,17.51%,KIF14;SVIL;CDC6;ECT2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.2582204645230733,0.6652576251162892,1.0,1.0,1.0,8/53,17.49%,APOE;HTRA2;NEU4;CELA2A;NGLY1;FBXO27;FBXO17;LRSAM1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.3652959899996086,-0.66436056972483,0.8852459016393442,1.0,1.0,1/9,2.36%,COL1A1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.3799068172601988,-0.6643568535804472,0.8529411764705882,1.0,1.0,3/8,29.89%,BLOC1S2;BNIP3;VDAC2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.26573270528903714,0.6641622054362021,1.0,1.0,1.0,15/80,18.95%,LGR5;DSP;ERBB2;TMPRSS2;HID1;VWA2;MANSC1;ITGB4;FA2H;TPPP3;SLC44A4;ERBB3;RAB3D;CAMSAP3;ARHGEF10L
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.321490270917141,0.663992546490056,0.9230769230769231,1.0,1.0,5/14,21.38%,PML;SIRT6;LIG4;RAD50;PPP1R10
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.44742147344451333,0.6639127865696842,0.9047619047619048,1.0,1.0,3/5,30.93%,CHRM3;DOCK4;ZDHHC21
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.4078716681246494,-0.6635916697746029,0.8615384615384616,1.0,1.0,2/7,18.84%,IMPA2;IMPA1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.2664636857035487,-0.6635832661286852,1.0,1.0,1.0,28/125,23.65%,PWP2;SNRPD2;EIF6;DDX20;RPL3;RPL38;GEMIN4;RPS27;STRAP;DDX1;BRIX1;MRPL20;NOP53;RPL5;SRSF9;EIF2S2;RPS14;EIF2S3;SRSF5;DENR;RPS15;RPSA;SRPK1;RPS28;CRNKL1;RPL11;RPL24;RPS19
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.34022628640242736,0.6634070457055913,0.8461538461538461,1.0,1.0,6/12,34.96%,PARP11;PARP16;PARP6;TNKS;TNKS2;TIPARP
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.39530853239799946,-0.6633941380086826,0.8571428571428571,1.0,1.0,2/8,14.46%,NOS2;BPIFB1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.4363558596883668,-0.6632887863042407,0.8846153846153846,1.0,1.0,3/5,34.24%,PCNA;RPS3;DDX11
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.29111226141846774,-0.6630889648828319,1.0,1.0,1.0,9/43,26.22%,USP50;CAV2;RNF26;HOOK2;CAV1;VPS18;PHETA1;LAMTOR1;ALS2CL
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.3103598964222303,-0.663007593905721,0.9473684210526315,1.0,1.0,8/23,28.69%,USP50;OTUB1;USP17L2;VCPIP1;OTUB2;OTUD4;USP5;YOD1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.2863484204363793,0.6628143535170401,0.972972972972973,1.0,1.0,4/38,15.34%,COX10;NR4A3;SDHAF4;ME3
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.24378669673777506,0.6627584579476294,1.0,1.0,1.0,24/111,21.39%,ADAMTS12;PSME4;PSMA1;RIPK2;GBP2;PLCB1;PTGIS;TANK;RPS6KA4;NFKB1;TAB3;TAB1;PELI1;CD40;PELI2;IRAK4;HAS2;IL1RAP;EGR1;RC3H1;TAB2;PSMD4;TRAF6;CUL1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.3062128110700012,-0.6627222960076727,0.9666666666666667,1.0,1.0,3/23,11.40%,EIF6;CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.36443410167534873,-0.6626806075507782,0.9423076923076923,1.0,1.0,2/15,14.76%,DARS2;YARS2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.3245802078212283,0.6625152268872464,0.9302325581395349,1.0,1.0,3/15,14.90%,NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),0.3798001904833242,0.6621870573018392,0.813953488372093,1.0,1.0,2/6,19.11%,TRIP13;DMRT1
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.23336145935396238,0.6619707966093135,1.0,1.0,1.0,21/91,24.29%,GLA;GOLGA4;GBF1;ABCA1;BET1;RPS6KA3;DST;SEC22B;DOP1A;PAM;ARFIP1;MON2;CTSC;RAB5A;ADAM10;GNAS;COG2;VPS45;TSG101;SEC31A;SSPN
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.37311009647740456,-0.6616370093813683,0.7931034482758621,1.0,1.0,1/10,11.90%,APOD
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.37121612933110326,-0.6616322034822919,0.8596491228070176,1.0,1.0,2/8,25.01%,GRN;AGER
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.2935978036260662,-0.6615503471396061,0.9661016949152542,1.0,1.0,4/44,10.81%,TGFB1;PLA2G10;RBM4B;METTL18
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.30853411502411865,0.6614889702294753,0.8809523809523809,1.0,1.0,3/16,16.50%,RALB;STING1;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.25361520202006366,-0.6614203523561679,1.0,1.0,1.0,3/170,1.26%,NEK2;PSMB9;KIF14
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.3464222979103142,0.6611921092550738,0.8636363636363636,1.0,1.0,3/12,17.37%,PML;WRAP53;DYRK3
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.32129771668871604,-0.6611672841938118,1.0,1.0,1.0,4/24,7.39%,IL7;GPR183;VAV3;PTPRC
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.3335713061294504,-0.6611189746582345,0.8771929824561403,1.0,1.0,9/25,22.54%,CAV2;SVIL;CSRP3;POPDC2;MYL6;LMOD3;CAV1;SIX4;EGR2
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.345681856958,0.6610896345378976,0.8444444444444444,1.0,1.0,2/6,12.08%,SLC7A2;SLC25A29
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.35905911158192844,-0.6609328293300976,0.8840579710144928,1.0,1.0,1/12,5.53%,BLK
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.40948478252754306,0.660721145053479,0.8095238095238095,1.0,1.0,2/5,26.15%,ATP8A2;ATP11B
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.34272284313506185,0.6603743262014417,0.8888888888888888,1.0,1.0,4/12,16.98%,SSC5D;ARRB1;OTUD7B;BCL3
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.39484689541184453,0.6598947872384651,0.9047619047619048,1.0,1.0,3/7,30.96%,RAP1A;FMR1;RAP1B
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.4087134792994651,0.6598429902277668,0.8048780487804879,1.0,1.0,1/5,17.37%,DYRK3
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.2970416360260572,-0.6598305614819951,0.958904109589041,1.0,1.0,9/38,21.04%,CLDN5;MARVELD2;CLDN6;CLDN1;CLDN18;ECT2;CLDN2;CLDN20;CLDN9
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.31293344617035923,0.6591857324821305,0.9473684210526315,1.0,1.0,2/19,6.44%,BCL2;PML
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.24459288389500553,0.6589793081574632,1.0,1.0,1.0,9/112,8.36%,NUP210;MAPKAPK2;SIRT1;NUP42;MLST8;ATF3;AAAS;VASH1;ABL1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.3797197725107866,0.6589346266728617,0.8604651162790697,1.0,1.0,2/8,13.82%,LBP;PLSCR1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.2239388081326038,0.6588847588207647,1.0,1.0,1.0,81/322,24.15%,KLHL20;SIRT1;KCTD21;PSME4;SPOPL;PSMA1;ZNRF1;ARRB2;ERCC8;RNF168;MVB12A;UBXN2A;PML;UBAP1L;WWP2;TRIM71;RNF166;MAEA;RBBP6;UBE2E1;SHARPIN;UBAP1;UBE3D;ANAPC16;UBE2D4;RNF128;RNF150;RNF217;KLHL3;UBE2A;USP44;FBXL14;RNF130;KLHL42;RNF146;PTPN23;ARRB1;KLHL22;SMURF1;PELI1;OTUD7B;CNOT4;ANAPC7;ARIH1;UBE4B;NEDD4;ZNRF3;FBXL22;UBE2L3;FAF1;RNF185;CDC26;UBXN2B;TBL1X;SPOP;FBXO11;RC3H1;TRIM9;TRPC4AP;PSMD4;OTUD7A;RNF216;HECTD3;SIAH2;MVB12B;FZR1;RNF19A;NFE2L2;MIB1;UBE2D2;RNF40;CDC34;AGAP3;TSG101;PSMD5;APPBP2;FBXL17;PSMD10;BAG6;UBE4A;UBE2D3
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),-0.41733782347179826,-0.6586019034194588,0.9636363636363636,1.0,1.0,3/5,38.19%,TNFSF4;SUPT6H;CD226
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.41396182516376195,-0.6584901405601993,0.8653846153846154,1.0,1.0,1/6,6.00%,HLA-A
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.2926043617558487,0.6584810340659875,0.9444444444444444,1.0,1.0,2/19,5.11%,SEMA6C;SEMA5A
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.3670404321028647,-0.6579715967998174,0.9259259259259259,1.0,1.0,4/14,28.97%,WDR12;RPL35;DDX18;RPL7L1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.2760975445698562,0.6579627572193208,1.0,1.0,1.0,18/58,25.34%,PIGQ;ZDHHC12;DPM3;ZDHHC18;ZDHHC16;CWH43;ZDHHC14;ZDHHC3;ZDHHC13;GPLD1;ZDHHC5;ZDHHC9;ZDHHC23;ATG12;PIGF;ZDHHC20;PIGU;PIGZ
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.4107635479005053,-0.6577724482659684,0.8461538461538461,1.0,1.0,1/6,22.34%,USP17L2
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.31194368721555765,-0.6577161336920643,0.9166666666666666,1.0,1.0,3/16,26.06%,ACTL6A;BRD8;ING3
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.3408433810172066,-0.657518916016367,0.8970588235294118,1.0,1.0,4/12,19.59%,IFIT1;ATP5IF1;PAM16;PLN
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.4055401669771519,-0.6569775362492596,0.9259259259259259,1.0,1.0,4/8,38.74%,FLOT1;EHD2;RIPOR2;CD53
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),0.44124748401823694,0.6567820299222715,0.9111111111111111,1.0,1.0,2/5,22.64%,MLXIPL;TRAP1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.3905236176110277,0.6563436551314319,0.8333333333333334,1.0,1.0,1/6,10.09%,IL23A
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.2953222839916657,0.6562780845631075,0.9666666666666667,1.0,1.0,2/25,6.50%,KIAA0319;DCC
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.2872099693159978,-0.6561590763843623,0.9841269841269841,1.0,1.0,12/48,32.71%,CHMP3;CC2D1B;NUP93;SEC13;RAN;NDC1;CHMP4B;NUP155;VPS4A;NUP133;REEP4;CCNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.2872099693159978,-0.6561590763843623,0.9841269841269841,1.0,1.0,12/48,32.71%,CHMP3;CC2D1B;NUP93;SEC13;RAN;NDC1;CHMP4B;NUP155;VPS4A;NUP133;REEP4;CCNB1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.2655948217245355,0.6560632523041544,1.0,1.0,1.0,8/71,7.89%,SLC39A8;SLC12A1;SLC8A1;TRPM2;SLC8A3;KCNJ3;KCNJ6;SLC12A9
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.3809539975174529,-0.6557299949110902,0.875,1.0,1.0,3/9,22.44%,CYP24A1;CYP3A4;LDHD
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.39648164821175214,-0.6551139919669566,0.8490566037735849,1.0,1.0,3/5,29.58%,RFPL1;RPS3;RFFL
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.41958103938623825,-0.655085331203166,0.8518518518518519,1.0,1.0,1/5,8.08%,SOD2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.34352222620353445,0.6550442820301061,0.8947368421052632,1.0,1.0,4/16,20.57%,HSF1;ATM;TP53;ATR
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.3552803603473534,0.6549580095616715,0.8666666666666667,1.0,1.0,3/8,19.88%,TOM1L2;BMP4;AURKAIP1
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),-0.42744813181769914,-0.6544167524460524,0.875,1.0,1.0,3/7,27.05%,SFRP4;FGFR4;GCM2
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.39624809007894246,-0.653892077405649,0.8846153846153846,1.0,1.0,1/8,3.72%,DCN
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.3949905063432169,0.6538453938395101,0.926829268292683,1.0,1.0,1/5,28.04%,AQP1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.34439204406560764,-0.6538180403705167,0.8983050847457628,1.0,1.0,1/18,4.32%,MISP
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.26383723407133464,0.6536665976512217,0.9629629629629629,1.0,1.0,19/69,20.48%,RFWD3;BRCC3;SIRT1;IFI16;RNF168;MYC;TANK;SPIDR;LIG4;EYA3;ATM;EEF1D;RAD9A;H2AX;BRAT1;GADD45A;MEN1;TP53;CLK2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.32857213364457144,0.6536529641439245,0.9024390243902439,1.0,1.0,5/12,21.68%,KPTN;RNF152;ATM;SZT2;SESN2
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.28632897633734955,-0.6536119341841001,0.967741935483871,1.0,1.0,4/43,15.69%,TGFBI;UBE2L6;SIAH1;MFGE8
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.3854325753759653,0.6525135821154969,0.8787878787878788,1.0,1.0,4/9,22.21%,PKD2;ABCC8;KCNJ8;ABCC9
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.3734980452928258,0.6524489392245155,0.8,1.0,1.0,2/9,6.04%,F2;HS3ST5
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.3705521668541438,-0.6520754339754115,0.863013698630137,1.0,1.0,3/10,18.51%,TMEM204;HEY2;HEY1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2707886820937695,-0.6519182077597564,0.9833333333333333,1.0,1.0,9/61,19.81%,IL7;STAT1;PTPRC;PALM3;HIPK1;IFNGR2;CDC37;SPATA2;CASP8
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.32538984746369715,-0.6514246603790236,0.9104477611940298,1.0,1.0,3/25,8.97%,ELOVL2;PPT1;ACSL5
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.33539094727940916,-0.6512124498088165,0.9402985074626866,1.0,1.0,3/18,11.40%,GPER1;CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.31508810377170426,-0.6507849399694545,0.9285714285714286,1.0,1.0,3/27,11.62%,CAV3;CLU;ATP5IF1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.41639772356113636,-0.6507603606058046,0.875,1.0,1.0,1/6,12.79%,ST6GALNAC2
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.3650982459539678,-0.6505206039792878,0.9508196721311475,1.0,1.0,1/16,3.80%,CYP26B1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.31703003924147344,-0.6504971428013949,0.9636363636363636,1.0,1.0,1/25,1.76%,DISC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.3116683420853127,0.6500499573686537,1.0,1.0,1.0,3/12,13.02%,ZBTB1;IL23A;TICAM1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3931656648903038,0.6498101750497088,0.8536585365853658,1.0,1.0,1/8,5.76%,SNCA
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.31271301415661834,-0.649620187899266,0.9552238805970149,1.0,1.0,3/27,10.54%,TGFB1;DUSP16;STRADB
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.328370804274652,0.6495407456350561,1.0,1.0,1.0,5/17,13.91%,PARD3;RNF10;RIMS2;UNC13B;ATPSCKMT
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.24626956026535665,0.6494790142029362,1.0,1.0,1.0,29/106,25.21%,PSAT1;PDIA6;EXOSC1;CHAC1;ATF3;EIF2AK3;ERN1;ALDH18A1;KHSRP;PREB;CNOT4;CXXC1;DNAJC3;FUS;ATF6;YIF1A;H2AX;EIF4EBP1;EDEM1;NOP14;EIF4A3;CNOT6;EIF4E;DDX10;SLC30A5;SEC31A;DCP1A;SLC7A5;XPOT
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.41315311762730744,-0.6493715240754129,0.8888888888888888,1.0,1.0,1/6,18.86%,EXOSC2
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.3939713601960924,0.6492955669075537,0.918918918918919,1.0,1.0,1/7,4.71%,WNT4
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.3202291939927764,-0.6492354430237156,0.8867924528301887,1.0,1.0,2/18,11.56%,ANXA1;REST
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.3970175620838233,0.6489786302120151,0.8888888888888888,1.0,1.0,1/5,12.23%,LGALS9
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.44065584391765966,0.6489362792082913,0.9047619047619048,1.0,1.0,1/5,19.01%,ADAM8
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.3791084363339727,-0.6489089805798806,0.896551724137931,1.0,1.0,3/10,23.85%,BRCA1;ZNF366;VPS18
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.37555425190224245,-0.6488320820423634,0.9137931034482759,1.0,1.0,2/9,20.47%,XRCC1;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.2637532788576407,-0.6488224640308025,1.0,1.0,1.0,15/82,23.29%,TGFB1;TERF2IP;DYNLL1;CDKN2D;CDKN1A;ATG14;CACTIN;IGFBP3;NTRK3;WARS1;ACTN3;PFKFB1;CDKN1B;INHA;PARK7
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.42196290022159305,-0.6486016921921164,0.8867924528301887,1.0,1.0,3/5,21.77%,SOD2;CAV1;ALAS2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.30869779687876153,0.6484660140489359,0.8787878787878788,1.0,1.0,5/20,19.56%,SERPINE1;HMGB1;LGALS9;CXCL12;MOSPD2
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.28488775757194734,-0.6484290805740243,0.9666666666666667,1.0,1.0,4/35,19.12%,TGFB1;TIPRL;CALM1;ARPP19
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.34462926693468093,0.6483571687131402,0.9090909090909091,1.0,1.0,4/9,22.02%,ABCA1;SREBF2;SMAD7;NFE2L2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.33770055623750794,0.6476382887257347,0.8918918918918919,1.0,1.0,7/17,29.85%,PDZD11;ADAM10;TPR;AFDN;NUP153;ANO6;NUP98
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.2689807220769063,-0.647618378263732,0.9859154929577465,1.0,1.0,10/67,22.49%,KIF14;RAB11A;SVIL;ANKRD53;CDC6;CALM1;ECT2;AURKA;CXCR5;DCDC1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.2565494504198295,0.6475743517402279,1.0,1.0,1.0,15/53,19.91%,ELOF1;CDCA4;TAF1B;H1-10;MYO1C;SF3B1;POLR1H;ARID1A;SERTAD2;BAZ1B;ARID1B;ATAD2B;KAT2B;EP300;POLR2F
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.35942798905889894,-0.6470789759011972,0.8870967741935484,1.0,1.0,1/10,11.40%,BRCA1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.28889719771340405,0.646856185659392,0.95,1.0,1.0,7/32,24.25%,STX5;EMC2;UBE2J2;EMC10;EMC4;BAG6;EMC8
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.30487488740123386,0.6465615204838999,0.9777777777777777,1.0,1.0,6/30,12.52%,OSR1;SLC8A1;WNT4;ADGRV1;CCN1;BMP4
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.2974380545838112,0.6464288507554643,0.9444444444444444,1.0,1.0,8/19,26.67%,UGDH;NAGK;UAP1;SLC35D1;GNPNAT1;PMM2;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.31038018942187773,-0.6460845046811745,0.9661016949152542,1.0,1.0,4/28,21.06%,TERF2IP;TERT;PIF1;NOP10
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3706123755097744,-0.6459239253108514,0.8793103448275862,1.0,1.0,6/9,44.27%,AP2S1;CLTA;VLDLR;AP2A2;AP2M1;AP2A1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3706123755097744,-0.6459239253108514,0.8793103448275862,1.0,1.0,6/9,44.27%,AP2S1;CLTA;VLDLR;AP2A2;AP2M1;AP2A1
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.38538181015354545,0.6458297226499524,0.9130434782608695,1.0,1.0,3/5,28.88%,COQ2;GK;COQ3
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.36264286383450894,0.6455726321441315,0.8611111111111112,1.0,1.0,2/8,13.15%,RIN2;RAP1A
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.39063620242691627,0.6451058835714388,0.8611111111111112,1.0,1.0,1/7,2.41%,SLC3A2
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.3164312581937337,-0.6449838180557814,1.0,1.0,1.0,7/32,16.11%,LRPAP1;PPT1;CLU;PROM2;VTN;PIK3CB;RAC1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.32562225400321887,-0.6447932315416635,0.9523809523809523,1.0,1.0,2/17,10.40%,TGFB1;PIK3R3
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.37314529417797704,0.6446789117945106,0.8571428571428571,1.0,1.0,2/10,21.05%,ABCB10;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2872749632237156,-0.6444561881715418,0.9696969696969697,1.0,1.0,1/57,0.73%,PSMB9
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.42989694695190644,-0.6441642073558121,0.9019607843137255,1.0,1.0,3/6,26.39%,BTBD18;GPAT2;DDX4
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.39046493824025674,0.6440575378798544,0.8947368421052632,1.0,1.0,1/6,8.05%,PLIN5
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.4061140594884488,-0.6438875431675996,0.9354838709677419,1.0,1.0,2/8,12.29%,GATA4;HEY2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.31180209773777723,-0.6438715219570189,0.8870967741935484,1.0,1.0,2/19,8.92%,COL5A1;C12ORF57
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.36401979352496633,-0.6438538947200798,0.8448275862068966,1.0,1.0,2/13,11.07%,CAVIN1;POLR1G
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.23458707401196624,0.6438223210062868,1.0,1.0,1.0,17/65,24.77%,SMYD5;NCOA3;PLK3;RAB11FIP3;MYC;MLLT3;CSPP1;SETD2;SHH;EFHC1;GIT1;PIK3R4;CIB1;MYO19;PRDM15;CDK2AP2;BCL2L1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.3590158751714699,-0.6437552665553288,0.9444444444444444,1.0,1.0,6/14,23.27%,CEACAM1;APOLD1;ALOX15B;SOX9;CAV1;CD24
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.4074995700896887,0.643645095470846,0.9512195121951219,1.0,1.0,1/5,21.85%,SLC2A5
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.33651836443154587,0.6434683854728135,0.9166666666666666,1.0,1.0,2/10,9.25%,DEF8;PLEKHM1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.2342714710208702,0.6430281020143347,1.0,1.0,1.0,21/98,21.39%,KIT;NFATC3;PSME4;PSMA1;FER;MAPK8;MAP3K1;NFKB1;MAP2K7;TAB3;VAV2;TAB1;PIK3CA;MALT1;SOS1;TAB2;PLCG2;PAK2;PSMD4;TRAF6;CUL1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.2403087491442751,0.6430007032353132,1.0,1.0,1.0,7/81,12.58%,CPN1;NAA40;AANAT;F12;TESC;MMP16;TSPAN17
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.3128350040222736,0.6426467031011349,0.9736842105263158,1.0,1.0,10/20,35.45%,BCR;TAOK2;PEAK1;DLC1;WHAMM;TRIP6;PTPRK;PIP5K1A;RHOD;RCC2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.2285775331458587,-0.642591933617436,1.0,1.0,1.0,35/287,19.90%,PSMB9;ARIH2;TRIM62;DTL;TRIM5;UBE2L6;UBE2U;UBE3A;FBXL7;RNF213;PRAME;FBXL13;TRAF3IP2;CCNF;BRCA1;SIAH1;STUB1;RNF187;TRIM56;RNF20;IFI27;TRIM36;ZNF738;FBXO40;PSMA7;RBX1;PSMB6;RNF26;TRIM22;RNF144B;PSMA3;C10ORF90;RNF8;FBXL18;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.3620756000062078,0.6422583969105369,0.9787234042553191,1.0,1.0,3/13,11.18%,SMARCAL1;SLFN11;TIMELESS
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.2832656043554007,-0.6422033777396582,0.9848484848484849,1.0,1.0,10/68,17.37%,TGFB1;MYOT;ACTG1;LRP4;MARVELD2;CLDN1;LIMS2;SMAD3;VASP;TGFB3
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2559201270069244,0.6416193880156952,1.0,1.0,1.0,10/52,14.92%,UBE2E3;ZNRF1;UBE2E1;RNF152;UBE2E2;UBE2D4;KLHL3;UBE2A;RNF146;PELI1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3009591643374723,-0.6414280604234234,0.9661016949152542,1.0,1.0,5/40,11.22%,TERF2IP;LRRC19;NLRP12;TLR2;C1QTNF4
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.396362074792651,0.6414062215918512,0.8571428571428571,1.0,1.0,1/7,7.51%,NOP9
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.3727000995972876,0.641381873515784,0.8653846153846154,1.0,1.0,1/9,7.05%,BDH2
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.418505854169524,-0.6412038313265315,0.864406779661017,1.0,1.0,1/5,12.79%,ST6GALNAC2
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.39586712064575624,0.6411283090990312,0.8333333333333334,1.0,1.0,2/6,13.85%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.28295789896193113,-0.6410541482314442,0.9857142857142858,1.0,1.0,1/43,0.48%,CRLF1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.23231842317342605,0.6410203441697853,1.0,1.0,1.0,47/191,24.24%,KLHL20;SIRT1;PSME4;SPOPL;PSMA1;ZNRF1;ARRB2;ERCC8;UBXN2A;PML;WWP2;TRIM71;MAEA;RHBDD1;SHARPIN;UBE3D;UBE2A;USP44;KLHL42;ARRB1;KLHL22;SMURF1;PELI1;UBE4B;NEDD4;FBXL22;FAF1;RNF185;UBXN2B;TBL1X;SPOP;TRIM9;PSMD4;RNF216;HECTD3;SIAH2;NFE2L2;CDC34;AGAP3;PSMD5;APPBP2;FBXL17;PSMD10;BAG6;UBE2D3;RNF139;NR1D1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.3506269896702748,0.6407769111200502,0.8936170212765957,1.0,1.0,1/8,7.80%,DCUN1D1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.3190330781672467,0.6405697157601186,0.926829268292683,1.0,1.0,5/13,23.03%,NSMAF;SMPD3;SAMD8;PLA2G6;ORMDL2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.3618455061725702,0.640562343681403,0.9354838709677419,1.0,1.0,2/10,10.20%,MICU1;MCU
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.28183891086115753,-0.6403940408730767,0.9344262295081968,1.0,1.0,4/30,17.21%,PPP1R1B;TIPRL;CALM1;BOD1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.3612907729948611,0.639994130890474,0.8974358974358975,1.0,1.0,6/9,30.03%,ADCY2;ADCY3;ADCY6;ADCY9;ADCY5;ADCY10
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.3541027197384272,-0.6398716270213614,0.96,1.0,1.0,2/11,18.84%,IMPA2;IMPA1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3541027197384272,-0.6398716270213614,0.96,1.0,1.0,2/11,18.84%,IMPA2;IMPA1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.32056709403780315,-0.6397212214462282,0.9375,1.0,1.0,5/21,20.02%,ERI2;RPS21;WDR12;EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.3485901312585282,0.6395560961581019,0.94,1.0,1.0,3/10,17.27%,SLC27A2;ACSL1;SLC27A4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.27423586160835994,-0.6395069696406795,1.0,1.0,1.0,8/60,16.11%,FCGR3A;HCK;VAV3;ACTG1;WAS;NCKIPSD;PIK3CB;RAC1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.27423586160835994,-0.6395069696406795,1.0,1.0,1.0,8/60,16.11%,FCGR3A;HCK;VAV3;ACTG1;WAS;NCKIPSD;PIK3CB;RAC1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.3773027658050162,0.6394727268743172,0.92,1.0,1.0,1/6,4.52%,MTERF3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.2988054604307112,-0.6391804721372742,0.9636363636363636,1.0,1.0,3/29,16.42%,CAV3;TMEM35A;TOR1A
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.30196986106993745,-0.6391681224634279,0.9666666666666667,1.0,1.0,4/29,21.06%,TERF2IP;TERT;PIF1;NOP10
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.37529499166060215,-0.6390860318352761,0.8571428571428571,1.0,1.0,1/10,6.29%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.376767368970623,-0.6388272243787639,0.95,1.0,1.0,4/10,20.00%,TAF7;BRCA1;SET;KLF15
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.29989186452684646,0.6385511479780583,1.0,1.0,1.0,9/24,22.07%,CACNB4;JPH1;JSRP1;ANK2;JPH4;DMD;PDE4D;JPH3;HPCA
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.4356347922170972,-0.6385338553089807,0.9433962264150944,1.0,1.0,1/6,12.36%,PDZK1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.36134105627296165,0.6382859905602278,0.9047619047619048,1.0,1.0,1/7,11.71%,EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.36134105627296165,0.6382859905602278,0.9047619047619048,1.0,1.0,1/7,11.71%,EEFSEC
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.31638060873357116,0.6379099207287511,0.9361702127659575,1.0,1.0,3/13,16.50%,RALB;STING1;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.25876137508038055,0.6377250660147807,1.0,1.0,1.0,9/50,20.95%,APOE;COMMD1;OSBPL7;TMTC3;FOXF2;GPX1;MARCHF7;XPO1;GNA12
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.30497225575350995,-0.6376812996968754,0.9384615384615385,1.0,1.0,4/23,17.66%,ITGB2;ARHGAP12;ITGAM;VAMP7
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.3762411036803903,0.637632028178213,0.926829268292683,1.0,1.0,4/7,24.22%,FAF1;CCDC22;PSMD10;NFKBIB
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.24106421438975295,-0.6374045735381934,1.0,1.0,1.0,14/151,15.44%,TGFB1;CLDN5;LRPAP1;RIN3;ESR1;PINK1;GPER1;PTRH2;SPI1;REST;HEY2;NOS2;SFRP1;TERT
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.3439190874626858,0.637375192931178,0.8541666666666666,1.0,1.0,5/12,29.99%,FER;RC3H1;CD55;LGALS3;SLAMF8
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.35273686342996824,-0.6367437469002823,0.9076923076923077,1.0,1.0,3/10,22.50%,AGT;SOX9;SIX4
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.40461859492184044,-0.636694150074626,0.8260869565217391,1.0,1.0,2/6,30.50%,VPS18;VPS4A
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.3336837523881267,0.6362086467014985,0.9444444444444444,1.0,1.0,4/13,17.88%,BRCC3;LIG4;ATM;NIPBL
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3251336409049518,-0.6357716140464377,0.9824561403508771,1.0,1.0,5/16,18.98%,HLA-DRB1;BTN3A3;GNL1;IL18BP;IL18
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.3386162119218667,-0.6356174278497185,0.890625,1.0,1.0,3/12,19.93%,ERVW-1;JAM2;CD81
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.31150450148526043,-0.6355521073158179,1.0,1.0,1.0,4/25,15.33%,PIGH;MPPE1;PIGC;PIGL
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.2890807257595444,0.6353347220318297,0.918918918918919,1.0,1.0,8/19,26.80%,MOV10;TNRC6C;TNRC6A;AGO3;AGO2;CNOT6;NRDE2;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.27461411461124147,0.634635536091463,1.0,1.0,1.0,6/21,23.23%,ABL1;COL16A1;LIMS1;IQSEC1;PTPRJ;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.3438690605899981,-0.6346203933561233,0.9090909090909091,1.0,1.0,1/12,1.85%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.3793540318142077,-0.6345605835821841,0.9180327868852459,1.0,1.0,2/6,15.58%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.29711431886953665,-0.6344034041957565,0.9838709677419355,1.0,1.0,9/40,16.03%,HLA-A;IL27;ZFPM1;SLC11A1;HLA-DPB1;IL12A;TXK;HLA-DPA1;ISG15
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.3770089344862789,-0.6343137946394358,0.9272727272727272,1.0,1.0,1/8,10.09%,DCTN1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.26684323117872816,-0.6342878650565431,0.9726027397260274,1.0,1.0,12/75,17.46%,SCN5A;ASIC5;SLC5A2;SLC6A12;SLC5A1;SLC9A2;SLC24A1;ATP1A4;SCNN1G;SLC6A4;SLC9C1;ATP4A
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.41735457969300316,-0.6341356900637708,0.9259259259259259,1.0,1.0,2/6,19.13%,ADA;ACP3
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.30830659285620576,-0.6340764740029433,0.9130434782608695,1.0,1.0,3/20,15.59%,OBSCN;CSRP3;TTN
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.2867969889899967,-0.6340754730831352,0.9701492537313433,1.0,1.0,8/50,14.20%,GALNT15;B3GNT5;MUCL1;ST6GALNAC2;GALNT6;CHST4;GCNT1;MUC5B
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3472970490540473,-0.6340230073061639,0.9310344827586207,1.0,1.0,1/14,10.02%,ACAA2
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.32335873144955457,-0.6340053114810862,0.9464285714285714,1.0,1.0,4/28,17.39%,ITGB2;PDZK1;ITGAM;FIS1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2920939280814635,0.6338841292981297,0.9142857142857143,1.0,1.0,4/22,15.58%,LPCAT2;PLA2G5;PLA2G4C;NR1H3
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.39283748854360884,-0.6338080264271059,0.9166666666666666,1.0,1.0,1/6,11.49%,DGAT2L6
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.4233653626002512,-0.6337510676834562,0.8714285714285714,1.0,1.0,1/6,1.48%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.4233653626002512,-0.6337510676834562,0.8714285714285714,1.0,1.0,1/6,1.48%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.4233653626002512,-0.6337510676834562,0.8714285714285714,1.0,1.0,1/6,1.48%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.4233653626002512,-0.6337510676834562,0.8714285714285714,1.0,1.0,1/6,1.48%,ELOVL2
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.4041540399914326,0.6335399365617856,0.9318181818181818,1.0,1.0,1/6,1.35%,CYP7B1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.37157489284711714,-0.6330696961054048,0.921875,1.0,1.0,2/11,21.32%,BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.37157489284711714,-0.6330696961054048,0.921875,1.0,1.0,2/11,21.32%,BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.3443685540000499,0.6327253421003973,0.8780487804878049,1.0,1.0,3/10,14.28%,SIRT1;WDTC1;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.38039801925544053,-0.6326181836046908,0.9032258064516129,1.0,1.0,3/10,20.56%,GPER1;GRN;CD300LF
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.3447109908554833,-0.6325910396797275,0.9104477611940298,1.0,1.0,3/13,20.67%,SLC25A18;SLC25A22;ETFB
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.4114530956289264,-0.6322923473344619,0.9166666666666666,1.0,1.0,3/5,41.09%,APAF1;CYCS;BOK
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.28760276822570296,0.632212257051301,0.9736842105263158,1.0,1.0,5/19,24.77%,EIF2AK3;HSPA1A;CREB3L1;NCK1;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.283898079369341,0.6321602836020925,0.9696969696969697,1.0,1.0,9/19,28.17%,GDF6;GADD45G;MFHAS1;RELL1;EMC10;GADD45A;RELL2;BMP2;PRMT1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.30662617920693663,-0.6320646791435989,0.9848484848484849,1.0,1.0,4/26,14.83%,HLA-DRB1;HLA-A;IL12A;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.28737205132135957,-0.6316600153185625,0.9855072463768116,1.0,1.0,1/37,0.48%,CRLF1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.29295727373232905,-0.6316561462024932,1.0,1.0,1.0,1/28,1.85%,TGFB1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.33155495274159913,-0.6312311306885494,0.9607843137254902,1.0,1.0,3/14,25.34%,INTS5;TRNT1;PTCD1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.24962617075964583,-0.6309920682356637,1.0,1.0,1.0,17/79,24.80%,PSMB9;FBXL7;CDKN2D;CDKN1A;PSMA7;RBX1;PSMB6;MYO16;PSMA3;AURKA;PSMA5;ZFP36L1;SKP1;PSMD8;RFPL1;PSMD6;BRD7
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.37180303295027206,-0.6307471238953147,0.890625,1.0,1.0,4/10,23.89%,P2RY12;CD81;MTUS1;MST1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.33334959931984354,0.6306969852015206,0.9736842105263158,1.0,1.0,3/12,16.82%,PGRMC2;NAMPT;ARID5B
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.3171017014855591,-0.6306646425977227,0.9649122807017544,1.0,1.0,4/14,23.88%,PIK3CG;PIK3CB;KBTBD7;KBTBD6
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.28067899643973726,0.6301337346030295,0.9487179487179487,1.0,1.0,4/28,14.40%,FHIT;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.3105122066177691,0.6300163746842963,0.8918918918918919,1.0,1.0,6/18,21.50%,SETMAR;ATM;RAD52;RAD50;DNA2;SMARCAD1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.385604179269144,-0.6292033128805079,0.8983050847457628,1.0,1.0,1/7,11.90%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.385604179269144,-0.6292033128805079,0.8983050847457628,1.0,1.0,1/7,11.90%,APOD
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.3768183225007739,0.6286104612678166,0.9148936170212766,1.0,1.0,7/7,62.33%,EPHA4;PTPRS;RTN4R;RTN4RL1;INPP5F;CERS2;THY1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.24547237379565828,0.6284961251924016,1.0,1.0,1.0,12/80,18.07%,GBF1;KIF2B;STX18;TMED3;COG7;SEC22B;PLPP3;COG4;KIF3B;TMEM115;SCYL1;KIF4B
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.3888437404452022,0.6283188267126305,0.8571428571428571,1.0,1.0,1/7,3.76%,HTR2C
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.4005266243917191,-0.6277127430254121,0.8833333333333333,1.0,1.0,2/7,14.34%,CARTPT;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3660726886414196,0.6275872199964727,0.8695652173913043,1.0,1.0,4/6,27.16%,TWSG1;TARM1;TNFRSF14;HFE
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.40147916453828525,0.6259870176862503,0.8235294117647058,1.0,1.0,2/5,16.31%,ADAMTS12;TSPAN12
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.27382301696299594,0.6259541021912803,0.9555555555555556,1.0,1.0,13/36,27.21%,MYO1E;MYO1C;TRAK2;BICDL1;PPFIA2;MYO5A;NDE1;BICDL2;MYO19;MYO1D;MYO5C;FNBP1L;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.2905351983280415,0.6259304512162666,1.0,1.0,1.0,6/34,12.52%,OSR1;SLC8A1;WNT4;ADGRV1;CCN1;BMP4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2580738585027357,0.625493569529186,1.0,1.0,1.0,9/47,18.76%,CFLAR;NLRP2B;SHARPIN;HSPA1A;LAPTM5;ZNF675;FADD;CLIP3;CPNE1
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.3878927446245711,0.625445964249768,0.813953488372093,1.0,1.0,1/5,8.06%,OPRD1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.3072963626905318,-0.624542349786179,0.9846153846153847,1.0,1.0,3/26,8.35%,CCDC39;DRC1;CFAP74
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.4150938507212967,-0.6240014998343856,0.9,1.0,1.0,3/6,25.64%,TRDN;PLN;ATP2A2
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.3740757425766,-0.6239151808185076,0.9,1.0,1.0,1/6,17.44%,PRPS1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.3418243679530354,-0.6236321183241368,0.9636363636363636,1.0,1.0,3/12,22.88%,PTPRC;GLI3;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.2719449520265389,0.6234642903122622,1.0,1.0,1.0,6/36,15.39%,FGF10;RGN;DNAJC24;MYL3;PLSCR1;SETMAR
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3180077645477074,0.6233705150826466,0.9024390243902439,1.0,1.0,4/16,22.32%,PAG1;LAPTM5;MIA3;WNK1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.314110309096171,0.6233031827954373,0.9512195121951219,1.0,1.0,1/10,9.46%,PDE4B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.28754737493962246,-0.6232500241057889,1.0,1.0,1.0,1/35,1.85%,TGFB1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.28422627703661746,0.6231032303794342,0.9767441860465116,1.0,1.0,2/24,8.54%,PER2;GYS1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.320412776536378,-0.6230272250574378,0.9264705882352942,1.0,1.0,3/16,17.39%,PTPRC;SELP;FIS1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.34194507309159716,0.6229574990029528,0.9024390243902439,1.0,1.0,5/14,19.36%,SAMSN1;BANK1;ATM;LAPTM5;RC3H1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.37207086733583206,-0.6224900985456212,0.8928571428571429,1.0,1.0,2/8,10.01%,BLK;ORMDL3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3320913898081026,0.622099414249602,0.9210526315789473,1.0,1.0,3/10,23.14%,ICE1;CEBPA;ICE2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.26833443722824124,0.6217082861806819,1.0,1.0,1.0,2/26,7.62%,ERBB2;STAT5B
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.27549661508694345,0.621173000491653,1.0,1.0,1.0,9/24,26.78%,DCUN1D1;ABL1;UBE2L3;SMAD7;LIMK1;AXIN1;TRIB3;DCUN1D2;PLK1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.333746100225003,-0.6209157465823153,0.9333333333333333,1.0,1.0,6/16,27.63%,ROS1;ACTA2;TMEM79;EXPH5;BFSP1;WNT5B
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.27944815219127606,0.6207431692247698,0.9795918367346939,1.0,1.0,6/29,16.11%,KANK4;SLIT2;KANK1;PIK3CA;IQCJ-SCHIP1;SSH1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.284132307248536,-0.6206379410939302,0.9473684210526315,1.0,1.0,6/27,21.73%,GAS7;WAS;RAC1;VIL1;PSTPIP1;CATIP
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.25121335805643685,-0.6205199667584572,0.9866666666666667,1.0,1.0,9/72,18.72%,ARIH2;DAB2;CLU;STUB1;HERPUD1;NOP53;RBX1;ELOB;RNF144B
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.2866848830398271,-0.619890008200851,1.0,1.0,1.0,1/35,1.13%,AHR
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.37875270813989476,-0.6198567803123398,0.9285714285714286,1.0,1.0,7/7,62.14%,TMEM33;BCL2L11;BAK1;PTPN1;BAX;AGR2;DAB2IP
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.2685553490936453,0.6196992478638103,0.9310344827586207,1.0,1.0,7/42,15.66%,PUF60;CELF4;CELF5;TXNL4A;SF3B1;CELF2;LUC7L
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.4165783198351046,0.619579073405682,0.925,1.0,1.0,2/5,22.23%,PLSCR1;TPR
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.3706522871203272,-0.6189383891424615,0.9295774647887324,1.0,1.0,3/12,13.25%,ELOVL2;TECRL;HACD4
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.40411687724256384,0.6186342507517241,0.9230769230769231,1.0,1.0,3/6,30.54%,CERT1;GLTP;PLEKHA8
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.32674606869711,-0.6186216632658421,0.896551724137931,1.0,1.0,4/13,29.07%,TESPA1;CD81;RPS3;PRKD2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.34900729349808923,-0.6184111277087649,0.9482758620689655,1.0,1.0,2/10,14.35%,LATS2;SLC6A4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.34920465615645374,0.6183341037762967,0.9166666666666666,1.0,1.0,3/8,28.53%,CXCL12;CALCR;LGALS3
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.3295174565751609,-0.6181016713958956,0.9137931034482759,1.0,1.0,1/14,10.09%,DCTN1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.2774958911128009,-0.6176532425727541,1.0,1.0,1.0,7/43,21.09%,CASQ2;KCNJ11;ATP1A4;TRDN;ITPR3;ATP1A1;AGT
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.29619054093441777,0.6175219024136593,0.9523809523809523,1.0,1.0,2/19,5.28%,HTRA2;FZD5
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.3613327041866755,0.6174642716228053,0.8666666666666667,1.0,1.0,3/7,29.44%,F11R;ANK3;PDPN
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.38237932424387505,0.6169108893584472,0.8181818181818182,1.0,1.0,2/5,27.35%,RPS6KA4;FMR1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.32631344801747075,0.6168893462421499,0.9142857142857143,1.0,1.0,5/16,18.35%,SIRT7;RIOK1;USP36;BUD23;KAT2B
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.31774318935729273,-0.6167372324849903,0.967741935483871,1.0,1.0,1/22,1.44%,CASQ2
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),0.34661834603771685,0.6164910785339581,0.8378378378378378,1.0,1.0,2/6,20.07%,HAS2;ADCY6
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),0.3966124447252015,0.6163827487341588,0.8292682926829268,1.0,1.0,1/5,8.40%,LTBP1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.21504883945204306,-0.6163443114791988,1.0,1.0,1.0,91/327,27.26%,RPL37A;ANGPT2;RPL15;FIP1L1;DHX38;DDX20;RPL3;RPL38;ADAD2;COPS5;RPL35A;RPS9;RPL7A;STUB1;RPL13;RPS27;RPL13A;RPS4X;RPS16;YARS2;RPS20;RPS8;CDC40;RPS21;RPS11;ABCF1;MRPL34;RPL27A;RPL9;RPL5;NUP93;SRSF9;RPL21;RPL34;RPL4;RPL23;RPS14;ADARB2;WARS1;RPL18A;RPL32;SRSF5;RPL36;RPS27A;RPL18;RPL29;RPS7;RPS15;SLU7;RPSA;CPSF2;RPL41;RPS28;RPLP1;POLR2B;RPL12;EEF1A1;RPL11;PTMA;DRG1;RPL35;RPL22;RPL27;RPL24;TFIP11;RPLP2;RPS13;RPS19;SEC13;RPL28;RPL19;RPS24;RAE1;TSPAN15;RPL10;RPS25;CREBL2;RPS3A;PRPF4;RBM3;UPF1;ASMT;NDC1;FYTTD1;RPS6;HNRNPK;RPL8;DUSP11;RPLP0;XAB2;RPS12
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3329103706054522,-0.6162373192015204,1.0,1.0,1.0,5/12,29.77%,GNL3;CCT8;CCT6A;CCT7;CCT2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.2812520784147982,0.6162040407627788,1.0,1.0,1.0,8/38,20.37%,JADE3;TAF12;KAT6A;SUPT3H;KAT2B;KAT6B;KAT14;JADE2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.3724669174083943,0.616081683720149,0.9210526315789473,1.0,1.0,3/7,12.98%,SH3RF1;HLA-DRA;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.30350925353443486,0.6155067442785337,0.967741935483871,1.0,1.0,9/24,21.03%,IL23A;HCLS1;TESC;RUNX1;ACIN1;HSF1;FADD;IL23R;TRAF6
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.2711440342867307,0.6152791795375394,1.0,1.0,1.0,5/16,28.78%,NR4A3;APPL2;PRKAG2;ACADVL;SIRT4
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.34337557459775503,-0.6151290986884218,0.9365079365079365,1.0,1.0,3/10,17.80%,PBLD;STRAP;MUC4
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.40637164153975697,0.6147399654886705,0.9583333333333334,1.0,1.0,1/5,8.93%,MICU1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.25291234140143043,0.6146965020503355,0.975609756097561,1.0,1.0,9/43,18.27%,BCL2;IL16;PKD2;EPB41;ANK2;SLC8B1;F2R;WNK3;STIM2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.2681340408537319,0.6145972757500122,1.0,1.0,1.0,9/57,13.89%,CCN4;IL16;SNCA;SERPINE1;LPL;GPSM3;IL23A;LBP;ABCC1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.2868669791428644,0.6143573863421061,0.975609756097561,1.0,1.0,15/32,30.16%,MMP2;ITGA4;GRIN1;ABCC1;CACNA1A;GRM5;CDK5;CALCR;CACNA1B;FYN;FPR2;CACNB1;EPHA4;GRIN2A;IGF1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.22203722895552888,0.6136001977557385,1.0,1.0,1.0,20/108,21.42%,HDAC10;VPS16;TCIRG1;MTERF3;TMEM74;MVB12A;PLEKHM1;CHMP6;KLHL3;VTA1;PIP4K2A;VAMP8;MTMR3;MTMR14;STAM2;TBC1D5;PRKAG2;SNF8;PRKAA2;PIK3R4
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.3942156076390848,-0.6131840892454441,0.9152542372881356,1.0,1.0,1/5,14.43%,MCCC2
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.3733047954529052,-0.6130362044255143,0.9056603773584906,1.0,1.0,2/5,32.88%,BMP6;B2M
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.29903874307698947,0.6129324888444332,1.0,1.0,1.0,3/21,10.32%,APOE;DHFR;NUS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.30523953254392067,0.612900296036197,1.0,1.0,1.0,13/13,69.49%,RAB10;REEP2;REEP1;ATL2;ZFYVE27;RTN3;RAB18;REEP3;LNPK;ATL1;TMEM33;REEP4;RTN4
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.32796759082454485,0.6128498392271596,0.8918918918918919,1.0,1.0,5/8,33.96%,EHD1;ZDHHC2;EIPR1;SORL1;PLA2G4E
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.3249506712577862,0.6127807471257821,0.9117647058823529,1.0,1.0,8/8,67.51%,CBL;CTNND1;MET;GRB2;CDH1;SRC;CTNNB1;CBLL1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.3336610088223432,0.6124384632785955,0.9487179487179487,1.0,1.0,4/8,33.05%,MIEF2;DNM2;DNM3;MX2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.3336610088223432,0.6124384632785955,0.9487179487179487,1.0,1.0,4/8,33.05%,MIEF2;DNM2;DNM3;MX2
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),-0.3836186569160377,-0.6120948812834781,0.8448275862068966,1.0,1.0,1/5,21.14%,SOX9
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.28715364756925943,-0.6119381126044788,0.9692307692307692,1.0,1.0,1/25,3.79%,SCN5A
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.39995231468042214,-0.6116951699631132,0.9423076923076923,1.0,1.0,2/6,25.64%,TRDN;ATP2A2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.2426954838181854,0.6111653021146752,1.0,1.0,1.0,10/41,22.82%,APOE;SPRY4;RGS14;BMP4;NF1;ZNF675;PTPRJ;DUSP19;SPRY3;LYN
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.38687546046749977,0.6109200849641667,0.8888888888888888,1.0,1.0,2/5,23.52%,AGBL4;AGBL1
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.38833732749524646,0.6107260294489565,0.9347826086956522,1.0,1.0,1/5,14.12%,MYOCD
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.37069713865147474,0.6105567260951741,0.9375,1.0,1.0,2/5,23.56%,RAB11B;TRAPPC11
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.28588560692519194,-0.6092156096852226,0.9838709677419355,1.0,1.0,5/33,15.30%,ESR1;STAT1;NLRP12;CACTIN;NLRC3
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),0.3981375750857619,0.6090879952144707,0.9318181818181818,1.0,1.0,2/6,12.64%,NOTCH4;NOTCH1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.2312913282685544,0.6090448102042976,1.0,1.0,1.0,27/81,25.01%,NLGN1;CACNG4;CACNB4;JPH1;CNIH3;CACNG2;GRIN1;FGF12;JSRP1;ANK2;JPH4;FGF14;DLG2;SLMAP;NETO1;KCNG1;DMD;DLG1;PDE4D;LRRC7;JPH3;HPCA;GRIA4;ANK3;NOS1;NLGN2;FGF13
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.3222861753675365,0.6084678302769191,0.9024390243902439,1.0,1.0,3/11,15.36%,CHRNA1;NRXN1;GCH1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.32198734529050277,0.6076515448006194,0.9375,1.0,1.0,2/10,10.51%,PARD3;RNF10
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.3852432434591251,0.6069312157104702,0.9230769230769231,1.0,1.0,2/5,12.28%,LDLR;RNF128
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.2371087178533852,-0.6068777888419028,1.0,1.0,1.0,19/82,29.02%,HLA-DRB1;HLA-DMA;DYNLL1;DCTN1;HLA-DPB1;HLA-DPA1;DYNLL2;SEC24D;SEC13;ACTR1B;KIF22;KIF11;KLC1;DCTN2;KIF18A;RILP;ARF1;DCTN6;CAPZA2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.21804259747376747,-0.606408997283967,1.0,1.0,1.0,35/238,23.86%,PSMB9;TOMM20;ESR1;SENP3;FOXO4;ABRAXAS1;ACTL6A;CDC25A;USP50;NLRP3;USP13;COPS5;BRCA1;TFPT;TAF9B;USP6;COPS4;SMAD3;TOR1A;PSMA7;SUDS3;PSMB6;OTUB1;PSMA3;RPS27A;PSMA5;TAF10;AR;JOSD2;USP17L2;USP11;TNIP2;VCPIP1;OTUD1;PSMD8
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.29523018602618023,-0.6062610303270884,0.9672131147540983,1.0,1.0,2/16,14.09%,LRIT3;THBS1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.2779620654605297,-0.6060995688606614,1.0,1.0,1.0,3/30,12.52%,CYP1B1;ANXA1;ZNF580
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.39364477267874165,0.6058326762278347,0.95,1.0,1.0,2/6,11.51%,APOE;STARD4
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.2821844595900003,-0.6057480623694617,0.9836065573770492,1.0,1.0,7/31,23.07%,FSCN2;BAIAP2L1;AIF1L;LCP1;USH1C;BAIAP2L2;RFLNA
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.31082900344506587,0.6050758537184578,0.98,1.0,1.0,3/12,20.85%,NOTCH4;SHH;NRARP
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.3932397223938722,-0.6050533468568725,0.9166666666666666,1.0,1.0,3/6,30.79%,RAE1;NUP155;NUP133
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.2840996701009594,0.6049781107996113,0.9743589743589743,1.0,1.0,3/16,12.05%,ABL1;COL16A1;LIMS1
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),0.4145035507503033,0.6049602786191347,0.8936170212765957,1.0,1.0,2/5,34.34%,SYT7;CRH
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.27818788983045173,-0.6043347688967745,0.9850746268656716,1.0,1.0,6/30,22.02%,FSCN2;BAIAP2L1;AIF1L;LCP1;USH1C;BAIAP2L2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.2622554722147546,-0.6042268076540459,0.9846153846153847,1.0,1.0,10/57,22.75%,PDE6B;GPR88;CDC25A;GNGT1;RRH;PDE6A;CNGB1;COPS9;SDE2;PCNA
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.2960970939155023,-0.6037339222584055,0.9672131147540983,1.0,1.0,3/25,16.77%,TERF2IP;GNL3;PIF1
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.3868115072324341,-0.6034860199852031,0.9464285714285714,1.0,1.0,2/8,7.34%,S100A13;PIK3CG
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.34408102748892583,0.6032377555739774,0.9772727272727273,1.0,1.0,4/10,17.63%,NT5C1A;UPP2;NT5C3A;MACROD2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.24240725840990354,-0.6030437953031971,1.0,1.0,1.0,10/77,20.43%,TGFB1;TERF2IP;ATG14;CACTIN;BEX4;IGFBP3;NTRK3;WARS1;ARPP19;XRCC1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.3788642643524823,0.6029843939686355,0.851063829787234,1.0,1.0,3/6,11.46%,AKT2;ACSL1;IRS2
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.23427892595761998,0.602820616399071,1.0,1.0,1.0,16/63,22.23%,HSPB1;ATF3;EIF2AK3;EIF3H;EIF3E;PPP1R15B;IMPACT;DNAJC3;YTHDF1;KHDRBS1;AGO2;EIF4EBP1;NCK2;NCK1;LARP1;TPR
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.29576662019802386,0.6024298897204983,1.0,1.0,1.0,3/15,16.74%,NRG1;MYOCD;SKI
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.31800201340672646,-0.6020953473920685,0.9552238805970149,1.0,1.0,3/16,22.50%,ERVW-1;JAM2;SIX4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3208905052426124,0.6015567553145333,1.0,1.0,1.0,3/11,12.23%,HTRA2;PIH1D1;LGALS9
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.3373782253072728,-0.6015105921232039,0.9,1.0,1.0,3/13,19.35%,TULP1;RP1;USH1C
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.3943411615048365,-0.6014128366402841,0.9322033898305084,1.0,1.0,1/5,15.26%,NUCKS1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.384540664188099,-0.6014077172943186,0.875,1.0,1.0,1/5,17.66%,VAMP7
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3152262918281341,0.6013623393154602,0.9767441860465116,1.0,1.0,2/13,13.97%,SULT2A1;ENPP1
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.41039428274350276,-0.6013370208503824,0.9166666666666666,1.0,1.0,1/5,24.61%,SLC25A11
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.25272204816519994,0.6013067782844482,1.0,1.0,1.0,5/38,13.82%,PROX1;IFI16;N4BP1;RESF1;PLSCR1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.3612247052227067,0.6010889076134274,0.925,1.0,1.0,2/5,27.54%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.3537006688273981,-0.6010804560026884,0.9454545454545454,1.0,1.0,2/9,22.89%,COPS5;HSPA5
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.3655969086403152,0.6010499540052981,0.8421052631578947,1.0,1.0,4/7,24.52%,FNTA;EP300;PRKAA2;TPPP
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.3309519974280542,0.6009338677205478,0.9777777777777777,1.0,1.0,2/11,16.13%,MYOCD;MTHFR
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.3830370993962211,-0.6006800893807492,0.9433962264150944,1.0,1.0,2/8,14.77%,SLC22A3;SLC22A4
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.34087745076053777,0.6004637801787021,1.0,1.0,1.0,1/8,10.21%,CCNH
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.397560651126706,-0.6003626119161536,0.9272727272727272,1.0,1.0,1/5,12.50%,IL12A
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.31032672321645477,-0.5998507080343967,0.9830508474576272,1.0,1.0,5/20,26.90%,CHMP3;ATF5;AURKA;RAB6C;CHMP4B
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),0.38081237911025156,0.5994075145581449,0.86,1.0,1.0,5/5,61.93%,EPM2AIP1;GSK3B;GSK3A;INPP5K;PPP1R3F
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.2998013980051319,-0.5988684067455582,0.9841269841269841,1.0,1.0,3/26,8.38%,CYP1B1;NQO1;ARG2
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.39089611072518016,-0.5983572582066338,0.8928571428571429,1.0,1.0,2/6,17.44%,PAICS;PRPS1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.2720077879535904,-0.5983468811213345,0.9850746268656716,1.0,1.0,2/42,4.32%,ADSS1;GUCY2C
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.39000324150957416,-0.5983056065165993,0.9354838709677419,1.0,1.0,2/7,7.34%,S100A13;PIK3CG
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.39000324150957416,-0.5983056065165993,0.9354838709677419,1.0,1.0,2/7,7.34%,S100A13;PIK3CG
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.36271634294219945,0.5982950734732428,0.9090909090909091,1.0,1.0,2/7,8.36%,BICD1;ABL1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.3250879789693741,-0.598216231649993,0.967741935483871,1.0,1.0,2/16,8.97%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.2696469435484101,0.5980803703773867,1.0,1.0,1.0,7/34,16.36%,TRPM2;ABI3;ABL1;ABL2;HCLS1;RAPGEF3;F11R
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.37779269877535027,0.5979774567012619,0.9423076923076923,1.0,1.0,1/7,25.90%,THOC1
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.37779269877535027,0.5979774567012619,0.9423076923076923,1.0,1.0,1/7,25.90%,THOC1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.286424767995048,-0.5977552378712863,0.9818181818181818,1.0,1.0,1/26,6.65%,RTP5
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.307949085645639,0.597734129737053,0.9354838709677419,1.0,1.0,7/19,22.30%,ZBTB20;MLXIPL;INSR;PFKFB4;PFKFB3;PRKAA2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.307949085645639,0.597734129737053,0.9354838709677419,1.0,1.0,7/19,22.30%,ZBTB20;MLXIPL;INSR;PFKFB4;PFKFB3;PRKAA2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.3064991149071114,-0.5965552863009077,0.984375,1.0,1.0,7/22,23.65%,HLA-DRB1;PTPRC;DDX60;CD81;DHX58;USP17L2;RPS19
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.3410464300368378,0.5964089670375163,0.9024390243902439,1.0,1.0,1/5,11.98%,TRIM44
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.34270191575716197,0.5962395311444811,0.8888888888888888,1.0,1.0,2/7,18.89%,AGO3;AGO2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.26589280814232574,-0.5961291235077144,0.9682539682539683,1.0,1.0,2/25,12.56%,NUDT13;GLRX
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.21649347671562474,-0.5954177709847421,1.0,1.0,1.0,34/229,23.86%,PSMB9;TOMM20;ESR1;FOXO4;ABRAXAS1;ATXN7L3;ACTL6A;CDC25A;USP50;NLRP3;USP13;COPS5;BRCA1;TFPT;TAF9B;USP6;SMAD3;PSMA7;SUDS3;PSMB6;SPATA2;OTUB1;PSMA3;RPS27A;PSMA5;TAF10;AR;JOSD2;USP17L2;USP11;TNIP2;VCPIP1;OTUD1;PSMD8
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.36067942582466056,-0.5948843080957935,0.9433962264150944,1.0,1.0,1/6,10.63%,LRP2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.21598930384125167,-0.5948454970277207,1.0,1.0,1.0,52/269,27.12%,POLQ;TICRR;TRAIP;FANCF;RPA3;UBE2U;RAD51AP2;ABRAXAS1;EYA1;BRCA1;REXO4;CDKN2D;TNP1;DCLRE1C;RAD1;NUCKS1;POLE2;SMUG1;DDX1;RAD54L;NOP53;SMARCA5;TOPBP1;RMI2;DCLRE1A;RNF8;RPS27A;XRCC1;OGG1;APTX;RPA2;DDB1;UBXN1;PCNA;VCPIP1;FANCC;PARK7;MSH6;RECQL4;FANCI;PARP4;CENPX;FAAP20;POLD4;UPF1;BLM;CHEK1;RAD9B;NUDT1;PARP2;MLH1;ZRANB3
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.30178938969837976,0.5947773627419213,0.8936170212765957,1.0,1.0,5/15,21.23%,PPARG;ADIPOR1;ADIPOR2;PRKAG2;PRKAA2
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.38837483386146787,0.5941508341894921,0.9487179487179487,1.0,1.0,4/7,19.39%,GREM1;EMILIN1;PMEPA1;SMAD7
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.3267198441170416,-0.5940442380939394,0.9701492537313433,1.0,1.0,4/12,18.51%,CEACAM1;HEY2;TMEM100;HEY1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.27577807072006,-0.5938217695851649,1.0,1.0,1.0,2/40,3.31%,TERF2IP;FOXM1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.2636813653225727,0.5932939186724087,0.9761904761904762,1.0,1.0,4/34,14.40%,FHIT;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.2733671134902621,0.5931766659351307,0.9767441860465116,1.0,1.0,3/21,15.03%,MVB12A;CHMP6;VTA1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.38464252505886115,-0.5930849563879377,0.9661016949152542,1.0,1.0,1/5,13.17%,TMLHE
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.38464252505886115,-0.5930849563879377,0.9661016949152542,1.0,1.0,1/5,13.17%,TMLHE
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.3241245517288549,-0.592752444056152,0.9411764705882353,1.0,1.0,3/12,26.08%,IMPA2;IMPA1;NUDT3
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.32545684238961986,-0.5921068480813486,0.9761904761904762,1.0,1.0,1/15,5.98%,ANXA1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.36637015391742067,-0.5918839671000209,0.8947368421052632,1.0,1.0,1/8,12.22%,CAMLG
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.30869667862228706,0.5918260832667988,0.9761904761904762,1.0,1.0,3/10,17.98%,JAG1;NOTCH1;RBPJ
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.35198248455246006,-0.5913151022718758,1.0,1.0,1.0,4/9,21.14%,PBLD;STRAP;MUC4;SOX9
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.21266723166784293,0.5911261483402379,1.0,1.0,1.0,24/103,21.83%,PITPNM1;PI4KB;PLCB1;PIK3C2B;MTMR8;PI4K2B;PLA2G5;PLA2G4C;PIK3R5;PIK3CA;PGAP1;PIP4K2A;MTMR3;MTMR14;LCLAT1;RAB5A;PLCG2;MTMR1;PIP4P2;MTM1;PTEN;PIK3R4;PIK3CD;CDS1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.2905859000192113,0.5910869570944266,1.0,1.0,1.0,4/20,18.22%,SIRT1;HDAC1;SMCHD1;BAZ2A
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.3421280304979323,-0.5909617169611032,0.9838709677419355,1.0,1.0,1/8,7.39%,PTPRC
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.33034353132497546,-0.5908657958007446,0.9824561403508771,1.0,1.0,1/10,8.37%,ZFPM1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.3454869321001286,0.590363693792648,0.9487179487179487,1.0,1.0,2/6,20.75%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.31402549519532214,0.5900719168661158,0.9347826086956522,1.0,1.0,4/14,19.32%,GNL3L;HDAC4;RASD2;EGR1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.273943819616046,0.5898552570857201,0.9714285714285714,1.0,1.0,4/15,21.73%,CHST6;NAGK;CHST3;LARGE1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.29403176804827424,0.5892329718197267,0.9444444444444444,1.0,1.0,6/21,17.20%,LAMB4;NTN4;NTNG2;QSOX1;EMILIN1;HAS2
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.34657640232108317,0.5889475931020878,0.8717948717948718,1.0,1.0,5/5,65.35%,ANO6;CLCN3;KCNMA1;P2RX7;SHANK3
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.3338671641017552,0.5885943889441791,0.9411764705882353,1.0,1.0,5/10,21.65%,NOTCH1;SMAD2;ACVR1;MDM4;BMPR1A
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.22436134879405856,0.5883559872563168,1.0,1.0,1.0,19/102,21.20%,BCL2;CREB3L2;TMEM117;CHAC1;ATF3;EIF2AK3;RHBDD1;ERN1;TMTC3;PPP1R15B;CREB3L1;NIBAN1;ATF6;RNF185;CREB3L3;QRICH1;TP53;THBS4;NCK1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.2626317594893345,-0.588040139778562,0.984375,1.0,1.0,2/36,8.52%,HMGB3;ENDOG
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.2733365658182911,-0.5877426429098116,0.9841269841269841,1.0,1.0,10/31,26.84%,HOOK2;GRN;TPP1;ACP3;SNAPIN;VPS18;ACP2;LAMTOR1;HPS4;NAGPA
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),0.3593804129799239,0.5876029317418886,0.9245283018867925,1.0,1.0,1/5,9.77%,ACD
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.28744873275414684,0.5871845975548909,1.0,1.0,1.0,7/15,31.20%,DSCC1;NIPBL;MAU2;POGZ;RB1;PDS5A;NAA50
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.24986500824905383,-0.5870655728078471,1.0,1.0,1.0,1/61,0.73%,PSMB9
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.3207295186039075,-0.5867431505058014,0.9655172413793104,1.0,1.0,5/15,25.63%,HVCN1;GPR68;MCOLN1;HYAL1;PKD1L3
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),0.3741596709602705,0.5865335438816976,0.9512195121951219,1.0,1.0,1/5,6.84%,LOXL1
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),0.37615607436482235,0.5861822479256643,0.875,1.0,1.0,2/5,20.05%,IL23A;IL23R
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),0.37615607436482235,0.5861822479256643,0.875,1.0,1.0,2/5,20.05%,IL23A;IL23R
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.3599581304840564,-0.5860713047871784,0.8421052631578947,1.0,1.0,1/5,13.01%,ACOT4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.3699019860575925,-0.5857537413936572,0.9473684210526315,1.0,1.0,1/6,10.84%,STOML2
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3022184073609011,-0.5855395556392696,0.9841269841269841,1.0,1.0,2/15,15.18%,CAMLG;EMC1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.302172636466005,-0.5854531364195555,0.9137931034482759,1.0,1.0,3/16,15.27%,TAF7;BRCA1;SET
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2723108720207948,0.5851611899855262,1.0,1.0,1.0,11/25,26.78%,DCUN1D1;CDC14B;UBE2L3;PTEN;FZR1;AXIN1;TRIB3;GORASP1;DCUN1D2;BTRC;PLK1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.33373448683869555,-0.5850023391070519,0.9811320754716981,1.0,1.0,2/8,30.71%,CDC7;NUGGC
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.3031170037764358,0.5849969302851749,0.9761904761904762,1.0,1.0,2/12,14.53%,PCGF5;SMCHD1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.35365412684269426,-0.5849954846883344,0.9032258064516129,1.0,1.0,1/6,10.09%,DCTN1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.36733809606698625,0.5845830661893604,0.9361702127659575,1.0,1.0,1/5,25.25%,ABHD12
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.3030344474586224,-0.5842937261975171,0.9830508474576272,1.0,1.0,2/16,16.22%,HPR;ITIH4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2531620787477883,0.5833000213999653,1.0,1.0,1.0,1/25,2.53%,SAMSN1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.3687690855790783,-0.582445301530316,0.9310344827586207,1.0,1.0,1/5,16.40%,BEX4
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.28345234427883587,0.5815054649563629,0.9512195121951219,1.0,1.0,5/14,27.47%,NOTCH1;RUNX1;FAP;RB1;AEBP1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.3086216326229743,0.5810613083940273,0.9655172413793104,1.0,1.0,4/8,26.15%,RPS6KA4;BAZ1B;CCNA2;NEK11
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.3300692075212846,-0.5796398841102051,1.0,1.0,1.0,1/11,11.49%,DGAT2L6
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.39556506795597307,-0.5783365810797463,0.95,1.0,1.0,2/5,14.77%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.3379607105081971,-0.5780440489175406,0.9811320754716981,1.0,1.0,2/11,14.06%,ABCB1;OPRM1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.2807556118872695,-0.5776195289214675,0.9836065573770492,1.0,1.0,5/23,20.47%,KANK3;TMSB10;SCIN;VIL1;TMSB4X
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.3248069967723444,0.5765549571886794,0.925,1.0,1.0,2/7,20.75%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.2796403197603947,-0.5764878653920399,0.9692307692307692,1.0,1.0,3/29,14.92%,DONSON;RAD1;TIPRL
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.2337138923904402,-0.5764415984360772,0.9841269841269841,1.0,1.0,13/79,28.41%,MRPL40;MRPL19;MRPS34;MRPL34;MRPS22;MRPL20;MRPS25;MRPS26;GADD45GIP1;MRPL21;MRPS2;GFM2;MRPL50
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.34744839733549837,-0.5756091412548257,0.9166666666666666,1.0,1.0,2/7,21.14%,REST;SOX9
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.28433705650332614,-0.5752983665002145,1.0,1.0,1.0,7/19,29.77%,CLU;TMEM35A;HSPA4;HSP90AB1;PFDN6;PSMG1;CCT2
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.29923562225296557,-0.5748900060229377,0.9836065573770492,1.0,1.0,2/16,10.40%,ABCG2;ABCB1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.23994598070998507,-0.5747966076561156,1.0,1.0,1.0,1/65,0.69%,F8
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.3584912959381046,0.5744385628180511,0.9245283018867925,1.0,1.0,5/5,64.16%,NCEH1;TMEM86B;AGMO;PLAAT3;LIPE
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.3216005478180518,0.5742888130414258,0.9714285714285714,1.0,1.0,1/7,17.82%,DNA2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.30571207684764445,-0.5738705964795708,0.9482758620689655,1.0,1.0,3/14,32.21%,CMPK2;ENTPD5;AK8
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.2850452072190307,-0.5737023736662875,0.9836065573770492,1.0,1.0,4/19,18.98%,TGFB1;IL12A;VSIR;IL18
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.24446985485894424,-0.5731350759814987,1.0,1.0,1.0,1/73,0.73%,PSMB9
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.3070557559391081,0.5727202158508602,0.9333333333333333,1.0,1.0,1/10,2.58%,OSR1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.3466878103945979,0.5724243921279825,0.9090909090909091,1.0,1.0,1/6,9.69%,ADGRV1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.3286763292921253,-0.5722011677680776,0.9672131147540983,1.0,1.0,1/9,5.82%,SLC22A3
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.20567730301791232,0.5720834054311918,1.0,1.0,1.0,20/92,21.39%,KLRD1;MUC13;PSME4;PSMA1;CARD9;NFKB1;TAB3;TAB1;MUC7;MUC20;MALT1;EP300;TAB2;PLCG2;PAK3;PAK2;PSMD4;RAF1;TRAF6;CUL1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.20567730301791232,0.5720834054311918,1.0,1.0,1.0,20/92,21.39%,KLRD1;MUC13;PSME4;PSMA1;CARD9;NFKB1;TAB3;TAB1;MUC7;MUC20;MALT1;EP300;TAB2;PLCG2;PAK3;PAK2;PSMD4;RAF1;TRAF6;CUL1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.20567730301791232,0.5720834054311918,1.0,1.0,1.0,20/92,21.39%,KLRD1;MUC13;PSME4;PSMA1;CARD9;NFKB1;TAB3;TAB1;MUC7;MUC20;MALT1;EP300;TAB2;PLCG2;PAK3;PAK2;PSMD4;RAF1;TRAF6;CUL1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.25361156749618174,0.5716361003174013,1.0,1.0,1.0,9/22,24.97%,CBLB;CHMP6;GPRC5A;SRCIN1;ZFYVE28;PTK6;SOCS4;TSG101;CBL
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.2703858625375784,-0.5710091549560262,1.0,1.0,1.0,4/31,15.27%,TAF7;SPI1;BRCA1;SET
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.36843159354676963,-0.5703284467111868,0.9622641509433962,1.0,1.0,1/6,12.50%,IL12A
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.3270151005260228,0.5700468388947181,0.9393939393939394,1.0,1.0,5/8,36.07%,SNAP91;DNM2;DNM3;MX2;PICALM
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.24703910470989204,-0.5698944188856887,1.0,1.0,1.0,1/58,0.69%,F8
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.24703910470989204,-0.5698944188856887,1.0,1.0,1.0,1/58,0.69%,F8
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.24703910470989204,-0.5698944188856887,1.0,1.0,1.0,1/58,0.69%,F8
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3269040187459833,-0.569806829280762,0.9838709677419355,1.0,1.0,1/9,10.09%,DCTN1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.28797503506373034,-0.5696060062966055,0.9824561403508771,1.0,1.0,1/22,3.01%,SP100
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),0.3880825839609789,0.5692939567192578,0.9019607843137255,1.0,1.0,1/5,10.31%,GPD1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.2663043561636418,-0.5692629943339423,0.9827586206896551,1.0,1.0,4/30,16.91%,IFT27;TMEM17;GLI3;HIPK1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.33843093870511165,-0.569143272510549,0.9672131147540983,1.0,1.0,2/9,14.87%,SLC22A3;OAZ2
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.30520908350463155,-0.568723342984141,1.0,1.0,1.0,2/16,7.50%,NQO1;CHRNE
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.3247919620634602,0.5685267916362874,0.9047619047619048,1.0,1.0,4/7,36.15%,BRPF1;ING5;BRPF3;PHF14
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.2732726920843817,0.5685000684076298,0.9767441860465116,1.0,1.0,20/20,72.69%,ME3;UQCRC2;SLC25A14;SDHB;MTFR1L;SURF1;UQCRHL;OXA1L;NDUFS7;NDUFS8;UQCRB;MDH2;MTFR2;SIRT3;ATP5F1D;UQCRC1;UQCR10;MTFR1;UQCRH;SDHC
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.3227817997243802,0.5684735834140022,1.0,1.0,1.0,4/11,21.38%,CRK;FRMD5;CCDC125;SPINT2
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.25668844888079967,-0.5684132402291274,1.0,1.0,1.0,8/38,19.91%,KCNJ15;KCNJ11;ATP1A4;KCNJ4;ATP4A;KCNE2;KCNJ13;ATP1A1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.2281813882979579,-0.5680080180006147,1.0,1.0,1.0,9/67,21.50%,HAT1;ACTL6A;TAF6;SPI1;LEF1;POLE3;BRD8;TAF6L;TAF10
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.3360159895688457,-0.567953031098131,1.0,1.0,1.0,2/7,21.37%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.37219672950606286,-0.5678766405568856,0.8695652173913043,1.0,1.0,3/5,29.24%,CD4;ZFP36;NPR2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.37219672950606286,-0.5678766405568856,0.8695652173913043,1.0,1.0,3/5,29.24%,CD4;ZFP36;NPR2
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),-0.3648373441194517,-0.5677872051151129,0.9821428571428571,1.0,1.0,1/5,9.89%,DAO
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.2869341439568318,0.5676396229455271,0.9583333333333334,1.0,1.0,5/15,26.50%,ERN1;RNF185;NCK1;BAG6;TMEM259
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),-0.3665308943915478,-0.567374694423645,0.9047619047619048,1.0,1.0,1/5,24.61%,SLC25A11
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.3013053238251757,0.5669813290441301,0.8974358974358975,1.0,1.0,3/7,25.83%,NTRK2;DOCK3;FYN
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.359411190412401,0.5669084970898818,0.9117647058823529,1.0,1.0,3/7,24.10%,ELAPOR2;MAFG;MAFF
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.2375682529261593,-0.5665573840419373,1.0,1.0,1.0,1/84,0.73%,PSMB9
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.3244257351762188,0.565647071734649,0.9347826086956522,1.0,1.0,3/8,22.02%,EIF2AK3;QRICH1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.27261444611349606,0.5653693838182076,1.0,1.0,1.0,7/24,23.98%,HPSE;GFI1B;INSR;DUSP6;NIPBL;CDK1;BAG6
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.27459656475963434,0.5649070008026469,1.0,1.0,1.0,4/13,21.73%,CHST6;NAGK;CHST3;LARGE1
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.3521117529364701,-0.5645973896171862,0.9672131147540983,1.0,1.0,1/5,20.45%,SLC23A1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.3256824890606799,0.5641933436014119,0.9444444444444444,1.0,1.0,7/11,30.03%,ADCY2;ADCY3;ADCY6;PDE4D;ADCY9;ADCY5;ADCY10
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.32920866376989244,0.5639740264282369,0.9285714285714286,1.0,1.0,4/10,21.04%,RIDA;SHMT2;GLYAT;GCAT
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.29867899895891215,0.56377539474017,0.9230769230769231,1.0,1.0,1/12,4.39%,SLC8A1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.2638750386922701,0.5635784274636111,0.96,1.0,1.0,1/20,3.94%,CFLAR
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.33337324256973294,0.5635158492093462,0.9375,1.0,1.0,3/8,29.67%,NUDT5;ENTPD2;ENTPD7
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.30491501345582317,0.5631501326133203,0.9285714285714286,1.0,1.0,2/9,18.09%,SLC6A17;SLC36A4
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.2876294136231036,-0.5631123749257781,0.9692307692307692,1.0,1.0,2/14,12.14%,SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.22145675029099993,-0.5630920693851719,1.0,1.0,1.0,19/84,29.02%,HLA-DRB1;HLA-DMA;DYNLL1;DCTN1;HLA-DPB1;HLA-DPA1;DYNLL2;SEC24D;SEC13;ACTR1B;KIF22;KIF11;KLC1;DCTN2;KIF18A;RILP;ARF1;DCTN6;CAPZA2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.32813156137958094,0.5626009571375973,0.9736842105263158,1.0,1.0,3/10,15.00%,NOTCH4;NOTCH1;NEXMIF
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.31487019898896096,0.5623148384323454,0.9705882352941176,1.0,1.0,2/11,14.10%,DRD5;NF1
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),0.3637817833126639,0.5616624561987958,0.8636363636363636,1.0,1.0,3/5,15.27%,SLC22A5;SLC25A29;SLC6A20
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.36109052172321504,-0.5613483013616263,0.9354838709677419,1.0,1.0,1/7,19.16%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.2435374394723528,0.5608250833652234,1.0,1.0,1.0,6/22,16.65%,HMGB1;TICAM2;TLR5;LBP;NR1H3;MFHAS1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.3035548563388434,0.560023579968233,1.0,1.0,1.0,1/11,4.45%,PID1
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),-0.3616428316398514,-0.5594708517588411,0.9615384615384616,1.0,1.0,3/5,23.29%,RFK;AGT;PARK7
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.3327666880990011,-0.5566686720243789,0.96,1.0,1.0,4/7,29.41%,GPX3;XRCC1;RNF112;DAPK1
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.36012755297174626,-0.5563009660414647,0.9318181818181818,1.0,1.0,3/5,23.14%,CD27;CD81;ZP3
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.23501425627861178,0.5561696624784501,1.0,1.0,1.0,3/26,15.54%,RNF168;ZMYND11;BRD4
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.30905949968907054,0.5560999649882465,1.0,1.0,1.0,2/8,20.75%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.21403425239922025,0.5544651778402895,1.0,1.0,1.0,14/77,19.11%,TGFA;CEP120;DRD3;MAP10;PKN2;SPAST;CDC14B;PLSCR1;INSR;CSPP1;PKP4;UBXN2B;PRKCE;DMRT1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.2701266919747063,0.5542077128442129,0.9722222222222222,1.0,1.0,6/19,25.76%,LPL;IRS2;GPLD1;SLC2A5;SLC30A8;EIF2B3
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.3280895882620554,-0.5539801196051554,0.9814814814814815,1.0,1.0,1/9,11.67%,GNL3
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.31935740625475223,-0.553942015584318,0.9811320754716981,1.0,1.0,4/10,29.77%,CCT8;CCT6A;CCT7;CCT2
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),0.3322582407363283,0.553817647200946,0.9473684210526315,1.0,1.0,1/5,7.69%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.325617153587863,-0.5536153605886552,0.9642857142857143,1.0,1.0,1/8,11.56%,REST
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.29739582280234167,-0.552231683602617,0.984375,1.0,1.0,3/17,15.30%,FTH1;SFRP1;NLRC3
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.23575271792263902,-0.5521851304724097,0.9846153846153847,1.0,1.0,5/46,21.21%,HAT1;ACTL6A;LEF1;BRD8;MSL1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.31441189088729254,-0.5521388595262369,0.9841269841269841,1.0,1.0,3/14,19.54%,BRCA1;CEP76;C10ORF90
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.24119238878528654,-0.55174190924642,1.0,1.0,1.0,4/56,12.59%,COL5A1;CAV3;A4GALT;AHNAK2
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.3281685513327925,0.5515728216708768,0.8936170212765957,1.0,1.0,2/6,27.75%,UXT;LRPPRC
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.3362735995047971,0.5514995806564547,0.9767441860465116,1.0,1.0,7/7,66.38%,ZSWIM6;RAPGEF2;SALL1;LHX6;ERBB4;SHANK3;INHBA
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.21844159328733948,-0.5509548145953928,1.0,1.0,1.0,24/98,29.63%,UVSSA;RPA3;COPS5;COPS4;RBX1;RPS27A;XRCC1;OGG1;POLR2B;RPA2;DDB1;PCNA;FANCC;CDK7;COPS7A;POLD4;XAB2;TCEA1;CETN2;POLR2K;PRPF19;UBB;BRCA2;COPS7B
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2127486485694783,0.5486785074927715,1.0,1.0,1.0,13/94,16.40%,FHIT;PRICKLE1;NKD2;COMMD1;TRIB2;HSPA1A;N4BP1;RNF217;RNF180;EIF3H;RYBP;FOXF2;ARIH1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.2848812389719359,-0.5484899830773152,0.95,1.0,1.0,7/18,36.75%,RPS27A;MAN1B1;UBB;SEL1L;UBC;AMFR;TRIM13
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.24308784077695242,-0.5484145370304793,1.0,1.0,1.0,3/40,12.52%,CYP1B1;ANXA1;ZNF580
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.32714329928814606,-0.5479602662823341,0.95,1.0,1.0,7/7,67.30%,PRKD2;SPHK2;CAMK2D;PRKD1;C6ORF89;VEGFA;KDM5A
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.2575661588363561,-0.5475735738114438,1.0,1.0,1.0,4/33,14.92%,DONSON;CDC6;RAD1;TIPRL
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.3454063658241624,-0.547527610556921,0.9824561403508771,1.0,1.0,1/6,16.14%,SMAD3
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.3485549619820508,0.5472419016284996,0.9387755102040817,1.0,1.0,2/6,12.64%,HES1;NOTCH1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.33849067057874754,-0.547240782770808,0.9482758620689655,1.0,1.0,2/7,20.38%,CAV2;LMOD3
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.31353082593066267,0.5469728548213382,0.9743589743589743,1.0,1.0,2/7,25.56%,XPO1;RRS1
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.3527047176493886,-0.5467401124235469,0.9242424242424242,1.0,1.0,1/6,24.61%,SLC25A11
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.2843407456214909,0.5467233710412536,0.9743589743589743,1.0,1.0,2/12,7.60%,LDLR;LRFN5
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.22455982506092922,0.545401447014737,1.0,1.0,1.0,8/25,26.63%,KAT6A;CPA4;KAT2B;KAT6B;EP300;PHF20L1;BAG6;CREBBP
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.28264700293007383,0.545393400476307,0.975,1.0,1.0,3/14,19.37%,NUDT18;ADPRM;NUDT5
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.3194863109287259,0.5450331313781711,0.9591836734693877,1.0,1.0,3/7,17.98%,BMP4;NOTCH1;RBPJ
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.23012274617347,0.5445790883556492,1.0,1.0,1.0,8/28,23.14%,SNAPC3;GTF3C4;ICE1;POLR3G;POLR3K;RO60;GTF3C5;ICE2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.2932120278978402,0.5443186957233599,0.9210526315789473,1.0,1.0,7/14,26.77%,MTMR3;SMG5;SMG6;MTMR1;PPP1R16B;IGBP1;MTMR9
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),-0.35441885746125,-0.5441939668051188,0.9622641509433962,1.0,1.0,1/6,4.35%,HTR1B
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.3187946153427589,-0.5437724927848133,0.9722222222222222,1.0,1.0,1/8,9.94%,CAV2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.29541508474292083,0.5423490189025132,1.0,1.0,1.0,2/11,17.66%,ARID1A;PMEPA1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.2947530637707843,-0.5413391660866541,0.9344262295081968,1.0,1.0,3/14,23.29%,CREB3;HERPUD1;PARK7
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.3270292891088986,0.5412447485295574,0.9375,1.0,1.0,5/7,36.07%,SNAP91;DNM2;DNM3;MX2;PICALM
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.32794822573523497,-0.5404757178644021,0.9821428571428571,1.0,1.0,3/9,30.52%,NUP93;NDC1;RTN4
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.23405159089695554,0.5395168932619852,1.0,1.0,1.0,7/33,21.20%,BCL2;STYXL1;LCK;FBH1;BID;TP53;NCK1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.34661508704061894,-0.5395061696179416,0.9032258064516129,1.0,1.0,5/5,65.35%,SLC6A6;MT3;RIPK1;SLC6A13;HEBP2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.3186682123835524,-0.5392308417511544,0.9473684210526315,1.0,1.0,3/9,20.70%,TPI1;TKFC;ANGPTL3
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.2097522527549286,-0.5381390913862076,1.0,1.0,1.0,12/93,23.64%,EEF2;MRPL40;MRPL19;MRPS34;MRPL34;MRPS22;MRPL20;MRPS25;EEF1A1;MRPS26;GADD45GIP1;MRPL21
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.3201157849874491,0.5381006859889841,0.9795918367346939,1.0,1.0,1/7,15.34%,ME3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.3169684308263695,0.5366868666419305,0.9166666666666666,1.0,1.0,7/7,68.31%,RNF122;HEBP2;MAPT;PIP5KL1;BAX;PRELID1;ARL6IP5
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.26588002805800703,-0.535794359562096,1.0,1.0,1.0,1/18,5.98%,ANXA1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.26418702519483195,-0.5352627002650974,1.0,1.0,1.0,7/19,28.11%,STUB1;CDC37;SPATA2;CASP8;FLOT1;NUPR1;CYLD
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.35376755572135504,-0.5350835588159488,0.9482758620689655,1.0,1.0,2/7,15.73%,CD63;LIMS2
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),-0.3524576488030291,-0.5343067830297442,0.9482758620689655,1.0,1.0,1/5,25.63%,PKD1L3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2994388792612367,-0.5335182967609959,1.0,1.0,1.0,6/14,24.16%,RPL5;RPL23;RPS7;RPL11;PARK7;BAG5
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.28846649228822163,0.5334863436441347,0.9565217391304348,1.0,1.0,5/8,38.16%,ZFAND6;PEX12;LONP2;PEX16;HACL1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.26171133667028273,-0.5334173733703064,0.9848484848484849,1.0,1.0,3/20,14.94%,SOX10;MYRF;EIF2B2
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.3077419598721135,-0.5328942671827424,0.9491525423728814,1.0,1.0,4/11,31.10%,BRD8;LMO2;KLF9;CTSS
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.2597756322232318,0.5320905060535305,0.9787234042553191,1.0,1.0,4/11,20.05%,TRIB2;IL23A;FOXP3;IL23R
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.31922116448814863,0.5315644879850765,0.9523809523809523,1.0,1.0,1/9,12.21%,ADCY3
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.30408542246982356,0.5314029257137298,1.0,1.0,1.0,7/7,69.60%,DMRT1;SIRT2;NPM2;OOEP;FBXO5;WEE2;FBXO43
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.2571229723479452,0.5308633670157133,1.0,1.0,1.0,3/21,12.52%,SIRT1;CDA;BMP4
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.26518183294022923,-0.5308580274531705,0.9852941176470589,1.0,1.0,5/20,25.53%,AGBL5;TTLL4;TPGS1;CFAP20;GGCX
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.30750266193319276,-0.5300499052008494,0.9629629629629629,1.0,1.0,2/10,20.70%,ALK;ANGPTL3
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.24497036799075894,0.529978840649598,1.0,1.0,1.0,6/23,21.08%,ABCA1;ABCC1;ABCA7;ATP8A2;ATP10A;ATP8B1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.2906009320881972,-0.5299255234837368,1.0,1.0,1.0,4/12,21.40%,GATA4;HEY1;SOX9;ENG
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.32675287466348946,-0.5296808770751533,0.9824561403508771,1.0,1.0,2/7,26.55%,PRPS1;CTPS1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.32832790336532347,0.5295689823721971,0.8604651162790697,1.0,1.0,1/5,20.10%,PHF1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.306209362917137,-0.5290552290818914,0.96875,1.0,1.0,3/13,25.62%,EIF6;RPS15;RAN
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.2823479337563843,0.5289395691958112,0.9545454545454546,1.0,1.0,11/11,71.78%,UQCRC2;UQCC3;UQCRHL;UQCRQ;UQCRB;CYC1;CYCS;UQCRFS1;UQCRC1;UQCR10;UQCRH
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.3206206497229839,-0.5286400468442973,0.9333333333333333,1.0,1.0,2/8,20.38%,CAV2;LMOD3
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.26355591736103456,-0.5283702192939238,1.0,1.0,1.0,4/23,19.98%,CACTIN;NLRC3;RNF26;DHX58
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.31797523406703854,-0.5281343281933348,0.9636363636363636,1.0,1.0,2/6,30.61%,CASP8;TRADD
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.31478974041548996,-0.5274910724498622,0.9473684210526315,1.0,1.0,6/6,68.53%,CDC7;DBF4;DBF4B;ATRX;WIZ;INO80
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.307202797029361,-0.527389184426309,0.9649122807017544,1.0,1.0,3/8,22.58%,NLRC3;NOP53;PIK3IP1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.32896960383701607,0.5265781366509985,0.926829268292683,1.0,1.0,2/7,12.98%,LGALS9;TWSG1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.28559676432568537,0.5260350680950725,0.9302325581395349,1.0,1.0,5/10,35.15%,RPUSD1;NAF1;RPUSD2;RPUSD4;GAR1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.2890165057989966,0.5254240406367465,0.926829268292683,1.0,1.0,2/8,19.45%,NSD1;EP300
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.30385321691961487,-0.5253826282905603,0.95,1.0,1.0,1/7,10.09%,DCTN1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.28048693372625955,0.5253298703937054,1.0,1.0,1.0,1/11,8.28%,ABCA1
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.3125567120991066,0.5250590656570975,0.9722222222222222,1.0,1.0,3/8,18.50%,GMPS;HPRT1;SHMT2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.3500193423597679,0.5246686881309072,0.9230769230769231,1.0,1.0,5/5,65.00%,ABHD12;MGLL;ABHD6;ABHD2;LYPLA2
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.32707930367504834,0.5241449647354129,0.9591836734693877,1.0,1.0,5/5,67.30%,HNRNPU;SIRT2;RCC2;BECN1;CCNB1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.2958105947939824,0.5238290206646281,1.0,1.0,1.0,3/7,19.45%,ARHGAP35;PIK3CA;CXCL12
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.23451061072728724,0.5226741067592104,0.9743589743589743,1.0,1.0,5/25,20.01%,RFX6;EFNA5;CDK16;GPLD1;PLA2G6
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.2823437081370958,0.5225848043608524,0.9761904761904762,1.0,1.0,2/12,9.82%,ABL1;ABL2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.31717722817203164,-0.522302517181889,0.9846153846153847,1.0,1.0,2/8,31.70%,BNIP3;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.34854881054593606,-0.5220779545310446,0.9672131147540983,1.0,1.0,1/5,19.16%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.34854881054593606,-0.5220779545310446,0.9672131147540983,1.0,1.0,1/5,19.16%,DDX3X
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.26075032723563607,0.5214813202640248,0.96,1.0,1.0,2/14,13.82%,HMGB1;PLSCR1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.28324411575888725,0.5209212921964813,1.0,1.0,1.0,4/12,26.88%,ARPC3;MAGEL2;JMY;WHAMM
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.23310177725470527,0.5206490234482296,1.0,1.0,1.0,9/44,21.11%,RIPK2;ITGA4;GRIN1;TIMELESS;ABCC1;CACNA1A;GRM5;TP53;CDK5
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.3333173993170878,-0.5205732943336693,0.9636363636363636,1.0,1.0,1/6,14.46%,BPIFB1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2711372518670431,0.5196847643104705,0.9777777777777777,1.0,1.0,12/12,72.90%,RAPGEF3;EHD1;MAPK14;IL4;ADGRB1;CAMK1;DCSTAMP;CD53;ADAM9;RIPOR2;EHD2;FLOT1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.2984839233409723,0.5190330763712453,0.9347826086956522,1.0,1.0,5/9,29.68%,HM13;FURIN;SPPL3;SEC11A;PCSK5
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.31414041079698485,0.5187162566024058,0.9473684210526315,1.0,1.0,2/8,19.51%,PIP4K2A;RUBCN
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.3397610621566388,-0.5176419089874744,1.0,1.0,1.0,2/5,26.10%,TRNT1;SUPV3L1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.30622188005976547,-0.5173714465707834,0.9666666666666667,1.0,1.0,3/6,32.74%,XRCC1;FANCB;RAD21
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.2783094515102982,0.5167567242061606,1.0,1.0,1.0,2/11,13.85%,SP7;SOX5
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.27773036844738413,0.5165666555565763,0.9743589743589743,1.0,1.0,5/13,36.39%,EPHB2;EIF2AK4;ZDHHC2;SHISA7;ADCY8
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.29484660062845697,-0.5157847604126432,0.9649122807017544,1.0,1.0,2/9,28.27%,PYGL;PHKA1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.29267568649345344,0.515373499158614,0.9777777777777777,1.0,1.0,5/7,38.16%,ZFAND6;PEX12;LONP2;PEX16;HACL1
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.31613112635093954,-0.5151387025955851,0.9824561403508771,1.0,1.0,1/7,11.13%,C4BPA
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.31613112635093954,-0.5151387025955851,0.9824561403508771,1.0,1.0,1/7,11.13%,C4BPA
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.31613112635093954,-0.5151387025955851,0.9824561403508771,1.0,1.0,1/7,11.13%,C4BPA
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.24548668521534966,-0.5146095135254897,1.0,1.0,1.0,4/27,17.40%,ESR1;BRCA1;ZNF366;WBP2
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.2972889444867788,0.5138524548896386,0.9375,1.0,1.0,1/5,19.66%,ADAM10
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.2862725373365316,0.5135300758883095,0.9361702127659575,1.0,1.0,9/9,71.38%,PPP1R12B;TNNC2;ANXA6;ATP1A2;PVALEF;MYL5;SRI;TPM1;MYL9
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.22818786638440536,-0.5126827320217665,0.9852941176470589,1.0,1.0,3/37,14.30%,KCNJ15;KCNQ1;KCNJ4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.30942565250783516,0.5120007202285923,1.0,1.0,1.0,1/6,12.64%,TANK
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.2085118968419893,0.5117094663024973,1.0,1.0,1.0,10/68,19.91%,INTS11;SP1;INTS9;SNAPC3;INTS14;GTF2F2;ICE1;RPRD2;POU2F1;POLR2F
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",-0.33682065815639073,-0.5109012974179661,0.9821428571428571,1.0,1.0,1/5,21.75%,TALDO1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.26706826269787365,-0.5106922518526735,0.9365079365079365,1.0,1.0,1/14,9.51%,ALOX15
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.29222072365609547,-0.5097307121064318,0.9807692307692307,1.0,1.0,1/9,13.01%,ACOT4
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.25953973466716357,0.5093031011237902,0.9555555555555556,1.0,1.0,4/13,25.39%,YAE1;ISCA2;LTO1;CIAO2A
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.26763206248391275,-0.5090067534494703,0.9827586206896551,1.0,1.0,2/14,23.06%,CDC6;PTTG1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.2735714009362788,0.5088434299270134,1.0,1.0,1.0,8/8,72.65%,KDM5B;KDM5C;RIOX2;KDM5A;KDM1B;KDM5D;RIOX1;KDM1A
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.27839052448028817,0.5087629001040426,0.9393939393939394,1.0,1.0,3/11,19.03%,TTLL9;TTLL1;CEP41
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.2911308131771648,-0.5064768414366942,0.9615384615384616,1.0,1.0,2/11,24.17%,HSPA5;KDELR3
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.2687958880732735,0.5064418051152654,0.9772727272727273,1.0,1.0,5/13,29.67%,ENPP1;SMPDL3A;ITPA;ENTPD2;ENTPD7
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.20747325228132146,0.506111631432198,1.0,1.0,1.0,10/69,19.91%,INTS11;SP1;INTS9;SNAPC3;INTS14;GTF2F2;ICE1;RPRD2;POU2F1;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.24284073177966448,-0.5057321363399555,1.0,1.0,1.0,10/30,27.24%,PINK1;PRXL2C;GAPDHS;TMSB4X;ACTN3;PFKFB2;PFKFB1;ENTPD5;SLC4A4;NUPR1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.26217451255410873,-0.5047290476441064,0.9642857142857143,1.0,1.0,3/17,31.57%,MSN;ATRAID;VPS35
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.3148898790829695,0.5045196970379995,0.9375,1.0,1.0,1/5,21.31%,NEMF
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.30506414867214693,0.5044889797164512,0.9545454545454546,1.0,1.0,3/7,14.14%,HCLS1;TESC;RUNX1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.2060193547172448,-0.5036180770827512,1.0,1.0,1.0,3/98,6.07%,PSMB9;VAV3;TEC
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),0.29833296376662377,0.503043749507926,0.9761904761904762,1.0,1.0,1/5,17.37%,SHH
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.26691627298394943,0.5030276487318018,0.9545454545454546,1.0,1.0,2/11,14.72%,ITGA3;INSR
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.28524122165863985,0.5028871684525862,0.925,1.0,1.0,2/6,20.94%,BNIP3L;AFG1L
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.3097707356170375,0.5013289497071906,0.9459459459459459,1.0,1.0,3/7,21.00%,PUM3;KAT2B;PNKP
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.27067725605984316,0.5009583304482595,0.9285714285714286,1.0,1.0,4/7,27.99%,CLEC16A;RUBCN;IRAK3;UBQLN4
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.24147648819617368,0.5006140692486533,1.0,1.0,1.0,5/16,31.02%,SHH;HSD3B2;UGT2B7;AKR1D1;HSD17B11
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.2776559568769089,-0.5000278818826995,0.9666666666666667,1.0,1.0,4/12,31.10%,BRD8;LMO2;KLF9;CTSS
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.2826940895777621,-0.4994573873680436,1.0,1.0,1.0,4/13,30.79%,NUP93;NDC1;RTN4;NUP133
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.2872073799648373,-0.4980595889492851,0.9523809523809523,1.0,1.0,1/8,14.09%,THBS1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.2849209874274201,-0.4962529241580818,0.9692307692307692,1.0,1.0,3/9,33.33%,CELSR1;SHROOM3;ACTB
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.2453275548504429,0.49589990572196563,1.0,1.0,1.0,12/12,75.48%,PARP11;PARP16;PARP6;TIPARP;PARP12;PARP3;PARP8;PARP9;PARP15;PARP14;PARP4;PARP10
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.21506292352371736,0.49540421830088993,1.0,1.0,1.0,30/30,78.52%,CCNH;GTF2F2;POLR2F;ERCC3;POLR2C;ERCC2;GTF2H3;MNAT1;RNGTT;GTF2H2;POLR2D;POLR2H;POLR2G;GTF2H1;NCBP1;POLR2E;POLR2J;NCBP2;POLR2L;SUPT5H;POLR2A;GTF2F1;CMTR2;POLR2I;GTF2H5;POLR2K;CDK7;POLR2B;RNMT;CMTR1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.21506292352371736,0.49540421830088993,1.0,1.0,1.0,30/30,78.52%,CCNH;GTF2F2;POLR2F;ERCC3;POLR2C;ERCC2;GTF2H3;MNAT1;RNGTT;GTF2H2;POLR2D;POLR2H;POLR2G;GTF2H1;NCBP1;POLR2E;POLR2J;NCBP2;POLR2L;SUPT5H;POLR2A;GTF2F1;CMTR2;POLR2I;GTF2H5;POLR2K;CDK7;POLR2B;RNMT;CMTR1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.25561058659650215,0.4951617848255444,1.0,1.0,1.0,11/11,74.45%,CBL;PPIA;ITGAV;CTNND1;MET;GRB2;CDH1;SRC;CTNNB1;CBLL1;CD4
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.25010611506704983,0.49481461079782346,0.9512195121951219,1.0,1.0,2/12,18.36%,NOTCH1;HDAC5
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),0.30136237714761727,0.4947838408831831,0.9545454545454546,1.0,1.0,1/6,16.15%,EMILIN1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.29998658787311194,0.49398751054764106,0.9782608695652174,1.0,1.0,1/8,14.92%,PELI1
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.25297424303948096,0.4931147387806806,1.0,1.0,1.0,1/14,8.36%,ABL1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.23057243608834116,0.48982629258871896,1.0,1.0,1.0,6/25,21.42%,DACH1;MYC;ATM;SMG5;SMG6;BMPR2
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.27823538758030764,-0.489411585989704,1.0,1.0,1.0,3/9,25.16%,RNF20;RNF8;PAF1
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.3185663383654499,0.4893523176624153,0.9795918367346939,1.0,1.0,1/5,10.62%,KHSRP
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.2780898160553079,-0.48925858362235636,0.9841269841269841,1.0,1.0,2/9,19.13%,TMEM100;ACP3
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.3104244060771718,0.4887567323713892,0.9782608695652174,1.0,1.0,3/6,32.03%,ADAR;PPM1F;CORO1C
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.20651779990795868,-0.4883501336195449,1.0,1.0,1.0,1/81,0.73%,PSMB9
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.28911970800467635,0.4876343051018236,0.9318181818181818,1.0,1.0,2/5,19.51%,CLEC16A;RUBCN
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.31958674739867193,0.4871029567511922,0.9782608695652174,1.0,1.0,2/5,12.23%,TWIST1;LGALS9
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.26468781443132783,0.48556790866619987,1.0,1.0,1.0,4/10,20.27%,SETMAR;FBH1;MUS81;XRN2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.24529375631183412,-0.4844071053759859,1.0,1.0,1.0,5/20,30.25%,THBS1;MSN;CCL5;CSF1R;CXCL17
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.25468622091933096,-0.48405790939228904,0.9855072463768116,1.0,1.0,6/19,26.57%,RPL5;RPL23;RPS7;RPL11;SKP1;GOLGA2
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.3083350828048368,-0.48400163937101803,0.9811320754716981,1.0,1.0,1/5,19.90%,TPI1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.24011019446852405,-0.48337012992439543,0.9852941176470589,1.0,1.0,5/18,28.14%,COX17;COX20;COX16;TIMM21;COA3
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.28109404619134215,0.48286424034671716,0.9444444444444444,1.0,1.0,6/6,71.90%,DLG1;PTPN22;DUSP1;EZR;DUSP10;CYLD
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.2857972599912106,0.4827607607968286,1.0,1.0,1.0,1/7,15.92%,HSF1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.28663472460300365,-0.48268732321072555,0.9682539682539683,1.0,1.0,2/7,26.94%,TFIP11;KLC1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.2656156347347401,0.4824725148919215,0.926829268292683,1.0,1.0,4/8,23.07%,KCNJ3;KCND3;KCNJ8;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.27108480346641894,0.481698571641972,0.9607843137254902,1.0,1.0,7/7,72.90%,DENND6A;AFDN;TJP1;SERPINF2;PTPRU;ADAM19;FLOT1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.24630194616302326,0.4815935249158717,1.0,1.0,1.0,3/17,15.00%,NOTCH4;NOTCH1;NEXMIF
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.263169907209674,-0.4814152045055241,1.0,1.0,1.0,4/12,30.17%,TXN;PARK7;PDE8A;RACK1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.19349795222916552,-0.48130412056989585,1.0,1.0,1.0,10/79,23.64%,MRPL40;MRPL19;MRPS34;MRPL34;MRPS22;MRPL20;MRPS25;MRPS26;GADD45GIP1;MRPL21
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.28014097762691403,-0.48024730446678954,1.0,1.0,1.0,2/9,27.24%,CASP8;NUPR1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.3136557059961315,-0.4787612921590697,0.9591836734693877,1.0,1.0,5/5,68.64%,HPS4;TRAPPC6A;RAB32;HPS1;RAB38
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.3030550355434807,0.4785432734209917,0.975,1.0,1.0,2/5,21.20%,IMPACT;NCK1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.26917313252847036,0.47773836637102485,1.0,1.0,1.0,2/7,21.90%,TWIST1;UBR5
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.20713045187733103,0.4777312675819205,1.0,1.0,1.0,1/32,6.33%,UBXN2A
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.3056092843326886,-0.4770312574957829,0.9811320754716981,1.0,1.0,5/5,69.45%,TDG;ALKBH1;ALKBH2;ALKBH3;FTO
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.28002166511915827,0.4764662203224916,0.926829268292683,1.0,1.0,7/7,72.01%,ADAM10;GALNT11;NCSTN;PSEN1;ADAM17;APH1B;APH1A
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.2443229374229936,0.4760828312028102,0.9714285714285714,1.0,1.0,9/17,35.25%,MAP3K10;TRAF6;DUSP19;EDN1;TAOK3;MAP3K7;MAP3K4;DVL2;MAP3K11
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.2700611313162577,0.4760267232803536,0.9743589743589743,1.0,1.0,9/9,73.00%,F2R;NLGN2;TJP1;PARD6A;FERMT2;PRTN3;F2RL1;CSF1R;MYADM
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.29036236711594143,0.47601791474774663,0.9772727272727273,1.0,1.0,1/7,15.98%,LIG4
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.3060079693605168,0.47420599608901187,0.9791666666666666,1.0,1.0,6/6,69.41%,ATPAF2;ATPAF1;ATP23;OXA1L;ATP5F1D;TMEM70
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.3055327759433357,0.4733611203652215,1.0,1.0,1.0,1/7,16.56%,ATM
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.22837679003771172,-0.47306673194729093,0.9841269841269841,1.0,1.0,3/17,23.08%,SCIN;SOX9;PTHLH
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.2834909012487503,-0.47234656899322025,1.0,1.0,1.0,3/11,29.07%,CD81;TMEM30A;SEC16A
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.2761718815690116,-0.47156475515022833,0.9818181818181818,1.0,1.0,1/7,24.17%,KDELR3
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.27382533841327805,0.4715261363530928,1.0,1.0,1.0,1/8,14.67%,DSCC1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.27382533841327805,0.4715261363530928,1.0,1.0,1.0,1/8,14.67%,DSCC1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.2637679625679706,0.47060327967743354,0.9512195121951219,1.0,1.0,2/11,18.54%,NETO1;RAB5A
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.2685504167981935,0.46941538220778944,1.0,1.0,1.0,1/11,10.03%,GCC2
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.23263859668840592,0.469282732797865,1.0,1.0,1.0,7/17,25.92%,MYO1E;MYO1C;MYO5A;MYO19;MYO1D;MYO5C;FNBP1L
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.21000506591727933,-0.4691378295221572,1.0,1.0,1.0,14/52,26.97%,OAS1;IFIT1;OAS2;ISG15;DDX3X;ISG20;SRPK1;DDB1;IFITM3;OAS3;MX1;PARP10;CCL5;PPID
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.23251068303522104,-0.46901943046734407,1.0,1.0,1.0,2/23,14.68%,PLA2G10;SERINC1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.27406959724043456,0.4683648192606158,1.0,1.0,1.0,3/6,31.59%,GAS6;PPIA;NECTIN2
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.27406959724043456,0.4683648192606158,1.0,1.0,1.0,3/6,31.59%,GAS6;PPIA;NECTIN2
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.3014120928765196,0.4683643247463385,1.0,1.0,1.0,3/5,29.36%,LIG4;POLB;LIG3
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.3104852637390868,-0.46797173955666005,0.96,1.0,1.0,1/5,14.35%,SLC6A4
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.2936615181893215,0.46794513315917974,0.9767441860465116,1.0,1.0,1/7,13.56%,MRRF
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.2918746041754613,-0.4662261143353507,1.0,1.0,1.0,1/5,14.85%,LCP1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.22779282057073616,-0.4639213217431852,1.0,1.0,1.0,8/31,25.37%,GPER1;CAMK2A;BAIAP3;SNAPIN;PREPL;VPS18;SYT11;CPLX2
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.23800956131350484,0.4633053325159297,1.0,1.0,1.0,2/11,17.68%,HSF1;FADD
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.30991546494398026,-0.4622213194950813,0.9607843137254902,1.0,1.0,3/5,33.76%,VPS36;VPS25;VPS28
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.30991546494398026,-0.4622213194950813,0.9607843137254902,1.0,1.0,3/5,33.76%,VPS36;VPS25;VPS28
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.27958287218642575,0.46200735994224196,1.0,1.0,1.0,3/7,26.06%,FUT9;CXCL12;ST3GAL4
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.28532188177034973,-0.46181196018872567,1.0,1.0,1.0,7/7,71.48%,CCL5;PRKCQ;PRELID1;JAK3;CD274;IDO1;LGALS3
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.2971411092338558,-0.46129788317995174,0.9850746268656716,1.0,1.0,1/6,17.28%,KCNE3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.2865488026616117,-0.460531267789897,0.9824561403508771,1.0,1.0,6/6,71.36%,PARP10;TLK1;MAP1S;TLK2;SPTY2D1;PADI2
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.28603452480041364,-0.4596244113542272,0.9827586206896551,1.0,1.0,1/7,17.66%,VAMP7
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.22303743071304655,-0.4585389831096276,1.0,1.0,1.0,3/25,18.66%,PINK1;PHF23;FEZ1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.2479008130568997,0.45810005304622026,1.0,1.0,1.0,4/11,25.38%,STX18;MOSPD3;BNIP1;LPCAT3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.25016441646452525,0.4570401126114693,1.0,1.0,1.0,4/10,24.25%,EMC2;EMC10;EMC4;EMC8
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.2911770630621566,-0.45429960819399706,1.0,1.0,1.0,1/9,17.31%,SCPEP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.2911770630621566,-0.45429960819399706,1.0,1.0,1.0,1/9,17.31%,SCPEP1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.24594015091885513,-0.45401271326151227,0.9846153846153847,1.0,1.0,3/11,22.74%,KCNQ1;ATP1A1;KCNJ5
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.22524953024381225,-0.45309160708830254,1.0,1.0,1.0,5/18,27.63%,ITGAX;AGT;SOX9;SIX4;WNT5B
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.2700297883863978,0.4507518646610898,1.0,1.0,1.0,6/6,73.00%,WNK1;MAPK7;MBP;MAP2K5;APOA1;MYADM
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.2700297883863978,0.4507518646610898,1.0,1.0,1.0,6/6,73.00%,WNK1;MAPK7;MBP;MAP2K5;APOA1;MYADM
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.2806189555125725,0.449518371961952,1.0,1.0,1.0,5/5,71.94%,STIM2;STIM1;ORAI2;ORAI1;CRACR2A
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.2549689883404398,-0.4492337718077368,1.0,1.0,1.0,2/11,19.77%,ATOX1;MT2A
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.30490516866757034,-0.4488931884790625,1.0,1.0,1.0,2/5,25.82%,NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.24847529951173375,0.4464242124687514,1.0,1.0,1.0,1/9,7.80%,DCUN1D1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.27657563353561837,-0.44582157931261235,1.0,1.0,1.0,3/9,27.24%,ACTN3;PFKFB1;NUPR1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.27657563353561837,-0.44582157931261235,1.0,1.0,1.0,3/9,27.24%,ACTN3;PFKFB1;NUPR1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.25365627176352223,0.4455148780090799,0.9787234042553191,1.0,1.0,9/9,74.64%,FURIN;EPHA4;NELL1;DAB2IP;RIC1;RGP1;EFNA1;ANXA2;ATRAID
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.2773694390715667,-0.4445699650066412,0.9636363636363636,1.0,1.0,5/5,72.27%,LDLRAP1;SCAP;FGF1;PRKAA1;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.1854184374499622,0.4426147269313241,1.0,1.0,1.0,6/36,20.95%,FLNA;BANP;HDAC4;PDE3B;MDM4;GIT1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.2610932083520316,-0.4424777658940957,1.0,1.0,1.0,1/8,14.29%,CDC6
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.2781152075515494,0.44244122649001283,0.9772727272727273,1.0,1.0,6/6,72.19%,PHF1;OGT;MACROH2A1;PHF19;SUPT6H;MTF2
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.25678028397879815,0.4414979109133712,0.9777777777777777,1.0,1.0,8/8,74.33%,PREX1;SYK;PRKCD;IL15;KMT2E;DNASE1;F2RL1;CCL5
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.25014509576320376,0.4395112666806014,1.0,1.0,1.0,10/10,75.00%,ADAM8;PLVAP;XG;JAM3;MDK;CD99;THY1;ICAM1;RIPOR2;AGER
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.27434328201667146,-0.43783966717077266,0.9811320754716981,1.0,1.0,2/6,25.76%,DLG4;CRHBP
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.27434328201667146,-0.43783966717077266,0.9811320754716981,1.0,1.0,2/6,25.76%,DLG4;CRHBP
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.2566277637572203,0.4377584242856179,1.0,1.0,1.0,2/8,20.70%,ITPK1;IPPK
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.22666009115952235,0.43718148310392296,1.0,1.0,1.0,4/14,22.94%,RNF216;IFNLR1;HERC5;TRAF3
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.27407994654498313,0.43701411159926556,0.9807692307692307,1.0,1.0,3/6,28.51%,NF1;CDK1;EPHA4
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.24671043213454769,-0.4362898503167064,1.0,1.0,1.0,1/9,15.44%,TERT
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.2591044637353144,-0.4347642686317438,1.0,1.0,1.0,4/9,35.53%,HSPA5;MBTPS2;MBTPS1;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.2238233961947067,0.4337822647475972,0.9761904761904762,1.0,1.0,2/8,23.09%,RNF207;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.2635423939038264,-0.43323905104808097,0.9833333333333333,1.0,1.0,1/8,14.63%,RNF20
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.28297100466251884,-0.4298678571751854,1.0,1.0,1.0,1/5,21.81%,LAGE3
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.28251988723518895,-0.4284535361897436,1.0,1.0,1.0,2/5,31.46%,EDNRB;PTK2B
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.16116259858999432,0.4280131759461693,1.0,1.0,1.0,11/94,20.73%,MRPL4;MRPL41;LARS2;MTRF1;MRRF;EARS2;DAP3;NOA1;AURKAIP1;QRSL1;MRPL2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.25011606313834733,0.427875556038543,1.0,1.0,1.0,7/7,75.00%,LYN;EPHA4;PICALM;ROCK2;EFNA3;EFNA1;AGER
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.2442836692846364,0.4261332290147546,1.0,1.0,1.0,8/8,75.58%,PNKP;CMPK1;AK1;AK4;AK7;AK5;AK8;CMPK2
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.259584510039073,0.4260937843949186,1.0,1.0,1.0,6/6,74.05%,EMP2;FLOT2;S100A10;FLOT1;RFTN1;ANXA2
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2208175178438079,-0.4248576731050018,1.0,1.0,1.0,5/17,30.13%,SRP14;SPCS2;SPCS1;ZFAND2A;SRP54
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.2762239251622576,0.4241913507147397,1.0,1.0,1.0,1/5,14.16%,EIF3E
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.23052093576030908,-0.42416757492833,1.0,1.0,1.0,5/18,27.68%,FUT2;MPDU1;B3GALT2;FUT1;B4GALNT2
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.21560015915753386,0.4226999735075574,1.0,1.0,1.0,5/19,30.42%,AKAP9;NDE1;TPPP;CLASP2;CCDC57
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.2319734146015377,-0.42257523737257224,1.0,1.0,1.0,5/17,27.68%,FUT2;MPDU1;B3GALT2;FUT1;B4GALNT2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.17330545491810184,-0.42248728461223944,1.0,1.0,1.0,10/85,23.64%,MRPL40;MRPL19;MRPS34;MRPL34;MRPS22;MRPL20;MRPS25;MRPS26;GADD45GIP1;MRPL21
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.19081191210900142,0.42053654431370213,1.0,0.9999362526655673,1.0,1/24,5.67%,TENT4A
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.24985039662491404,-0.4204732843817205,1.0,1.0,1.0,1/9,14.63%,RNF20
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.23940791657387295,-0.41942237254854375,1.0,1.0,1.0,4/8,33.44%,MESP1;TBX19;MESP2;SCX
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.1890418401555185,-0.4183533757345378,1.0,1.0,1.0,2/28,16.94%,DNAJA1;TNFRSF11A
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.27400386847195357,-0.4182893730093853,0.9848484848484849,1.0,1.0,5/5,72.61%,MX1;DNM1;MX2;DNM3;DNM2
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.27400386847195357,-0.4182893730093853,0.9848484848484849,1.0,1.0,5/5,72.61%,MX1;DNM1;MX2;DNM3;DNM2
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.2615616258071859,0.41646971372487657,1.0,0.9999846779007108,1.0,2/7,21.61%,LGALS9;PDE4D
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.25279002933644457,-0.4135701208816126,0.9821428571428571,1.0,1.0,1/6,23.29%,PARK7
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.24789394192013636,0.4115805320340488,1.0,1.0,1.0,2/6,24.38%,CFAP100;MAP2
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.18145603693746676,-0.4115430062182402,1.0,1.0,1.0,12/51,32.71%,CHMP3;CC2D1B;NUP93;SEC13;RAN;NDC1;CHMP4B;NUP155;VPS4A;NUP133;REEP4;CCNB1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2288345457359539,0.41053921778903524,1.0,0.9998585793794963,1.0,11/11,77.13%,PAPOLA;LEO1;CDC73;ZC3H3;BARD1;DHX36;NCBP1;NCBP2;AHCYL1;PAF1;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.19999226036144088,0.407571474766044,1.0,0.9997569367174155,1.0,14/14,80.01%,BMPER;DLL1;TJP1;S100A1;FGF1;SMAD1;VEGFA;PKM;PDPK1;JAK1;JMJD8;FGF2;FUT1;ITGA5
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.2567604162636852,0.4038807224560734,1.0,0.9997780842505612,1.0,6/6,74.33%,PREX1;PRKCD;IL15;KMT2E;F2RL1;CCL5
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.25228821928721135,0.40273267803331025,1.0,0.999572006776776,1.0,2/6,23.20%,METTL16;METTL4
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.238793573677567,-0.3995889383106671,1.0,1.0,1.0,1/7,15.83%,HAAO
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),-0.25341572393099754,-0.39622166550243604,1.0,1.0,1.0,1/5,22.34%,USP17L2
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.21381311665699354,0.39588666368768965,1.0,0.9997521983559496,1.0,10/10,78.63%,XPO5;STAT3;FMR1;PUM2;LIMD1;DHX9;PUM1;FXR1;ZFP36;WTIP
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.23366636640048744,-0.393229861393414,1.0,1.0,1.0,2/7,26.83%,VDR;KLF9
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.23414294050359147,-0.39250114023438726,1.0,1.0,1.0,2/6,25.64%,CALM1;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.2037948580008145,0.39078694566453426,1.0,0.9997142879805361,1.0,4/14,24.60%,KLHL18;DYRK3;PLCG2;EZH2
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.24259187620889747,0.38845168045006134,0.9795918367346939,0.9995174903515308,1.0,5/5,75.75%,CHD7;ADCYAP1;SELENOT;DRD2;GHRL
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.20765457787022235,-0.3871027814367745,1.0,1.0,1.0,1/14,12.02%,PGAM1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.16677635399326382,0.384533505315374,1.0,0.9994297423272585,1.0,24/24,83.34%,ZMYND11;THOC1;SCAF8;CCNT1;HMGN1;SETD5;WDR43;ZNF326;ERCC6;SUPT16H;THOC5;KAT7;CCNT2;EAF2;TSFM;ELL;ALYREF;CCNK;LDB1;SUPT5H;EAF1;HTATSF1;CCAR2;TCEA2
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.23501045594493963,-0.37148783024376775,1.0,1.0,1.0,2/6,26.87%,LARP6;CDK9
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),0.22495164410058044,0.37008324920857216,1.0,0.9995598511661675,1.0,5/5,77.51%,PIK3CD;GDNF;FGF2;EGF;SIX4
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.22462168090854678,-0.34233970654270324,1.0,0.9999317056513574,1.0,2/5,26.35%,CAV1;FUCA2
